Upload folder using huggingface_hub
Browse filesThis view is limited to 50 files because it contains too many changes.
See raw diff
- .gitattributes +6 -0
- .gitignore +174 -0
- LICENSE +674 -0
- README.md +14 -0
- _misc/depmap.ipynb +107 -0
- _misc/genedisease_to_drugtrait.ipynb +199 -0
- _misc/harmonize_genetic_data.py +344 -0
- approval_prediction_benchmark.ipynb +0 -0
- classifier.py +293 -0
- clinical_data_curation/adverse_events_drug.py +137 -0
- clinical_data_curation/drug_trials_extractor.py +707 -0
- clinical_data_curation/drugs_organs_approved.csv +377 -0
- clinical_data_curation/drugs_organs_tested.csv +377 -0
- clinical_data_curation/get_trials.ipynb +0 -0
- clinical_evidence_data/adverse_events_FDA_data/tahoe_drug_ae_seriousness_ratio.csv +300 -0
- clinical_evidence_data/adverse_events_FDA_data/tahoe_drug_ae_severity_score.csv +300 -0
- clinical_evidence_data/adverse_events_FDA_data/tahoe_drugs_faers_adverse_events.csv +0 -0
- clinical_evidence_data/drug_organ_trials_clean.csv +0 -0
- clinical_evidence_data/drugs_organs_approved.csv +377 -0
- clinical_evidence_data/drugs_organs_tested.csv +377 -0
- clinical_evidence_data/tahoe_drugs_clinical_trials.csv +3 -0
- data/Tahoe96M_edist_matrix_within_plate.tsv +0 -0
- data/cell_line_metadata.csv +1001 -0
- data/coefficients_E-dist.csv +16 -0
- data/coefficients_LDVAE (vs ctrl).csv +261 -0
- data/coefficients_LDVAE.csv +261 -0
- data/coefficients_approval rate.csv +11 -0
- data/coefficients_mrVI (vs ctrl).csv +161 -0
- data/coefficients_mrVI.csv +161 -0
- data/drug_metadata.csv +380 -0
- data/drug_trials_matched.csv +0 -0
- data/drugs_organs_approved.csv +377 -0
- data/drugs_organs_tested.csv +377 -0
- data/indication_to_organ_mapping_all.tsv +1013 -0
- data/indication_to_organ_mapping_confident.tsv +422 -0
- data/mapping.csv +0 -0
- data/organ_to_conditions_mapping.json +1067 -0
- data/standardized_conditions.txt +0 -0
- data/tahoe_drugs_clinical_trials.csv +3 -0
- data/tahoe_drugs_drug_info.csv +0 -0
- data/tahoe_drugs_pubchem_trials_info.csv +697 -0
- data/trial_conditions_standardized.csv +0 -0
- data_for_classifier/assoc_drug_organ.tsv +523 -0
- data_for_classifier/depmap_dependency_scores.tsv +0 -0
- data_for_classifier/ldvae_embeddings.tsv +3 -0
- data_for_classifier/ldvae_raw_embeddings.tsv +3 -0
- data_for_classifier/max_edist.csv +0 -0
- data_for_classifier/tahoe_drug_ae_seriousness_ratio.csv +300 -0
- data_for_classifier/tahoe_drug_ae_severity_score.csv +300 -0
- data_for_classifier/tahoe_largest_edist_per_drug_cell_line_combo.csv +0 -0
.gitattributes
CHANGED
@@ -33,3 +33,9 @@ saved_model/**/* filter=lfs diff=lfs merge=lfs -text
|
|
33 |
*.zip filter=lfs diff=lfs merge=lfs -text
|
34 |
*.zst filter=lfs diff=lfs merge=lfs -text
|
35 |
*tfevents* filter=lfs diff=lfs merge=lfs -text
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33 |
*.zip filter=lfs diff=lfs merge=lfs -text
|
34 |
*.zst filter=lfs diff=lfs merge=lfs -text
|
35 |
*tfevents* filter=lfs diff=lfs merge=lfs -text
|
36 |
+
clinical_evidence_data/tahoe_drugs_clinical_trials.csv filter=lfs diff=lfs merge=lfs -text
|
37 |
+
data/tahoe_drugs_clinical_trials.csv filter=lfs diff=lfs merge=lfs -text
|
38 |
+
data_for_classifier/ldvae_embeddings.tsv filter=lfs diff=lfs merge=lfs -text
|
39 |
+
data_for_classifier/ldvae_raw_embeddings.tsv filter=lfs diff=lfs merge=lfs -text
|
40 |
+
data_for_classifier/tahoe_pseudobulk_z-space_by_sample.csv filter=lfs diff=lfs merge=lfs -text
|
41 |
+
representations/ldvae/ldvae_cellline_drug_aggr.h5ad filter=lfs diff=lfs merge=lfs -text
|
.gitignore
ADDED
@@ -0,0 +1,174 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
# Byte-compiled / optimized / DLL files
|
2 |
+
__pycache__/
|
3 |
+
*.py[cod]
|
4 |
+
*$py.class
|
5 |
+
|
6 |
+
# C extensions
|
7 |
+
*.so
|
8 |
+
|
9 |
+
# Distribution / packaging
|
10 |
+
.Python
|
11 |
+
build/
|
12 |
+
develop-eggs/
|
13 |
+
dist/
|
14 |
+
downloads/
|
15 |
+
eggs/
|
16 |
+
.eggs/
|
17 |
+
lib/
|
18 |
+
lib64/
|
19 |
+
parts/
|
20 |
+
sdist/
|
21 |
+
var/
|
22 |
+
wheels/
|
23 |
+
share/python-wheels/
|
24 |
+
*.egg-info/
|
25 |
+
.installed.cfg
|
26 |
+
*.egg
|
27 |
+
MANIFEST
|
28 |
+
|
29 |
+
# PyInstaller
|
30 |
+
# Usually these files are written by a python script from a template
|
31 |
+
# before PyInstaller builds the exe, so as to inject date/other infos into it.
|
32 |
+
*.manifest
|
33 |
+
*.spec
|
34 |
+
|
35 |
+
# Installer logs
|
36 |
+
pip-log.txt
|
37 |
+
pip-delete-this-directory.txt
|
38 |
+
|
39 |
+
# Unit test / coverage reports
|
40 |
+
htmlcov/
|
41 |
+
.tox/
|
42 |
+
.nox/
|
43 |
+
.coverage
|
44 |
+
.coverage.*
|
45 |
+
.cache
|
46 |
+
nosetests.xml
|
47 |
+
coverage.xml
|
48 |
+
*.cover
|
49 |
+
*.py,cover
|
50 |
+
.hypothesis/
|
51 |
+
.pytest_cache/
|
52 |
+
cover/
|
53 |
+
|
54 |
+
# Translations
|
55 |
+
*.mo
|
56 |
+
*.pot
|
57 |
+
|
58 |
+
# Django stuff:
|
59 |
+
*.log
|
60 |
+
local_settings.py
|
61 |
+
db.sqlite3
|
62 |
+
db.sqlite3-journal
|
63 |
+
|
64 |
+
# Flask stuff:
|
65 |
+
instance/
|
66 |
+
.webassets-cache
|
67 |
+
|
68 |
+
# Scrapy stuff:
|
69 |
+
.scrapy
|
70 |
+
|
71 |
+
# Sphinx documentation
|
72 |
+
docs/_build/
|
73 |
+
|
74 |
+
# PyBuilder
|
75 |
+
.pybuilder/
|
76 |
+
target/
|
77 |
+
|
78 |
+
# Jupyter Notebook
|
79 |
+
.ipynb_checkpoints
|
80 |
+
|
81 |
+
# IPython
|
82 |
+
profile_default/
|
83 |
+
ipython_config.py
|
84 |
+
|
85 |
+
# pyenv
|
86 |
+
# For a library or package, you might want to ignore these files since the code is
|
87 |
+
# intended to run in multiple environments; otherwise, check them in:
|
88 |
+
# .python-version
|
89 |
+
|
90 |
+
# pipenv
|
91 |
+
# According to pypa/pipenv#598, it is recommended to include Pipfile.lock in version control.
|
92 |
+
# However, in case of collaboration, if having platform-specific dependencies or dependencies
|
93 |
+
# having no cross-platform support, pipenv may install dependencies that don't work, or not
|
94 |
+
# install all needed dependencies.
|
95 |
+
#Pipfile.lock
|
96 |
+
|
97 |
+
# UV
|
98 |
+
# Similar to Pipfile.lock, it is generally recommended to include uv.lock in version control.
|
99 |
+
# This is especially recommended for binary packages to ensure reproducibility, and is more
|
100 |
+
# commonly ignored for libraries.
|
101 |
+
#uv.lock
|
102 |
+
|
103 |
+
# poetry
|
104 |
+
# Similar to Pipfile.lock, it is generally recommended to include poetry.lock in version control.
|
105 |
+
# This is especially recommended for binary packages to ensure reproducibility, and is more
|
106 |
+
# commonly ignored for libraries.
|
107 |
+
# https://python-poetry.org/docs/basic-usage/#commit-your-poetrylock-file-to-version-control
|
108 |
+
#poetry.lock
|
109 |
+
|
110 |
+
# pdm
|
111 |
+
# Similar to Pipfile.lock, it is generally recommended to include pdm.lock in version control.
|
112 |
+
#pdm.lock
|
113 |
+
# pdm stores project-wide configurations in .pdm.toml, but it is recommended to not include it
|
114 |
+
# in version control.
|
115 |
+
# https://pdm.fming.dev/latest/usage/project/#working-with-version-control
|
116 |
+
.pdm.toml
|
117 |
+
.pdm-python
|
118 |
+
.pdm-build/
|
119 |
+
|
120 |
+
# PEP 582; used by e.g. github.com/David-OConnor/pyflow and github.com/pdm-project/pdm
|
121 |
+
__pypackages__/
|
122 |
+
|
123 |
+
# Celery stuff
|
124 |
+
celerybeat-schedule
|
125 |
+
celerybeat.pid
|
126 |
+
|
127 |
+
# SageMath parsed files
|
128 |
+
*.sage.py
|
129 |
+
|
130 |
+
# Environments
|
131 |
+
.env
|
132 |
+
.venv
|
133 |
+
env/
|
134 |
+
venv/
|
135 |
+
ENV/
|
136 |
+
env.bak/
|
137 |
+
venv.bak/
|
138 |
+
|
139 |
+
# Spyder project settings
|
140 |
+
.spyderproject
|
141 |
+
.spyproject
|
142 |
+
|
143 |
+
# Rope project settings
|
144 |
+
.ropeproject
|
145 |
+
|
146 |
+
# mkdocs documentation
|
147 |
+
/site
|
148 |
+
|
149 |
+
# mypy
|
150 |
+
.mypy_cache/
|
151 |
+
.dmypy.json
|
152 |
+
dmypy.json
|
153 |
+
|
154 |
+
# Pyre type checker
|
155 |
+
.pyre/
|
156 |
+
|
157 |
+
# pytype static type analyzer
|
158 |
+
.pytype/
|
159 |
+
|
160 |
+
# Cython debug symbols
|
161 |
+
cython_debug/
|
162 |
+
|
163 |
+
# PyCharm
|
164 |
+
# JetBrains specific template is maintained in a separate JetBrains.gitignore that can
|
165 |
+
# be found at https://github.com/github/gitignore/blob/main/Global/JetBrains.gitignore
|
166 |
+
# and can be added to the global gitignore or merged into this file. For a more nuclear
|
167 |
+
# option (not recommended) you can uncomment the following to ignore the entire idea folder.
|
168 |
+
#.idea/
|
169 |
+
|
170 |
+
# Ruff stuff:
|
171 |
+
.ruff_cache/
|
172 |
+
|
173 |
+
# PyPI configuration file
|
174 |
+
.pypirc
|
LICENSE
ADDED
@@ -0,0 +1,674 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
GNU GENERAL PUBLIC LICENSE
|
2 |
+
Version 3, 29 June 2007
|
3 |
+
|
4 |
+
Copyright (C) 2007 Free Software Foundation, Inc. <https://fsf.org/>
|
5 |
+
Everyone is permitted to copy and distribute verbatim copies
|
6 |
+
of this license document, but changing it is not allowed.
|
7 |
+
|
8 |
+
Preamble
|
9 |
+
|
10 |
+
The GNU General Public License is a free, copyleft license for
|
11 |
+
software and other kinds of works.
|
12 |
+
|
13 |
+
The licenses for most software and other practical works are designed
|
14 |
+
to take away your freedom to share and change the works. By contrast,
|
15 |
+
the GNU General Public License is intended to guarantee your freedom to
|
16 |
+
share and change all versions of a program--to make sure it remains free
|
17 |
+
software for all its users. We, the Free Software Foundation, use the
|
18 |
+
GNU General Public License for most of our software; it applies also to
|
19 |
+
any other work released this way by its authors. You can apply it to
|
20 |
+
your programs, too.
|
21 |
+
|
22 |
+
When we speak of free software, we are referring to freedom, not
|
23 |
+
price. Our General Public Licenses are designed to make sure that you
|
24 |
+
have the freedom to distribute copies of free software (and charge for
|
25 |
+
them if you wish), that you receive source code or can get it if you
|
26 |
+
want it, that you can change the software or use pieces of it in new
|
27 |
+
free programs, and that you know you can do these things.
|
28 |
+
|
29 |
+
To protect your rights, we need to prevent others from denying you
|
30 |
+
these rights or asking you to surrender the rights. Therefore, you have
|
31 |
+
certain responsibilities if you distribute copies of the software, or if
|
32 |
+
you modify it: responsibilities to respect the freedom of others.
|
33 |
+
|
34 |
+
For example, if you distribute copies of such a program, whether
|
35 |
+
gratis or for a fee, you must pass on to the recipients the same
|
36 |
+
freedoms that you received. You must make sure that they, too, receive
|
37 |
+
or can get the source code. And you must show them these terms so they
|
38 |
+
know their rights.
|
39 |
+
|
40 |
+
Developers that use the GNU GPL protect your rights with two steps:
|
41 |
+
(1) assert copyright on the software, and (2) offer you this License
|
42 |
+
giving you legal permission to copy, distribute and/or modify it.
|
43 |
+
|
44 |
+
For the developers' and authors' protection, the GPL clearly explains
|
45 |
+
that there is no warranty for this free software. For both users' and
|
46 |
+
authors' sake, the GPL requires that modified versions be marked as
|
47 |
+
changed, so that their problems will not be attributed erroneously to
|
48 |
+
authors of previous versions.
|
49 |
+
|
50 |
+
Some devices are designed to deny users access to install or run
|
51 |
+
modified versions of the software inside them, although the manufacturer
|
52 |
+
can do so. This is fundamentally incompatible with the aim of
|
53 |
+
protecting users' freedom to change the software. The systematic
|
54 |
+
pattern of such abuse occurs in the area of products for individuals to
|
55 |
+
use, which is precisely where it is most unacceptable. Therefore, we
|
56 |
+
have designed this version of the GPL to prohibit the practice for those
|
57 |
+
products. If such problems arise substantially in other domains, we
|
58 |
+
stand ready to extend this provision to those domains in future versions
|
59 |
+
of the GPL, as needed to protect the freedom of users.
|
60 |
+
|
61 |
+
Finally, every program is threatened constantly by software patents.
|
62 |
+
States should not allow patents to restrict development and use of
|
63 |
+
software on general-purpose computers, but in those that do, we wish to
|
64 |
+
avoid the special danger that patents applied to a free program could
|
65 |
+
make it effectively proprietary. To prevent this, the GPL assures that
|
66 |
+
patents cannot be used to render the program non-free.
|
67 |
+
|
68 |
+
The precise terms and conditions for copying, distribution and
|
69 |
+
modification follow.
|
70 |
+
|
71 |
+
TERMS AND CONDITIONS
|
72 |
+
|
73 |
+
0. Definitions.
|
74 |
+
|
75 |
+
"This License" refers to version 3 of the GNU General Public License.
|
76 |
+
|
77 |
+
"Copyright" also means copyright-like laws that apply to other kinds of
|
78 |
+
works, such as semiconductor masks.
|
79 |
+
|
80 |
+
"The Program" refers to any copyrightable work licensed under this
|
81 |
+
License. Each licensee is addressed as "you". "Licensees" and
|
82 |
+
"recipients" may be individuals or organizations.
|
83 |
+
|
84 |
+
To "modify" a work means to copy from or adapt all or part of the work
|
85 |
+
in a fashion requiring copyright permission, other than the making of an
|
86 |
+
exact copy. The resulting work is called a "modified version" of the
|
87 |
+
earlier work or a work "based on" the earlier work.
|
88 |
+
|
89 |
+
A "covered work" means either the unmodified Program or a work based
|
90 |
+
on the Program.
|
91 |
+
|
92 |
+
To "propagate" a work means to do anything with it that, without
|
93 |
+
permission, would make you directly or secondarily liable for
|
94 |
+
infringement under applicable copyright law, except executing it on a
|
95 |
+
computer or modifying a private copy. Propagation includes copying,
|
96 |
+
distribution (with or without modification), making available to the
|
97 |
+
public, and in some countries other activities as well.
|
98 |
+
|
99 |
+
To "convey" a work means any kind of propagation that enables other
|
100 |
+
parties to make or receive copies. Mere interaction with a user through
|
101 |
+
a computer network, with no transfer of a copy, is not conveying.
|
102 |
+
|
103 |
+
An interactive user interface displays "Appropriate Legal Notices"
|
104 |
+
to the extent that it includes a convenient and prominently visible
|
105 |
+
feature that (1) displays an appropriate copyright notice, and (2)
|
106 |
+
tells the user that there is no warranty for the work (except to the
|
107 |
+
extent that warranties are provided), that licensees may convey the
|
108 |
+
work under this License, and how to view a copy of this License. If
|
109 |
+
the interface presents a list of user commands or options, such as a
|
110 |
+
menu, a prominent item in the list meets this criterion.
|
111 |
+
|
112 |
+
1. Source Code.
|
113 |
+
|
114 |
+
The "source code" for a work means the preferred form of the work
|
115 |
+
for making modifications to it. "Object code" means any non-source
|
116 |
+
form of a work.
|
117 |
+
|
118 |
+
A "Standard Interface" means an interface that either is an official
|
119 |
+
standard defined by a recognized standards body, or, in the case of
|
120 |
+
interfaces specified for a particular programming language, one that
|
121 |
+
is widely used among developers working in that language.
|
122 |
+
|
123 |
+
The "System Libraries" of an executable work include anything, other
|
124 |
+
than the work as a whole, that (a) is included in the normal form of
|
125 |
+
packaging a Major Component, but which is not part of that Major
|
126 |
+
Component, and (b) serves only to enable use of the work with that
|
127 |
+
Major Component, or to implement a Standard Interface for which an
|
128 |
+
implementation is available to the public in source code form. A
|
129 |
+
"Major Component", in this context, means a major essential component
|
130 |
+
(kernel, window system, and so on) of the specific operating system
|
131 |
+
(if any) on which the executable work runs, or a compiler used to
|
132 |
+
produce the work, or an object code interpreter used to run it.
|
133 |
+
|
134 |
+
The "Corresponding Source" for a work in object code form means all
|
135 |
+
the source code needed to generate, install, and (for an executable
|
136 |
+
work) run the object code and to modify the work, including scripts to
|
137 |
+
control those activities. However, it does not include the work's
|
138 |
+
System Libraries, or general-purpose tools or generally available free
|
139 |
+
programs which are used unmodified in performing those activities but
|
140 |
+
which are not part of the work. For example, Corresponding Source
|
141 |
+
includes interface definition files associated with source files for
|
142 |
+
the work, and the source code for shared libraries and dynamically
|
143 |
+
linked subprograms that the work is specifically designed to require,
|
144 |
+
such as by intimate data communication or control flow between those
|
145 |
+
subprograms and other parts of the work.
|
146 |
+
|
147 |
+
The Corresponding Source need not include anything that users
|
148 |
+
can regenerate automatically from other parts of the Corresponding
|
149 |
+
Source.
|
150 |
+
|
151 |
+
The Corresponding Source for a work in source code form is that
|
152 |
+
same work.
|
153 |
+
|
154 |
+
2. Basic Permissions.
|
155 |
+
|
156 |
+
All rights granted under this License are granted for the term of
|
157 |
+
copyright on the Program, and are irrevocable provided the stated
|
158 |
+
conditions are met. This License explicitly affirms your unlimited
|
159 |
+
permission to run the unmodified Program. The output from running a
|
160 |
+
covered work is covered by this License only if the output, given its
|
161 |
+
content, constitutes a covered work. This License acknowledges your
|
162 |
+
rights of fair use or other equivalent, as provided by copyright law.
|
163 |
+
|
164 |
+
You may make, run and propagate covered works that you do not
|
165 |
+
convey, without conditions so long as your license otherwise remains
|
166 |
+
in force. You may convey covered works to others for the sole purpose
|
167 |
+
of having them make modifications exclusively for you, or provide you
|
168 |
+
with facilities for running those works, provided that you comply with
|
169 |
+
the terms of this License in conveying all material for which you do
|
170 |
+
not control copyright. Those thus making or running the covered works
|
171 |
+
for you must do so exclusively on your behalf, under your direction
|
172 |
+
and control, on terms that prohibit them from making any copies of
|
173 |
+
your copyrighted material outside their relationship with you.
|
174 |
+
|
175 |
+
Conveying under any other circumstances is permitted solely under
|
176 |
+
the conditions stated below. Sublicensing is not allowed; section 10
|
177 |
+
makes it unnecessary.
|
178 |
+
|
179 |
+
3. Protecting Users' Legal Rights From Anti-Circumvention Law.
|
180 |
+
|
181 |
+
No covered work shall be deemed part of an effective technological
|
182 |
+
measure under any applicable law fulfilling obligations under article
|
183 |
+
11 of the WIPO copyright treaty adopted on 20 December 1996, or
|
184 |
+
similar laws prohibiting or restricting circumvention of such
|
185 |
+
measures.
|
186 |
+
|
187 |
+
When you convey a covered work, you waive any legal power to forbid
|
188 |
+
circumvention of technological measures to the extent such circumvention
|
189 |
+
is effected by exercising rights under this License with respect to
|
190 |
+
the covered work, and you disclaim any intention to limit operation or
|
191 |
+
modification of the work as a means of enforcing, against the work's
|
192 |
+
users, your or third parties' legal rights to forbid circumvention of
|
193 |
+
technological measures.
|
194 |
+
|
195 |
+
4. Conveying Verbatim Copies.
|
196 |
+
|
197 |
+
You may convey verbatim copies of the Program's source code as you
|
198 |
+
receive it, in any medium, provided that you conspicuously and
|
199 |
+
appropriately publish on each copy an appropriate copyright notice;
|
200 |
+
keep intact all notices stating that this License and any
|
201 |
+
non-permissive terms added in accord with section 7 apply to the code;
|
202 |
+
keep intact all notices of the absence of any warranty; and give all
|
203 |
+
recipients a copy of this License along with the Program.
|
204 |
+
|
205 |
+
You may charge any price or no price for each copy that you convey,
|
206 |
+
and you may offer support or warranty protection for a fee.
|
207 |
+
|
208 |
+
5. Conveying Modified Source Versions.
|
209 |
+
|
210 |
+
You may convey a work based on the Program, or the modifications to
|
211 |
+
produce it from the Program, in the form of source code under the
|
212 |
+
terms of section 4, provided that you also meet all of these conditions:
|
213 |
+
|
214 |
+
a) The work must carry prominent notices stating that you modified
|
215 |
+
it, and giving a relevant date.
|
216 |
+
|
217 |
+
b) The work must carry prominent notices stating that it is
|
218 |
+
released under this License and any conditions added under section
|
219 |
+
7. This requirement modifies the requirement in section 4 to
|
220 |
+
"keep intact all notices".
|
221 |
+
|
222 |
+
c) You must license the entire work, as a whole, under this
|
223 |
+
License to anyone who comes into possession of a copy. This
|
224 |
+
License will therefore apply, along with any applicable section 7
|
225 |
+
additional terms, to the whole of the work, and all its parts,
|
226 |
+
regardless of how they are packaged. This License gives no
|
227 |
+
permission to license the work in any other way, but it does not
|
228 |
+
invalidate such permission if you have separately received it.
|
229 |
+
|
230 |
+
d) If the work has interactive user interfaces, each must display
|
231 |
+
Appropriate Legal Notices; however, if the Program has interactive
|
232 |
+
interfaces that do not display Appropriate Legal Notices, your
|
233 |
+
work need not make them do so.
|
234 |
+
|
235 |
+
A compilation of a covered work with other separate and independent
|
236 |
+
works, which are not by their nature extensions of the covered work,
|
237 |
+
and which are not combined with it such as to form a larger program,
|
238 |
+
in or on a volume of a storage or distribution medium, is called an
|
239 |
+
"aggregate" if the compilation and its resulting copyright are not
|
240 |
+
used to limit the access or legal rights of the compilation's users
|
241 |
+
beyond what the individual works permit. Inclusion of a covered work
|
242 |
+
in an aggregate does not cause this License to apply to the other
|
243 |
+
parts of the aggregate.
|
244 |
+
|
245 |
+
6. Conveying Non-Source Forms.
|
246 |
+
|
247 |
+
You may convey a covered work in object code form under the terms
|
248 |
+
of sections 4 and 5, provided that you also convey the
|
249 |
+
machine-readable Corresponding Source under the terms of this License,
|
250 |
+
in one of these ways:
|
251 |
+
|
252 |
+
a) Convey the object code in, or embodied in, a physical product
|
253 |
+
(including a physical distribution medium), accompanied by the
|
254 |
+
Corresponding Source fixed on a durable physical medium
|
255 |
+
customarily used for software interchange.
|
256 |
+
|
257 |
+
b) Convey the object code in, or embodied in, a physical product
|
258 |
+
(including a physical distribution medium), accompanied by a
|
259 |
+
written offer, valid for at least three years and valid for as
|
260 |
+
long as you offer spare parts or customer support for that product
|
261 |
+
model, to give anyone who possesses the object code either (1) a
|
262 |
+
copy of the Corresponding Source for all the software in the
|
263 |
+
product that is covered by this License, on a durable physical
|
264 |
+
medium customarily used for software interchange, for a price no
|
265 |
+
more than your reasonable cost of physically performing this
|
266 |
+
conveying of source, or (2) access to copy the
|
267 |
+
Corresponding Source from a network server at no charge.
|
268 |
+
|
269 |
+
c) Convey individual copies of the object code with a copy of the
|
270 |
+
written offer to provide the Corresponding Source. This
|
271 |
+
alternative is allowed only occasionally and noncommercially, and
|
272 |
+
only if you received the object code with such an offer, in accord
|
273 |
+
with subsection 6b.
|
274 |
+
|
275 |
+
d) Convey the object code by offering access from a designated
|
276 |
+
place (gratis or for a charge), and offer equivalent access to the
|
277 |
+
Corresponding Source in the same way through the same place at no
|
278 |
+
further charge. You need not require recipients to copy the
|
279 |
+
Corresponding Source along with the object code. If the place to
|
280 |
+
copy the object code is a network server, the Corresponding Source
|
281 |
+
may be on a different server (operated by you or a third party)
|
282 |
+
that supports equivalent copying facilities, provided you maintain
|
283 |
+
clear directions next to the object code saying where to find the
|
284 |
+
Corresponding Source. Regardless of what server hosts the
|
285 |
+
Corresponding Source, you remain obligated to ensure that it is
|
286 |
+
available for as long as needed to satisfy these requirements.
|
287 |
+
|
288 |
+
e) Convey the object code using peer-to-peer transmission, provided
|
289 |
+
you inform other peers where the object code and Corresponding
|
290 |
+
Source of the work are being offered to the general public at no
|
291 |
+
charge under subsection 6d.
|
292 |
+
|
293 |
+
A separable portion of the object code, whose source code is excluded
|
294 |
+
from the Corresponding Source as a System Library, need not be
|
295 |
+
included in conveying the object code work.
|
296 |
+
|
297 |
+
A "User Product" is either (1) a "consumer product", which means any
|
298 |
+
tangible personal property which is normally used for personal, family,
|
299 |
+
or household purposes, or (2) anything designed or sold for incorporation
|
300 |
+
into a dwelling. In determining whether a product is a consumer product,
|
301 |
+
doubtful cases shall be resolved in favor of coverage. For a particular
|
302 |
+
product received by a particular user, "normally used" refers to a
|
303 |
+
typical or common use of that class of product, regardless of the status
|
304 |
+
of the particular user or of the way in which the particular user
|
305 |
+
actually uses, or expects or is expected to use, the product. A product
|
306 |
+
is a consumer product regardless of whether the product has substantial
|
307 |
+
commercial, industrial or non-consumer uses, unless such uses represent
|
308 |
+
the only significant mode of use of the product.
|
309 |
+
|
310 |
+
"Installation Information" for a User Product means any methods,
|
311 |
+
procedures, authorization keys, or other information required to install
|
312 |
+
and execute modified versions of a covered work in that User Product from
|
313 |
+
a modified version of its Corresponding Source. The information must
|
314 |
+
suffice to ensure that the continued functioning of the modified object
|
315 |
+
code is in no case prevented or interfered with solely because
|
316 |
+
modification has been made.
|
317 |
+
|
318 |
+
If you convey an object code work under this section in, or with, or
|
319 |
+
specifically for use in, a User Product, and the conveying occurs as
|
320 |
+
part of a transaction in which the right of possession and use of the
|
321 |
+
User Product is transferred to the recipient in perpetuity or for a
|
322 |
+
fixed term (regardless of how the transaction is characterized), the
|
323 |
+
Corresponding Source conveyed under this section must be accompanied
|
324 |
+
by the Installation Information. But this requirement does not apply
|
325 |
+
if neither you nor any third party retains the ability to install
|
326 |
+
modified object code on the User Product (for example, the work has
|
327 |
+
been installed in ROM).
|
328 |
+
|
329 |
+
The requirement to provide Installation Information does not include a
|
330 |
+
requirement to continue to provide support service, warranty, or updates
|
331 |
+
for a work that has been modified or installed by the recipient, or for
|
332 |
+
the User Product in which it has been modified or installed. Access to a
|
333 |
+
network may be denied when the modification itself materially and
|
334 |
+
adversely affects the operation of the network or violates the rules and
|
335 |
+
protocols for communication across the network.
|
336 |
+
|
337 |
+
Corresponding Source conveyed, and Installation Information provided,
|
338 |
+
in accord with this section must be in a format that is publicly
|
339 |
+
documented (and with an implementation available to the public in
|
340 |
+
source code form), and must require no special password or key for
|
341 |
+
unpacking, reading or copying.
|
342 |
+
|
343 |
+
7. Additional Terms.
|
344 |
+
|
345 |
+
"Additional permissions" are terms that supplement the terms of this
|
346 |
+
License by making exceptions from one or more of its conditions.
|
347 |
+
Additional permissions that are applicable to the entire Program shall
|
348 |
+
be treated as though they were included in this License, to the extent
|
349 |
+
that they are valid under applicable law. If additional permissions
|
350 |
+
apply only to part of the Program, that part may be used separately
|
351 |
+
under those permissions, but the entire Program remains governed by
|
352 |
+
this License without regard to the additional permissions.
|
353 |
+
|
354 |
+
When you convey a copy of a covered work, you may at your option
|
355 |
+
remove any additional permissions from that copy, or from any part of
|
356 |
+
it. (Additional permissions may be written to require their own
|
357 |
+
removal in certain cases when you modify the work.) You may place
|
358 |
+
additional permissions on material, added by you to a covered work,
|
359 |
+
for which you have or can give appropriate copyright permission.
|
360 |
+
|
361 |
+
Notwithstanding any other provision of this License, for material you
|
362 |
+
add to a covered work, you may (if authorized by the copyright holders of
|
363 |
+
that material) supplement the terms of this License with terms:
|
364 |
+
|
365 |
+
a) Disclaiming warranty or limiting liability differently from the
|
366 |
+
terms of sections 15 and 16 of this License; or
|
367 |
+
|
368 |
+
b) Requiring preservation of specified reasonable legal notices or
|
369 |
+
author attributions in that material or in the Appropriate Legal
|
370 |
+
Notices displayed by works containing it; or
|
371 |
+
|
372 |
+
c) Prohibiting misrepresentation of the origin of that material, or
|
373 |
+
requiring that modified versions of such material be marked in
|
374 |
+
reasonable ways as different from the original version; or
|
375 |
+
|
376 |
+
d) Limiting the use for publicity purposes of names of licensors or
|
377 |
+
authors of the material; or
|
378 |
+
|
379 |
+
e) Declining to grant rights under trademark law for use of some
|
380 |
+
trade names, trademarks, or service marks; or
|
381 |
+
|
382 |
+
f) Requiring indemnification of licensors and authors of that
|
383 |
+
material by anyone who conveys the material (or modified versions of
|
384 |
+
it) with contractual assumptions of liability to the recipient, for
|
385 |
+
any liability that these contractual assumptions directly impose on
|
386 |
+
those licensors and authors.
|
387 |
+
|
388 |
+
All other non-permissive additional terms are considered "further
|
389 |
+
restrictions" within the meaning of section 10. If the Program as you
|
390 |
+
received it, or any part of it, contains a notice stating that it is
|
391 |
+
governed by this License along with a term that is a further
|
392 |
+
restriction, you may remove that term. If a license document contains
|
393 |
+
a further restriction but permits relicensing or conveying under this
|
394 |
+
License, you may add to a covered work material governed by the terms
|
395 |
+
of that license document, provided that the further restriction does
|
396 |
+
not survive such relicensing or conveying.
|
397 |
+
|
398 |
+
If you add terms to a covered work in accord with this section, you
|
399 |
+
must place, in the relevant source files, a statement of the
|
400 |
+
additional terms that apply to those files, or a notice indicating
|
401 |
+
where to find the applicable terms.
|
402 |
+
|
403 |
+
Additional terms, permissive or non-permissive, may be stated in the
|
404 |
+
form of a separately written license, or stated as exceptions;
|
405 |
+
the above requirements apply either way.
|
406 |
+
|
407 |
+
8. Termination.
|
408 |
+
|
409 |
+
You may not propagate or modify a covered work except as expressly
|
410 |
+
provided under this License. Any attempt otherwise to propagate or
|
411 |
+
modify it is void, and will automatically terminate your rights under
|
412 |
+
this License (including any patent licenses granted under the third
|
413 |
+
paragraph of section 11).
|
414 |
+
|
415 |
+
However, if you cease all violation of this License, then your
|
416 |
+
license from a particular copyright holder is reinstated (a)
|
417 |
+
provisionally, unless and until the copyright holder explicitly and
|
418 |
+
finally terminates your license, and (b) permanently, if the copyright
|
419 |
+
holder fails to notify you of the violation by some reasonable means
|
420 |
+
prior to 60 days after the cessation.
|
421 |
+
|
422 |
+
Moreover, your license from a particular copyright holder is
|
423 |
+
reinstated permanently if the copyright holder notifies you of the
|
424 |
+
violation by some reasonable means, this is the first time you have
|
425 |
+
received notice of violation of this License (for any work) from that
|
426 |
+
copyright holder, and you cure the violation prior to 30 days after
|
427 |
+
your receipt of the notice.
|
428 |
+
|
429 |
+
Termination of your rights under this section does not terminate the
|
430 |
+
licenses of parties who have received copies or rights from you under
|
431 |
+
this License. If your rights have been terminated and not permanently
|
432 |
+
reinstated, you do not qualify to receive new licenses for the same
|
433 |
+
material under section 10.
|
434 |
+
|
435 |
+
9. Acceptance Not Required for Having Copies.
|
436 |
+
|
437 |
+
You are not required to accept this License in order to receive or
|
438 |
+
run a copy of the Program. Ancillary propagation of a covered work
|
439 |
+
occurring solely as a consequence of using peer-to-peer transmission
|
440 |
+
to receive a copy likewise does not require acceptance. However,
|
441 |
+
nothing other than this License grants you permission to propagate or
|
442 |
+
modify any covered work. These actions infringe copyright if you do
|
443 |
+
not accept this License. Therefore, by modifying or propagating a
|
444 |
+
covered work, you indicate your acceptance of this License to do so.
|
445 |
+
|
446 |
+
10. Automatic Licensing of Downstream Recipients.
|
447 |
+
|
448 |
+
Each time you convey a covered work, the recipient automatically
|
449 |
+
receives a license from the original licensors, to run, modify and
|
450 |
+
propagate that work, subject to this License. You are not responsible
|
451 |
+
for enforcing compliance by third parties with this License.
|
452 |
+
|
453 |
+
An "entity transaction" is a transaction transferring control of an
|
454 |
+
organization, or substantially all assets of one, or subdividing an
|
455 |
+
organization, or merging organizations. If propagation of a covered
|
456 |
+
work results from an entity transaction, each party to that
|
457 |
+
transaction who receives a copy of the work also receives whatever
|
458 |
+
licenses to the work the party's predecessor in interest had or could
|
459 |
+
give under the previous paragraph, plus a right to possession of the
|
460 |
+
Corresponding Source of the work from the predecessor in interest, if
|
461 |
+
the predecessor has it or can get it with reasonable efforts.
|
462 |
+
|
463 |
+
You may not impose any further restrictions on the exercise of the
|
464 |
+
rights granted or affirmed under this License. For example, you may
|
465 |
+
not impose a license fee, royalty, or other charge for exercise of
|
466 |
+
rights granted under this License, and you may not initiate litigation
|
467 |
+
(including a cross-claim or counterclaim in a lawsuit) alleging that
|
468 |
+
any patent claim is infringed by making, using, selling, offering for
|
469 |
+
sale, or importing the Program or any portion of it.
|
470 |
+
|
471 |
+
11. Patents.
|
472 |
+
|
473 |
+
A "contributor" is a copyright holder who authorizes use under this
|
474 |
+
License of the Program or a work on which the Program is based. The
|
475 |
+
work thus licensed is called the contributor's "contributor version".
|
476 |
+
|
477 |
+
A contributor's "essential patent claims" are all patent claims
|
478 |
+
owned or controlled by the contributor, whether already acquired or
|
479 |
+
hereafter acquired, that would be infringed by some manner, permitted
|
480 |
+
by this License, of making, using, or selling its contributor version,
|
481 |
+
but do not include claims that would be infringed only as a
|
482 |
+
consequence of further modification of the contributor version. For
|
483 |
+
purposes of this definition, "control" includes the right to grant
|
484 |
+
patent sublicenses in a manner consistent with the requirements of
|
485 |
+
this License.
|
486 |
+
|
487 |
+
Each contributor grants you a non-exclusive, worldwide, royalty-free
|
488 |
+
patent license under the contributor's essential patent claims, to
|
489 |
+
make, use, sell, offer for sale, import and otherwise run, modify and
|
490 |
+
propagate the contents of its contributor version.
|
491 |
+
|
492 |
+
In the following three paragraphs, a "patent license" is any express
|
493 |
+
agreement or commitment, however denominated, not to enforce a patent
|
494 |
+
(such as an express permission to practice a patent or covenant not to
|
495 |
+
sue for patent infringement). To "grant" such a patent license to a
|
496 |
+
party means to make such an agreement or commitment not to enforce a
|
497 |
+
patent against the party.
|
498 |
+
|
499 |
+
If you convey a covered work, knowingly relying on a patent license,
|
500 |
+
and the Corresponding Source of the work is not available for anyone
|
501 |
+
to copy, free of charge and under the terms of this License, through a
|
502 |
+
publicly available network server or other readily accessible means,
|
503 |
+
then you must either (1) cause the Corresponding Source to be so
|
504 |
+
available, or (2) arrange to deprive yourself of the benefit of the
|
505 |
+
patent license for this particular work, or (3) arrange, in a manner
|
506 |
+
consistent with the requirements of this License, to extend the patent
|
507 |
+
license to downstream recipients. "Knowingly relying" means you have
|
508 |
+
actual knowledge that, but for the patent license, your conveying the
|
509 |
+
covered work in a country, or your recipient's use of the covered work
|
510 |
+
in a country, would infringe one or more identifiable patents in that
|
511 |
+
country that you have reason to believe are valid.
|
512 |
+
|
513 |
+
If, pursuant to or in connection with a single transaction or
|
514 |
+
arrangement, you convey, or propagate by procuring conveyance of, a
|
515 |
+
covered work, and grant a patent license to some of the parties
|
516 |
+
receiving the covered work authorizing them to use, propagate, modify
|
517 |
+
or convey a specific copy of the covered work, then the patent license
|
518 |
+
you grant is automatically extended to all recipients of the covered
|
519 |
+
work and works based on it.
|
520 |
+
|
521 |
+
A patent license is "discriminatory" if it does not include within
|
522 |
+
the scope of its coverage, prohibits the exercise of, or is
|
523 |
+
conditioned on the non-exercise of one or more of the rights that are
|
524 |
+
specifically granted under this License. You may not convey a covered
|
525 |
+
work if you are a party to an arrangement with a third party that is
|
526 |
+
in the business of distributing software, under which you make payment
|
527 |
+
to the third party based on the extent of your activity of conveying
|
528 |
+
the work, and under which the third party grants, to any of the
|
529 |
+
parties who would receive the covered work from you, a discriminatory
|
530 |
+
patent license (a) in connection with copies of the covered work
|
531 |
+
conveyed by you (or copies made from those copies), or (b) primarily
|
532 |
+
for and in connection with specific products or compilations that
|
533 |
+
contain the covered work, unless you entered into that arrangement,
|
534 |
+
or that patent license was granted, prior to 28 March 2007.
|
535 |
+
|
536 |
+
Nothing in this License shall be construed as excluding or limiting
|
537 |
+
any implied license or other defenses to infringement that may
|
538 |
+
otherwise be available to you under applicable patent law.
|
539 |
+
|
540 |
+
12. No Surrender of Others' Freedom.
|
541 |
+
|
542 |
+
If conditions are imposed on you (whether by court order, agreement or
|
543 |
+
otherwise) that contradict the conditions of this License, they do not
|
544 |
+
excuse you from the conditions of this License. If you cannot convey a
|
545 |
+
covered work so as to satisfy simultaneously your obligations under this
|
546 |
+
License and any other pertinent obligations, then as a consequence you may
|
547 |
+
not convey it at all. For example, if you agree to terms that obligate you
|
548 |
+
to collect a royalty for further conveying from those to whom you convey
|
549 |
+
the Program, the only way you could satisfy both those terms and this
|
550 |
+
License would be to refrain entirely from conveying the Program.
|
551 |
+
|
552 |
+
13. Use with the GNU Affero General Public License.
|
553 |
+
|
554 |
+
Notwithstanding any other provision of this License, you have
|
555 |
+
permission to link or combine any covered work with a work licensed
|
556 |
+
under version 3 of the GNU Affero General Public License into a single
|
557 |
+
combined work, and to convey the resulting work. The terms of this
|
558 |
+
License will continue to apply to the part which is the covered work,
|
559 |
+
but the special requirements of the GNU Affero General Public License,
|
560 |
+
section 13, concerning interaction through a network will apply to the
|
561 |
+
combination as such.
|
562 |
+
|
563 |
+
14. Revised Versions of this License.
|
564 |
+
|
565 |
+
The Free Software Foundation may publish revised and/or new versions of
|
566 |
+
the GNU General Public License from time to time. Such new versions will
|
567 |
+
be similar in spirit to the present version, but may differ in detail to
|
568 |
+
address new problems or concerns.
|
569 |
+
|
570 |
+
Each version is given a distinguishing version number. If the
|
571 |
+
Program specifies that a certain numbered version of the GNU General
|
572 |
+
Public License "or any later version" applies to it, you have the
|
573 |
+
option of following the terms and conditions either of that numbered
|
574 |
+
version or of any later version published by the Free Software
|
575 |
+
Foundation. If the Program does not specify a version number of the
|
576 |
+
GNU General Public License, you may choose any version ever published
|
577 |
+
by the Free Software Foundation.
|
578 |
+
|
579 |
+
If the Program specifies that a proxy can decide which future
|
580 |
+
versions of the GNU General Public License can be used, that proxy's
|
581 |
+
public statement of acceptance of a version permanently authorizes you
|
582 |
+
to choose that version for the Program.
|
583 |
+
|
584 |
+
Later license versions may give you additional or different
|
585 |
+
permissions. However, no additional obligations are imposed on any
|
586 |
+
author or copyright holder as a result of your choosing to follow a
|
587 |
+
later version.
|
588 |
+
|
589 |
+
15. Disclaimer of Warranty.
|
590 |
+
|
591 |
+
THERE IS NO WARRANTY FOR THE PROGRAM, TO THE EXTENT PERMITTED BY
|
592 |
+
APPLICABLE LAW. EXCEPT WHEN OTHERWISE STATED IN WRITING THE COPYRIGHT
|
593 |
+
HOLDERS AND/OR OTHER PARTIES PROVIDE THE PROGRAM "AS IS" WITHOUT WARRANTY
|
594 |
+
OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO,
|
595 |
+
THE IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR
|
596 |
+
PURPOSE. THE ENTIRE RISK AS TO THE QUALITY AND PERFORMANCE OF THE PROGRAM
|
597 |
+
IS WITH YOU. SHOULD THE PROGRAM PROVE DEFECTIVE, YOU ASSUME THE COST OF
|
598 |
+
ALL NECESSARY SERVICING, REPAIR OR CORRECTION.
|
599 |
+
|
600 |
+
16. Limitation of Liability.
|
601 |
+
|
602 |
+
IN NO EVENT UNLESS REQUIRED BY APPLICABLE LAW OR AGREED TO IN WRITING
|
603 |
+
WILL ANY COPYRIGHT HOLDER, OR ANY OTHER PARTY WHO MODIFIES AND/OR CONVEYS
|
604 |
+
THE PROGRAM AS PERMITTED ABOVE, BE LIABLE TO YOU FOR DAMAGES, INCLUDING ANY
|
605 |
+
GENERAL, SPECIAL, INCIDENTAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF THE
|
606 |
+
USE OR INABILITY TO USE THE PROGRAM (INCLUDING BUT NOT LIMITED TO LOSS OF
|
607 |
+
DATA OR DATA BEING RENDERED INACCURATE OR LOSSES SUSTAINED BY YOU OR THIRD
|
608 |
+
PARTIES OR A FAILURE OF THE PROGRAM TO OPERATE WITH ANY OTHER PROGRAMS),
|
609 |
+
EVEN IF SUCH HOLDER OR OTHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF
|
610 |
+
SUCH DAMAGES.
|
611 |
+
|
612 |
+
17. Interpretation of Sections 15 and 16.
|
613 |
+
|
614 |
+
If the disclaimer of warranty and limitation of liability provided
|
615 |
+
above cannot be given local legal effect according to their terms,
|
616 |
+
reviewing courts shall apply local law that most closely approximates
|
617 |
+
an absolute waiver of all civil liability in connection with the
|
618 |
+
Program, unless a warranty or assumption of liability accompanies a
|
619 |
+
copy of the Program in return for a fee.
|
620 |
+
|
621 |
+
END OF TERMS AND CONDITIONS
|
622 |
+
|
623 |
+
How to Apply These Terms to Your New Programs
|
624 |
+
|
625 |
+
If you develop a new program, and you want it to be of the greatest
|
626 |
+
possible use to the public, the best way to achieve this is to make it
|
627 |
+
free software which everyone can redistribute and change under these terms.
|
628 |
+
|
629 |
+
To do so, attach the following notices to the program. It is safest
|
630 |
+
to attach them to the start of each source file to most effectively
|
631 |
+
state the exclusion of warranty; and each file should have at least
|
632 |
+
the "copyright" line and a pointer to where the full notice is found.
|
633 |
+
|
634 |
+
<one line to give the program's name and a brief idea of what it does.>
|
635 |
+
Copyright (C) <year> <name of author>
|
636 |
+
|
637 |
+
This program is free software: you can redistribute it and/or modify
|
638 |
+
it under the terms of the GNU General Public License as published by
|
639 |
+
the Free Software Foundation, either version 3 of the License, or
|
640 |
+
(at your option) any later version.
|
641 |
+
|
642 |
+
This program is distributed in the hope that it will be useful,
|
643 |
+
but WITHOUT ANY WARRANTY; without even the implied warranty of
|
644 |
+
MERCHANTABILITY or FITNESS FOR A PARTICULAR PURPOSE. See the
|
645 |
+
GNU General Public License for more details.
|
646 |
+
|
647 |
+
You should have received a copy of the GNU General Public License
|
648 |
+
along with this program. If not, see <https://www.gnu.org/licenses/>.
|
649 |
+
|
650 |
+
Also add information on how to contact you by electronic and paper mail.
|
651 |
+
|
652 |
+
If the program does terminal interaction, make it output a short
|
653 |
+
notice like this when it starts in an interactive mode:
|
654 |
+
|
655 |
+
<program> Copyright (C) <year> <name of author>
|
656 |
+
This program comes with ABSOLUTELY NO WARRANTY; for details type `show w'.
|
657 |
+
This is free software, and you are welcome to redistribute it
|
658 |
+
under certain conditions; type `show c' for details.
|
659 |
+
|
660 |
+
The hypothetical commands `show w' and `show c' should show the appropriate
|
661 |
+
parts of the General Public License. Of course, your program's commands
|
662 |
+
might be different; for a GUI interface, you would use an "about box".
|
663 |
+
|
664 |
+
You should also get your employer (if you work as a programmer) or school,
|
665 |
+
if any, to sign a "copyright disclaimer" for the program, if necessary.
|
666 |
+
For more information on this, and how to apply and follow the GNU GPL, see
|
667 |
+
<https://www.gnu.org/licenses/>.
|
668 |
+
|
669 |
+
The GNU General Public License does not permit incorporating your program
|
670 |
+
into proprietary programs. If your program is a subroutine library, you
|
671 |
+
may consider it more useful to permit linking proprietary applications with
|
672 |
+
the library. If this is what you want to do, use the GNU Lesser General
|
673 |
+
Public License instead of this License. But first, please read
|
674 |
+
<https://www.gnu.org/licenses/why-not-lgpl.html>.
|
README.md
ADDED
@@ -0,0 +1,14 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
# clinOracle team - tahoe-hack-2025
|
2 |
+
|
3 |
+
Predicting clinical outcomes from _in vitro_ transcriptional responses.
|
4 |
+
|
5 |
+
## Code
|
6 |
+
- `representations/` - scripts to train and transcriptome effect representations on Tahoe-100M
|
7 |
+
- `clinical_data_curation/` - scripts to curate clinical trial data
|
8 |
+
- `approval_prediction_benchmark.ipynb` - benchmark on clinical approval prediction
|
9 |
+
- `classifier.py` - Benchmarking classifier implementation
|
10 |
+
|
11 |
+
## Data
|
12 |
+
- `clinical_evidence_data/` - Curated clinical evidence data on Tahoe drugs
|
13 |
+
- `data_for_classifier/` - input data for benchmarks
|
14 |
+
- `data/` - misc processed data
|
_misc/depmap.ipynb
ADDED
@@ -0,0 +1,107 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
{
|
2 |
+
"cells": [
|
3 |
+
{
|
4 |
+
"cell_type": "code",
|
5 |
+
"execution_count": 1,
|
6 |
+
"metadata": {},
|
7 |
+
"outputs": [
|
8 |
+
{
|
9 |
+
"name": "stderr",
|
10 |
+
"output_type": "stream",
|
11 |
+
"text": [
|
12 |
+
"/home/ubuntu/miniconda3/envs/rapids_singlecell/lib/python3.12/site-packages/tqdm/auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
|
13 |
+
" from .autonotebook import tqdm as notebook_tqdm\n"
|
14 |
+
]
|
15 |
+
}
|
16 |
+
],
|
17 |
+
"source": [
|
18 |
+
"from datasets import load_dataset\n",
|
19 |
+
"import pandas as pd"
|
20 |
+
]
|
21 |
+
},
|
22 |
+
{
|
23 |
+
"cell_type": "code",
|
24 |
+
"execution_count": 3,
|
25 |
+
"metadata": {},
|
26 |
+
"outputs": [],
|
27 |
+
"source": [
|
28 |
+
"drug_metadata = pd.DataFrame(load_dataset(\"tahoebio/Tahoe-100M\",\"drug_metadata\", split=\"train\"))\n",
|
29 |
+
"drug_metadata = drug_metadata.loc[drug_metadata[\"targets\"].notna()]\n",
|
30 |
+
"target_to_drug = dict(zip(drug_metadata[\"targets\"], drug_metadata[\"drug\"]))\n",
|
31 |
+
"cell_metadata = pd.DataFrame(load_dataset(\"tahoebio/Tahoe-100M\",\"cell_line_metadata\", split=\"train\"))\n",
|
32 |
+
"depmap = pd.read_csv(\"../CRISPRGeneDependency.csv\", index_col=0)"
|
33 |
+
]
|
34 |
+
},
|
35 |
+
{
|
36 |
+
"cell_type": "code",
|
37 |
+
"execution_count": 4,
|
38 |
+
"metadata": {},
|
39 |
+
"outputs": [],
|
40 |
+
"source": [
|
41 |
+
"depmap_to_tahoe = dict(zip(cell_metadata[\"Cell_ID_DepMap\"], cell_metadata[\"Cell_ID_Cellosaur\"]))\n",
|
42 |
+
"depmap.index = depmap.index.map(depmap_to_tahoe)\n",
|
43 |
+
"depmap = depmap.loc[depmap.index.notna()]\n",
|
44 |
+
"depmap.columns = depmap.columns.map(lambda x: x.split(\" \")[0])"
|
45 |
+
]
|
46 |
+
},
|
47 |
+
{
|
48 |
+
"cell_type": "code",
|
49 |
+
"execution_count": 5,
|
50 |
+
"metadata": {},
|
51 |
+
"outputs": [],
|
52 |
+
"source": [
|
53 |
+
"depmap = depmap.reset_index().melt(id_vars='index')\n",
|
54 |
+
"depmap[\"drug\"] = depmap[\"variable\"].map(target_to_drug)"
|
55 |
+
]
|
56 |
+
},
|
57 |
+
{
|
58 |
+
"cell_type": "code",
|
59 |
+
"execution_count": 6,
|
60 |
+
"metadata": {},
|
61 |
+
"outputs": [],
|
62 |
+
"source": [
|
63 |
+
"depmap = depmap.dropna(subset=[\"drug\"])\n",
|
64 |
+
"depmap[\"drug_cellline\"] = depmap[\"drug\"] + \"_\" + depmap[\"index\"]"
|
65 |
+
]
|
66 |
+
},
|
67 |
+
{
|
68 |
+
"cell_type": "code",
|
69 |
+
"execution_count": 9,
|
70 |
+
"metadata": {},
|
71 |
+
"outputs": [],
|
72 |
+
"source": [
|
73 |
+
"depmap.index = depmap[\"drug_cellline\"]\n",
|
74 |
+
"depmap[\"depmap_dependency_score\"] = depmap[\"value\"]\n",
|
75 |
+
"depmap[[\"depmap_dependency_score\"]].to_csv(\"data_for_classifier/depmap_dependency_scores.tsv\", index=True, sep='\\t')"
|
76 |
+
]
|
77 |
+
},
|
78 |
+
{
|
79 |
+
"cell_type": "code",
|
80 |
+
"execution_count": null,
|
81 |
+
"metadata": {},
|
82 |
+
"outputs": [],
|
83 |
+
"source": []
|
84 |
+
}
|
85 |
+
],
|
86 |
+
"metadata": {
|
87 |
+
"kernelspec": {
|
88 |
+
"display_name": "Python 3",
|
89 |
+
"language": "python",
|
90 |
+
"name": "python3"
|
91 |
+
},
|
92 |
+
"language_info": {
|
93 |
+
"codemirror_mode": {
|
94 |
+
"name": "ipython",
|
95 |
+
"version": 3
|
96 |
+
},
|
97 |
+
"file_extension": ".py",
|
98 |
+
"mimetype": "text/x-python",
|
99 |
+
"name": "python",
|
100 |
+
"nbconvert_exporter": "python",
|
101 |
+
"pygments_lexer": "ipython3",
|
102 |
+
"version": "3.12.10"
|
103 |
+
}
|
104 |
+
},
|
105 |
+
"nbformat": 4,
|
106 |
+
"nbformat_minor": 2
|
107 |
+
}
|
_misc/genedisease_to_drugtrait.ipynb
ADDED
@@ -0,0 +1,199 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
{
|
2 |
+
"cells": [
|
3 |
+
{
|
4 |
+
"cell_type": "code",
|
5 |
+
"execution_count": 48,
|
6 |
+
"metadata": {},
|
7 |
+
"outputs": [],
|
8 |
+
"source": [
|
9 |
+
"from datasets import load_dataset\n",
|
10 |
+
"import pandas as pd"
|
11 |
+
]
|
12 |
+
},
|
13 |
+
{
|
14 |
+
"cell_type": "code",
|
15 |
+
"execution_count": 49,
|
16 |
+
"metadata": {},
|
17 |
+
"outputs": [],
|
18 |
+
"source": [
|
19 |
+
"# import json\n",
|
20 |
+
"# import os\n",
|
21 |
+
"\n",
|
22 |
+
"# # Read in the organ to conditions mapping JSON file\n",
|
23 |
+
"# with open(\"clin-oracle-tahoe-hack-2025/data/organ_to_conditions_mapping.json\", \"r\") as f:\n",
|
24 |
+
"# organ_to_conditions = json.load(f)\n",
|
25 |
+
" \n",
|
26 |
+
"# # Display basic information about the mapping\n",
|
27 |
+
"# print(f\"Loaded organ to conditions mapping with {len(organ_to_conditions)} organs\")\n",
|
28 |
+
"# print(f\"Sample organ: {list(organ_to_conditions.keys())[0]}\")\n",
|
29 |
+
"# print(f\"Sample conditions: {organ_to_conditions[list(organ_to_conditions.keys())[0]][:3]}...\")\n"
|
30 |
+
]
|
31 |
+
},
|
32 |
+
{
|
33 |
+
"cell_type": "code",
|
34 |
+
"execution_count": 55,
|
35 |
+
"metadata": {},
|
36 |
+
"outputs": [],
|
37 |
+
"source": [
|
38 |
+
"drug_metadata = pd.DataFrame(load_dataset(\"tahoebio/Tahoe-100M\",\"drug_metadata\", split=\"train\"))\n",
|
39 |
+
"drug_metadata = drug_metadata.loc[drug_metadata[\"targets\"].notna()]\n",
|
40 |
+
"target_to_drug = dict(zip(drug_metadata[\"targets\"], drug_metadata[\"drug\"]))"
|
41 |
+
]
|
42 |
+
},
|
43 |
+
{
|
44 |
+
"cell_type": "code",
|
45 |
+
"execution_count": 57,
|
46 |
+
"metadata": {},
|
47 |
+
"outputs": [],
|
48 |
+
"source": [
|
49 |
+
"df = pd.read_csv(\"/home/ubuntu/tahoe/clin-oracle-tahoe-hack-2025/indication_to_organ_mapping_confident.tsv\", sep='\\t')"
|
50 |
+
]
|
51 |
+
},
|
52 |
+
{
|
53 |
+
"cell_type": "code",
|
54 |
+
"execution_count": 58,
|
55 |
+
"metadata": {},
|
56 |
+
"outputs": [],
|
57 |
+
"source": [
|
58 |
+
"indic = pd.read_csv(\"genetic_support/data/indic.tsv\", sep='\\t')\n",
|
59 |
+
"assoc = pd.read_csv(\"genetic_support/data/assoc.tsv.gz\", sep='\\t')"
|
60 |
+
]
|
61 |
+
},
|
62 |
+
{
|
63 |
+
"cell_type": "code",
|
64 |
+
"execution_count": 59,
|
65 |
+
"metadata": {},
|
66 |
+
"outputs": [],
|
67 |
+
"source": [
|
68 |
+
"assoc = assoc.merge(df, left_on=\"mesh_term\", right_on=\"indication_mesh_term\")"
|
69 |
+
]
|
70 |
+
},
|
71 |
+
{
|
72 |
+
"cell_type": "code",
|
73 |
+
"execution_count": 61,
|
74 |
+
"metadata": {},
|
75 |
+
"outputs": [
|
76 |
+
{
|
77 |
+
"data": {
|
78 |
+
"text/plain": [
|
79 |
+
"189"
|
80 |
+
]
|
81 |
+
},
|
82 |
+
"execution_count": 61,
|
83 |
+
"metadata": {},
|
84 |
+
"output_type": "execute_result"
|
85 |
+
}
|
86 |
+
],
|
87 |
+
"source": [
|
88 |
+
"len(target_to_drug)"
|
89 |
+
]
|
90 |
+
},
|
91 |
+
{
|
92 |
+
"cell_type": "code",
|
93 |
+
"execution_count": 62,
|
94 |
+
"metadata": {},
|
95 |
+
"outputs": [],
|
96 |
+
"source": [
|
97 |
+
"assoc[\"drug\"] = assoc[\"gene\"].map(target_to_drug)\n",
|
98 |
+
"assoc[\"drug_organ\"] = assoc[\"drug\"] + \"_\" + assoc[\"organ\"]"
|
99 |
+
]
|
100 |
+
},
|
101 |
+
{
|
102 |
+
"cell_type": "code",
|
103 |
+
"execution_count": 63,
|
104 |
+
"metadata": {},
|
105 |
+
"outputs": [],
|
106 |
+
"source": [
|
107 |
+
"assoc = assoc.loc[assoc[\"drug_organ\"].notna()]"
|
108 |
+
]
|
109 |
+
},
|
110 |
+
{
|
111 |
+
"cell_type": "code",
|
112 |
+
"execution_count": null,
|
113 |
+
"metadata": {},
|
114 |
+
"outputs": [],
|
115 |
+
"source": [
|
116 |
+
"assoc[[\"drug_organ\",]]"
|
117 |
+
]
|
118 |
+
},
|
119 |
+
{
|
120 |
+
"cell_type": "code",
|
121 |
+
"execution_count": 66,
|
122 |
+
"metadata": {},
|
123 |
+
"outputs": [
|
124 |
+
{
|
125 |
+
"data": {
|
126 |
+
"text/plain": [
|
127 |
+
"arow 3885\n",
|
128 |
+
"gene ABL1\n",
|
129 |
+
"mesh_id D014012\n",
|
130 |
+
"source OTG\n",
|
131 |
+
"original_trait Tinnitus / tiniitis | non-cancer illness code,...\n",
|
132 |
+
"original_link https://genetics.opentargets.org/study/NEALE2_...\n",
|
133 |
+
"extra_info NaN\n",
|
134 |
+
"l2g_rank 4.0\n",
|
135 |
+
"l2g_share 0.12\n",
|
136 |
+
"pval 0.0\n",
|
137 |
+
"year 2018.0\n",
|
138 |
+
"beta NaN\n",
|
139 |
+
"odds_ratio 4.072184\n",
|
140 |
+
"pic_qtl_pval NaN\n",
|
141 |
+
"pic_h4 NaN\n",
|
142 |
+
"af_gnomad_nfe 0.02489\n",
|
143 |
+
"mesh_term Tinnitus\n",
|
144 |
+
"indication_mesh_term Tinnitus\n",
|
145 |
+
"organ CNS/Brain\n",
|
146 |
+
"drug Flumatinib (mesylate)\n",
|
147 |
+
"drug_organ Flumatinib (mesylate)_CNS/Brain\n",
|
148 |
+
"Name: 234, dtype: object"
|
149 |
+
]
|
150 |
+
},
|
151 |
+
"execution_count": 66,
|
152 |
+
"metadata": {},
|
153 |
+
"output_type": "execute_result"
|
154 |
+
}
|
155 |
+
],
|
156 |
+
"source": [
|
157 |
+
"assoc.iloc[0]"
|
158 |
+
]
|
159 |
+
},
|
160 |
+
{
|
161 |
+
"cell_type": "code",
|
162 |
+
"execution_count": 67,
|
163 |
+
"metadata": {},
|
164 |
+
"outputs": [],
|
165 |
+
"source": [
|
166 |
+
"assoc[\"is_associated_with_indication\"] = 1\n",
|
167 |
+
"assoc[[\"drug_organ\",\"is_associated_with_indication\"]].to_csv(\"/home/ubuntu/tahoe/clin-oracle-tahoe-hack-2025/data_for_classifier/assoc_drug_organ_label.tsv\", sep='\\t', index=False)"
|
168 |
+
]
|
169 |
+
},
|
170 |
+
{
|
171 |
+
"cell_type": "code",
|
172 |
+
"execution_count": null,
|
173 |
+
"metadata": {},
|
174 |
+
"outputs": [],
|
175 |
+
"source": []
|
176 |
+
}
|
177 |
+
],
|
178 |
+
"metadata": {
|
179 |
+
"kernelspec": {
|
180 |
+
"display_name": "Python 3",
|
181 |
+
"language": "python",
|
182 |
+
"name": "python3"
|
183 |
+
},
|
184 |
+
"language_info": {
|
185 |
+
"codemirror_mode": {
|
186 |
+
"name": "ipython",
|
187 |
+
"version": 3
|
188 |
+
},
|
189 |
+
"file_extension": ".py",
|
190 |
+
"mimetype": "text/x-python",
|
191 |
+
"name": "python",
|
192 |
+
"nbconvert_exporter": "python",
|
193 |
+
"pygments_lexer": "ipython3",
|
194 |
+
"version": "3.12.10"
|
195 |
+
}
|
196 |
+
},
|
197 |
+
"nbformat": 4,
|
198 |
+
"nbformat_minor": 2
|
199 |
+
}
|
_misc/harmonize_genetic_data.py
ADDED
@@ -0,0 +1,344 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
import pandas as pd
|
2 |
+
import re
|
3 |
+
|
4 |
+
def load_indications(file_path):
|
5 |
+
"""
|
6 |
+
Load indications from a TSV file.
|
7 |
+
"""
|
8 |
+
try:
|
9 |
+
# Read the TSV file
|
10 |
+
df = pd.read_csv(file_path, sep='\t', na_values=['', 'NA', 'N/A'])
|
11 |
+
return df
|
12 |
+
except Exception as e:
|
13 |
+
print(f"Error loading file: {e}")
|
14 |
+
return None
|
15 |
+
|
16 |
+
def map_indication_to_organ(indication, areas=None):
|
17 |
+
"""
|
18 |
+
Map a medical indication to an organ.
|
19 |
+
Returns the organ name if a confident mapping exists, otherwise None.
|
20 |
+
"""
|
21 |
+
# List of target organs
|
22 |
+
target_organs = [
|
23 |
+
'Bowel', 'Lung', 'Esophagus/Stomach', 'Pancreas', 'Skin',
|
24 |
+
'Uterus', 'Breast', 'Ovary/Fallopian Tube', 'Cervix',
|
25 |
+
'CNS/Brain', 'Liver', 'Kidney', 'Peripheral Nervous System',
|
26 |
+
'Vulva/Vagina', 'Bladder/Urinary Tract'
|
27 |
+
]
|
28 |
+
|
29 |
+
# Dictionary mapping indication keywords to organs
|
30 |
+
keyword_to_organ = {
|
31 |
+
# Bowel related
|
32 |
+
'bowel': 'Bowel',
|
33 |
+
'intestinal': 'Bowel',
|
34 |
+
'colon': 'Bowel',
|
35 |
+
'colorectal': 'Bowel',
|
36 |
+
'rectal': 'Bowel',
|
37 |
+
'anus': 'Bowel',
|
38 |
+
'colitis': 'Bowel',
|
39 |
+
'crohn': 'Bowel',
|
40 |
+
'inflammatory bowel': 'Bowel',
|
41 |
+
'diverticulitis': 'Bowel',
|
42 |
+
'ileus': 'Bowel',
|
43 |
+
'short bowel': 'Bowel',
|
44 |
+
|
45 |
+
# Lung related
|
46 |
+
'lung': 'Lung',
|
47 |
+
'pulmonary': 'Lung',
|
48 |
+
'respiratory': 'Lung',
|
49 |
+
'bronch': 'Lung',
|
50 |
+
'pneumonia': 'Lung',
|
51 |
+
'emphysema': 'Lung',
|
52 |
+
'asthma': 'Lung',
|
53 |
+
'chronic obstructive pulmonary': 'Lung',
|
54 |
+
'idiopathic pulmonary fibrosis': 'Lung',
|
55 |
+
|
56 |
+
# Esophagus/Stomach related
|
57 |
+
'esophag': 'Esophagus/Stomach',
|
58 |
+
'stomach': 'Esophagus/Stomach',
|
59 |
+
'gastric': 'Esophagus/Stomach',
|
60 |
+
'gastroesophageal': 'Esophagus/Stomach',
|
61 |
+
'duodenal': 'Esophagus/Stomach',
|
62 |
+
'peptic ulcer': 'Esophagus/Stomach',
|
63 |
+
'gastritis': 'Esophagus/Stomach',
|
64 |
+
'barrett': 'Esophagus/Stomach',
|
65 |
+
|
66 |
+
# Pancreas related
|
67 |
+
'pancrea': 'Pancreas',
|
68 |
+
'exocrine pancreatic': 'Pancreas',
|
69 |
+
|
70 |
+
# Skin related
|
71 |
+
'skin': 'Skin',
|
72 |
+
'dermat': 'Skin',
|
73 |
+
'cutaneous': 'Skin',
|
74 |
+
'melanoma': 'Skin',
|
75 |
+
'psoriasis': 'Skin',
|
76 |
+
'eczema': 'Skin',
|
77 |
+
'acne': 'Skin',
|
78 |
+
'rosacea': 'Skin',
|
79 |
+
'alopecia': 'Skin',
|
80 |
+
'vitiligo': 'Skin',
|
81 |
+
'keratosis': 'Skin',
|
82 |
+
'keloid': 'Skin',
|
83 |
+
'ichthyosis': 'Skin',
|
84 |
+
'pruritus': 'Skin',
|
85 |
+
'urticaria': 'Skin',
|
86 |
+
'pemphigus': 'Skin',
|
87 |
+
'pemphigoid': 'Skin',
|
88 |
+
'scleroderma': 'Skin',
|
89 |
+
|
90 |
+
# Uterus related
|
91 |
+
'uter': 'Uterus',
|
92 |
+
'endometri': 'Uterus',
|
93 |
+
'myometri': 'Uterus',
|
94 |
+
'leiomyoma': 'Uterus',
|
95 |
+
|
96 |
+
# Breast related
|
97 |
+
'breast': 'Breast',
|
98 |
+
'mammary': 'Breast',
|
99 |
+
|
100 |
+
# Ovary/Fallopian tube related
|
101 |
+
'ovar': 'Ovary/Fallopian Tube',
|
102 |
+
'fallopian': 'Ovary/Fallopian Tube',
|
103 |
+
'polycystic ovary': 'Ovary/Fallopian Tube',
|
104 |
+
|
105 |
+
# Cervix related
|
106 |
+
'cervix': 'Cervix',
|
107 |
+
'cervical': 'Cervix',
|
108 |
+
|
109 |
+
# CNS/Brain related
|
110 |
+
'brain': 'CNS/Brain',
|
111 |
+
'central nervous': 'CNS/Brain',
|
112 |
+
'cns': 'CNS/Brain',
|
113 |
+
'cerebr': 'CNS/Brain',
|
114 |
+
'alzheimer': 'CNS/Brain',
|
115 |
+
'parkinson': 'CNS/Brain',
|
116 |
+
'glioma': 'CNS/Brain',
|
117 |
+
'glioblastoma': 'CNS/Brain',
|
118 |
+
'medulloblastoma': 'CNS/Brain',
|
119 |
+
'meningioma': 'CNS/Brain',
|
120 |
+
'epilepsy': 'CNS/Brain',
|
121 |
+
'dementia': 'CNS/Brain',
|
122 |
+
'encephalitis': 'CNS/Brain',
|
123 |
+
'encephalopathy': 'CNS/Brain',
|
124 |
+
'huntington': 'CNS/Brain',
|
125 |
+
'multiple sclerosis': 'CNS/Brain',
|
126 |
+
'stroke': 'CNS/Brain',
|
127 |
+
|
128 |
+
# Liver related
|
129 |
+
'liver': 'Liver',
|
130 |
+
'hepat': 'Liver',
|
131 |
+
'biliary': 'Liver',
|
132 |
+
'cholang': 'Liver',
|
133 |
+
'cirrhosis': 'Liver',
|
134 |
+
'fatty liver': 'Liver',
|
135 |
+
|
136 |
+
# Kidney related
|
137 |
+
'kidney': 'Kidney',
|
138 |
+
'renal': 'Kidney',
|
139 |
+
'nephro': 'Kidney',
|
140 |
+
'nephri': 'Kidney',
|
141 |
+
'glomerulo': 'Kidney',
|
142 |
+
'polycystic kidney': 'Kidney',
|
143 |
+
|
144 |
+
# Peripheral Nervous System related
|
145 |
+
'peripheral nervous': 'Peripheral Nervous System',
|
146 |
+
'neuropathy': 'Peripheral Nervous System',
|
147 |
+
'neuralgia': 'Peripheral Nervous System',
|
148 |
+
|
149 |
+
# Vulva/Vagina related
|
150 |
+
'vulva': 'Vulva/Vagina',
|
151 |
+
'vagina': 'Vulva/Vagina',
|
152 |
+
'vulvar': 'Vulva/Vagina',
|
153 |
+
'vaginal': 'Vulva/Vagina',
|
154 |
+
'vaginitis': 'Vulva/Vagina',
|
155 |
+
|
156 |
+
# Bladder/Urinary Tract related
|
157 |
+
'bladder': 'Bladder/Urinary Tract',
|
158 |
+
'urinary': 'Bladder/Urinary Tract',
|
159 |
+
'urethral': 'Bladder/Urinary Tract',
|
160 |
+
'urethra': 'Bladder/Urinary Tract',
|
161 |
+
'cystitis': 'Bladder/Urinary Tract',
|
162 |
+
}
|
163 |
+
|
164 |
+
# Indications that are too general or affect multiple systems
|
165 |
+
too_general = [
|
166 |
+
'Neoplasms', 'Inflammation', 'Pain', 'Infection', 'Fever',
|
167 |
+
'Autoimmune Diseases', 'Immune System Diseases',
|
168 |
+
'Nervous System Diseases', 'Metabolic Diseases',
|
169 |
+
'Arthritis', 'Diabetes Mellitus', 'Hypertension',
|
170 |
+
'Depression', 'Anxiety Disorders', 'HIV Infections',
|
171 |
+
'Sepsis', 'Wound Healing', 'Cachexia', 'Fatigue',
|
172 |
+
'Nausea', 'Vomiting', 'Multiple Myeloma', 'Leukemia', 'Lymphoma'
|
173 |
+
]
|
174 |
+
|
175 |
+
# Specific disease to organ mapping
|
176 |
+
specific_disease_mapping = {
|
177 |
+
'Ulcerative Colitis': 'Bowel',
|
178 |
+
'Crohn Disease': 'Bowel',
|
179 |
+
'Asthma': 'Lung',
|
180 |
+
'Psoriasis': 'Skin',
|
181 |
+
'Lupus Erythematosus, Cutaneous': 'Skin',
|
182 |
+
'Lupus Nephritis': 'Kidney',
|
183 |
+
'Alzheimer Disease': 'CNS/Brain',
|
184 |
+
'Parkinson Disease': 'CNS/Brain',
|
185 |
+
'Amyotrophic Lateral Sclerosis': 'CNS/Brain',
|
186 |
+
'Huntington Disease': 'CNS/Brain',
|
187 |
+
'Non-alcoholic Fatty Liver Disease': 'Liver',
|
188 |
+
'Carcinoma, Non-Small-Cell Lung': 'Lung',
|
189 |
+
'Small Cell Lung Carcinoma': 'Lung',
|
190 |
+
'Liver Cirrhosis': 'Liver',
|
191 |
+
'Liver Neoplasms': 'Liver',
|
192 |
+
'Liver Cirrhosis, Biliary': 'Liver',
|
193 |
+
'Breast Neoplasms': 'Breast',
|
194 |
+
'Ovarian Neoplasms': 'Ovary/Fallopian Tube',
|
195 |
+
'Brain Neoplasms': 'CNS/Brain',
|
196 |
+
'Brain Injuries': 'CNS/Brain',
|
197 |
+
'Brain Injuries, Traumatic': 'CNS/Brain',
|
198 |
+
'Brain Ischemia': 'CNS/Brain',
|
199 |
+
'Pancreatic Neoplasms': 'Pancreas',
|
200 |
+
'Urinary Bladder Neoplasms': 'Bladder/Urinary Tract',
|
201 |
+
'Stomach Neoplasms': 'Esophagus/Stomach',
|
202 |
+
'Uterine Cervical Neoplasms': 'Cervix',
|
203 |
+
'Endometrial Neoplasms': 'Uterus',
|
204 |
+
'Kidney Neoplasms': 'Kidney',
|
205 |
+
'Colorectal Neoplasms': 'Bowel',
|
206 |
+
'Inflammatory Bowel Diseases': 'Bowel',
|
207 |
+
'COVID-19': 'Lung',
|
208 |
+
'Severe Acute Respiratory Syndrome': 'Lung',
|
209 |
+
'Pulmonary Disease, Chronic Obstructive': 'Lung',
|
210 |
+
'Idiopathic Pulmonary Fibrosis': 'Lung',
|
211 |
+
'Respiratory Distress Syndrome': 'Lung',
|
212 |
+
'Esophageal Neoplasms': 'Esophagus/Stomach',
|
213 |
+
'Acne Vulgaris': 'Skin',
|
214 |
+
'Psoriatic Arthritis': 'Skin',
|
215 |
+
'Alopecia': 'Skin',
|
216 |
+
'Alopecia Areata': 'Skin',
|
217 |
+
'Vitiligo': 'Skin',
|
218 |
+
'Rosacea': 'Skin',
|
219 |
+
'Hidradenitis Suppurativa': 'Skin',
|
220 |
+
'Pemphigus': 'Skin',
|
221 |
+
'Pemphigoid, Bullous': 'Skin',
|
222 |
+
'Scleroderma, Systemic': 'Skin',
|
223 |
+
'Scleroderma, Diffuse': 'Skin',
|
224 |
+
'Scleroderma, Limited': 'Skin',
|
225 |
+
'Fallopian Tube Neoplasms': 'Ovary/Fallopian Tube',
|
226 |
+
'Polycystic Ovary Syndrome': 'Ovary/Fallopian Tube',
|
227 |
+
'Endometriosis': 'Uterus',
|
228 |
+
'Leiomyoma': 'Uterus',
|
229 |
+
'Carcinoma, Squamous Cell': 'Skin',
|
230 |
+
'Neoplasms, Basal Cell': 'Skin',
|
231 |
+
'Melanoma': 'Skin',
|
232 |
+
'Glioblastoma': 'CNS/Brain',
|
233 |
+
'Medulloblastoma': 'CNS/Brain',
|
234 |
+
'Irritable Bowel Syndrome': 'Bowel',
|
235 |
+
'Diabetic Nephropathies': 'Kidney',
|
236 |
+
'Diabetic Neuropathies': 'Peripheral Nervous System',
|
237 |
+
'Multiple Sclerosis': 'CNS/Brain',
|
238 |
+
}
|
239 |
+
|
240 |
+
# First, check if the indication is too general
|
241 |
+
if indication in too_general:
|
242 |
+
return None
|
243 |
+
|
244 |
+
# Check if the indication is in our specific disease mapping
|
245 |
+
if indication in specific_disease_mapping:
|
246 |
+
return specific_disease_mapping[indication]
|
247 |
+
|
248 |
+
# Check for keyword matches
|
249 |
+
indication_lower = indication.lower()
|
250 |
+
for keyword, organ in keyword_to_organ.items():
|
251 |
+
if keyword in indication_lower:
|
252 |
+
return organ
|
253 |
+
|
254 |
+
# Use the 'areas' context for additional mapping
|
255 |
+
if areas:
|
256 |
+
areas_lower = str(areas).lower()
|
257 |
+
if 'digestive' in areas_lower:
|
258 |
+
if any(term in indication_lower for term in ['bowel', 'colon', 'rectal', 'intestin']):
|
259 |
+
return 'Bowel'
|
260 |
+
elif any(term in indication_lower for term in ['liver', 'hepat', 'biliary']):
|
261 |
+
return 'Liver'
|
262 |
+
elif 'pancrea' in indication_lower:
|
263 |
+
return 'Pancreas'
|
264 |
+
elif any(term in indication_lower for term in ['stomach', 'gastric', 'esophag']):
|
265 |
+
return 'Esophagus/Stomach'
|
266 |
+
elif 'respiratory' in areas_lower:
|
267 |
+
return 'Lung'
|
268 |
+
elif 'neurology' in areas_lower:
|
269 |
+
if 'peripheral' in indication_lower:
|
270 |
+
return 'Peripheral Nervous System'
|
271 |
+
else:
|
272 |
+
return 'CNS/Brain'
|
273 |
+
elif 'dermatology' in areas_lower:
|
274 |
+
return 'Skin'
|
275 |
+
elif 'oncology' in areas_lower:
|
276 |
+
# For oncology, need more specific organ information
|
277 |
+
if any(term in indication_lower for term in ['lung', 'pulmonary', 'bronch']):
|
278 |
+
return 'Lung'
|
279 |
+
elif any(term in indication_lower for term in ['brain', 'glioma', 'cerebr']):
|
280 |
+
return 'CNS/Brain'
|
281 |
+
elif any(term in indication_lower for term in ['liver', 'hepatic']):
|
282 |
+
return 'Liver'
|
283 |
+
elif any(term in indication_lower for term in ['skin', 'melanoma', 'basal cell']):
|
284 |
+
return 'Skin'
|
285 |
+
elif any(term in indication_lower for term in ['breast', 'mammary']):
|
286 |
+
return 'Breast'
|
287 |
+
elif any(term in indication_lower for term in ['colon', 'rectal', 'colorectal']):
|
288 |
+
return 'Bowel'
|
289 |
+
elif any(term in indication_lower for term in ['pancreas', 'pancreatic']):
|
290 |
+
return 'Pancreas'
|
291 |
+
elif any(term in indication_lower for term in ['kidney', 'renal']):
|
292 |
+
return 'Kidney'
|
293 |
+
elif any(term in indication_lower for term in ['bladder', 'urinary']):
|
294 |
+
return 'Bladder/Urinary Tract'
|
295 |
+
elif any(term in indication_lower for term in ['cervix', 'cervical']):
|
296 |
+
return 'Cervix'
|
297 |
+
elif any(term in indication_lower for term in ['uterus', 'uterine', 'endometri']):
|
298 |
+
return 'Uterus'
|
299 |
+
elif any(term in indication_lower for term in ['ovary', 'ovarian', 'fallopian']):
|
300 |
+
return 'Ovary/Fallopian Tube'
|
301 |
+
|
302 |
+
# If no confident mapping is found, return None
|
303 |
+
return None
|
304 |
+
|
305 |
+
def main():
|
306 |
+
# Load indications from TSV file
|
307 |
+
file_path = '../genetic_support/data/indic.tsv' # Update this path if necessary
|
308 |
+
indications_df = load_indications(file_path)
|
309 |
+
indications_df = indications_df.dropna(subset=['indication_mesh_term'])
|
310 |
+
|
311 |
+
if indications_df is not None:
|
312 |
+
# Add a new column for organ mapping
|
313 |
+
indications_df['organ'] = indications_df.apply(
|
314 |
+
lambda row: map_indication_to_organ(row['indication_mesh_term'], row.get('areas')),
|
315 |
+
axis=1
|
316 |
+
)
|
317 |
+
|
318 |
+
# Display indications with their mapped organs
|
319 |
+
mapped_df = indications_df[['indication_mesh_term', 'organ']]
|
320 |
+
all_mappings = mapped_df.copy() # Save all mappings for reference
|
321 |
+
|
322 |
+
# Show only confident mappings
|
323 |
+
mapped_df = mapped_df[mapped_df['organ'].notnull()]
|
324 |
+
|
325 |
+
print(f"Successfully mapped {len(mapped_df)} out of {len(indications_df)} indications to organs.")
|
326 |
+
print(mapped_df.head(20)) # Display first 20 mappings
|
327 |
+
|
328 |
+
# Save the results to CSV files
|
329 |
+
mapped_df.to_csv('indication_to_organ_mapping_confident.tsv', index=False, sep='\t')
|
330 |
+
all_mappings.to_csv('indication_to_organ_mapping_all.tsv', index=False, sep='\t')
|
331 |
+
print("Mappings saved to 'indication_to_organ_mapping_confident.tsv'")
|
332 |
+
|
333 |
+
# Summary of organ distribution
|
334 |
+
if not mapped_df.empty:
|
335 |
+
organ_counts = mapped_df['organ'].value_counts()
|
336 |
+
print("\nDistribution of indications across organs:")
|
337 |
+
print(organ_counts)
|
338 |
+
|
339 |
+
# Indications that couldn't be confidently mapped
|
340 |
+
unmapped = indications_df[indications_df['organ'].isnull()]
|
341 |
+
print(f"\nNumber of indications that couldn't be confidently mapped: {len(unmapped)}")
|
342 |
+
|
343 |
+
if __name__ == "__main__":
|
344 |
+
main()
|
approval_prediction_benchmark.ipynb
ADDED
The diff for this file is too large to render.
See raw diff
|
|
classifier.py
ADDED
@@ -0,0 +1,293 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
import os
|
2 |
+
import argparse
|
3 |
+
import numpy as np
|
4 |
+
import pandas as pd
|
5 |
+
import matplotlib.pyplot as plt
|
6 |
+
import seaborn as sns
|
7 |
+
from sklearn.model_selection import train_test_split
|
8 |
+
from sklearn.preprocessing import OneHotEncoder, StandardScaler
|
9 |
+
from sklearn.metrics import roc_curve, auc, precision_recall_curve
|
10 |
+
import statsmodels.api as sm
|
11 |
+
# import warnings
|
12 |
+
# warnings.filterwarnings('ignore')
|
13 |
+
|
14 |
+
def load_data(file_path):
|
15 |
+
df = pd.read_csv(file_path, index_col=0)
|
16 |
+
return df
|
17 |
+
|
18 |
+
def explore_data(df):
|
19 |
+
print("Dataset shape:", df.shape)
|
20 |
+
print("\nFeature data types:")
|
21 |
+
print(df.dtypes)
|
22 |
+
print("\nCheck for missing values:")
|
23 |
+
print(df.isnull().sum())
|
24 |
+
|
25 |
+
# Check class balance for target variable
|
26 |
+
print("\nTarget variable distribution:")
|
27 |
+
target_dist = df['is_effective'].value_counts(normalize=True) * 100
|
28 |
+
print(target_dist)
|
29 |
+
|
30 |
+
return df
|
31 |
+
|
32 |
+
def analyze_feature_correlations(df):
|
33 |
+
numeric_cols = df.select_dtypes(include=['int64', 'float64']).columns.tolist()
|
34 |
+
corr_matrix = df[numeric_cols].corr(method='spearman')
|
35 |
+
|
36 |
+
#plt.figure(figsize=(5,5))
|
37 |
+
sns.heatmap(corr_matrix, annot=True, cmap='coolwarm', linewidths=0.5, fmt='.2f', annot_kws={"size": 8})
|
38 |
+
plt.title('Feature Correlation Matrix')
|
39 |
+
plt.tight_layout()
|
40 |
+
plt.savefig('feature_correlation_matrix.png', dpi=300, bbox_inches='tight')
|
41 |
+
plt.close()
|
42 |
+
|
43 |
+
# Show correlations with target variable
|
44 |
+
target_corr = corr_matrix['is_effective'].sort_values(ascending=False)
|
45 |
+
print("Correlations with target variable 'is_effective':")
|
46 |
+
print(target_corr)
|
47 |
+
|
48 |
+
return corr_matrix
|
49 |
+
|
50 |
+
def prepare_data(X, y, split_seed=42):
|
51 |
+
"""
|
52 |
+
Prepare data for model training by scaling numeric features and encoding categorical features.
|
53 |
+
|
54 |
+
Args:
|
55 |
+
X: DataFrame containing features. Expects indices to be drug-cell_line.
|
56 |
+
y: Series containing target variable
|
57 |
+
|
58 |
+
Returns:
|
59 |
+
X_train, X_test, y_train, y_test: Train-test split of prepared data
|
60 |
+
"""
|
61 |
+
|
62 |
+
# Assert that indices of X and y are the same
|
63 |
+
assert X.index.equals(y.index), "X and y must have the same indices"
|
64 |
+
|
65 |
+
# Extract drug and cell line info
|
66 |
+
drug_name = X.index.str.split('_CVCL_').str[0]
|
67 |
+
cell_line_name = 'CVCL_' + X.index.str.split('_CVCL_').str[1]
|
68 |
+
|
69 |
+
cat_cols = X.select_dtypes(include=['object', 'category']).columns.tolist()
|
70 |
+
num_cols = X.select_dtypes(include=['int64', 'float64']).columns.tolist()
|
71 |
+
# Create a copy of X to avoid modifying the original
|
72 |
+
X_processed = X.copy()
|
73 |
+
|
74 |
+
scaler = StandardScaler()
|
75 |
+
if num_cols:
|
76 |
+
X_processed[num_cols] = scaler.fit_transform(X_processed[num_cols])
|
77 |
+
|
78 |
+
if cat_cols:
|
79 |
+
encoder = OneHotEncoder(sparse_output=False, handle_unknown='ignore', drop='first')
|
80 |
+
encoded_cats = encoder.fit_transform(X_processed[cat_cols])
|
81 |
+
feature_names = encoder.get_feature_names_out(cat_cols)
|
82 |
+
|
83 |
+
encoded_df = pd.DataFrame(
|
84 |
+
encoded_cats,
|
85 |
+
columns=feature_names,
|
86 |
+
index=X_processed.index
|
87 |
+
)
|
88 |
+
|
89 |
+
X_processed = X_processed.drop(cat_cols, axis=1)
|
90 |
+
X_processed = pd.concat([X_processed, encoded_df], axis=1)
|
91 |
+
|
92 |
+
# Split based on unique drugs to prevent data leakage
|
93 |
+
unique_drugs = drug_name.unique()
|
94 |
+
train_drugs, test_drugs = train_test_split(
|
95 |
+
unique_drugs, test_size=0.8, random_state=split_seed
|
96 |
+
)
|
97 |
+
|
98 |
+
# Create train/test masks based on drug splits
|
99 |
+
train_mask = drug_name.isin(train_drugs)
|
100 |
+
test_mask = drug_name.isin(test_drugs)
|
101 |
+
|
102 |
+
# Split the data
|
103 |
+
X_train, X_test = X_processed.loc[train_mask], X_processed.loc[test_mask]
|
104 |
+
y_train, y_test = y.loc[train_mask], y.loc[test_mask]
|
105 |
+
|
106 |
+
# # Verify stratification is reasonable
|
107 |
+
# print(f"Train set positive rate: {y_train.mean():.4f}")
|
108 |
+
# print(f"Test set positive rate: {y_test.mean():.4f}")
|
109 |
+
|
110 |
+
# print(f"Training set: {X_train.shape}")
|
111 |
+
# print(f"Testing set: {X_test.shape}")
|
112 |
+
|
113 |
+
return X_train, X_test, y_train, y_test
|
114 |
+
|
115 |
+
def evaluate_model(model, X_test, y_test):
|
116 |
+
"""Evaluate model performance and return PR AUC score."""
|
117 |
+
X_test_const = sm.add_constant(X_test)
|
118 |
+
y_prob = model.predict(X_test_const)
|
119 |
+
y_pred = (y_prob > 0.5).astype(int)
|
120 |
+
|
121 |
+
# Calculate ROC AUC for model
|
122 |
+
fpr, tpr, _ = roc_curve(y_test, y_prob)
|
123 |
+
roc_auc = auc(fpr, tpr)
|
124 |
+
print(f"\nROC AUC: {roc_auc:.4f}")
|
125 |
+
|
126 |
+
# Calculate baseline ROC AUC (random classifier)
|
127 |
+
no_skill_prob = np.ones(len(y_test)) * np.mean(y_test)
|
128 |
+
fpr_baseline, tpr_baseline, _ = roc_curve(y_test, no_skill_prob)
|
129 |
+
roc_auc_baseline = auc(fpr_baseline, tpr_baseline)
|
130 |
+
print(f"Baseline ROC AUC: {roc_auc_baseline:.4f}")
|
131 |
+
|
132 |
+
# Calculate PR AUC for model
|
133 |
+
precision, recall, _ = precision_recall_curve(y_test, y_prob)
|
134 |
+
pr_auc = auc(recall, precision)
|
135 |
+
print(f"PR AUC: {pr_auc:.4f}")
|
136 |
+
|
137 |
+
# Calculate baseline PR AUC
|
138 |
+
no_skill = (y_test.sum()/y_test.shape[0])[0]
|
139 |
+
precision_baseline = np.ones_like(recall) * no_skill
|
140 |
+
pr_auc_baseline = auc(recall, precision_baseline)
|
141 |
+
print(f"Baseline PR AUC: {pr_auc_baseline:.4f}")
|
142 |
+
|
143 |
+
# # ROC curve with baseline comparison
|
144 |
+
# plt.figure(figsize=(5,5))
|
145 |
+
# plt.plot(fpr, tpr, color='darkorange', lw=2, label=f'Model ROC (AUC = {roc_auc:.2f})')
|
146 |
+
# plt.plot(fpr_baseline, tpr_baseline, color='green', lw=2, linestyle='--',
|
147 |
+
# label=f'Baseline ROC (AUC = {roc_auc_baseline:.2f})')
|
148 |
+
# plt.plot([0, 1], [0, 1], color='navy', lw=2, linestyle='--')
|
149 |
+
# plt.xlim([0.0, 1.0])
|
150 |
+
# plt.ylim([0.0, 1.05])
|
151 |
+
# plt.xlabel('False Positive Rate')
|
152 |
+
# plt.ylabel('True Positive Rate')
|
153 |
+
# plt.title('Receiver Operating Characteristic')
|
154 |
+
# plt.legend(loc='lower right')
|
155 |
+
# plt.tight_layout()
|
156 |
+
# plt.savefig('roc_curve.png')
|
157 |
+
|
158 |
+
# Plot Precision-Recall curve with baseline
|
159 |
+
plt.figure(figsize=(5,5))
|
160 |
+
plt.plot(recall, precision, color='blue', lw=2,
|
161 |
+
label=f'Model (AUC = {pr_auc:.2f})')
|
162 |
+
plt.plot([0, 1], [no_skill, no_skill], linestyle='--', color='red',
|
163 |
+
label=f'No Skill ({no_skill:.2f})')
|
164 |
+
plt.xlabel('Recall')
|
165 |
+
plt.ylabel('Precision')
|
166 |
+
plt.title('Precision-Recall Curve')
|
167 |
+
plt.legend()
|
168 |
+
plt.tight_layout()
|
169 |
+
plt.savefig('precision_recall_curve.png')
|
170 |
+
|
171 |
+
return y_pred, y_prob, pr_auc, pr_auc_baseline
|
172 |
+
|
173 |
+
def train_linear_model(X_train, y_train, alpha=0.01):
|
174 |
+
X_train_const = sm.add_constant(X_train)
|
175 |
+
final_logit = sm.Logit(y_train, X_train_const)
|
176 |
+
# Train model with L1 regularization (Lasso) and robust standard errors
|
177 |
+
final_model = final_logit.fit_regularized(
|
178 |
+
method='l1',
|
179 |
+
alpha=alpha,
|
180 |
+
cov_type='HC3',
|
181 |
+
trim_mode='auto',
|
182 |
+
maxiter=10_000
|
183 |
+
)
|
184 |
+
# Try L2 regularization (Ridge) if L1 fails to converge
|
185 |
+
if not hasattr(final_model, 'params'):
|
186 |
+
print("L1 regularization did not converge, trying L2...")
|
187 |
+
final_model = final_logit.fit_regularized(
|
188 |
+
method='l2',
|
189 |
+
alpha=alpha,
|
190 |
+
cov_type='HC3',
|
191 |
+
trim_mode='auto',
|
192 |
+
maxiter=10_000
|
193 |
+
)
|
194 |
+
train_pred_proba = final_model.predict(X_train_const)
|
195 |
+
train_precision, train_recall, _ = precision_recall_curve(y_train, train_pred_proba)
|
196 |
+
train_pr_auc = auc(train_recall, train_precision)
|
197 |
+
print(f"Model training Precision-Recall AUC: {train_pr_auc:.4f}")
|
198 |
+
fpr, tpr, _ = roc_curve(y_train, train_pred_proba)
|
199 |
+
train_roc_auc = auc(fpr, tpr)
|
200 |
+
print(f"Model training ROC AUC: {train_roc_auc:.4f}")
|
201 |
+
print(f"Regularization: alpha={alpha}")
|
202 |
+
return final_model
|
203 |
+
|
204 |
+
def analyze_coefficients(model, feature_names):
|
205 |
+
feature_names = ['const'] + feature_names.tolist()
|
206 |
+
coefficients = model.params
|
207 |
+
odds_ratios = np.exp(coefficients)
|
208 |
+
coef_df = pd.DataFrame({
|
209 |
+
'Feature': feature_names,
|
210 |
+
'Coefficient': coefficients,
|
211 |
+
'Odds_Ratio': odds_ratios,
|
212 |
+
'HC_Std_Error': model.bse,
|
213 |
+
'z_value': model.tvalues,
|
214 |
+
'p_value': model.pvalues,
|
215 |
+
'CI_Lower_95': model.conf_int(alpha=0.05).iloc[:, 0],
|
216 |
+
'CI_Upper_95': model.conf_int(alpha=0.05).iloc[:, 1]
|
217 |
+
})
|
218 |
+
|
219 |
+
# Sort by absolute coefficient value (excluding constant)
|
220 |
+
coef_df['Abs_Coefficient'] = np.abs(coef_df['Coefficient'])
|
221 |
+
coef_df = coef_df.sort_values('Abs_Coefficient', ascending=False).drop('Abs_Coefficient', axis=1)
|
222 |
+
|
223 |
+
# Add significance indicator
|
224 |
+
coef_df['Significant'] = coef_df['p_value'] < 0.05
|
225 |
+
|
226 |
+
# Print top significant coefficients (excluding constant)
|
227 |
+
print("\nTop significant features (p < 0.05):")
|
228 |
+
sig_features = coef_df[coef_df['Significant'] & (coef_df['Feature'] != 'const')]
|
229 |
+
if len(sig_features) > 0:
|
230 |
+
print(sig_features.head(10)[['Feature', 'Coefficient', 'p_value', 'Odds_Ratio', 'CI_Lower_95', 'CI_Upper_95']])
|
231 |
+
else:
|
232 |
+
print("No statistically significant features found.")
|
233 |
+
|
234 |
+
# Count significant coefficients (excluding constant)
|
235 |
+
n_significant = sum(coef_df['Significant'] & (coef_df['Feature'] != 'const'))
|
236 |
+
n_features = sum(coef_df['Feature'] != 'const')
|
237 |
+
print(f"\nNumber of significant coefficients (p < 0.05): {n_significant} out of {n_features}")
|
238 |
+
|
239 |
+
# Plot top coefficients with confidence intervals (excluding constant)
|
240 |
+
plt.figure(figsize=(5,5))
|
241 |
+
# Get top 15 features by absolute coefficient value (excluding constant)
|
242 |
+
top_coefs = coef_df[coef_df['Feature'] != 'const'].head(15)
|
243 |
+
# Plot coefficients with confidence intervals
|
244 |
+
colors = ['blue' if sig else 'gray' for sig in top_coefs['Significant']]
|
245 |
+
for i, (coef, ci_lower, ci_upper, color) in enumerate(zip(
|
246 |
+
top_coefs['Coefficient'],
|
247 |
+
top_coefs['CI_Lower_95'],
|
248 |
+
top_coefs['CI_Upper_95'],
|
249 |
+
colors)):
|
250 |
+
plt.errorbar(
|
251 |
+
x=coef,
|
252 |
+
y=i,
|
253 |
+
xerr=[[coef - ci_lower], [ci_upper - coef]],
|
254 |
+
fmt='o',
|
255 |
+
capsize=5,
|
256 |
+
color=color
|
257 |
+
)
|
258 |
+
# Add feature names as y-tick labels
|
259 |
+
plt.yticks(range(len(top_coefs)), top_coefs['Feature'])
|
260 |
+
plt.axvline(x=0, color='black', linestyle='-', alpha=0.3)
|
261 |
+
plt.title('Top Logistic Regression Coefficients with 95% CIs')
|
262 |
+
plt.xlabel('Coefficient Value')
|
263 |
+
plt.tight_layout()
|
264 |
+
plt.savefig('top_coefficients.png', dpi=300, bbox_inches='tight')
|
265 |
+
|
266 |
+
return coef_df
|
267 |
+
|
268 |
+
# def main():
|
269 |
+
# parser = argparse.ArgumentParser()
|
270 |
+
# parser.add_argument('--file_path', type=str, help='Path to the input CSV file')
|
271 |
+
# parser.add_argument('--output_dir', type=str, default='results', help='Directory to save results')
|
272 |
+
# args = parser.parse_args()
|
273 |
+
|
274 |
+
# if not os.path.exists(args.output_dir):
|
275 |
+
# os.makedirs(args.output_dir)
|
276 |
+
|
277 |
+
# df = load_data(args.file_path)
|
278 |
+
# df = explore_data(df)
|
279 |
+
# corr_matrix = analyze_feature_correlations(df)
|
280 |
+
# X_train, X_test, y_train, y_test = prepare_data(df)
|
281 |
+
# lr_model = train_linear_model(X_train, y_train)
|
282 |
+
# lr_pred, lr_prob = evaluate_model(lr_model, X_test, y_test)
|
283 |
+
# coef_df = analyze_coefficients(lr_model, X_train.columns)
|
284 |
+
|
285 |
+
# results = {
|
286 |
+
# 'logistic_regression': lr_model,
|
287 |
+
# 'lr_coefficients': coef_df,
|
288 |
+
# }
|
289 |
+
|
290 |
+
# return results, df
|
291 |
+
|
292 |
+
# if __name__ == "__main__":
|
293 |
+
# results, df = main()
|
clinical_data_curation/adverse_events_drug.py
ADDED
@@ -0,0 +1,137 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
from typing import List
|
2 |
+
import requests
|
3 |
+
import pandas as pd
|
4 |
+
import time
|
5 |
+
|
6 |
+
from datasets import load_dataset
|
7 |
+
from requests.adapters import HTTPAdapter
|
8 |
+
from urllib3.util.retry import Retry
|
9 |
+
|
10 |
+
# if getting bad gateway errors, try:
|
11 |
+
# Retry session setup
|
12 |
+
session = requests.Session()
|
13 |
+
retries = Retry(
|
14 |
+
total=5, # Retry up to 5 times
|
15 |
+
backoff_factor=1, # Wait 1s, then 2s, then 4s...
|
16 |
+
status_forcelist=[502, 503, 504],
|
17 |
+
allowed_methods=["GET"],
|
18 |
+
)
|
19 |
+
session.mount("https://", HTTPAdapter(max_retries=retries))
|
20 |
+
|
21 |
+
|
22 |
+
def get_faers_adverse_events(drug_name: str, limit: int = 100) -> List:
|
23 |
+
"""
|
24 |
+
Fetch and parse adverse event reports for a drug from openFDA FAERS.
|
25 |
+
Adds serious outcome flags and event context fields.
|
26 |
+
Args:
|
27 |
+
drug_name (str): The name of the drug to search for.
|
28 |
+
limit (int): The maximum number of records to fetch.
|
29 |
+
Returns:
|
30 |
+
List: A list of dictionaries containing adverse event data.
|
31 |
+
"""
|
32 |
+
print(f"Fetching FAERS data for: {drug_name}")
|
33 |
+
url = "https://api.fda.gov/drug/event.json"
|
34 |
+
params = {"search": f'patient.drug.medicinalproduct:"{drug_name}"', "limit": limit}
|
35 |
+
|
36 |
+
try:
|
37 |
+
response = requests.get(url, params=params, timeout=10)
|
38 |
+
response.raise_for_status()
|
39 |
+
results = response.json().get("results", [])
|
40 |
+
|
41 |
+
# Extract detailed adverse event fields
|
42 |
+
events = []
|
43 |
+
for entry in results:
|
44 |
+
patient = entry.get("patient", {})
|
45 |
+
reactions = [r.get("reactionmeddrapt") for r in patient.get("reaction", [])]
|
46 |
+
|
47 |
+
event = {
|
48 |
+
"drug_name": drug_name,
|
49 |
+
"safetyreportid": entry.get("safetyreportid"),
|
50 |
+
"serious": entry.get("serious"),
|
51 |
+
"seriousnessdeath": entry.get("seriousnessdeath"),
|
52 |
+
"seriousnesshospitalization": entry.get("seriousnesshospitalization"),
|
53 |
+
"seriousnessdisabling": entry.get("seriousnessdisabling"),
|
54 |
+
"seriousnesslifethreatening": entry.get("seriousnesslifethreatening"),
|
55 |
+
"seriousnesscongenitalanomali": entry.get("seriousnesscongenitalanomali"),
|
56 |
+
"reactions": reactions,
|
57 |
+
"receivedate": entry.get("receivedate"),
|
58 |
+
"occurcountry": entry.get("occurcountry"),
|
59 |
+
}
|
60 |
+
events.append(event)
|
61 |
+
print(f"Fetched {len(events)} events for {drug_name}")
|
62 |
+
|
63 |
+
return events
|
64 |
+
|
65 |
+
except requests.exceptions.RequestException as e:
|
66 |
+
print(f"Failed to fetch data for {drug_name}: {e}")
|
67 |
+
return []
|
68 |
+
|
69 |
+
|
70 |
+
def pull_faers_data(drug_list: List[str], output_filename_prefix: str) -> pd.DataFrame:
|
71 |
+
"""
|
72 |
+
Pull FAERS data for a list of drugs and save to CSV.
|
73 |
+
Args:
|
74 |
+
drug_list (List[str]): List of drug names to fetch data for.
|
75 |
+
"""
|
76 |
+
all_events = []
|
77 |
+
for drug in drug_list:
|
78 |
+
events = get_faers_adverse_events(drug, limit=100)
|
79 |
+
all_events.extend(events)
|
80 |
+
time.sleep(1) # be polite to openFDA rate limits
|
81 |
+
|
82 |
+
# Convert to DataFrame and show or save
|
83 |
+
df = pd.DataFrame(all_events)
|
84 |
+
df.to_csv(f"{output_filename_prefix}_faers_adverse_events.csv", index=False)
|
85 |
+
print(df.head(), df.shape)
|
86 |
+
return df
|
87 |
+
|
88 |
+
|
89 |
+
# example drug list
|
90 |
+
drug_list = ["pembrolizumab", "nivolumab", "ipilimumab"]
|
91 |
+
|
92 |
+
# test out fx
|
93 |
+
pull_faers_data(drug_list=drug_list, output_filename_prefix="test")
|
94 |
+
|
95 |
+
|
96 |
+
# load tahoe drug data metadata, gather the AEs for each unique drug
|
97 |
+
ds = load_dataset("tahoebio/Tahoe-100M", "drug_metadata")
|
98 |
+
drug_metadata = ds["train"].to_pandas()
|
99 |
+
|
100 |
+
# get adverse events for each unique drug in the tahoe dataset
|
101 |
+
tahoe_drug_list = drug_metadata["drug"].unique().tolist()
|
102 |
+
adverse_events = pull_faers_data(drug_list=tahoe_drug_list, output_filename_prefix="tahoe_drugs")
|
103 |
+
# adverse_events = pd.read_csv("tahoe_drugs_faers_adverse_events.csv")
|
104 |
+
|
105 |
+
# summarize the adverse events for each drug so we can try to predict the severity of a drug
|
106 |
+
def compute_severity_score(df: pd.DataFrame) -> float:
|
107 |
+
weights = {
|
108 |
+
"seriousnessdeath": 5,
|
109 |
+
"seriousnesslifethreatening": 4,
|
110 |
+
"seriousnesshospitalization": 3,
|
111 |
+
"seriousnessdisabling": 2,
|
112 |
+
"seriousnesscongenitalanomali": 1,
|
113 |
+
}
|
114 |
+
score = 0
|
115 |
+
for k, w in weights.items():
|
116 |
+
score += df[k].fillna("0").astype(int).sum() * w
|
117 |
+
return score
|
118 |
+
|
119 |
+
|
120 |
+
def compute_seriousness_ratio(df: pd.DataFrame) -> float:
|
121 |
+
"""
|
122 |
+
Compute the ratio of serious to non-serious adverse events.
|
123 |
+
"""
|
124 |
+
seriousness_ae_ratio = (
|
125 |
+
df.groupby("drug_name")["serious"]
|
126 |
+
.apply(lambda x: x.fillna("0").astype(int).mean())
|
127 |
+
.reset_index(name="mean_serious_flag")
|
128 |
+
)
|
129 |
+
return seriousness_ae_ratio
|
130 |
+
|
131 |
+
|
132 |
+
ae_score_df = adverse_events.groupby("drug_name").apply(compute_severity_score).reset_index(name="ae_severity_score")
|
133 |
+
seriousness_ratio = compute_seriousness_ratio(adverse_events)
|
134 |
+
|
135 |
+
# write out outputs
|
136 |
+
ae_score_df.to_csv("tahoe_drug_ae_severity_score.csv", index=False)
|
137 |
+
seriousness_ratio.to_csv("tahoe_drug_ae_seriousness_ratio.csv", index=False)
|
clinical_data_curation/drug_trials_extractor.py
ADDED
@@ -0,0 +1,707 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
import os
|
2 |
+
import requests
|
3 |
+
import pandas as pd
|
4 |
+
import json
|
5 |
+
import time
|
6 |
+
import re
|
7 |
+
from typing import List, Dict, Any, Union, Optional
|
8 |
+
|
9 |
+
import anthropic
|
10 |
+
|
11 |
+
class DrugTrialExtractor:
|
12 |
+
"""
|
13 |
+
A class to extract information about which drugs are in clinical trials and their indications
|
14 |
+
using PubChem IDs and clinical trials data sources.
|
15 |
+
"""
|
16 |
+
|
17 |
+
def __init__(self):
|
18 |
+
# Base URLs for APIs
|
19 |
+
self.pubchem_base_url = "https://pubchem.ncbi.nlm.nih.gov/rest/pug"
|
20 |
+
self.pubchem_view_url = "https://pubchem.ncbi.nlm.nih.gov/rest/pug_view/data/compound"
|
21 |
+
self.clinicaltrials_api_url = "https://clinicaltrials.gov/api/v2/studies"
|
22 |
+
|
23 |
+
# For rate limiting
|
24 |
+
self.request_delay = 0.5 # seconds between API requests
|
25 |
+
|
26 |
+
def get_drug_info_from_pubchem(self, pubchem_id: str) -> Dict[str, Any]:
|
27 |
+
"""
|
28 |
+
Get basic drug information from PubChem using a PubChem ID (CID)
|
29 |
+
|
30 |
+
Parameters:
|
31 |
+
-----------
|
32 |
+
pubchem_id : str
|
33 |
+
The PubChem Compound ID (CID)
|
34 |
+
|
35 |
+
Returns:
|
36 |
+
--------
|
37 |
+
Dict[str, Any]
|
38 |
+
Dictionary with drug information
|
39 |
+
"""
|
40 |
+
try:
|
41 |
+
# Validate the PubChem ID format
|
42 |
+
try:
|
43 |
+
# Ensure it's numeric and can be converted to integer
|
44 |
+
int(pubchem_id)
|
45 |
+
except ValueError:
|
46 |
+
return {
|
47 |
+
"pubchem_id": pubchem_id,
|
48 |
+
"error": "Invalid PubChem ID format - must be numeric"
|
49 |
+
}
|
50 |
+
|
51 |
+
# First check if the compound exists with a simple request
|
52 |
+
check_url = f"{self.pubchem_base_url}/compound/cid/{pubchem_id}/cids/JSON"
|
53 |
+
check_response = requests.get(check_url)
|
54 |
+
|
55 |
+
if check_response.status_code != 200:
|
56 |
+
error_msg = f"Error code {check_response.status_code}"
|
57 |
+
if check_response.status_code == 400:
|
58 |
+
error_msg = "PubChem ID doesn't exist or has been deprecated"
|
59 |
+
elif check_response.status_code == 404:
|
60 |
+
error_msg = "PubChem ID not found"
|
61 |
+
elif check_response.status_code == 429:
|
62 |
+
error_msg = "Rate limit exceeded - try again later"
|
63 |
+
|
64 |
+
return {"pubchem_id": pubchem_id, "error": error_msg}
|
65 |
+
|
66 |
+
# Get drug properties (name, formula, etc.)
|
67 |
+
property_url = f"{self.pubchem_base_url}/compound/cid/{pubchem_id}/property/IUPACName,MolecularFormula,MolecularWeight,CanonicalSMILES/JSON"
|
68 |
+
property_response = requests.get(property_url)
|
69 |
+
|
70 |
+
if property_response.status_code != 200:
|
71 |
+
print(f"Error retrieving properties for PubChem ID {pubchem_id}: {property_response.status_code}")
|
72 |
+
print(f"Response: {property_response.text}")
|
73 |
+
return {"pubchem_id": pubchem_id, "error": "Failed to retrieve properties"}
|
74 |
+
|
75 |
+
property_data = property_response.json()
|
76 |
+
|
77 |
+
# Add delay to respect rate limits
|
78 |
+
time.sleep(self.request_delay)
|
79 |
+
|
80 |
+
# Get synonyms to find common drug names
|
81 |
+
synonyms_url = f"{self.pubchem_base_url}/compound/cid/{pubchem_id}/synonyms/JSON"
|
82 |
+
synonyms_response = requests.get(synonyms_url)
|
83 |
+
|
84 |
+
if synonyms_response.status_code != 200:
|
85 |
+
print(f"Error retrieving synonyms for PubChem ID {pubchem_id}: {synonyms_response.status_code}")
|
86 |
+
synonyms = []
|
87 |
+
else:
|
88 |
+
synonyms_data = synonyms_response.json()
|
89 |
+
synonyms = synonyms_data.get("InformationList", {}).get("Information", [{}])[0].get("Synonym", [])
|
90 |
+
|
91 |
+
# Add delay to respect rate limits
|
92 |
+
time.sleep(self.request_delay)
|
93 |
+
|
94 |
+
# Compile the drug information
|
95 |
+
props = property_data.get("PropertyTable", {}).get("Properties", [{}])[0]
|
96 |
+
|
97 |
+
# Find the common name (usually a drug name) from synonyms
|
98 |
+
# This is heuristic-based and prioritizes known drug name patterns
|
99 |
+
common_name = None
|
100 |
+
drug_name_candidates = []
|
101 |
+
|
102 |
+
if synonyms:
|
103 |
+
for syn in synonyms:
|
104 |
+
# Skip very long names and suspected CAS numbers or identifiers
|
105 |
+
if len(syn) > 50 or bool(re.match(r'^\d+-\d+-\d+$', syn)):
|
106 |
+
continue
|
107 |
+
|
108 |
+
# Prioritize names that look like drug names (no special chars, not too long)
|
109 |
+
if len(syn) < 20 and syn.isalpha() and syn[0].isupper():
|
110 |
+
drug_name_candidates.append(syn)
|
111 |
+
|
112 |
+
# Sort by length (shorter names first)
|
113 |
+
drug_name_candidates.sort(key=len)
|
114 |
+
|
115 |
+
if drug_name_candidates:
|
116 |
+
common_name = drug_name_candidates[0]
|
117 |
+
else:
|
118 |
+
# Fallback to any reasonable synonym
|
119 |
+
sorted_synonyms = sorted([s for s in synonyms if len(s) < 30], key=len)
|
120 |
+
if sorted_synonyms:
|
121 |
+
common_name = sorted_synonyms[0]
|
122 |
+
|
123 |
+
drug_info = {
|
124 |
+
"pubchem_id": pubchem_id,
|
125 |
+
"iupac_name": props.get("IUPACName", ""),
|
126 |
+
"common_name": common_name,
|
127 |
+
"molecular_formula": props.get("MolecularFormula", ""),
|
128 |
+
"molecular_weight": props.get("MolecularWeight", ""),
|
129 |
+
"canonical_smiles": props.get("CanonicalSMILES", ""),
|
130 |
+
"synonyms": synonyms[:10] if len(synonyms) > 10 else synonyms # Limit to 10 synonyms
|
131 |
+
}
|
132 |
+
|
133 |
+
return drug_info
|
134 |
+
|
135 |
+
except Exception as e:
|
136 |
+
print(f"Error in get_drug_info_from_pubchem for ID {pubchem_id}: {str(e)}")
|
137 |
+
return {"pubchem_id": pubchem_id, "error": str(e)}
|
138 |
+
|
139 |
+
def get_clinical_trials_sections(self, pubchem_id: str) -> Optional[Dict[str, Any]]:
|
140 |
+
"""
|
141 |
+
Get the clinical trials sections from PubChem for a given compound
|
142 |
+
|
143 |
+
Parameters:
|
144 |
+
-----------
|
145 |
+
pubchem_id : str
|
146 |
+
The PubChem Compound ID (CID)
|
147 |
+
|
148 |
+
Returns:
|
149 |
+
--------
|
150 |
+
Optional[Dict[str, Any]]
|
151 |
+
Dictionary with clinical trials sections or None if not found
|
152 |
+
"""
|
153 |
+
try:
|
154 |
+
# Using PUG-View to get the clinical trials sections
|
155 |
+
url = f"{self.pubchem_view_url}/{pubchem_id}/JSON?response_type=display"
|
156 |
+
response = requests.get(url)
|
157 |
+
|
158 |
+
if response.status_code != 200:
|
159 |
+
print(f"Error retrieving clinical trials sections for PubChem ID {pubchem_id}: {response.status_code}")
|
160 |
+
return None
|
161 |
+
|
162 |
+
data = response.json()
|
163 |
+
|
164 |
+
# Navigate through the JSON to find the clinical trials section
|
165 |
+
record = data.get("Record", {})
|
166 |
+
section = record.get("Section", [])
|
167 |
+
|
168 |
+
clinical_trials_data = None
|
169 |
+
|
170 |
+
# Look for "Drug and Medication Information" section
|
171 |
+
for s in section:
|
172 |
+
if s.get("TOCHeading") == "Drug and Medication Information":
|
173 |
+
drug_section = s.get("Section", [])
|
174 |
+
for ds in drug_section:
|
175 |
+
if ds.get("TOCHeading") == "Clinical Trials":
|
176 |
+
clinical_trials_data = ds
|
177 |
+
break
|
178 |
+
break
|
179 |
+
|
180 |
+
return clinical_trials_data
|
181 |
+
|
182 |
+
except Exception as e:
|
183 |
+
print(f"Error in get_clinical_trials_sections for ID {pubchem_id}: {str(e)}")
|
184 |
+
return None
|
185 |
+
|
186 |
+
def extract_trials_from_pubchem(self, pubchem_id: str) -> List[Dict[str, Any]]:
|
187 |
+
"""
|
188 |
+
Extract clinical trials information from PubChem for a given compound ID
|
189 |
+
|
190 |
+
Parameters:
|
191 |
+
-----------
|
192 |
+
pubchem_id : str
|
193 |
+
The PubChem Compound ID (CID)
|
194 |
+
|
195 |
+
Returns:
|
196 |
+
--------
|
197 |
+
List[Dict[str, Any]]
|
198 |
+
List of dictionaries with clinical trial information
|
199 |
+
"""
|
200 |
+
clinical_trials_section = self.get_clinical_trials_sections(pubchem_id)
|
201 |
+
|
202 |
+
if not clinical_trials_section:
|
203 |
+
return []
|
204 |
+
|
205 |
+
trial_list = []
|
206 |
+
|
207 |
+
# Process the clinical trials section to extract trials information
|
208 |
+
try:
|
209 |
+
section_list = clinical_trials_section.get("Section", [])
|
210 |
+
|
211 |
+
for section in section_list:
|
212 |
+
source_name = section.get("TOCHeading", "Unknown Source")
|
213 |
+
|
214 |
+
# Look for information about trials in this source
|
215 |
+
info_list = section.get("Information", [])
|
216 |
+
|
217 |
+
for info in info_list:
|
218 |
+
if "ExternalTableName" in info.get("Value", {}):
|
219 |
+
# This means there are trials in this source
|
220 |
+
trial_list.append({
|
221 |
+
"pubchem_id": pubchem_id,
|
222 |
+
"source": source_name,
|
223 |
+
"has_trials": True,
|
224 |
+
"trial_count": info.get("Value", {}).get("ExternalTableNumRows", "Unknown")
|
225 |
+
})
|
226 |
+
|
227 |
+
except Exception as e:
|
228 |
+
print(f"Error extracting trials from PubChem for ID {pubchem_id}: {str(e)}")
|
229 |
+
|
230 |
+
return trial_list
|
231 |
+
|
232 |
+
def search_clinicaltrials_gov(self, drug_name: str, max_results: int = 100) -> List[Dict[str, Any]]:
|
233 |
+
"""
|
234 |
+
Search ClinicalTrials.gov for trials involving a specific drug
|
235 |
+
|
236 |
+
Parameters:
|
237 |
+
-----------
|
238 |
+
drug_name : str
|
239 |
+
The name of the drug to search for
|
240 |
+
max_results : int, optional
|
241 |
+
Maximum number of results to return (default 100)
|
242 |
+
|
243 |
+
Returns:
|
244 |
+
--------
|
245 |
+
List[Dict[str, Any]]
|
246 |
+
List of dictionaries with clinical trial information
|
247 |
+
"""
|
248 |
+
try:
|
249 |
+
# Skip names that are too long or complex as they'll likely cause a 400 error
|
250 |
+
if len(drug_name) > 150 or drug_name.count('[') > 2:
|
251 |
+
print(f"Skipping search for complex name: {drug_name}")
|
252 |
+
return []
|
253 |
+
|
254 |
+
# Using the new ClinicalTrials.gov API v2
|
255 |
+
params = {
|
256 |
+
"query.term": drug_name,
|
257 |
+
"pageSize": min(max_results, 100) # API limits to 1000 per request
|
258 |
+
}
|
259 |
+
|
260 |
+
trials = []
|
261 |
+
|
262 |
+
# Make initial request
|
263 |
+
response = requests.get(self.clinicaltrials_api_url, params=params)
|
264 |
+
|
265 |
+
if response.status_code != 200:
|
266 |
+
print(f"Error searching ClinicalTrials.gov for {drug_name}: {response.status_code}")
|
267 |
+
if response.status_code == 400:
|
268 |
+
# If it's a 400 Bad Request, the drug name is likely invalid for the API
|
269 |
+
print(f"Drug name '{drug_name}' is not valid for the ClinicalTrials.gov API.")
|
270 |
+
return []
|
271 |
+
|
272 |
+
data = response.json()
|
273 |
+
studies = data.get('studies', [])
|
274 |
+
|
275 |
+
# Process all studies from the first page
|
276 |
+
for study in studies:
|
277 |
+
try:
|
278 |
+
# Extract the protocol section which contains most of the important information
|
279 |
+
protocol = study.get("protocolSection", {})
|
280 |
+
|
281 |
+
# Extract identification information
|
282 |
+
identification = protocol.get("identificationModule", {})
|
283 |
+
nct_id = identification.get("nctId", "Unknown")
|
284 |
+
brief_title = identification.get("briefTitle", "Unknown")
|
285 |
+
|
286 |
+
# Extract status information
|
287 |
+
status_module = protocol.get("statusModule", {})
|
288 |
+
overall_status = status_module.get("overallStatus", "Unknown")
|
289 |
+
|
290 |
+
# FIXED: Extract phase information from designModule.phases array
|
291 |
+
design_module = protocol.get("designModule", {})
|
292 |
+
phases = design_module.get("phases", [])
|
293 |
+
phase = phases[0] if phases else "Unknown"
|
294 |
+
|
295 |
+
# Extract conditions
|
296 |
+
conditions_module = protocol.get("conditionsModule", {})
|
297 |
+
conditions = conditions_module.get("conditions", [])
|
298 |
+
|
299 |
+
# Extract interventions (drugs, etc.)
|
300 |
+
interventions = []
|
301 |
+
intervention_module = protocol.get("armsInterventionsModule", {})
|
302 |
+
intervention_list = intervention_module.get("interventions", [])
|
303 |
+
|
304 |
+
for intervention in intervention_list:
|
305 |
+
intervention_name = intervention.get("name", "")
|
306 |
+
intervention_type = intervention.get("type", "")
|
307 |
+
intervention_description = intervention.get("description", "")
|
308 |
+
|
309 |
+
interventions.append({
|
310 |
+
"name": intervention_name,
|
311 |
+
"type": intervention_type,
|
312 |
+
"description": intervention_description
|
313 |
+
})
|
314 |
+
|
315 |
+
# Create a dictionary for this trial
|
316 |
+
trial_info = {
|
317 |
+
"nct_id": nct_id,
|
318 |
+
"title": brief_title,
|
319 |
+
"status": overall_status,
|
320 |
+
"phase": phase,
|
321 |
+
"conditions": conditions,
|
322 |
+
"interventions": interventions
|
323 |
+
}
|
324 |
+
|
325 |
+
trials.append(trial_info)
|
326 |
+
|
327 |
+
except Exception as e:
|
328 |
+
print(f"Error processing study {study.get('protocolSection', {}).get('identificationModule', {}).get('nctId', 'Unknown')}: {str(e)}")
|
329 |
+
|
330 |
+
# Check if there are more pages
|
331 |
+
next_page_token = data.get("nextPageToken")
|
332 |
+
|
333 |
+
# Continue getting data if there's a next page and we haven't reached max_results
|
334 |
+
while next_page_token and len(trials) < max_results:
|
335 |
+
# Add delay to respect rate limits
|
336 |
+
time.sleep(self.request_delay)
|
337 |
+
|
338 |
+
# Update parameters with the next page token
|
339 |
+
params["pageToken"] = next_page_token
|
340 |
+
|
341 |
+
# Make the request for the next page
|
342 |
+
response = requests.get(self.clinicaltrials_api_url, params=params)
|
343 |
+
|
344 |
+
if response.status_code != 200:
|
345 |
+
print(f"Error retrieving next page for {drug_name}: {response.status_code}")
|
346 |
+
break
|
347 |
+
|
348 |
+
data = response.json()
|
349 |
+
studies = data.get("studies", [])
|
350 |
+
|
351 |
+
# Process all studies from this page
|
352 |
+
for study in studies:
|
353 |
+
if len(trials) >= max_results:
|
354 |
+
break
|
355 |
+
|
356 |
+
try:
|
357 |
+
# Extract the protocol section
|
358 |
+
protocol = study.get("protocolSection", {})
|
359 |
+
|
360 |
+
# Extract identification information
|
361 |
+
identification = protocol.get("identificationModule", {})
|
362 |
+
nct_id = identification.get("nctId", "Unknown")
|
363 |
+
brief_title = identification.get("briefTitle", "Unknown")
|
364 |
+
|
365 |
+
# Extract status information
|
366 |
+
status_module = protocol.get("statusModule", {})
|
367 |
+
overall_status = status_module.get("overallStatus", "Unknown")
|
368 |
+
|
369 |
+
# FIXED: Extract phase information from designModule.phases array
|
370 |
+
design_module = protocol.get("designModule", {})
|
371 |
+
phases = design_module.get("phases", [])
|
372 |
+
phase = phases[0] if phases else "Unknown"
|
373 |
+
|
374 |
+
# Extract conditions
|
375 |
+
conditions_module = protocol.get("conditionsModule", {})
|
376 |
+
conditions = conditions_module.get("conditions", [])
|
377 |
+
|
378 |
+
# Extract interventions (drugs, etc.)
|
379 |
+
interventions = []
|
380 |
+
intervention_module = protocol.get("armsInterventionsModule", {})
|
381 |
+
intervention_list = intervention_module.get("interventions", [])
|
382 |
+
|
383 |
+
for intervention in intervention_list:
|
384 |
+
intervention_name = intervention.get("name", "")
|
385 |
+
intervention_type = intervention.get("type", "")
|
386 |
+
intervention_description = intervention.get("description", "")
|
387 |
+
|
388 |
+
interventions.append({
|
389 |
+
"name": intervention_name,
|
390 |
+
"type": intervention_type,
|
391 |
+
"description": intervention_description
|
392 |
+
})
|
393 |
+
|
394 |
+
# Create a dictionary for this trial
|
395 |
+
trial_info = {
|
396 |
+
"nct_id": nct_id,
|
397 |
+
"title": brief_title,
|
398 |
+
"status": overall_status,
|
399 |
+
"phase": phase,
|
400 |
+
"conditions": conditions,
|
401 |
+
"interventions": interventions
|
402 |
+
}
|
403 |
+
|
404 |
+
trials.append(trial_info)
|
405 |
+
|
406 |
+
except Exception as e:
|
407 |
+
print(f"Error processing study {study.get('protocolSection', {}).get('identificationModule', {}).get('nctId', 'Unknown')}: {str(e)}")
|
408 |
+
|
409 |
+
# Update the next page token for the next iteration
|
410 |
+
next_page_token = data.get("nextPageToken")
|
411 |
+
|
412 |
+
return trials
|
413 |
+
|
414 |
+
except Exception as e:
|
415 |
+
print(f"Error in search_clinicaltrials_gov for drug {drug_name}: {str(e)}")
|
416 |
+
return []
|
417 |
+
|
418 |
+
def get_trials_for_drug(self, pubchem_id: str, max_results: int = 100) -> Dict[str, Any]:
|
419 |
+
"""
|
420 |
+
Get complete clinical trial information for a drug with the given PubChem ID
|
421 |
+
|
422 |
+
Parameters:
|
423 |
+
-----------
|
424 |
+
pubchem_id : str
|
425 |
+
The PubChem Compound ID (CID)
|
426 |
+
max_results : int, optional
|
427 |
+
Maximum number of clinical trials to retrieve per drug (default 100)
|
428 |
+
|
429 |
+
Returns:
|
430 |
+
--------
|
431 |
+
Dict[str, Any]
|
432 |
+
Dictionary with drug information and associated clinical trials
|
433 |
+
"""
|
434 |
+
# Get drug information
|
435 |
+
drug_info = self.get_drug_info_from_pubchem(pubchem_id)
|
436 |
+
|
437 |
+
# Check if PubChem has clinical trials information
|
438 |
+
pubchem_trials_info = self.extract_trials_from_pubchem(pubchem_id)
|
439 |
+
|
440 |
+
# Search ClinicalTrials.gov using drug names
|
441 |
+
trials = []
|
442 |
+
|
443 |
+
# Try with common name first as it's most likely to work
|
444 |
+
if drug_info.get("common_name"):
|
445 |
+
print(f"Searching ClinicalTrials.gov for common name: {drug_info['common_name']}")
|
446 |
+
trials.extend(self.search_clinicaltrials_gov(drug_info["common_name"], max_results))
|
447 |
+
|
448 |
+
# Try with a filtered list of synonyms (prioritizing drug names over chemical identifiers)
|
449 |
+
if len(trials) < max_results and drug_info.get("synonyms"):
|
450 |
+
drug_synonyms = []
|
451 |
+
for synonym in drug_info.get("synonyms", []):
|
452 |
+
# Skip long and complex names, molecular identifiers, and registry numbers
|
453 |
+
if (len(synonym) < 30 and
|
454 |
+
not any(char in synonym for char in "[](){}-=") and
|
455 |
+
not synonym.isdigit() and
|
456 |
+
not bool(re.match(r'^\d+-\d+-\d+$', synonym))): # Skip CAS registry numbers
|
457 |
+
drug_synonyms.append(synonym)
|
458 |
+
|
459 |
+
# Prioritize shorter names as they're more likely to be common drug names
|
460 |
+
drug_synonyms.sort(key=len)
|
461 |
+
|
462 |
+
# Try up to 3 prioritized synonyms
|
463 |
+
for synonym in drug_synonyms[:3]:
|
464 |
+
if len(trials) >= max_results:
|
465 |
+
break
|
466 |
+
|
467 |
+
print(f"Searching ClinicalTrials.gov for synonym: {synonym}")
|
468 |
+
try:
|
469 |
+
more_trials = self.search_clinicaltrials_gov(synonym, max_results - len(trials))
|
470 |
+
|
471 |
+
# Filter to avoid duplicates
|
472 |
+
existing_nct_ids = {t["nct_id"] for t in trials}
|
473 |
+
for trial in more_trials:
|
474 |
+
if trial["nct_id"] not in existing_nct_ids:
|
475 |
+
trials.append(trial)
|
476 |
+
existing_nct_ids.add(trial["nct_id"])
|
477 |
+
except Exception as e:
|
478 |
+
print(f"Error searching for synonym {synonym}: {str(e)}")
|
479 |
+
|
480 |
+
# As a last resort, try with IUPAC name (least likely to work with clinical trials API)
|
481 |
+
if len(trials) < max_results and len(trials) == 0 and drug_info.get("iupac_name"):
|
482 |
+
# Only use IUPAC name if it's reasonably short
|
483 |
+
if len(drug_info["iupac_name"]) < 100: # Avoid extremely long IUPAC names
|
484 |
+
print(f"Searching ClinicalTrials.gov for IUPAC name: {drug_info['iupac_name']}")
|
485 |
+
try:
|
486 |
+
more_trials = self.search_clinicaltrials_gov(drug_info["iupac_name"], max_results - len(trials))
|
487 |
+
|
488 |
+
# Filter to avoid duplicates
|
489 |
+
existing_nct_ids = {t["nct_id"] for t in trials}
|
490 |
+
for trial in more_trials:
|
491 |
+
if trial["nct_id"] not in existing_nct_ids:
|
492 |
+
trials.append(trial)
|
493 |
+
existing_nct_ids.add(trial["nct_id"])
|
494 |
+
except Exception as e:
|
495 |
+
print(f"Error searching for IUPAC name: {str(e)}")
|
496 |
+
|
497 |
+
# Compile results
|
498 |
+
result = {
|
499 |
+
"drug_info": drug_info,
|
500 |
+
"pubchem_trials_info": pubchem_trials_info,
|
501 |
+
"clinicaltrials_gov_trials": trials,
|
502 |
+
}
|
503 |
+
|
504 |
+
return result
|
505 |
+
|
506 |
+
def process_multiple_drugs(self, pubchem_ids: List[str], max_results_per_drug: int = 100) -> Dict[str, List[Dict[str, Any]]]:
|
507 |
+
"""
|
508 |
+
Process multiple drugs and get their clinical trial information
|
509 |
+
|
510 |
+
Parameters:
|
511 |
+
-----------
|
512 |
+
pubchem_ids : List[str]
|
513 |
+
List of PubChem Compound IDs (CIDs)
|
514 |
+
max_results_per_drug : int, optional
|
515 |
+
Maximum number of clinical trials to retrieve per drug (default 100)
|
516 |
+
|
517 |
+
Returns:
|
518 |
+
--------
|
519 |
+
Dict[str, List[Dict[str, Any]]]
|
520 |
+
Dictionary with results for each drug
|
521 |
+
"""
|
522 |
+
results = {}
|
523 |
+
|
524 |
+
for pubchem_id in pubchem_ids:
|
525 |
+
print(f"Processing PubChem ID: {pubchem_id}")
|
526 |
+
drug_results = self.get_trials_for_drug(pubchem_id, max_results_per_drug)
|
527 |
+
results[pubchem_id] = drug_results
|
528 |
+
|
529 |
+
# Add delay to respect rate limits
|
530 |
+
time.sleep(self.request_delay)
|
531 |
+
|
532 |
+
return results
|
533 |
+
|
534 |
+
def save_results_to_csv(self, results: Dict[str, Any], output_prefix: str = "drug_trials") -> Dict[str, str]:
|
535 |
+
"""
|
536 |
+
Save the results to CSV files
|
537 |
+
|
538 |
+
Parameters:
|
539 |
+
-----------
|
540 |
+
results : Dict[str, Any]
|
541 |
+
Results from process_multiple_drugs
|
542 |
+
output_prefix : str, optional
|
543 |
+
Prefix for output CSV files (default "drug_trials")
|
544 |
+
|
545 |
+
Returns:
|
546 |
+
--------
|
547 |
+
Dict[str, str]
|
548 |
+
Dictionary with paths to the output files
|
549 |
+
"""
|
550 |
+
# Create DataFrames
|
551 |
+
drug_info_rows = []
|
552 |
+
all_trials = []
|
553 |
+
pubchem_trials_rows = []
|
554 |
+
|
555 |
+
for pubchem_id, drug_data in results.items():
|
556 |
+
# Add drug info
|
557 |
+
drug_info = drug_data.get("drug_info", {})
|
558 |
+
drug_info_rows.append(drug_info)
|
559 |
+
|
560 |
+
# Add PubChem trials info
|
561 |
+
for trial_info in drug_data.get("pubchem_trials_info", []):
|
562 |
+
pubchem_trials_rows.append(trial_info)
|
563 |
+
|
564 |
+
# Add ClinicalTrials.gov trials
|
565 |
+
for trial in drug_data.get("clinicaltrials_gov_trials", []):
|
566 |
+
trial_copy = trial.copy()
|
567 |
+
|
568 |
+
# Add drug info to the trial
|
569 |
+
trial_copy["pubchem_id"] = pubchem_id
|
570 |
+
trial_copy["drug_name"] = drug_info.get("common_name", drug_info.get("iupac_name", ""))
|
571 |
+
|
572 |
+
# Convert lists to strings for CSV
|
573 |
+
if "conditions" in trial_copy:
|
574 |
+
trial_copy["conditions"] = "; ".join(trial_copy["conditions"])
|
575 |
+
|
576 |
+
if "interventions" in trial_copy:
|
577 |
+
interventions_list = trial_copy["interventions"]
|
578 |
+
intervention_strings = []
|
579 |
+
|
580 |
+
for intervention in interventions_list:
|
581 |
+
int_str = f"{intervention.get('name', '')} ({intervention.get('type', '')})"
|
582 |
+
intervention_strings.append(int_str)
|
583 |
+
|
584 |
+
trial_copy["interventions"] = "; ".join(intervention_strings)
|
585 |
+
|
586 |
+
all_trials.append(trial_copy)
|
587 |
+
|
588 |
+
# Create DataFrames
|
589 |
+
drug_info_df = pd.DataFrame(drug_info_rows)
|
590 |
+
trials_df = pd.DataFrame(all_trials)
|
591 |
+
pubchem_trials_df = pd.DataFrame(pubchem_trials_rows)
|
592 |
+
|
593 |
+
# Save to CSV
|
594 |
+
drug_info_path = f"{output_prefix}_drug_info.csv"
|
595 |
+
trials_path = f"{output_prefix}_clinical_trials.csv"
|
596 |
+
pubchem_trials_path = f"{output_prefix}_pubchem_trials_info.csv"
|
597 |
+
|
598 |
+
drug_info_df.to_csv(drug_info_path, index=False)
|
599 |
+
trials_df.to_csv(trials_path, index=False)
|
600 |
+
pubchem_trials_df.to_csv(pubchem_trials_path, index=False)
|
601 |
+
|
602 |
+
return {
|
603 |
+
"drug_info": drug_info_path,
|
604 |
+
"clinical_trials": trials_path,
|
605 |
+
"pubchem_trials_info": pubchem_trials_path
|
606 |
+
}
|
607 |
+
|
608 |
+
# In your shared code:
|
609 |
+
def get_anthropic_client():
|
610 |
+
# Get API key from environment variable
|
611 |
+
api_key = os.environ.get("ANTHROPIC_API_KEY")
|
612 |
+
|
613 |
+
if not api_key:
|
614 |
+
raise ValueError("Missing ANTHROPIC_API_KEY environment variable")
|
615 |
+
|
616 |
+
return anthropic.Anthropic(api_key=api_key)
|
617 |
+
|
618 |
+
def standardize_medical_conditions(disease_list):
|
619 |
+
"""
|
620 |
+
Standardizes a list of medical conditions using Claude API to identify and group similar conditions.
|
621 |
+
|
622 |
+
Args:
|
623 |
+
disease_list (list): List of medical condition strings to standardize
|
624 |
+
api_key (str): Your Anthropic API key
|
625 |
+
|
626 |
+
Returns:
|
627 |
+
pandas.DataFrame: DataFrame with original conditions and their standardized labels
|
628 |
+
"""
|
629 |
+
# Initialize the Claude client
|
630 |
+
client = get_anthropic_client()
|
631 |
+
|
632 |
+
# Create chunks if your list is very large (Claude has context limits)
|
633 |
+
chunk_size = 50 # Adjust based on your needs
|
634 |
+
all_groups = {}
|
635 |
+
|
636 |
+
# Remove duplicates to reduce API costs while processing
|
637 |
+
unique_diseases = list(set(disease_list))
|
638 |
+
|
639 |
+
for i in range(0, len(unique_diseases), chunk_size):
|
640 |
+
chunk = unique_diseases[i:i+chunk_size]
|
641 |
+
|
642 |
+
# Format the prompt for Claude
|
643 |
+
formatted_diseases = "\n".join([f"- {d}" for d in chunk])
|
644 |
+
|
645 |
+
prompt = f"""
|
646 |
+
Here's a list of medical conditions:
|
647 |
+
{formatted_diseases}
|
648 |
+
|
649 |
+
Please group these conditions into standardized categories where entries refer to the same basic condition.
|
650 |
+
For each group, select the most appropriate, specific, and concise label.
|
651 |
+
|
652 |
+
IMPORTANT: Only group conditions when there's a clear case for doing so. When a condition is unique or
|
653 |
+
doesn't clearly fit with others, keep it as its own separate category.
|
654 |
+
|
655 |
+
Examples:
|
656 |
+
- "Prostate Cancer" and "Prostate Cancer; Prostate Adenocarcinoma" can be grouped as "Prostate Cancer"
|
657 |
+
- But "Small Cell Lung Cancer" should NOT be grouped with "Non-Small Cell Lung Cancer" as they are distinct conditions
|
658 |
+
- "Diabetes" and "Diabetes Mellitus Type 2" can be grouped, but should use the more specific "Diabetes Mellitus Type 2" as the label
|
659 |
+
|
660 |
+
Format your response as a JSON dictionary where keys are the standardized labels and values are
|
661 |
+
lists of all original terms that should map to that label. Include every term from the input list.
|
662 |
+
"""
|
663 |
+
|
664 |
+
# Call Claude API
|
665 |
+
message = client.messages.create(
|
666 |
+
model="claude-3-7-sonnet-20250219",
|
667 |
+
max_tokens=4000,
|
668 |
+
temperature=0, # Keep it deterministic
|
669 |
+
system="You are a medical terminology expert. Follow instructions exactly.",
|
670 |
+
messages=[
|
671 |
+
{"role": "user", "content": prompt}
|
672 |
+
]
|
673 |
+
)
|
674 |
+
|
675 |
+
# Extract JSON from response
|
676 |
+
response_content = message.content[0].text
|
677 |
+
json_match = re.search(r'```(?:json)?\s*([\s\S]*?)\s*```', response_content)
|
678 |
+
|
679 |
+
if json_match:
|
680 |
+
json_str = json_match.group(1)
|
681 |
+
else:
|
682 |
+
# If no code block, try to find JSON directly
|
683 |
+
json_str = response_content
|
684 |
+
|
685 |
+
try:
|
686 |
+
chunk_groups = json.loads(json_str)
|
687 |
+
all_groups.update(chunk_groups)
|
688 |
+
except json.JSONDecodeError:
|
689 |
+
print(f"Warning: Could not parse JSON for chunk {i}. Skipping this chunk.")
|
690 |
+
continue
|
691 |
+
|
692 |
+
# Convert to a mapping dictionary
|
693 |
+
condition_mapping = {}
|
694 |
+
for standard_label, variants in all_groups.items():
|
695 |
+
for variant in variants:
|
696 |
+
condition_mapping[variant] = standard_label
|
697 |
+
|
698 |
+
# Apply mapping to original list (preserving order and duplicates)
|
699 |
+
mapped_diseases = [condition_mapping.get(disease, disease) for disease in disease_list]
|
700 |
+
|
701 |
+
# Create a DataFrame with the results
|
702 |
+
result_df = pd.DataFrame({
|
703 |
+
"Original": disease_list,
|
704 |
+
"Standardized": mapped_diseases
|
705 |
+
})
|
706 |
+
|
707 |
+
return result_df
|
clinical_data_curation/drugs_organs_approved.csv
ADDED
@@ -0,0 +1,377 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
pubchem_id,Bladder/Urinary Tract,Bowel,Breast,CNS/Brain,Cervix,Esophagus/Stomach,Kidney,Liver,Lung,Ovary/Fallopian Tube,Pancreas,Peripheral Nervous System,Skin,Uterus
|
2 |
+
104741,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
3 |
+
74990,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
4 |
+
60838,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
5 |
+
9887053,0,1,0,0,0,1,0,1,0,0,1,0,0,0
|
6 |
+
135410875,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
7 |
+
65348,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
8 |
+
176870,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
9 |
+
36314,1,0,1,0,0,1,0,0,1,0,0,0,0,0
|
10 |
+
2187,0,0,1,1,0,0,0,0,0,0,0,0,0,1
|
11 |
+
60699,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
12 |
+
60750,0,0,0,0,0,0,0,0,1,0,1,0,0,0
|
13 |
+
5281004,0,1,0,0,0,1,1,0,1,0,0,0,0,0
|
14 |
+
148124,0,0,1,0,0,1,0,0,0,0,0,0,0,0
|
15 |
+
23725625,0,0,0,0,0,0,1,0,0,1,0,0,0,0
|
16 |
+
5329102,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
17 |
+
3385,0,1,1,0,0,1,0,1,1,1,0,0,1,0
|
18 |
+
5330286,0,0,1,0,0,0,1,0,0,0,0,0,0,0
|
19 |
+
123631,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
20 |
+
78357807,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
21 |
+
6918289,0,0,1,0,0,0,1,1,1,0,0,0,0,0
|
22 |
+
11167602,0,1,0,0,0,0,1,0,0,0,0,0,0,0
|
23 |
+
443939,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
24 |
+
135398658,0,1,0,0,0,0,0,1,1,0,0,0,1,0
|
25 |
+
2563,0,0,0,1,0,0,0,0,0,0,0,1,0,0
|
26 |
+
10184665,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
27 |
+
46220502,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
28 |
+
25102846,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
29 |
+
444795,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
30 |
+
11707110,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
31 |
+
6256,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
32 |
+
16052011,0,0,1,0,0,0,0,0,0,0,0,0,0,1
|
33 |
+
44631912,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
34 |
+
10184653,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
35 |
+
445639,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
36 |
+
11626560,0,0,0,0,0,0,0,0,1,0,0,0,0,1
|
37 |
+
168311648,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
38 |
+
135398744,0,0,0,0,0,0,0,1,1,0,0,1,0,0
|
39 |
+
1054,0,1,0,0,0,1,1,0,1,0,0,0,0,1
|
40 |
+
119607,1,1,0,1,0,0,1,0,0,0,1,0,1,1
|
41 |
+
42611257,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
42 |
+
60961,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
43 |
+
10288191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
44 |
+
6436173,0,1,0,0,0,0,1,1,0,0,0,0,0,0
|
45 |
+
4594,0,1,0,1,0,1,0,0,0,0,1,0,0,0
|
46 |
+
12108541,0,1,0,1,0,1,0,0,0,0,1,0,0,0
|
47 |
+
16923,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
48 |
+
3100,0,1,0,0,0,0,1,1,1,0,0,0,1,0
|
49 |
+
21800,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
50 |
+
54684461,1,1,0,1,0,0,1,0,1,0,0,0,1,0
|
51 |
+
5284373,0,1,0,0,0,1,1,1,1,0,0,0,1,0
|
52 |
+
44462760,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
53 |
+
24906252,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
54 |
+
2662,1,1,0,0,0,0,0,1,0,0,1,0,0,1
|
55 |
+
5388983,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
56 |
+
107969,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
57 |
+
4740,0,1,0,1,0,0,1,1,1,0,0,0,0,0
|
58 |
+
4829,0,0,0,0,0,0,1,1,1,1,0,0,0,0
|
59 |
+
56649450,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
60 |
+
5564,0,0,1,0,0,0,0,0,0,0,0,0,1,0
|
61 |
+
3657,1,1,0,0,0,0,1,1,1,1,0,0,1,0
|
62 |
+
12560,0,0,0,0,0,1,0,0,1,0,1,0,1,0
|
63 |
+
50922675,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
64 |
+
6419992,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
65 |
+
637568,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
66 |
+
110635,1,0,0,1,0,0,1,0,1,0,0,0,0,0
|
67 |
+
468595,1,1,0,1,0,0,1,1,0,0,0,0,1,0
|
68 |
+
16222096,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
69 |
+
135400182,0,1,0,0,0,0,0,1,0,0,0,0,1,0
|
70 |
+
9887712,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
71 |
+
16760658,1,0,0,0,0,0,1,1,1,0,0,0,1,0
|
72 |
+
249332,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
73 |
+
24776445,0,0,0,0,0,1,1,0,0,0,0,0,1,0
|
74 |
+
3081361,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
75 |
+
126941,0,1,0,1,0,0,0,0,0,0,0,0,1,0
|
76 |
+
67307512,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
77 |
+
9915743,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
78 |
+
451668,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
79 |
+
6442177,0,1,0,1,1,0,1,1,0,0,0,0,1,0
|
80 |
+
10174505,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
81 |
+
9926791,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
82 |
+
2244,1,1,0,1,0,1,0,0,1,0,0,0,0,0
|
83 |
+
31307,1,1,0,1,1,0,1,1,0,0,0,0,1,0
|
84 |
+
387447,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
85 |
+
52920501,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
86 |
+
392622,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
87 |
+
12136798,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
88 |
+
2754,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
89 |
+
23679632,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
90 |
+
6112,0,0,1,0,0,0,1,1,0,0,0,1,0,0
|
91 |
+
2812,0,0,1,0,0,0,1,0,1,0,0,0,0,0
|
92 |
+
19090,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
93 |
+
4055,0,1,0,1,0,0,1,0,1,0,0,0,0,0
|
94 |
+
77995,1,1,0,1,0,1,0,1,1,1,0,0,0,0
|
95 |
+
6279,0,0,1,0,0,0,0,0,0,1,0,0,0,1
|
96 |
+
5282164,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
97 |
+
11672905,0,1,0,1,0,0,0,0,1,0,0,1,0,0
|
98 |
+
25145656,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
99 |
+
3578572,1,1,0,1,0,0,0,1,0,0,0,0,0,0
|
100 |
+
156391,1,1,0,0,0,0,1,0,0,0,0,0,0,0
|
101 |
+
72165228,1,0,0,0,0,0,0,0,1,0,0,0,0,0
|
102 |
+
190,0,0,1,1,0,0,0,0,0,0,0,0,0,0
|
103 |
+
16004692,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
104 |
+
9931953,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
105 |
+
3339,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
106 |
+
5743,1,0,1,0,1,0,0,0,1,0,0,0,0,0
|
107 |
+
9444,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
108 |
+
24788740,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
109 |
+
441243,0,0,0,0,0,0,0,1,0,0,0,0,1,0
|
110 |
+
157921,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
111 |
+
156419,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
112 |
+
5284443,0,0,0,1,0,1,0,0,1,0,0,1,0,0
|
113 |
+
71481097,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
114 |
+
11557040,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
115 |
+
2554,0,0,0,1,0,0,0,0,0,0,0,1,0,0
|
116 |
+
135401907,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
117 |
+
445154,0,0,0,0,0,0,0,0,0,0,1,0,1,1
|
118 |
+
2123,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
119 |
+
24775005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
120 |
+
5311068,1,0,1,1,0,1,1,1,1,0,1,0,0,0
|
121 |
+
6321424,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
122 |
+
14296,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
123 |
+
11256664,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
124 |
+
2478,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
125 |
+
51082,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
126 |
+
60606,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
127 |
+
6314,1,1,0,1,0,0,0,0,1,0,0,1,0,0
|
128 |
+
25022378,0,0,0,1,0,0,1,0,1,0,0,0,0,0
|
129 |
+
8813,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
130 |
+
370,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
131 |
+
148195,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
132 |
+
45375953,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
133 |
+
5381,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
134 |
+
165411828,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
135 |
+
25227436,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
136 |
+
68873,0,0,1,0,0,0,0,0,0,1,0,0,0,0
|
137 |
+
51039094,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
138 |
+
117947097,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
139 |
+
6253,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
140 |
+
2375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
141 |
+
5493444,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
142 |
+
6029,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
143 |
+
24785956,0,0,0,1,0,0,0,0,0,0,0,0,0,1
|
144 |
+
20179,0,0,0,0,0,0,1,0,0,0,0,0,0,1
|
145 |
+
53235510,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
146 |
+
56959,0,0,0,0,0,0,1,0,1,0,0,0,1,0
|
147 |
+
65628,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
148 |
+
441074,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
149 |
+
4495,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
150 |
+
24812758,0,0,0,1,0,0,1,0,0,1,0,0,0,0
|
151 |
+
10461508,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
152 |
+
24997615,0,0,0,1,0,0,1,0,0,1,0,0,0,0
|
153 |
+
67462786,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
154 |
+
86705695,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
155 |
+
25141092,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
156 |
+
10348973,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
157 |
+
636362,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
158 |
+
2520,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
159 |
+
5823908,0,0,0,1,0,0,1,0,1,0,0,0,0,0
|
160 |
+
138611145,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
161 |
+
3034010,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
162 |
+
6918638,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
163 |
+
4463,0,0,0,1,0,0,0,1,0,0,0,0,0,0
|
164 |
+
338,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
165 |
+
56671814,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
166 |
+
71621331,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
167 |
+
9821849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
168 |
+
60490,0,0,0,0,0,0,0,0,1,0,0,1,0,0
|
169 |
+
49831257,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
170 |
+
135398745,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
171 |
+
2435,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
172 |
+
135413536,0,0,1,0,0,0,0,0,0,1,0,0,0,0
|
173 |
+
441313,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
174 |
+
656656,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
175 |
+
92727,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
176 |
+
5583,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
177 |
+
3440,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
178 |
+
6480466,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
179 |
+
56844015,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
180 |
+
25183872,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
181 |
+
21585658,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
182 |
+
71616,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
183 |
+
444972,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
184 |
+
55245,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
185 |
+
4030,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
186 |
+
9082,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
187 |
+
11950170,1,0,0,0,0,0,0,0,1,0,0,0,0,0
|
188 |
+
6918111,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
189 |
+
5284616,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
190 |
+
164726578,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
191 |
+
667493,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
192 |
+
2179,0,1,0,1,0,0,0,0,0,0,0,0,0,0
|
193 |
+
71576688,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
194 |
+
6252,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
195 |
+
3397,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
196 |
+
135526609,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
197 |
+
5282451,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
198 |
+
5905,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
199 |
+
14992,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
200 |
+
46926350,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
201 |
+
49846579,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
202 |
+
24826799,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
203 |
+
5509,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
204 |
+
118869362,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
205 |
+
5311180,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
206 |
+
22049997,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
207 |
+
9853654,0,0,0,0,0,1,0,0,0,0,0,0,0,0
|
208 |
+
44582816,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
209 |
+
162368359,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
210 |
+
58507717,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
211 |
+
24872560,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
212 |
+
148123,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
213 |
+
146681181,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
214 |
+
67171867,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
215 |
+
11570805,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
216 |
+
25166913,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
217 |
+
67330085,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
218 |
+
16362,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
219 |
+
121408882,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
220 |
+
1923,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
221 |
+
126689157,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
222 |
+
118598754,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
223 |
+
72172,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
224 |
+
4659569,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
225 |
+
4922,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
226 |
+
9415,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
227 |
+
445858,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
228 |
+
5324346,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
229 |
+
9560989,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
230 |
+
3463,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
231 |
+
3000226,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
232 |
+
46188928,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
233 |
+
10114,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
234 |
+
53340664,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
235 |
+
6918837,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
236 |
+
119182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
237 |
+
6989,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
238 |
+
67501411,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
239 |
+
129073603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
240 |
+
104850,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
241 |
+
28061,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
242 |
+
3000518,0,0,0,0,0,0,0,0,0,1,0,0,0,0
|
243 |
+
446727,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
244 |
+
285033,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
245 |
+
204,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
246 |
+
23675320,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
247 |
+
54680690,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
248 |
+
10180,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
249 |
+
9966051,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
250 |
+
11219835,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
251 |
+
11338033,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
252 |
+
25262965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
253 |
+
451417,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
254 |
+
54755438,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
255 |
+
163659,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
256 |
+
44241743,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
257 |
+
5282230,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
258 |
+
91885558,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
259 |
+
10029385,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
260 |
+
71766360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
261 |
+
3610,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
262 |
+
71571562,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
263 |
+
10195250,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
264 |
+
10621,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
265 |
+
155074,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
266 |
+
16063245,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
267 |
+
16759173,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
268 |
+
185462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
269 |
+
24963252,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
270 |
+
16735117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
271 |
+
440936,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
272 |
+
5344,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
273 |
+
5459308,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
274 |
+
54704426,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
275 |
+
57363,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
276 |
+
58282870,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
277 |
+
6917864,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
278 |
+
45256689,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
279 |
+
6918132,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
280 |
+
9046,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
281 |
+
6019,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
282 |
+
138911318,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
283 |
+
443872,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
284 |
+
441207,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
285 |
+
23674502,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
286 |
+
6364534,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
287 |
+
16218542,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
288 |
+
68911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
289 |
+
67517580,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
290 |
+
54677470,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
291 |
+
11310,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
292 |
+
135151360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
293 |
+
82146,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
294 |
+
119369,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
295 |
+
46205871,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
296 |
+
9875462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
297 |
+
2749,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
298 |
+
67448836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
299 |
+
104849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
300 |
+
9827599,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
301 |
+
11960271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
302 |
+
32798,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
303 |
+
51003603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
304 |
+
3033819,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
305 |
+
117965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
306 |
+
2359994,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
307 |
+
73442,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
308 |
+
66065,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
309 |
+
10138980,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
310 |
+
10206,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
311 |
+
16217067,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
312 |
+
275182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
313 |
+
10143,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
314 |
+
238053,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
315 |
+
5327711,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
316 |
+
46208890,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
317 |
+
54676228,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
318 |
+
77999,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
319 |
+
3045381,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
320 |
+
45256693,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
321 |
+
137319707,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
322 |
+
71420,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
323 |
+
16124208,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
324 |
+
24199313,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
325 |
+
5311027,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
326 |
+
66068,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
327 |
+
46910592,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
328 |
+
13982876,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
329 |
+
16747388,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
330 |
+
33630,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
331 |
+
70817911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
332 |
+
46220375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
333 |
+
23582824,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
334 |
+
130956,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
335 |
+
1936439,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
336 |
+
64982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
337 |
+
4614,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
338 |
+
121241171,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
339 |
+
5717952,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
340 |
+
73053710,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
341 |
+
135397144,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
342 |
+
3198,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
343 |
+
107971,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
344 |
+
118701008,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
345 |
+
92044433,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
346 |
+
118959080,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
347 |
+
24721416,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
348 |
+
23665037,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
349 |
+
11683005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
350 |
+
16048568,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
351 |
+
168312271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
352 |
+
137628686,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
353 |
+
3064778,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
354 |
+
14982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
355 |
+
2747117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
356 |
+
146673142,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
357 |
+
44093,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
358 |
+
167811,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
359 |
+
5312125,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
360 |
+
4006,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
361 |
+
104769,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
362 |
+
135565635,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
363 |
+
11595577,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
364 |
+
11957481,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
365 |
+
170014,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
366 |
+
276389,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
367 |
+
5405,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
368 |
+
158550,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
369 |
+
23663985,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
370 |
+
9562059,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
371 |
+
72205932,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
372 |
+
1986,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
373 |
+
86295191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
374 |
+
1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
375 |
+
6437836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
376 |
+
118704762,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
377 |
+
2194,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
clinical_data_curation/drugs_organs_tested.csv
ADDED
@@ -0,0 +1,377 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
pubchem_id,Bladder/Urinary Tract,Bowel,Breast,CNS/Brain,Cervix,Esophagus/Stomach,Kidney,Liver,Lung,Ovary/Fallopian Tube,Pancreas,Peripheral Nervous System,Skin,Uterus
|
2 |
+
104741,0,1,1,0,0,1,0,0,1,1,0,0,1,1
|
3 |
+
74990,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
4 |
+
60838,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
5 |
+
9887053,1,1,1,0,0,1,0,1,1,1,1,1,1,1
|
6 |
+
135410875,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
7 |
+
65348,1,1,1,0,0,1,0,1,1,1,1,0,1,0
|
8 |
+
176870,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
9 |
+
36314,1,1,1,1,1,1,0,1,1,1,1,1,1,1
|
10 |
+
2187,0,0,1,1,0,0,0,0,1,1,0,0,0,1
|
11 |
+
60699,1,1,1,1,1,0,1,1,1,1,0,0,1,1
|
12 |
+
60750,1,1,1,1,1,0,1,1,1,1,1,0,1,1
|
13 |
+
5281004,0,1,1,0,0,1,1,1,1,0,0,0,1,0
|
14 |
+
148124,1,1,1,1,1,1,0,0,1,1,1,0,1,1
|
15 |
+
23725625,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
16 |
+
5329102,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
17 |
+
3385,1,1,1,1,1,1,1,1,1,1,1,1,1,1
|
18 |
+
5330286,1,1,1,1,0,0,1,1,1,1,1,0,1,1
|
19 |
+
123631,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
20 |
+
78357807,0,1,0,1,0,0,1,0,1,0,0,0,1,0
|
21 |
+
6918289,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
22 |
+
11167602,1,1,0,1,0,1,1,1,1,1,1,0,1,0
|
23 |
+
443939,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
24 |
+
135398658,1,1,1,1,0,1,1,1,1,1,1,1,1,1
|
25 |
+
2563,0,0,0,1,0,0,0,0,1,0,0,1,0,0
|
26 |
+
10184665,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
27 |
+
46220502,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
28 |
+
25102846,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
29 |
+
444795,1,1,1,1,1,0,1,1,1,0,1,0,1,0
|
30 |
+
11707110,0,1,1,1,1,1,1,1,1,0,1,0,1,0
|
31 |
+
6256,0,1,1,1,0,1,1,1,1,1,1,0,1,0
|
32 |
+
16052011,0,1,1,0,0,0,0,0,0,1,1,0,1,1
|
33 |
+
44631912,0,1,1,1,0,1,1,1,1,1,1,0,1,1
|
34 |
+
10184653,1,1,1,1,0,1,1,1,1,0,1,0,1,1
|
35 |
+
445639,0,1,0,1,0,1,1,1,1,0,1,0,1,0
|
36 |
+
11626560,1,1,1,1,0,1,1,1,1,0,0,0,1,1
|
37 |
+
168311648,1,1,1,1,0,1,1,1,1,1,0,1,1,1
|
38 |
+
135398744,1,1,0,1,0,0,1,1,1,0,1,1,0,1
|
39 |
+
1054,1,1,1,1,0,1,1,1,1,1,1,1,1,1
|
40 |
+
119607,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
41 |
+
42611257,1,1,0,1,0,0,0,0,1,1,1,0,1,0
|
42 |
+
60961,0,1,1,1,0,1,0,0,1,1,1,0,0,1
|
43 |
+
10288191,0,1,1,1,0,0,0,1,1,1,1,0,1,0
|
44 |
+
6436173,0,1,1,1,0,0,1,1,1,0,0,0,1,0
|
45 |
+
4594,0,1,1,1,0,1,0,1,1,1,1,1,1,1
|
46 |
+
12108541,0,1,1,1,0,1,0,1,1,1,1,1,1,1
|
47 |
+
16923,1,1,1,1,0,0,1,1,1,0,0,0,1,0
|
48 |
+
3100,0,1,1,1,0,1,1,1,1,1,1,1,1,1
|
49 |
+
21800,0,1,0,1,0,0,0,0,1,0,0,0,1,0
|
50 |
+
54684461,1,1,1,1,0,1,1,0,1,1,1,0,1,1
|
51 |
+
5284373,0,1,1,1,0,1,1,1,1,0,0,0,1,0
|
52 |
+
44462760,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
53 |
+
24906252,0,1,1,1,0,0,1,1,1,1,1,1,0,0
|
54 |
+
2662,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
55 |
+
5388983,1,1,1,1,1,0,1,0,1,1,0,0,1,0
|
56 |
+
107969,0,0,1,1,0,0,1,0,1,0,0,1,0,0
|
57 |
+
4740,0,1,1,1,0,0,1,1,1,1,1,0,0,1
|
58 |
+
4829,0,1,1,1,0,0,1,1,1,1,1,0,1,1
|
59 |
+
56649450,0,1,1,1,0,1,0,1,1,1,1,0,1,1
|
60 |
+
5564,0,1,1,1,0,0,1,0,1,0,0,0,1,0
|
61 |
+
3657,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
62 |
+
12560,0,1,1,1,0,1,1,1,1,0,1,0,1,1
|
63 |
+
50922675,0,1,0,1,0,0,0,1,1,0,1,0,1,0
|
64 |
+
6419992,0,1,1,1,0,0,0,0,1,0,0,1,1,0
|
65 |
+
637568,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
66 |
+
110635,1,1,1,1,0,1,1,1,1,0,1,0,1,0
|
67 |
+
468595,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
68 |
+
16222096,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
69 |
+
135400182,0,1,0,0,0,1,0,1,1,0,1,0,1,0
|
70 |
+
9887712,0,0,1,1,0,0,1,1,1,1,1,1,0,0
|
71 |
+
16760658,1,1,1,1,0,1,1,1,1,0,0,0,1,1
|
72 |
+
249332,1,1,0,1,0,0,1,1,1,1,0,0,0,0
|
73 |
+
24776445,0,1,1,1,0,1,1,1,1,1,1,0,1,0
|
74 |
+
3081361,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
75 |
+
126941,1,1,1,1,0,1,0,1,1,0,0,0,1,0
|
76 |
+
67307512,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
77 |
+
9915743,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
78 |
+
451668,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
79 |
+
6442177,1,1,1,1,1,1,1,1,1,1,1,1,1,1
|
80 |
+
10174505,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
81 |
+
9926791,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
82 |
+
2244,1,1,1,1,0,1,1,0,1,1,1,0,1,0
|
83 |
+
31307,1,1,1,1,1,0,1,1,1,0,1,1,1,1
|
84 |
+
387447,1,1,1,1,1,1,1,1,1,1,1,1,1,0
|
85 |
+
52920501,0,1,1,0,0,1,1,1,1,1,1,0,1,0
|
86 |
+
392622,0,0,1,1,0,0,1,1,1,0,0,0,0,0
|
87 |
+
12136798,1,1,1,1,1,1,0,1,1,0,1,0,1,0
|
88 |
+
2754,0,0,1,1,0,0,1,1,1,0,0,0,1,0
|
89 |
+
23679632,0,0,1,1,0,0,0,1,1,0,1,1,1,0
|
90 |
+
6112,0,1,1,1,0,0,1,1,1,1,1,1,0,0
|
91 |
+
2812,0,1,1,1,0,0,1,1,1,0,0,0,1,0
|
92 |
+
19090,0,1,1,1,0,0,0,1,1,0,0,0,1,1
|
93 |
+
4055,0,1,0,1,0,0,1,1,1,1,1,0,1,0
|
94 |
+
77995,1,1,1,1,0,1,1,1,1,1,1,0,0,0
|
95 |
+
6279,0,0,1,1,0,0,1,0,1,1,0,0,0,1
|
96 |
+
5282164,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
97 |
+
11672905,0,1,1,1,0,0,0,0,1,0,0,1,0,0
|
98 |
+
25145656,0,1,1,0,0,1,1,1,1,0,0,0,1,0
|
99 |
+
3578572,1,1,1,1,0,0,1,1,1,0,0,0,1,0
|
100 |
+
156391,1,1,1,1,0,1,1,1,1,1,0,0,0,1
|
101 |
+
72165228,1,1,1,1,0,0,1,1,1,0,0,0,1,1
|
102 |
+
190,1,1,1,1,0,1,1,1,1,1,0,0,1,1
|
103 |
+
16004692,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
104 |
+
9931953,1,1,1,0,1,1,0,1,1,1,1,0,0,1
|
105 |
+
3339,0,1,1,1,1,1,1,1,1,0,0,0,0,0
|
106 |
+
5743,1,1,1,1,1,1,0,1,1,0,0,0,1,0
|
107 |
+
9444,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
108 |
+
24788740,0,0,1,1,0,1,0,1,1,1,0,0,1,1
|
109 |
+
441243,1,1,1,1,0,1,1,1,1,1,0,0,1,0
|
110 |
+
157921,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
111 |
+
156419,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
112 |
+
5284443,0,1,1,1,0,1,1,1,1,0,1,1,1,0
|
113 |
+
71481097,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
114 |
+
11557040,1,0,1,0,0,1,1,0,1,0,1,0,0,0
|
115 |
+
2554,0,0,0,1,0,0,0,1,1,0,0,1,0,0
|
116 |
+
135401907,0,1,0,1,0,0,1,1,1,1,0,0,0,0
|
117 |
+
445154,0,1,0,1,0,0,1,1,1,1,1,1,1,1
|
118 |
+
2123,1,1,1,1,0,0,1,1,1,1,0,0,1,0
|
119 |
+
24775005,0,1,1,1,0,1,0,1,1,1,1,0,1,0
|
120 |
+
5311068,1,1,1,1,0,1,1,1,1,0,1,0,0,0
|
121 |
+
6321424,0,0,1,1,0,0,0,0,1,1,1,0,1,0
|
122 |
+
14296,0,1,1,1,0,0,1,1,1,0,1,0,1,0
|
123 |
+
11256664,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
124 |
+
2478,1,0,1,1,0,0,0,0,1,1,0,0,1,0
|
125 |
+
51082,1,0,1,1,0,0,0,1,1,1,1,0,0,0
|
126 |
+
60606,0,1,1,1,0,0,1,1,1,1,1,0,0,0
|
127 |
+
6314,1,1,1,1,1,1,1,0,1,0,0,1,1,0
|
128 |
+
25022378,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
129 |
+
8813,0,1,0,0,0,0,1,1,1,0,1,0,1,0
|
130 |
+
370,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
131 |
+
148195,1,1,1,1,0,0,0,1,1,1,0,0,0,0
|
132 |
+
45375953,1,0,1,1,0,0,1,1,1,1,0,0,1,1
|
133 |
+
5381,0,1,1,0,0,0,0,0,0,0,0,0,1,0
|
134 |
+
165411828,0,1,0,1,0,0,0,1,1,0,0,0,0,1
|
135 |
+
25227436,0,0,1,1,0,1,0,0,1,0,0,0,1,1
|
136 |
+
68873,0,0,1,0,0,0,1,0,0,1,0,0,1,1
|
137 |
+
51039094,0,1,1,0,0,1,0,0,1,0,0,0,0,0
|
138 |
+
117947097,0,1,1,1,0,0,1,1,0,1,0,0,0,0
|
139 |
+
6253,0,1,1,1,0,0,0,1,0,0,0,0,0,0
|
140 |
+
2375,1,0,1,1,0,0,1,0,0,1,0,0,0,0
|
141 |
+
5493444,0,1,0,0,0,0,1,0,1,0,0,0,0,0
|
142 |
+
6029,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
143 |
+
24785956,0,0,0,1,0,0,0,0,0,1,0,0,0,1
|
144 |
+
20179,0,1,1,1,1,0,1,0,0,0,1,1,0,1
|
145 |
+
53235510,1,1,1,1,0,1,0,1,1,0,0,0,1,0
|
146 |
+
56959,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
147 |
+
65628,1,0,1,1,0,1,1,1,1,1,1,0,0,0
|
148 |
+
441074,0,0,0,1,0,0,0,1,0,0,0,1,0,0
|
149 |
+
4495,0,1,1,1,1,1,0,0,1,0,1,0,1,0
|
150 |
+
24812758,0,0,1,1,0,0,1,1,1,1,0,0,0,0
|
151 |
+
10461508,0,1,1,1,0,1,1,1,1,1,0,0,0,0
|
152 |
+
24997615,0,0,1,1,0,0,1,1,1,1,0,0,0,0
|
153 |
+
67462786,1,0,1,1,0,0,0,1,1,0,0,0,0,0
|
154 |
+
86705695,1,1,1,1,0,1,0,1,1,0,1,0,0,0
|
155 |
+
25141092,0,1,1,1,0,0,1,1,1,1,0,0,1,0
|
156 |
+
10348973,0,0,0,0,0,0,0,0,0,0,0,0,0,1
|
157 |
+
636362,1,0,0,1,0,0,0,1,1,0,0,0,0,0
|
158 |
+
2520,0,1,1,1,0,0,0,1,1,0,1,0,1,0
|
159 |
+
5823908,0,0,0,1,0,1,1,0,1,0,0,0,1,0
|
160 |
+
138611145,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
161 |
+
3034010,0,0,1,1,0,0,0,1,1,1,0,0,0,0
|
162 |
+
6918638,1,0,1,1,0,0,0,1,1,1,1,0,1,0
|
163 |
+
4463,0,1,1,1,0,0,0,1,1,0,1,0,1,1
|
164 |
+
338,0,1,0,1,0,0,0,0,0,0,0,0,1,0
|
165 |
+
56671814,1,0,0,1,0,1,1,1,1,0,0,0,0,0
|
166 |
+
71621331,1,1,1,0,0,1,0,1,1,0,0,0,0,0
|
167 |
+
9821849,1,1,1,0,0,0,1,1,1,0,0,0,0,0
|
168 |
+
60490,0,0,0,0,0,0,0,0,1,0,0,1,1,0
|
169 |
+
49831257,0,1,0,0,0,0,1,0,0,0,0,0,0,0
|
170 |
+
135398745,0,1,1,1,0,1,0,0,1,0,0,0,1,0
|
171 |
+
2435,0,0,0,1,0,0,0,0,0,1,0,0,1,0
|
172 |
+
135413536,0,1,1,1,0,0,0,0,1,1,1,0,1,0
|
173 |
+
441313,0,1,1,1,0,0,1,1,1,0,0,0,0,0
|
174 |
+
656656,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
175 |
+
92727,0,0,1,1,0,0,0,1,1,0,0,0,0,0
|
176 |
+
5583,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
177 |
+
3440,0,1,1,1,0,0,0,1,0,0,0,0,0,0
|
178 |
+
6480466,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
179 |
+
56844015,1,0,1,1,0,0,1,0,1,0,0,0,0,0
|
180 |
+
25183872,1,0,1,1,0,0,1,0,1,0,0,0,0,0
|
181 |
+
21585658,0,0,0,0,0,0,1,1,1,0,0,0,1,0
|
182 |
+
71616,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
183 |
+
444972,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
184 |
+
55245,0,0,1,1,0,0,0,0,1,0,0,0,0,1
|
185 |
+
4030,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
186 |
+
9082,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
187 |
+
11950170,1,0,0,0,0,0,0,0,1,0,0,0,1,0
|
188 |
+
6918111,0,1,1,1,0,0,1,1,0,0,0,0,0,0
|
189 |
+
5284616,0,0,1,1,0,0,1,0,1,0,0,0,1,0
|
190 |
+
164726578,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
191 |
+
667493,0,0,0,1,0,0,1,0,1,0,0,1,1,0
|
192 |
+
2179,0,1,0,1,0,1,0,1,0,0,1,0,1,0
|
193 |
+
71576688,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
194 |
+
6252,0,1,0,1,0,0,0,1,1,0,0,0,0,0
|
195 |
+
3397,0,0,0,0,0,0,1,0,0,1,0,0,1,0
|
196 |
+
135526609,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
197 |
+
5282451,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
198 |
+
5905,0,1,1,0,0,0,0,1,0,0,0,0,0,0
|
199 |
+
14992,0,1,0,0,0,0,1,0,1,0,0,0,0,0
|
200 |
+
46926350,0,0,1,0,0,0,0,0,1,0,1,0,1,0
|
201 |
+
49846579,0,0,1,0,0,0,0,0,1,0,0,0,0,0
|
202 |
+
24826799,0,0,0,1,0,0,0,0,1,0,1,0,0,0
|
203 |
+
5509,0,0,1,1,0,0,0,1,0,0,0,0,0,0
|
204 |
+
118869362,0,1,0,0,0,0,0,0,1,1,1,0,1,0
|
205 |
+
5311180,0,0,0,0,0,0,1,1,1,0,0,0,0,0
|
206 |
+
22049997,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
207 |
+
9853654,0,0,0,0,0,1,0,0,0,0,0,0,0,0
|
208 |
+
44582816,0,0,0,1,0,0,0,0,0,0,1,0,0,0
|
209 |
+
162368359,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
210 |
+
58507717,0,0,1,1,0,0,0,0,0,0,0,0,1,0
|
211 |
+
24872560,1,0,0,0,0,0,0,1,1,1,0,0,1,0
|
212 |
+
148123,0,0,1,0,0,1,0,0,0,0,0,0,1,0
|
213 |
+
146681181,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
214 |
+
67171867,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
215 |
+
11570805,0,1,1,1,0,0,0,0,0,1,0,0,0,0
|
216 |
+
25166913,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
217 |
+
67330085,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
218 |
+
16362,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
219 |
+
121408882,0,1,0,1,0,0,0,0,0,0,1,0,0,0
|
220 |
+
1923,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
221 |
+
126689157,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
222 |
+
118598754,0,1,1,0,0,0,0,0,1,0,0,0,0,0
|
223 |
+
72172,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
224 |
+
4659569,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
225 |
+
4922,0,0,0,0,0,0,0,1,0,0,1,0,0,0
|
226 |
+
9415,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
227 |
+
445858,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
228 |
+
5324346,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
229 |
+
9560989,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
230 |
+
3463,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
231 |
+
3000226,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
232 |
+
46188928,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
233 |
+
10114,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
234 |
+
53340664,0,0,1,0,0,1,1,0,0,0,0,0,0,0
|
235 |
+
6918837,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
236 |
+
119182,1,1,0,0,0,1,0,0,0,0,0,0,0,0
|
237 |
+
6989,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
238 |
+
67501411,0,1,0,0,0,0,0,0,0,0,0,0,0,1
|
239 |
+
129073603,0,1,0,0,0,0,0,0,1,0,0,0,0,0
|
240 |
+
104850,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
241 |
+
28061,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
242 |
+
3000518,0,0,0,0,0,0,0,0,0,1,0,0,0,0
|
243 |
+
446727,1,1,0,0,0,0,0,0,1,0,0,0,0,0
|
244 |
+
285033,0,0,0,0,0,0,0,1,0,1,0,0,1,0
|
245 |
+
204,0,0,0,1,0,0,1,0,0,0,0,0,1,0
|
246 |
+
23675320,0,0,0,0,0,0,1,1,0,0,0,0,1,0
|
247 |
+
54680690,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
248 |
+
10180,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
249 |
+
9966051,0,0,1,0,0,0,0,0,0,0,0,0,1,0
|
250 |
+
11219835,0,1,0,1,0,0,0,0,0,0,0,0,0,0
|
251 |
+
11338033,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
252 |
+
25262965,0,0,0,1,0,0,0,1,0,0,0,0,0,0
|
253 |
+
451417,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
254 |
+
54755438,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
255 |
+
163659,0,1,0,0,0,0,0,0,1,0,0,0,0,0
|
256 |
+
44241743,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
257 |
+
5282230,0,0,0,0,0,1,0,0,0,0,0,0,1,0
|
258 |
+
91885558,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
259 |
+
10029385,0,0,0,0,0,0,0,0,0,0,1,0,0,0
|
260 |
+
71766360,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
261 |
+
3610,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
262 |
+
71571562,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
263 |
+
10195250,0,0,0,0,0,0,0,0,0,0,0,0,0,1
|
264 |
+
10621,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
265 |
+
155074,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
266 |
+
16063245,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
267 |
+
16759173,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
268 |
+
185462,0,0,0,0,0,0,0,0,0,0,1,0,0,0
|
269 |
+
24963252,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
270 |
+
16735117,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
271 |
+
440936,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
272 |
+
5344,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
273 |
+
5459308,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
274 |
+
54704426,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
275 |
+
57363,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
276 |
+
58282870,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
277 |
+
6917864,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
278 |
+
45256689,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
279 |
+
6918132,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
280 |
+
9046,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
281 |
+
6019,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
282 |
+
138911318,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
283 |
+
443872,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
284 |
+
441207,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
285 |
+
23674502,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
286 |
+
6364534,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
287 |
+
16218542,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
288 |
+
68911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
289 |
+
67517580,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
290 |
+
54677470,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
291 |
+
11310,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
292 |
+
135151360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
293 |
+
82146,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
294 |
+
119369,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
295 |
+
46205871,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
296 |
+
9875462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
297 |
+
2749,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
298 |
+
67448836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
299 |
+
104849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
300 |
+
9827599,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
301 |
+
11960271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
302 |
+
32798,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
303 |
+
51003603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
304 |
+
3033819,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
305 |
+
117965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
306 |
+
2359994,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
307 |
+
73442,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
308 |
+
66065,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
309 |
+
10138980,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
310 |
+
10206,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
311 |
+
16217067,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
312 |
+
275182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
313 |
+
10143,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
314 |
+
238053,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
315 |
+
5327711,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
316 |
+
46208890,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
317 |
+
54676228,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
318 |
+
77999,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
319 |
+
3045381,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
320 |
+
45256693,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
321 |
+
137319707,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
322 |
+
71420,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
323 |
+
16124208,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
324 |
+
24199313,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
325 |
+
5311027,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
326 |
+
66068,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
327 |
+
46910592,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
328 |
+
13982876,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
329 |
+
16747388,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
330 |
+
33630,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
331 |
+
70817911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
332 |
+
46220375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
333 |
+
23582824,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
334 |
+
130956,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
335 |
+
1936439,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
336 |
+
64982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
337 |
+
4614,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
338 |
+
121241171,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
339 |
+
5717952,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
340 |
+
73053710,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
341 |
+
135397144,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
342 |
+
3198,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
343 |
+
107971,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
344 |
+
118701008,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
345 |
+
92044433,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
346 |
+
118959080,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
347 |
+
24721416,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
348 |
+
23665037,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
349 |
+
11683005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
350 |
+
16048568,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
351 |
+
168312271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
352 |
+
137628686,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
353 |
+
3064778,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
354 |
+
14982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
355 |
+
2747117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
356 |
+
146673142,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
357 |
+
44093,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
358 |
+
167811,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
359 |
+
5312125,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
360 |
+
4006,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
361 |
+
104769,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
362 |
+
135565635,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
363 |
+
11595577,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
364 |
+
11957481,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
365 |
+
170014,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
366 |
+
276389,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
367 |
+
5405,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
368 |
+
158550,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
369 |
+
23663985,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
370 |
+
9562059,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
371 |
+
72205932,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
372 |
+
1986,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
373 |
+
86295191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
374 |
+
1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
375 |
+
6437836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
376 |
+
118704762,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
377 |
+
2194,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
clinical_data_curation/get_trials.ipynb
ADDED
The diff for this file is too large to render.
See raw diff
|
|
clinical_evidence_data/adverse_events_FDA_data/tahoe_drug_ae_seriousness_ratio.csv
ADDED
@@ -0,0 +1,300 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
drug_name,mean_serious_flag
|
2 |
+
5-Azacytidine,1.01
|
3 |
+
5-Fluorouracil,1.13
|
4 |
+
8-Hydroxyquinoline,1.1428571428571428
|
5 |
+
9-ING-41,1.0
|
6 |
+
Abemaciclib,1.34
|
7 |
+
Abiraterone acetate,1.01
|
8 |
+
Acetazolamide,1.09
|
9 |
+
Acetohexamide,1.25
|
10 |
+
Adagrasib,1.032258064516129
|
11 |
+
Adenine,1.12
|
12 |
+
Adenosine,1.14
|
13 |
+
Afatinib,1.03
|
14 |
+
Aliskiren,1.01
|
15 |
+
Allantoin,1.05
|
16 |
+
Allopurinol,1.62
|
17 |
+
Almonertinib (mesylate),1.0
|
18 |
+
Alpelisib,1.42
|
19 |
+
Altretamine,1.1
|
20 |
+
Amsacrine,1.0
|
21 |
+
Anastrozole,1.12
|
22 |
+
Anethole trithione,1.02
|
23 |
+
Apalutamide,1.08
|
24 |
+
Aprepitant,1.01
|
25 |
+
Arbutin,1.0
|
26 |
+
Artemether,1.06
|
27 |
+
Artesunate,1.01
|
28 |
+
Asciminib,1.07
|
29 |
+
Aspirin,1.34
|
30 |
+
Ataluren,1.631578947368421
|
31 |
+
Atazanavir (sulfate),1.05
|
32 |
+
Auranofin,1.1237113402061856
|
33 |
+
Azithromycin (hydrate),1.0169491525423728
|
34 |
+
Baicalin,1.6666666666666667
|
35 |
+
Belinostat,1.02
|
36 |
+
Belumosudil,1.56
|
37 |
+
Belumosudil (mesylate),1.02
|
38 |
+
Belzutifan,1.07
|
39 |
+
Bendamustine,1.03
|
40 |
+
Benproperine (phosphate),1.0357142857142858
|
41 |
+
Benztropine (mesylate),1.3
|
42 |
+
Berbamine,1.1111111111111112
|
43 |
+
Berbamine (dihydrochloride),1.3333333333333333
|
44 |
+
Berberine (chloride hydrate),1.0
|
45 |
+
Bestatin,1.2
|
46 |
+
Betamethasone dipropionate,1.39
|
47 |
+
Bexarotene,1.32
|
48 |
+
Bicalutamide,1.11
|
49 |
+
Bimatoprost,1.14
|
50 |
+
Bimiralisib,1.0
|
51 |
+
Binimetinib,1.03
|
52 |
+
Bisoprolol (hemifumarate),1.0
|
53 |
+
Bortezomib,1.0
|
54 |
+
Bosentan (hydrate),1.0303030303030303
|
55 |
+
Brimonidine,1.95
|
56 |
+
Brivudine,1.01
|
57 |
+
Budesonide,1.03
|
58 |
+
Busulfan,1.01
|
59 |
+
Cabozantinib (S-malate),1.1408450704225352
|
60 |
+
Canagliflozin,1.26
|
61 |
+
Canagliflozin (hemihydrate),1.1764705882352942
|
62 |
+
Capivasertib,1.13
|
63 |
+
Capmatinib,1.21
|
64 |
+
Captopril,1.01
|
65 |
+
Carbamazepine,1.08
|
66 |
+
Carbidopa (monohydrate),1.0434782608695652
|
67 |
+
Celecoxib,1.13
|
68 |
+
Cepharanthine,1.04
|
69 |
+
Chlorhexidine (diacetate),1.2195121951219512
|
70 |
+
Ciclopirox,1.47
|
71 |
+
Cilostazol,1.19
|
72 |
+
Cinacalcet,1.09
|
73 |
+
Citalopram (hydrobromide),1.28
|
74 |
+
Clobetasol propionate,1.38
|
75 |
+
Clofarabine,1.01
|
76 |
+
Clonidine (hydrochloride),1.28
|
77 |
+
Clopidogrel,1.07
|
78 |
+
Clotrimazole,1.2
|
79 |
+
Cloxacillin (sodium),1.08
|
80 |
+
Cobimetinib,1.01
|
81 |
+
Cyclosporin A,1.0
|
82 |
+
Cysteamine (hydrochloride),1.03125
|
83 |
+
Cytarabine,1.0
|
84 |
+
Cytarabine (hydrochloride),1.0
|
85 |
+
Dabrafenib,1.01
|
86 |
+
Dapagliflozin,1.08
|
87 |
+
Daptomycin,1.08
|
88 |
+
Darolutamide,1.3
|
89 |
+
Decitabine,1.04
|
90 |
+
Delamanid,1.0
|
91 |
+
Demeclocycline,1.16
|
92 |
+
Dexamethasone,1.04
|
93 |
+
Dexmedetomidine,1.03
|
94 |
+
Diammonium Glycyrrhizinate,1.0
|
95 |
+
Digitoxin,1.04
|
96 |
+
Dihydroartemisinin,1.0
|
97 |
+
Dimethyl fumarate,1.54
|
98 |
+
Dinaciclib,1.0
|
99 |
+
Diphenhydramine,1.09
|
100 |
+
Docetaxel,1.02
|
101 |
+
Docetaxel (Trihydrate),1.0
|
102 |
+
Dorzolamide (hydrochloride),1.4
|
103 |
+
Doxorubicin (hydrochloride),1.02
|
104 |
+
Doxycycline (monohydrate),1.2
|
105 |
+
Drospirenone,1.26
|
106 |
+
Econazole,1.19
|
107 |
+
Edoxaban (tosylate monohydrate),1.0
|
108 |
+
Elagolix sodium,1.8
|
109 |
+
Encorafenib,1.09
|
110 |
+
Entecavir (monohydrate),1.024390243902439
|
111 |
+
Entrectinib,1.14
|
112 |
+
Epirubicin (hydrochloride),1.01
|
113 |
+
Eplerenone,1.12
|
114 |
+
Erdafitinib,1.33
|
115 |
+
Erlotinib,1.0
|
116 |
+
Erythromycin,1.39
|
117 |
+
Esmolol (hydrochloride),1.11
|
118 |
+
Everolimus,1.05
|
119 |
+
Fenofibrate,1.28
|
120 |
+
Ferulic acid,1.0
|
121 |
+
Filgotinib,1.01
|
122 |
+
Finasteride,1.22
|
123 |
+
Fingolimod (hydrochloride),1.02
|
124 |
+
Flumatinib (mesylate),1.0
|
125 |
+
Flutamide,1.17
|
126 |
+
Fluvoxamine,1.1
|
127 |
+
Fluvoxamine (maleate),1.17
|
128 |
+
Folic acid,1.46
|
129 |
+
Fulvestrant,1.07
|
130 |
+
Fumaric acid,1.08
|
131 |
+
Furosemide,1.52
|
132 |
+
Fusidic acid,1.02
|
133 |
+
Futibatinib,1.088235294117647
|
134 |
+
Gallic acid,2.0
|
135 |
+
Gefitinib,1.02
|
136 |
+
Gemcitabine,1.0
|
137 |
+
Gemfibrozil,1.34
|
138 |
+
Glasdegib,1.02
|
139 |
+
Glycyrrhizic acid,1.01
|
140 |
+
Goserelin (acetate),1.06
|
141 |
+
Harringtonine,1.0
|
142 |
+
Hesperidin,1.06
|
143 |
+
Hexylresorcinol,1.5555555555555556
|
144 |
+
Homoharringtonine,1.0120481927710843
|
145 |
+
Hydroxyurea,1.47
|
146 |
+
Idarubicin (hydrochloride),1.03
|
147 |
+
Idoxuridine,1.3
|
148 |
+
Indacaterol (maleate),1.0
|
149 |
+
Infigratinib,1.0952380952380953
|
150 |
+
Ipatasertib,1.02
|
151 |
+
Irinotecan,1.24
|
152 |
+
Irinotecan (hydrochloride),1.01
|
153 |
+
Ivabradine (hydrochloride),1.01
|
154 |
+
Ivermectin,1.17
|
155 |
+
Ixazomib,1.02
|
156 |
+
Ixazomib citrate,1.0208333333333333
|
157 |
+
LY2090314,1.0
|
158 |
+
Lactate (calcium),1.1
|
159 |
+
Lapatinib ditosylate,1.03
|
160 |
+
Larotrectinib,1.05
|
161 |
+
Larotrectinib sulfate,1.0
|
162 |
+
Lenalidomide (hemihydrate),1.0625
|
163 |
+
Levobupivacaine (hydrochloride),1.0
|
164 |
+
Lidocaine (hydrochloride),1.09
|
165 |
+
Ligustrazine,1.0
|
166 |
+
Lipoic acid,1.24
|
167 |
+
Lonafarnib,1.0392156862745099
|
168 |
+
Loperamide (hydrochloride),1.05
|
169 |
+
Lopinavir,1.02
|
170 |
+
Lumateperone (tosylate),1.0
|
171 |
+
Macitentan,1.05
|
172 |
+
Mebendazole,1.1
|
173 |
+
Medroxyprogesterone acetate,1.31
|
174 |
+
Megestrol,1.16
|
175 |
+
Meloxicam,1.31
|
176 |
+
Menadione,1.36
|
177 |
+
Methotrexate,1.04
|
178 |
+
Methyl aminolevulinate (hydrochloride),1.0
|
179 |
+
Methylprednisolone succinate,1.0810810810810811
|
180 |
+
Methylthiouracil,2.0
|
181 |
+
Mifepristone,1.68
|
182 |
+
Minodronic acid,1.02
|
183 |
+
Mozavaptan,1.0
|
184 |
+
Nafamostat (mesylate),1.041237113402062
|
185 |
+
Naproxen,1.17
|
186 |
+
Neratinib,1.13
|
187 |
+
Neratinib (maleate),1.3333333333333333
|
188 |
+
Nevirapine,1.01
|
189 |
+
Nimesulide,1.0
|
190 |
+
Norepinephrine (hydrochloride),1.03
|
191 |
+
Olanzapine,1.03
|
192 |
+
Oleic acid,1.5357142857142858
|
193 |
+
Omeprazole,1.44
|
194 |
+
Omeprazole (sodium),1.15
|
195 |
+
Orlistat,1.04
|
196 |
+
Ornidazole,1.04
|
197 |
+
Osimertinib (mesylate),1.01
|
198 |
+
Oxaliplatin,1.03
|
199 |
+
Oxaprozin,1.54
|
200 |
+
PH-797804,1.0
|
201 |
+
Paclitaxel,1.02
|
202 |
+
Palmatine (chloride),1.0
|
203 |
+
Panobinostat,1.29
|
204 |
+
Pemetrexed,1.0
|
205 |
+
Pemigatinib,1.75
|
206 |
+
Penfluridol,1.0
|
207 |
+
Pentagastrin,1.0
|
208 |
+
Pentamidine (isethionate),1.08
|
209 |
+
Pentoxifylline,1.22
|
210 |
+
Peretinoin,1.0
|
211 |
+
Perindopril (erbumine),1.02
|
212 |
+
Phenylephrine (hydrochloride),1.19
|
213 |
+
Phenytoin (sodium),1.14
|
214 |
+
Pimitespib,1.0
|
215 |
+
Pimozide,1.08
|
216 |
+
Pioglitazone,1.19
|
217 |
+
Piroxicam,1.09
|
218 |
+
Pitavastatin (Calcium),1.23
|
219 |
+
Ponatinib,1.07
|
220 |
+
Posaconazole,1.04
|
221 |
+
Pralsetinib,1.01
|
222 |
+
Pravastatin (sodium),1.36
|
223 |
+
Procainamide (hydrochloride),1.14
|
224 |
+
Proglumide,1.25
|
225 |
+
Pyridoxine,1.13
|
226 |
+
Pyridoxine (hydrochloride),1.07
|
227 |
+
Quinestrol,1.2
|
228 |
+
Radotinib,1.0
|
229 |
+
Raltitrexed,1.01
|
230 |
+
Ranolazine,1.01
|
231 |
+
Rapamycin,1.11
|
232 |
+
Regorafenib,1.02
|
233 |
+
Relugolix,1.3
|
234 |
+
Resveratrol,1.47
|
235 |
+
Retinoic acid,1.03
|
236 |
+
Ribociclib,1.04
|
237 |
+
Rifaximin,1.01
|
238 |
+
Rimonabant,1.0192307692307692
|
239 |
+
Ritonavir,1.05
|
240 |
+
Ropivacaine (hydrochloride monohydrate),1.0
|
241 |
+
Rosiglitazone,1.02
|
242 |
+
Roxadustat,1.03
|
243 |
+
Sacubitril/Valsartan,1.27
|
244 |
+
Salicylic acid,1.16
|
245 |
+
Sapanisertib,1.0
|
246 |
+
Saquinavir,1.04
|
247 |
+
Selinexor,1.01
|
248 |
+
Sildenafil,1.33
|
249 |
+
Silodosin,1.11
|
250 |
+
Sinomenine,1.0
|
251 |
+
Sivelestat (sodium tetrahydrate),1.0
|
252 |
+
Sodium Salicylate,1.04
|
253 |
+
Sonidegib,1.07
|
254 |
+
Sulfatinib,1.0
|
255 |
+
Sulfisoxazole,1.1978021978021978
|
256 |
+
Sunitinib,1.16
|
257 |
+
Tadalafil,1.05
|
258 |
+
Talc,1.07
|
259 |
+
Tazarotene,1.76
|
260 |
+
Temsirolimus,1.04
|
261 |
+
Temuterkib,1.0
|
262 |
+
Terfenadine,1.2584269662921348
|
263 |
+
Tetracycline (hydrochloride),1.45
|
264 |
+
Thymol,1.14
|
265 |
+
Thymopentin,1.027027027027027
|
266 |
+
Tirabrutinib,1.0208333333333333
|
267 |
+
Tirabrutinib (hydrochloride),1.0
|
268 |
+
Tofacitinib,1.02
|
269 |
+
Tofacitinib (citrate),1.02
|
270 |
+
Tolcapone,1.09
|
271 |
+
Tolmetin,1.59
|
272 |
+
Tomivosertib,1.0
|
273 |
+
Topotecan (hydrochloride),1.01
|
274 |
+
Trametinib,1.0
|
275 |
+
Tranilast,1.0930232558139534
|
276 |
+
Triamcinolone,1.34
|
277 |
+
Triclosan,1.1
|
278 |
+
Trifluridine,1.34
|
279 |
+
Trimetrexate,1.0
|
280 |
+
Tucatinib,1.07
|
281 |
+
Tucidinostat,1.0
|
282 |
+
Uridine,1.2604166666666667
|
283 |
+
Valdecoxib,1.21
|
284 |
+
Vandetanib,1.02
|
285 |
+
Vemurafenib,1.06
|
286 |
+
Verapamil,1.35
|
287 |
+
Verteporfin,1.05
|
288 |
+
Vilanterol,1.06
|
289 |
+
Vinblastine (sulfate),1.06
|
290 |
+
Vismodegib,1.02
|
291 |
+
Vitamin K4,1.3333333333333333
|
292 |
+
Volasertib,1.0
|
293 |
+
Voriconazole,1.08
|
294 |
+
Vortioxetine,1.64
|
295 |
+
Zileuton,1.62
|
296 |
+
crizotinib,1.12
|
297 |
+
olaparib,1.17
|
298 |
+
palbociclib,1.08
|
299 |
+
venetoclax,1.0
|
300 |
+
vincristine,1.01
|
clinical_evidence_data/adverse_events_FDA_data/tahoe_drug_ae_severity_score.csv
ADDED
@@ -0,0 +1,300 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
drug_name,ae_severity_score
|
2 |
+
5-Azacytidine,371
|
3 |
+
5-Fluorouracil,285
|
4 |
+
8-Hydroxyquinoline,54
|
5 |
+
9-ING-41,8
|
6 |
+
Abemaciclib,275
|
7 |
+
Abiraterone acetate,250
|
8 |
+
Acetazolamide,218
|
9 |
+
Acetohexamide,11
|
10 |
+
Adagrasib,2380
|
11 |
+
Adenine,417
|
12 |
+
Adenosine,257
|
13 |
+
Afatinib,306
|
14 |
+
Aliskiren,310
|
15 |
+
Allantoin,1400
|
16 |
+
Allopurinol,55
|
17 |
+
Almonertinib (mesylate),57
|
18 |
+
Alpelisib,341
|
19 |
+
Altretamine,238
|
20 |
+
Amsacrine,431
|
21 |
+
Anastrozole,186
|
22 |
+
Anethole trithione,478
|
23 |
+
Apalutamide,301
|
24 |
+
Aprepitant,320
|
25 |
+
Arbutin,200
|
26 |
+
Artemether,570
|
27 |
+
Artesunate,289
|
28 |
+
Asciminib,1653
|
29 |
+
Aspirin,167
|
30 |
+
Ataluren,273
|
31 |
+
Atazanavir (sulfate),136
|
32 |
+
Auranofin,326
|
33 |
+
Azithromycin (hydrate),171
|
34 |
+
Baicalin,34
|
35 |
+
Belinostat,1895
|
36 |
+
Belumosudil,2846
|
37 |
+
Belumosudil (mesylate),2785
|
38 |
+
Belzutifan,2537
|
39 |
+
Bendamustine,340
|
40 |
+
Benproperine (phosphate),604
|
41 |
+
Benztropine (mesylate),284
|
42 |
+
Berbamine,47
|
43 |
+
Berbamine (dihydrochloride),30
|
44 |
+
Berberine (chloride hydrate),50
|
45 |
+
Bestatin,151
|
46 |
+
Betamethasone dipropionate,171
|
47 |
+
Bexarotene,175
|
48 |
+
Bicalutamide,237
|
49 |
+
Bimatoprost,202
|
50 |
+
Bimiralisib,38
|
51 |
+
Binimetinib,416
|
52 |
+
Bisoprolol (hemifumarate),270
|
53 |
+
Bortezomib,208
|
54 |
+
Bosentan (hydrate),117
|
55 |
+
Brimonidine,6
|
56 |
+
Brivudine,1301
|
57 |
+
Budesonide,250
|
58 |
+
Busulfan,242
|
59 |
+
Cabozantinib (S-malate),1570
|
60 |
+
Canagliflozin,183
|
61 |
+
Canagliflozin (hemihydrate),144
|
62 |
+
Capivasertib,2569
|
63 |
+
Capmatinib,1138
|
64 |
+
Captopril,293
|
65 |
+
Carbamazepine,199
|
66 |
+
Carbidopa (monohydrate),396
|
67 |
+
Celecoxib,255
|
68 |
+
Cepharanthine,879
|
69 |
+
Chlorhexidine (diacetate),448
|
70 |
+
Ciclopirox,109
|
71 |
+
Cilostazol,249
|
72 |
+
Cinacalcet,308
|
73 |
+
Citalopram (hydrobromide),230
|
74 |
+
Clobetasol propionate,201
|
75 |
+
Clofarabine,435
|
76 |
+
Clonidine (hydrochloride),168
|
77 |
+
Clopidogrel,168
|
78 |
+
Clotrimazole,171
|
79 |
+
Cloxacillin (sodium),1007
|
80 |
+
Cobimetinib,280
|
81 |
+
Cyclosporin A,260
|
82 |
+
Cysteamine (hydrochloride),770
|
83 |
+
Cytarabine,309
|
84 |
+
Cytarabine (hydrochloride),247
|
85 |
+
Dabrafenib,221
|
86 |
+
Dapagliflozin,264
|
87 |
+
Daptomycin,369
|
88 |
+
Darolutamide,2187
|
89 |
+
Decitabine,320
|
90 |
+
Delamanid,441
|
91 |
+
Demeclocycline,380
|
92 |
+
Dexamethasone,304
|
93 |
+
Dexmedetomidine,260
|
94 |
+
Diammonium Glycyrrhizinate,688
|
95 |
+
Digitoxin,315
|
96 |
+
Dihydroartemisinin,30
|
97 |
+
Dimethyl fumarate,107
|
98 |
+
Dinaciclib,128
|
99 |
+
Diphenhydramine,319
|
100 |
+
Docetaxel,265
|
101 |
+
Docetaxel (Trihydrate),19
|
102 |
+
Dorzolamide (hydrochloride),93
|
103 |
+
Doxorubicin (hydrochloride),280
|
104 |
+
Doxycycline (monohydrate),128
|
105 |
+
Drospirenone,148
|
106 |
+
Econazole,287
|
107 |
+
Edoxaban (tosylate monohydrate),30
|
108 |
+
Elagolix sodium,1969
|
109 |
+
Encorafenib,584
|
110 |
+
Entecavir (monohydrate),271
|
111 |
+
Entrectinib,541
|
112 |
+
Epirubicin (hydrochloride),273
|
113 |
+
Eplerenone,245
|
114 |
+
Erdafitinib,268
|
115 |
+
Erlotinib,384
|
116 |
+
Erythromycin,134
|
117 |
+
Esmolol (hydrochloride),1364
|
118 |
+
Everolimus,315
|
119 |
+
Fenofibrate,196
|
120 |
+
Ferulic acid,160
|
121 |
+
Filgotinib,1563
|
122 |
+
Finasteride,180
|
123 |
+
Fingolimod (hydrochloride),684
|
124 |
+
Flumatinib (mesylate),115
|
125 |
+
Flutamide,228
|
126 |
+
Fluvoxamine,221
|
127 |
+
Fluvoxamine (maleate),247
|
128 |
+
Folic acid,134
|
129 |
+
Fulvestrant,253
|
130 |
+
Fumaric acid,996
|
131 |
+
Furosemide,128
|
132 |
+
Fusidic acid,156
|
133 |
+
Futibatinib,538
|
134 |
+
Gallic acid,30
|
135 |
+
Gefitinib,170
|
136 |
+
Gemcitabine,319
|
137 |
+
Gemfibrozil,156
|
138 |
+
Glasdegib,449
|
139 |
+
Glycyrrhizic acid,410
|
140 |
+
Goserelin (acetate),309
|
141 |
+
Harringtonine,0
|
142 |
+
Hesperidin,245
|
143 |
+
Hexylresorcinol,148
|
144 |
+
Homoharringtonine,193
|
145 |
+
Hydroxyurea,151
|
146 |
+
Idarubicin (hydrochloride),309
|
147 |
+
Idoxuridine,48
|
148 |
+
Indacaterol (maleate),503
|
149 |
+
Infigratinib,474
|
150 |
+
Ipatasertib,1090
|
151 |
+
Irinotecan,173
|
152 |
+
Irinotecan (hydrochloride),263
|
153 |
+
Ivabradine (hydrochloride),555
|
154 |
+
Ivermectin,332
|
155 |
+
Ixazomib,351
|
156 |
+
Ixazomib citrate,1591
|
157 |
+
LY2090314,6
|
158 |
+
Lactate (calcium),1416
|
159 |
+
Lapatinib ditosylate,614
|
160 |
+
Larotrectinib,1324
|
161 |
+
Larotrectinib sulfate,66
|
162 |
+
Lenalidomide (hemihydrate),431
|
163 |
+
Levobupivacaine (hydrochloride),1593
|
164 |
+
Lidocaine (hydrochloride),216
|
165 |
+
Ligustrazine,279
|
166 |
+
Lipoic acid,147
|
167 |
+
Lonafarnib,341
|
168 |
+
Loperamide (hydrochloride),297
|
169 |
+
Lopinavir,236
|
170 |
+
Lumateperone (tosylate),30
|
171 |
+
Macitentan,341
|
172 |
+
Mebendazole,188
|
173 |
+
Medroxyprogesterone acetate,142
|
174 |
+
Megestrol,259
|
175 |
+
Meloxicam,142
|
176 |
+
Menadione,355
|
177 |
+
Methotrexate,243
|
178 |
+
Methyl aminolevulinate (hydrochloride),79
|
179 |
+
Methylprednisolone succinate,146
|
180 |
+
Methylthiouracil,0
|
181 |
+
Mifepristone,85
|
182 |
+
Minodronic acid,570
|
183 |
+
Mozavaptan,11
|
184 |
+
Nafamostat (mesylate),1758
|
185 |
+
Naproxen,206
|
186 |
+
Neratinib,917
|
187 |
+
Neratinib (maleate),87
|
188 |
+
Nevirapine,277
|
189 |
+
Nimesulide,223
|
190 |
+
Norepinephrine (hydrochloride),2095
|
191 |
+
Olanzapine,283
|
192 |
+
Oleic acid,176
|
193 |
+
Omeprazole,153
|
194 |
+
Omeprazole (sodium),232
|
195 |
+
Orlistat,179
|
196 |
+
Ornidazole,488
|
197 |
+
Osimertinib (mesylate),1337
|
198 |
+
Oxaliplatin,240
|
199 |
+
Oxaprozin,62
|
200 |
+
PH-797804,9
|
201 |
+
Paclitaxel,268
|
202 |
+
Palmatine (chloride),0
|
203 |
+
Panobinostat,230
|
204 |
+
Pemetrexed,312
|
205 |
+
Pemigatinib,2744
|
206 |
+
Penfluridol,116
|
207 |
+
Pentagastrin,0
|
208 |
+
Pentamidine (isethionate),371
|
209 |
+
Pentoxifylline,202
|
210 |
+
Peretinoin,3
|
211 |
+
Perindopril (erbumine),217
|
212 |
+
Phenylephrine (hydrochloride),305
|
213 |
+
Phenytoin (sodium),248
|
214 |
+
Pimitespib,27
|
215 |
+
Pimozide,303
|
216 |
+
Pioglitazone,290
|
217 |
+
Piroxicam,144
|
218 |
+
Pitavastatin (Calcium),189
|
219 |
+
Ponatinib,309
|
220 |
+
Posaconazole,393
|
221 |
+
Pralsetinib,1882
|
222 |
+
Pravastatin (sodium),162
|
223 |
+
Procainamide (hydrochloride),1430
|
224 |
+
Proglumide,33
|
225 |
+
Pyridoxine,342
|
226 |
+
Pyridoxine (hydrochloride),274
|
227 |
+
Quinestrol,35
|
228 |
+
Radotinib,36
|
229 |
+
Raltitrexed,220
|
230 |
+
Ranolazine,211
|
231 |
+
Rapamycin,253
|
232 |
+
Regorafenib,351
|
233 |
+
Relugolix,2417
|
234 |
+
Resveratrol,113
|
235 |
+
Retinoic acid,138
|
236 |
+
Ribociclib,370
|
237 |
+
Rifaximin,395
|
238 |
+
Rimonabant,127
|
239 |
+
Ritonavir,291
|
240 |
+
Ropivacaine (hydrochloride monohydrate),60
|
241 |
+
Rosiglitazone,333
|
242 |
+
Roxadustat,2174
|
243 |
+
Sacubitril/Valsartan,460
|
244 |
+
Salicylic acid,284
|
245 |
+
Sapanisertib,93
|
246 |
+
Saquinavir,161
|
247 |
+
Selinexor,480
|
248 |
+
Sildenafil,258
|
249 |
+
Silodosin,289
|
250 |
+
Sinomenine,0
|
251 |
+
Sivelestat (sodium tetrahydrate),95
|
252 |
+
Sodium Salicylate,1260
|
253 |
+
Sonidegib,373
|
254 |
+
Sulfatinib,3
|
255 |
+
Sulfisoxazole,252
|
256 |
+
Sunitinib,268
|
257 |
+
Tadalafil,331
|
258 |
+
Talc,274
|
259 |
+
Tazarotene,131
|
260 |
+
Temsirolimus,303
|
261 |
+
Temuterkib,27
|
262 |
+
Terfenadine,670
|
263 |
+
Tetracycline (hydrochloride),388
|
264 |
+
Thymol,1049
|
265 |
+
Thymopentin,630
|
266 |
+
Tirabrutinib,776
|
267 |
+
Tirabrutinib (hydrochloride),196
|
268 |
+
Tofacitinib,347
|
269 |
+
Tofacitinib (citrate),371
|
270 |
+
Tolcapone,770
|
271 |
+
Tolmetin,464
|
272 |
+
Tomivosertib,0
|
273 |
+
Topotecan (hydrochloride),300
|
274 |
+
Trametinib,291
|
275 |
+
Tranilast,980
|
276 |
+
Triamcinolone,129
|
277 |
+
Triclosan,1232
|
278 |
+
Trifluridine,238
|
279 |
+
Trimetrexate,6
|
280 |
+
Tucatinib,641
|
281 |
+
Tucidinostat,2775
|
282 |
+
Uridine,1535
|
283 |
+
Valdecoxib,335
|
284 |
+
Vandetanib,196
|
285 |
+
Vemurafenib,173
|
286 |
+
Verapamil,172
|
287 |
+
Verteporfin,254
|
288 |
+
Vilanterol,481
|
289 |
+
Vinblastine (sulfate),290
|
290 |
+
Vismodegib,350
|
291 |
+
Vitamin K4,34
|
292 |
+
Volasertib,53
|
293 |
+
Voriconazole,320
|
294 |
+
Vortioxetine,44
|
295 |
+
Zileuton,1066
|
296 |
+
crizotinib,333
|
297 |
+
olaparib,239
|
298 |
+
palbociclib,283
|
299 |
+
venetoclax,378
|
300 |
+
vincristine,262
|
clinical_evidence_data/adverse_events_FDA_data/tahoe_drugs_faers_adverse_events.csv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
clinical_evidence_data/drug_organ_trials_clean.csv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
clinical_evidence_data/drugs_organs_approved.csv
ADDED
@@ -0,0 +1,377 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
pubchem_id,Bladder/Urinary Tract,Bowel,Breast,CNS/Brain,Cervix,Esophagus/Stomach,Kidney,Liver,Lung,Ovary/Fallopian Tube,Pancreas,Peripheral Nervous System,Skin,Uterus
|
2 |
+
104741,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
3 |
+
74990,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
4 |
+
60838,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
5 |
+
9887053,0,1,0,0,0,1,0,1,0,0,1,0,0,0
|
6 |
+
135410875,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
7 |
+
65348,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
8 |
+
176870,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
9 |
+
36314,1,0,1,0,0,1,0,0,1,0,0,0,0,0
|
10 |
+
2187,0,0,1,1,0,0,0,0,0,0,0,0,0,1
|
11 |
+
60699,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
12 |
+
60750,0,0,0,0,0,0,0,0,1,0,1,0,0,0
|
13 |
+
5281004,0,1,0,0,0,1,1,0,1,0,0,0,0,0
|
14 |
+
148124,0,0,1,0,0,1,0,0,0,0,0,0,0,0
|
15 |
+
23725625,0,0,0,0,0,0,1,0,0,1,0,0,0,0
|
16 |
+
5329102,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
17 |
+
3385,0,1,1,0,0,1,0,1,1,1,0,0,1,0
|
18 |
+
5330286,0,0,1,0,0,0,1,0,0,0,0,0,0,0
|
19 |
+
123631,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
20 |
+
78357807,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
21 |
+
6918289,0,0,1,0,0,0,1,1,1,0,0,0,0,0
|
22 |
+
11167602,0,1,0,0,0,0,1,0,0,0,0,0,0,0
|
23 |
+
443939,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
24 |
+
135398658,0,1,0,0,0,0,0,1,1,0,0,0,1,0
|
25 |
+
2563,0,0,0,1,0,0,0,0,0,0,0,1,0,0
|
26 |
+
10184665,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
27 |
+
46220502,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
28 |
+
25102846,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
29 |
+
444795,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
30 |
+
11707110,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
31 |
+
6256,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
32 |
+
16052011,0,0,1,0,0,0,0,0,0,0,0,0,0,1
|
33 |
+
44631912,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
34 |
+
10184653,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
35 |
+
445639,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
36 |
+
11626560,0,0,0,0,0,0,0,0,1,0,0,0,0,1
|
37 |
+
168311648,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
38 |
+
135398744,0,0,0,0,0,0,0,1,1,0,0,1,0,0
|
39 |
+
1054,0,1,0,0,0,1,1,0,1,0,0,0,0,1
|
40 |
+
119607,1,1,0,1,0,0,1,0,0,0,1,0,1,1
|
41 |
+
42611257,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
42 |
+
60961,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
43 |
+
10288191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
44 |
+
6436173,0,1,0,0,0,0,1,1,0,0,0,0,0,0
|
45 |
+
4594,0,1,0,1,0,1,0,0,0,0,1,0,0,0
|
46 |
+
12108541,0,1,0,1,0,1,0,0,0,0,1,0,0,0
|
47 |
+
16923,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
48 |
+
3100,0,1,0,0,0,0,1,1,1,0,0,0,1,0
|
49 |
+
21800,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
50 |
+
54684461,1,1,0,1,0,0,1,0,1,0,0,0,1,0
|
51 |
+
5284373,0,1,0,0,0,1,1,1,1,0,0,0,1,0
|
52 |
+
44462760,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
53 |
+
24906252,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
54 |
+
2662,1,1,0,0,0,0,0,1,0,0,1,0,0,1
|
55 |
+
5388983,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
56 |
+
107969,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
57 |
+
4740,0,1,0,1,0,0,1,1,1,0,0,0,0,0
|
58 |
+
4829,0,0,0,0,0,0,1,1,1,1,0,0,0,0
|
59 |
+
56649450,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
60 |
+
5564,0,0,1,0,0,0,0,0,0,0,0,0,1,0
|
61 |
+
3657,1,1,0,0,0,0,1,1,1,1,0,0,1,0
|
62 |
+
12560,0,0,0,0,0,1,0,0,1,0,1,0,1,0
|
63 |
+
50922675,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
64 |
+
6419992,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
65 |
+
637568,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
66 |
+
110635,1,0,0,1,0,0,1,0,1,0,0,0,0,0
|
67 |
+
468595,1,1,0,1,0,0,1,1,0,0,0,0,1,0
|
68 |
+
16222096,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
69 |
+
135400182,0,1,0,0,0,0,0,1,0,0,0,0,1,0
|
70 |
+
9887712,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
71 |
+
16760658,1,0,0,0,0,0,1,1,1,0,0,0,1,0
|
72 |
+
249332,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
73 |
+
24776445,0,0,0,0,0,1,1,0,0,0,0,0,1,0
|
74 |
+
3081361,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
75 |
+
126941,0,1,0,1,0,0,0,0,0,0,0,0,1,0
|
76 |
+
67307512,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
77 |
+
9915743,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
78 |
+
451668,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
79 |
+
6442177,0,1,0,1,1,0,1,1,0,0,0,0,1,0
|
80 |
+
10174505,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
81 |
+
9926791,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
82 |
+
2244,1,1,0,1,0,1,0,0,1,0,0,0,0,0
|
83 |
+
31307,1,1,0,1,1,0,1,1,0,0,0,0,1,0
|
84 |
+
387447,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
85 |
+
52920501,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
86 |
+
392622,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
87 |
+
12136798,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
88 |
+
2754,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
89 |
+
23679632,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
90 |
+
6112,0,0,1,0,0,0,1,1,0,0,0,1,0,0
|
91 |
+
2812,0,0,1,0,0,0,1,0,1,0,0,0,0,0
|
92 |
+
19090,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
93 |
+
4055,0,1,0,1,0,0,1,0,1,0,0,0,0,0
|
94 |
+
77995,1,1,0,1,0,1,0,1,1,1,0,0,0,0
|
95 |
+
6279,0,0,1,0,0,0,0,0,0,1,0,0,0,1
|
96 |
+
5282164,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
97 |
+
11672905,0,1,0,1,0,0,0,0,1,0,0,1,0,0
|
98 |
+
25145656,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
99 |
+
3578572,1,1,0,1,0,0,0,1,0,0,0,0,0,0
|
100 |
+
156391,1,1,0,0,0,0,1,0,0,0,0,0,0,0
|
101 |
+
72165228,1,0,0,0,0,0,0,0,1,0,0,0,0,0
|
102 |
+
190,0,0,1,1,0,0,0,0,0,0,0,0,0,0
|
103 |
+
16004692,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
104 |
+
9931953,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
105 |
+
3339,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
106 |
+
5743,1,0,1,0,1,0,0,0,1,0,0,0,0,0
|
107 |
+
9444,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
108 |
+
24788740,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
109 |
+
441243,0,0,0,0,0,0,0,1,0,0,0,0,1,0
|
110 |
+
157921,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
111 |
+
156419,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
112 |
+
5284443,0,0,0,1,0,1,0,0,1,0,0,1,0,0
|
113 |
+
71481097,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
114 |
+
11557040,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
115 |
+
2554,0,0,0,1,0,0,0,0,0,0,0,1,0,0
|
116 |
+
135401907,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
117 |
+
445154,0,0,0,0,0,0,0,0,0,0,1,0,1,1
|
118 |
+
2123,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
119 |
+
24775005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
120 |
+
5311068,1,0,1,1,0,1,1,1,1,0,1,0,0,0
|
121 |
+
6321424,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
122 |
+
14296,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
123 |
+
11256664,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
124 |
+
2478,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
125 |
+
51082,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
126 |
+
60606,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
127 |
+
6314,1,1,0,1,0,0,0,0,1,0,0,1,0,0
|
128 |
+
25022378,0,0,0,1,0,0,1,0,1,0,0,0,0,0
|
129 |
+
8813,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
130 |
+
370,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
131 |
+
148195,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
132 |
+
45375953,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
133 |
+
5381,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
134 |
+
165411828,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
135 |
+
25227436,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
136 |
+
68873,0,0,1,0,0,0,0,0,0,1,0,0,0,0
|
137 |
+
51039094,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
138 |
+
117947097,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
139 |
+
6253,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
140 |
+
2375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
141 |
+
5493444,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
142 |
+
6029,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
143 |
+
24785956,0,0,0,1,0,0,0,0,0,0,0,0,0,1
|
144 |
+
20179,0,0,0,0,0,0,1,0,0,0,0,0,0,1
|
145 |
+
53235510,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
146 |
+
56959,0,0,0,0,0,0,1,0,1,0,0,0,1,0
|
147 |
+
65628,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
148 |
+
441074,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
149 |
+
4495,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
150 |
+
24812758,0,0,0,1,0,0,1,0,0,1,0,0,0,0
|
151 |
+
10461508,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
152 |
+
24997615,0,0,0,1,0,0,1,0,0,1,0,0,0,0
|
153 |
+
67462786,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
154 |
+
86705695,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
155 |
+
25141092,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
156 |
+
10348973,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
157 |
+
636362,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
158 |
+
2520,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
159 |
+
5823908,0,0,0,1,0,0,1,0,1,0,0,0,0,0
|
160 |
+
138611145,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
161 |
+
3034010,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
162 |
+
6918638,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
163 |
+
4463,0,0,0,1,0,0,0,1,0,0,0,0,0,0
|
164 |
+
338,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
165 |
+
56671814,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
166 |
+
71621331,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
167 |
+
9821849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
168 |
+
60490,0,0,0,0,0,0,0,0,1,0,0,1,0,0
|
169 |
+
49831257,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
170 |
+
135398745,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
171 |
+
2435,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
172 |
+
135413536,0,0,1,0,0,0,0,0,0,1,0,0,0,0
|
173 |
+
441313,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
174 |
+
656656,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
175 |
+
92727,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
176 |
+
5583,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
177 |
+
3440,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
178 |
+
6480466,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
179 |
+
56844015,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
180 |
+
25183872,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
181 |
+
21585658,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
182 |
+
71616,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
183 |
+
444972,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
184 |
+
55245,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
185 |
+
4030,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
186 |
+
9082,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
187 |
+
11950170,1,0,0,0,0,0,0,0,1,0,0,0,0,0
|
188 |
+
6918111,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
189 |
+
5284616,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
190 |
+
164726578,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
191 |
+
667493,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
192 |
+
2179,0,1,0,1,0,0,0,0,0,0,0,0,0,0
|
193 |
+
71576688,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
194 |
+
6252,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
195 |
+
3397,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
196 |
+
135526609,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
197 |
+
5282451,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
198 |
+
5905,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
199 |
+
14992,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
200 |
+
46926350,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
201 |
+
49846579,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
202 |
+
24826799,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
203 |
+
5509,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
204 |
+
118869362,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
205 |
+
5311180,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
206 |
+
22049997,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
207 |
+
9853654,0,0,0,0,0,1,0,0,0,0,0,0,0,0
|
208 |
+
44582816,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
209 |
+
162368359,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
210 |
+
58507717,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
211 |
+
24872560,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
212 |
+
148123,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
213 |
+
146681181,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
214 |
+
67171867,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
215 |
+
11570805,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
216 |
+
25166913,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
217 |
+
67330085,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
218 |
+
16362,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
219 |
+
121408882,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
220 |
+
1923,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
221 |
+
126689157,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
222 |
+
118598754,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
223 |
+
72172,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
224 |
+
4659569,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
225 |
+
4922,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
226 |
+
9415,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
227 |
+
445858,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
228 |
+
5324346,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
229 |
+
9560989,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
230 |
+
3463,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
231 |
+
3000226,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
232 |
+
46188928,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
233 |
+
10114,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
234 |
+
53340664,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
235 |
+
6918837,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
236 |
+
119182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
237 |
+
6989,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
238 |
+
67501411,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
239 |
+
129073603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
240 |
+
104850,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
241 |
+
28061,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
242 |
+
3000518,0,0,0,0,0,0,0,0,0,1,0,0,0,0
|
243 |
+
446727,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
244 |
+
285033,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
245 |
+
204,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
246 |
+
23675320,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
247 |
+
54680690,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
248 |
+
10180,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
249 |
+
9966051,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
250 |
+
11219835,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
251 |
+
11338033,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
252 |
+
25262965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
253 |
+
451417,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
254 |
+
54755438,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
255 |
+
163659,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
256 |
+
44241743,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
257 |
+
5282230,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
258 |
+
91885558,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
259 |
+
10029385,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
260 |
+
71766360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
261 |
+
3610,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
262 |
+
71571562,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
263 |
+
10195250,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
264 |
+
10621,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
265 |
+
155074,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
266 |
+
16063245,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
267 |
+
16759173,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
268 |
+
185462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
269 |
+
24963252,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
270 |
+
16735117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
271 |
+
440936,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
272 |
+
5344,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
273 |
+
5459308,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
274 |
+
54704426,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
275 |
+
57363,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
276 |
+
58282870,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
277 |
+
6917864,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
278 |
+
45256689,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
279 |
+
6918132,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
280 |
+
9046,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
281 |
+
6019,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
282 |
+
138911318,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
283 |
+
443872,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
284 |
+
441207,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
285 |
+
23674502,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
286 |
+
6364534,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
287 |
+
16218542,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
288 |
+
68911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
289 |
+
67517580,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
290 |
+
54677470,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
291 |
+
11310,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
292 |
+
135151360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
293 |
+
82146,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
294 |
+
119369,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
295 |
+
46205871,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
296 |
+
9875462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
297 |
+
2749,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
298 |
+
67448836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
299 |
+
104849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
300 |
+
9827599,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
301 |
+
11960271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
302 |
+
32798,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
303 |
+
51003603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
304 |
+
3033819,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
305 |
+
117965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
306 |
+
2359994,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
307 |
+
73442,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
308 |
+
66065,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
309 |
+
10138980,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
310 |
+
10206,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
311 |
+
16217067,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
312 |
+
275182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
313 |
+
10143,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
314 |
+
238053,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
315 |
+
5327711,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
316 |
+
46208890,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
317 |
+
54676228,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
318 |
+
77999,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
319 |
+
3045381,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
320 |
+
45256693,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
321 |
+
137319707,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
322 |
+
71420,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
323 |
+
16124208,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
324 |
+
24199313,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
325 |
+
5311027,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
326 |
+
66068,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
327 |
+
46910592,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
328 |
+
13982876,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
329 |
+
16747388,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
330 |
+
33630,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
331 |
+
70817911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
332 |
+
46220375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
333 |
+
23582824,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
334 |
+
130956,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
335 |
+
1936439,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
336 |
+
64982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
337 |
+
4614,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
338 |
+
121241171,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
339 |
+
5717952,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
340 |
+
73053710,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
341 |
+
135397144,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
342 |
+
3198,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
343 |
+
107971,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
344 |
+
118701008,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
345 |
+
92044433,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
346 |
+
118959080,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
347 |
+
24721416,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
348 |
+
23665037,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
349 |
+
11683005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
350 |
+
16048568,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
351 |
+
168312271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
352 |
+
137628686,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
353 |
+
3064778,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
354 |
+
14982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
355 |
+
2747117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
356 |
+
146673142,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
357 |
+
44093,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
358 |
+
167811,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
359 |
+
5312125,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
360 |
+
4006,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
361 |
+
104769,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
362 |
+
135565635,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
363 |
+
11595577,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
364 |
+
11957481,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
365 |
+
170014,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
366 |
+
276389,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
367 |
+
5405,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
368 |
+
158550,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
369 |
+
23663985,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
370 |
+
9562059,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
371 |
+
72205932,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
372 |
+
1986,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
373 |
+
86295191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
374 |
+
1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
375 |
+
6437836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
376 |
+
118704762,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
377 |
+
2194,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
clinical_evidence_data/drugs_organs_tested.csv
ADDED
@@ -0,0 +1,377 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
pubchem_id,Bladder/Urinary Tract,Bowel,Breast,CNS/Brain,Cervix,Esophagus/Stomach,Kidney,Liver,Lung,Ovary/Fallopian Tube,Pancreas,Peripheral Nervous System,Skin,Uterus
|
2 |
+
104741,0,1,1,0,0,1,0,0,1,1,0,0,1,1
|
3 |
+
74990,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
4 |
+
60838,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
5 |
+
9887053,1,1,1,0,0,1,0,1,1,1,1,1,1,1
|
6 |
+
135410875,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
7 |
+
65348,1,1,1,0,0,1,0,1,1,1,1,0,1,0
|
8 |
+
176870,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
9 |
+
36314,1,1,1,1,1,1,0,1,1,1,1,1,1,1
|
10 |
+
2187,0,0,1,1,0,0,0,0,1,1,0,0,0,1
|
11 |
+
60699,1,1,1,1,1,0,1,1,1,1,0,0,1,1
|
12 |
+
60750,1,1,1,1,1,0,1,1,1,1,1,0,1,1
|
13 |
+
5281004,0,1,1,0,0,1,1,1,1,0,0,0,1,0
|
14 |
+
148124,1,1,1,1,1,1,0,0,1,1,1,0,1,1
|
15 |
+
23725625,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
16 |
+
5329102,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
17 |
+
3385,1,1,1,1,1,1,1,1,1,1,1,1,1,1
|
18 |
+
5330286,1,1,1,1,0,0,1,1,1,1,1,0,1,1
|
19 |
+
123631,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
20 |
+
78357807,0,1,0,1,0,0,1,0,1,0,0,0,1,0
|
21 |
+
6918289,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
22 |
+
11167602,1,1,0,1,0,1,1,1,1,1,1,0,1,0
|
23 |
+
443939,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
24 |
+
135398658,1,1,1,1,0,1,1,1,1,1,1,1,1,1
|
25 |
+
2563,0,0,0,1,0,0,0,0,1,0,0,1,0,0
|
26 |
+
10184665,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
27 |
+
46220502,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
28 |
+
25102846,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
29 |
+
444795,1,1,1,1,1,0,1,1,1,0,1,0,1,0
|
30 |
+
11707110,0,1,1,1,1,1,1,1,1,0,1,0,1,0
|
31 |
+
6256,0,1,1,1,0,1,1,1,1,1,1,0,1,0
|
32 |
+
16052011,0,1,1,0,0,0,0,0,0,1,1,0,1,1
|
33 |
+
44631912,0,1,1,1,0,1,1,1,1,1,1,0,1,1
|
34 |
+
10184653,1,1,1,1,0,1,1,1,1,0,1,0,1,1
|
35 |
+
445639,0,1,0,1,0,1,1,1,1,0,1,0,1,0
|
36 |
+
11626560,1,1,1,1,0,1,1,1,1,0,0,0,1,1
|
37 |
+
168311648,1,1,1,1,0,1,1,1,1,1,0,1,1,1
|
38 |
+
135398744,1,1,0,1,0,0,1,1,1,0,1,1,0,1
|
39 |
+
1054,1,1,1,1,0,1,1,1,1,1,1,1,1,1
|
40 |
+
119607,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
41 |
+
42611257,1,1,0,1,0,0,0,0,1,1,1,0,1,0
|
42 |
+
60961,0,1,1,1,0,1,0,0,1,1,1,0,0,1
|
43 |
+
10288191,0,1,1,1,0,0,0,1,1,1,1,0,1,0
|
44 |
+
6436173,0,1,1,1,0,0,1,1,1,0,0,0,1,0
|
45 |
+
4594,0,1,1,1,0,1,0,1,1,1,1,1,1,1
|
46 |
+
12108541,0,1,1,1,0,1,0,1,1,1,1,1,1,1
|
47 |
+
16923,1,1,1,1,0,0,1,1,1,0,0,0,1,0
|
48 |
+
3100,0,1,1,1,0,1,1,1,1,1,1,1,1,1
|
49 |
+
21800,0,1,0,1,0,0,0,0,1,0,0,0,1,0
|
50 |
+
54684461,1,1,1,1,0,1,1,0,1,1,1,0,1,1
|
51 |
+
5284373,0,1,1,1,0,1,1,1,1,0,0,0,1,0
|
52 |
+
44462760,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
53 |
+
24906252,0,1,1,1,0,0,1,1,1,1,1,1,0,0
|
54 |
+
2662,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
55 |
+
5388983,1,1,1,1,1,0,1,0,1,1,0,0,1,0
|
56 |
+
107969,0,0,1,1,0,0,1,0,1,0,0,1,0,0
|
57 |
+
4740,0,1,1,1,0,0,1,1,1,1,1,0,0,1
|
58 |
+
4829,0,1,1,1,0,0,1,1,1,1,1,0,1,1
|
59 |
+
56649450,0,1,1,1,0,1,0,1,1,1,1,0,1,1
|
60 |
+
5564,0,1,1,1,0,0,1,0,1,0,0,0,1,0
|
61 |
+
3657,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
62 |
+
12560,0,1,1,1,0,1,1,1,1,0,1,0,1,1
|
63 |
+
50922675,0,1,0,1,0,0,0,1,1,0,1,0,1,0
|
64 |
+
6419992,0,1,1,1,0,0,0,0,1,0,0,1,1,0
|
65 |
+
637568,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
66 |
+
110635,1,1,1,1,0,1,1,1,1,0,1,0,1,0
|
67 |
+
468595,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
68 |
+
16222096,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
69 |
+
135400182,0,1,0,0,0,1,0,1,1,0,1,0,1,0
|
70 |
+
9887712,0,0,1,1,0,0,1,1,1,1,1,1,0,0
|
71 |
+
16760658,1,1,1,1,0,1,1,1,1,0,0,0,1,1
|
72 |
+
249332,1,1,0,1,0,0,1,1,1,1,0,0,0,0
|
73 |
+
24776445,0,1,1,1,0,1,1,1,1,1,1,0,1,0
|
74 |
+
3081361,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
75 |
+
126941,1,1,1,1,0,1,0,1,1,0,0,0,1,0
|
76 |
+
67307512,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
77 |
+
9915743,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
78 |
+
451668,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
79 |
+
6442177,1,1,1,1,1,1,1,1,1,1,1,1,1,1
|
80 |
+
10174505,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
81 |
+
9926791,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
82 |
+
2244,1,1,1,1,0,1,1,0,1,1,1,0,1,0
|
83 |
+
31307,1,1,1,1,1,0,1,1,1,0,1,1,1,1
|
84 |
+
387447,1,1,1,1,1,1,1,1,1,1,1,1,1,0
|
85 |
+
52920501,0,1,1,0,0,1,1,1,1,1,1,0,1,0
|
86 |
+
392622,0,0,1,1,0,0,1,1,1,0,0,0,0,0
|
87 |
+
12136798,1,1,1,1,1,1,0,1,1,0,1,0,1,0
|
88 |
+
2754,0,0,1,1,0,0,1,1,1,0,0,0,1,0
|
89 |
+
23679632,0,0,1,1,0,0,0,1,1,0,1,1,1,0
|
90 |
+
6112,0,1,1,1,0,0,1,1,1,1,1,1,0,0
|
91 |
+
2812,0,1,1,1,0,0,1,1,1,0,0,0,1,0
|
92 |
+
19090,0,1,1,1,0,0,0,1,1,0,0,0,1,1
|
93 |
+
4055,0,1,0,1,0,0,1,1,1,1,1,0,1,0
|
94 |
+
77995,1,1,1,1,0,1,1,1,1,1,1,0,0,0
|
95 |
+
6279,0,0,1,1,0,0,1,0,1,1,0,0,0,1
|
96 |
+
5282164,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
97 |
+
11672905,0,1,1,1,0,0,0,0,1,0,0,1,0,0
|
98 |
+
25145656,0,1,1,0,0,1,1,1,1,0,0,0,1,0
|
99 |
+
3578572,1,1,1,1,0,0,1,1,1,0,0,0,1,0
|
100 |
+
156391,1,1,1,1,0,1,1,1,1,1,0,0,0,1
|
101 |
+
72165228,1,1,1,1,0,0,1,1,1,0,0,0,1,1
|
102 |
+
190,1,1,1,1,0,1,1,1,1,1,0,0,1,1
|
103 |
+
16004692,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
104 |
+
9931953,1,1,1,0,1,1,0,1,1,1,1,0,0,1
|
105 |
+
3339,0,1,1,1,1,1,1,1,1,0,0,0,0,0
|
106 |
+
5743,1,1,1,1,1,1,0,1,1,0,0,0,1,0
|
107 |
+
9444,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
108 |
+
24788740,0,0,1,1,0,1,0,1,1,1,0,0,1,1
|
109 |
+
441243,1,1,1,1,0,1,1,1,1,1,0,0,1,0
|
110 |
+
157921,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
111 |
+
156419,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
112 |
+
5284443,0,1,1,1,0,1,1,1,1,0,1,1,1,0
|
113 |
+
71481097,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
114 |
+
11557040,1,0,1,0,0,1,1,0,1,0,1,0,0,0
|
115 |
+
2554,0,0,0,1,0,0,0,1,1,0,0,1,0,0
|
116 |
+
135401907,0,1,0,1,0,0,1,1,1,1,0,0,0,0
|
117 |
+
445154,0,1,0,1,0,0,1,1,1,1,1,1,1,1
|
118 |
+
2123,1,1,1,1,0,0,1,1,1,1,0,0,1,0
|
119 |
+
24775005,0,1,1,1,0,1,0,1,1,1,1,0,1,0
|
120 |
+
5311068,1,1,1,1,0,1,1,1,1,0,1,0,0,0
|
121 |
+
6321424,0,0,1,1,0,0,0,0,1,1,1,0,1,0
|
122 |
+
14296,0,1,1,1,0,0,1,1,1,0,1,0,1,0
|
123 |
+
11256664,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
124 |
+
2478,1,0,1,1,0,0,0,0,1,1,0,0,1,0
|
125 |
+
51082,1,0,1,1,0,0,0,1,1,1,1,0,0,0
|
126 |
+
60606,0,1,1,1,0,0,1,1,1,1,1,0,0,0
|
127 |
+
6314,1,1,1,1,1,1,1,0,1,0,0,1,1,0
|
128 |
+
25022378,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
129 |
+
8813,0,1,0,0,0,0,1,1,1,0,1,0,1,0
|
130 |
+
370,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
131 |
+
148195,1,1,1,1,0,0,0,1,1,1,0,0,0,0
|
132 |
+
45375953,1,0,1,1,0,0,1,1,1,1,0,0,1,1
|
133 |
+
5381,0,1,1,0,0,0,0,0,0,0,0,0,1,0
|
134 |
+
165411828,0,1,0,1,0,0,0,1,1,0,0,0,0,1
|
135 |
+
25227436,0,0,1,1,0,1,0,0,1,0,0,0,1,1
|
136 |
+
68873,0,0,1,0,0,0,1,0,0,1,0,0,1,1
|
137 |
+
51039094,0,1,1,0,0,1,0,0,1,0,0,0,0,0
|
138 |
+
117947097,0,1,1,1,0,0,1,1,0,1,0,0,0,0
|
139 |
+
6253,0,1,1,1,0,0,0,1,0,0,0,0,0,0
|
140 |
+
2375,1,0,1,1,0,0,1,0,0,1,0,0,0,0
|
141 |
+
5493444,0,1,0,0,0,0,1,0,1,0,0,0,0,0
|
142 |
+
6029,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
143 |
+
24785956,0,0,0,1,0,0,0,0,0,1,0,0,0,1
|
144 |
+
20179,0,1,1,1,1,0,1,0,0,0,1,1,0,1
|
145 |
+
53235510,1,1,1,1,0,1,0,1,1,0,0,0,1,0
|
146 |
+
56959,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
147 |
+
65628,1,0,1,1,0,1,1,1,1,1,1,0,0,0
|
148 |
+
441074,0,0,0,1,0,0,0,1,0,0,0,1,0,0
|
149 |
+
4495,0,1,1,1,1,1,0,0,1,0,1,0,1,0
|
150 |
+
24812758,0,0,1,1,0,0,1,1,1,1,0,0,0,0
|
151 |
+
10461508,0,1,1,1,0,1,1,1,1,1,0,0,0,0
|
152 |
+
24997615,0,0,1,1,0,0,1,1,1,1,0,0,0,0
|
153 |
+
67462786,1,0,1,1,0,0,0,1,1,0,0,0,0,0
|
154 |
+
86705695,1,1,1,1,0,1,0,1,1,0,1,0,0,0
|
155 |
+
25141092,0,1,1,1,0,0,1,1,1,1,0,0,1,0
|
156 |
+
10348973,0,0,0,0,0,0,0,0,0,0,0,0,0,1
|
157 |
+
636362,1,0,0,1,0,0,0,1,1,0,0,0,0,0
|
158 |
+
2520,0,1,1,1,0,0,0,1,1,0,1,0,1,0
|
159 |
+
5823908,0,0,0,1,0,1,1,0,1,0,0,0,1,0
|
160 |
+
138611145,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
161 |
+
3034010,0,0,1,1,0,0,0,1,1,1,0,0,0,0
|
162 |
+
6918638,1,0,1,1,0,0,0,1,1,1,1,0,1,0
|
163 |
+
4463,0,1,1,1,0,0,0,1,1,0,1,0,1,1
|
164 |
+
338,0,1,0,1,0,0,0,0,0,0,0,0,1,0
|
165 |
+
56671814,1,0,0,1,0,1,1,1,1,0,0,0,0,0
|
166 |
+
71621331,1,1,1,0,0,1,0,1,1,0,0,0,0,0
|
167 |
+
9821849,1,1,1,0,0,0,1,1,1,0,0,0,0,0
|
168 |
+
60490,0,0,0,0,0,0,0,0,1,0,0,1,1,0
|
169 |
+
49831257,0,1,0,0,0,0,1,0,0,0,0,0,0,0
|
170 |
+
135398745,0,1,1,1,0,1,0,0,1,0,0,0,1,0
|
171 |
+
2435,0,0,0,1,0,0,0,0,0,1,0,0,1,0
|
172 |
+
135413536,0,1,1,1,0,0,0,0,1,1,1,0,1,0
|
173 |
+
441313,0,1,1,1,0,0,1,1,1,0,0,0,0,0
|
174 |
+
656656,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
175 |
+
92727,0,0,1,1,0,0,0,1,1,0,0,0,0,0
|
176 |
+
5583,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
177 |
+
3440,0,1,1,1,0,0,0,1,0,0,0,0,0,0
|
178 |
+
6480466,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
179 |
+
56844015,1,0,1,1,0,0,1,0,1,0,0,0,0,0
|
180 |
+
25183872,1,0,1,1,0,0,1,0,1,0,0,0,0,0
|
181 |
+
21585658,0,0,0,0,0,0,1,1,1,0,0,0,1,0
|
182 |
+
71616,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
183 |
+
444972,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
184 |
+
55245,0,0,1,1,0,0,0,0,1,0,0,0,0,1
|
185 |
+
4030,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
186 |
+
9082,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
187 |
+
11950170,1,0,0,0,0,0,0,0,1,0,0,0,1,0
|
188 |
+
6918111,0,1,1,1,0,0,1,1,0,0,0,0,0,0
|
189 |
+
5284616,0,0,1,1,0,0,1,0,1,0,0,0,1,0
|
190 |
+
164726578,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
191 |
+
667493,0,0,0,1,0,0,1,0,1,0,0,1,1,0
|
192 |
+
2179,0,1,0,1,0,1,0,1,0,0,1,0,1,0
|
193 |
+
71576688,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
194 |
+
6252,0,1,0,1,0,0,0,1,1,0,0,0,0,0
|
195 |
+
3397,0,0,0,0,0,0,1,0,0,1,0,0,1,0
|
196 |
+
135526609,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
197 |
+
5282451,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
198 |
+
5905,0,1,1,0,0,0,0,1,0,0,0,0,0,0
|
199 |
+
14992,0,1,0,0,0,0,1,0,1,0,0,0,0,0
|
200 |
+
46926350,0,0,1,0,0,0,0,0,1,0,1,0,1,0
|
201 |
+
49846579,0,0,1,0,0,0,0,0,1,0,0,0,0,0
|
202 |
+
24826799,0,0,0,1,0,0,0,0,1,0,1,0,0,0
|
203 |
+
5509,0,0,1,1,0,0,0,1,0,0,0,0,0,0
|
204 |
+
118869362,0,1,0,0,0,0,0,0,1,1,1,0,1,0
|
205 |
+
5311180,0,0,0,0,0,0,1,1,1,0,0,0,0,0
|
206 |
+
22049997,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
207 |
+
9853654,0,0,0,0,0,1,0,0,0,0,0,0,0,0
|
208 |
+
44582816,0,0,0,1,0,0,0,0,0,0,1,0,0,0
|
209 |
+
162368359,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
210 |
+
58507717,0,0,1,1,0,0,0,0,0,0,0,0,1,0
|
211 |
+
24872560,1,0,0,0,0,0,0,1,1,1,0,0,1,0
|
212 |
+
148123,0,0,1,0,0,1,0,0,0,0,0,0,1,0
|
213 |
+
146681181,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
214 |
+
67171867,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
215 |
+
11570805,0,1,1,1,0,0,0,0,0,1,0,0,0,0
|
216 |
+
25166913,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
217 |
+
67330085,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
218 |
+
16362,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
219 |
+
121408882,0,1,0,1,0,0,0,0,0,0,1,0,0,0
|
220 |
+
1923,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
221 |
+
126689157,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
222 |
+
118598754,0,1,1,0,0,0,0,0,1,0,0,0,0,0
|
223 |
+
72172,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
224 |
+
4659569,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
225 |
+
4922,0,0,0,0,0,0,0,1,0,0,1,0,0,0
|
226 |
+
9415,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
227 |
+
445858,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
228 |
+
5324346,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
229 |
+
9560989,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
230 |
+
3463,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
231 |
+
3000226,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
232 |
+
46188928,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
233 |
+
10114,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
234 |
+
53340664,0,0,1,0,0,1,1,0,0,0,0,0,0,0
|
235 |
+
6918837,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
236 |
+
119182,1,1,0,0,0,1,0,0,0,0,0,0,0,0
|
237 |
+
6989,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
238 |
+
67501411,0,1,0,0,0,0,0,0,0,0,0,0,0,1
|
239 |
+
129073603,0,1,0,0,0,0,0,0,1,0,0,0,0,0
|
240 |
+
104850,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
241 |
+
28061,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
242 |
+
3000518,0,0,0,0,0,0,0,0,0,1,0,0,0,0
|
243 |
+
446727,1,1,0,0,0,0,0,0,1,0,0,0,0,0
|
244 |
+
285033,0,0,0,0,0,0,0,1,0,1,0,0,1,0
|
245 |
+
204,0,0,0,1,0,0,1,0,0,0,0,0,1,0
|
246 |
+
23675320,0,0,0,0,0,0,1,1,0,0,0,0,1,0
|
247 |
+
54680690,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
248 |
+
10180,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
249 |
+
9966051,0,0,1,0,0,0,0,0,0,0,0,0,1,0
|
250 |
+
11219835,0,1,0,1,0,0,0,0,0,0,0,0,0,0
|
251 |
+
11338033,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
252 |
+
25262965,0,0,0,1,0,0,0,1,0,0,0,0,0,0
|
253 |
+
451417,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
254 |
+
54755438,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
255 |
+
163659,0,1,0,0,0,0,0,0,1,0,0,0,0,0
|
256 |
+
44241743,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
257 |
+
5282230,0,0,0,0,0,1,0,0,0,0,0,0,1,0
|
258 |
+
91885558,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
259 |
+
10029385,0,0,0,0,0,0,0,0,0,0,1,0,0,0
|
260 |
+
71766360,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
261 |
+
3610,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
262 |
+
71571562,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
263 |
+
10195250,0,0,0,0,0,0,0,0,0,0,0,0,0,1
|
264 |
+
10621,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
265 |
+
155074,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
266 |
+
16063245,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
267 |
+
16759173,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
268 |
+
185462,0,0,0,0,0,0,0,0,0,0,1,0,0,0
|
269 |
+
24963252,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
270 |
+
16735117,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
271 |
+
440936,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
272 |
+
5344,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
273 |
+
5459308,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
274 |
+
54704426,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
275 |
+
57363,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
276 |
+
58282870,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
277 |
+
6917864,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
278 |
+
45256689,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
279 |
+
6918132,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
280 |
+
9046,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
281 |
+
6019,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
282 |
+
138911318,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
283 |
+
443872,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
284 |
+
441207,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
285 |
+
23674502,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
286 |
+
6364534,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
287 |
+
16218542,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
288 |
+
68911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
289 |
+
67517580,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
290 |
+
54677470,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
291 |
+
11310,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
292 |
+
135151360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
293 |
+
82146,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
294 |
+
119369,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
295 |
+
46205871,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
296 |
+
9875462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
297 |
+
2749,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
298 |
+
67448836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
299 |
+
104849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
300 |
+
9827599,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
301 |
+
11960271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
302 |
+
32798,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
303 |
+
51003603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
304 |
+
3033819,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
305 |
+
117965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
306 |
+
2359994,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
307 |
+
73442,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
308 |
+
66065,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
309 |
+
10138980,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
310 |
+
10206,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
311 |
+
16217067,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
312 |
+
275182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
313 |
+
10143,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
314 |
+
238053,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
315 |
+
5327711,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
316 |
+
46208890,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
317 |
+
54676228,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
318 |
+
77999,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
319 |
+
3045381,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
320 |
+
45256693,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
321 |
+
137319707,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
322 |
+
71420,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
323 |
+
16124208,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
324 |
+
24199313,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
325 |
+
5311027,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
326 |
+
66068,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
327 |
+
46910592,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
328 |
+
13982876,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
329 |
+
16747388,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
330 |
+
33630,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
331 |
+
70817911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
332 |
+
46220375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
333 |
+
23582824,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
334 |
+
130956,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
335 |
+
1936439,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
336 |
+
64982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
337 |
+
4614,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
338 |
+
121241171,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
339 |
+
5717952,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
340 |
+
73053710,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
341 |
+
135397144,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
342 |
+
3198,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
343 |
+
107971,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
344 |
+
118701008,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
345 |
+
92044433,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
346 |
+
118959080,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
347 |
+
24721416,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
348 |
+
23665037,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
349 |
+
11683005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
350 |
+
16048568,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
351 |
+
168312271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
352 |
+
137628686,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
353 |
+
3064778,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
354 |
+
14982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
355 |
+
2747117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
356 |
+
146673142,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
357 |
+
44093,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
358 |
+
167811,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
359 |
+
5312125,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
360 |
+
4006,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
361 |
+
104769,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
362 |
+
135565635,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
363 |
+
11595577,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
364 |
+
11957481,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
365 |
+
170014,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
366 |
+
276389,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
367 |
+
5405,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
368 |
+
158550,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
369 |
+
23663985,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
370 |
+
9562059,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
371 |
+
72205932,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
372 |
+
1986,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
373 |
+
86295191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
374 |
+
1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
375 |
+
6437836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
376 |
+
118704762,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
377 |
+
2194,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
clinical_evidence_data/tahoe_drugs_clinical_trials.csv
ADDED
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
1 |
+
version https://git-lfs.github.com/spec/v1
|
2 |
+
oid sha256:d2947165c10d719debd38bf07d9729beeba193d3e22a1f5072fb933c4bd2dabd
|
3 |
+
size 16008886
|
data/Tahoe96M_edist_matrix_within_plate.tsv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
data/cell_line_metadata.csv
ADDED
@@ -0,0 +1,1001 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
,cell_name,Cell_ID_DepMap,Cell_ID_Cellosaur,Organ,Driver_Gene_Symbol,Driver_VarZyg,Driver_VarType,Driver_ProtEffect_or_CdnaEffect,Driver_Mech_InferDM,Driver_GeneType_DM
|
2 |
+
0,A549,ACH-000681,CVCL_0023,Lung,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
3 |
+
1,A549,ACH-000681,CVCL_0023,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
4 |
+
2,A549,ACH-000681,CVCL_0023,Lung,KRAS,Hom,Missense,p.G12S,GoF,Oncogene
|
5 |
+
3,A549,ACH-000681,CVCL_0023,Lung,SMARCA4,Hom,Frameshift,p.Q729fs,LoF,Suppressor
|
6 |
+
4,A549,ACH-000681,CVCL_0023,Lung,STK11,Hom,Stopgain,p.Q37*,LoF,Suppressor
|
7 |
+
5,A549,ACH-000681,CVCL_0023,Lung,ZFHX3,Het,Missense,p.L1473F,,Suppressor
|
8 |
+
6,HOP-92,ACH-000825,CVCL_1286,Lung,ACVR2A,Het,Missense,p.K133M,LoF,Suppressor
|
9 |
+
7,HOP-92,ACH-000825,CVCL_1286,Lung,GNAS,Het,Missense,p.V117M,,Oncogene
|
10 |
+
8,HOP-92,ACH-000825,CVCL_1286,Lung,NF1,Het,Frameshift,p.M799fs,LoF,Suppressor
|
11 |
+
9,HOP-92,ACH-000825,CVCL_1286,Lung,SOS1,Het,Missense,p.N233Y,GoF,Oncogene
|
12 |
+
10,HOP-92,ACH-000825,CVCL_1286,Lung,TP53,Hom,Missense,p.R175L,LoF,Suppressor
|
13 |
+
11,HMVII,ACH-002040,CVCL_1282,Vulva/Vagina,B2M,Hom,Deletion,DEL,LoF,Suppressor
|
14 |
+
12,HMVII,ACH-002040,CVCL_1282,Vulva/Vagina,BRAF,Het,Missense,p.G469V,GoF,Oncogene
|
15 |
+
13,HMVII,ACH-002040,CVCL_1282,Vulva/Vagina,BRCA2,Het,Missense,p.M784V,,Suppressor
|
16 |
+
14,HMVII,ACH-002040,CVCL_1282,Vulva/Vagina,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
17 |
+
15,HMVII,ACH-002040,CVCL_1282,Vulva/Vagina,RB1,Het,Missense,p.L819V,,Suppressor
|
18 |
+
16,HMVII,ACH-002040,CVCL_1282,Vulva/Vagina,TP53,Het,Missense,p.N268I,LoF,Suppressor
|
19 |
+
17,Hs 936.T(C1),,CVCL_1034,Skin,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
20 |
+
18,MM485,ACH-001973,CVCL_2610,Skin,APC,Het,Missense,p.P2783S,LoF,Suppressor
|
21 |
+
19,MM485,ACH-001973,CVCL_2610,Skin,CDKN2A,Hom,Stopgain,p.W59*,LoF,Suppressor
|
22 |
+
20,MM485,ACH-001973,CVCL_2610,Skin,NRAS,Het,Missense,p.Q61R,GoF,Oncogene
|
23 |
+
21,MM485,ACH-001973,CVCL_2610,Skin,SMARCB1,Het,Missense,p.W349L,LoF,Suppressor
|
24 |
+
22,MM485,ACH-001973,CVCL_2610,Skin,TP53,Hom,Stopgain,p.R196*,LoF,Suppressor
|
25 |
+
23,MM415,ACH-001569,CVCL_2608,Skin,KMT2D,Het,Missense,p.T680P,,Suppressor
|
26 |
+
24,MM415,ACH-001569,CVCL_2608,Skin,MTOR,Het,Missense,p.L2185F,,Oncogene
|
27 |
+
25,MM415,ACH-001569,CVCL_2608,Skin,NF1,Het,Stopgain,p.R1276*,LoF,Suppressor
|
28 |
+
26,MM415,ACH-001569,CVCL_2608,Skin,NRAS,Het,Missense,p.Q61L,GoF,Oncogene
|
29 |
+
27,MM415,ACH-001569,CVCL_2608,Skin,SMARCB1,Het,Missense,p.T214M,LoF,Suppressor
|
30 |
+
28,MM415,ACH-001569,CVCL_2608,Skin,TP53,Hom,Missense,p.A347V,,Suppressor
|
31 |
+
29,MCF-7,ACH-000019,CVCL_0031,Breast,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
32 |
+
30,MCF-7,ACH-000019,CVCL_0031,Breast,GNAS,,Gain,GAIN,GoF,Oncogene
|
33 |
+
31,MCF-7,ACH-000019,CVCL_0031,Breast,NRAS,,Gain,GAIN,GoF,Oncogene
|
34 |
+
32,MCF-7,ACH-000019,CVCL_0031,Breast,PIK3CA,Het,Missense,p.E545K,GoF,Oncogene
|
35 |
+
33,MCF-7,ACH-000019,CVCL_0031,Breast,SMAD3,Het,Splice_site,p.V90F,LoF,Suppressor
|
36 |
+
34,MCF-7,ACH-000019,CVCL_0031,Breast,WNK2,Het,Missense,p.L312Q,,Suppressor
|
37 |
+
35,SK-MEL-30,ACH-000810,CVCL_0039,Skin,APC,Het,Missense,p.G1339R,,Suppressor
|
38 |
+
36,SK-MEL-30,ACH-000810,CVCL_0039,Skin,APC,Het,Stopgain,p.Q1406*,LoF,Suppressor
|
39 |
+
37,SK-MEL-30,ACH-000810,CVCL_0039,Skin,BRAF,Het,Missense,p.E275K,,Oncogene
|
40 |
+
38,SK-MEL-30,ACH-000810,CVCL_0039,Skin,CDKN2A,Hom,Missense,p.P63L,LoF,Suppressor
|
41 |
+
39,SK-MEL-30,ACH-000810,CVCL_0039,Skin,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
42 |
+
40,SK-MEL-30,ACH-000810,CVCL_0039,Skin,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
43 |
+
41,SK-MEL-30,ACH-000810,CVCL_0039,Skin,TP53,Het,Missense,p.R273H,LoF,Suppressor
|
44 |
+
42,SK-MEL-30,ACH-000810,CVCL_0039,Skin,TP53,Het,Frameshift,p.T284fs,LoF,Suppressor
|
45 |
+
43,SW620,ACH-000651,CVCL_0547,Bowel,APC,Hom,Stopgain,p.Q1338*,LoF,Suppressor
|
46 |
+
44,SW620,ACH-000651,CVCL_0547,Bowel,EGFR,Het,Missense,p.C186S,,Oncogene
|
47 |
+
45,SW620,ACH-000651,CVCL_0547,Bowel,EP300,Het,Missense,p.P1440L,LoF,Suppressor
|
48 |
+
46,SW620,ACH-000651,CVCL_0547,Bowel,KRAS,,Gain,GAIN,GoF,Oncogene
|
49 |
+
47,SW620,ACH-000651,CVCL_0547,Bowel,KRAS,Hom,Missense,p.G12V,GoF,Oncogene
|
50 |
+
48,SW620,ACH-000651,CVCL_0547,Bowel,MYC,,Gain,GAIN,GoF,Oncogene
|
51 |
+
49,SW620,ACH-000651,CVCL_0547,Bowel,TP53,Hom,Missense,p.P309S,LoF,Suppressor
|
52 |
+
50,SW620,ACH-000651,CVCL_0547,Bowel,TP53,Hom,Missense,p.R273H,LoF,Suppressor
|
53 |
+
51,COLO 205,ACH-001039,CVCL_0218,Bowel,APC,Hom,Frameshift,p.T1556fs,LoF,Suppressor
|
54 |
+
52,COLO 205,ACH-001039,CVCL_0218,Bowel,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
55 |
+
53,COLO 205,ACH-001039,CVCL_0218,Bowel,CTNNB1,Hom,Missense,p.N287S,,Oncogene
|
56 |
+
54,COLO 205,ACH-001039,CVCL_0218,Bowel,GNAS,Het,Missense,p.S95I,,Oncogene
|
57 |
+
55,COLO 205,ACH-001039,CVCL_0218,Bowel,MTOR,Het,Missense,p.P1193L,,Oncogene
|
58 |
+
56,COLO 205,ACH-001039,CVCL_0218,Bowel,PMS2,Het,Missense,p.E504Q,,Suppressor
|
59 |
+
57,COLO 205,ACH-001039,CVCL_0218,Bowel,TP53,Hom,Frameshift,p.Y103fs,LoF,Suppressor
|
60 |
+
58,COLO 205,ACH-001039,CVCL_0218,Bowel,TP53,Hom,Frameshift,p.Y107fs,LoF,Suppressor
|
61 |
+
59,HCC-2998,ACH-001081,CVCL_1266,Bowel,ACVR2A,Het,Stopgain,p.E112*,LoF,Suppressor
|
62 |
+
60,HCC-2998,ACH-001081,CVCL_1266,Bowel,APC,Het,Missense,p.I2167S,LoF,Suppressor
|
63 |
+
61,HCC-2998,ACH-001081,CVCL_1266,Bowel,APC,Het,Stopgain,p.L665*,LoF,Suppressor
|
64 |
+
62,HCC-2998,ACH-001081,CVCL_1266,Bowel,APC,Het,Missense,p.N2720K,,Suppressor
|
65 |
+
63,HCC-2998,ACH-001081,CVCL_1266,Bowel,APC,Het,Stopgain,p.R1450*,LoF,Suppressor
|
66 |
+
64,HCC-2998,ACH-001081,CVCL_1266,Bowel,APC,Het,Missense,p.R168I,LoF,Suppressor
|
67 |
+
65,HCC-2998,ACH-001081,CVCL_1266,Bowel,APC,Het,Missense,p.S1864Y,LoF,Suppressor
|
68 |
+
66,HCC-2998,ACH-001081,CVCL_1266,Bowel,ARID1A,Het,Stopgain,p.R1772*,LoF,Suppressor
|
69 |
+
67,HCC-2998,ACH-001081,CVCL_1266,Bowel,ATM,Het,Missense,p.E1133K,,Suppressor
|
70 |
+
68,HCC-2998,ACH-001081,CVCL_1266,Bowel,ATM,Het,Stopgain,p.E277*,LoF,Suppressor
|
71 |
+
69,HCC-2998,ACH-001081,CVCL_1266,Bowel,ATM,Het,Missense,p.L1439I,,Suppressor
|
72 |
+
70,HCC-2998,ACH-001081,CVCL_1266,Bowel,ATM,Het,Stopgain,p.R250*,LoF,Suppressor
|
73 |
+
71,HCC-2998,ACH-001081,CVCL_1266,Bowel,ATM,Het,Missense,p.R337C,LoF,Suppressor
|
74 |
+
72,HCC-2998,ACH-001081,CVCL_1266,Bowel,B2M,Het,Stopgain,p.E56*,LoF,Suppressor
|
75 |
+
73,HCC-2998,ACH-001081,CVCL_1266,Bowel,BRCA2,Het,Missense,p.D1177N,,Suppressor
|
76 |
+
74,HCC-2998,ACH-001081,CVCL_1266,Bowel,BRCA2,Het,Missense,p.E3342K,,Suppressor
|
77 |
+
75,HCC-2998,ACH-001081,CVCL_1266,Bowel,BRCA2,Het,Missense,p.K817N,,Suppressor
|
78 |
+
76,HCC-2998,ACH-001081,CVCL_1266,Bowel,BRCA2,Het,Missense,p.K981N,,Suppressor
|
79 |
+
77,HCC-2998,ACH-001081,CVCL_1266,Bowel,BRCA2,Het,Missense,p.L2136V,,Suppressor
|
80 |
+
78,HCC-2998,ACH-001081,CVCL_1266,Bowel,BRCA2,Het,Missense,p.P288S,,Suppressor
|
81 |
+
79,HCC-2998,ACH-001081,CVCL_1266,Bowel,BRCA2,Het,Missense,p.R2896C,,Suppressor
|
82 |
+
80,HCC-2998,ACH-001081,CVCL_1266,Bowel,CDKN2A,Het,Missense,p.A36G,LoF,Suppressor
|
83 |
+
81,HCC-2998,ACH-001081,CVCL_1266,Bowel,EP300,Het,Stopgain,p.E465*,LoF,Suppressor
|
84 |
+
82,HCC-2998,ACH-001081,CVCL_1266,Bowel,EP300,Het,Missense,p.L1584R,LoF,Suppressor
|
85 |
+
83,HCC-2998,ACH-001081,CVCL_1266,Bowel,FBXW7,Het,Missense,p.R609W,LoF,Suppressor
|
86 |
+
84,HCC-2998,ACH-001081,CVCL_1266,Bowel,JAK1,Het,Missense,p.R755Q,,Oncogene
|
87 |
+
85,HCC-2998,ACH-001081,CVCL_1266,Bowel,KMT2D,Het,Missense,p.T2131P,,Suppressor
|
88 |
+
86,HCC-2998,ACH-001081,CVCL_1266,Bowel,KRAS,Het,Missense,p.A146T,GoF,Oncogene
|
89 |
+
87,HCC-2998,ACH-001081,CVCL_1266,Bowel,MSH6,Het,Missense,p.K885N,,Suppressor
|
90 |
+
88,HCC-2998,ACH-001081,CVCL_1266,Bowel,MTOR,Het,Missense,p.I2500M,GoF,Oncogene
|
91 |
+
89,HCC-2998,ACH-001081,CVCL_1266,Bowel,MYCL,Het,Missense,p.R357I,,Oncogene
|
92 |
+
90,HCC-2998,ACH-001081,CVCL_1266,Bowel,NF1,Het,Missense,p.K609N,,Suppressor
|
93 |
+
91,HCC-2998,ACH-001081,CVCL_1266,Bowel,NF2,Het,Missense,p.K99T,LoF,Suppressor
|
94 |
+
92,HCC-2998,ACH-001081,CVCL_1266,Bowel,PIK3CB,Het,Missense,p.R149Q,,Oncogene
|
95 |
+
93,HCC-2998,ACH-001081,CVCL_1266,Bowel,PIK3CB,Het,Missense,p.R562Q,,Oncogene
|
96 |
+
94,HCC-2998,ACH-001081,CVCL_1266,Bowel,PIK3R1,Het,Stopgain,p.R98*,LoF,Suppressor
|
97 |
+
95,HCC-2998,ACH-001081,CVCL_1266,Bowel,PIK3R1,Het,Splice_site,,LoF,Suppressor
|
98 |
+
96,HCC-2998,ACH-001081,CVCL_1266,Bowel,PMS2,Het,Missense,p.A854T,,Suppressor
|
99 |
+
97,HCC-2998,ACH-001081,CVCL_1266,Bowel,PMS2,Het,Missense,p.D286E,,Suppressor
|
100 |
+
98,HCC-2998,ACH-001081,CVCL_1266,Bowel,POLE,Het,Missense,p.P286R,LoF,Suppressor
|
101 |
+
99,HCC-2998,ACH-001081,CVCL_1266,Bowel,PRDM2,Het,Missense,p.L595V,,Suppressor
|
102 |
+
100,HCC-2998,ACH-001081,CVCL_1266,Bowel,PRDM2,Het,Missense,p.S470Y,,Suppressor
|
103 |
+
101,HCC-2998,ACH-001081,CVCL_1266,Bowel,PTEN,Het,Missense,p.F341V,LoF,Suppressor
|
104 |
+
102,HCC-2998,ACH-001081,CVCL_1266,Bowel,PTEN,Het,Missense,p.R130Q,LoF,Suppressor
|
105 |
+
103,HCC-2998,ACH-001081,CVCL_1266,Bowel,PTEN,Het,Missense,p.Y46C,LoF,Suppressor
|
106 |
+
104,HCC-2998,ACH-001081,CVCL_1266,Bowel,PTPN11,Het,Missense,p.I54T,,Oncogene
|
107 |
+
105,HCC-2998,ACH-001081,CVCL_1266,Bowel,RAF1,Het,Missense,p.S257L,GoF,Oncogene
|
108 |
+
106,HCC-2998,ACH-001081,CVCL_1266,Bowel,RB1,Het,Stopgain,p.E137*,LoF,Suppressor
|
109 |
+
107,HCC-2998,ACH-001081,CVCL_1266,Bowel,RB1,Het,Missense,p.F473C,LoF,Suppressor
|
110 |
+
108,HCC-2998,ACH-001081,CVCL_1266,Bowel,RB1,Het,Missense,p.K80N,,Suppressor
|
111 |
+
109,HCC-2998,ACH-001081,CVCL_1266,Bowel,SMAD2,Het,Missense,p.R321Q,LoF,Suppressor
|
112 |
+
110,HCC-2998,ACH-001081,CVCL_1266,Bowel,SMAD2,Het,Missense,p.S276L,LoF,Suppressor
|
113 |
+
111,HCC-2998,ACH-001081,CVCL_1266,Bowel,SMAD3,Het,Missense,p.S222L,LoF,Suppressor
|
114 |
+
112,HCC-2998,ACH-001081,CVCL_1266,Bowel,SOS1,Het,Missense,p.I736R,,Oncogene
|
115 |
+
113,HCC-2998,ACH-001081,CVCL_1266,Bowel,TP53,Het,Stopgain,p.R213*,LoF,Suppressor
|
116 |
+
114,HCC-2998,ACH-001081,CVCL_1266,Bowel,XPO1,Het,Missense,p.E571K,GoF,Oncogene
|
117 |
+
115,HCC-2998,ACH-001081,CVCL_1266,Bowel,XPO1,Het,Missense,p.R712I,,Oncogene
|
118 |
+
116,NCI-H1385,ACH-000737,CVCL_1466,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
119 |
+
117,SW1463,ACH-000470,CVCL_1718,Bowel,APC,Hom,Frameshift,p.V452fs,LoF,Suppressor
|
120 |
+
118,SW1463,ACH-000470,CVCL_1718,Bowel,ARID1A,Het,Missense,p.L2042V,,Suppressor
|
121 |
+
119,SW1463,ACH-000470,CVCL_1718,Bowel,FBXW7,Het,Missense,p.R399Q,LoF,Suppressor
|
122 |
+
120,SW1463,ACH-000470,CVCL_1718,Bowel,KRAS,Hom,Missense,p.G12C,GoF,Oncogene
|
123 |
+
121,SW1463,ACH-000470,CVCL_1718,Bowel,MTOR,Het,Missense,p.A1099G,,Oncogene
|
124 |
+
122,SW1463,ACH-000470,CVCL_1718,Bowel,RNF43,Het,Missense,p.R223P,,Suppressor
|
125 |
+
123,SW1463,ACH-000470,CVCL_1718,Bowel,SMAD4,Hom,Missense,p.R265G,LoF,Suppressor
|
126 |
+
124,SW1463,ACH-000470,CVCL_1718,Bowel,TP53,Hom,Missense,p.R248Q,LoF,Suppressor
|
127 |
+
125,SW837,ACH-000421,CVCL_1729,Bowel,ACVR2A,Hom,Splice_site,,LoF,Suppressor
|
128 |
+
126,SW837,ACH-000421,CVCL_1729,Bowel,APC,Het,Stopgain,p.R1450*,LoF,Suppressor
|
129 |
+
127,SW837,ACH-000421,CVCL_1729,Bowel,APC,Het,Stopgain,p.R213*,LoF,Suppressor
|
130 |
+
128,SW837,ACH-000421,CVCL_1729,Bowel,ATM,Het,Missense,p.H448R,,Suppressor
|
131 |
+
129,SW837,ACH-000421,CVCL_1729,Bowel,EGFR,Het,Missense,p.C186S,,Oncogene
|
132 |
+
130,SW837,ACH-000421,CVCL_1729,Bowel,EGFR,Het,Missense,p.R264G,,Oncogene
|
133 |
+
131,SW837,ACH-000421,CVCL_1729,Bowel,FBXW7,Hom,Frameshift,p.L323fs,LoF,Suppressor
|
134 |
+
132,SW837,ACH-000421,CVCL_1729,Bowel,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
135 |
+
133,SW837,ACH-000421,CVCL_1729,Bowel,TP53,Hom,Missense,p.R248W,LoF,Suppressor
|
136 |
+
134,LU65,ACH-000438,CVCL_1392,Lung,CDKN2A,Het,Missense,p.D23P,,Suppressor
|
137 |
+
135,LU65,ACH-000438,CVCL_1392,Lung,CDKN2A,Hom,Missense,p.H15R,LoF,Suppressor
|
138 |
+
136,LU65,ACH-000438,CVCL_1392,Lung,EGFR,Het,Missense,p.L858R,,Oncogene
|
139 |
+
137,LU65,ACH-000438,CVCL_1392,Lung,KRAS,,Gain,GAIN,GoF,Oncogene
|
140 |
+
138,LU65,ACH-000438,CVCL_1392,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
141 |
+
139,LU65,ACH-000438,CVCL_1392,Lung,RB1,Hom,Stopgain,p.S82*,LoF,Suppressor
|
142 |
+
140,LU65,ACH-000438,CVCL_1392,Lung,STK11,Hom,Splice_site,,LoF,Suppressor
|
143 |
+
141,LU65,ACH-000438,CVCL_1392,Lung,TP53,Het,Missense,p.E11Q,,Suppressor
|
144 |
+
142,LU65,ACH-000438,CVCL_1392,Lung,TP53,Hom,Splice_site,p.T125T,LoF,Suppressor
|
145 |
+
143,LU65,ACH-000438,CVCL_1392,Lung,WNK2,Hom,Missense,p.V1821M,,Suppressor
|
146 |
+
144,LU99,ACH-000444,CVCL_3015,Lung,BRCA2,Het,Missense,p.M784V,,Suppressor
|
147 |
+
145,LU99,ACH-000444,CVCL_3015,Lung,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
148 |
+
146,LU99,ACH-000444,CVCL_3015,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
149 |
+
147,LU99,ACH-000444,CVCL_3015,Lung,EP300,Hom,Frameshift,p.I967fs,LoF,Suppressor
|
150 |
+
148,LU99,ACH-000444,CVCL_3015,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
151 |
+
149,LU99,ACH-000444,CVCL_3015,Lung,NF2,Hom,Splice_site,,LoF,Suppressor
|
152 |
+
150,LU99,ACH-000444,CVCL_3015,Lung,PIK3CA,Het,Missense,p.T1025A,GoF,Oncogene
|
153 |
+
151,LU99,ACH-000444,CVCL_3015,Lung,POLE,Het,Missense,p.D535Y,LoF,Suppressor
|
154 |
+
152,LU99,ACH-000444,CVCL_3015,Lung,ZFHX3,Hom,Missense,p.E1900A,,Suppressor
|
155 |
+
153,HT-29,ACH-000552,CVCL_0320,Bowel,APC,Het,Stopgain,p.E853*,LoF,Suppressor
|
156 |
+
154,HT-29,ACH-000552,CVCL_0320,Bowel,APC,Het,Frameshift,p.T1556fs,LoF,Suppressor
|
157 |
+
155,HT-29,ACH-000552,CVCL_0320,Bowel,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
158 |
+
156,HT-29,ACH-000552,CVCL_0320,Bowel,MYC,,Gain,GAIN,GoF,Oncogene
|
159 |
+
157,HT-29,ACH-000552,CVCL_0320,Bowel,PIK3CA,Het,Missense,p.P449T,,Oncogene
|
160 |
+
158,HT-29,ACH-000552,CVCL_0320,Bowel,SMAD4,Hom,Stopgain,p.Q311*,LoF,Suppressor
|
161 |
+
159,HT-29,ACH-000552,CVCL_0320,Bowel,TP53,Hom,Missense,p.R273H,LoF,Suppressor
|
162 |
+
160,HT-29,ACH-000552,CVCL_0320,Bowel,ZFHX3,Het,Missense,p.I1217M,,Suppressor
|
163 |
+
161,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,APC,Het,Missense,p.D1810E,,Suppressor
|
164 |
+
162,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,ATM,Het,Missense,p.R924W,,Suppressor
|
165 |
+
163,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,CCND1,,Gain,GAIN,GoF,Oncogene
|
166 |
+
164,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,ERBB2,,Gain,GAIN,GoF,Oncogene
|
167 |
+
165,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,KMT2D,Het,Missense,p.Q3904H,,Suppressor
|
168 |
+
166,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
169 |
+
167,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,SMARCA4,Het,Missense,p.V1207I,,Suppressor
|
170 |
+
168,KYSE-410,ACH-000809,CVCL_1352,Esophagus/Stomach,TP53,Hom,Missense,p.R337C,LoF,Suppressor
|
171 |
+
169,NCI-H358,ACH-000860,CVCL_1559,Lung,ERBB3,Het,Missense,p.R421K,,Oncogene
|
172 |
+
170,NCI-H358,ACH-000860,CVCL_1559,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
173 |
+
171,NCI-H358,ACH-000860,CVCL_1559,Lung,POLE,Het,Missense,p.V1270F,,Suppressor
|
174 |
+
172,NCI-H358,ACH-000860,CVCL_1559,Lung,TP53,Hom,Deletion,DEL,LoF,Suppressor
|
175 |
+
173,NCI-H358,ACH-000860,CVCL_1559,Lung,ZFHX3,Het,Missense,p.R1402C,LoF,Suppressor
|
176 |
+
174,NCI-H1373,ACH-000845,CVCL_1465,Lung,ATM,Het,Stopgain,p.E2943*,LoF,Suppressor
|
177 |
+
175,NCI-H1373,ACH-000845,CVCL_1465,Lung,CDKN2A,Hom,Stopgain,p.C21*,LoF,Suppressor
|
178 |
+
176,NCI-H1373,ACH-000845,CVCL_1465,Lung,CHEK2,Het,Missense,p.D207Y,,Suppressor
|
179 |
+
177,NCI-H1373,ACH-000845,CVCL_1465,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
180 |
+
178,NCI-H1373,ACH-000845,CVCL_1465,Lung,NF1,Het,Missense,p.I1806M,LoF,Suppressor
|
181 |
+
179,NCI-H1373,ACH-000845,CVCL_1465,Lung,TP53,Hom,Stopgain,p.E339*,LoF,Suppressor
|
182 |
+
180,NCI-H1373,ACH-000845,CVCL_1465,Lung,TP53,Hom,Missense,p.P47L,,Suppressor
|
183 |
+
181,NCI-H1373,ACH-000845,CVCL_1465,Lung,WNK2,Het,Missense,p.G431R,,Suppressor
|
184 |
+
182,NCI-H1373,ACH-000845,CVCL_1465,Lung,WNK2,Het,Missense,p.P1097S,,Suppressor
|
185 |
+
183,NCI-H1373,ACH-000845,CVCL_1465,Lung,WNK2,Het,Missense,p.S1520I,,Suppressor
|
186 |
+
184,Calu-1,ACH-000511,CVCL_0608,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
187 |
+
185,Calu-1,ACH-000511,CVCL_0608,Lung,SETD1B,Het,Missense,p.Q1589P,,Suppressor
|
188 |
+
186,Calu-1,ACH-000511,CVCL_0608,Lung,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
189 |
+
187,Calu-1,ACH-000511,CVCL_0608,Lung,TP53,Hom,Deletion,DEL,LoF,Suppressor
|
190 |
+
188,DLD-1,ACH-001061,CVCL_0248,Bowel,ACVR2A,Hom,Frameshift,p.K437fs,LoF,Suppressor
|
191 |
+
189,DLD-1,ACH-001061,CVCL_0248,Bowel,APC,Hom,Frameshift,p.I1417fs,LoF,Suppressor
|
192 |
+
190,DLD-1,ACH-001061,CVCL_0248,Bowel,APC,Het,Missense,p.K993N,,Suppressor
|
193 |
+
191,DLD-1,ACH-001061,CVCL_0248,Bowel,APC,Het,Stopgain,p.R2166*,LoF,Suppressor
|
194 |
+
192,DLD-1,ACH-001061,CVCL_0248,Bowel,APC,Het,Missense,p.R727M,LoF,Suppressor
|
195 |
+
193,DLD-1,ACH-001061,CVCL_0248,Bowel,B2M,Het,Stopgain,p.Y30*,LoF,Suppressor
|
196 |
+
194,DLD-1,ACH-001061,CVCL_0248,Bowel,B2M,Het,Splice_site,,LoF,Suppressor
|
197 |
+
195,DLD-1,ACH-001061,CVCL_0248,Bowel,BRCA2,Het,Missense,p.L1053S,,Suppressor
|
198 |
+
196,DLD-1,ACH-001061,CVCL_0248,Bowel,BRCA2,Het,Frameshift,p.N1784fs,LoF,Suppressor
|
199 |
+
197,DLD-1,ACH-001061,CVCL_0248,Bowel,BRCA2,Het,Missense,p.R2784Q,LoF,Suppressor
|
200 |
+
198,DLD-1,ACH-001061,CVCL_0248,Bowel,CHEK2,Het,Missense,p.A247D,LoF,Suppressor
|
201 |
+
199,DLD-1,ACH-001061,CVCL_0248,Bowel,CHEK2,Het,Missense,p.R145W,LoF,Suppressor
|
202 |
+
200,DLD-1,ACH-001061,CVCL_0248,Bowel,EP300,Het,Stopgain,p.E1014*,LoF,Suppressor
|
203 |
+
201,DLD-1,ACH-001061,CVCL_0248,Bowel,EP300,Het,Missense,p.R838C,,Suppressor
|
204 |
+
202,DLD-1,ACH-001061,CVCL_0248,Bowel,ERBB3,Het,Missense,p.R667H,,Oncogene
|
205 |
+
203,DLD-1,ACH-001061,CVCL_0248,Bowel,FBXW7,Het,Missense,p.P29S,,Suppressor
|
206 |
+
204,DLD-1,ACH-001061,CVCL_0248,Bowel,GNAS,Het,Missense,p.K338N,,Oncogene
|
207 |
+
205,DLD-1,ACH-001061,CVCL_0248,Bowel,KMT2D,Het,Missense,p.E1517D,,Suppressor
|
208 |
+
206,DLD-1,ACH-001061,CVCL_0248,Bowel,KMT2D,Het,Missense,p.E1667D,,Suppressor
|
209 |
+
207,DLD-1,ACH-001061,CVCL_0248,Bowel,KMT2D,Het,Missense,p.F5284L,,Suppressor
|
210 |
+
208,DLD-1,ACH-001061,CVCL_0248,Bowel,KMT2D,Het,Missense,p.L2304M,,Suppressor
|
211 |
+
209,DLD-1,ACH-001061,CVCL_0248,Bowel,KMT2D,Het,Missense,p.P1931H,,Suppressor
|
212 |
+
210,DLD-1,ACH-001061,CVCL_0248,Bowel,KRAS,Het,Missense,p.G13D,GoF,Oncogene
|
213 |
+
211,DLD-1,ACH-001061,CVCL_0248,Bowel,MSH6,Het,Frameshift,p.D1171fs,LoF,Suppressor
|
214 |
+
212,DLD-1,ACH-001061,CVCL_0248,Bowel,MSH6,Het,Frameshift,p.L290fs,LoF,Suppressor
|
215 |
+
213,DLD-1,ACH-001061,CVCL_0248,Bowel,MSH6,Het,Missense,p.R1172del,,Suppressor
|
216 |
+
214,DLD-1,ACH-001061,CVCL_0248,Bowel,MSH6,Het,Missense,p.Y469F,,Suppressor
|
217 |
+
215,DLD-1,ACH-001061,CVCL_0248,Bowel,NF1,Het,Missense,p.A2596V,,Suppressor
|
218 |
+
216,DLD-1,ACH-001061,CVCL_0248,Bowel,PIK3CA,Het,Missense,p.D549N,GoF,Oncogene
|
219 |
+
217,DLD-1,ACH-001061,CVCL_0248,Bowel,PIK3CA,Het,Missense,p.E545K,GoF,Oncogene
|
220 |
+
218,DLD-1,ACH-001061,CVCL_0248,Bowel,PIK3R1,Het,Missense,p.P312L,,Suppressor
|
221 |
+
219,DLD-1,ACH-001061,CVCL_0248,Bowel,RNF43,Het,Frameshift,p.G659fs,LoF,Suppressor
|
222 |
+
220,DLD-1,ACH-001061,CVCL_0248,Bowel,RNF43,Het,Missense,p.L214M,,Suppressor
|
223 |
+
221,DLD-1,ACH-001061,CVCL_0248,Bowel,SETD1B,Het,Missense,p.D159N,,Suppressor
|
224 |
+
222,DLD-1,ACH-001061,CVCL_0248,Bowel,SETD1B,Het,Frameshift,p.H8fs,LoF,Suppressor
|
225 |
+
223,DLD-1,ACH-001061,CVCL_0248,Bowel,SETD1B,Het,Missense,p.Q780H,LoF,Suppressor
|
226 |
+
224,DLD-1,ACH-001061,CVCL_0248,Bowel,SMARCA4,Het,Missense,p.R885C,LoF,Suppressor
|
227 |
+
225,DLD-1,ACH-001061,CVCL_0248,Bowel,TGFBR2,Het,Frameshift,p.K128fs,LoF,Suppressor
|
228 |
+
226,DLD-1,ACH-001061,CVCL_0248,Bowel,TGFBR2,Het,Missense,p.L452P,LoF,Suppressor
|
229 |
+
227,DLD-1,ACH-001061,CVCL_0248,Bowel,TP53,Het,Missense,p.S241F,LoF,Suppressor
|
230 |
+
228,DLD-1,ACH-001061,CVCL_0248,Bowel,TP53,Het,Splice_site,,LoF,Suppressor
|
231 |
+
229,DLD-1,ACH-001061,CVCL_0248,Bowel,ZFHX3,Het,Missense,p.P1707H,,Suppressor
|
232 |
+
230,DLD-1,ACH-001061,CVCL_0248,Bowel,ZFHX3,Het,Missense,p.P3069T,LoF,Suppressor
|
233 |
+
231,LS123,ACH-000501,CVCL_1383,Bowel,ACVR2A,Het,Missense,p.R400H,LoF,Suppressor
|
234 |
+
232,LS123,ACH-000501,CVCL_1383,Bowel,APC,Het,Missense,p.M431I,,Suppressor
|
235 |
+
233,LS123,ACH-000501,CVCL_1383,Bowel,APC,Het,Stopgain,p.Q625*,LoF,Suppressor
|
236 |
+
234,LS123,ACH-000501,CVCL_1383,Bowel,APC,Het,Stopgain,p.R1450*,LoF,Suppressor
|
237 |
+
235,LS123,ACH-000501,CVCL_1383,Bowel,KRAS,Het,Missense,p.G12S,GoF,Oncogene
|
238 |
+
236,LS123,ACH-000501,CVCL_1383,Bowel,MTOR,Het,Missense,p.A1099G,,Oncogene
|
239 |
+
237,LS123,ACH-000501,CVCL_1383,Bowel,SMAD4,Hom,Stopgain,p.E234*,LoF,Suppressor
|
240 |
+
238,LS123,ACH-000501,CVCL_1383,Bowel,TP53,Hom,Missense,p.R175H,LoF,Suppressor
|
241 |
+
239,Caco-2,ACH-000003,CVCL_0025,Bowel,APC,Hom,Stopgain,p.Q1367*,LoF,Suppressor
|
242 |
+
240,Caco-2,ACH-000003,CVCL_0025,Bowel,CHEK2,,Deletion,DEL,LoF,Suppressor
|
243 |
+
241,Caco-2,ACH-000003,CVCL_0025,Bowel,CTNNB1,Het,Missense,p.G245A,,Oncogene
|
244 |
+
242,Caco-2,ACH-000003,CVCL_0025,Bowel,EP300,,Deletion,DEL,LoF,Suppressor
|
245 |
+
243,Caco-2,ACH-000003,CVCL_0025,Bowel,NF2,,Deletion,DEL,LoF,Suppressor
|
246 |
+
244,Caco-2,ACH-000003,CVCL_0025,Bowel,SMAD4,Hom,Missense,p.D351H,,Suppressor
|
247 |
+
245,Caco-2,ACH-000003,CVCL_0025,Bowel,SMARCB1,,Deletion,DEL,LoF,Suppressor
|
248 |
+
246,Caco-2,ACH-000003,CVCL_0025,Bowel,TP53,Hom,Stopgain,p.E204*,LoF,Suppressor
|
249 |
+
247,HCT-8,ACH-001084,CVCL_2478,Bowel,APC,,Frameshift,p.I1417fs,LoF,Suppressor
|
250 |
+
248,HCT-8,ACH-001084,CVCL_2478,Bowel,APC,,Missense,p.K993N,,Suppressor
|
251 |
+
249,HCT-8,ACH-001084,CVCL_2478,Bowel,APC,,Stopgain,p.R2166*,LoF,Suppressor
|
252 |
+
250,HCT-8,ACH-001084,CVCL_2478,Bowel,APC,,Missense,p.R727M,LoF,Suppressor
|
253 |
+
251,HCT-8,ACH-001084,CVCL_2478,Bowel,CTNNB1,,Missense,p.V79I,,Oncogene
|
254 |
+
252,HCT-8,ACH-001084,CVCL_2478,Bowel,KRAS,,Missense,p.G13D,GoF,Oncogene
|
255 |
+
253,HCT-8,ACH-001084,CVCL_2478,Bowel,PIK3CA,,Missense,p.D549N,GoF,Oncogene
|
256 |
+
254,HCT-8,ACH-001084,CVCL_2478,Bowel,PIK3CA,,Missense,p.E545K,GoF,Oncogene
|
257 |
+
255,HCT-8,ACH-001084,CVCL_2478,Bowel,SMAD2,,Frameshift,p.P164fs,LoF,Suppressor
|
258 |
+
256,HCT-8,ACH-001084,CVCL_2478,Bowel,SMAD3,,Missense,p.V244I,,Suppressor
|
259 |
+
257,SK-CO-1,ACH-000400,CVCL_0626,Bowel,APC,Het,Frameshift,p.F1089fs,LoF,Suppressor
|
260 |
+
258,SK-CO-1,ACH-000400,CVCL_0626,Bowel,APC,Het,Frameshift,p.P1443fs,LoF,Suppressor
|
261 |
+
259,SK-CO-1,ACH-000400,CVCL_0626,Bowel,EP300,Het,Missense,p.P842S,,Suppressor
|
262 |
+
260,SK-CO-1,ACH-000400,CVCL_0626,Bowel,GNAS,Het,Missense,p.R201C,,Oncogene
|
263 |
+
261,SK-CO-1,ACH-000400,CVCL_0626,Bowel,KRAS,Het,Missense,p.G12V,GoF,Oncogene
|
264 |
+
262,SK-CO-1,ACH-000400,CVCL_0626,Bowel,SETD1B,Het,Missense,p.Q1589P,,Suppressor
|
265 |
+
263,SW480,ACH-000842,CVCL_0546,Bowel,APC,Hom,Stopgain,p.Q1338*,LoF,Suppressor
|
266 |
+
264,SW480,ACH-000842,CVCL_0546,Bowel,ATM,Het,Missense,p.R2461P,LoF,Suppressor
|
267 |
+
265,SW480,ACH-000842,CVCL_0546,Bowel,KRAS,Hom,Missense,p.G12V,GoF,Oncogene
|
268 |
+
266,SW480,ACH-000842,CVCL_0546,Bowel,MYC,,Gain,GAIN,GoF,Oncogene
|
269 |
+
267,SW480,ACH-000842,CVCL_0546,Bowel,TP53,Hom,Missense,p.P309S,LoF,Suppressor
|
270 |
+
268,SW480,ACH-000842,CVCL_0546,Bowel,TP53,Hom,Missense,p.R273H,LoF,Suppressor
|
271 |
+
269,SW 1573,ACH-000677,CVCL_1720,Lung,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
272 |
+
270,SW 1573,ACH-000677,CVCL_1720,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
273 |
+
271,SW 1573,ACH-000677,CVCL_1720,Lung,CTNNB1,Het,Missense,p.S33F,GoF,Oncogene
|
274 |
+
272,SW 1573,ACH-000677,CVCL_1720,Lung,KRAS,Hom,Missense,p.G12C,GoF,Oncogene
|
275 |
+
273,SW 1573,ACH-000677,CVCL_1720,Lung,PIK3CA,Het,Missense,p.K111E,GoF,Oncogene
|
276 |
+
274,SW 1573,ACH-000677,CVCL_1720,Lung,PRDM2,Hom,Missense,p.L824Q,,Suppressor
|
277 |
+
275,SW 1573,ACH-000677,CVCL_1720,Lung,SMAD4,Hom,Deletion,DEL,LoF,Suppressor
|
278 |
+
276,SW 1573,ACH-000677,CVCL_1720,Lung,SMARCB1,Hom,Splice_site,,LoF,Suppressor
|
279 |
+
277,HCC1143,ACH-000374,CVCL_1245,Breast,AKT1,,Gain,GAIN,GoF,Oncogene
|
280 |
+
278,HCC1143,ACH-000374,CVCL_1245,Breast,CCND1,,Gain,GAIN,GoF,Oncogene
|
281 |
+
279,HCC1143,ACH-000374,CVCL_1245,Breast,FGFR2,Het,Missense,p.R203C,,Oncogene
|
282 |
+
280,HCC1143,ACH-000374,CVCL_1245,Breast,SMARCA4,Het,Missense,p.R1323H,LoF,Suppressor
|
283 |
+
281,HCC1143,ACH-000374,CVCL_1245,Breast,TP53,Hom,Missense,p.R248Q,LoF,Suppressor
|
284 |
+
282,HS-578T,ACH-000148,CVCL_0332,Breast,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
285 |
+
283,HS-578T,ACH-000148,CVCL_0332,Breast,HNF1A,Het,Missense,p.K273E,LoF,Suppressor
|
286 |
+
284,HS-578T,ACH-000148,CVCL_0332,Breast,HRAS,Het,Missense,p.G12D,GoF,Oncogene
|
287 |
+
285,HS-578T,ACH-000148,CVCL_0332,Breast,NF1,Het,Missense,p.G2724R,,Suppressor
|
288 |
+
286,HS-578T,ACH-000148,CVCL_0332,Breast,PIK3R1,Hom,Missense,p.89_90insN,,Suppressor
|
289 |
+
287,HS-578T,ACH-000148,CVCL_0332,Breast,TP53,Hom,Missense,p.V157F,LoF,Suppressor
|
290 |
+
288,SW1116,ACH-000489,CVCL_0544,Bowel,APC,Het,Frameshift,p.Q1429fs,LoF,Suppressor
|
291 |
+
289,SW1116,ACH-000489,CVCL_0544,Bowel,APC,Het,Stopgain,p.Q264*,LoF,Suppressor
|
292 |
+
290,SW1116,ACH-000489,CVCL_0544,Bowel,FBXW7,Het,Missense,p.H380Y,LoF,Suppressor
|
293 |
+
291,SW1116,ACH-000489,CVCL_0544,Bowel,KRAS,Het,Missense,p.G12A,GoF,Oncogene
|
294 |
+
292,SW1116,ACH-000489,CVCL_0544,Bowel,TP53,Hom,Missense,p.A159D,LoF,Suppressor
|
295 |
+
293,SW1116,ACH-000489,CVCL_0544,Bowel,WNK2,Het,Missense,p.A1048G,,Suppressor
|
296 |
+
294,SW1116,ACH-000489,CVCL_0544,Bowel,ZFHX3,Het,Missense,p.G918R,,Suppressor
|
297 |
+
295,LoVo,ACH-000950,CVCL_0399,Bowel,ACVR2A,Hom,Frameshift,p.K437fs,LoF,Suppressor
|
298 |
+
296,LoVo,ACH-000950,CVCL_0399,Bowel,APC,Het,Frameshift,p.M1431fs,LoF,Suppressor
|
299 |
+
297,LoVo,ACH-000950,CVCL_0399,Bowel,APC,Het,Stopgain,p.R1114*,LoF,Suppressor
|
300 |
+
298,LoVo,ACH-000950,CVCL_0399,Bowel,APC,Het,Missense,p.R2816Q,,Suppressor
|
301 |
+
299,LoVo,ACH-000950,CVCL_0399,Bowel,ARID1A,Het,Frameshift,p.F1924fs,LoF,Suppressor
|
302 |
+
300,LoVo,ACH-000950,CVCL_0399,Bowel,B2M,Hom,Frameshift,p.L15fs,LoF,Suppressor
|
303 |
+
301,LoVo,ACH-000950,CVCL_0399,Bowel,CHEK2,Het,Frameshift,p.T389fs,LoF,Suppressor
|
304 |
+
302,LoVo,ACH-000950,CVCL_0399,Bowel,FBXW7,Het,Missense,p.R425C,LoF,Suppressor
|
305 |
+
303,LoVo,ACH-000950,CVCL_0399,Bowel,FGFR3,Het,Missense,p.I533V,,Oncogene
|
306 |
+
304,LoVo,ACH-000950,CVCL_0399,Bowel,HNF1A,Het,Missense,p.V446M,LoF,Suppressor
|
307 |
+
305,LoVo,ACH-000950,CVCL_0399,Bowel,KMT2D,Het,Frameshift,p.H77fs,LoF,Suppressor
|
308 |
+
306,LoVo,ACH-000950,CVCL_0399,Bowel,KRAS,Het,Missense,p.G13D,GoF,Oncogene
|
309 |
+
307,LoVo,ACH-000950,CVCL_0399,Bowel,NF1,Het,Missense,p.R1674Q,,Suppressor
|
310 |
+
308,LoVo,ACH-000950,CVCL_0399,Bowel,PIK3CB,Het,Missense,p.E1051K,,Oncogene
|
311 |
+
309,LoVo,ACH-000950,CVCL_0399,Bowel,PRDM2,Het,Missense,p.S1618G,,Suppressor
|
312 |
+
310,LoVo,ACH-000950,CVCL_0399,Bowel,PRDM2,Het,Frameshift,p.V1490fs,LoF,Suppressor
|
313 |
+
311,LoVo,ACH-000950,CVCL_0399,Bowel,RAF1,Het,Missense,p.V98A,,Oncogene
|
314 |
+
312,LoVo,ACH-000950,CVCL_0399,Bowel,SETD1B,Het,Frameshift,p.H8fs,LoF,Suppressor
|
315 |
+
313,LoVo,ACH-000950,CVCL_0399,Bowel,SETD1B,Het,Missense,p.V1447I,,Suppressor
|
316 |
+
314,LoVo,ACH-000950,CVCL_0399,Bowel,SMAD2,Het,Missense,p.A292V,LoF,Suppressor
|
317 |
+
315,LoVo,ACH-000950,CVCL_0399,Bowel,TGFBR2,Hom,Frameshift,p.K128fs,LoF,Suppressor
|
318 |
+
316,LoVo,ACH-000950,CVCL_0399,Bowel,WNK2,Het,Missense,p.R2073C,,Suppressor
|
319 |
+
317,LoVo,ACH-000950,CVCL_0399,Bowel,WNK2,Het,Missense,p.V1544A,,Suppressor
|
320 |
+
318,SW948,ACH-000680,CVCL_0632,Bowel,APC,Het,Stopgain,p.Q1429*,LoF,Suppressor
|
321 |
+
319,SW948,ACH-000680,CVCL_0632,Bowel,APC,Het,Stopgain,p.R1114*,LoF,Suppressor
|
322 |
+
320,SW948,ACH-000680,CVCL_0632,Bowel,ARID1A,Het,Missense,p.G701A,,Suppressor
|
323 |
+
321,SW948,ACH-000680,CVCL_0632,Bowel,ATM,Het,Stopgain,p.Q2210*,LoF,Suppressor
|
324 |
+
322,SW948,ACH-000680,CVCL_0632,Bowel,EP300,Het,Splice_site,,LoF,Suppressor
|
325 |
+
323,SW948,ACH-000680,CVCL_0632,Bowel,KMT2D,Het,Missense,p.N2030H,,Suppressor
|
326 |
+
324,SW948,ACH-000680,CVCL_0632,Bowel,KMT2D,Het,Missense,p.R5120C,LoF,Suppressor
|
327 |
+
325,SW948,ACH-000680,CVCL_0632,Bowel,KRAS,Het,Missense,p.Q61L,GoF,Oncogene
|
328 |
+
326,SW948,ACH-000680,CVCL_0632,Bowel,PIK3CA,Hom,Missense,p.E542K,GoF,Oncogene
|
329 |
+
327,SW948,ACH-000680,CVCL_0632,Bowel,SMAD4,Hom,Missense,p.D441Y,LoF,Suppressor
|
330 |
+
328,SW948,ACH-000680,CVCL_0632,Bowel,TP53,Hom,Frameshift,p.T118fs,LoF,Suppressor
|
331 |
+
329,LS 174T,,CVCL_1384,Bowel,CTNNB1,Hom,Missense,p.S45F,GoF,Oncogene
|
332 |
+
330,LS 174T,,CVCL_1384,Bowel,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
333 |
+
331,LS 174T,,CVCL_1384,Bowel,PIK3CA,,Missense,p.H1047R,GoF,Oncogene
|
334 |
+
332,SW1417,ACH-000236,CVCL_1717,Bowel,APC,Hom,Stopgain,p.R1450*,LoF,Suppressor
|
335 |
+
333,SW1417,ACH-000236,CVCL_1717,Bowel,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
336 |
+
334,SW1417,ACH-000236,CVCL_1717,Bowel,PIK3R1,Hom,Deletion,DEL,LoF,Suppressor
|
337 |
+
335,SW1417,ACH-000236,CVCL_1717,Bowel,TP53,Hom,Frameshift,p.C238fs,LoF,Suppressor
|
338 |
+
336,RKO,ACH-000943,CVCL_0504,Bowel,ACVR2A,Het,Frameshift,p.K437fs,LoF,Suppressor
|
339 |
+
337,RKO,ACH-000943,CVCL_0504,Bowel,ARID1A,Het,Frameshift,p.D1633fs,LoF,Suppressor
|
340 |
+
338,RKO,ACH-000943,CVCL_0504,Bowel,ARID1A,Het,Frameshift,p.P1115fs,LoF,Suppressor
|
341 |
+
339,RKO,ACH-000943,CVCL_0504,Bowel,B2M,Het,Stopgain,p.R117*,LoF,Suppressor
|
342 |
+
340,RKO,ACH-000943,CVCL_0504,Bowel,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
343 |
+
341,RKO,ACH-000943,CVCL_0504,Bowel,BRCA2,Het,Frameshift,p.N1784fs,LoF,Suppressor
|
344 |
+
342,RKO,ACH-000943,CVCL_0504,Bowel,EP300,Het,Frameshift,p.K292fs,LoF,Suppressor
|
345 |
+
343,RKO,ACH-000943,CVCL_0504,Bowel,EP300,Het,Frameshift,p.M1470fs,LoF,Suppressor
|
346 |
+
344,RKO,ACH-000943,CVCL_0504,Bowel,HNF1A,Het,Frameshift,p.P379fs,LoF,Suppressor
|
347 |
+
345,RKO,ACH-000943,CVCL_0504,Bowel,KMT2D,Het,Frameshift,p.G1960fs,LoF,Suppressor
|
348 |
+
346,RKO,ACH-000943,CVCL_0504,Bowel,KMT2D,Het,Stopgain,p.G3465*,LoF,Suppressor
|
349 |
+
347,RKO,ACH-000943,CVCL_0504,Bowel,KMT2D,Het,Missense,p.L1600P,LoF,Suppressor
|
350 |
+
348,RKO,ACH-000943,CVCL_0504,Bowel,KMT2D,Het,Missense,p.L5056P,LoF,Suppressor
|
351 |
+
349,RKO,ACH-000943,CVCL_0504,Bowel,KMT2D,Het,Frameshift,p.P2550fs,LoF,Suppressor
|
352 |
+
350,RKO,ACH-000943,CVCL_0504,Bowel,MSH6,Het,Frameshift,p.Y1066fs,LoF,Suppressor
|
353 |
+
351,RKO,ACH-000943,CVCL_0504,Bowel,NF1,Het,Frameshift,p.N2320fs,LoF,Suppressor
|
354 |
+
352,RKO,ACH-000943,CVCL_0504,Bowel,NF1,Het,Missense,p.V2184A,LoF,Suppressor
|
355 |
+
353,RKO,ACH-000943,CVCL_0504,Bowel,NF1,Het,Frameshift,p.Y628fs,LoF,Suppressor
|
356 |
+
354,RKO,ACH-000943,CVCL_0504,Bowel,NF2,Het,Frameshift,p.P275fs,LoF,Suppressor
|
357 |
+
355,RKO,ACH-000943,CVCL_0504,Bowel,PIK3CA,Het,Missense,p.H1047R,GoF,Oncogene
|
358 |
+
356,RKO,ACH-000943,CVCL_0504,Bowel,POLE,Het,Missense,p.K995E,,Suppressor
|
359 |
+
357,RKO,ACH-000943,CVCL_0504,Bowel,PRDM2,Het,Missense,p.S876G,,Suppressor
|
360 |
+
358,RKO,ACH-000943,CVCL_0504,Bowel,RNF43,Hom,Frameshift,p.G659fs,LoF,Suppressor
|
361 |
+
359,RKO,ACH-000943,CVCL_0504,Bowel,RNF43,Het,Missense,p.H549N,,Suppressor
|
362 |
+
360,RKO,ACH-000943,CVCL_0504,Bowel,SETD1B,Het,Frameshift,p.H8fs,LoF,Suppressor
|
363 |
+
361,RKO,ACH-000943,CVCL_0504,Bowel,SETD1B,Het,Missense,p.T1700A,LoF,Suppressor
|
364 |
+
362,RKO,ACH-000943,CVCL_0504,Bowel,SMAD3,Het,Missense,p.A13T,,Suppressor
|
365 |
+
363,RKO,ACH-000943,CVCL_0504,Bowel,TGFBR2,Het,Frameshift,p.K128fs,LoF,Suppressor
|
366 |
+
364,RKO,ACH-000943,CVCL_0504,Bowel,TGFBR2,Het,Missense,p.L452P,LoF,Suppressor
|
367 |
+
365,RKO,ACH-000943,CVCL_0504,Bowel,ZFHX3,Het,Frameshift,p.F1596fs,LoF,Suppressor
|
368 |
+
366,RKO,ACH-000943,CVCL_0504,Bowel,ZFHX3,Het,Missense,p.S112N,,Suppressor
|
369 |
+
367,T84,ACH-000381,CVCL_0555,Bowel,APC,Hom,Frameshift,p.L1488fs,LoF,Suppressor
|
370 |
+
368,T84,ACH-000381,CVCL_0555,Bowel,KRAS,Het,Missense,p.G13D,GoF,Oncogene
|
371 |
+
369,T84,ACH-000381,CVCL_0555,Bowel,PIK3CA,Het,Missense,p.E542K,GoF,Oncogene
|
372 |
+
370,T84,ACH-000381,CVCL_0555,Bowel,SMAD4,Hom,Missense,p.K244N,LoF,Suppressor
|
373 |
+
371,T84,ACH-000381,CVCL_0555,Bowel,TP53,Hom,Splice_site,,LoF,Suppressor
|
374 |
+
372,T84,ACH-000381,CVCL_0555,Bowel,ZFHX3,Het,Missense,p.A3398P,,Suppressor
|
375 |
+
373,SHP-77,ACH-000790,CVCL_1693,Lung,ABL1,Het,Missense,p.V1128E,,Oncogene
|
376 |
+
374,SHP-77,ACH-000790,CVCL_1693,Lung,ACVR2A,Hom,Missense,p.L147R,LoF,Suppressor
|
377 |
+
375,SHP-77,ACH-000790,CVCL_1693,Lung,ARID1A,Het,Missense,p.P253S,,Suppressor
|
378 |
+
376,SHP-77,ACH-000790,CVCL_1693,Lung,EGFR,Het,Missense,p.Q656R,,Oncogene
|
379 |
+
377,SHP-77,ACH-000790,CVCL_1693,Lung,KMT2D,Hom,Missense,p.Q3950R,,Suppressor
|
380 |
+
378,SHP-77,ACH-000790,CVCL_1693,Lung,KRAS,Hom,Missense,p.G12V,GoF,Oncogene
|
381 |
+
379,SHP-77,ACH-000790,CVCL_1693,Lung,RAC1,Het,Missense,p.Y32C,,Oncogene
|
382 |
+
380,SHP-77,ACH-000790,CVCL_1693,Lung,SETD1B,Het,Missense,p.T482M,,Suppressor
|
383 |
+
381,SHP-77,ACH-000790,CVCL_1693,Lung,TP53,Hom,Missense,p.C176W,LoF,Suppressor
|
384 |
+
382,SW 900,ACH-000669,CVCL_1731,Lung,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
385 |
+
383,SW 900,ACH-000669,CVCL_1731,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
386 |
+
384,SW 900,ACH-000669,CVCL_1731,Lung,KMT2D,Hom,Stopgain,p.K5522*,LoF,Suppressor
|
387 |
+
385,SW 900,ACH-000669,CVCL_1731,Lung,KRAS,Het,Missense,p.G12V,GoF,Oncogene
|
388 |
+
386,SW 900,ACH-000669,CVCL_1731,Lung,SMAD3,Hom,Missense,p.K334E,LoF,Suppressor
|
389 |
+
387,SW 900,ACH-000669,CVCL_1731,Lung,TP53,Hom,Stopgain,p.Q167*,LoF,Suppressor
|
390 |
+
388,MIA PaCa-2,ACH-000601,CVCL_0428,Pancreas,ARID1A,Het,Missense,p.P1723L,,Suppressor
|
391 |
+
389,MIA PaCa-2,ACH-000601,CVCL_0428,Pancreas,ARID1A,Hom,Stopgain,p.Q321*,LoF,Suppressor
|
392 |
+
390,MIA PaCa-2,ACH-000601,CVCL_0428,Pancreas,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
393 |
+
391,MIA PaCa-2,ACH-000601,CVCL_0428,Pancreas,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
394 |
+
392,MIA PaCa-2,ACH-000601,CVCL_0428,Pancreas,KRAS,Hom,Missense,p.G12C,GoF,Oncogene
|
395 |
+
393,MIA PaCa-2,ACH-000601,CVCL_0428,Pancreas,TP53,Hom,Missense,p.R248W,LoF,Suppressor
|
396 |
+
394,HCT15,ACH-000997,CVCL_0292,Bowel,ACVR2A,Hom,Frameshift,p.K437fs,LoF,Suppressor
|
397 |
+
395,HCT15,ACH-000997,CVCL_0292,Bowel,APC,Het,Missense,p.E2550Q,,Suppressor
|
398 |
+
396,HCT15,ACH-000997,CVCL_0292,Bowel,APC,Hom,Frameshift,p.I1417fs,LoF,Suppressor
|
399 |
+
397,HCT15,ACH-000997,CVCL_0292,Bowel,APC,Het,Missense,p.I1779M,,Suppressor
|
400 |
+
398,HCT15,ACH-000997,CVCL_0292,Bowel,APC,Het,Missense,p.K1561N,,Suppressor
|
401 |
+
399,HCT15,ACH-000997,CVCL_0292,Bowel,APC,Het,Missense,p.K993N,,Suppressor
|
402 |
+
400,HCT15,ACH-000997,CVCL_0292,Bowel,APC,Het,Stopgain,p.R2166*,LoF,Suppressor
|
403 |
+
401,HCT15,ACH-000997,CVCL_0292,Bowel,APC,Het,Missense,p.R727M,LoF,Suppressor
|
404 |
+
402,HCT15,ACH-000997,CVCL_0292,Bowel,ARID1A,Het,Missense,p.R270H,,Suppressor
|
405 |
+
403,HCT15,ACH-000997,CVCL_0292,Bowel,ATM,Het,Missense,p.E586D,,Suppressor
|
406 |
+
404,HCT15,ACH-000997,CVCL_0292,Bowel,B2M,Het,Stopgain,p.Y30*,LoF,Suppressor
|
407 |
+
405,HCT15,ACH-000997,CVCL_0292,Bowel,B2M,Het,Splice_site,,LoF,Suppressor
|
408 |
+
406,HCT15,ACH-000997,CVCL_0292,Bowel,BRCA2,Het,Missense,p.A487V,,Suppressor
|
409 |
+
407,HCT15,ACH-000997,CVCL_0292,Bowel,BRCA2,Het,Frameshift,p.N1784fs,LoF,Suppressor
|
410 |
+
408,HCT15,ACH-000997,CVCL_0292,Bowel,BRCA2,Het,Missense,p.R2784Q,LoF,Suppressor
|
411 |
+
409,HCT15,ACH-000997,CVCL_0292,Bowel,CHEK2,Het,Missense,p.A247D,LoF,Suppressor
|
412 |
+
410,HCT15,ACH-000997,CVCL_0292,Bowel,CHEK2,Het,Missense,p.R145W,LoF,Suppressor
|
413 |
+
411,HCT15,ACH-000997,CVCL_0292,Bowel,EP300,Hom,Stopgain,p.E1014*,LoF,Suppressor
|
414 |
+
412,HCT15,ACH-000997,CVCL_0292,Bowel,ERBB3,Het,Missense,p.R667H,,Oncogene
|
415 |
+
413,HCT15,ACH-000997,CVCL_0292,Bowel,GNAS,Het,Missense,p.K338N,,Oncogene
|
416 |
+
414,HCT15,ACH-000997,CVCL_0292,Bowel,KMT2D,Het,Missense,p.E1517D,,Suppressor
|
417 |
+
415,HCT15,ACH-000997,CVCL_0292,Bowel,KMT2D,Het,Missense,p.P1152H,,Suppressor
|
418 |
+
416,HCT15,ACH-000997,CVCL_0292,Bowel,KMT2D,Het,Missense,p.P1931H,,Suppressor
|
419 |
+
417,HCT15,ACH-000997,CVCL_0292,Bowel,KRAS,Het,Missense,p.G13D,GoF,Oncogene
|
420 |
+
418,HCT15,ACH-000997,CVCL_0292,Bowel,MSH6,Het,Frameshift,p.D1171fs,LoF,Suppressor
|
421 |
+
419,HCT15,ACH-000997,CVCL_0292,Bowel,MSH6,Het,Frameshift,p.L290fs,LoF,Suppressor
|
422 |
+
420,HCT15,ACH-000997,CVCL_0292,Bowel,MSH6,Het,Missense,p.R1172del,,Suppressor
|
423 |
+
421,HCT15,ACH-000997,CVCL_0292,Bowel,MSH6,Het,Missense,p.T1189I,LoF,Suppressor
|
424 |
+
422,HCT15,ACH-000997,CVCL_0292,Bowel,NF1,Het,Missense,p.A2596V,,Suppressor
|
425 |
+
423,HCT15,ACH-000997,CVCL_0292,Bowel,NF1,Het,Missense,p.A74D,,Suppressor
|
426 |
+
424,HCT15,ACH-000997,CVCL_0292,Bowel,NF1,Het,Missense,p.P2456S,,Suppressor
|
427 |
+
425,HCT15,ACH-000997,CVCL_0292,Bowel,PIK3CA,Het,Missense,p.D549N,GoF,Oncogene
|
428 |
+
426,HCT15,ACH-000997,CVCL_0292,Bowel,PIK3CA,Het,Missense,p.E545K,GoF,Oncogene
|
429 |
+
427,HCT15,ACH-000997,CVCL_0292,Bowel,PIK3R1,Het,Missense,p.P312L,,Suppressor
|
430 |
+
428,HCT15,ACH-000997,CVCL_0292,Bowel,POLE,Het,Missense,p.A1375V,,Suppressor
|
431 |
+
429,HCT15,ACH-000997,CVCL_0292,Bowel,PRDM2,Het,Stopgain,p.E1259*,LoF,Suppressor
|
432 |
+
430,HCT15,ACH-000997,CVCL_0292,Bowel,PRDM2,Het,Stopgain,p.Q1699*,LoF,Suppressor
|
433 |
+
431,HCT15,ACH-000997,CVCL_0292,Bowel,RNF43,Het,Frameshift,p.G659fs,LoF,Suppressor
|
434 |
+
432,HCT15,ACH-000997,CVCL_0292,Bowel,RNF43,Het,Missense,p.L214M,,Suppressor
|
435 |
+
433,HCT15,ACH-000997,CVCL_0292,Bowel,SETD1B,Het,Missense,p.D159N,,Suppressor
|
436 |
+
434,HCT15,ACH-000997,CVCL_0292,Bowel,SETD1B,Het,Missense,p.Q780H,LoF,Suppressor
|
437 |
+
435,HCT15,ACH-000997,CVCL_0292,Bowel,SMARCA4,Het,Missense,p.R885C,LoF,Suppressor
|
438 |
+
436,HCT15,ACH-000997,CVCL_0292,Bowel,TGFBR2,Het,Missense,p.L452P,LoF,Suppressor
|
439 |
+
437,HCT15,ACH-000997,CVCL_0292,Bowel,TP53,Het,Missense,p.S241F,LoF,Suppressor
|
440 |
+
438,HCT15,ACH-000997,CVCL_0292,Bowel,TP53,Het,Splice_site,,LoF,Suppressor
|
441 |
+
439,HCT15,ACH-000997,CVCL_0292,Bowel,WNK2,Het,Missense,p.V1971M,,Suppressor
|
442 |
+
440,HCT15,ACH-000997,CVCL_0292,Bowel,ZFHX3,Het,Frameshift,p.E763fs,LoF,Suppressor
|
443 |
+
441,HCT15,ACH-000997,CVCL_0292,Bowel,ZFHX3,Het,Missense,p.P1707H,,Suppressor
|
444 |
+
442,HCT15,ACH-000997,CVCL_0292,Bowel,ZFHX3,Het,Missense,p.P3069T,LoF,Suppressor
|
445 |
+
443,HCT15,ACH-000997,CVCL_0292,Bowel,ZFHX3,Het,Missense,p.R1402C,LoF,Suppressor
|
446 |
+
444,HCT15,ACH-000997,CVCL_0292,Bowel,ZFHX3,Het,Missense,p.S1180N,,Suppressor
|
447 |
+
445,CFPAC-1,ACH-000138,CVCL_1119,Pancreas,KRAS,Het,Missense,p.G12V,GoF,Oncogene
|
448 |
+
446,CFPAC-1,ACH-000138,CVCL_1119,Pancreas,SMAD4,Hom,Deletion,DEL,LoF,Suppressor
|
449 |
+
447,CFPAC-1,ACH-000138,CVCL_1119,Pancreas,TP53,Hom,Missense,p.C242R,LoF,Suppressor
|
450 |
+
448,AsPC-1,ACH-000222,CVCL_0152,Pancreas,CDKN2A,Het,Frameshift,p.L27fs,LoF,Suppressor
|
451 |
+
449,AsPC-1,ACH-000222,CVCL_0152,Pancreas,FBXW7,Het,Missense,p.R385C,LoF,Suppressor
|
452 |
+
450,AsPC-1,ACH-000222,CVCL_0152,Pancreas,KRAS,Hom,Missense,p.G12D,GoF,Oncogene
|
453 |
+
451,AsPC-1,ACH-000222,CVCL_0152,Pancreas,RNF43,Hom,Stopgain,p.S720*,LoF,Suppressor
|
454 |
+
452,AsPC-1,ACH-000222,CVCL_0152,Pancreas,SMAD4,Hom,Missense,p.R100T,LoF,Suppressor
|
455 |
+
453,AsPC-1,ACH-000222,CVCL_0152,Pancreas,TP53,Hom,Frameshift,p.C135fs,LoF,Suppressor
|
456 |
+
454,Panc 02.13,ACH-000031,CVCL_1634,Pancreas,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
457 |
+
455,Panc 02.13,ACH-000031,CVCL_1634,Pancreas,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
458 |
+
456,Panc 02.13,ACH-000031,CVCL_1634,Pancreas,KRAS,Het,Missense,p.Q61R,GoF,Oncogene
|
459 |
+
457,Panc 02.13,ACH-000031,CVCL_1634,Pancreas,SMARCA4,Het,Missense,p.T910M,LoF,Suppressor
|
460 |
+
458,Panc 02.13,ACH-000031,CVCL_1634,Pancreas,TP53,Hom,Missense,p.R273C,LoF,Suppressor
|
461 |
+
459,Hs 766T,ACH-000178,CVCL_0334,Pancreas,ARID1A,Het,Stopgain,p.Q538*,LoF,Suppressor
|
462 |
+
460,Hs 766T,ACH-000178,CVCL_0334,Pancreas,CDKN2A,Hom,Splice_site,,LoF,Suppressor
|
463 |
+
461,Hs 766T,ACH-000178,CVCL_0334,Pancreas,KRAS,Hom,Missense,p.Q61H,GoF,Oncogene
|
464 |
+
462,Hs 766T,ACH-000178,CVCL_0334,Pancreas,SMAD4,Hom,Deletion,DEL,LoF,Suppressor
|
465 |
+
463,BxPC-3,ACH-000535,CVCL_0186,Pancreas,BRAF,Het,Missense,p.V487_492NA,,Oncogene
|
466 |
+
464,BxPC-3,ACH-000535,CVCL_0186,Pancreas,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
467 |
+
465,BxPC-3,ACH-000535,CVCL_0186,Pancreas,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
468 |
+
466,BxPC-3,ACH-000535,CVCL_0186,Pancreas,EP300,Het,Stopgain,p.R397*,LoF,Suppressor
|
469 |
+
467,BxPC-3,ACH-000535,CVCL_0186,Pancreas,RNF43,Hom,Missense,p.S495Y,,Suppressor
|
470 |
+
468,BxPC-3,ACH-000535,CVCL_0186,Pancreas,SMAD4,Hom,Deletion,DEL,LoF,Suppressor
|
471 |
+
469,BxPC-3,ACH-000535,CVCL_0186,Pancreas,SMARCB1,Hom,Deletion,DEL,LoF,Suppressor
|
472 |
+
470,BxPC-3,ACH-000535,CVCL_0186,Pancreas,TP53,Hom,Missense,p.Y220C,LoF,Suppressor
|
473 |
+
471,PANC-1,ACH-000164,CVCL_0480,Pancreas,AKT2,,Gain,GAIN,GoF,Oncogene
|
474 |
+
472,PANC-1,ACH-000164,CVCL_0480,Pancreas,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
475 |
+
473,PANC-1,ACH-000164,CVCL_0480,Pancreas,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
476 |
+
474,PANC-1,ACH-000164,CVCL_0480,Pancreas,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
477 |
+
475,PANC-1,ACH-000164,CVCL_0480,Pancreas,TP53,Hom,Missense,p.R273H,LoF,Suppressor
|
478 |
+
476,KLE,ACH-000293,CVCL_1329,Uterus,AKT2,,Gain,GAIN,GoF,Oncogene
|
479 |
+
477,KLE,ACH-000293,CVCL_1329,Uterus,CCNE1,,Gain,GAIN,GoF,Oncogene
|
480 |
+
478,KLE,ACH-000293,CVCL_1329,Uterus,FBXW7,Het,Missense,p.R399Q,LoF,Suppressor
|
481 |
+
479,KLE,ACH-000293,CVCL_1329,Uterus,KRAS,,Gain,GAIN,GoF,Oncogene
|
482 |
+
480,KLE,ACH-000293,CVCL_1329,Uterus,TP53,Hom,Missense,p.R175H,LoF,Suppressor
|
483 |
+
481,BT-474,ACH-000927,CVCL_0179,Breast,ACVR2A,Het,Missense,p.S17F,,Suppressor
|
484 |
+
482,BT-474,ACH-000927,CVCL_0179,Breast,ATM,Het,Missense,p.E2468K,LoF,Suppressor
|
485 |
+
483,BT-474,ACH-000927,CVCL_0179,Breast,BRCA2,Het,Stopgain,p.S3094*,LoF,Suppressor
|
486 |
+
484,BT-474,ACH-000927,CVCL_0179,Breast,ERBB2,,Gain,GAIN,GoF,Oncogene
|
487 |
+
485,BT-474,ACH-000927,CVCL_0179,Breast,HNF1A,Het,Stopgain,p.Q495*,LoF,Suppressor
|
488 |
+
486,BT-474,ACH-000927,CVCL_0179,Breast,KMT2D,Het,Missense,p.E1623K,,Suppressor
|
489 |
+
487,BT-474,ACH-000927,CVCL_0179,Breast,LASP1,,Gain,GAIN,GoF,Oncogene
|
490 |
+
488,BT-474,ACH-000927,CVCL_0179,Breast,MAPK1,Het,Missense,p.H61Q,,Oncogene
|
491 |
+
489,BT-474,ACH-000927,CVCL_0179,Breast,PIK3CA,Het,Missense,p.K111N,GoF,Oncogene
|
492 |
+
490,BT-474,ACH-000927,CVCL_0179,Breast,TGFBR2,Het,Missense,p.M36I,,Suppressor
|
493 |
+
491,BT-474,ACH-000927,CVCL_0179,Breast,TP53,Hom,Missense,p.E285K,LoF,Suppressor
|
494 |
+
492,BT-474,ACH-000927,CVCL_0179,Breast,WNK2,Het,Missense,p.E398Q,,Suppressor
|
495 |
+
493,SW48,ACH-000958,CVCL_1724,Bowel,ACVR2A,Hom,Frameshift,p.K437fs,LoF,Suppressor
|
496 |
+
494,SW48,ACH-000958,CVCL_1724,Bowel,APC,Het,Missense,p.R2714C,,Suppressor
|
497 |
+
495,SW48,ACH-000958,CVCL_1724,Bowel,ARID1A,Het,Frameshift,p.A339fs,LoF,Suppressor
|
498 |
+
496,SW48,ACH-000958,CVCL_1724,Bowel,B2M,Het,Stopgain,p.Q22*,LoF,Suppressor
|
499 |
+
497,SW48,ACH-000958,CVCL_1724,Bowel,B2M,Het,Frameshift,p.V69fs,LoF,Suppressor
|
500 |
+
498,SW48,ACH-000958,CVCL_1724,Bowel,BRCA2,Het,Frameshift,p.K1691fs,LoF,Suppressor
|
501 |
+
499,SW48,ACH-000958,CVCL_1724,Bowel,BRCA2,Het,Frameshift,p.N1784fs,LoF,Suppressor
|
502 |
+
500,SW48,ACH-000958,CVCL_1724,Bowel,CTNNB1,Het,Missense,p.S33Y,GoF,Oncogene
|
503 |
+
501,SW48,ACH-000958,CVCL_1724,Bowel,EGFR,Het,Missense,p.G674S,GoF,Oncogene
|
504 |
+
502,SW48,ACH-000958,CVCL_1724,Bowel,EP300,Het,Frameshift,p.M1470fs,LoF,Suppressor
|
505 |
+
503,SW48,ACH-000958,CVCL_1724,Bowel,EP300,Het,Missense,p.T594M,LoF,Suppressor
|
506 |
+
504,SW48,ACH-000958,CVCL_1724,Bowel,FBXW7,Het,Frameshift,p.S588fs,LoF,Suppressor
|
507 |
+
505,SW48,ACH-000958,CVCL_1724,Bowel,KMT2D,Het,Stopgain,p.R4904*,LoF,Suppressor
|
508 |
+
506,SW48,ACH-000958,CVCL_1724,Bowel,KMT2D,Het,Frameshift,p.R755fs,LoF,Suppressor
|
509 |
+
507,SW48,ACH-000958,CVCL_1724,Bowel,MAP2K1,Het,Missense,p.D175G,,Oncogene
|
510 |
+
508,SW48,ACH-000958,CVCL_1724,Bowel,MAP2K1,Het,Missense,p.Q56P,GoF,Oncogene
|
511 |
+
509,SW48,ACH-000958,CVCL_1724,Bowel,PIK3CA,Het,Missense,p.G914R,GoF,Oncogene
|
512 |
+
510,SW48,ACH-000958,CVCL_1724,Bowel,RNF43,Het,Frameshift,p.G659fs,LoF,Suppressor
|
513 |
+
511,SW48,ACH-000958,CVCL_1724,Bowel,RNF43,Het,Frameshift,p.V299fs,LoF,Suppressor
|
514 |
+
512,SW48,ACH-000958,CVCL_1724,Bowel,SETD1B,Hom,Frameshift,p.H8fs,LoF,Suppressor
|
515 |
+
513,SW48,ACH-000958,CVCL_1724,Bowel,SMARCA4,Het,Missense,p.A703V,,Suppressor
|
516 |
+
514,SW48,ACH-000958,CVCL_1724,Bowel,TGFBR2,Hom,Frameshift,p.K128fs,LoF,Suppressor
|
517 |
+
515,SW48,ACH-000958,CVCL_1724,Bowel,ZFHX3,Het,Frameshift,p.A3407fs,LoF,Suppressor
|
518 |
+
516,LS411N,ACH-000985,CVCL_1385,Bowel,ACVR2A,Hom,Frameshift,p.K437fs,LoF,Suppressor
|
519 |
+
517,LS411N,ACH-000985,CVCL_1385,Bowel,APC,Het,Stopgain,p.Q789*,LoF,Suppressor
|
520 |
+
518,LS411N,ACH-000985,CVCL_1385,Bowel,APC,Het,Frameshift,p.T1556fs,LoF,Suppressor
|
521 |
+
519,LS411N,ACH-000985,CVCL_1385,Bowel,ARID1A,Het,Frameshift,p.P1326fs,LoF,Suppressor
|
522 |
+
520,LS411N,ACH-000985,CVCL_1385,Bowel,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
523 |
+
521,LS411N,ACH-000985,CVCL_1385,Bowel,BRCA2,Het,Missense,p.E3111K,LoF,Suppressor
|
524 |
+
522,LS411N,ACH-000985,CVCL_1385,Bowel,CHEK2,Het,Missense,p.P85H,,Suppressor
|
525 |
+
523,LS411N,ACH-000985,CVCL_1385,Bowel,EP300,Het,Frameshift,p.H2324fs,LoF,Suppressor
|
526 |
+
524,LS411N,ACH-000985,CVCL_1385,Bowel,ERBB2,Het,Missense,p.E744K,,Oncogene
|
527 |
+
525,LS411N,ACH-000985,CVCL_1385,Bowel,FBXW7,Het,Missense,p.R425H,LoF,Suppressor
|
528 |
+
526,LS411N,ACH-000985,CVCL_1385,Bowel,GNAS,Het,Missense,p.R160C,,Oncogene
|
529 |
+
527,LS411N,ACH-000985,CVCL_1385,Bowel,GNAS,Het,Missense,p.R356C,,Oncogene
|
530 |
+
528,LS411N,ACH-000985,CVCL_1385,Bowel,HNF1A,Het,Missense,p.L408I,LoF,Suppressor
|
531 |
+
529,LS411N,ACH-000985,CVCL_1385,Bowel,KMT2D,Het,Missense,p.E1018D,,Suppressor
|
532 |
+
530,LS411N,ACH-000985,CVCL_1385,Bowel,KMT2D,Het,Missense,p.G4437V,LoF,Suppressor
|
533 |
+
531,LS411N,ACH-000985,CVCL_1385,Bowel,KMT2D,Het,Frameshift,p.P853fs,LoF,Suppressor
|
534 |
+
532,LS411N,ACH-000985,CVCL_1385,Bowel,MAPK3,Het,Missense,p.S172C,,Oncogene
|
535 |
+
533,LS411N,ACH-000985,CVCL_1385,Bowel,MET,Het,Missense,p.T86I,,Oncogene
|
536 |
+
534,LS411N,ACH-000985,CVCL_1385,Bowel,NF1,Het,Missense,p.T2784I,,Suppressor
|
537 |
+
535,LS411N,ACH-000985,CVCL_1385,Bowel,PTEN,Het,Frameshift,p.C105fs,LoF,Suppressor
|
538 |
+
536,LS411N,ACH-000985,CVCL_1385,Bowel,PTEN,Het,Frameshift,p.K164fs,LoF,Suppressor
|
539 |
+
537,LS411N,ACH-000985,CVCL_1385,Bowel,RNF43,Het,Frameshift,p.G659fs,LoF,Suppressor
|
540 |
+
538,LS411N,ACH-000985,CVCL_1385,Bowel,SETD1B,Hom,Frameshift,p.H8fs,LoF,Suppressor
|
541 |
+
539,LS411N,ACH-000985,CVCL_1385,Bowel,SETD1B,Het,Frameshift,p.K42fs,LoF,Suppressor
|
542 |
+
540,LS411N,ACH-000985,CVCL_1385,Bowel,SETD1B,Het,Missense,p.V65A,,Suppressor
|
543 |
+
541,LS411N,ACH-000985,CVCL_1385,Bowel,SETD1B,Het,Missense,p.V723A,LoF,Suppressor
|
544 |
+
542,LS411N,ACH-000985,CVCL_1385,Bowel,TP53,Hom,Stopgain,p.Y126*,LoF,Suppressor
|
545 |
+
543,LS411N,ACH-000985,CVCL_1385,Bowel,WNK2,Het,Splice_site,p.S612S,LoF,Suppressor
|
546 |
+
544,LS411N,ACH-000985,CVCL_1385,Bowel,WNK2,Het,Splice_site,,LoF,Suppressor
|
547 |
+
545,LS411N,ACH-000985,CVCL_1385,Bowel,ZFHX3,Het,Missense,p.C3029Y,LoF,Suppressor
|
548 |
+
546,LS411N,ACH-000985,CVCL_1385,Bowel,ZFHX3,Het,Missense,p.P802L,,Suppressor
|
549 |
+
547,HOP62,ACH-000861,CVCL_1285,Lung,B2M,Het,Missense,p.E70Q,,Suppressor
|
550 |
+
548,HOP62,ACH-000861,CVCL_1285,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
551 |
+
549,HOP62,ACH-000861,CVCL_1285,Lung,MSH6,Het,Missense,p.E221D,,Suppressor
|
552 |
+
550,HOP62,ACH-000861,CVCL_1285,Lung,POLE,Het,Missense,p.K604N,,Suppressor
|
553 |
+
551,HOP62,ACH-000861,CVCL_1285,Lung,RAF1,Het,Missense,p.R143Q,,Oncogene
|
554 |
+
552,HOP62,ACH-000861,CVCL_1285,Lung,TERT,Het,Promoter,1-124C>T,GoF,Oncogene
|
555 |
+
553,HOP62,ACH-000861,CVCL_1285,Lung,TP53,Hom,Splice_site,,LoF,Suppressor
|
556 |
+
554,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,APC,Het,Missense,p.S770P,,Suppressor
|
557 |
+
555,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,ERBB2,Het,Missense,p.R678Q,GoF,Oncogene
|
558 |
+
556,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,FGFR3,Het,Missense,p.K651E,GoF,Oncogene
|
559 |
+
557,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,PIK3CA,Het,Missense,p.P124L,,Oncogene
|
560 |
+
558,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,PTEN,Hom,Frameshift,p.N212fs,LoF,Suppressor
|
561 |
+
559,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,RB1,Hom,Splice_site,,LoF,Suppressor
|
562 |
+
560,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
563 |
+
561,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,TP53,Het,Missense,p.E271K,LoF,Suppressor
|
564 |
+
562,J82,ACH-000396,CVCL_0359,Bladder/Urinary Tract,TP53,Het,Missense,p.K320N,LoF,Suppressor
|
565 |
+
563,CCF-STTG1,ACH-000329,CVCL_1118,CNS/Brain,ARID1A,Het,Missense,p.P1144T,,Suppressor
|
566 |
+
564,CCF-STTG1,ACH-000329,CVCL_1118,CNS/Brain,PTEN,Hom,Missense,p.L112R,LoF,Suppressor
|
567 |
+
565,CCF-STTG1,ACH-000329,CVCL_1118,CNS/Brain,PTPN11,Het,Missense,p.R498W,GoF,Oncogene
|
568 |
+
566,BT-20,ACH-000536,CVCL_0178,Breast,BRCA2,Hom,Missense,p.T3357R,,Suppressor
|
569 |
+
567,BT-20,ACH-000536,CVCL_0178,Breast,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
570 |
+
568,BT-20,ACH-000536,CVCL_0178,Breast,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
571 |
+
569,BT-20,ACH-000536,CVCL_0178,Breast,EGFR,,Gain,GAIN,GoF,Oncogene
|
572 |
+
570,BT-20,ACH-000536,CVCL_0178,Breast,NRAS,,Gain,GAIN,GoF,Oncogene
|
573 |
+
571,BT-20,ACH-000536,CVCL_0178,Breast,PIK3CA,Het,Missense,p.H1047R,GoF,Oncogene
|
574 |
+
572,BT-20,ACH-000536,CVCL_0178,Breast,PIK3CA,Het,Missense,p.P539R,GoF,Oncogene
|
575 |
+
573,BT-20,ACH-000536,CVCL_0178,Breast,RB1,Hom,Missense,p.I388S,LoF,Suppressor
|
576 |
+
574,BT-20,ACH-000536,CVCL_0178,Breast,RB1,Het,Missense,p.P515L,LoF,Suppressor
|
577 |
+
575,BT-20,ACH-000536,CVCL_0178,Breast,TP53,Hom,Missense,p.K132Q,LoF,Suppressor
|
578 |
+
576,DU4475,ACH-000258,CVCL_1183,Breast,APC,Hom,Stopgain,p.E1577*,LoF,Suppressor
|
579 |
+
577,DU4475,ACH-000258,CVCL_1183,Breast,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
580 |
+
578,DU4475,ACH-000258,CVCL_1183,Breast,RB1,Hom,Deletion,DEL,LoF,Suppressor
|
581 |
+
579,DU4475,ACH-000258,CVCL_1183,Breast,SETD1B,Het,Missense,p.Q1402R,,Suppressor
|
582 |
+
580,DU4475,ACH-000258,CVCL_1183,Breast,ZFHX3,Het,Missense,p.A2398D,,Suppressor
|
583 |
+
581,LS 180,ACH-000957,CVCL_0397,Bowel,ACVR2A,Hom,Frameshift,p.K437fs,LoF,Suppressor
|
584 |
+
582,LS 180,ACH-000957,CVCL_0397,Bowel,APC,Het,Missense,p.R1788C,,Suppressor
|
585 |
+
583,LS 180,ACH-000957,CVCL_0397,Bowel,ARID1A,Het,Frameshift,p.K1094fs,LoF,Suppressor
|
586 |
+
584,LS 180,ACH-000957,CVCL_0397,Bowel,BRAF,Het,Missense,p.D211G,,Oncogene
|
587 |
+
585,LS 180,ACH-000957,CVCL_0397,Bowel,BRCA2,Het,Frameshift,p.T3033fs,LoF,Suppressor
|
588 |
+
586,LS 180,ACH-000957,CVCL_0397,Bowel,CTNNB1,Hom,Missense,p.S45F,GoF,Oncogene
|
589 |
+
587,LS 180,ACH-000957,CVCL_0397,Bowel,EP300,Het,Missense,p.G30V,,Suppressor
|
590 |
+
588,LS 180,ACH-000957,CVCL_0397,Bowel,HNF1A,Het,Frameshift,p.P291fs,LoF,Suppressor
|
591 |
+
589,LS 180,ACH-000957,CVCL_0397,Bowel,JAK1,Het,Missense,p.R681W,,Oncogene
|
592 |
+
590,LS 180,ACH-000957,CVCL_0397,Bowel,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
593 |
+
591,LS 180,ACH-000957,CVCL_0397,Bowel,PIK3CA,Het,Missense,p.H1047R,GoF,Oncogene
|
594 |
+
592,LS 180,ACH-000957,CVCL_0397,Bowel,PRDM2,Het,Frameshift,p.V1490fs,LoF,Suppressor
|
595 |
+
593,LS 180,ACH-000957,CVCL_0397,Bowel,PTEN,Het,Missense,p.I67K,LoF,Suppressor
|
596 |
+
594,LS 180,ACH-000957,CVCL_0397,Bowel,RNF43,Het,Missense,p.K108E,,Suppressor
|
597 |
+
595,LS 180,ACH-000957,CVCL_0397,Bowel,RNF43,Het,Missense,p.R389H,,Suppressor
|
598 |
+
596,LS 180,ACH-000957,CVCL_0397,Bowel,SETD1B,Hom,Frameshift,p.H8fs,LoF,Suppressor
|
599 |
+
597,LS 180,ACH-000957,CVCL_0397,Bowel,SETD1B,Het,Frameshift,p.Q1589fs,LoF,Suppressor
|
600 |
+
598,LS 180,ACH-000957,CVCL_0397,Bowel,STK11,Het,Missense,p.I46T,LoF,Suppressor
|
601 |
+
599,LS 180,ACH-000957,CVCL_0397,Bowel,TGFBR2,Hom,Frameshift,p.K128fs,LoF,Suppressor
|
602 |
+
600,LS 180,ACH-000957,CVCL_0397,Bowel,WNK2,Het,Missense,p.A1529T,,Suppressor
|
603 |
+
601,LS 180,ACH-000957,CVCL_0397,Bowel,WNK2,Het,Frameshift,p.D1638fs,LoF,Suppressor
|
604 |
+
602,LS 180,ACH-000957,CVCL_0397,Bowel,ZFHX3,Het,Frameshift,p.A3407fs,LoF,Suppressor
|
605 |
+
603,LS 180,ACH-000957,CVCL_0397,Bowel,ZFHX3,Het,Missense,p.D3699G,LoF,Suppressor
|
606 |
+
604,COLO 201,ACH-000253,CVCL_1987,Bowel,APC,Hom,Frameshift,p.T1556fs,LoF,Suppressor
|
607 |
+
605,COLO 201,ACH-000253,CVCL_1987,Bowel,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
608 |
+
606,COLO 201,ACH-000253,CVCL_1987,Bowel,CTNNB1,Hom,Missense,p.N287S,,Oncogene
|
609 |
+
607,COLO 201,ACH-000253,CVCL_1987,Bowel,GNAS,Het,Missense,p.S95I,,Oncogene
|
610 |
+
608,COLO 201,ACH-000253,CVCL_1987,Bowel,MTOR,Het,Missense,p.P1193L,,Oncogene
|
611 |
+
609,COLO 201,ACH-000253,CVCL_1987,Bowel,TP53,Hom,Frameshift,p.Y103fs,LoF,Suppressor
|
612 |
+
610,COLO 201,ACH-000253,CVCL_1987,Bowel,TP53,Hom,Frameshift,p.Y107fs,LoF,Suppressor
|
613 |
+
611,HepG2/C3A,ACH-001021,CVCL_1098,Liver,ATM,Het,Missense,p.V2906I,,Suppressor
|
614 |
+
612,HepG2/C3A,ACH-001021,CVCL_1098,Liver,EGFR,Het,Missense,p.C186S,,Oncogene
|
615 |
+
613,HepG2/C3A,ACH-001021,CVCL_1098,Liver,ERBB3,Het,Missense,p.R421K,,Oncogene
|
616 |
+
614,HepG2/C3A,ACH-001021,CVCL_1098,Liver,NRAS,Het,Missense,p.Q61L,GoF,Oncogene
|
617 |
+
615,HepG2/C3A,ACH-001021,CVCL_1098,Liver,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
618 |
+
616,RPMI-7951,ACH-000348,CVCL_1666,Skin,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
619 |
+
617,RPMI-7951,ACH-000348,CVCL_1666,Skin,CDKN2A,Hom,Missense,p.L16R,LoF,Suppressor
|
620 |
+
618,RPMI-7951,ACH-000348,CVCL_1666,Skin,PTEN,Hom,Deletion,DEL,LoF,Suppressor
|
621 |
+
619,RPMI-7951,ACH-000348,CVCL_1666,Skin,TERT,,Promoter,242_243CC>TT,,Oncogene
|
622 |
+
620,RPMI-7951,ACH-000348,CVCL_1666,Skin,TP53,Hom,Stopgain,p.S166*,LoF,Suppressor
|
623 |
+
621,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,ACVR2A,Het,Frameshift,p.K437fs,LoF,Suppressor
|
624 |
+
622,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,ARID1A,Het,Frameshift,p.Y551fs,LoF,Suppressor
|
625 |
+
623,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,CDKN2B,Het,Missense,p.A23V,,Suppressor
|
626 |
+
624,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,FBXW7,Het,Missense,p.G104V,,Suppressor
|
627 |
+
625,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,KMT2D,Het,Missense,p.G4397V,,Suppressor
|
628 |
+
626,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,KMT2D,Het,Missense,p.P4209Q,,Suppressor
|
629 |
+
627,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,KRAS,Het,Missense,p.G13C,GoF,Oncogene
|
630 |
+
628,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,MSH6,Het,Missense,p.A35T,,Suppressor
|
631 |
+
629,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,NF1,Het,Frameshift,p.P678fs,LoF,Suppressor
|
632 |
+
630,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,PIK3CA,Het,Missense,p.H1047Y,GoF,Oncogene
|
633 |
+
631,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,POLE,Het,Missense,p.D2166N,,Suppressor
|
634 |
+
632,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,POLE,Het,Missense,p.S828Y,LoF,Suppressor
|
635 |
+
633,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,PRDM2,Het,Missense,p.E278D,,Suppressor
|
636 |
+
634,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,PTEN,Het,Frameshift,p.K267fs,LoF,Suppressor
|
637 |
+
635,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,RNF43,Het,Missense,p.C298Y,LoF,Suppressor
|
638 |
+
636,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,RNF43,Het,Frameshift,p.G659fs,LoF,Suppressor
|
639 |
+
637,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,SETD1B,Het,Missense,p.E1078D,,Suppressor
|
640 |
+
638,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,SMARCA4,Het,Stopgain,p.E419*,LoF,Suppressor
|
641 |
+
639,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,STK11,Hom,Frameshift,p.P281fs,LoF,Suppressor
|
642 |
+
640,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,WNK2,Het,Stopgain,p.G1139*,LoF,Suppressor
|
643 |
+
641,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,WNK2,Het,Missense,p.L71P,,Suppressor
|
644 |
+
642,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,WNK2,Het,Missense,p.S1520N,,Suppressor
|
645 |
+
643,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,ZFHX3,Het,Frameshift,p.A3407fs,LoF,Suppressor
|
646 |
+
644,TOV-21G,ACH-000885,CVCL_3613,Ovary/Fallopian Tube,ZFHX3,Het,Missense,p.P2787L,,Suppressor
|
647 |
+
645,Panc 10.05,ACH-000060,CVCL_1639,Pancreas,EP300,Hom,Frameshift,p.K1488fs,LoF,Suppressor
|
648 |
+
646,Panc 10.05,ACH-000060,CVCL_1639,Pancreas,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
649 |
+
647,Panc 10.05,ACH-000060,CVCL_1639,Pancreas,NF1,Het,Missense,p.G1417S,LoF,Suppressor
|
650 |
+
648,Panc 10.05,ACH-000060,CVCL_1639,Pancreas,RNF43,Hom,Frameshift,p.M18fs,LoF,Suppressor
|
651 |
+
649,Panc 10.05,ACH-000060,CVCL_1639,Pancreas,TGFBR2,Hom,Frameshift,p.S156fs,LoF,Suppressor
|
652 |
+
650,Panc 10.05,ACH-000060,CVCL_1639,Pancreas,TP53,Hom,Missense,p.I255N,LoF,Suppressor
|
653 |
+
651,HCT116,ACH-000971,CVCL_0291,Bowel,ABL1,Het,Missense,p.Y276C,,Oncogene
|
654 |
+
652,HCT116,ACH-000971,CVCL_0291,Bowel,ACVR2A,Hom,Frameshift,p.K437fs,LoF,Suppressor
|
655 |
+
653,HCT116,ACH-000971,CVCL_0291,Bowel,ATM,Het,Missense,p.A1127V,,Suppressor
|
656 |
+
654,HCT116,ACH-000971,CVCL_0291,Bowel,BRCA2,Het,Frameshift,p.I2675fs,LoF,Suppressor
|
657 |
+
655,HCT116,ACH-000971,CVCL_0291,Bowel,CDKN2A,Het,Frameshift,p.E33fs,LoF,Suppressor
|
658 |
+
656,HCT116,ACH-000971,CVCL_0291,Bowel,CDKN2A,Het,Frameshift,p.R24fs,LoF,Suppressor
|
659 |
+
657,HCT116,ACH-000971,CVCL_0291,Bowel,CHEK2,Het,Missense,p.L355P,LoF,Suppressor
|
660 |
+
658,HCT116,ACH-000971,CVCL_0291,Bowel,CTNNB1,Het,Missense,p.S45NA,,Oncogene
|
661 |
+
659,HCT116,ACH-000971,CVCL_0291,Bowel,EP300,Het,Frameshift,p.M1470fs,LoF,Suppressor
|
662 |
+
660,HCT116,ACH-000971,CVCL_0291,Bowel,EP300,Het,Frameshift,p.N1700fs,LoF,Suppressor
|
663 |
+
661,HCT116,ACH-000971,CVCL_0291,Bowel,GNAS,Het,Missense,p.Y318C,,Oncogene
|
664 |
+
662,HCT116,ACH-000971,CVCL_0291,Bowel,HNF1A,Het,Frameshift,p.P291fs,LoF,Suppressor
|
665 |
+
663,HCT116,ACH-000971,CVCL_0291,Bowel,KMT2D,Het,Frameshift,p.R2443fs,LoF,Suppressor
|
666 |
+
664,HCT116,ACH-000971,CVCL_0291,Bowel,KMT2D,Het,Missense,p.V160M,LoF,Suppressor
|
667 |
+
665,HCT116,ACH-000971,CVCL_0291,Bowel,KRAS,Het,Missense,p.G13D,GoF,Oncogene
|
668 |
+
666,HCT116,ACH-000971,CVCL_0291,Bowel,NF1,Het,Missense,p.P388T,LoF,Suppressor
|
669 |
+
667,HCT116,ACH-000971,CVCL_0291,Bowel,PIK3CA,Het,Missense,p.H1047R,GoF,Oncogene
|
670 |
+
668,HCT116,ACH-000971,CVCL_0291,Bowel,PRDM2,Hom,Frameshift,p.V1490fs,LoF,Suppressor
|
671 |
+
669,HCT116,ACH-000971,CVCL_0291,Bowel,SETD1B,Hom,Frameshift,p.H8fs,LoF,Suppressor
|
672 |
+
670,HCT116,ACH-000971,CVCL_0291,Bowel,SETD1B,Het,Frameshift,p.R1623fs,LoF,Suppressor
|
673 |
+
671,HCT116,ACH-000971,CVCL_0291,Bowel,SETD1B,Het,Frameshift,p.S1055fs,LoF,Suppressor
|
674 |
+
672,HCT116,ACH-000971,CVCL_0291,Bowel,SMARCA4,Het,Missense,p.L1163P,LoF,Suppressor
|
675 |
+
673,HCT116,ACH-000971,CVCL_0291,Bowel,SMARCA4,Het,Frameshift,p.S122fs,LoF,Suppressor
|
676 |
+
674,HCT116,ACH-000971,CVCL_0291,Bowel,TGFBR2,Hom,Frameshift,p.K128fs,LoF,Suppressor
|
677 |
+
675,HCT116,ACH-000971,CVCL_0291,Bowel,WNK2,Het,Frameshift,p.D1638fs,LoF,Suppressor
|
678 |
+
676,HCT116,ACH-000971,CVCL_0291,Bowel,WNK2,Het,Frameshift,p.H758fs,LoF,Suppressor
|
679 |
+
677,HCT116,ACH-000971,CVCL_0291,Bowel,ZFHX3,Het,Missense,p.G3519S,,Suppressor
|
680 |
+
678,Panc 03.27,ACH-000139,CVCL_1635,Pancreas,ATM,Het,Missense,p.E2351G,LoF,Suppressor
|
681 |
+
679,Panc 03.27,ACH-000139,CVCL_1635,Pancreas,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
682 |
+
680,Panc 03.27,ACH-000139,CVCL_1635,Pancreas,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
683 |
+
681,Panc 03.27,ACH-000139,CVCL_1635,Pancreas,KRAS,Het,Missense,p.G12V,GoF,Oncogene
|
684 |
+
682,Panc 03.27,ACH-000139,CVCL_1635,Pancreas,TP53,Hom,Splice_site,375+5G>T,LoF,Suppressor
|
685 |
+
683,Panc 03.27,ACH-000139,CVCL_1635,Pancreas,ZFHX3,Hom,Missense,p.P802A,,Suppressor
|
686 |
+
684,Hs 852.T,ACH-000274,CVCL_0950,Skin,CCND1,,Gain,GAIN,GoF,Oncogene
|
687 |
+
685,Hs 852.T,ACH-000274,CVCL_0950,Skin,EGFR,,Gain,GAIN,GoF,Oncogene
|
688 |
+
686,Hs 852.T,ACH-000274,CVCL_0950,Skin,FGFR3,,Gain,GAIN,GoF,Oncogene
|
689 |
+
687,Hs 852.T,ACH-000274,CVCL_0950,Skin,NRAS,Het,Missense,p.G12V,GoF,Oncogene
|
690 |
+
688,Hs 852.T,ACH-000274,CVCL_0950,Skin,POLE,Het,Missense,p.R2159H,,Suppressor
|
691 |
+
689,Hs 852.T,ACH-000274,CVCL_0950,Skin,TERT,,Gain,GAIN,GoF,Oncogene
|
692 |
+
690,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,CDKN2A,Het,Missense,p.D23P,,Suppressor
|
693 |
+
691,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,CDKN2B,Het,Missense,p.D76A,LoF,Suppressor
|
694 |
+
692,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,CTNNB1,Het,Missense,p.G34E,GoF,Oncogene
|
695 |
+
693,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,EP300,Het,Stopgain,p.E1025*,LoF,Suppressor
|
696 |
+
694,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,EP300,Het,Stopgain,p.E643*,LoF,Suppressor
|
697 |
+
695,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,EP300,Het,Missense,p.K350R,LoF,Suppressor
|
698 |
+
696,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,GNAS,Het,Missense,p.F219V,,Oncogene
|
699 |
+
697,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
700 |
+
698,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,NF1,Het,Missense,p.E1438G,LoF,Suppressor
|
701 |
+
699,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,PIK3CA,Het,Missense,p.E453K,GoF,Oncogene
|
702 |
+
700,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,PIK3CA,Het,Missense,p.E545A,GoF,Oncogene
|
703 |
+
701,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,PRDM2,Het,Missense,p.P1326S,,Suppressor
|
704 |
+
702,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,SOS1,Het,Missense,p.E783G,,Oncogene
|
705 |
+
703,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,XPO1,Het,Missense,p.C585F,,Oncogene
|
706 |
+
704,AGS,ACH-000880,CVCL_0139,Esophagus/Stomach,ZFHX3,Het,Missense,p.F3474L,LoF,Suppressor
|
707 |
+
705,NCI-N87,ACH-000427,CVCL_1603,Esophagus/Stomach,ERBB2,,Gain,GAIN,GoF,Oncogene
|
708 |
+
706,NCI-N87,ACH-000427,CVCL_1603,Esophagus/Stomach,ERBB3,,Missense,p.T757K,,Oncogene
|
709 |
+
707,NCI-N87,ACH-000427,CVCL_1603,Esophagus/Stomach,KMT2D,Het,Missense,p.S537F,,Suppressor
|
710 |
+
708,NCI-N87,ACH-000427,CVCL_1603,Esophagus/Stomach,LASP1,,Gain,GAIN,GoF,Oncogene
|
711 |
+
709,NCI-N87,ACH-000427,CVCL_1603,Esophagus/Stomach,SETD1B,Het,Missense,p.Q1589P,,Suppressor
|
712 |
+
710,NCI-N87,ACH-000427,CVCL_1603,Esophagus/Stomach,SMAD4,Hom,Deletion,DEL,LoF,Suppressor
|
713 |
+
711,NCI-N87,ACH-000427,CVCL_1603,Esophagus/Stomach,TP53,Hom,Missense,p.R248Q,LoF,Suppressor
|
714 |
+
712,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,ARID1A,Hom,Deletion,DEL,LoF,Suppressor
|
715 |
+
713,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,BRCA2,Het,Missense,p.E2292A,LoF,Suppressor
|
716 |
+
714,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,CDKN2A,Hom,Stopgain,p.R29*,LoF,Suppressor
|
717 |
+
715,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,MET,,Gain,GAIN,GoF,Oncogene
|
718 |
+
716,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,STK11,Het,Missense,p.P149L,LoF,Suppressor
|
719 |
+
717,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,TP53,,Missense,p.G262_269NA,,Suppressor
|
720 |
+
718,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,TP53,Het,Splice_site,,LoF,Suppressor
|
721 |
+
719,SNU-5,ACH-000303,CVCL_0078,Esophagus/Stomach,ZFHX3,Hom,Missense,p.S1608G,,Suppressor
|
722 |
+
720,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ACVR2A,Het,Missense,p.A349T,,Suppressor
|
723 |
+
721,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ACVR2A,Het,Missense,p.L329M,LoF,Suppressor
|
724 |
+
722,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ARID1A,Het,Missense,p.G1544C,,Suppressor
|
725 |
+
723,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ARID1A,Het,Stopgain,p.Q1618*,LoF,Suppressor
|
726 |
+
724,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ARID1A,Het,Stopgain,p.Q1898*,LoF,Suppressor
|
727 |
+
725,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ARID1A,Het,Missense,p.Q404H,,Suppressor
|
728 |
+
726,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ATM,Het,Missense,p.P2353H,LoF,Suppressor
|
729 |
+
727,HEC-1-A,ACH-000954,CVCL_0293,Uterus,BRAF,Het,Missense,p.R682Q,,Oncogene
|
730 |
+
728,HEC-1-A,ACH-000954,CVCL_0293,Uterus,EP300,Het,Missense,p.D1399N,LoF,Suppressor
|
731 |
+
729,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ERBB2,Het,Missense,p.T798I,GoF,Oncogene
|
732 |
+
730,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ERBB2,Het,Missense,p.V842I,GoF,Oncogene
|
733 |
+
731,HEC-1-A,ACH-000954,CVCL_0293,Uterus,KMT2D,Het,Missense,p.P2641H,,Suppressor
|
734 |
+
732,HEC-1-A,ACH-000954,CVCL_0293,Uterus,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
735 |
+
733,HEC-1-A,ACH-000954,CVCL_0293,Uterus,MET,Het,Missense,p.V1350D,,Oncogene
|
736 |
+
734,HEC-1-A,ACH-000954,CVCL_0293,Uterus,MSH6,Het,Frameshift,p.F1088fs,LoF,Suppressor
|
737 |
+
735,HEC-1-A,ACH-000954,CVCL_0293,Uterus,MSH6,Het,Splice_site,,LoF,Suppressor
|
738 |
+
736,HEC-1-A,ACH-000954,CVCL_0293,Uterus,MTOR,Het,Missense,p.R2254M,,Oncogene
|
739 |
+
737,HEC-1-A,ACH-000954,CVCL_0293,Uterus,NF1,Het,Missense,p.L792I,,Suppressor
|
740 |
+
738,HEC-1-A,ACH-000954,CVCL_0293,Uterus,PIK3CA,Het,Missense,p.G1049R,GoF,Oncogene
|
741 |
+
739,HEC-1-A,ACH-000954,CVCL_0293,Uterus,PMS2,Hom,Stopgain,p.R802*,LoF,Suppressor
|
742 |
+
740,HEC-1-A,ACH-000954,CVCL_0293,Uterus,PRDM2,Het,Missense,p.N1324I,,Suppressor
|
743 |
+
741,HEC-1-A,ACH-000954,CVCL_0293,Uterus,RNF43,Het,Frameshift,p.G659fs,LoF,Suppressor
|
744 |
+
742,HEC-1-A,ACH-000954,CVCL_0293,Uterus,SETD1B,Het,Frameshift,p.H8fs,LoF,Suppressor
|
745 |
+
743,HEC-1-A,ACH-000954,CVCL_0293,Uterus,SETD1B,Het,Frameshift,p.P1361fs,LoF,Suppressor
|
746 |
+
744,HEC-1-A,ACH-000954,CVCL_0293,Uterus,SMAD4,Het,Missense,p.L344S,LoF,Suppressor
|
747 |
+
745,HEC-1-A,ACH-000954,CVCL_0293,Uterus,SMARCA4,Het,Frameshift,p.G271fs,LoF,Suppressor
|
748 |
+
746,HEC-1-A,ACH-000954,CVCL_0293,Uterus,TP53,Hom,Missense,p.R248Q,LoF,Suppressor
|
749 |
+
747,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ZFHX3,Het,Stopgain,p.R1114*,LoF,Suppressor
|
750 |
+
748,HEC-1-A,ACH-000954,CVCL_0293,Uterus,ZFHX3,Het,Frameshift,p.S2505fs,LoF,Suppressor
|
751 |
+
749,C-33 A,ACH-001333,CVCL_1094,Cervix,ARID1A,Het,Frameshift,p.Q758fs,LoF,Suppressor
|
752 |
+
750,C-33 A,ACH-001333,CVCL_1094,Cervix,BRCA2,Het,Missense,p.A3029T,,Suppressor
|
753 |
+
751,C-33 A,ACH-001333,CVCL_1094,Cervix,HNF1A,Het,Frameshift,p.P291fs,LoF,Suppressor
|
754 |
+
752,C-33 A,ACH-001333,CVCL_1094,Cervix,KMT2D,Het,Frameshift,p.A2119fs,LoF,Suppressor
|
755 |
+
753,C-33 A,ACH-001333,CVCL_1094,Cervix,KMT2D,Het,Missense,p.R1614W,LoF,Suppressor
|
756 |
+
754,C-33 A,ACH-001333,CVCL_1094,Cervix,KMT2D,Het,Missense,p.R1617W,LoF,Suppressor
|
757 |
+
755,C-33 A,ACH-001333,CVCL_1094,Cervix,KMT2D,Het,Frameshift,p.V1244fs,LoF,Suppressor
|
758 |
+
756,C-33 A,ACH-001333,CVCL_1094,Cervix,PIK3CA,Het,Missense,p.R88Q,GoF,Oncogene
|
759 |
+
757,C-33 A,ACH-001333,CVCL_1094,Cervix,PTEN,Het,Stopgain,p.R130*,LoF,Suppressor
|
760 |
+
758,C-33 A,ACH-001333,CVCL_1094,Cervix,PTEN,Het,Stopgain,p.R233*,LoF,Suppressor
|
761 |
+
759,C-33 A,ACH-001333,CVCL_1094,Cervix,RB1,Hom,Splice_site,,LoF,Suppressor
|
762 |
+
760,C-33 A,ACH-001333,CVCL_1094,Cervix,SETD1B,Het,Frameshift,p.H8fs,LoF,Suppressor
|
763 |
+
761,C-33 A,ACH-001333,CVCL_1094,Cervix,SETD1B,Het,Missense,p.R980W,,Suppressor
|
764 |
+
762,C-33 A,ACH-001333,CVCL_1094,Cervix,SETD1B,Het,Missense,p.T482M,,Suppressor
|
765 |
+
763,C-33 A,ACH-001333,CVCL_1094,Cervix,SMARCA4,Het,Missense,p.M527T,LoF,Suppressor
|
766 |
+
764,C-33 A,ACH-001333,CVCL_1094,Cervix,SMARCA4,Het,Missense,p.Q1248R,LoF,Suppressor
|
767 |
+
765,C-33 A,ACH-001333,CVCL_1094,Cervix,SMARCA4,Het,Stopgain,p.Q1537*,LoF,Suppressor
|
768 |
+
766,C-33 A,ACH-001333,CVCL_1094,Cervix,TP53,Hom,Missense,p.R273C,LoF,Suppressor
|
769 |
+
767,C-33 A,ACH-001333,CVCL_1094,Cervix,WNK2,Het,Missense,p.A678T,,Suppressor
|
770 |
+
768,C-33 A,ACH-001333,CVCL_1094,Cervix,WNK2,Het,Frameshift,p.D1638fs,LoF,Suppressor
|
771 |
+
769,C-33 A,ACH-001333,CVCL_1094,Cervix,ZFHX3,Het,Frameshift,p.R1893fs,LoF,Suppressor
|
772 |
+
770,SK-HEP-1,ACH-000361,CVCL_0525,Liver,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
773 |
+
771,SK-HEP-1,ACH-000361,CVCL_0525,Liver,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
774 |
+
772,SK-HEP-1,ACH-000361,CVCL_0525,Liver,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
775 |
+
773,SK-HEP-1,ACH-000361,CVCL_0525,Liver,NF2,Het,Missense,p.I264V,,Suppressor
|
776 |
+
774,SK-HEP-1,ACH-000361,CVCL_0525,Liver,SMARCA4,Hom,Stopgain,p.E1582*,LoF,Suppressor
|
777 |
+
775,NCI-H1573,ACH-000916,CVCL_1478,Lung,CDKN2A,Het,Missense,p.D23P,,Suppressor
|
778 |
+
776,NCI-H1573,ACH-000916,CVCL_1478,Lung,EGFR,,Gain,GAIN,GoF,Oncogene
|
779 |
+
777,NCI-H1573,ACH-000916,CVCL_1478,Lung,ERBB3,Het,Missense,p.E332K,GoF,Oncogene
|
780 |
+
778,NCI-H1573,ACH-000916,CVCL_1478,Lung,FBXW7,Het,Missense,p.V619L,,Suppressor
|
781 |
+
779,NCI-H1573,ACH-000916,CVCL_1478,Lung,FBXW7,Het,Stopgain,p.W593*,LoF,Suppressor
|
782 |
+
780,NCI-H1573,ACH-000916,CVCL_1478,Lung,KMT2D,Het,Missense,p.L2398P,,Suppressor
|
783 |
+
781,NCI-H1573,ACH-000916,CVCL_1478,Lung,KMT2D,Het,Missense,p.V361F,,Suppressor
|
784 |
+
782,NCI-H1573,ACH-000916,CVCL_1478,Lung,KRAS,Het,Missense,p.G12A,GoF,Oncogene
|
785 |
+
783,NCI-H1573,ACH-000916,CVCL_1478,Lung,MET,,Gain,GAIN,GoF,Oncogene
|
786 |
+
784,NCI-H1573,ACH-000916,CVCL_1478,Lung,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
787 |
+
785,NCI-H1573,ACH-000916,CVCL_1478,Lung,PIK3R1,Het,Stopgain,p.G71*,LoF,Suppressor
|
788 |
+
786,NCI-H1573,ACH-000916,CVCL_1478,Lung,PTPN11,Het,Stopgain,p.R351*,,Oncogene
|
789 |
+
787,NCI-H1573,ACH-000916,CVCL_1478,Lung,RNF43,Het,Missense,p.A605G,,Suppressor
|
790 |
+
788,NCI-H1573,ACH-000916,CVCL_1478,Lung,SMARCA4,Hom,Stopgain,p.E1399*,LoF,Suppressor
|
791 |
+
789,NCI-H1573,ACH-000916,CVCL_1478,Lung,STK11,Het,Missense,p.S216F,LoF,Suppressor
|
792 |
+
790,NCI-H1573,ACH-000916,CVCL_1478,Lung,TP53,Hom,Missense,p.R248L,LoF,Suppressor
|
793 |
+
791,SK-MEL-2,ACH-001190,CVCL_0069,Skin,CCND1,,Gain,GAIN,GoF,Oncogene
|
794 |
+
792,SK-MEL-2,ACH-001190,CVCL_0069,Skin,EP300,Het,Missense,p.P989S,,Suppressor
|
795 |
+
793,SK-MEL-2,ACH-001190,CVCL_0069,Skin,NRAS,Het,Missense,p.Q61R,GoF,Oncogene
|
796 |
+
794,SK-MEL-2,ACH-001190,CVCL_0069,Skin,POLE,Het,Missense,p.T1052A,,Suppressor
|
797 |
+
795,SK-MEL-2,ACH-001190,CVCL_0069,Skin,SETD1B,Het,Frameshift,p.L1255fs,LoF,Suppressor
|
798 |
+
796,SK-MEL-2,ACH-001190,CVCL_0069,Skin,TERT,,Promoter,1-146C>T,GoF,Oncogene
|
799 |
+
797,SK-MEL-2,ACH-001190,CVCL_0069,Skin,TP53,Hom,Missense,p.G245S,LoF,Suppressor
|
800 |
+
798,SK-MEL-2,ACH-001190,CVCL_0069,Skin,ZFHX3,Het,Frameshift,p.H3611fs,LoF,Suppressor
|
801 |
+
799,NCI-H1155,ACH-000980,CVCL_1456,Lung,APC,Het,Stopgain,p.R232*,LoF,Suppressor
|
802 |
+
800,NCI-H1155,ACH-000980,CVCL_1456,Lung,EGFR,Het,Missense,p.R264G,,Oncogene
|
803 |
+
801,NCI-H1155,ACH-000980,CVCL_1456,Lung,EP300,Hom,Splice_site,,LoF,Suppressor
|
804 |
+
802,NCI-H1155,ACH-000980,CVCL_1456,Lung,KMT2D,Het,Missense,p.A3561D,,Suppressor
|
805 |
+
803,NCI-H1155,ACH-000980,CVCL_1456,Lung,KMT2D,Het,Missense,p.V38M,,Suppressor
|
806 |
+
804,NCI-H1155,ACH-000980,CVCL_1456,Lung,KRAS,Hom,Missense,p.Q61H,GoF,Oncogene
|
807 |
+
805,NCI-H1155,ACH-000980,CVCL_1456,Lung,LASP1,Het,Missense,p.A209V,,Oncogene
|
808 |
+
806,NCI-H1155,ACH-000980,CVCL_1456,Lung,MSH6,Hom,Stopgain,p.R911*,LoF,Suppressor
|
809 |
+
807,NCI-H1155,ACH-000980,CVCL_1456,Lung,NF2,Het,Missense,p.A403T,,Suppressor
|
810 |
+
808,NCI-H1155,ACH-000980,CVCL_1456,Lung,PIK3CA,Het,Missense,p.D843E,,Oncogene
|
811 |
+
809,NCI-H1155,ACH-000980,CVCL_1456,Lung,PTEN,Hom,Stopgain,p.R233*,LoF,Suppressor
|
812 |
+
810,NCI-H1155,ACH-000980,CVCL_1456,Lung,RB1,Het,Stopgain,p.R467*,LoF,Suppressor
|
813 |
+
811,NCI-H1155,ACH-000980,CVCL_1456,Lung,SMAD4,Het,Frameshift,p.R38fs,LoF,Suppressor
|
814 |
+
812,NCI-H1155,ACH-000980,CVCL_1456,Lung,SMARCA4,Het,Missense,p.R466L,,Suppressor
|
815 |
+
813,NCI-H1155,ACH-000980,CVCL_1456,Lung,SMARCA4,Het,Missense,p.S1238P,LoF,Suppressor
|
816 |
+
814,NCI-H1155,ACH-000980,CVCL_1456,Lung,TP53,Hom,Missense,p.R273H,LoF,Suppressor
|
817 |
+
815,NCI-H1155,ACH-000980,CVCL_1456,Lung,ZFHX3,Het,Missense,p.A896T,,Suppressor
|
818 |
+
816,NCI-H460,ACH-000463,CVCL_0459,Lung,ARID1A,Hom,Missense,p.LI1917del,,Suppressor
|
819 |
+
817,NCI-H460,ACH-000463,CVCL_0459,Lung,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
820 |
+
818,NCI-H460,ACH-000463,CVCL_0459,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
821 |
+
819,NCI-H460,ACH-000463,CVCL_0459,Lung,KRAS,Hom,Missense,p.Q61H,GoF,Oncogene
|
822 |
+
820,NCI-H460,ACH-000463,CVCL_0459,Lung,MAP2K1,Het,Missense,p.Y134C,,Oncogene
|
823 |
+
821,NCI-H460,ACH-000463,CVCL_0459,Lung,MYC,,Gain,GAIN,GoF,Oncogene
|
824 |
+
822,NCI-H460,ACH-000463,CVCL_0459,Lung,PIK3CA,Het,Missense,p.E545K,GoF,Oncogene
|
825 |
+
823,NCI-H460,ACH-000463,CVCL_0459,Lung,STK11,Hom,Stopgain,p.Q37*,LoF,Suppressor
|
826 |
+
824,NCI-H460,ACH-000463,CVCL_0459,Lung,ZFHX3,Het,Missense,p.P3675Q,,Suppressor
|
827 |
+
825,NCI-H1299,ACH-000510,CVCL_0060,Lung,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
828 |
+
826,NCI-H1299,ACH-000510,CVCL_0060,Lung,SMARCA4,Hom,Splice_site,,LoF,Suppressor
|
829 |
+
827,NCI-H1299,ACH-000510,CVCL_0060,Lung,SOS1,Het,Missense,p.Y215H,,Oncogene
|
830 |
+
828,NCI-H1299,ACH-000510,CVCL_0060,Lung,TP53,Hom,Deletion,DEL,LoF,Suppressor
|
831 |
+
829,NCI-H1299,ACH-000510,CVCL_0060,Lung,ZFHX3,Het,Missense,p.F3044V,LoF,Suppressor
|
832 |
+
830,NCI-H661,ACH-000853,CVCL_1577,Lung,BRCA2,Het,Missense,p.G2584V,LoF,Suppressor
|
833 |
+
831,NCI-H661,ACH-000853,CVCL_1577,Lung,CDKN2A,Hom,Splice_site,,LoF,Suppressor
|
834 |
+
832,NCI-H661,ACH-000853,CVCL_1577,Lung,LASP1,Het,Stopgain,p.E48*,,Oncogene
|
835 |
+
833,NCI-H661,ACH-000853,CVCL_1577,Lung,PTPN11,Het,Missense,p.N58S,,Oncogene
|
836 |
+
834,NCI-H661,ACH-000853,CVCL_1577,Lung,SMARCA4,Hom,Frameshift,p.L1161fs,LoF,Suppressor
|
837 |
+
835,NCI-H661,ACH-000853,CVCL_1577,Lung,TP53,Het,Missense,p.R158L,LoF,Suppressor
|
838 |
+
836,NCI-H661,ACH-000853,CVCL_1577,Lung,TP53,Het,Missense,p.S215I,LoF,Suppressor
|
839 |
+
837,NCI-H661,ACH-000853,CVCL_1577,Lung,WNK2,Hom,Frameshift,p.G64fs,LoF,Suppressor
|
840 |
+
838,NCI-H661,ACH-000853,CVCL_1577,Lung,ZFHX3,Het,Missense,p.H2506P,,Suppressor
|
841 |
+
839,NCI-H596,ACH-000628,CVCL_1571,Lung,KMT2D,Het,Missense,p.M4058V,,Suppressor
|
842 |
+
840,NCI-H596,ACH-000628,CVCL_1571,Lung,PIK3CA,Het,Missense,p.E545K,GoF,Oncogene
|
843 |
+
841,NCI-H596,ACH-000628,CVCL_1571,Lung,RB1,Hom,Frameshift,p.S182fs,LoF,Suppressor
|
844 |
+
842,NCI-H596,ACH-000628,CVCL_1571,Lung,TGFBR2,Hom,Frameshift,p.S75fs,LoF,Suppressor
|
845 |
+
843,NCI-H596,ACH-000628,CVCL_1571,Lung,TP53,Hom,Missense,p.G245C,LoF,Suppressor
|
846 |
+
844,A-427,ACH-000757,CVCL_1055,Lung,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
847 |
+
845,A-427,ACH-000757,CVCL_1055,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
848 |
+
846,A-427,ACH-000757,CVCL_1055,Lung,CTNNB1,Hom,Missense,p.T41A,GoF,Oncogene
|
849 |
+
847,A-427,ACH-000757,CVCL_1055,Lung,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
850 |
+
848,A-427,ACH-000757,CVCL_1055,Lung,POLE,Hom,Missense,p.R37L,,Suppressor
|
851 |
+
849,A-427,ACH-000757,CVCL_1055,Lung,SMARCA4,Het,Missense,p.A1307D,LoF,Suppressor
|
852 |
+
850,Panc 08.13,ACH-000417,CVCL_1638,Pancreas,ATM,Het,Missense,p.F1234S,LoF,Suppressor
|
853 |
+
851,Panc 08.13,ACH-000417,CVCL_1638,Pancreas,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
854 |
+
852,Panc 08.13,ACH-000417,CVCL_1638,Pancreas,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
855 |
+
853,Panc 08.13,ACH-000417,CVCL_1638,Pancreas,KRAS,Hom,Missense,p.G12D,GoF,Oncogene
|
856 |
+
854,Panc 08.13,ACH-000417,CVCL_1638,Pancreas,SMAD4,Hom,Frameshift,p.C123fs,LoF,Suppressor
|
857 |
+
855,CHP-212,ACH-000120,CVCL_1125,Peripheral Nervous System,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
858 |
+
856,H4,ACH-000389,CVCL_1239,CNS/Brain,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
859 |
+
857,H4,ACH-000389,CVCL_1239,CNS/Brain,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
860 |
+
858,H4,ACH-000389,CVCL_1239,CNS/Brain,PTEN,Hom,Deletion,DEL,LoF,Suppressor
|
861 |
+
859,H4,ACH-000389,CVCL_1239,CNS/Brain,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
862 |
+
860,A498,ACH-000555,CVCL_1056,Kidney,APC,Het,Missense,p.C1270R,LoF,Suppressor
|
863 |
+
861,A498,ACH-000555,CVCL_1056,Kidney,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
864 |
+
862,A498,ACH-000555,CVCL_1056,Kidney,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
865 |
+
863,A498,ACH-000555,CVCL_1056,Kidney,PIK3CB,Het,Missense,p.D1067V,GoF,Oncogene
|
866 |
+
864,A498,ACH-000555,CVCL_1056,Kidney,SMARCA4,Het,Missense,p.A923P,LoF,Suppressor
|
867 |
+
865,A498,ACH-000555,CVCL_1056,Kidney,VHL,Hom,Frameshift,p.G144fs,LoF,Suppressor
|
868 |
+
866,SW 1088,ACH-000437,CVCL_1715,CNS/Brain,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
869 |
+
867,SW 1088,ACH-000437,CVCL_1715,CNS/Brain,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
870 |
+
868,SW 1088,ACH-000437,CVCL_1715,CNS/Brain,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
871 |
+
869,SW 1088,ACH-000437,CVCL_1715,CNS/Brain,POLE,Het,Missense,p.V1270F,,Suppressor
|
872 |
+
870,SW 1088,ACH-000437,CVCL_1715,CNS/Brain,PTEN,Hom,Deletion,DEL,LoF,Suppressor
|
873 |
+
871,SW 1088,ACH-000437,CVCL_1715,CNS/Brain,TP53,Hom,Missense,p.R273C,LoF,Suppressor
|
874 |
+
872,BT-483,ACH-000818,CVCL_2319,Breast,APC,Het,Missense,p.T1160K,LoF,Suppressor
|
875 |
+
873,BT-483,ACH-000818,CVCL_2319,Breast,NF1,Het,Missense,p.R1204W,LoF,Suppressor
|
876 |
+
874,BT-483,ACH-000818,CVCL_2319,Breast,PIK3CA,Het,Missense,p.E542K,GoF,Oncogene
|
877 |
+
875,BT-483,ACH-000818,CVCL_2319,Breast,TP53,Het,Missense,p.M246I,LoF,Suppressor
|
878 |
+
876,BT-483,ACH-000818,CVCL_2319,Breast,WNK2,Het,Missense,p.L1162P,,Suppressor
|
879 |
+
877,SNU-423,ACH-000493,CVCL_0366,Liver,ARID1A,Hom,Stopgain,p.G623*,LoF,Suppressor
|
880 |
+
878,SNU-423,ACH-000493,CVCL_0366,Liver,RNF43,Het,Missense,p.I485V,,Suppressor
|
881 |
+
879,SNU-423,ACH-000493,CVCL_0366,Liver,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
882 |
+
880,SNU-423,ACH-000493,CVCL_0366,Liver,TP53,Hom,Splice_site,,LoF,Suppressor
|
883 |
+
881,SW 1271,ACH-000890,CVCL_1716,Lung,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
884 |
+
882,SW 1271,ACH-000890,CVCL_1716,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
885 |
+
883,SW 1271,ACH-000890,CVCL_1716,Lung,NRAS,Hom,Missense,p.Q61R,GoF,Oncogene
|
886 |
+
884,SW 1271,ACH-000890,CVCL_1716,Lung,PMS2,Het,Missense,p.H88Y,,Suppressor
|
887 |
+
885,SW 1271,ACH-000890,CVCL_1716,Lung,SMARCA4,Hom,Missense,p.N774K,LoF,Suppressor
|
888 |
+
886,SW 1271,ACH-000890,CVCL_1716,Lung,TP53,Hom,Missense,p.C277F,LoF,Suppressor
|
889 |
+
887,Hs 695T,ACH-000799,CVCL_0851,Skin,ATM,Hom,Stopgain,p.Q1825*,LoF,Suppressor
|
890 |
+
888,Hs 695T,ACH-000799,CVCL_0851,Skin,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
891 |
+
889,Hs 695T,ACH-000799,CVCL_0851,Skin,BRCA2,Het,Missense,p.K2950N,,Suppressor
|
892 |
+
890,Hs 695T,ACH-000799,CVCL_0851,Skin,NF1,Het,Stopgain,p.Q959*,LoF,Suppressor
|
893 |
+
891,Hs 695T,ACH-000799,CVCL_0851,Skin,POLE,Het,Missense,p.V1270F,,Suppressor
|
894 |
+
892,Hs 695T,ACH-000799,CVCL_0851,Skin,TERT,,Promoter,1-146C>T,GoF,Oncogene
|
895 |
+
893,C32,ACH-000580,CVCL_1097,Skin,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
896 |
+
894,C32,ACH-000580,CVCL_1097,Skin,CDKN2A,Hom,Stoploss,Ter157Serext*13,,Suppressor
|
897 |
+
895,C32,ACH-000580,CVCL_1097,Skin,PTEN,Hom,Deletion,DEL,LoF,Suppressor
|
898 |
+
896,C32,ACH-000580,CVCL_1097,Skin,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
899 |
+
897,KATO III,ACH-000793,CVCL_0371,Esophagus/Stomach,ATM,Het,Missense,p.S2581I,,Suppressor
|
900 |
+
898,KATO III,ACH-000793,CVCL_0371,Esophagus/Stomach,BRCA2,Het,Missense,p.G2044V,,Suppressor
|
901 |
+
899,KATO III,ACH-000793,CVCL_0371,Esophagus/Stomach,CTNNB1,,Gain,GAIN,GoF,Oncogene
|
902 |
+
900,KATO III,ACH-000793,CVCL_0371,Esophagus/Stomach,FGFR2,,Gain,GAIN,GoF,Oncogene
|
903 |
+
901,KATO III,ACH-000793,CVCL_0371,Esophagus/Stomach,KMT2D,Het,Missense,p.A3242P,,Suppressor
|
904 |
+
902,KATO III,ACH-000793,CVCL_0371,Esophagus/Stomach,KMT2D,Het,Stopgain,p.E1747*,LoF,Suppressor
|
905 |
+
903,KATO III,ACH-000793,CVCL_0371,Esophagus/Stomach,TP53,,Deletion,DEL,LoF,Suppressor
|
906 |
+
904,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,ARID1A,Het,Frameshift,p.D1633fs,LoF,Suppressor
|
907 |
+
905,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,ARID1A,Het,Missense,p.P121S,,Suppressor
|
908 |
+
906,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,ARID1A,Het,Frameshift,p.Q372fs,LoF,Suppressor
|
909 |
+
907,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,ATM,Het,Frameshift,p.L1154fs,LoF,Suppressor
|
910 |
+
908,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,BRCA2,Het,Missense,p.R1190W,,Suppressor
|
911 |
+
909,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,BRCA2,Het,Frameshift,p.S309fs,LoF,Suppressor
|
912 |
+
910,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,JAK1,Het,Frameshift,p.K860fs,,Oncogene
|
913 |
+
911,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,KMT2D,Het,Frameshift,p.A2119fs,LoF,Suppressor
|
914 |
+
912,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,KMT2D,Het,Missense,p.P2363del,,Suppressor
|
915 |
+
913,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,KMT2D,Het,Missense,p.R5030C,LoF,Suppressor
|
916 |
+
914,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,KRAS,Het,Missense,p.G12D,GoF,Oncogene
|
917 |
+
915,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,PRDM2,Het,Missense,p.S67F,LoF,Suppressor
|
918 |
+
916,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,SETD1B,Hom,Frameshift,p.H8fs,LoF,Suppressor
|
919 |
+
917,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,SMAD3,Het,Frameshift,p.V380fs,LoF,Suppressor
|
920 |
+
918,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,SMAD4,Het,Missense,p.R265H,LoF,Suppressor
|
921 |
+
919,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,TGFBR2,Het,Frameshift,p.S409fs,LoF,Suppressor
|
922 |
+
920,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,WNK2,Het,Missense,p.G1850C,,Suppressor
|
923 |
+
921,SNU-1,ACH-000932,CVCL_0099,Esophagus/Stomach,WNK2,Het,Missense,p.W547C,,Suppressor
|
924 |
+
922,AN3 CA,ACH-000940,CVCL_0028,Uterus,ARID1A,Het,Frameshift,p.D1633fs,LoF,Suppressor
|
925 |
+
923,AN3 CA,ACH-000940,CVCL_0028,Uterus,ARID1A,Het,Missense,p.LEMLRENT1836del,,Suppressor
|
926 |
+
924,AN3 CA,ACH-000940,CVCL_0028,Uterus,FBXW7,Het,Missense,p.R361W,LoF,Suppressor
|
927 |
+
925,AN3 CA,ACH-000940,CVCL_0028,Uterus,FGFR2,Het,Missense,p.K82R,GoF,Oncogene
|
928 |
+
926,AN3 CA,ACH-000940,CVCL_0028,Uterus,FGFR2,Hom,Missense,p.N321K,GoF,Oncogene
|
929 |
+
927,AN3 CA,ACH-000940,CVCL_0028,Uterus,HRAS,Het,Missense,p.F82L,,Oncogene
|
930 |
+
928,AN3 CA,ACH-000940,CVCL_0028,Uterus,KMT2D,Het,Frameshift,p.P2210fs,LoF,Suppressor
|
931 |
+
929,AN3 CA,ACH-000940,CVCL_0028,Uterus,MAPK3,Het,Missense,p.P373S,,Oncogene
|
932 |
+
930,AN3 CA,ACH-000940,CVCL_0028,Uterus,MET,Het,Missense,p.G344R,,Oncogene
|
933 |
+
931,AN3 CA,ACH-000940,CVCL_0028,Uterus,PIK3R1,Het,Missense,p.R557_561NA,,Suppressor
|
934 |
+
932,AN3 CA,ACH-000940,CVCL_0028,Uterus,POLE,Het,Missense,p.S30L,,Suppressor
|
935 |
+
933,AN3 CA,ACH-000940,CVCL_0028,Uterus,PTEN,Hom,Frameshift,p.R130fs,LoF,Suppressor
|
936 |
+
934,AN3 CA,ACH-000940,CVCL_0028,Uterus,SETD1B,Het,Frameshift,p.P749fs,LoF,Suppressor
|
937 |
+
935,AN3 CA,ACH-000940,CVCL_0028,Uterus,SMARCA4,Het,Missense,p.P1456L,,Suppressor
|
938 |
+
936,AN3 CA,ACH-000940,CVCL_0028,Uterus,TERT,Het,Missense,p.D848G,,Oncogene
|
939 |
+
937,AN3 CA,ACH-000940,CVCL_0028,Uterus,TP53,Het,Missense,p.G389W,,Suppressor
|
940 |
+
938,AN3 CA,ACH-000940,CVCL_0028,Uterus,TP53,Het,Missense,p.R213Q,LoF,Suppressor
|
941 |
+
939,AN3 CA,ACH-000940,CVCL_0028,Uterus,TP53,Het,Frameshift,p.S90fs,LoF,Suppressor
|
942 |
+
940,AN3 CA,ACH-000940,CVCL_0028,Uterus,WNK2,Het,Missense,p.P702S,,Suppressor
|
943 |
+
941,AN3 CA,ACH-000940,CVCL_0028,Uterus,ZFHX3,Het,Frameshift,p.R1893fs,LoF,Suppressor
|
944 |
+
942,NCI-H2347,ACH-000875,CVCL_1550,Lung,B2M,Hom,Stopgain,p.Q28*,LoF,Suppressor
|
945 |
+
943,NCI-H2347,ACH-000875,CVCL_1550,Lung,EP300,Het,Missense,p.V5L,,Suppressor
|
946 |
+
944,NCI-H2347,ACH-000875,CVCL_1550,Lung,KRAS,Het,Missense,p.L19F,GoF,Oncogene
|
947 |
+
945,NCI-H2347,ACH-000875,CVCL_1550,Lung,NF1,Het,Missense,p.H31L,LoF,Suppressor
|
948 |
+
946,NCI-H2347,ACH-000875,CVCL_1550,Lung,NRAS,Hom,Missense,p.Q61R,GoF,Oncogene
|
949 |
+
947,NCI-H2347,ACH-000875,CVCL_1550,Lung,TP53,Hom,Splice_site,p.T125T,LoF,Suppressor
|
950 |
+
948,NCI-H2347,ACH-000875,CVCL_1550,Lung,TP53,Hom,Synonymous_splicing,Thr125Thr,,Suppressor
|
951 |
+
949,EKVX,ACH-000706,CVCL_1195,Lung,SMARCA4,Hom,Stopgain,p.Q418*,LoF,Suppressor
|
952 |
+
950,EKVX,ACH-000706,CVCL_1195,Lung,STK11,Hom,Missense,p.S216F,LoF,Suppressor
|
953 |
+
951,EKVX,ACH-000706,CVCL_1195,Lung,TP53,Hom,Stopgain,p.E204*,LoF,Suppressor
|
954 |
+
952,EKVX,ACH-000706,CVCL_1195,Lung,VHL,Het,Missense,p.S111I,,Suppressor
|
955 |
+
953,NCI-H2087,ACH-000841,CVCL_1524,Lung,ATM,Het,Missense,p.E848Q,,Suppressor
|
956 |
+
954,NCI-H2087,ACH-000841,CVCL_1524,Lung,ATM,Het,Missense,p.L2965F,LoF,Suppressor
|
957 |
+
955,NCI-H2087,ACH-000841,CVCL_1524,Lung,BRAF,Het,Missense,p.L597V,GoF,Oncogene
|
958 |
+
956,NCI-H2087,ACH-000841,CVCL_1524,Lung,MYC,,Gain,GAIN,GoF,Oncogene
|
959 |
+
957,NCI-H2087,ACH-000841,CVCL_1524,Lung,MYC,Het,Missense,p.E54K,,Oncogene
|
960 |
+
958,NCI-H2087,ACH-000841,CVCL_1524,Lung,NRAS,Het,Missense,p.Q61K,GoF,Oncogene
|
961 |
+
959,NCI-H2087,ACH-000841,CVCL_1524,Lung,PRDM2,Hom,Missense,p.P619S,,Suppressor
|
962 |
+
960,NCI-H2087,ACH-000841,CVCL_1524,Lung,RB1,Het,Splice_site,,LoF,Suppressor
|
963 |
+
961,NCI-H2087,ACH-000841,CVCL_1524,Lung,TP53,Hom,Missense,p.V157F,LoF,Suppressor
|
964 |
+
962,A-172,ACH-000558,CVCL_0131,CNS/Brain,ABL1,,Fusion,ABL1-CBFB,,Oncogene
|
965 |
+
963,A-172,ACH-000558,CVCL_0131,CNS/Brain,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
966 |
+
964,A-172,ACH-000558,CVCL_0131,CNS/Brain,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
967 |
+
965,A-172,ACH-000558,CVCL_0131,CNS/Brain,PTEN,Hom,Deletion,DEL,LoF,Suppressor
|
968 |
+
966,A-172,ACH-000558,CVCL_0131,CNS/Brain,RB1,Het,Missense,p.V852L,,Suppressor
|
969 |
+
967,hTERT-HPNE,,CVCL_C466,Pancreas,TERT,,Transgene,,,Oncogene
|
970 |
+
968,NCI-H23,ACH-000900,CVCL_1547,Lung,ATM,Hom,Missense,p.Q1919P,LoF,Suppressor
|
971 |
+
969,NCI-H23,ACH-000900,CVCL_1547,Lung,KMT2D,Het,Missense,p.G3465V,,Suppressor
|
972 |
+
970,NCI-H23,ACH-000900,CVCL_1547,Lung,KMT2D,Het,Missense,p.S4328T,,Suppressor
|
973 |
+
971,NCI-H23,ACH-000900,CVCL_1547,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
974 |
+
972,NCI-H23,ACH-000900,CVCL_1547,Lung,MYC,,Gain,GAIN,GoF,Oncogene
|
975 |
+
973,NCI-H23,ACH-000900,CVCL_1547,Lung,PMS2,Het,Missense,p.E491K,,Suppressor
|
976 |
+
974,NCI-H23,ACH-000900,CVCL_1547,Lung,SMARCA4,Hom,Stopgain,p.1566_1567KE>N*,LoF,Suppressor
|
977 |
+
975,NCI-H23,ACH-000900,CVCL_1547,Lung,STK11,Hom,Stopgain,p.W332*,LoF,Suppressor
|
978 |
+
976,NCI-H23,ACH-000900,CVCL_1547,Lung,TP53,Hom,Missense,p.M246I,LoF,Suppressor
|
979 |
+
977,NCI-H1792,ACH-000496,CVCL_1495,Lung,CDKN2A,Het,Stopgain,p.W110*,LoF,Suppressor
|
980 |
+
978,NCI-H1792,ACH-000496,CVCL_1495,Lung,KRAS,Het,Missense,p.G12C,GoF,Oncogene
|
981 |
+
979,NCI-H1792,ACH-000496,CVCL_1495,Lung,MYC,,Gain,GAIN,GoF,Oncogene
|
982 |
+
980,NCI-H1792,ACH-000496,CVCL_1495,Lung,SOS1,,Gain,GAIN,GoF,Oncogene
|
983 |
+
981,NCI-H1792,ACH-000496,CVCL_1495,Lung,TP53,Hom,Splice_site,,LoF,Suppressor
|
984 |
+
982,NCI-H2122,ACH-000311,CVCL_1531,Lung,CDKN2A,,Deletion,DEL,LoF,Suppressor
|
985 |
+
983,NCI-H2122,ACH-000311,CVCL_1531,Lung,CDKN2B,Hom,Deletion,DEL,LoF,Suppressor
|
986 |
+
984,NCI-H2122,ACH-000311,CVCL_1531,Lung,KRAS,Hom,Missense,p.G12C,GoF,Oncogene
|
987 |
+
985,NCI-H2122,ACH-000311,CVCL_1531,Lung,MYC,,Gain,GAIN,GoF,Oncogene
|
988 |
+
986,NCI-H2122,ACH-000311,CVCL_1531,Lung,STK11,Hom,Frameshift,p.P281fs,LoF,Suppressor
|
989 |
+
987,NCI-H2122,ACH-000311,CVCL_1531,Lung,TP53,Het,Missense,p.C176F,LoF,Suppressor
|
990 |
+
988,NCI-H2122,ACH-000311,CVCL_1531,Lung,TP53,Het,Missense,p.Q16L,LoF,Suppressor
|
991 |
+
989,NCI-H2030,ACH-000521,CVCL_1517,Lung,KRAS,Hom,Missense,p.G12C,GoF,Oncogene
|
992 |
+
990,NCI-H2030,ACH-000521,CVCL_1517,Lung,POLE,Hom,Missense,p.S780L,,Suppressor
|
993 |
+
991,NCI-H2030,ACH-000521,CVCL_1517,Lung,STK11,Hom,Stopgain,p.E317*,LoF,Suppressor
|
994 |
+
992,NCI-H2030,ACH-000521,CVCL_1517,Lung,STK11,Hom,Missense,p.E357K,,Suppressor
|
995 |
+
993,NCI-H2030,ACH-000521,CVCL_1517,Lung,STK11,Hom,Missense,p.M392I,,Suppressor
|
996 |
+
994,NCI-H2030,ACH-000521,CVCL_1517,Lung,TP53,Hom,Missense,p.G262V,LoF,Suppressor
|
997 |
+
995,LOX-IMVI,ACH-000750,CVCL_1381,Skin,ARID1A,Het,Stopgain,p.Q1212*,LoF,Suppressor
|
998 |
+
996,LOX-IMVI,ACH-000750,CVCL_1381,Skin,BRAF,Het,Missense,p.V600E,GoF,Oncogene
|
999 |
+
997,LOX-IMVI,ACH-000750,CVCL_1381,Skin,CDKN2A,Hom,Deletion,DEL,LoF,Suppressor
|
1000 |
+
998,LOX-IMVI,ACH-000750,CVCL_1381,Skin,NF1,Het,Stopgain,p.Q1174*,LoF,Suppressor
|
1001 |
+
999,LOX-IMVI,ACH-000750,CVCL_1381,Skin,TERT,,Promoter,1-124C>T,GoF,Oncogene
|
data/coefficients_E-dist.csv
ADDED
@@ -0,0 +1,16 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
Feature,Coefficient,Odds_Ratio,HC_Std_Error,z_value,p_value,CI_Lower_95,CI_Upper_95,Significant,split_seed,X_features
|
2 |
+
const,-1.013787145504068,0.36284223790653564,0.06129156989068605,-16.540401025983908,1.8776818836532333e-61,-1.1339164150457322,-0.8936578759624036,True,432,E-dist
|
3 |
+
max_e_distance,0.0,1.0,0.10473557938849125,0.0,1.0,-0.20527796350137847,0.20527796350137847,False,432,E-dist
|
4 |
+
approval_rate,0.0,1.0,0.06408982281905011,0.0,1.0,-0.12561374450089152,0.12561374450089152,False,432,E-dist
|
5 |
+
const,-1.326265472950734,0.2654668053755506,0.06772575178953655,-19.58288299363904,2.1641802722081273e-85,-1.4590055072841246,-1.1935254386173433,True,43,E-dist
|
6 |
+
max_e_distance,-0.8354009450098836,0.4337005564942426,0.12152839666264699,-6.874121340783333,6.237310078399719e-12,-1.0735922255675694,-0.5972096644521978,True,43,E-dist
|
7 |
+
approval_rate,0.3771145994456478,1.4580713939706058,0.06930683471580742,5.441232469957771,5.2913210579186074e-08,0.24127569952019493,0.5129534993711007,True,43,E-dist
|
8 |
+
const,-0.9832310817188966,0.3741003950158178,0.062137267135908766,-15.823532753192055,2.1413285700413293e-56,-1.105017887403022,-0.8614442760347711,True,5235,E-dist
|
9 |
+
approval_rate,0.6644784661772544,1.9434766681642863,0.06662214842557289,9.973837258034065,1.984116982296628e-23,0.5339014546904497,0.795055477664059,True,5235,E-dist
|
10 |
+
max_e_distance,-0.15292946390843343,0.8581902530628214,0.1207765638141659,-1.2662180399811664,0.2054350305822502,-0.38964717916070213,0.08378825134383527,False,5235,E-dist
|
11 |
+
const,-1.0365340401381151,0.35468186715826494,0.06028665699941084,-17.193423747948817,2.9743724525559917e-66,-1.15469371660528,-0.9183743636709503,True,332,E-dist
|
12 |
+
max_e_distance,-0.6572514229865971,0.5182738943010444,0.11004670256356665,-5.972477209000849,2.336777993574761e-09,-0.8729389966285794,-0.44156384934461484,True,332,E-dist
|
13 |
+
approval_rate,0.5000354359046812,1.6487796956650873,0.06385409287628752,7.830906577491628,4.843644997178721e-15,0.3748837136016821,0.6251871582076804,True,332,E-dist
|
14 |
+
const,-0.8224181905632236,0.43936789354206485,0.05460795964675023,-15.060408700184178,2.949579536166945e-51,-0.9294478247400707,-0.7153885563863766,True,2132,E-dist
|
15 |
+
approval_rate,0.50284471962431,1.6534180978647148,0.05796473721901896,8.67501076946693,4.135113454016432e-18,0.38923592230170445,0.6164535169469155,True,2132,E-dist
|
16 |
+
max_e_distance,-0.19407296836060603,0.8235978054942833,0.0761129241436711,-2.549803079359729,0.01077837802669012,-0.34325155844023053,-0.04489437828098153,True,2132,E-dist
|
data/coefficients_LDVAE (vs ctrl).csv
ADDED
@@ -0,0 +1,261 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
Feature,Coefficient,Odds_Ratio,HC_Std_Error,z_value,p_value,CI_Lower_95,CI_Upper_95,Significant,split_seed,X_features
|
2 |
+
const,-1.0853817316199363,0.3377728227148319,0.03987545814309449,-27.219291819168713,3.839660890629482e-163,-1.163536193447436,-1.0072272697924367,True,432,LDVAE (vs ctrl)
|
3 |
+
approval_rate,0.5595908518222618,1.7499563623460475,0.04432346888026038,12.625159220592447,1.5343080269424117e-36,0.4727184491470695,0.646463254497454,True,432,LDVAE (vs ctrl)
|
4 |
+
ldvae_minusctrl_16,-0.47500487278816567,0.6218820261582596,103401.31670202976,-4.593799072762111e-06,0.9999963346786445,-202663.33169487107,202662.38168512547,False,432,LDVAE (vs ctrl)
|
5 |
+
ldvae_minusctrl_18,-0.4718230302172032,0.6238639082094792,162142.59815929466,-2.909926420160527e-06,0.9999976782146363,-317794.1245749982,317793.1809289378,False,432,LDVAE (vs ctrl)
|
6 |
+
ldvae_minusctrl_0,-0.37143420795688226,0.6897443840286038,66789.69551993374,-5.561250205819935e-06,0.999995562764322,-130905.76919167429,130905.02632325837,False,432,LDVAE (vs ctrl)
|
7 |
+
ldvae_minusctrl_21,-0.3537984253461665,0.7020164618193427,44038.27303968195,-8.033885094162667e-06,0.9999935898871202,-86313.78289754323,86313.07530069254,False,432,LDVAE (vs ctrl)
|
8 |
+
ldvae_minusctrl_42,0.33335768273043026,1.3956464078209492,70953.81654603581,4.698234696285058e-06,0.9999962513510728,-139066.59163820962,139067.2583535751,False,432,LDVAE (vs ctrl)
|
9 |
+
ldvae_minusctrl_19,0.31844366634227306,1.3749861610022838,64868.51729929104,4.909063434778914e-06,0.9999960831340774,-127139.63919345755,127140.27608079024,False,432,LDVAE (vs ctrl)
|
10 |
+
ldvae_minusctrl_29,0.282500002526782,1.3264417784483784,47674.69168799519,5.92557586686853e-06,0.999995272074502,-93440.3961825191,93440.96118252417,False,432,LDVAE (vs ctrl)
|
11 |
+
ldvae_minusctrl_9,-0.2648243979209657,0.7673406847652273,94905.54572464104,-2.790399611518248e-06,0.9999977735832315,-186011.71637781366,186011.18672901782,False,432,LDVAE (vs ctrl)
|
12 |
+
ldvae_minusctrl_32,-0.2617223589175221,0.7697247012426351,57009.22094869189,-4.590877660880007e-06,0.9999963370095939,-111736.28156848138,111735.75812376355,False,432,LDVAE (vs ctrl)
|
13 |
+
ldvae_minusctrl_41,0.25762976426604645,1.2938596968412153,126898.60452783915,2.0302017128133773e-06,0.999998380133398,-248716.4369331919,248716.95219272043,False,432,LDVAE (vs ctrl)
|
14 |
+
ldvae_minusctrl_34,0.23304815905335471,1.262442275888219,96796.74216189783,2.4076033330085527e-06,0.9999980790104721,-189717.89540997046,189718.36150628855,False,432,LDVAE (vs ctrl)
|
15 |
+
ldvae_minusctrl_44,0.2328740607438014,1.2622225059534202,87604.20161486293,2.6582521894051707e-06,0.9999978790216194,-171700.84718545625,171701.31293357775,False,432,LDVAE (vs ctrl)
|
16 |
+
ldvae_minusctrl_8,0.2299451847063066,1.2585310212911245,86713.34366574013,2.651785469058742e-06,0.9999978841813156,-169954.8006187104,169955.2605090798,False,432,LDVAE (vs ctrl)
|
17 |
+
ldvae_minusctrl_46,0.20510392720179482,1.2276526448377072,152104.59430657278,1.3484400529572422e-06,0.9999989241005006,-298119.3216200316,298119.73182788596,False,432,LDVAE (vs ctrl)
|
18 |
+
ldvae_minusctrl_48,0.1855883404200791,1.203926550454745,91364.75561161299,2.0312902845053935e-06,0.9999983792648435,-179071.44486672484,179071.81604340568,False,432,LDVAE (vs ctrl)
|
19 |
+
ldvae_minusctrl_40,0.16606353149523667,1.1806481076802597,415691.81796195114,3.994871304164969e-07,0.9999996812553864,-814740.8258098731,814741.1579369361,False,432,LDVAE (vs ctrl)
|
20 |
+
ldvae_minusctrl_31,-0.16212287233669403,0.8503367152617626,188225.78600916825,-8.613212661988684e-07,0.9999993127650598,-368915.92366258526,368915.59941684065,False,432,LDVAE (vs ctrl)
|
21 |
+
ldvae_minusctrl_25,0.15521423147074886,1.1679081369842808,115717.55301454687,1.3413196825138263e-06,0.9999989297817342,-226802.08107338476,226802.39150184768,False,432,LDVAE (vs ctrl)
|
22 |
+
ldvae_minusctrl_14,-0.1452443810290176,0.8648109239009921,85025.1295226412,-1.7082523936684003e-06,0.9999986370117891,-166646.3368896111,166646.046400849,False,432,LDVAE (vs ctrl)
|
23 |
+
ldvae_minusctrl_30,-0.14272508626882938,0.8669923842471566,40474.864564976306,-3.5262647028677692e-06,0.9999971864478363,-79329.41955157627,79329.13410140375,False,432,LDVAE (vs ctrl)
|
24 |
+
ldvae_minusctrl_1,0.11765881986620416,1.124860265914818,47558.83848281628,2.473963276220803e-06,0.9999980260628979,-93213.49291405758,93213.72823169733,False,432,LDVAE (vs ctrl)
|
25 |
+
ldvae_minusctrl_12,0.10873910860540721,1.114871452028753,72294.35171094009,1.5041162418910252e-06,0.999998799888873,-141694.2169000056,141694.4343782228,False,432,LDVAE (vs ctrl)
|
26 |
+
ldvae_minusctrl_49,0.10413872774633172,1.1097543979638609,53161.60418401782,1.958908677508256e-06,0.9999984370170102,-104194.72542232103,104194.93369977653,False,432,LDVAE (vs ctrl)
|
27 |
+
ldvae_minusctrl_37,-0.09626734765803882,0.908221172804833,384697.2548953837,-2.50241836750871e-07,0.999999800335902,-753992.8608137248,753992.6682790294,False,432,LDVAE (vs ctrl)
|
28 |
+
ldvae_minusctrl_36,0.09402820465585326,1.0985907308536993,94717.4331418427,9.927233196347572e-07,0.9999992079213901,-185642.66363788754,185642.85169429684,False,432,LDVAE (vs ctrl)
|
29 |
+
ldvae_minusctrl_23,0.09157191822668237,1.0958955887258666,61343.95465425236,1.4927618987527177e-06,0.999998808948328,-120231.85021967463,120232.03336351107,False,432,LDVAE (vs ctrl)
|
30 |
+
ldvae_minusctrl_43,-0.09113124983092213,0.9128978853427954,123712.94891913988,-7.366346904436536e-07,0.9999994122505536,-242473.0154340074,242472.83317150775,False,432,LDVAE (vs ctrl)
|
31 |
+
ldvae_minusctrl_5,-0.08887860512080359,0.9149566378835222,99011.39938917365,-8.976603266807476e-07,0.9999992837706845,-194058.86574029655,194058.68798308633,False,432,LDVAE (vs ctrl)
|
32 |
+
ldvae_minusctrl_10,-0.08357390873253406,0.9198231011993422,113898.75204095754,-7.337561407387609e-07,0.9999994145473039,-223237.53545824348,223237.36831042604,False,432,LDVAE (vs ctrl)
|
33 |
+
ldvae_minusctrl_6,-0.08171948830867944,0.9215304225010135,39742.70464737769,-2.056213562558115e-06,0.9999983593789448,-77894.35147656122,77894.1880375846,False,432,LDVAE (vs ctrl)
|
34 |
+
ldvae_minusctrl_45,-0.08100826816973054,0.9221860666221645,154753.0697690249,-5.234679240330328e-07,0.9999995823330253,-303310.5242525712,303310.3622360349,False,432,LDVAE (vs ctrl)
|
35 |
+
ldvae_minusctrl_3,0.07897988910748095,1.082182558194356,94830.23218260359,8.328555914046328e-07,0.9999993354773823,-185863.7607435851,185863.9187033633,False,432,LDVAE (vs ctrl)
|
36 |
+
ldvae_minusctrl_15,-0.07472589885768408,0.9279978167324665,40621.71274322552,-1.839555592597363e-06,0.999998532246994,-79617.16869295263,79617.01924115492,False,432,LDVAE (vs ctrl)
|
37 |
+
ldvae_minusctrl_27,-0.0710510089162436,0.9314143804777216,53356.82549436776,-1.3316198678975683e-06,0.9999989375210665,-104577.5273493583,104577.38524734047,False,432,LDVAE (vs ctrl)
|
38 |
+
ldvae_minusctrl_17,0.06510721361729276,1.067273444497011,154218.1494872183,4.2217607871561764e-07,0.9999996631522249,-302261.9536501484,302262.08386457566,False,432,LDVAE (vs ctrl)
|
39 |
+
ldvae_minusctrl_26,0.051899060784138716,1.0532694209580056,31868.209265300997,1.6285527797336223e-06,0.9999987006028807,-62460.49051271483,62460.59431083639,False,432,LDVAE (vs ctrl)
|
40 |
+
ldvae_minusctrl_33,-0.051456764857259314,0.9498447157463173,88948.61174922319,-5.784999208569289e-07,0.9999995384238447,-174336.1269600786,174336.02404654888,False,432,LDVAE (vs ctrl)
|
41 |
+
ldvae_minusctrl_28,0.03816802892561071,1.0389057844360012,48983.988738400374,7.791939755957312e-07,0.999999378293157,-96006.81557835141,96006.89191440927,False,432,LDVAE (vs ctrl)
|
42 |
+
ldvae_minusctrl_13,-0.03506147009280394,0.9655460622272847,45021.927730137315,-7.787643013192009e-07,0.9999993786359874,-88241.39192710437,88241.3218041642,False,432,LDVAE (vs ctrl)
|
43 |
+
ldvae_minusctrl_22,0.030147932966437804,1.0306069834253773,83954.35260838945,3.5909910599948047e-07,0.9999997134803675,-164547.47730988672,164547.53760575264,False,432,LDVAE (vs ctrl)
|
44 |
+
ldvae_minusctrl_2,-0.02944106753318388,0.9709880986789935,95246.6792340996,-3.091033490083461e-07,0.9999997533712102,-186680.09038694183,186680.03150480674,False,432,LDVAE (vs ctrl)
|
45 |
+
ldvae_minusctrl_47,0.02023845212875468,1.0204446382143761,51917.23649307502,3.898214445881415e-07,0.9999996889674879,-101755.89346482349,101755.93394172774,False,432,LDVAE (vs ctrl)
|
46 |
+
ldvae_minusctrl_24,-0.018763378444535458,0.981411557899855,51836.64919462023,-3.6197128356210917e-07,0.9999997111887013,-101597.9842640713,101597.9467373144,False,432,LDVAE (vs ctrl)
|
47 |
+
ldvae_minusctrl_35,-0.01856258851235412,0.9816086352449189,66466.23031308678,-2.792784911212162e-07,0.9999997771680038,-130271.43616438299,130271.39903920598,False,432,LDVAE (vs ctrl)
|
48 |
+
ldvae_minusctrl_11,0.017207087981347142,1.0173559827086416,149506.39254614455,1.1509265716538671e-07,0.9999999081693458,-293027.1276418629,293027.1620560389,False,432,LDVAE (vs ctrl)
|
49 |
+
ldvae_minusctrl_39,0.011260280739890263,1.011323916328295,50955.16360986852,2.2098409547073807e-07,0.999999823680202,-99870.27424140753,99870.296761969,False,432,LDVAE (vs ctrl)
|
50 |
+
ldvae_minusctrl_20,-0.008461636563789504,0.9915740623215877,85519.66865031149,-9.894374823163776e-08,0.9999999210543109,-167615.47898604622,167615.46206277312,False,432,LDVAE (vs ctrl)
|
51 |
+
ldvae_minusctrl_4,-0.003548932054279624,0.9964573579619365,113589.50182749605,-3.124348638899085e-08,0.9999999750713046,-222631.33615267096,222631.32905480685,False,432,LDVAE (vs ctrl)
|
52 |
+
ldvae_minusctrl_38,0.0035180065477389316,1.0035242019958526,74247.5687631089,4.738211104209126e-08,0.9999999621945451,-145522.557197348,145522.56423336113,False,432,LDVAE (vs ctrl)
|
53 |
+
ldvae_minusctrl_7,0.002385450889773501,1.0023882983414492,55564.06419409379,4.293154081459476e-08,0.9999999657455864,-108903.56226964452,108903.5670405463,False,432,LDVAE (vs ctrl)
|
54 |
+
const,-1.0227919943801935,0.35958956528020847,0.041129180852288214,-24.867793940595604,1.660318475050613e-136,-1.1034037075643128,-0.9421802811960742,True,43,LDVAE (vs ctrl)
|
55 |
+
approval_rate,0.5086710610451822,1.663079594472307,0.043543476584423674,11.681911986493597,1.5770766152933813e-31,0.42332741517804867,0.5940147069123158,True,43,LDVAE (vs ctrl)
|
56 |
+
ldvae_minusctrl_44,0.4174075291134292,1.5180210246581032,83228.15042513043,5.015220535135124e-06,0.999995998432966,-163123.75992560852,163124.59474066674,False,43,LDVAE (vs ctrl)
|
57 |
+
ldvae_minusctrl_34,0.4138136557755951,1.5125752409611724,95538.96138582556,4.331360209207693e-06,0.9999965440745618,-187252.50962292525,187253.33725023683,False,43,LDVAE (vs ctrl)
|
58 |
+
ldvae_minusctrl_18,-0.3847772492810236,0.6806022239555436,154497.17980349725,-2.490513093963374e-06,0.9999980128580539,-302809.2929051129,302808.5233506143,False,43,LDVAE (vs ctrl)
|
59 |
+
ldvae_minusctrl_16,-0.35353644666216405,0.7022003992609507,95049.31219625483,-3.719505575507933e-06,0.9999970322639274,-186293.58219640984,186292.8751235165,False,43,LDVAE (vs ctrl)
|
60 |
+
ldvae_minusctrl_32,-0.2922927240225092,0.7465499708748118,54043.17618863045,-5.408503804482192e-06,0.9999956846383173,-105922.97123259235,105922.38664714429,False,43,LDVAE (vs ctrl)
|
61 |
+
ldvae_minusctrl_46,0.2451780098073293,1.2778487625721984,146540.66338320955,1.673105635984322e-06,0.9999986650548445,-287214.1773236884,287214.667679708,False,43,LDVAE (vs ctrl)
|
62 |
+
ldvae_minusctrl_15,-0.2441156793404622,0.7833970061720706,39220.12284578711,-6.224245658289268e-06,0.9999950337704866,-76870.27236265865,76869.78413129998,False,43,LDVAE (vs ctrl)
|
63 |
+
ldvae_minusctrl_38,-0.2270471036967091,0.7968832452593828,70812.07150147349,-3.2063333112912056e-06,0.9999974417161541,-138789.33686066687,138788.8827664595,False,43,LDVAE (vs ctrl)
|
64 |
+
ldvae_minusctrl_28,0.21985202313681554,1.2458923537035942,46900.90430734452,4.687586015316713e-06,0.999996259847491,-91923.86343273162,91924.30313677789,False,43,LDVAE (vs ctrl)
|
65 |
+
ldvae_minusctrl_27,0.20254828592155,1.2245192107329819,51455.9149987996,3.936346014375125e-06,0.9999968592502891,-100851.53764091567,100851.94273748751,False,43,LDVAE (vs ctrl)
|
66 |
+
ldvae_minusctrl_30,-0.1883730920431708,0.8283056153420058,37958.79764238209,-4.962567408427258e-06,0.9999960404440829,-74398.06464860485,74397.68790242077,False,43,LDVAE (vs ctrl)
|
67 |
+
ldvae_minusctrl_9,-0.1697625822577283,0.843865141371761,90752.57737159624,-1.8706089366764434e-06,0.9999985074700102,-177871.95291509558,177871.61338993107,False,43,LDVAE (vs ctrl)
|
68 |
+
ldvae_minusctrl_29,-0.14923800801457632,0.8613640789455689,44491.989585857955,-3.3542669007099767e-06,0.9999973236822272,-87202.84642682076,87202.54795080473,False,43,LDVAE (vs ctrl)
|
69 |
+
ldvae_minusctrl_11,0.13388000682180975,1.1432556285374609,138793.27657867767,9.646000881456045e-07,0.9999992303604823,-272029.68951050803,272029.9572705217,False,43,LDVAE (vs ctrl)
|
70 |
+
ldvae_minusctrl_13,0.133562144389016,1.1428922882712385,41808.135812400425,3.194644817179365e-06,0.9999974510422232,-81942.30689091967,81942.57401520845,False,43,LDVAE (vs ctrl)
|
71 |
+
ldvae_minusctrl_37,0.12782988943163337,1.1363596794634214,369014.15661608614,3.464091746610812e-07,0.9999997236054678,-723254.3289230623,723254.5845828411,False,43,LDVAE (vs ctrl)
|
72 |
+
ldvae_minusctrl_12,-0.1260483733387936,0.881572201161211,67021.53718727463,-1.8807144483508859e-06,0.9999984994069784,-131359.92512394354,131359.67302719684,False,43,LDVAE (vs ctrl)
|
73 |
+
ldvae_minusctrl_41,-0.12577629706111415,0.8818120886765799,120994.6414005995,-1.039519565537478e-06,0.999999170583388,-237145.26524381104,237145.0136912169,False,43,LDVAE (vs ctrl)
|
74 |
+
ldvae_minusctrl_4,-0.11631203342472608,0.8901974086099017,105355.35460663983,-1.1039973607321116e-06,0.9999991191375507,-206492.81691949358,206492.5842954267,False,43,LDVAE (vs ctrl)
|
75 |
+
ldvae_minusctrl_36,0.11349263279033954,1.1201836362342745,93749.01813511096,1.2106007619917053e-06,0.9999990340803427,-183744.5856381771,183744.81262344265,False,43,LDVAE (vs ctrl)
|
76 |
+
ldvae_minusctrl_48,-0.10621425202182701,0.8992319651686811,82267.62196238787,-1.2910820744324827e-06,0.999998969865546,-161241.6823542886,161241.4699257846,False,43,LDVAE (vs ctrl)
|
77 |
+
ldvae_minusctrl_35,-0.105601148561831,0.8997834564411934,62797.892654561045,-1.68160338027141e-06,0.9999986582746255,-123081.71350910062,123081.5023068035,False,43,LDVAE (vs ctrl)
|
78 |
+
ldvae_minusctrl_49,-0.09567770600483448,0.9087568557536102,50252.87090032894,-1.9039251746353102e-06,0.9999984808874982,-98493.91276209166,98493.72140667964,False,43,LDVAE (vs ctrl)
|
79 |
+
ldvae_minusctrl_33,0.0795584569082235,1.0828088553372623,82042.68169703394,9.6972033656842e-07,0.9999992262751152,-160800.6217628131,160800.7808797269,False,43,LDVAE (vs ctrl)
|
80 |
+
ldvae_minusctrl_23,-0.07914101254047626,0.9239096324144603,58920.56801473285,-1.3431814255539316e-06,0.9999989282962782,-115482.2703985316,115482.11211650653,False,43,LDVAE (vs ctrl)
|
81 |
+
ldvae_minusctrl_39,0.07758553983865192,1.0806746692418319,47773.412897620234,1.6240317601951511e-06,0.9999987042101323,-93634.09111235713,93634.2462834368,False,43,LDVAE (vs ctrl)
|
82 |
+
ldvae_minusctrl_31,0.07192245594018781,1.0745720141564474,181044.0215529027,3.972650150127792e-07,0.9999996830283779,-354839.6899375267,354839.83378243854,False,43,LDVAE (vs ctrl)
|
83 |
+
ldvae_minusctrl_42,-0.07169418766183117,0.9308155071568045,67640.11898000826,-1.0599358597080695e-06,0.9999991542935421,-132572.268805008,132572.12541663265,False,43,LDVAE (vs ctrl)
|
84 |
+
ldvae_minusctrl_21,0.07054427282503827,1.0730920771968373,42048.97204154543,1.6776693792975193e-06,0.9999986614135041,-82414.40024408788,82414.54133263353,False,43,LDVAE (vs ctrl)
|
85 |
+
ldvae_minusctrl_5,0.06958030610500962,1.0720581505623896,94419.67873483957,7.369258933872589e-07,0.9999994120182072,-185059.1001718219,185059.23933243408,False,43,LDVAE (vs ctrl)
|
86 |
+
ldvae_minusctrl_26,0.06418350384028437,1.06628804876149,30787.10496320912,2.0847528183304103e-06,0.9999983366079132,-60341.55273264038,60341.68109964806,False,43,LDVAE (vs ctrl)
|
87 |
+
ldvae_minusctrl_24,0.06417789401830112,1.0662820670921318,46849.991221364544,1.369859253869715e-06,0.9999989070104509,-91824.23129199819,91824.35964778623,False,43,LDVAE (vs ctrl)
|
88 |
+
ldvae_minusctrl_7,0.06311248648159101,1.0651466470915065,53032.713225313084,1.1900670858278235e-06,0.9999990504638459,-103942.14481156817,103942.27103654115,False,43,LDVAE (vs ctrl)
|
89 |
+
ldvae_minusctrl_19,0.056491839430679744,1.0581179799198692,64042.46308572668,8.820997305344153e-07,0.999999296186244,-125520.86463742076,125520.97762109964,False,43,LDVAE (vs ctrl)
|
90 |
+
ldvae_minusctrl_40,-0.05646241472849348,0.9451020057430919,383997.834207364,-1.4703836766434213e-07,0.9999998826803566,-752621.9816502309,752621.8687254016,False,43,LDVAE (vs ctrl)
|
91 |
+
ldvae_minusctrl_25,-0.05578261069726651,0.9457447083276695,107676.13904920708,-5.180591651022547e-07,0.9999995866485906,-211041.4103133835,211041.2987481621,False,43,LDVAE (vs ctrl)
|
92 |
+
ldvae_minusctrl_43,-0.05264146436809328,0.9487201014727287,117526.88167205482,-4.47909989775643e-07,0.9999996426195346,-230348.5079339924,230348.40265106366,False,43,LDVAE (vs ctrl)
|
93 |
+
ldvae_minusctrl_45,-0.04778452599719804,0.9533391847579477,149798.91396949478,-3.1899113772566426e-07,0.9999997454818962,-293600.5240879498,293600.42851889774,False,43,LDVAE (vs ctrl)
|
94 |
+
ldvae_minusctrl_14,0.04735393540973616,1.0484930422294043,80689.2467506595,5.868679820009488e-07,0.9999995317470979,-158147.9702170228,158148.0649248936,False,43,LDVAE (vs ctrl)
|
95 |
+
ldvae_minusctrl_1,-0.04423292420294247,0.9567310856923732,45883.42618260172,-9.640283623744493e-07,0.9999992308166535,-89929.9070381257,89929.81857227729,False,43,LDVAE (vs ctrl)
|
96 |
+
ldvae_minusctrl_0,0.04244133650636493,1.04335484773787,62512.53417052022,6.789252278686135e-07,0.9999994582960428,-122522.27311521259,122522.35799788561,False,43,LDVAE (vs ctrl)
|
97 |
+
ldvae_minusctrl_22,0.04048214661616207,1.0413127185809006,80334.19779143795,5.039217136550117e-07,0.9999995979286448,-157452.09391598892,157452.17488028214,False,43,LDVAE (vs ctrl)
|
98 |
+
ldvae_minusctrl_10,0.029340025188721107,1.029774684283445,108424.9606580781,2.7060212898066806e-07,0.9999997840907392,-212508.98857498018,212509.04725503054,False,43,LDVAE (vs ctrl)
|
99 |
+
ldvae_minusctrl_20,0.020140411557773824,1.0203445981434642,81146.85052613274,2.481970825384992e-07,0.9999998019673798,-159044.88434966374,159044.92463048687,False,43,LDVAE (vs ctrl)
|
100 |
+
ldvae_minusctrl_8,0.018452656813324492,1.0186239591237478,81298.84106090323,2.2697318402732325e-07,0.9999998189016007,-159342.78201155964,159342.81891687325,False,43,LDVAE (vs ctrl)
|
101 |
+
ldvae_minusctrl_47,0.015609486464259473,1.0157319508705345,49462.174510431774,3.155843150601349e-07,0.9999997482001474,-96944.06502799489,96944.09624696782,False,43,LDVAE (vs ctrl)
|
102 |
+
ldvae_minusctrl_2,0.012623724157696713,1.0127037397070797,92135.7417449976,1.3701223779839057e-07,0.9999998906800508,-180582.72288535474,180582.74813280304,False,43,LDVAE (vs ctrl)
|
103 |
+
ldvae_minusctrl_17,-0.010284470910040448,0.9897682334274249,146782.64428006753,-7.006598743661574e-08,0.9999999440954304,-287688.7066289575,287688.68606001564,False,43,LDVAE (vs ctrl)
|
104 |
+
ldvae_minusctrl_3,-0.006300381422460513,0.9937194243640746,88347.78828841359,-7.131340291046968e-08,0.9999999431001368,-173158.48945944163,173158.4768586788,False,43,LDVAE (vs ctrl)
|
105 |
+
ldvae_minusctrl_6,0.0022972619212538914,1.0022999026491821,37320.40176723601,6.155512300166829e-08,0.9999999508861177,-73146.64105508565,73146.64564960949,False,43,LDVAE (vs ctrl)
|
106 |
+
const,-1.071602534141101,0.34245927476644894,0.04224893815716062,-25.364011046973,6.295807687489017e-142,-1.1544089313141959,-0.9887961369680063,True,5235,LDVAE (vs ctrl)
|
107 |
+
ldvae_minusctrl_38,-0.45023378199685493,0.63747910306235,67267.0052584108,-6.69323363314973e-06,0.9999946595722223,-131841.3578881336,131840.4574205696,False,5235,LDVAE (vs ctrl)
|
108 |
+
ldvae_minusctrl_40,-0.4393345908788003,0.644465111403522,342784.4940329924,-1.2816641316235123e-06,0.9999989773799772,-671845.7020980411,671844.8234288592,False,5235,LDVAE (vs ctrl)
|
109 |
+
ldvae_minusctrl_16,-0.42263062791601197,0.6553206455652654,89917.67729607369,-4.700195118746316e-06,0.999996249786882,-176235.83170442723,176234.98644317142,False,5235,LDVAE (vs ctrl)
|
110 |
+
ldvae_minusctrl_19,0.37917462956759307,1.4610781609140444,57933.02547399854,6.5450514014286025e-06,0.9999947778045372,-113546.26426984907,113547.02261910819,False,5235,LDVAE (vs ctrl)
|
111 |
+
ldvae_minusctrl_46,0.3211438809476524,1.3787039358524846,133520.57108559477,2.4052015231554077e-06,0.9999980809268391,-261695.1893791049,261695.8316668668,False,5235,LDVAE (vs ctrl)
|
112 |
+
ldvae_minusctrl_45,0.303336959405673,1.354370755527028,138686.89023270068,2.1872071606530973e-06,0.9999982548611752,-271821.00664699374,271821.6133209125,False,5235,LDVAE (vs ctrl)
|
113 |
+
ldvae_minusctrl_18,-0.3021934955021827,0.7391950201390874,139560.88881999953,-2.1653165013296863e-06,0.9999982723273944,-273534.61793109326,273534.01354410226,False,5235,LDVAE (vs ctrl)
|
114 |
+
ldvae_minusctrl_11,0.297062831321336,1.3458998614581796,130152.46168501404,2.2824219186899965e-06,0.9999981788907898,-255093.8403390255,255094.43446468815,False,5235,LDVAE (vs ctrl)
|
115 |
+
ldvae_minusctrl_28,0.2947957290903764,1.3428520250633917,42970.843900941174,6.86036629324656e-06,0.9999945262196532,-84221.01163540826,84221.60122686643,False,5235,LDVAE (vs ctrl)
|
116 |
+
approval_rate,0.2851892558310349,1.330013717155242,0.042255891131592054,6.74910049684923,1.487645262082665e-11,0.202369231078469,0.3680092805836008,True,5235,LDVAE (vs ctrl)
|
117 |
+
ldvae_minusctrl_27,0.2641790115132205,1.3023613131043943,48510.13034244632,5.4458524363531565e-06,0.9999956548384207,-95077.84417752695,95078.37253554998,False,5235,LDVAE (vs ctrl)
|
118 |
+
ldvae_minusctrl_8,0.23740012673654812,1.2679483563265916,76763.19572765882,3.0926295405782544e-06,0.9999975324386373,-150452.86156428352,150453.33636453698,False,5235,LDVAE (vs ctrl)
|
119 |
+
ldvae_minusctrl_14,0.23352313871478428,1.2630420527226174,76606.76448608459,3.048335747911702e-06,0.9999975677799706,-150146.26584172915,150146.73288800658,False,5235,LDVAE (vs ctrl)
|
120 |
+
ldvae_minusctrl_30,-0.21700145631559692,0.8049287970737863,34456.22069877839,-6.297889086927357e-06,0.9999949750115319,-67533.16861442549,67532.73461151286,False,5235,LDVAE (vs ctrl)
|
121 |
+
ldvae_minusctrl_41,0.2164236289899965,1.241628257328758,110502.31364282587,1.9585438698554107e-06,0.9999984373080846,-216580.3385246588,216580.77137191678,False,5235,LDVAE (vs ctrl)
|
122 |
+
ldvae_minusctrl_31,-0.2133435912513415,0.8078785095359752,170342.43238960905,-1.2524395023512387e-06,0.9999990006978577,-333865.24586617417,333864.81917899166,False,5235,LDVAE (vs ctrl)
|
123 |
+
ldvae_minusctrl_9,-0.19652918640044587,0.8215773520597272,79315.71335983388,-2.4778089747342526e-06,0.9999980229944745,-155456.1381225632,155455.7450641904,False,5235,LDVAE (vs ctrl)
|
124 |
+
ldvae_minusctrl_23,0.19562680164301863,1.2160729841986013,54303.37805683617,3.602479415521213e-06,0.9999971256372937,-106432.46960345992,106432.86085706319,False,5235,LDVAE (vs ctrl)
|
125 |
+
ldvae_minusctrl_7,-0.19512408224759234,0.8227325652163354,49687.625825053416,-3.927015610176471e-06,0.9999968666948746,-97386.15221848924,97385.76197032473,False,5235,LDVAE (vs ctrl)
|
126 |
+
ldvae_minusctrl_37,0.16770218519492297,1.1825843670659726,345917.64026397874,4.848037962647556e-07,0.9999996131825359,-677985.9488322956,677986.284236666,False,5235,LDVAE (vs ctrl)
|
127 |
+
ldvae_minusctrl_22,0.15182374242263572,1.1639550624514405,71977.41509661953,2.1093247405291472e-06,0.9999983170023559,-141072.98946592142,141073.29311340628,False,5235,LDVAE (vs ctrl)
|
128 |
+
ldvae_minusctrl_0,-0.1513871320205797,0.8595148885071227,59395.32771207174,-2.548805400223614e-06,0.9999979663475227,-116412.85455274644,116412.5517784824,False,5235,LDVAE (vs ctrl)
|
129 |
+
ldvae_minusctrl_21,-0.1493022435995189,0.8613087504971559,38887.6574717206,-3.839322121886427e-06,0.999996936664155,-76218.55738994593,76218.25878545872,False,5235,LDVAE (vs ctrl)
|
130 |
+
ldvae_minusctrl_43,0.1445572602533667,1.1555278588874254,109483.59712210779,1.320355414447527e-06,0.9999989465088001,-214583.7626999641,214584.05181448464,False,5235,LDVAE (vs ctrl)
|
131 |
+
ldvae_minusctrl_26,0.14056617847808003,1.150925243525613,27882.618038004537,5.041355093932918e-06,0.999995977580605,-54648.78658299727,54649.067715354235,False,5235,LDVAE (vs ctrl)
|
132 |
+
ldvae_minusctrl_15,-0.1346268160775464,0.874042029266202,34518.76083723653,-3.900105705194376e-06,0.9999968881658723,-67655.66265875135,67655.3934051192,False,5235,LDVAE (vs ctrl)
|
133 |
+
ldvae_minusctrl_48,0.12885201865810048,1.137521779710718,80564.6521224832,1.599361696022786e-06,0.9999987238939956,-157903.68773504684,157903.94543908414,False,5235,LDVAE (vs ctrl)
|
134 |
+
ldvae_minusctrl_33,-0.1287681428171988,0.879177785600649,77728.08834559245,-1.656648781128818e-06,0.9999986781855149,-152344.38251265153,152344.1249763659,False,5235,LDVAE (vs ctrl)
|
135 |
+
ldvae_minusctrl_35,-0.12529874532640814,0.8822333001363388,57968.30459762523,-2.1615043978971436e-06,0.9999982753690128,-113615.91455493841,113615.66395744774,False,5235,LDVAE (vs ctrl)
|
136 |
+
ldvae_minusctrl_12,0.12396985174950215,1.1319817432155779,61669.599124727625,2.0102263272179117e-06,0.9999983960714498,-120870.06925563724,120870.31719534073,False,5235,LDVAE (vs ctrl)
|
137 |
+
ldvae_minusctrl_25,0.12386133418018805,1.131858909973199,98686.37533733224,1.2551006535279277e-06,0.9999989985745663,-193421.61756463884,193421.86528730718,False,5235,LDVAE (vs ctrl)
|
138 |
+
ldvae_minusctrl_47,0.1154849064092957,1.1224175731089783,45204.42813809643,2.5547255250414237e-06,0.9999979616239465,-88598.93560749161,88599.16657730442,False,5235,LDVAE (vs ctrl)
|
139 |
+
ldvae_minusctrl_44,0.11327847130248292,1.1199437617269237,78307.39069523446,1.4465872288268787e-06,0.9999988457903842,-153479.55220749517,153479.7787644378,False,5235,LDVAE (vs ctrl)
|
140 |
+
ldvae_minusctrl_2,-0.11047037756362854,0.8954128541069295,84187.83674127933,-1.312189288140507e-06,0.9999989530244261,-165005.23841962297,165005.0174788678,False,5235,LDVAE (vs ctrl)
|
141 |
+
ldvae_minusctrl_36,0.10753957940756936,1.113534932927308,83694.94789393916,1.2848992933700952e-06,0.9999989747986916,-164038.97602049776,164039.1910996566,False,5235,LDVAE (vs ctrl)
|
142 |
+
ldvae_minusctrl_32,-0.10537234101244954,0.8999893572437664,49507.33150900506,-2.1284189189894633e-06,0.9999983017674057,-97032.69210067594,97032.4813559939,False,5235,LDVAE (vs ctrl)
|
143 |
+
ldvae_minusctrl_3,0.10489441680986868,1.1105933441769287,79931.22216556521,1.3123084317739576e-06,0.9999989529293632,-156662.21179036066,156662.42157919428,False,5235,LDVAE (vs ctrl)
|
144 |
+
ldvae_minusctrl_34,0.09653279624503257,1.1013457005549614,88862.19888831247,1.0863201389643867e-06,0.999999133241933,-174166.61287533143,174166.80594092392,False,5235,LDVAE (vs ctrl)
|
145 |
+
ldvae_minusctrl_5,-0.09575516761905783,0.9086864647069642,88349.62186796275,-1.0838209105429174e-06,0.9999991352360288,-173162.172664107,173161.98115377175,False,5235,LDVAE (vs ctrl)
|
146 |
+
ldvae_minusctrl_6,0.09456604239117747,1.099181753327277,34367.062612793154,2.7516475136858285e-06,0.9999978045029321,-67358.1104094652,67358.29954154998,False,5235,LDVAE (vs ctrl)
|
147 |
+
ldvae_minusctrl_4,-0.09085830011457985,0.913147094570896,98013.27683602065,-9.269999233531258e-07,0.9999992603610733,-192102.58346365453,192102.40174705433,False,5235,LDVAE (vs ctrl)
|
148 |
+
ldvae_minusctrl_39,-0.05641449416381619,0.945147296650059,44526.926678955235,-1.2669748031471344e-06,0.9999989891003657,-87271.2290475021,87271.11621851378,False,5235,LDVAE (vs ctrl)
|
149 |
+
ldvae_minusctrl_24,-0.04915048203382137,0.9520378543259966,45249.607837333766,-1.0862079116908753e-06,0.9999991333314774,-88687.65082621758,88687.5525252535,False,5235,LDVAE (vs ctrl)
|
150 |
+
ldvae_minusctrl_49,0.04822435659389446,1.0494060700865526,45688.752621015556,1.0554973341888216e-06,0.9999991578349731,-89548.26141139389,89548.35786010708,False,5235,LDVAE (vs ctrl)
|
151 |
+
ldvae_minusctrl_1,0.045609843620001166,1.0466659678786865,42514.32239342242,1.072811256355756e-06,0.9999991440204619,-83326.49510838903,83326.58632807629,False,5235,LDVAE (vs ctrl)
|
152 |
+
ldvae_minusctrl_29,0.023015261784519982,1.0232821565398218,41061.16894382517,5.605116068664929e-07,0.9999995527764427,-80478.38927775012,80478.43530827369,False,5235,LDVAE (vs ctrl)
|
153 |
+
ldvae_minusctrl_13,0.01854690020638827,1.0187199622256697,38980.23934251784,4.7580262510492515e-07,0.9999996203644315,-76399.84667318604,76399.88376698644,False,5235,LDVAE (vs ctrl)
|
154 |
+
ldvae_minusctrl_10,0.011051438424546353,1.0111127311530144,101561.93306041732,1.0881477037239983e-07,0.9999999131783748,-199057.71994724733,199057.7420501242,False,5235,LDVAE (vs ctrl)
|
155 |
+
ldvae_minusctrl_20,-0.008379772798765034,0.9916552396303248,74510.07685981826,-1.1246495980041153e-07,0.9999999102659449,-146037.07551032788,146037.05875078228,False,5235,LDVAE (vs ctrl)
|
156 |
+
ldvae_minusctrl_17,-0.0015682364834117006,0.998432992556863,136029.6714371492,-1.1528635384055048e-08,0.9999999908014798,-266613.2584138658,266613.2552773928,False,5235,LDVAE (vs ctrl)
|
157 |
+
ldvae_minusctrl_42,-0.00035781561232259534,0.999642248396049,62699.48627947048,-5.706834833186726e-09,0.9999999954466046,-122888.73531474103,122888.7345991098,False,5235,LDVAE (vs ctrl)
|
158 |
+
const,-1.3339677488676625,0.2634299610319781,0.04876542258225801,-27.354787023889973,9.471989159809526e-165,-1.4295462208197645,-1.2383892769155604,True,332,LDVAE (vs ctrl)
|
159 |
+
approval_rate,0.7293425744636697,2.0737168450280077,0.04807055327904571,15.172335758856248,5.392319804608311e-52,0.6351260213198263,0.823559127607513,True,332,LDVAE (vs ctrl)
|
160 |
+
ldvae_minusctrl_34,0.5964614515785163,1.8156825390127758,107835.24028258324,5.531229401589717e-06,0.9999955867174583,-211352.5907566344,211353.78367953756,False,332,LDVAE (vs ctrl)
|
161 |
+
ldvae_minusctrl_42,0.4890555983674445,1.6307753855501919,75439.12493629857,6.4827846131620315e-06,0.9999948274862461,-147857.47884476432,147858.45695596104,False,332,LDVAE (vs ctrl)
|
162 |
+
ldvae_minusctrl_19,-0.4121874930059956,0.6622001065234843,71554.10643888346,-5.760500878563237e-06,0.9999954037852865,-140243.88375365018,140243.05937866418,False,332,LDVAE (vs ctrl)
|
163 |
+
ldvae_minusctrl_28,0.36851236581023994,1.4455825163172846,52473.03800283357,7.022889846597792e-06,0.9999943965446192,-102844.89613258957,102845.63315732118,False,332,LDVAE (vs ctrl)
|
164 |
+
ldvae_minusctrl_18,-0.35044340660446865,0.7043756956295613,172679.68337695312,-2.0294420267117594e-06,0.9999983807395398,-338446.3107240146,338445.60983720137,False,332,LDVAE (vs ctrl)
|
165 |
+
ldvae_minusctrl_40,0.34448168846285526,1.411258258632521,418916.813641635,8.223152598442713e-07,0.99999934388735,-821061.5227741938,821062.2117375707,False,332,LDVAE (vs ctrl)
|
166 |
+
ldvae_minusctrl_17,-0.3313028295065381,0.7179877082520701,166640.69352791685,-1.988126804399286e-06,0.9999984137043179,-326610.08897632343,326609.42637066444,False,332,LDVAE (vs ctrl)
|
167 |
+
ldvae_minusctrl_44,0.3072793216300314,1.3597207144401693,95376.17481349436,3.221761852275038e-06,0.9999974294059595,-186933.56033832353,186934.17489696678,False,332,LDVAE (vs ctrl)
|
168 |
+
ldvae_minusctrl_0,-0.30373220890997304,0.7380584854754323,70744.82221421525,-4.293348960440839e-06,0.9999965744031504,-138657.60736475996,138656.99990034214,False,332,LDVAE (vs ctrl)
|
169 |
+
ldvae_minusctrl_38,-0.2993237034774905,0.7413194029229776,81358.53611662866,-3.679069434686061e-06,0.9999970645273,-159460.0999471969,159459.50129978993,False,332,LDVAE (vs ctrl)
|
170 |
+
ldvae_minusctrl_48,-0.26007408973828067,0.7709944609095836,94812.55701034454,-2.7430342344833633e-06,0.9999978113753345,-185829.45709651566,185828.93694833617,False,332,LDVAE (vs ctrl)
|
171 |
+
ldvae_minusctrl_20,0.2404671680615701,1.2718431760668574,90198.74801275728,2.665970131066116e-06,0.9999978728635929,-176786.05708843996,176786.5380227761,False,332,LDVAE (vs ctrl)
|
172 |
+
ldvae_minusctrl_7,0.23239784462824134,1.261621558356485,59723.85070598033,3.891206643261042e-06,0.9999968952662964,-117056.36400392391,117056.82879961315,False,332,LDVAE (vs ctrl)
|
173 |
+
ldvae_minusctrl_11,0.23175027711639615,1.2608048376924743,157483.9671321916,1.4715801318483779e-06,0.9999988258489328,-308662.67197130807,308663.1354718623,False,332,LDVAE (vs ctrl)
|
174 |
+
ldvae_minusctrl_16,-0.21581273014777924,0.8058862059338401,110370.48770647199,-1.9553481608392334e-06,0.9999984398578915,-216322.39667353604,216321.96504807577,False,332,LDVAE (vs ctrl)
|
175 |
+
ldvae_minusctrl_22,-0.1805368611552114,0.8348219076298706,89963.8759312704,-2.006770598602665e-06,0.9999983988287223,-176326.13727178096,176325.77619805865,False,332,LDVAE (vs ctrl)
|
176 |
+
ldvae_minusctrl_4,-0.17858345013583002,0.8364542517438854,120522.53141467679,-1.4817432727278643e-06,0.9999988177399196,-236219.99948181392,236219.64231491362,False,332,LDVAE (vs ctrl)
|
177 |
+
ldvae_minusctrl_32,-0.17612611341505213,0.83851222902793,61346.83747609018,-2.870989290747008e-06,0.9999977092819707,-120237.76814468222,120237.4158924554,False,332,LDVAE (vs ctrl)
|
178 |
+
ldvae_minusctrl_27,-0.16370348000277357,0.8489937281783118,57910.81283849826,-2.8268206225892565e-06,0.9999977445234691,-113503.27118237638,113502.94377541637,False,332,LDVAE (vs ctrl)
|
179 |
+
ldvae_minusctrl_37,-0.13394362284965894,0.8746393728888102,414042.3860632851,-3.235022001568363e-07,0.9999997418825891,-811508.2987006905,811508.0308134449,False,332,LDVAE (vs ctrl)
|
180 |
+
ldvae_minusctrl_46,0.120610955679078,1.1281859126554459,160099.73898637347,7.533488589218969e-07,0.9999993989145766,-313789.60173659946,313789.84295851085,False,332,LDVAE (vs ctrl)
|
181 |
+
ldvae_minusctrl_14,0.12023454203103497,1.1277613279951362,90934.48539843096,1.3222106168438225e-06,0.9999989450285627,-178228.1960990661,178228.43656815015,False,332,LDVAE (vs ctrl)
|
182 |
+
ldvae_minusctrl_39,0.11890198596503289,1.1262595236379969,53957.485472659086,2.203623555165149e-06,0.9999982417627875,-105754.60932076903,105754.84712474095,False,332,LDVAE (vs ctrl)
|
183 |
+
ldvae_minusctrl_6,-0.10489018356992985,0.9004233984402379,41723.25258837155,-2.513950304995234e-06,0.9999979941578651,-81776.1772812594,81775.96750089225,False,332,LDVAE (vs ctrl)
|
184 |
+
ldvae_minusctrl_8,-0.10274559386980647,0.9023565093102061,93183.67885465031,-1.102613624324395e-06,0.9999991202416126,-182636.75724765507,182636.55175646732,False,332,LDVAE (vs ctrl)
|
185 |
+
ldvae_minusctrl_1,-0.0985030992234653,0.9061928841156681,52550.84603703287,-1.8744341271698962e-06,0.9999985044179497,-102997.86409279308,102997.66708659462,False,332,LDVAE (vs ctrl)
|
186 |
+
ldvae_minusctrl_33,-0.0950101069136899,0.9093637435609168,96541.3547236544,-9.841389442446956e-07,0.9999992147707307,-189217.67328717536,189217.48326696153,False,332,LDVAE (vs ctrl)
|
187 |
+
ldvae_minusctrl_30,-0.09406031756188887,0.910227857859785,42993.589518239554,-2.187775401306858e-06,0.9999982544077848,-84265.98108216586,84265.79296153075,False,332,LDVAE (vs ctrl)
|
188 |
+
ldvae_minusctrl_9,-0.08834216100815166,0.9154475926583724,97524.53802422747,-9.058454702569862e-07,0.9999992772398848,-191144.6704785539,191144.49379423188,False,332,LDVAE (vs ctrl)
|
189 |
+
ldvae_minusctrl_25,-0.08725341722501102,0.916444823299494,122096.52162772094,-7.146265598871976e-07,0.9999994298105012,-239304.87228136606,239304.69777453158,False,332,LDVAE (vs ctrl)
|
190 |
+
ldvae_minusctrl_5,-0.08438021383243481,0.9190817420628298,104448.93256328496,-8.078609494770026e-07,0.9999993554202211,-204716.23042790525,204716.06166747757,False,332,LDVAE (vs ctrl)
|
191 |
+
ldvae_minusctrl_41,-0.08232484445023569,0.9209727372162583,134378.36218807605,-6.126346765189308e-07,0.9999995111882501,-263376.8325149525,263376.66786526365,False,332,LDVAE (vs ctrl)
|
192 |
+
ldvae_minusctrl_43,0.0779316020860053,1.0810487146642944,132491.6748206793,5.881999921238956e-07,0.9999995306843076,-259678.83296832166,259678.9888315258,False,332,LDVAE (vs ctrl)
|
193 |
+
ldvae_minusctrl_12,0.06442769866314557,1.0665484625772352,74884.1474777852,8.603649882274271e-07,0.9999993135280593,-146770.16764174626,146770.2964971436,False,332,LDVAE (vs ctrl)
|
194 |
+
ldvae_minusctrl_23,-0.06067492441263475,0.941129128159016,67346.0964357346,-9.009419643280165e-07,0.9999992811523165,-131995.9841883255,131995.8628384767,False,332,LDVAE (vs ctrl)
|
195 |
+
ldvae_minusctrl_47,0.05986647787694843,1.0616947773402043,54601.15723273046,1.0964324001737769e-06,0.999999125173516,-107016.2418238825,107016.36155683827,False,332,LDVAE (vs ctrl)
|
196 |
+
ldvae_minusctrl_21,0.056367850724080334,1.0579867933731026,48431.206913108304,1.1638745824610848e-06,0.9999990713624399,-94923.36490964885,94923.47764535029,False,332,LDVAE (vs ctrl)
|
197 |
+
ldvae_minusctrl_29,-0.05413215710744228,0.9473069048884288,49293.66933956248,-1.0981563724653885e-06,0.9999991237979851,-96613.87070352588,96613.76243921167,False,332,LDVAE (vs ctrl)
|
198 |
+
ldvae_minusctrl_13,-0.05314414726171327,0.9482433159528871,47830.880512361735,-1.1110844436154241e-06,0.9999991134828767,-93746.85629721498,93746.75000892047,False,332,LDVAE (vs ctrl)
|
199 |
+
ldvae_minusctrl_15,0.05028209053049338,1.0515676918287107,42732.04250719977,1.1766835278707198e-06,0.9999990611423801,-83753.21401785569,83753.31458203674,False,332,LDVAE (vs ctrl)
|
200 |
+
ldvae_minusctrl_45,-0.033226505205673745,0.9673194318863145,164741.88835770247,-2.0168826238976546e-07,0.9999998390760494,-322888.2011527205,322888.13469971006,False,332,LDVAE (vs ctrl)
|
201 |
+
ldvae_minusctrl_3,-0.026677620540689923,0.9736750837805231,99276.87179676132,-2.6871939111159844e-07,0.9999997855929467,-194579.11989707296,194579.06654183188,False,332,LDVAE (vs ctrl)
|
202 |
+
ldvae_minusctrl_2,0.02324470764540229,1.0235169713327656,104151.06588569214,2.231826188981476e-07,0.9999998219260341,-204132.31484270722,204132.3613321225,False,332,LDVAE (vs ctrl)
|
203 |
+
ldvae_minusctrl_31,-0.022067072972540933,0.9781746237711824,203448.38370722963,-1.0846521643689406e-07,0.9999999134572785,-398751.5268461286,398751.4827119826,False,332,LDVAE (vs ctrl)
|
204 |
+
ldvae_minusctrl_26,0.014385514974806229,1.014489484448593,34733.83965571176,4.1416425933320687e-07,0.9999996695447319,-68077.06038446918,68077.08915549914,False,332,LDVAE (vs ctrl)
|
205 |
+
ldvae_minusctrl_49,0.012300387621001007,1.0123763485188029,56582.32520809777,2.1738922138252174e-07,0.9999998265484966,-110899.30726901682,110899.33186979206,False,332,LDVAE (vs ctrl)
|
206 |
+
ldvae_minusctrl_24,-0.005534244111303829,0.9944810416063404,53368.77662833861,-1.036981632508542e-07,0.9999999172608366,-104600.88562475075,104600.87455626254,False,332,LDVAE (vs ctrl)
|
207 |
+
ldvae_minusctrl_10,0.003465037813479912,1.003471047996837,122851.93757017772,2.8204991162638767e-08,0.999999977495673,-240785.36960347366,240785.3765335493,False,332,LDVAE (vs ctrl)
|
208 |
+
ldvae_minusctrl_36,-0.0009385468780807017,0.9990618934192831,104666.79885300067,-8.966997064645536e-09,0.9999999928453714,-205143.15706752642,205143.15519043268,False,332,LDVAE (vs ctrl)
|
209 |
+
ldvae_minusctrl_35,-0.0008786113100583839,0.9991217745558417,71349.08290292624,-1.2314262136400206e-08,0.9999999901746404,-139841.63369830928,139841.63194108664,False,332,LDVAE (vs ctrl)
|
210 |
+
const,-0.8971996459555441,0.4077097943768504,0.040902665763689575,-21.934991991451398,1.2045918698298732e-106,-0.9773673977240552,-0.817031894187033,True,2132,LDVAE (vs ctrl)
|
211 |
+
approval_rate,0.7523062936931597,2.121888074881759,0.04677958746799762,16.081935186106975,3.4154112344311574e-58,0.6606199870442431,0.8439926003420763,True,2132,LDVAE (vs ctrl)
|
212 |
+
ldvae_minusctrl_20,0.462443208080092,1.5879489390861048,88772.85752037339,5.209286047528223e-06,0.9999958435910898,-173991.14110142944,173992.06598784562,False,2132,LDVAE (vs ctrl)
|
213 |
+
ldvae_minusctrl_38,-0.2967128835852599,0.7432573831244217,80191.10709848849,-3.70007216911029e-06,0.9999970477695425,-157171.97850631527,157171.38508054812,False,2132,LDVAE (vs ctrl)
|
214 |
+
ldvae_minusctrl_0,-0.2568127453314766,0.7735130441336224,71210.09204449241,-3.606409400103271e-06,0.9999971225016198,-139569.47255573267,139568.95893024202,False,2132,LDVAE (vs ctrl)
|
215 |
+
ldvae_minusctrl_12,0.24755937724524887,1.2808954161670314,77956.61931452963,3.1756043222760497e-06,0.99999746623434,-152791.91865360038,152792.4137723549,False,2132,LDVAE (vs ctrl)
|
216 |
+
ldvae_minusctrl_42,0.2182255204416085,1.2438675535501968,76983.0340930592,2.834722260723207e-06,0.999997738218874,-150883.75601749468,150884.1924685356,False,2132,LDVAE (vs ctrl)
|
217 |
+
ldvae_minusctrl_46,-0.20542771719176917,0.814298952254937,162139.57655816307,-1.2669807184187242e-06,0.9999989890956459,-317787.93595029163,317787.52509485726,False,2132,LDVAE (vs ctrl)
|
218 |
+
ldvae_minusctrl_47,0.17459708880171237,1.1907663468507093,55790.098216565915,3.1295354262321186e-06,0.999997502992001,-109346.40860133269,109346.75779551029,False,2132,LDVAE (vs ctrl)
|
219 |
+
ldvae_minusctrl_43,0.16016609218182384,1.1737057981602586,133899.56268425085,1.1961659095146727e-06,0.9999990455976886,-262438.16024070285,262438.4805728872,False,2132,LDVAE (vs ctrl)
|
220 |
+
ldvae_minusctrl_7,-0.14980440192511088,0.8608763457141059,62021.19854136068,-2.4153741857344043e-06,0.9999980728102287,-121559.46522347699,121559.16561467314,False,2132,LDVAE (vs ctrl)
|
221 |
+
ldvae_minusctrl_11,-0.138581771498508,0.8705920587411636,160942.00985041098,-8.610664898948019e-07,0.9999993129683419,-315440.68148806767,315440.4043245246,False,2132,LDVAE (vs ctrl)
|
222 |
+
ldvae_minusctrl_33,-0.13677922822879643,0.872162753794924,94123.45242166326,-1.4531896643149015e-06,0.999998840522403,-184478.71362625755,184478.4400678011,False,2132,LDVAE (vs ctrl)
|
223 |
+
ldvae_minusctrl_49,-0.13571638416728327,0.8730902195869141,56593.54138823786,-2.398089620090287e-06,0.9999980866013167,-110921.4385949073,110921.16716213898,False,2132,LDVAE (vs ctrl)
|
224 |
+
ldvae_minusctrl_29,0.12573470511576687,1.1339812889391427,49173.171090590724,2.5569777650525812e-06,0.999997959826919,-96377.51860847887,96377.7700778891,False,2132,LDVAE (vs ctrl)
|
225 |
+
ldvae_minusctrl_5,0.12392043166891167,1.131925801968923,108871.25238970053,1.1382291371586612e-06,0.9999990918245448,-213383.60971515166,213383.85755601502,False,2132,LDVAE (vs ctrl)
|
226 |
+
ldvae_minusctrl_9,0.12041782837943711,1.1279680501949134,97701.53592652081,1.2325070147310757e-06,0.9999990166016819,-191491.37123239858,191491.61206805534,False,2132,LDVAE (vs ctrl)
|
227 |
+
ldvae_minusctrl_22,0.11101748550296674,1.1174144452372359,89524.65599632854,1.2400772085348157e-06,0.9999990105615411,-175464.99046365623,175465.21249862722,False,2132,LDVAE (vs ctrl)
|
228 |
+
ldvae_minusctrl_18,-0.10895195263321046,0.8967735040686061,173772.73782866017,-6.269795480844471e-07,0.9999994997426986,-340588.41659104766,340588.19868714234,False,2132,LDVAE (vs ctrl)
|
229 |
+
ldvae_minusctrl_3,-0.09639623303603424,0.9081041239187796,101327.60490752273,-9.513323948001224e-07,0.99999924094657,-198598.55265468164,198598.35986221556,False,2132,LDVAE (vs ctrl)
|
230 |
+
ldvae_minusctrl_34,-0.09587065165763982,0.908581531983359,105202.91445014019,-9.112927351749053e-07,0.9999992728935962,-206194.01926157484,206193.82752027153,False,2132,LDVAE (vs ctrl)
|
231 |
+
ldvae_minusctrl_23,-0.08764148637225919,0.9160892483367148,68966.69970270661,-1.2707797640028247e-06,0.9999989860644461,-135172.33519138058,135172.15990840783,False,2132,LDVAE (vs ctrl)
|
232 |
+
ldvae_minusctrl_44,0.0781274246675724,1.081260429142961,97258.51367243762,8.032965106859654e-07,0.9999993590621163,-190623.1058604495,190623.26211529883,False,2132,LDVAE (vs ctrl)
|
233 |
+
ldvae_minusctrl_37,-0.07785230525371878,0.9251010490187993,420467.780200331,-1.8515641131081723e-07,0.9999998522665581,-824101.7837044577,824101.6279998472,False,2132,LDVAE (vs ctrl)
|
234 |
+
ldvae_minusctrl_10,0.07693028451850574,1.0799667833637858,123106.6736020739,6.249075071849698e-07,0.9999995013959481,-241284.56958630812,241284.72344687718,False,2132,LDVAE (vs ctrl)
|
235 |
+
ldvae_minusctrl_36,0.07512061978457032,1.078014172880158,100800.12799705367,7.452432975756346e-07,0.9999994053818788,-197564.545390633,197564.69563187257,False,2132,LDVAE (vs ctrl)
|
236 |
+
ldvae_minusctrl_19,-0.07452662752500852,0.9281827585203131,72097.57910541611,-1.0336911231934823e-06,0.9999991752338122,-141308.7329457706,141308.58389251557,False,2132,LDVAE (vs ctrl)
|
237 |
+
ldvae_minusctrl_2,-0.0663930968123176,0.9357629465513368,104790.54675560434,-6.335790666992279e-07,0.9999994944770446,-205385.76395434194,205385.6311681483,False,2132,LDVAE (vs ctrl)
|
238 |
+
ldvae_minusctrl_24,0.06546868956182209,1.0676593079094008,54476.715108816024,1.2017738116376848e-06,0.9999990411232301,-106772.33414063886,106772.46507801798,False,2132,LDVAE (vs ctrl)
|
239 |
+
ldvae_minusctrl_25,-0.061759110358838465,0.9401093221142888,118900.42625687482,-5.19418746451025e-07,0.9999995855638016,-233040.61496904562,233040.4914508249,False,2132,LDVAE (vs ctrl)
|
240 |
+
ldvae_minusctrl_35,0.06034612182436406,1.0622041349595428,70491.9795176569,8.560707507050288e-07,0.9999993169543651,-138161.6807074209,138161.80139966452,False,2132,LDVAE (vs ctrl)
|
241 |
+
ldvae_minusctrl_21,0.05892329433748923,1.060693876393136,48164.15340803761,1.2233848239436956e-06,0.9999990238801371,-94399.94710232149,94400.06494891015,False,2132,LDVAE (vs ctrl)
|
242 |
+
ldvae_minusctrl_48,0.05658657352149495,1.0582182245128873,97280.44166001392,5.816849980930366e-07,0.9999995358825208,-190666.10546720366,190666.21864035068,False,2132,LDVAE (vs ctrl)
|
243 |
+
ldvae_minusctrl_1,-0.05237912611293454,0.9489690196977418,51980.97082741909,-1.007659635423843e-06,0.9999991960039344,-101880.88308229475,101880.77832404253,False,2132,LDVAE (vs ctrl)
|
244 |
+
ldvae_minusctrl_14,0.04756890286076396,1.0487184583338074,91946.55373778094,5.173538422812888e-07,0.9999995872113567,-180211.88625972444,180211.98139753018,False,2132,LDVAE (vs ctrl)
|
245 |
+
ldvae_minusctrl_17,-0.0466882614330797,0.9543848697927827,170510.3704694107,-2.7381479088074295e-07,0.9999997815274059,-334194.2317988884,334194.13842236553,False,2132,LDVAE (vs ctrl)
|
246 |
+
ldvae_minusctrl_45,0.045757096950352155,1.046820104276492,168585.14428450493,2.714183218488831e-07,0.9999997834395115,-330420.7653690212,330420.85688321514,False,2132,LDVAE (vs ctrl)
|
247 |
+
ldvae_minusctrl_8,-0.042395979049196036,0.9584901633936558,90413.51275387136,-4.68911977401085e-07,0.9999996258623729,-177207.27110931976,177207.18631736166,False,2132,LDVAE (vs ctrl)
|
248 |
+
ldvae_minusctrl_30,-0.04153677310787553,0.9593140577335111,44580.13348919074,-9.317328113866431e-07,0.999999256584775,-87375.49760157488,87375.41452802868,False,2132,LDVAE (vs ctrl)
|
249 |
+
ldvae_minusctrl_32,-0.03998454741461175,0.9608042859478823,62116.720210229374,-6.437002352874887e-07,0.9999994864015205,-121746.57443434828,121746.49446525345,False,2132,LDVAE (vs ctrl)
|
250 |
+
ldvae_minusctrl_13,-0.038293971972511526,0.9624299718635229,47993.78446885148,-7.978944022921292e-07,0.9999993633723753,-94066.12733469869,94066.05074675474,False,2132,LDVAE (vs ctrl)
|
251 |
+
ldvae_minusctrl_41,0.03584676270432843,1.0364970043230484,136486.10661978778,2.626403785125728e-07,0.9999997904432969,-267507.8175181152,267507.88921164064,False,2132,LDVAE (vs ctrl)
|
252 |
+
ldvae_minusctrl_26,-0.03212170969165996,0.9683887126147956,34552.245748264395,-9.296562060158845e-07,0.9999992582416664,-67721.18937328512,67721.12512986573,False,2132,LDVAE (vs ctrl)
|
253 |
+
ldvae_minusctrl_31,0.031088036958481932,1.0315763167303877,212051.5459968153,1.466060377553146e-07,0.999999883025306,-415613.3619317597,415613.4241078336,False,2132,LDVAE (vs ctrl)
|
254 |
+
ldvae_minusctrl_15,-0.0204156947206855,0.9797912945714998,42742.41330506243,-4.776448764128967e-07,0.9999996188945276,-83773.61110594269,83773.57027455326,False,2132,LDVAE (vs ctrl)
|
255 |
+
ldvae_minusctrl_6,-0.018660594937219343,0.9815124360061105,42341.91985341154,-4.407120650604093e-07,0.9999996483626475,-82988.65660956306,82988.61928837317,False,2132,LDVAE (vs ctrl)
|
256 |
+
ldvae_minusctrl_27,-0.016459416489207637,0.9836752995777528,58120.4055706228,-2.831951416651352e-07,0.9999997740429688,-113913.91814469831,113913.88522586532,False,2132,LDVAE (vs ctrl)
|
257 |
+
ldvae_minusctrl_16,0.01511561940481214,1.0152304381692663,111478.31594991726,1.3559246276740475e-07,0.9999998918128674,-218493.46920339548,218493.4994346343,False,2132,LDVAE (vs ctrl)
|
258 |
+
ldvae_minusctrl_39,0.013324953948823756,1.0134141267821286,53657.65075837628,2.4833278685320845e-07,0.9999998018591034,-105167.04965649187,105167.07630639977,False,2132,LDVAE (vs ctrl)
|
259 |
+
ldvae_minusctrl_40,-0.009262494884321956,0.9907802698834193,429173.53035581915,-2.1582167186878015e-08,0.999999982779922,-841164.671877808,841164.6533528183,False,2132,LDVAE (vs ctrl)
|
260 |
+
ldvae_minusctrl_4,0.006714160829033626,1.0067367513373204,118179.04935156218,5.6813461149616815e-08,0.9999999546694165,-231626.67374208267,231626.6871704043,False,2132,LDVAE (vs ctrl)
|
261 |
+
ldvae_minusctrl_28,-0.004331636068469518,0.9956777319359023,52711.40785133449,-8.217644424687576e-08,0.9999999344326839,-103312.46529465349,103312.45663138136,False,2132,LDVAE (vs ctrl)
|
data/coefficients_LDVAE.csv
ADDED
@@ -0,0 +1,261 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
Feature,Coefficient,Odds_Ratio,HC_Std_Error,z_value,p_value,CI_Lower_95,CI_Upper_95,Significant,split_seed,X_features
|
2 |
+
const,-1.1078602230152717,0.33026489876046133,0.04085330851506828,-27.118004961743797,6.039637690980767e-162,-1.187931236354109,-1.0277892096764343,True,432,LDVAE
|
3 |
+
18,-0.8853727569716104,0.41256035986297007,192197.46973063986,-4.606578630886448e-06,0.9999963244820324,-376701.00396453834,376699.2332190244,False,432,LDVAE
|
4 |
+
approval_rate,0.773399807111307,2.1671215386433915,0.07672709008246978,10.07987930051852,6.780936841654818e-24,0.6230174739111058,0.9237821403115081,True,432,LDVAE
|
5 |
+
48,0.6310501717506465,1.8795834285874005,140864.59217848215,4.479835294245383e-06,0.9999964256085838,-276088.8963165759,276090.15841691935,False,432,LDVAE
|
6 |
+
21,-0.49650126153839685,0.6086564685158906,74165.05679249672,-6.694544344886525e-06,0.9999946585264257,-145361.33672592283,145360.34372339974,False,432,LDVAE
|
7 |
+
34,0.4482808019139596,1.565618262539673,131629.2639475687,3.405631760521895e-06,0.9999972826989985,-257988.1683679493,257989.06492955313,False,432,LDVAE
|
8 |
+
29,0.41409476439083986,1.5130004986616137,66804.96522164553,6.1985626819347355e-06,0.999995054262537,-130934.91172811172,130935.7399176405,False,432,LDVAE
|
9 |
+
46,0.3936580912229027,1.4823936186284532,396765.0156901985,9.921693588284463e-07,0.9999992083633868,-777644.7474201673,777645.5347363497,False,432,LDVAE
|
10 |
+
42,0.3723672288034357,1.4511657933330797,102248.01438430141,3.641804010040579e-06,0.999997094260807,-200402.05331673534,200402.79805119298,False,432,LDVAE
|
11 |
+
6,-0.3688850665151992,0.6915048829491495,84784.32448586226,-4.350864015867822e-06,0.9999965285127757,-166174.59133091397,166173.85356078096,False,432,LDVAE
|
12 |
+
16,-0.35861932977274247,0.6986402522816862,139127.4502097935,-2.577631727110445e-06,0.9999979433474415,-272685.1502914146,272684.4330527551,False,432,LDVAE
|
13 |
+
7,-0.32538332730360264,0.7222504422570595,89494.75918279149,-3.635780801856932e-06,0.9999970990666317,-175406.8301866839,175406.1794200293,False,432,LDVAE
|
14 |
+
26,0.3246880946749428,1.3835990267678924,54263.72978694734,5.9835196723437105e-06,0.9999952258420342,-106354.63136113546,106355.28073732479,False,432,LDVAE
|
15 |
+
9,-0.26795941208697793,0.7649388277434083,148431.93791806145,-1.805267894803738e-06,0.9999985596046186,-290921.52043429774,290920.9845154736,False,432,LDVAE
|
16 |
+
37,-0.2671633897669162,0.7655479785404234,707516.8960263188,-3.776070808589963e-07,0.9999996987131401,-1386707.9018285447,1386707.367501765,False,432,LDVAE
|
17 |
+
41,0.26655708905754005,1.3054621148098131,194803.49382301504,1.368338338426904e-06,0.9999989082239659,-381807.56539859134,381808.09851276944,False,432,LDVAE
|
18 |
+
19,0.26160124843387605,1.2990084574858245,85663.50777201533,3.0538236786905928e-06,0.9999975634012354,-167897.12842126863,167897.6516237655,False,432,LDVAE
|
19 |
+
33,0.25019422895690746,1.2842748358264928,144462.53445354145,1.731896992554626e-06,0.9999986181461288,-283141.114450089,283141.6148385469,False,432,LDVAE
|
20 |
+
3,0.22342219905053573,1.2503483582027657,199455.2175531075,1.120162218825119e-06,0.99999910623986,-390924.8195104929,390925.26635489095,False,432,LDVAE
|
21 |
+
23,0.22160595423483093,1.248079480521722,98140.49860655637,2.2580479759252652e-06,0.9999981983383824,-192351.62108769963,192352.0642996081,False,432,LDVAE
|
22 |
+
49,0.2173266975809609,1.2427500392563804,128874.48283966881,1.6863438967303902e-06,0.9999986544922406,-252589.12756527853,252589.56221867367,False,432,LDVAE
|
23 |
+
0,0.21126089123010514,1.2352345748951152,85386.77078306177,2.474164197716833e-06,0.9999980259025858,-167354.7842300868,167355.20675186926,False,432,LDVAE
|
24 |
+
2,-0.2091199061997879,0.8112979501568625,305091.8785608547,-6.854325562064285e-07,0.9999994531039459,-597969.3030748493,597968.8848350369,False,432,LDVAE
|
25 |
+
15,0.20393244620731743,1.226215315163037,65013.37312143242,3.1367768878321543e-06,0.9999974972141505,-127423.66589902573,127424.07376391815,False,432,LDVAE
|
26 |
+
44,0.18781502819365248,1.206610305818682,121438.62498323257,1.5465839490490337e-06,0.9999987660045451,-238015.1434841737,238015.51911423006,False,432,LDVAE
|
27 |
+
8,0.1838395595367538,1.2018229865906174,186074.92383450214,9.879867515101792e-07,0.9999992117006247,-364699.96530209837,364700.3329812175,False,432,LDVAE
|
28 |
+
5,-0.18167421709649667,0.8338729577225154,124241.88350372075,-1.4622622578887092e-06,0.9999988332835206,-243509.79871293085,243509.43536449663,False,432,LDVAE
|
29 |
+
39,-0.17896892073558646,0.8361318853571708,88763.29584614838,-2.0162491605290283e-06,0.999998391265924,-173973.04197644533,173972.68403860388,False,432,LDVAE
|
30 |
+
27,-0.1689931912914182,0.8445146534206274,76126.79013099465,-2.219891197312068e-06,0.999998228783087,-149205.93590858002,149205.59792219743,False,432,LDVAE
|
31 |
+
43,0.16692368331238036,1.1816640811785737,241428.75731643688,6.913993393653437e-07,0.9999994483431418,-473191.502248794,473191.83609616064,False,432,LDVAE
|
32 |
+
30,-0.15970221076122984,0.8523975860035881,85487.49390018552,-1.8681353666502002e-06,0.9999985094436334,-167552.56887516196,167552.2494707404,False,432,LDVAE
|
33 |
+
32,-0.1534213427505506,0.8577682312351413,68913.58334736069,-2.2262859555165835e-06,0.9999982236808082,-135068.29482776893,135067.98798508343,False,432,LDVAE
|
34 |
+
36,0.1471064213328535,1.1584772431622188,181661.2659564175,8.097841912438611e-07,0.9999993538856963,-356049.39155410917,356049.6857669519,False,432,LDVAE
|
35 |
+
14,-0.14197321314336958,0.8676444976433985,134859.67619208797,-1.0527476941376415e-06,0.9999991600288685,-264320.2502764393,264319.96633001306,False,432,LDVAE
|
36 |
+
4,0.12186033777423887,1.1295963288256188,151583.01560107776,8.039181519843866e-07,0.9999993585661184,-297097.1293857478,297097.37310642336,False,432,LDVAE
|
37 |
+
1,-0.09296653696728416,0.9112239921042228,88634.51862634602,-1.0488750704361638e-06,0.9999991631187751,-173720.55726121974,173720.37132814582,False,432,LDVAE
|
38 |
+
47,-0.09163407451730943,0.9124389731357566,94612.00371743846,-9.685248268388576e-07,0.9999992272289939,-185436.21142542362,185436.0281572746,False,432,LDVAE
|
39 |
+
10,0.08314737485631107,1.0867019492912184,230191.19290153793,3.612100611159201e-07,0.9999997117960691,-451166.36449795164,451166.53079270135,False,432,LDVAE
|
40 |
+
25,0.07907045304940738,1.0822805693507815,259603.80300388052,3.045812585735712e-07,0.9999997569793163,-508814.0250667838,508814.18320768996,False,432,LDVAE
|
41 |
+
22,0.06671780800980079,1.0689937741267381,122404.3732649088,5.450606561696077e-07,0.9999995651045177,-239908.0964316107,239908.22986722674,False,432,LDVAE
|
42 |
+
38,-0.055837642524880736,0.9456926636999824,119805.25268709319,-4.660700701555819e-07,0.9999996281298867,-234814.0362630657,234813.92458778067,False,432,LDVAE
|
43 |
+
20,-0.04731888975211331,0.9537831974023983,137178.03128936337,-3.44945100227447e-07,0.9999997247736302,-268864.0481161506,268863.9534783711,False,432,LDVAE
|
44 |
+
11,-0.04724276071070252,0.9538558107668881,225855.78878312817,-2.0917223758238973e-07,0.9999998331047011,-442669.25895757746,442669.164472056,False,432,LDVAE
|
45 |
+
17,0.043427089252539366,1.0443838447292433,191038.52262829454,2.2732111123490975e-07,0.999999818623995,-374428.5805841082,374428.66743828665,False,432,LDVAE
|
46 |
+
35,-0.041893227562730374,0.9589721669019021,84115.4926129066,-4.98044132672681e-07,0.9999996026182759,-164863.37795636946,164863.29416991436,False,432,LDVAE
|
47 |
+
40,-0.040258732800171455,0.9605408835664841,536863.017421608,-7.498883606012213e-08,0.9999999401675654,-1052232.219036584,1052232.1385191183,False,432,LDVAE
|
48 |
+
13,-0.039118939423452855,0.9616363258739905,84214.09157758913,-4.64517739141214e-07,0.9999996293684678,-165056.62560177204,165056.5473638932,False,432,LDVAE
|
49 |
+
45,-0.02878089910043425,0.9716293260060482,218287.2166122006,-1.3184876121978833e-07,0.999999894799909,-427835.1116263057,427835.0540645074,False,432,LDVAE
|
50 |
+
31,-0.0249359836477398,0.9753723498097221,280941.5055120546,-8.87586318094599e-08,0.999999929180858,-550635.2575020718,550635.2076301044,False,432,LDVAE
|
51 |
+
28,-0.018709262698151295,0.9814646691558855,82159.02259417888,-2.2772012260375746e-07,0.99999981830563,-161028.74399886586,161028.70658034048,False,432,LDVAE
|
52 |
+
24,-0.013689858595714076,0.9864034213701285,117550.13507760921,-1.1645974363768895e-07,0.9999999070785686,-230394.04481979113,230394.01744007392,False,432,LDVAE
|
53 |
+
12,-0.0055886509634464525,0.9944269364952089,128676.50698210826,-4.3431789489153e-08,0.9999999653464458,-252201.32492999994,252201.313752698,False,432,LDVAE
|
54 |
+
const,-1.04100895586389,0.35309824163131553,0.04011902732342142,-25.948010839638442,1.9147641225881667e-148,-1.1196408045125743,-0.9623771072152056,True,43,LDVAE
|
55 |
+
46,0.8652042172727489,2.375491152770575,330912.3062761104,2.6146027236316496e-06,0.9999979138488542,-648575.3371380469,648577.0675464814,False,43,LDVAE
|
56 |
+
18,-0.6570040530295125,0.5184021155504244,198437.2840937227,-3.310890168801176e-06,0.9999973582918518,-388930.58701769245,388929.27300958644,False,43,LDVAE
|
57 |
+
0,-0.6255945103835763,0.5349433046151597,89557.27100424985,-6.985412835479202e-06,0.9999944264469478,-175529.65131653336,175528.4001275126,False,43,LDVAE
|
58 |
+
40,-0.49398656270448366,0.6101889823252682,491921.01886377065,-1.004198933896917e-06,0.9999991987651746,-964147.9741978017,964146.9862246762,False,43,LDVAE
|
59 |
+
approval_rate,0.4101383490145478,1.5070262662897773,0.07634414200822344,5.372230772733939,7.776849115320653e-08,0.2605065802478185,0.5597701177812772,True,43,LDVAE
|
60 |
+
43,-0.4098769296555278,0.663731930827345,222464.15735203755,-1.842440303796533e-06,0.9999985299453275,-436022.14613797475,436021.32638411544,False,43,LDVAE
|
61 |
+
37,0.40701401494124706,1.5023251605132675,551254.5782554928,7.383412873037512e-07,0.9999994108888862,-1080438.712679568,1080439.5267075978,False,43,LDVAE
|
62 |
+
30,-0.358100917697534,0.6990025297210818,76508.90398183344,-4.680512973791427e-06,0.9999962654909615,-149955.05440194436,149954.338200109,False,43,LDVAE
|
63 |
+
7,0.3510638078383332,1.4205779670296175,83356.79792570772,4.211579818015815e-06,0.9999966396454866,-163375.97073716237,163376.67286477805,False,43,LDVAE
|
64 |
+
8,-0.3373137196845214,0.7136849077744837,157604.9008404072,-2.1402489255463555e-06,0.9999982923284261,-308900.2667479243,308899.592120485,False,43,LDVAE
|
65 |
+
38,-0.33015183183126373,0.7188145862111611,104788.46962176052,-3.1506503818880464e-06,0.9999974861447039,-205381.956605552,205381.29630188836,False,43,LDVAE
|
66 |
+
11,0.3280195031031118,1.3882160465460927,190876.74125997315,1.7184885960325092e-06,0.9999986288444813,-374111.2103364148,374111.866375421,False,43,LDVAE
|
67 |
+
28,0.29312209424423824,1.3406064607725239,88106.83649099819,3.3268938701957174e-06,0.9999973455227456,-172685.9331920216,172686.51943621007,False,43,LDVAE
|
68 |
+
33,0.2893762830272222,1.3355941954146902,132109.59598446492,2.1904259177452227e-06,0.9999982522929787,-258929.76076540555,258930.33951797162,False,43,LDVAE
|
69 |
+
16,-0.28772255625102205,0.7499696377651626,142977.85870789603,-2.0123574296831486e-06,0.9999983943710761,-280231.74137668905,280231.1659315765,False,43,LDVAE
|
70 |
+
19,0.27748570851610027,1.319807257004811,104037.08486132073,2.6671807354654634e-06,0.9999978718976703,-203908.66189901743,203909.21687043444,False,43,LDVAE
|
71 |
+
3,-0.24999299540034456,0.7788062382782074,152019.7056374262,-1.6444775652742614e-06,0.9999986878967401,-297953.3979827314,297952.8979967406,False,43,LDVAE
|
72 |
+
9,-0.2392628606478506,0.787207929187696,134798.63588246054,-1.774964999322983e-06,0.9999985837828311,-264200.71075761196,264200.2322318906,False,43,LDVAE
|
73 |
+
49,-0.2209723049134982,0.8017388842104742,127317.15878266779,-1.7356050592575749e-06,0.9999986151875195,-249537.26680030118,249536.82485569137,False,43,LDVAE
|
74 |
+
10,-0.2043851567598908,0.8151483508200089,207905.5547104964,-9.830673213348837e-07,0.9999992156257621,-407487.60380355146,407487.195033238,False,43,LDVAE
|
75 |
+
44,0.19792236680288805,1.2188677655470463,102966.51808330977,1.922201221204255e-06,0.9999984663053229,-201810.46913441253,201810.86497914616,False,43,LDVAE
|
76 |
+
17,-0.1971847498422339,0.8210389324864928,169734.8006950741,-1.1617225756577356e-06,0.999999073079493,-332674.2934701792,332673.89910067955,False,43,LDVAE
|
77 |
+
36,0.18116461080123383,1.1986124676135226,149689.18159093632,1.2102719039263111e-06,0.9999990343427335,-293385.2236289005,293385.58595812204,False,43,LDVAE
|
78 |
+
34,0.17187866343204572,1.1875337332042655,114681.7852571638,1.498744225568367e-06,0.9999988041751219,-224771.99690813417,224772.34066546106,False,43,LDVAE
|
79 |
+
13,0.15949009599148725,1.1729126456263759,69973.60835023606,2.279289288515721e-06,0.9999981813902671,-137145.59274467785,137145.91172486986,False,43,LDVAE
|
80 |
+
20,0.15851977295239925,1.1717750934492825,124774.18080881616,1.2704533255585095e-06,0.9999989863249064,-244552.74206599552,244553.05910554144,False,43,LDVAE
|
81 |
+
35,-0.1510339632737697,0.859818495912329,89577.62961823799,-1.6860678711576357e-06,0.9999986547124772,-175569.07890617815,175568.7768382516,False,43,LDVAE
|
82 |
+
39,0.14785223078025048,1.1593415687057778,82535.30090444398,1.7913817379963003e-06,0.9999985706841688,-161766.06937365557,161766.36507811715,False,43,LDVAE
|
83 |
+
29,0.1452394933247944,1.156316467184457,45735.116091020594,3.1756668778481578e-06,0.9999974661844279,-89639.03512766534,89639.325606652,False,43,LDVAE
|
84 |
+
15,-0.1428424327729103,0.8668906516908971,58649.43053141334,-2.4355297481772172e-06,0.9999980567284166,-114950.91439778676,114950.62871292121,False,43,LDVAE
|
85 |
+
27,0.12844726116997984,1.1370614524192235,84505.95090354228,1.5199788866537166e-06,0.9999987872323136,-165628.49180299175,165628.7486975141,False,43,LDVAE
|
86 |
+
47,-0.11855813116715977,0.8882001820428042,97689.51177181058,-1.213621902872188e-06,0.9999990316698211,-191468.04329818152,191467.8061819192,False,43,LDVAE
|
87 |
+
4,-0.11717146473904548,0.8894326737466315,144312.46067880682,-8.119289504724857e-07,0.9999993521744259,-282847.3426222788,282847.10827934934,False,43,LDVAE
|
88 |
+
5,-0.1121250664209042,0.8939324495767959,130151.94036736256,-8.614936212585359e-07,0.9999993126275404,-255093.22776310187,255093.003512969,False,43,LDVAE
|
89 |
+
41,0.0967894863732373,1.1016284414108755,180539.87056300006,5.361114199949658e-07,0.9999995722449752,-353851.5472875169,353851.7408664896,False,43,LDVAE
|
90 |
+
32,-0.09012567261796996,0.9138163363633633,70956.64127387799,-1.2701513346735714e-06,0.9999989865658602,-139072.55148640176,139072.37123505655,False,43,LDVAE
|
91 |
+
12,-0.08893968223048858,0.9149007566831417,117612.24078115488,-7.5621110217585e-07,0.9999993966308368,-230515.84501179878,230515.66713243432,False,43,LDVAE
|
92 |
+
14,0.07726848435123265,1.0803320897190622,118833.67642189974,6.502237974772689e-07,0.999999481196471,-232909.64866892574,232909.80320589442,False,43,LDVAE
|
93 |
+
42,0.06958030256411953,1.0720581467663495,94304.13372068887,7.378287654940271e-07,0.9999994112978196,-184832.63610549687,184832.77526610202,False,43,LDVAE
|
94 |
+
22,-0.06836641391925985,0.9339182102443345,100693.85474323847,-6.789531902774893e-07,0.9999994582737319,-197356.39712766898,197356.26039484117,False,43,LDVAE
|
95 |
+
21,-0.06419392219268419,0.9378231171805538,63971.149305322244,-1.0034823962017424e-06,0.9999991993368891,-125381.2128819883,125381.0844941439,False,43,LDVAE
|
96 |
+
25,0.0620194392966435,1.0639830276087001,207456.66845523455,2.989512930987137e-07,0.9999997614713788,-406607.53650548717,406607.66054436576,False,43,LDVAE
|
97 |
+
23,-0.04112231029937005,0.9597117401387086,105957.11145472883,-3.8810335365682315e-07,0.9999996903383261,-207672.16347947522,207672.08123485462,False,43,LDVAE
|
98 |
+
45,-0.037918332949368846,0.9627915660281844,165342.70666594038,-2.2933175411225925e-07,0.9999998170197341,-324065.78808994684,324065.7122532809,False,43,LDVAE
|
99 |
+
6,0.029991646643496038,1.0304459262353853,66232.63907958794,4.528227632218732e-07,0.9999996386997084,-129813.55720538583,129813.61718867913,False,43,LDVAE
|
100 |
+
26,-0.02663285855590697,0.9737186683852663,48807.37283664873,-5.45672856538362e-07,0.9999995646160525,-95660.7195727086,95660.66630699148,False,43,LDVAE
|
101 |
+
1,0.017529930573089728,1.0176844815746835,84301.35150995592,2.0794364810414052e-07,0.9999998340849736,-165227.59527763433,165227.63033749547,False,43,LDVAE
|
102 |
+
24,-0.01022862047590465,0.9898235139566621,106196.11415865921,-9.63182180152362e-08,0.999999923149181,-208140.56927769663,208140.5488204557,False,43,LDVAE
|
103 |
+
31,0.009156211347569353,1.0091982576810856,233814.0669609831,3.916022447484848e-08,0.9999999687546615,-458267.1411661521,458267.15947857476,False,43,LDVAE
|
104 |
+
48,-0.008848362435023962,0.9911906691172566,142991.95436843677,-6.188014195697362e-08,0.9999999506267901,-280259.08948949334,280259.0717927685,False,43,LDVAE
|
105 |
+
2,-0.007413502675391967,0.9926139095535276,231200.63760875154,-3.2065234560198056e-08,0.9999999744156444,-453144.9303293524,453144.91550234705,False,43,LDVAE
|
106 |
+
const,-1.0154495631190565,0.3622395436823274,0.03959991401817431,-25.642721412299476,5.097201133159372e-145,-1.093063968385561,-0.9378351578525521,True,5235,LDVAE
|
107 |
+
19,0.7104723339322627,2.0349522086629195,67361.80286516222,1.0547109841380162e-05,0.9999915846238966,-132025.99707707102,132027.4180217389,False,5235,LDVAE
|
108 |
+
18,-0.5394392499127636,0.5830751201443456,135580.01228990196,-3.978752035803888e-06,0.9999968254151794,-265732.48055095563,265731.40167245583,False,5235,LDVAE
|
109 |
+
6,-0.5393635328347576,0.58311927056015,66716.08133891653,-8.084460627937668e-06,0.9999935495336826,-130761.65597745402,130760.57725038835,False,5235,LDVAE
|
110 |
+
43,0.5230591883068798,1.687181167788677,163218.44173560903,3.2046574072442273e-06,0.999997443053332,-319901.7443553546,319902.79047373123,False,5235,LDVAE
|
111 |
+
42,-0.5080517670992536,0.6016666244200486,63741.261046052765,-7.970532097446089e-06,0.9999936404354981,-124931.08403119641,124930.06792766221,False,5235,LDVAE
|
112 |
+
9,-0.48001123987061983,0.618776436799962,83156.83032027082,-5.7723609476443616e-06,0.9999953943223205,-162984.87250747904,162983.91248499928,False,5235,LDVAE
|
113 |
+
23,0.47241177453932043,1.603857675527044,57879.973362265904,8.161921077304834e-06,0.999993487729186,-113442.19080440434,113443.13562795341,False,5235,LDVAE
|
114 |
+
11,0.4717987376465149,1.6028747529158314,135328.88454889614,3.486312173629479e-06,0.9999972183253425,-265239.2679850778,265240.2115825531,False,5235,LDVAE
|
115 |
+
16,-0.4253136500030362,0.6535647623891288,84957.8786003333,-5.006170787336111e-06,0.99999600565362,-166514.80757322942,166513.95694592944,False,5235,LDVAE
|
116 |
+
38,-0.40399252074216035,0.6676491147701308,80053.20088815909,-5.046550497169641e-06,0.999995973435273,-156901.79458046242,156900.98659542095,False,5235,LDVAE
|
117 |
+
approval_rate,0.4010379380714367,1.4933739231518472,0.0714658549066941,5.611602052407156,2.0046201046990394e-08,0.2609674363299511,0.5411084398129222,True,5235,LDVAE
|
118 |
+
48,0.3645029515729631,1.4397981808424978,86194.40775431423,4.228846871503898e-06,0.9999966258683712,-168937.5703642643,168938.29937016743,False,5235,LDVAE
|
119 |
+
33,0.32669605266543733,1.3863800266203774,102772.74777384097,3.178819869488711e-06,0.9999974636687046,-201430.55753289466,201431.21092499996,False,5235,LDVAE
|
120 |
+
31,-0.31775213504876954,0.7277831579969865,184720.89235944676,-1.7201743180758267e-06,0.9999986274994698,-362046.61396875075,362045.97846448066,False,5235,LDVAE
|
121 |
+
46,0.31464484337252174,1.3697727406907882,216537.1406488771,1.4530756360301711e-06,0.9999988406133843,-424404.6823422399,424405.3116319267,False,5235,LDVAE
|
122 |
+
14,0.3095070918182879,1.362753236338904,88747.15205405664,3.4875157642215326e-06,0.9999972173650161,-173940.91224935907,173941.5312635427,False,5235,LDVAE
|
123 |
+
1,-0.30168676908542286,0.7395696847011278,65082.60717542798,-4.63544381791953e-06,0.9999963014509452,-127559.86777057602,127559.26439703784,False,5235,LDVAE
|
124 |
+
17,-0.2956046527535968,0.7440815404661987,132879.27681837464,-2.2246106378020294e-06,0.9999982250175183,-260438.89246039515,260438.30125108964,False,5235,LDVAE
|
125 |
+
36,0.2398651409980949,1.2710777224893726,106435.13406741443,2.2536274614561754e-06,0.9999982018654427,-208608.78959668343,208609.2693269654,False,5235,LDVAE
|
126 |
+
28,0.23198974954459783,1.2611068018430462,62366.684612403435,3.7197704349103703e-06,0.9999970320526003,-122236.22368572956,122236.68766522866,False,5235,LDVAE
|
127 |
+
26,0.22568086076304983,1.2531756639283687,39058.64749710659,5.777999885422759e-06,0.9999953898230991,-76553.31669831368,76553.7680600352,False,5235,LDVAE
|
128 |
+
39,-0.21353848217251048,0.8077210766906735,62404.36014091576,-3.4218519617910927e-06,0.9999972697571503,-122310.51189294396,122310.08481597962,False,5235,LDVAE
|
129 |
+
34,0.2111036810311648,1.235040398685498,87584.03365642879,2.410298683653622e-06,0.9999980768598934,-171661.3404836633,171661.7626910254,False,5235,LDVAE
|
130 |
+
40,-0.21001253440435422,0.8105740858431607,414492.87432730885,-5.06673449441535e-07,0.9999995957330773,-812391.3155425466,812390.8955174778,False,5235,LDVAE
|
131 |
+
32,-0.20209984823873556,0.81701334652575,40245.63997559508,-5.021658205989238e-06,0.9999959932964478,-78880.20698678005,78879.80278708358,False,5235,LDVAE
|
132 |
+
30,-0.19150065009736153,0.8257190883085077,44148.18379556206,-4.3376790081365e-06,0.9999965390328897,-86529.04172280655,86528.65872150636,False,5235,LDVAE
|
133 |
+
45,0.16174647426774463,1.1755621682784785,138252.4191062898,1.1699359426281892e-06,0.9999990665261742,-270969.600477391,270969.9239703395,False,5235,LDVAE
|
134 |
+
4,-0.16159129756974505,0.8507888529648564,109316.37064732653,-1.478198522443326e-06,0.9999988205682211,-214256.3109806891,214255.98779809396,False,5235,LDVAE
|
135 |
+
22,0.15078140888137914,1.1627424651245515,84394.73241766158,1.7866210907000232e-06,0.9999985744826158,-165410.4852421028,165410.78680492056,False,5235,LDVAE
|
136 |
+
3,0.13957556137689067,1.1497856818250298,126562.23916755595,1.1028215231883372e-06,0.9999991200757333,-248057.2909955929,248057.57014671562,False,5235,LDVAE
|
137 |
+
15,0.12561220791159525,1.1338423879093322,37382.799849402705,3.3601605127926834e-06,0.999997318979805,-73268.81573389075,73269.06695830656,False,5235,LDVAE
|
138 |
+
44,-0.12518014926862586,0.8823379357323412,84062.01804292548,-1.489140424926556e-06,0.9999988118378461,-164758.65301203943,164758.40265174088,False,5235,LDVAE
|
139 |
+
47,-0.09739187319041324,0.9072004289408053,53572.65719749784,-1.8179399396108733e-06,0.9999985494937897,-105000.57605507947,105000.38127133308,False,5235,LDVAE
|
140 |
+
20,0.07991020130505465,1.0831897942776076,72082.11676208334,1.1085995375081581e-06,0.9999991154655449,-141278.27287289297,141278.4326932956,False,5235,LDVAE
|
141 |
+
41,-0.07404668255105727,0.928628342089417,155549.88601483998,-4.7603173777956334e-07,0.999999620181626,-304872.2484350796,304872.10034171445,False,5235,LDVAE
|
142 |
+
25,-0.06963250612467235,0.9327365318925781,150538.25925943858,-4.6255687070665043e-07,0.9999996309330144,-295049.636076359,295049.4968113468,False,5235,LDVAE
|
143 |
+
7,0.0655540197857693,1.0677504154043003,54766.93799257242,1.1969633904794868e-06,0.9999990449613909,-107341.16045496053,107341.29156300011,False,5235,LDVAE
|
144 |
+
0,0.06204910384362592,1.0640145906513603,61416.67180208626,1.0102974000867006e-06,0.9999991938993027,-120374.40273330193,120374.52683150962,False,5235,LDVAE
|
145 |
+
24,-0.061925118976187965,0.9399532688190215,70351.76732089788,-8.802212273321698e-07,0.9999992976850727,-137886.99212282072,137886.8682725828,False,5235,LDVAE
|
146 |
+
35,0.05956099849069878,1.0613705010036278,52197.87317436862,1.1410617879340295e-06,0.9999990895644165,-102305.89193035343,102306.01105235041,False,5235,LDVAE
|
147 |
+
8,-0.05935653797543106,0.9423707183052044,108644.7516321457,-5.463359903145908e-07,0.9999995640869483,-212939.85966484278,212939.74095176684,False,5235,LDVAE
|
148 |
+
5,-0.05312728105728016,0.94825930935338,99788.45004482285,-5.323991006315511e-07,0.9999995752069775,-195581.8212882082,195581.7150336461,False,5235,LDVAE
|
149 |
+
49,0.029757960756757355,1.0302051536990442,87119.55778929942,3.4157612265121506e-07,0.9999997274616854,-170751.16585812203,170751.22537404354,False,5235,LDVAE
|
150 |
+
37,0.02812116665141083,1.0285202992322588,491342.9831088927,5.7233272109593855e-08,0.9999999543344558,-963014.5228287352,963014.5790710684,False,5235,LDVAE
|
151 |
+
10,-0.017617989717582223,0.9825362996450692,160331.16515707172,-1.0988499771907974e-07,0.9999999123244568,-314243.3269251935,314243.291689214,False,5235,LDVAE
|
152 |
+
13,-0.015761253377176453,0.9843623051792129,56252.657998974384,-2.801868202825868e-07,0.999999776443262,-110253.19947389216,110253.1679513854,False,5235,LDVAE
|
153 |
+
21,-0.011368801259888664,0.9886955793533874,49108.03912283896,-2.315059094795196e-07,0.9999998152850091,-96249.99940094959,96249.97666334706,False,5235,LDVAE
|
154 |
+
2,0.010045020430581654,1.0100956410012192,189338.37119329532,5.305327370925096e-08,0.999999957669612,-371096.3783853144,371096.3984753553,False,5235,LDVAE
|
155 |
+
29,0.007582515480154255,1.0076113355474756,47505.78606069335,1.5961246216338447e-07,0.9999998726476808,-93109.6221537084,93109.63731873936,False,5235,LDVAE
|
156 |
+
12,-0.005716494170986043,0.9942998138920374,81009.5044058949,-7.056572204594384e-08,0.9999999436966999,-158775.716757487,158775.70532449867,False,5235,LDVAE
|
157 |
+
27,0.0008957401526021151,1.0008961414476223,53430.01792734916,1.6764736141771226e-08,0.9999999866236758,-104720.90993519362,104720.91172667393,False,5235,LDVAE
|
158 |
+
const,-1.3142267214164842,0.2686820089727373,0.04639667116820665,-28.325883912056582,1.659168928972161e-176,-1.4051625259087173,-1.2232909169242512,True,332,LDVAE
|
159 |
+
approval_rate,0.7100602661848314,2.034113843233705,0.0740779853987323,9.585307461627902,9.218267073063153e-22,0.5648700827560321,0.8552504496136307,True,332,LDVAE
|
160 |
+
46,0.6691056610629424,1.9524903514155831,392768.66895461234,1.7035616991646121e-06,0.9999986407544219,-769811.7763011144,769813.1145124366,False,332,LDVAE
|
161 |
+
7,0.5307145222750472,1.7001466673883865,92563.24888073397,5.733533866760263e-06,0.9999954253018489,-181420.10338373377,181421.1648127783,False,332,LDVAE
|
162 |
+
28,0.48995919802116933,1.6322496195822502,93983.8691609549,5.213226507860354e-06,0.9999958404470575,-184204.50872399824,184205.48864239428,False,332,LDVAE
|
163 |
+
18,-0.47346062162830305,0.6228431100849441,239924.8969934266,-1.9733701152376645e-06,0.9999984254784523,-470244.63056222006,470243.68364097684,False,332,LDVAE
|
164 |
+
38,-0.42947312309490987,0.6508519232481627,138815.3009633661,-3.0938457080336515e-06,0.9999975314682761,-272073.41986440896,272072.56091816275,False,332,LDVAE
|
165 |
+
14,0.38349273683451185,1.467400894434507,148894.26545584202,2.5756044778517365e-06,0.9999979449649524,-291827.0143052598,291827.7812907335,False,332,LDVAE
|
166 |
+
16,-0.3743076004633228,0.6877653223563237,164349.20137755986,-2.277513960067411e-06,0.9999981828067742,-322118.88989553845,322118.14128033747,False,332,LDVAE
|
167 |
+
34,0.36245632786828696,1.4368544691182525,157738.36266803805,2.2978324469557217e-06,0.9999981665949672,-309161.1473533441,309161.87226599985,False,332,LDVAE
|
168 |
+
17,-0.315332656938437,0.7295461453114114,228577.92464691118,-1.3795411670901184e-06,0.9999988992854018,-448004.81530151324,448004.1846361993,False,332,LDVAE
|
169 |
+
5,-0.29283363595153056,0.7461462622851943,163997.02866105383,-1.7856033023424709e-06,0.9999985752946934,-321428.56258088443,321427.97691361257,False,332,LDVAE
|
170 |
+
43,-0.27102000403474663,0.7626012411507568,290609.9579198339,-9.325902180871199e-07,0.9999992559006634,-569585.3220915791,569584.780051571,False,332,LDVAE
|
171 |
+
35,-0.2678285501505142,0.7650389356696987,116634.87791730318,-2.296298971054017e-06,0.999998167818504,-228600.42788769046,228599.89223059014,False,332,LDVAE
|
172 |
+
49,-0.25511864403331797,0.7748245641960824,166800.14932386388,-1.5294869043430675e-06,0.999998779646013,-326922.54040932027,326922.0301720322,False,332,LDVAE
|
173 |
+
0,-0.24220352263890163,0.7848964171048735,106972.98312024148,-2.264156009996058e-06,0.9999981934648764,-209663.43643800708,209662.95203096178,False,332,LDVAE
|
174 |
+
20,0.2386474959394395,1.2695309428867987,141626.95869230997,1.6850428629051506e-06,0.9999986555303154,-277583.49962937355,277583.9769243654,False,332,LDVAE
|
175 |
+
23,-0.23139416015150635,0.7934266672175182,129145.0708856136,-1.7917382255839778e-06,0.9999985703997328,-253119.91911083512,253119.4563225148,False,332,LDVAE
|
176 |
+
8,-0.22049573655980106,0.8021210586495058,218048.59159531444,-1.01122293405604e-06,0.9999991931608334,-427367.606902236,427367.16591076285,False,332,LDVAE
|
177 |
+
40,-0.16869965745945847,0.8447625834291346,668215.2034444163,-2.524630636804888e-07,0.9999997985636193,-1309677.9013728185,1309677.5639735034,False,332,LDVAE
|
178 |
+
48,-0.16868381744085342,0.8447759645901516,156155.48094829984,-1.0802298863701204e-06,0.9999991381012515,-306059.2873310157,306058.9499633808,False,332,LDVAE
|
179 |
+
44,0.1644034854777587,1.1786898033784077,132078.3039528186,1.2447425546627812e-06,0.9999990068391335,-258868.5544831732,258868.88329014418,False,332,LDVAE
|
180 |
+
24,-0.16171849108333222,0.850680645023147,145945.7442396337,-1.1080726740328973e-06,0.9999991158859212,-286048.56412506715,286048.24068808503,False,332,LDVAE
|
181 |
+
6,-0.15953606163126666,0.8525392228869819,104025.94268847577,-1.5336180332345156e-06,0.9999987763498491,-203887.26066330192,203886.94159117865,False,332,LDVAE
|
182 |
+
4,-0.15833902108917688,0.8535603579486006,192789.65096845335,-8.213045684443211e-07,0.9999993446937652,-377860.9308292372,377860.61415119504,False,332,LDVAE
|
183 |
+
9,-0.1402079830757011,0.8691774424007152,158377.0049402493,-8.852799251292648e-07,0.9999992936488158,-310413.3658701939,310413.08545422775,False,332,LDVAE
|
184 |
+
36,0.13739429755290644,1.1472804292136896,201616.225121237,6.814644876437287e-07,0.9999994562700065,-395160.4025422466,395160.6773308418,False,332,LDVAE
|
185 |
+
37,0.12565430799501165,1.1338901237732792,874575.1898832724,1.4367467708726386e-07,0.9999998853641934,-1714135.748289185,1714135.999597801,False,332,LDVAE
|
186 |
+
10,-0.11019899043660761,0.8956558906059001,279810.4400110193,-3.9383444889428655e-07,0.9999996857655737,-548418.4951188936,548418.2747209127,False,332,LDVAE
|
187 |
+
42,0.09935306992907467,1.1044561809926159,123604.41770244352,8.037986972945431e-07,0.9999993586614294,-242260.10767376446,242260.30637990433,False,332,LDVAE
|
188 |
+
39,0.09933785924693209,1.1044393815884719,102433.25841328192,9.69781307220932e-07,0.9999992262264676,-200765.3979712578,200765.5966469763,False,332,LDVAE
|
189 |
+
21,-0.09514872047383936,0.909237702150677,81054.18859802606,-1.17389023466403e-06,0.9999990633711057,-158863.38559696864,158863.19529952767,False,332,LDVAE
|
190 |
+
33,-0.09497456108204562,0.9093960682259489,178355.71698001737,-5.32500794985374e-07,0.999999575125837,-349570.8766922141,349570.68674309197,False,332,LDVAE
|
191 |
+
29,0.08659879688507165,1.090459096358083,83709.59454769711,1.0345145900297999e-06,0.9999991745767807,-164067.70387513994,164067.8770727337,False,332,LDVAE
|
192 |
+
26,-0.08076791703366429,0.9224077417298064,62073.41528904027,-1.3011676038377211e-06,0.9999989618184579,-121661.73913183392,121661.57759599984,False,332,LDVAE
|
193 |
+
27,0.06695796524574288,1.0692505315466136,102410.87297764182,6.53816956138642e-07,0.999999478329545,-200721.55570351897,200721.68961944943,False,332,LDVAE
|
194 |
+
22,-0.06606411284918486,0.9360708481986212,154340.58577055947,-4.28041091844726e-07,0.9999996584726214,-302502.05552722455,302501.9233989988,False,332,LDVAE
|
195 |
+
2,0.06543865493537214,1.0676272416424635,330855.41386239213,1.9778626008093398e-07,0.9999998421893967,-648464.6298217278,648464.7606990377,False,332,LDVAE
|
196 |
+
30,-0.06412829905202767,0.9378846620982468,100173.38463518763,-6.401730288496362e-07,0.999999489215824,-196336.2902227448,196336.16196614673,False,332,LDVAE
|
197 |
+
31,0.06375923484399344,1.0658357517558679,274792.38126611133,2.320269381204148e-07,0.9999998148692884,-538583.1067483424,538583.2342668121,False,332,LDVAE
|
198 |
+
15,-0.06285363195608411,0.9390809150669922,71946.81288637008,-8.736124566817521e-07,0.9999993029581087,-141013.22491335956,141013.09920609568,False,332,LDVAE
|
199 |
+
25,0.050309340213972896,1.051596347105892,277281.77469464066,1.8143760176584473e-07,0.9999998552337388,-543462.2416615052,543462.3422801857,False,332,LDVAE
|
200 |
+
47,0.04862712451784345,1.0498288223205858,113469.78543555285,4.28546897583252e-07,0.9999996580690469,-222396.64416004665,222396.74141429568,False,332,LDVAE
|
201 |
+
32,-0.04432937502252343,0.9566388126450166,97738.58316657603,-4.535504156733355e-07,0.9999996381191257,-191564.14723583683,191564.05857708678,False,332,LDVAE
|
202 |
+
45,0.04212227006828164,1.0430220013258287,213613.66046942034,1.971890279662691e-07,0.999999842665919,-418675.03900356125,418675.12324810144,False,332,LDVAE
|
203 |
+
19,-0.040556963463789085,0.9602544635330874,112410.9293342496,-3.607919950843437e-07,0.9999997121296375,-220321.41352076977,220321.33240684282,False,332,LDVAE
|
204 |
+
12,-0.03873445860528336,0.9620061276816394,151546.72075721368,-2.5559417196059377e-07,0.9999997960653564,-297026.15339374606,297026.0759248288,False,332,LDVAE
|
205 |
+
11,0.021698547475925842,1.0219356729442224,267006.7495940774,8.126591372283102e-08,0.9999999351591822,-523323.59113494895,523323.6345320439,False,332,LDVAE
|
206 |
+
13,-0.019998763044025578,0.9801998857701103,95288.76957715444,-2.0987534137307506e-07,0.9999998325437054,-186762.57650112174,186762.53650359565,False,332,LDVAE
|
207 |
+
1,-0.012779988297793485,0.9873013289727839,103655.05373685855,-1.23293441439306e-07,0.9999999016260667,-203160.184919795,203160.1593598184,False,332,LDVAE
|
208 |
+
41,0.012661082002929522,1.0127415728433322,223021.38632126362,5.6770708010446847e-08,0.9999999547035285,-437113.87231078855,437113.8976329526,False,332,LDVAE
|
209 |
+
3,0.00935784069435154,1.0094017621821059,234049.77471230784,3.998226747218247e-08,0.9999999680987661,-458729.1196679962,458729.1383836776,False,332,LDVAE
|
210 |
+
const,-0.865984964690654,0.420637035890725,0.040674769597808455,-21.290470069123955,1.3912552842710945e-100,-0.9457060481818234,-0.7862638811994846,True,2132,LDVAE
|
211 |
+
approval_rate,0.7761625404770758,2.1731169957370984,0.07377312725275494,10.520938577239061,6.918096332073849e-26,0.6315698680347858,0.9207552129193658,True,2132,LDVAE
|
212 |
+
20,0.6183625094226224,1.855886555575964,148975.63396655425,4.150762731853504e-06,0.9999966881705007,-291986.25878595887,291987.4955109777,False,2132,LDVAE
|
213 |
+
32,-0.39967107625484216,0.6705405664808529,106222.34397895112,-3.762589501263882e-06,0.9999969978879283,-208192.3682232455,208191.568881093,False,2132,LDVAE
|
214 |
+
24,0.3916157335959015,1.4793691303099403,136017.88613599841,2.879148799624351e-06,0.9999977027716245,-266589.76646409323,266590.5496955605,False,2132,LDVAE
|
215 |
+
16,-0.37954431814965295,0.684173103455998,168707.34601719372,-2.249720163999094e-06,0.9999982049830151,-330660.7016653548,330659.9425767185,False,2132,LDVAE
|
216 |
+
42,-0.3539592875953859,0.7019035429547402,134363.04301673616,-2.634350038881577e-06,0.9999978980927763,-263347.07912529644,263346.3712067213,False,2132,LDVAE
|
217 |
+
49,-0.3365735121002906,0.7142133783207932,164888.96685944413,-2.0412130569487713e-06,0.9999983713476166,-323176.7730660412,323176.09991901694,False,2132,LDVAE
|
218 |
+
48,0.3292281121019832,1.3898948712693002,172504.25413472383,1.908521698513359e-06,0.9999984772200028,-338101.79605589126,338102.4545121155,False,2132,LDVAE
|
219 |
+
12,0.30897661481651373,1.3620305187973984,170703.0204216106,1.8100242986526443e-06,0.9999985558095574,-334571.46310194733,334572.0810551769,False,2132,LDVAE
|
220 |
+
19,0.30064766413893357,1.350733345891276,121922.71902658611,2.4658871335815205e-06,0.9999980325067275,-238963.83754164103,238964.43883696932,False,2132,LDVAE
|
221 |
+
8,-0.28668244744827726,0.7507500935963237,214470.75343634278,-1.3366971619902836e-06,0.9999989334699719,-420355.2391548494,420354.6657899544,False,2132,LDVAE
|
222 |
+
22,0.2569768703213622,1.2930152193869828,161569.45089448584,1.5905040767216748e-06,0.9999987309613533,-316670.04777823476,316670.56173197535,False,2132,LDVAE
|
223 |
+
27,-0.24734901968008716,0.7808681076281065,118461.54539366781,-2.0880110829054646e-06,0.9999983340081942,-232180.60987356532,232180.11517552595,False,2132,LDVAE
|
224 |
+
31,-0.2403449947508654,0.7863565253909841,326440.16611184546,-7.362604841602673e-07,0.9999994125491269,-639811.2090314844,639810.728341495,False,2132,LDVAE
|
225 |
+
21,0.24024006995528124,1.2715543756843273,84699.007931678,2.8363976842452462e-06,0.9999977368820795,-166006.76483229132,166007.24531243122,False,2132,LDVAE
|
226 |
+
17,-0.2324173352033393,0.7926152680186579,253023.70730630294,-9.185595202823497e-07,0.9999992670955405,-495917.5859724931,495917.1211378227,False,2132,LDVAE
|
227 |
+
38,-0.20785800601529658,0.812322373413851,149169.74654729484,-1.3934327222939566e-06,0.9999988882015444,-292367.53867367195,292367.12295765994,False,2132,LDVAE
|
228 |
+
6,-0.19662282016590832,0.8215004282800229,114061.46326951294,-1.72383217372298e-06,0.9999986245809231,-223556.55665500378,223556.16340936345,False,2132,LDVAE
|
229 |
+
15,0.18845905672856111,1.2073876475744116,76892.10856753943,2.4509544638514502e-06,0.999998044421274,-150705.5750286643,150705.95194677773,False,2132,LDVAE
|
230 |
+
45,0.15612318011527965,1.1689701881041707,234097.08802895717,6.669163697412915e-07,0.9999994678777252,-458821.70529927855,458822.0175456388,False,2132,LDVAE
|
231 |
+
11,-0.15568622404006527,0.8558276863988546,273858.3126696972,-5.684918691069266e-07,0.9999995464091147,-536752.5853857397,536752.2740132917,False,2132,LDVAE
|
232 |
+
0,0.1530221833251024,1.165350830012326,112791.74625288961,1.3566789096607512e-06,0.999998917526844,-221067.6073868609,221067.9134312276,False,2132,LDVAE
|
233 |
+
35,-0.14290093871712625,0.8668399349184188,128660.26181018437,-1.1106843457846488e-06,0.9999991138021086,-252169.6222903942,252169.33648851677,False,2132,LDVAE
|
234 |
+
13,0.13157362263454003,1.1406218802190309,102405.85873627859,1.284825148269846e-06,0.9999989748578508,-200711.66335537986,200711.92650262514,False,2132,LDVAE
|
235 |
+
43,0.12727235093355097,1.1357262917798683,328330.19655917416,3.876352290082858e-07,0.9999996907118356,-643515.2330205872,643515.4875652891,False,2132,LDVAE
|
236 |
+
34,-0.12672210400337977,0.8809784589698615,175891.76057680993,-7.204550320481991e-07,0.9999994251600531,-344741.64262999356,344741.3891857856,False,2132,LDVAE
|
237 |
+
28,0.11710532979742315,1.1242378391982608,100391.02379338244,1.1664920365633575e-06,0.9999990692740137,-196762.67390080343,196762.908111463,False,2132,LDVAE
|
238 |
+
33,-0.11698071427737593,0.889602349622134,170051.91115310858,-6.879117881365692e-07,0.999999451125805,-333295.7383430122,333295.5043815837,False,2132,LDVAE
|
239 |
+
44,-0.1030343484060924,0.9020959873900489,155150.13345329335,-6.640944877892098e-07,0.9999994701292613,-304088.77679938637,304088.57073068956,False,2132,LDVAE
|
240 |
+
25,0.09541350342566575,1.100113661855351,285798.0015826977,3.3384944225391017e-07,0.9999997336266844,-560153.6945421053,560153.8853691122,False,2132,LDVAE
|
241 |
+
18,0.0903068540680602,1.094510087054009,254582.30260189448,3.5472557654283773e-07,0.9999997169699392,-498972.0538941368,498972.2345078449,False,2132,LDVAE
|
242 |
+
23,0.0756497619911292,1.0785847466223089,126485.57948221352,5.98090013903657e-07,0.9999995227932119,-247907.1046990549,247907.2559985789,False,2132,LDVAE
|
243 |
+
36,0.07483058089796732,1.0777015521879838,200845.62587027444,3.7257759821117615e-07,0.9999997027260867,-393650.11832756316,393650.267988725,False,2132,LDVAE
|
244 |
+
1,0.07102279380387654,1.073605697147161,112191.4998847828,6.330496862669164e-07,0.9999994948994291,-219891.2281229101,219891.3701684977,False,2132,LDVAE
|
245 |
+
46,0.06295419085188997,1.0649780523765366,409665.6669207581,1.536721183522251e-07,0.9999998773873894,-802929.8899130768,802930.0158214585,False,2132,LDVAE
|
246 |
+
39,-0.06108174618395016,0.9407463342097975,111135.22924141627,-5.496164141728976e-07,0.9999995614695487,-217821.10780852474,217820.98564503237,False,2132,LDVAE
|
247 |
+
29,-0.05847913136050735,0.9431979234517214,88381.19127574314,-6.616694176259352e-07,0.9999994720641873,-173224.01029033356,173223.89333207082,False,2132,LDVAE
|
248 |
+
10,-0.05814760085725047,0.9435106741742918,305372.99599515373,-1.9041500597575196e-07,0.9999998480708066,-598520.1321491963,598520.0158539946,False,2132,LDVAE
|
249 |
+
4,0.055345783445428766,1.0569060121000216,202853.8418443415,2.72835766590499e-07,0.9999997823085542,-397586.16879471013,397586.27948627697,False,2132,LDVAE
|
250 |
+
9,0.05150824338137265,1.0528578653652763,165186.24956107477,3.118191951099923e-07,0.9999997512042784,-323759.0483727085,323759.15138919523,False,2132,LDVAE
|
251 |
+
2,-0.047896656956719054,0.9532322919135223,359662.58634511224,-1.3317108527590935e-07,0.9999998937448471,-704925.7637196044,704925.6679262905,False,2132,LDVAE
|
252 |
+
41,-0.044996628154257486,0.9560007053145734,238165.11515684857,-1.8893039026569457e-07,0.9999998492553586,-466795.09307788586,466795.0030846296,False,2132,LDVAE
|
253 |
+
30,-0.036513804031562784,0.9641447847194247,104225.29326032312,-3.5033534461123935e-07,0.9999997204728375,-204277.85758216257,204277.78455455453,False,2132,LDVAE
|
254 |
+
3,-0.024639546146482397,0.9756615296116465,234144.43832262047,-1.0523225032803179e-07,0.9999999160368122,-458914.6909322423,458914.64165314997,False,2132,LDVAE
|
255 |
+
5,-0.02162586708718053,0.978606295393128,170392.9739240657,-1.2691759870813645e-07,0.9999998987344075,-333964.11373570847,333964.07048397424,False,2132,LDVAE
|
256 |
+
14,-0.017597999099381353,0.982555941349428,181488.2684609602,-9.696494020585605e-08,0.9999999226331713,-355710.4873980176,355710.45220201946,False,2132,LDVAE
|
257 |
+
37,0.01193237644890238,1.0120038512579603,826320.5348350663,1.4440372647018973e-08,0.9999999884782496,-1619558.4760302284,1619558.4998949815,False,2132,LDVAE
|
258 |
+
7,-0.011004609036971372,0.9890557201704823,110863.59644281534,-9.926260188255457e-08,0.9999999207999025,-217288.66722910994,217288.64521989189,False,2132,LDVAE
|
259 |
+
40,0.008961957723744581,1.0090022363019213,628982.2519871909,1.4248347541493252e-08,0.9999999886314634,-1232782.5518478334,1232782.5697717487,False,2132,LDVAE
|
260 |
+
26,-0.008310747890013676,0.9917236909051473,72639.77938020093,-1.1441042306192489e-07,0.9999999087136898,-142371.35974087694,142371.34311938117,False,2132,LDVAE
|
261 |
+
47,-0.004932883518832698,0.995079263170131,114157.66936997176,-4.321114425388096e-08,0.9999999655224951,-223744.92545705943,223744.9155912924,False,2132,LDVAE
|
data/coefficients_approval rate.csv
ADDED
@@ -0,0 +1,11 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
Feature,Coefficient,Odds_Ratio,HC_Std_Error,z_value,p_value,CI_Lower_95,CI_Upper_95,Significant,split_seed,X_features
|
2 |
+
const,-1.0097081934708991,0.3643252765561075,0.061683196036093325,-16.369258701836365,3.170521511205006e-60,-1.1306050361529658,-0.8888113507888324,True,432,approval rate
|
3 |
+
is_approved,0.24587144507984957,1.2787351752765106,0.07089189025980307,3.468259122147614,0.0005238419128543119,0.1069258933746697,0.38481699678502945,True,432,approval rate
|
4 |
+
const,-1.23135807786752,0.29189589102692315,0.063205406835268,-19.48184719507943,1.5652892874670123e-84,-1.355238398892847,-1.107477756842193,True,43,approval rate
|
5 |
+
is_approved,0.38482208076549956,1.4693528720451905,0.06866284395759524,5.604517066073724,2.0883641454293705e-08,0.25024537953251924,0.5193987819984799,True,43,approval rate
|
6 |
+
const,-0.9610663967523307,0.38248478788093293,0.058740948566214334,-16.361097670545643,3.6253391644796933e-60,-1.0761965403598306,-0.8459362531448309,True,5235,approval rate
|
7 |
+
is_approved,0.6698935146957179,1.9540292341594847,0.06662286405649169,10.055009255196437,8.731323016863624e-24,0.5393151005980861,0.8004719287933497,True,5235,approval rate
|
8 |
+
const,-0.9881802632595498,0.3722534783792413,0.05852282205135862,-16.885382977470563,5.764105654030467e-64,-1.1028828867538591,-0.8734776397652404,True,332,approval rate
|
9 |
+
is_approved,0.4955050894080537,1.6413270466348668,0.0619792274023547,7.994696129258761,1.2989382997751349e-15,0.3740280359098205,0.616982142906287,True,332,approval rate
|
10 |
+
const,-0.822996560779392,0.4391138497112739,0.05444331858466293,-15.116575957793213,1.2592204938783923e-51,-0.9297035044041715,-0.7162896171546125,True,2132,approval rate
|
11 |
+
is_approved,0.5028804012769497,1.653477095607513,0.057465943758762655,8.750929130964952,2.116032347698635e-18,0.39024922117217054,0.6155115813817288,True,2132,approval rate
|
data/coefficients_mrVI (vs ctrl).csv
ADDED
@@ -0,0 +1,161 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
Feature,Coefficient,Odds_Ratio,HC_Std_Error,z_value,p_value,CI_Lower_95,CI_Upper_95,Significant,split_seed,X_features
|
2 |
+
const,-1.042399886691631,0.3526074478110644,0.04102732724061574,-25.407452953934776,2.0862607628690864e-142,-1.1228119704651771,-0.9619878029180852,True,432,mrVI (vs ctrl)
|
3 |
+
X7,0.3096471996004971,1.3629441820487236,0.13492662420605714,2.294930310622834,0.021737118419600104,0.045195875601054813,0.5740985235999394,True,432,mrVI (vs ctrl)
|
4 |
+
X30,0.2793342688235328,1.3222492567100392,0.0908553183654349,3.074495514946135,0.002108588918648006,0.10126111702335985,0.45740742062370576,True,432,mrVI (vs ctrl)
|
5 |
+
X4,0.2676184122881928,1.3068483675800082,0.12864058497117212,2.0803575508317618,0.03749274973065698,0.015487498794530874,0.5197493257818546,True,432,mrVI (vs ctrl)
|
6 |
+
X11,0.2614609034320346,1.2988261609339706,0.10302658062445744,2.5378004573896003,0.011155156786360922,0.05953251595778586,0.46338929090628334,True,432,mrVI (vs ctrl)
|
7 |
+
X6,0.25994669098691253,1.2968609504456163,0.15432162924471035,1.6844475544948452,0.09209520698886572,-0.0425181443682629,0.5624115263420879,False,432,mrVI (vs ctrl)
|
8 |
+
X26,0.2490816307583375,1.282846748548666,0.16268088742388345,1.5311056799765737,0.12574327627108656,-0.06976704956548907,0.5679303110821641,False,432,mrVI (vs ctrl)
|
9 |
+
X1,0.23207146252804103,1.2612098548525923,0.09810086350309198,2.365641384193591,0.017998869424383307,0.0397973032097009,0.42434562184638114,True,432,mrVI (vs ctrl)
|
10 |
+
X3,-0.2193433773426734,0.8030459230303433,0.11508381160947653,-1.9059446700200504,0.05665738464106426,-0.44490350330083994,0.006216748615493151,False,432,mrVI (vs ctrl)
|
11 |
+
X20,-0.19870711387422957,0.8197899632809218,0.16611720368460997,-1.1961862436084272,0.23162388789582267,-0.5242908503085695,0.12687662256011034,False,432,mrVI (vs ctrl)
|
12 |
+
X28,0.1961532938045339,1.2167134056662603,0.1441111769524545,1.3611247784705085,0.173474260392129,-0.08629942279195568,0.47860601040102346,False,432,mrVI (vs ctrl)
|
13 |
+
X19,-0.19391055409316107,0.8237315803917139,0.10656909715372871,-1.819575836449473,0.06882362423161646,-0.40278214637941934,0.014961038193097187,False,432,mrVI (vs ctrl)
|
14 |
+
X12,0.1824843435986212,1.200195360066189,0.11435634457253022,1.5957518079189823,0.11054421672750983,-0.04164997316719052,0.40661866036443295,False,432,mrVI (vs ctrl)
|
15 |
+
X23,-0.16581401407224367,0.8472037875200149,0.1007903715042285,-1.6451374431662573,0.09994147052956315,-0.3633595122089437,0.03173148406445633,False,432,mrVI (vs ctrl)
|
16 |
+
X9,-0.14290711123285443,0.8668345843517999,0.11390297175859536,-1.2546390056945145,0.20960983695342628,-0.36615283361178425,0.08033861114607538,False,432,mrVI (vs ctrl)
|
17 |
+
approval_rate,0.13818392500486743,1.1481867111011332,0.04132854804336906,3.343546568823588,0.0008271481004837018,0.05718145930653075,0.21918639070320411,True,432,mrVI (vs ctrl)
|
18 |
+
X2,-0.13130563941477383,0.8769497030325228,0.12021936816027604,-1.0922170148134336,0.27473772548547903,-0.3669312712530761,0.10431999242352849,False,432,mrVI (vs ctrl)
|
19 |
+
X27,-0.12555838840282157,0.8820042641032739,0.10829477251206193,-1.1594131968727928,0.24628780007486129,-0.33781224224042117,0.08669546543477805,False,432,mrVI (vs ctrl)
|
20 |
+
X15,-0.1148884030051401,0.8914656232405054,0.10063659841218263,-1.1416165174282382,0.25361345523334244,-0.3121325114196388,0.08235570540935865,False,432,mrVI (vs ctrl)
|
21 |
+
X25,-0.11392341836559557,0.8923262890714804,0.11668651998839438,-0.9763203014103632,0.3289057625626626,-0.34262479502416165,0.11477795829297054,False,432,mrVI (vs ctrl)
|
22 |
+
X29,0.10205340485079824,1.1074426129562176,0.11580782921998642,0.8812306174648993,0.378193010700112,-0.12492576954814046,0.32903257924973695,False,432,mrVI (vs ctrl)
|
23 |
+
X14,0.09805388678706814,1.1030222218306656,0.1364437327080489,0.7186397267280557,0.4723629292506476,-0.16937091523691752,0.36547868881105383,False,432,mrVI (vs ctrl)
|
24 |
+
X22,0.0905712634254482,1.0947995240260173,0.09679374111603099,0.9357140490817105,0.3494204351835647,-0.09914098309086637,0.28028350994176277,False,432,mrVI (vs ctrl)
|
25 |
+
X13,0.057049873957843646,1.058708611067437,0.08654514289349052,0.6591920938654391,0.5097724232066319,-0.11257548915027038,0.22667523706595766,False,432,mrVI (vs ctrl)
|
26 |
+
X16,0.05634449440462736,1.0579620829841525,0.12212738079010489,0.4613584115216901,0.6445414839609802,-0.18302077347018708,0.2957097622794418,False,432,mrVI (vs ctrl)
|
27 |
+
X24,-0.055071335165138506,0.9464176326872884,0.13180704777479954,-0.41781783368087627,0.6760803109742688,-0.3134084017122959,0.20326573138201887,False,432,mrVI (vs ctrl)
|
28 |
+
X5,-0.0435266227034363,0.957407064987315,0.08922879114631538,-0.4878091717286892,0.625685014299148,-0.21841183973426087,0.13135859432738828,False,432,mrVI (vs ctrl)
|
29 |
+
X8,0.03830699303583548,1.0390501650855746,0.19209047497353304,0.19942161651228965,0.8419329525348543,-0.3381834196854819,0.4147974057571528,False,432,mrVI (vs ctrl)
|
30 |
+
X21,0.035268638868075464,1.035897953878,0.09721429895380004,0.36279270897007104,0.7167597387581228,-0.15526788586368248,0.2258051635998334,False,432,mrVI (vs ctrl)
|
31 |
+
X10,-0.02964472943748587,0.9707903655298002,0.10467631371174219,-0.28320379641111143,0.7770206183239974,-0.23480653434691678,0.17551707547194506,False,432,mrVI (vs ctrl)
|
32 |
+
X18,0.009848799192510636,1.0098974582284423,0.13511071269725816,0.07289428792059433,0.9418902394317864,-0.25496333161965395,0.27466093000467523,False,432,mrVI (vs ctrl)
|
33 |
+
X17,0.005757901742363324,1.0057745103201525,0.08844992811880872,0.0650978679669375,0.9480960779497982,-0.16760077180565838,0.17911657529038502,False,432,mrVI (vs ctrl)
|
34 |
+
const,-0.6792284011410464,0.5070080483085834,0.0368396008119262,-18.43745280000856,6.576734808721749e-76,-0.7514326919372543,-0.6070241103448386,True,43,mrVI (vs ctrl)
|
35 |
+
approval_rate,0.5657694564686028,1.7608021221852084,0.04026413854386091,14.05144818514603,7.547468073550727e-45,0.48685319505410435,0.6446857178831011,True,43,mrVI (vs ctrl)
|
36 |
+
X26,0.40617696646697266,1.501068167685153,0.16985788987827877,2.3912752404850997,0.01678996059082683,0.07326161981557566,0.7390923131183696,True,43,mrVI (vs ctrl)
|
37 |
+
X3,-0.3749994202811605,0.6872896772256308,0.1543349946655394,-2.429775703778814,0.015108169302932352,-0.6774904513797991,-0.07250838918252189,True,43,mrVI (vs ctrl)
|
38 |
+
X18,0.27324177075957845,1.314217945888807,0.1919856111714743,1.4232408829614278,0.1546663378027211,-0.10304311268642186,0.6495266542055788,False,43,mrVI (vs ctrl)
|
39 |
+
X12,0.2482093333822227,1.2817282126148544,0.13471022837275676,1.8425425922031882,0.06539582236805697,-0.015817862577546277,0.5122365293419917,False,43,mrVI (vs ctrl)
|
40 |
+
X25,0.20718920399948496,1.2302153114195713,0.1463575376239482,1.4156373997753224,0.15688169534724844,-0.07966629860941946,0.4940447066083894,False,43,mrVI (vs ctrl)
|
41 |
+
X30,0.20416049680262063,1.226494986183989,0.10202041602331358,2.001172949108207,0.0453737550597827,0.0042041557091329895,0.4041168378961083,True,43,mrVI (vs ctrl)
|
42 |
+
X16,-0.20281527288043547,0.816429044082153,0.15831862159459326,-1.2810575966217344,0.20017343632777762,-0.5131140692878635,0.10748352352699256,False,43,mrVI (vs ctrl)
|
43 |
+
X4,-0.19958578143904054,0.8190699567997238,0.15563764128702134,-1.2823747506618377,0.1997112171558464,-0.5046299530003665,0.10545839012228542,False,43,mrVI (vs ctrl)
|
44 |
+
X2,-0.19848708051563227,0.8199703642662763,0.12460557105356813,-1.592923003661709,0.11117746506095434,-0.4427095120536725,0.045735351022407944,False,43,mrVI (vs ctrl)
|
45 |
+
X1,0.196785794144911,1.2174832207379689,0.11148396955938478,1.7651487915496948,0.07753876232927881,-0.021718771045042856,0.4152903593348649,False,43,mrVI (vs ctrl)
|
46 |
+
X7,0.17892081046238126,1.1959260355881842,0.15049011796084788,1.188920660617264,0.2344708891483196,-0.11603440077006491,0.47387602169482745,False,43,mrVI (vs ctrl)
|
47 |
+
X21,0.16796415928525724,1.1828942141139553,0.13326709526282823,1.2603573219180604,0.20754049011827203,-0.09323454775415455,0.42916286632466905,False,43,mrVI (vs ctrl)
|
48 |
+
X14,-0.16310422958046464,0.8495026404961917,0.16149487036000854,-1.009965389097923,0.31251187249151247,-0.47962835917404645,0.15341990001311714,False,43,mrVI (vs ctrl)
|
49 |
+
X24,0.1563626947291429,1.169250207080372,0.15244856892846145,1.0256750576813758,0.3050447749900037,-0.14243100986531346,0.4551563993235993,False,43,mrVI (vs ctrl)
|
50 |
+
X11,0.1277769959866997,1.136299575074869,0.11260935203748688,1.1346925781454067,0.2565041480960716,-0.09293327832916676,0.34848727030256615,False,43,mrVI (vs ctrl)
|
51 |
+
X6,-0.11295061146626614,0.8931947726068388,0.16691869038169724,-0.6766804316998839,0.4986087347074828,-0.440105232960985,0.21420401002845277,False,43,mrVI (vs ctrl)
|
52 |
+
X5,-0.10700452790318478,0.8985216045622599,0.12958359278867732,-0.8257567613338667,0.408942086361899,-0.36098370275629654,0.146974646949927,False,43,mrVI (vs ctrl)
|
53 |
+
X8,-0.09905755497239847,0.9056905795271296,0.22865381924746153,-0.43322064463394344,0.664854482211954,-0.5472108056249545,0.3490956956801575,False,43,mrVI (vs ctrl)
|
54 |
+
X23,-0.09063945856485435,0.913346950963843,0.11294089008318453,-0.8025389077250544,0.42224129138500177,-0.311999535509793,0.13072061838008425,False,43,mrVI (vs ctrl)
|
55 |
+
X15,-0.08780326522101717,0.9159410564602382,0.12388270930708521,-0.7087612606483046,0.47847264163855163,-0.3306089137701491,0.1550023833281148,False,43,mrVI (vs ctrl)
|
56 |
+
X29,-0.08043189494300104,0.9227177431883786,0.15577823974911342,-0.5163230440435042,0.6056288041569577,-0.3857516344263092,0.2248878445403071,False,43,mrVI (vs ctrl)
|
57 |
+
X20,0.07536157344509965,1.0782739556377623,0.21516190303263888,0.3502551910115227,0.7261471902759982,-0.346348007343972,0.49707115423417125,False,43,mrVI (vs ctrl)
|
58 |
+
X10,0.06763132203734087,1.069970761112472,0.12213789625620218,0.5537292200896783,0.5797641746178427,-0.1717545557723049,0.3070171998469866,False,43,mrVI (vs ctrl)
|
59 |
+
X22,0.06513985941053602,1.0673082870539423,0.1369547982065098,0.47563035588073144,0.6343377451157035,-0.20328661258417396,0.333566331405246,False,43,mrVI (vs ctrl)
|
60 |
+
X13,-0.05421145252079154,0.9472317907739788,0.09510324184369102,-0.570027387813887,0.5686591224904942,-0.2406103813474286,0.1321874763058455,False,43,mrVI (vs ctrl)
|
61 |
+
X19,-0.04371732942057326,0.9572244984378745,0.12197384584593438,-0.3584156022742186,0.7200323172661145,-0.2827816743344451,0.19534701549329858,False,43,mrVI (vs ctrl)
|
62 |
+
X28,0.04367534533321702,1.0446431515551753,0.15292185285209456,0.2856056509821369,0.7751801748153777,-0.256045978706022,0.3433966693724561,False,43,mrVI (vs ctrl)
|
63 |
+
X9,-0.03884461600955731,0.9619001614203097,0.12089880883255523,-0.32129858337444067,0.7479841298554952,-0.27580192709515855,0.1981126950760439,False,43,mrVI (vs ctrl)
|
64 |
+
X27,0.03315710433868614,1.0337129272708696,0.12669270351564726,0.26171281706519944,0.7935428582744412,-0.21515603165599356,0.2814702403333659,False,43,mrVI (vs ctrl)
|
65 |
+
X17,0.01538573634626608,1.0155047061506421,0.10679965715289255,0.1440616642077804,0.8854517764131487,-0.1939377452346289,0.22470921792716106,False,43,mrVI (vs ctrl)
|
66 |
+
approval_rate,0.6200197434906008,1.8589647439369763,0.050710832389389844,12.226573973972604,2.241966443217681e-34,0.5206283383813495,0.7194111485998522,True,5235,mrVI (vs ctrl)
|
67 |
+
const,-0.5760994448582473,0.562086545800545,0.04126894579278935,-13.959635599872904,2.7483544226830264e-44,-0.6569850922920502,-0.4952137974244444,True,5235,mrVI (vs ctrl)
|
68 |
+
X6,0.48901804334271193,1.6307141428902463,0.16778566741440654,2.914540025250831,0.003562131280773532,0.1601641780884594,0.8178719085969645,True,5235,mrVI (vs ctrl)
|
69 |
+
X4,0.43429826694559137,1.5438792876085927,0.14023198199911138,3.0969987071019465,0.0019549072648570253,0.15944863274666388,0.7091479011445189,True,5235,mrVI (vs ctrl)
|
70 |
+
X18,0.40272173748485685,1.4958905834686511,0.15894921307743165,2.5336504012050196,0.011288128705171837,0.09118700448210781,0.7142564704876059,True,5235,mrVI (vs ctrl)
|
71 |
+
X16,0.36791115904544475,1.4447136835296497,0.1327907269443776,2.7706088181861723,0.005595160091116688,0.10764611675357211,0.6281762013373173,True,5235,mrVI (vs ctrl)
|
72 |
+
X5,0.35963795544829413,1.432810579381391,0.11919923307924009,3.017116353502187,0.002551918388913144,0.12601175162818812,0.5932641592684001,True,5235,mrVI (vs ctrl)
|
73 |
+
X3,0.33169514892031493,1.3933280262088925,0.13924348280155488,2.3821233299158115,0.017213131543063014,0.05878293754734493,0.6046073602932849,True,5235,mrVI (vs ctrl)
|
74 |
+
X12,-0.3054114357518247,0.7368201578632348,0.14361321721587367,-2.1266248446529987,0.033451266512996375,-0.5868881691988648,-0.023934702304784672,True,5235,mrVI (vs ctrl)
|
75 |
+
X10,0.26460576514090667,1.3029172191283394,0.13820937487183257,1.9145283406880818,0.055552681481186146,-0.0062796319336803075,0.5354911622154936,False,5235,mrVI (vs ctrl)
|
76 |
+
X8,-0.24911851260612286,0.7794875888048501,0.21097018071866372,-1.1808233360634568,0.23767291161092796,-0.6626124686266103,0.16437544341436458,False,5235,mrVI (vs ctrl)
|
77 |
+
X28,0.24437169513281926,1.276818829643949,0.13986097199576167,1.7472472244810702,0.08059446327960484,-0.029750772821638682,0.5184941630872772,False,5235,mrVI (vs ctrl)
|
78 |
+
X25,-0.2438988544244875,0.7835668845783788,0.13224503651578945,-1.8442949607062726,0.06514016551087601,-0.5030943631296192,0.01529665428064414,False,5235,mrVI (vs ctrl)
|
79 |
+
X30,0.22544752132289134,1.252883282733886,0.10736007850445942,2.0999194902183955,0.035735923943769655,0.015025634076758054,0.4358694085690246,True,5235,mrVI (vs ctrl)
|
80 |
+
X24,0.19973721185505275,1.2210818301650026,0.14564707582328262,1.371378111960168,0.17025711703686908,-0.08572581121215564,0.48520023492226116,False,5235,mrVI (vs ctrl)
|
81 |
+
X20,-0.18854600706213465,0.8281624012431121,0.19215503373652768,-0.9812181518005845,0.32648517472480565,-0.565162952633808,0.18807093850953865,False,5235,mrVI (vs ctrl)
|
82 |
+
X21,-0.17469263709596253,0.8397150783735614,0.11316435390356525,-1.5437072812241703,0.12265926159151984,-0.3964906950806951,0.04710542088877004,False,5235,mrVI (vs ctrl)
|
83 |
+
X29,-0.16874219307687294,0.8447266516952745,0.1335704023188551,-1.2633202427140768,0.20647411426657225,-0.4305353710223543,0.09305098486860841,False,5235,mrVI (vs ctrl)
|
84 |
+
X14,-0.1443691533894514,0.8655681616539562,0.1644404703470215,-0.8779417444184313,0.379975333731998,-0.46666655287044023,0.17792824609153746,False,5235,mrVI (vs ctrl)
|
85 |
+
X23,0.13663091042649872,1.1464049443131161,0.12063060732345299,1.1326388340244637,0.25736595353617553,-0.09980073536066283,0.37306255621366025,False,5235,mrVI (vs ctrl)
|
86 |
+
X26,0.12367529235895953,1.1316483564667001,0.17837335082112107,0.6933507263816856,0.4880894763770942,-0.22593005105216585,0.4732806357700849,False,5235,mrVI (vs ctrl)
|
87 |
+
X22,0.1051741832164793,1.110904094352738,0.11457285903293388,0.9179676941311822,0.35863577933030355,-0.1193844940938557,0.3297328605268143,False,5235,mrVI (vs ctrl)
|
88 |
+
X27,0.08915000231289127,1.0932446332511074,0.12760046121893884,0.6986652043516232,0.4847612841381381,-0.16094230608692872,0.33924231071271127,False,5235,mrVI (vs ctrl)
|
89 |
+
X2,-0.07783547099974154,0.925116622535897,0.12497519278900317,-0.6228073689084195,0.5334111153271307,-0.3227823478271376,0.16711140582765455,False,5235,mrVI (vs ctrl)
|
90 |
+
X7,0.07295728084590142,1.075684583597679,0.1529718246733203,0.4769328011985585,0.6334099737660652,-0.22686198616318198,0.3727765478549848,False,5235,mrVI (vs ctrl)
|
91 |
+
X1,-0.06181362534375595,0.9400580734656954,0.10577988986187913,-0.5843608404628553,0.5589775671159016,-0.26913839976165266,0.14551114907414073,False,5235,mrVI (vs ctrl)
|
92 |
+
X13,0.05921285233691493,1.061001053260601,0.10459049679585791,0.5661398898648308,0.5712986883604799,-0.1457807545081185,0.26420645918194835,False,5235,mrVI (vs ctrl)
|
93 |
+
X11,-0.05100868681082626,0.950270415677238,0.11274779654371245,-0.4524140459902481,0.6509707300426766,-0.27199030737275226,0.16997293375109973,False,5235,mrVI (vs ctrl)
|
94 |
+
X17,0.031502841217786605,1.0320043077404755,0.09061638937564528,0.34765058986397374,0.7281026081020637,-0.14610201836753614,0.20910770080310934,False,5235,mrVI (vs ctrl)
|
95 |
+
X9,0.014893120401364071,1.0150045755365407,0.13811917689029465,0.10782804196113466,0.9141320983036542,-0.25581549187793035,0.2856017326806585,False,5235,mrVI (vs ctrl)
|
96 |
+
X15,-0.013620249633538287,0.9864720862783954,0.1078138338110694,-0.12633118730761503,0.899469770117651,-0.22493148093842108,0.19769098167134452,False,5235,mrVI (vs ctrl)
|
97 |
+
X19,-0.0036904276691139947,0.9963163735899858,0.1152798722151575,-0.03201276682737996,0.9744618696603767,-0.22963482535320234,0.22225397001497438,False,5235,mrVI (vs ctrl)
|
98 |
+
const,-1.0797956109888642,0.33966494233237426,0.04146571971798042,-26.040681756710033,1.7155008077470342e-149,-1.1610669282291382,-0.9985242937485902,True,332,mrVI (vs ctrl)
|
99 |
+
X6,0.6139983972510716,1.8478049059091635,0.19980852060591028,3.072934003961139,0.0021196535925945663,0.22238089305925823,1.005615901442885,True,332,mrVI (vs ctrl)
|
100 |
+
approval_rate,0.496375857112187,1.642756883656601,0.04362973176294338,11.377009141591389,5.4434681044071556e-30,0.41086315420167474,0.5818885600226993,True,332,mrVI (vs ctrl)
|
101 |
+
X18,0.4367638586404417,1.5476905601481599,0.1604846931736084,2.7215296985860284,0.006498054603795448,0.12221963995020818,0.7513080773306753,True,332,mrVI (vs ctrl)
|
102 |
+
X30,0.3723295051318302,1.451111051063793,0.13123220648716946,2.837180865112047,0.004551382155347096,0.11511910680525445,0.6295399034584059,True,332,mrVI (vs ctrl)
|
103 |
+
X26,0.3676985137801704,1.444406504666393,0.17854297303837918,2.059439850937907,0.03945212149764671,0.017760716932241294,0.7176363106280994,True,332,mrVI (vs ctrl)
|
104 |
+
X15,0.35536574655986747,1.4267023703516462,0.12906628874372228,2.7533583712590657,0.005898728648684839,0.10240046900392441,0.6083310241158105,True,332,mrVI (vs ctrl)
|
105 |
+
X2,-0.2817779932671462,0.7544411569587849,0.12057991857059933,-2.3368567221428806,0.019446635298505578,-0.5181102909242933,-0.04544569560999909,True,332,mrVI (vs ctrl)
|
106 |
+
X4,0.2686463954720336,1.308192476468012,0.1615606879743147,1.6628203236838386,0.09634840712231102,-0.048006734275136576,0.5852995252192038,False,332,mrVI (vs ctrl)
|
107 |
+
X7,0.2642383706861924,1.3024386224893387,0.16508934019279836,1.6005780287061755,0.1094704118317517,-0.05933079032317318,0.587807531695558,False,332,mrVI (vs ctrl)
|
108 |
+
X21,-0.2617928022055774,0.7696704812135232,0.11298722302998337,-2.3170124478243483,0.020503053696641696,-0.48324369005753937,-0.04034191435361539,True,332,mrVI (vs ctrl)
|
109 |
+
X8,-0.2610779734069505,0.770220860529004,0.2109280355579822,-1.2377585213663194,0.21580561261619835,-0.6744893264303795,0.15233337961647853,False,332,mrVI (vs ctrl)
|
110 |
+
X19,-0.24341942899374427,0.7839426365348585,0.12116953096148951,-2.0089161612015203,0.04454602570229955,-0.4809073457018747,-0.005931512285613838,True,332,mrVI (vs ctrl)
|
111 |
+
X16,0.21076870283461957,1.2346267563645332,0.13496446210370097,1.5616607479432165,0.11836793034623042,-0.05375678208145529,0.47529418775069443,False,332,mrVI (vs ctrl)
|
112 |
+
X27,0.19388123246159883,1.2139520962918415,0.12629833716818858,1.53510518672476,0.1247579924606752,-0.053658959695347286,0.44142142461854494,False,332,mrVI (vs ctrl)
|
113 |
+
X24,0.19267692492450036,1.2124910046110544,0.1590907432627582,1.211113361927478,0.22585196103189165,-0.119135202144214,0.5044890519932147,False,332,mrVI (vs ctrl)
|
114 |
+
X28,0.18874287367531264,1.2077303732834732,0.17227304033231905,1.0956030805007149,0.2732525130320488,-0.14890608088324883,0.5263918282338741,False,332,mrVI (vs ctrl)
|
115 |
+
X1,-0.18858348104028827,0.8281313672848669,0.11423496182229245,-1.6508385701888248,0.09877154205440646,-0.4124798919872895,0.035312929906713,False,332,mrVI (vs ctrl)
|
116 |
+
X5,0.1877109137925186,1.206484686848775,0.1038142346383834,1.8081423462434885,0.07058434896640486,-0.015761247181303423,0.3911830747663406,False,332,mrVI (vs ctrl)
|
117 |
+
X22,-0.1579484979817804,0.8538937580879292,0.12124921214135777,-1.3026764891275084,0.19268523196697307,-0.3955925869326983,0.07969559096913748,False,332,mrVI (vs ctrl)
|
118 |
+
X14,-0.15048753399308862,0.8602884543023855,0.16707672715055594,-0.9007091326219331,0.36774299166311986,-0.4779519018630037,0.17697683387682644,False,332,mrVI (vs ctrl)
|
119 |
+
X29,-0.1268365752868184,0.8808776180067888,0.1348037299511377,-0.9408981141159287,0.3467570741644447,-0.3910470309727117,0.1373738803990749,False,332,mrVI (vs ctrl)
|
120 |
+
X25,-0.12397223858298573,0.8834043650993075,0.13635825900552462,-0.909165601608062,0.3632627185938332,-0.39122951522839844,0.14328503806242698,False,332,mrVI (vs ctrl)
|
121 |
+
X11,0.10628736507258717,1.112141421191569,0.12175495433651282,0.8729613152235637,0.38268416367534774,-0.1323479603662968,0.3449226905114712,False,332,mrVI (vs ctrl)
|
122 |
+
X23,0.09981158225320057,1.1049627038776766,0.1139909183090388,0.875609949755849,0.38124211451327683,-0.12360651219716294,0.32322967670356406,False,332,mrVI (vs ctrl)
|
123 |
+
X10,0.09491875453428168,1.099569516459517,0.13429012173936564,0.706818590264613,0.47967922028867127,-0.16828504755437435,0.3581225566229377,False,332,mrVI (vs ctrl)
|
124 |
+
X9,-0.09324969408700783,0.9109660090697856,0.11897146164514905,-0.7837988438365125,0.4331581523707094,-0.3264294740995884,0.1399300859255727,False,332,mrVI (vs ctrl)
|
125 |
+
X12,-0.08000209849212836,0.9231144092362819,0.13019783483439143,-0.6144656598467182,0.5389076586505578,-0.33518516563263,0.1751809686483733,False,332,mrVI (vs ctrl)
|
126 |
+
X13,-0.06879306277233062,0.9335198400991975,0.1092415819806519,-0.6297333078215104,0.5288690865010618,-0.2829026290685881,0.14531650352392683,False,332,mrVI (vs ctrl)
|
127 |
+
X3,-0.05836990007230526,0.9433009558030053,0.1380049214839561,-0.4229552065582756,0.6723279427605434,-0.32885457587013717,0.21211477572552667,False,332,mrVI (vs ctrl)
|
128 |
+
X20,-0.03913278171448903,0.9616230147162256,0.169664083508494,-0.23064859046923683,0.8175878154662245,-0.3716682748611334,0.29340271143215535,False,332,mrVI (vs ctrl)
|
129 |
+
X17,-0.030211690999308222,0.9702401207065291,0.09420503879472322,-0.3207014336583501,0.7484366607309985,-0.21485017419916433,0.15442679220054786,False,332,mrVI (vs ctrl)
|
130 |
+
const,-0.825408893076935,0.4380558378404986,0.04029623773235263,-20.483522520372645,3.0200843519002703e-93,-0.9043880677448102,-0.7464297184090598,True,2132,mrVI (vs ctrl)
|
131 |
+
X8,-0.6934890928003038,0.49982907310248514,0.20962230549695843,-3.308279103009704,0.000938712062574097,-1.1043412619305948,-0.2826369236700127,True,2132,mrVI (vs ctrl)
|
132 |
+
X22,0.624476109718114,1.8672674578665374,0.12459972041567159,5.0118580333473215,5.390696998471966e-07,0.38026514521963756,0.8686870742165904,True,2132,mrVI (vs ctrl)
|
133 |
+
X4,0.483719778316737,1.6220970351977637,0.14458856751120663,3.3454911867720476,0.0008213696948683908,0.20033139341853384,0.7671081632149401,True,2132,mrVI (vs ctrl)
|
134 |
+
X20,-0.43908854017974275,0.6446237020045651,0.17266804591109639,-2.5429635104912314,0.010991670720542215,-0.7775116914464002,-0.1006653889130853,True,2132,mrVI (vs ctrl)
|
135 |
+
approval_rate,0.4164007148281163,1.5164934285369112,0.044072402276734944,9.448105692389884,3.450178671782823e-21,0.33002039365355473,0.5027810360026779,True,2132,mrVI (vs ctrl)
|
136 |
+
X25,-0.4041592757095278,0.6675377902460011,0.1390049585323856,-2.9075169690106137,0.0036431057828654996,-0.6766039881054873,-0.13171456331356834,True,2132,mrVI (vs ctrl)
|
137 |
+
X21,-0.3914125896881722,0.676101146123888,0.12250805803574444,-3.194994647404899,0.001398334339312433,-0.631523971254174,-0.15130120812217035,True,2132,mrVI (vs ctrl)
|
138 |
+
X23,-0.38862357566094974,0.6779894337105128,0.1338881919736997,-2.9025978313105383,0.0037008154920146535,-0.6510396098845859,-0.1262075414373136,True,2132,mrVI (vs ctrl)
|
139 |
+
X15,-0.35704162087871616,0.6997433731944526,0.13191158246711082,-2.706673774971477,0.006796100363849909,-0.6155835716579386,-0.09849967009949367,True,2132,mrVI (vs ctrl)
|
140 |
+
X18,-0.3080550527173883,0.7348748600374329,0.1590515321812551,-1.9368254331956314,0.05276668587343347,-0.6197903274785617,0.003680222043785042,False,2132,mrVI (vs ctrl)
|
141 |
+
X2,0.30580137506528055,1.357712604186598,0.13512440126960326,2.263109935674303,0.023628913231443827,0.04096241514431981,0.5706403349862412,True,2132,mrVI (vs ctrl)
|
142 |
+
X1,0.2985981286051373,1.3479678049075232,0.1034704400183569,2.885830277247902,0.003903826164887801,0.09579979270464584,0.5013964645056288,True,2132,mrVI (vs ctrl)
|
143 |
+
X27,-0.29436304925558526,0.745005968477417,0.1758956703378536,-1.673509351823067,0.09422706709089095,-0.6391122281543087,0.0503861296431381,False,2132,mrVI (vs ctrl)
|
144 |
+
X16,0.24569458367781788,1.2785090363787945,0.14166370076523882,1.7343510182963253,0.0828558203358537,-0.031961167738709495,0.5233503350943453,False,2132,mrVI (vs ctrl)
|
145 |
+
X28,0.22347873580276525,1.2504190508364412,0.1675966279616221,1.3334321729548138,0.1823900202006401,-0.10500461893237265,0.5519620905379031,False,2132,mrVI (vs ctrl)
|
146 |
+
X26,-0.18694272951046917,0.829491240394501,0.14171704189352632,-1.3191266696839568,0.18712676844078568,-0.46470302761733484,0.09081756859639648,False,2132,mrVI (vs ctrl)
|
147 |
+
X14,-0.1707491024679873,0.8430330618541783,0.17219033654367244,-0.9916299944316584,0.3213780520292603,-0.5082359605794164,0.1667377556434418,False,2132,mrVI (vs ctrl)
|
148 |
+
X17,0.16237233017402047,1.1762981310840015,0.10201286422889488,1.5916848468217886,0.11145553481154506,-0.0375692096743879,0.3623138700224289,False,2132,mrVI (vs ctrl)
|
149 |
+
X13,-0.16228545999447377,0.8501984722455127,0.09659926881934916,-1.6799864220293916,0.09295995754915858,-0.35161654781330115,0.027045627824353602,False,2132,mrVI (vs ctrl)
|
150 |
+
X3,0.1584391718437708,1.1716806508838262,0.13526037841701186,1.1713642509212714,0.2414523954158464,-0.10666629838883127,0.4235446420763729,False,2132,mrVI (vs ctrl)
|
151 |
+
X24,0.1397429476242752,1.149978156243943,0.1397667833101614,0.9998294610112525,0.3173930457856129,-0.13419491389865507,0.41368080914720545,False,2132,mrVI (vs ctrl)
|
152 |
+
X6,0.12771515831538038,1.136229311127727,0.16045290109304786,0.7959666509321474,0.4260514193220354,-0.1867667490419609,0.44219706567272166,False,2132,mrVI (vs ctrl)
|
153 |
+
X10,-0.10409637820015995,0.9011384431345979,0.15991654650500217,-0.650941884846818,0.5150840023612073,-0.41752704988198885,0.209334293481669,False,2132,mrVI (vs ctrl)
|
154 |
+
X5,-0.0964458811372915,0.908059039392473,0.1565470677976096,-0.6160823226787016,0.5378401884166253,-0.4032724959059564,0.2103807336313734,False,2132,mrVI (vs ctrl)
|
155 |
+
X9,0.08928694732768157,1.0933943579053658,0.15859395886286648,0.5629908476204096,0.5734411162104345,-0.22155150020916364,0.40012539486452675,False,2132,mrVI (vs ctrl)
|
156 |
+
X7,-0.07905716525917872,0.9239871029731054,0.14656132449085932,-0.5394135562967659,0.5896015291441723,-0.3663120827877512,0.20819775226939374,False,2132,mrVI (vs ctrl)
|
157 |
+
X12,0.06923361345291446,1.0716865402999667,0.15656037124877076,0.4422167174278341,0.6583323899378983,-0.2376190756008964,0.3760863025067253,False,2132,mrVI (vs ctrl)
|
158 |
+
X11,0.06160005198879,1.0635369001877775,0.12983699080753647,0.47444146391302827,0.6351851309121104,-0.19287577385503957,0.31607587783261953,False,2132,mrVI (vs ctrl)
|
159 |
+
X19,-0.05640981948763739,0.9451517149179391,0.138829494430672,-0.40632446094375896,0.684504214716892,-0.32851062856365854,0.21569098958838373,False,2132,mrVI (vs ctrl)
|
160 |
+
X29,-0.03188994398917278,0.9686131779157298,0.13600835284673704,-0.23447048156746977,0.8146197468171767,-0.2984614171653931,0.23468152918704754,False,2132,mrVI (vs ctrl)
|
161 |
+
X30,0.022926409423092382,1.0231912395429612,0.10548594076311928,0.21734090114033539,0.8279426843099684,-0.183822235347947,0.22967505419413176,False,2132,mrVI (vs ctrl)
|
data/coefficients_mrVI.csv
ADDED
@@ -0,0 +1,161 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
Feature,Coefficient,Odds_Ratio,HC_Std_Error,z_value,p_value,CI_Lower_95,CI_Upper_95,Significant,split_seed,X_features
|
2 |
+
const,-1.0281910732162889,0.35765334447641445,0.039376375283756086,-26.111877129544933,2.6726150353666024e-150,-1.105367350614184,-0.9510147958183938,True,432,mrVI
|
3 |
+
X22,-0.22517511577958743,0.7983763982119652,0.10979137245407068,-2.0509363417766324,0.04027314645225103,-0.44036225160278897,-0.009987979956385923,True,432,mrVI
|
4 |
+
X18,0.2166191566590715,1.241871053743706,0.10620375969046783,2.0396561975810528,0.041384580523733276,0.008463612643007795,0.42477470067513523,True,432,mrVI
|
5 |
+
X14,-0.19887113137332546,0.819655514407646,0.11831563272359671,-1.680852536519148,0.09279156110329123,-0.4307655103196437,0.03302324757299277,False,432,mrVI
|
6 |
+
approval_rate,0.1864339208366067,1.2049449976975861,0.06767116669827918,2.7549978806756346,0.005869251564623851,0.05380087131617323,0.3190669703570402,True,432,mrVI
|
7 |
+
X17,0.15934277274106584,1.1727398610508668,0.10258695049336744,1.5532460217868338,0.12036437038772992,-0.04172395550972788,0.36040950099185953,False,432,mrVI
|
8 |
+
X3,-0.15556538737326428,0.8559311080122708,0.11338793444733535,-1.3719747884244144,0.1700712864288888,-0.3778016551714301,0.06667088042490155,False,432,mrVI
|
9 |
+
X28,-0.15320327899252006,0.857955299794859,0.12868024394770913,-1.190573426755207,0.2338210887143215,-0.4054119226518582,0.09900536466681809,False,432,mrVI
|
10 |
+
X20,0.13056179835196516,1.1394683549842244,0.11548955847311963,1.130507381603278,0.2582624898204522,-0.09579357684578196,0.3569171735497123,False,432,mrVI
|
11 |
+
X8,-0.11421175277500137,0.8920690377869046,0.2004395632742029,-0.5698064339661267,0.5688089912312484,-0.5070660778693764,0.2786425723193736,False,432,mrVI
|
12 |
+
X26,0.10688643155252857,1.1128078674408324,0.12794072744149573,0.8354371097460361,0.4034716428415017,-0.1438727863886584,0.3576456494937156,False,432,mrVI
|
13 |
+
X11,0.10235644962998469,1.107778268515086,0.08634154979028927,1.1854831176715408,0.23582648573441245,-0.06686987832835414,0.2715827775883235,False,432,mrVI
|
14 |
+
X9,-0.10119151006152893,0.9037599371904308,0.08817642347999646,-1.1476027952583612,0.25113257532401156,-0.274014124367874,0.07163110424481611,False,432,mrVI
|
15 |
+
X1,-0.09131620854894786,0.9127290525342652,0.09296046654822179,-0.9823122875741915,0.3259460228756721,-0.27351537496950307,0.09088295787160734,False,432,mrVI
|
16 |
+
X23,-0.07927313899832154,0.9237875675715355,0.13327392784602274,-0.594813556406241,0.5519681048492582,-0.34048523765471594,0.18193895965807283,False,432,mrVI
|
17 |
+
X27,0.07089285952558498,1.0734662080281379,0.13113801215129278,0.5405973322502137,0.5887851570611737,-0.18613292129512482,0.3279186403462948,False,432,mrVI
|
18 |
+
X10,0.06596921632783478,1.068193833731073,0.09311126480139434,0.7084987672388153,0.47863557745719376,-0.11652550923787014,0.2484639418935397,False,432,mrVI
|
19 |
+
X6,0.06091392154285564,1.0628074254262239,0.08580379569226143,0.7099210594520285,0.4777530902093702,-0.10725842775080982,0.22908627083652108,False,432,mrVI
|
20 |
+
X19,0.06030104126006792,1.062156251277061,0.09897922978699021,0.6092292432446657,0.5423724994643576,-0.13369468433994702,0.25429676686008285,False,432,mrVI
|
21 |
+
X13,-0.05834733134455789,0.9433222451456965,0.07384131169600211,-0.7901719241495667,0.4294273701430362,-0.20307364283991827,0.0863789801508025,False,432,mrVI
|
22 |
+
X4,-0.05699666508122261,0.9445972195162751,0.14618446947175365,-0.3898954881266353,0.6966138303687086,-0.34351296034495477,0.22951963018250957,False,432,mrVI
|
23 |
+
X15,-0.055098884058901024,0.9463915602876051,0.09405082454968391,-0.5858415842999242,0.5579819759413297,-0.23943511289257702,0.129237344774775,False,432,mrVI
|
24 |
+
X12,0.05265812689925484,1.054069225599441,0.09653822269610927,0.545464018588951,0.5854344208824944,-0.13655331271662657,0.24186956651513625,False,432,mrVI
|
25 |
+
X5,-0.044614744520824506,0.9563658560555917,0.08318187708077948,-0.5363517401452518,0.5917154781215973,-0.20764822776559005,0.11841873872394104,False,432,mrVI
|
26 |
+
X16,-0.043640133483490044,0.957298395132256,0.09893101606492571,-0.4411168025894955,0.6591284398435557,-0.23754136192469796,0.15026109495771786,False,432,mrVI
|
27 |
+
X30,0.04293605485501949,1.0438711422248517,0.07205684421195115,0.5958636590956649,0.5512663123139663,-0.09829276464001822,0.18416487435005718,False,432,mrVI
|
28 |
+
X2,-0.031514379898504946,0.9689770225623179,0.07123939081059726,-0.4423729560278189,0.6582193455436407,-0.17114102016784927,0.10811226037083937,False,432,mrVI
|
29 |
+
X7,0.02542017152989584,1.0257460192665975,0.1164609139249721,0.21827212816028854,0.8272170894123315,-0.20283902536966875,0.25367936842946043,False,432,mrVI
|
30 |
+
X25,0.024819655871647986,1.0251302276354064,0.0838615542097828,0.2959598841867478,0.7672607174390329,-0.13954597006707964,0.18918528181037564,False,432,mrVI
|
31 |
+
X29,-0.021324520156394352,0.9789012398347618,0.11018099022903058,-0.1935408287043671,0.8465354337858275,-0.2372752927862539,0.19462625247346518,False,432,mrVI
|
32 |
+
X24,-0.013079212327217715,0.9870059488854867,0.1070395461367199,-0.1221904688432801,0.9027481746539084,-0.2228728676767022,0.1967144430222668,False,432,mrVI
|
33 |
+
X21,0.008043431739784994,1.0080758670422534,0.12627986876788966,0.06369528111063631,0.9492128622470506,-0.23946056301772314,0.2555474264972931,False,432,mrVI
|
34 |
+
const,-0.7000023474973847,0.4965841380600759,0.03758698877210361,-18.62352825712162,2.071079519817913e-77,-0.7736714917780191,-0.6263332032167502,True,43,mrVI
|
35 |
+
approval_rate,0.6260632778152319,1.8702334783683652,0.07283312567061305,8.595858986563279,8.264423806697006e-18,0.48331297461935063,0.7688135810111131,True,43,mrVI
|
36 |
+
X8,-0.26803800643913017,0.7648787102342849,0.19462728673945,-1.3771861640241434,0.16845469841702054,-0.6495004788572023,0.1134244659789419,False,43,mrVI
|
37 |
+
X14,-0.23679266119889164,0.7891548934856469,0.1207429216139402,-1.961130789563014,0.04986376786262417,-0.47344443895035726,-0.00014088344742599346,True,43,mrVI
|
38 |
+
X17,0.18759672289804674,1.2063469251489327,0.09327114804807947,2.0113049621877095,0.04429325469363095,0.004788631927107628,0.3704048138689858,True,43,mrVI
|
39 |
+
X21,-0.13205442108355628,0.8762933049505423,0.11706818074914385,-1.1280129257883085,0.25931446031459615,-0.3615038390875035,0.09739499692039097,False,43,mrVI
|
40 |
+
X19,0.13198182994116484,1.1410875854503046,0.0974774774329334,1.3539725628617254,0.1757451313310704,-0.05907051513120051,0.32303417501353016,False,43,mrVI
|
41 |
+
X9,-0.1317976506938478,0.8765183400138874,0.0847111641572088,-1.5558474730586265,0.1197443663431117,-0.2978284815304374,0.034233180142741765,False,43,mrVI
|
42 |
+
X13,-0.12097586221697297,0.886055346746465,0.07011140328996125,-1.725480542967461,0.08444090727878793,-0.25839168757086006,0.016439963136914135,False,43,mrVI
|
43 |
+
X11,0.10772958250133957,1.1137465281108185,0.08360128252878557,1.2886116007161272,0.1975331483649384,-0.05612592031643779,0.27158508531911696,False,43,mrVI
|
44 |
+
X30,0.10766717575442913,1.113677024981871,0.07336571218462226,1.467540797307173,0.1422289995638524,-0.03612697782756191,0.2514613293364202,False,43,mrVI
|
45 |
+
X26,0.09727314266773363,1.1021613798098766,0.12118549771875016,0.802679730651329,0.42215987137657585,-0.14024606830957756,0.3347923536450448,False,43,mrVI
|
46 |
+
X10,0.0962231603934971,1.1010047372310938,0.09622233058092733,1.00000862390845,0.31730633441415834,-0.09236914205362753,0.28481546284062176,False,43,mrVI
|
47 |
+
X23,0.09132776781636665,1.0956280580284097,0.12165916795112054,0.7506854547374493,0.45284197872554177,-0.14711981975693922,0.3297753553896725,False,43,mrVI
|
48 |
+
X18,0.08996915019885358,1.0941405291668016,0.0999017158222111,0.9005766263210745,0.3678134668047741,-0.10583461480643545,0.2857729152041426,False,43,mrVI
|
49 |
+
X25,0.08701226638269385,1.0909100611565015,0.07861128943989103,1.106867308788091,0.26835130181771805,-0.06706302969774644,0.24108756246313415,False,43,mrVI
|
50 |
+
X16,0.08417828648695118,1.0878228206301621,0.09167884320359898,0.9181866125863883,0.35852117619906554,-0.09550894433639755,0.2638655173102999,False,43,mrVI
|
51 |
+
X28,0.08015480322689268,1.0834547769893224,0.12912347906452057,0.6207608701965104,0.5347569725927019,-0.1729225652980793,0.33323217175186465,False,43,mrVI
|
52 |
+
X5,-0.06669102055649791,0.9354842020749958,0.0804257871422555,-0.8292243436615198,0.40697747234346027,-0.22432266678360324,0.09094062567060741,False,43,mrVI
|
53 |
+
X24,0.0651965930797515,1.067368841086961,0.10186692134689791,0.6400173109947127,0.5221613451457972,-0.13445890397614285,0.2648520901356458,False,43,mrVI
|
54 |
+
X4,-0.060056642139013114,0.9417111915373378,0.14382592631289495,-0.4175647859785669,0.6762653475750613,-0.34195027775539893,0.22183699347737268,False,43,mrVI
|
55 |
+
X1,-0.058868885468482186,0.9428303798168962,0.0929468282911077,-0.6333608854742838,0.5264980017238345,-0.24104132139628184,0.12330355045931748,False,43,mrVI
|
56 |
+
X15,-0.053169244998038455,0.9482195174908162,0.08438895574219007,-0.63004980367895,0.5286619998910369,-0.2185685589456756,0.11223006894959867,False,43,mrVI
|
57 |
+
X12,0.04626435537131033,1.047351247291609,0.09735182975544004,0.4752284110892643,0.6346241787416809,-0.14454172477842694,0.2370704355210476,False,43,mrVI
|
58 |
+
X3,-0.04408738106526543,0.9568703414701136,0.11147979933051709,-0.39547416958075476,0.6924929809442472,-0.26258377275683137,0.1744090106263005,False,43,mrVI
|
59 |
+
X20,0.043065507812721386,1.0440062831786816,0.1078198457082882,0.3994209742169099,0.6895830419601838,-0.168257506594189,0.25438852221963176,False,43,mrVI
|
60 |
+
X29,0.03240570957816629,1.032936492534464,0.11479555335133569,0.2822906343679316,0.7777206663705674,-0.19258944057579797,0.25740085973213056,False,43,mrVI
|
61 |
+
X27,0.02781460971645833,1.0282050475255573,0.12795091308260537,0.21738500372014666,0.8279083170763075,-0.222964571714463,0.27859379114737964,False,43,mrVI
|
62 |
+
X22,0.024576494618922286,1.024880985989231,0.10719275021357519,0.22927385079639323,0.8186560762343311,-0.18551743520348327,0.23467042444132782,False,43,mrVI
|
63 |
+
X6,0.013053400337691373,1.0131389678783163,0.08587993431903763,0.15199592828283906,0.8791901470990356,-0.15526817792228778,0.18137497859767052,False,43,mrVI
|
64 |
+
X2,-0.002124779818513432,0.9978774759281873,0.06772327192109436,-0.031374441284955236,0.9749709240139772,-0.1348599536990711,0.13061039406204422,False,43,mrVI
|
65 |
+
X7,-5.832553865088524e-06,0.9999941674631442,0.11438810563453718,-5.098916388844805e-05,0.9999593165333828,-0.22420239985732116,0.224190734749591,False,43,mrVI
|
66 |
+
const,-0.5572641034828938,0.5727739724750398,0.03866783949424329,-14.411565548311977,4.376756937466581e-47,-0.6330516762515861,-0.48147653071420143,True,5235,mrVI
|
67 |
+
approval_rate,0.4455940156196361,1.5614174267508396,0.07258065880441873,6.139294172299635,8.288894587108831e-10,0.3033385383887854,0.5878494928504867,True,5235,mrVI
|
68 |
+
X4,0.41810744151334206,1.5190838783054244,0.14681866261724036,2.847781297418284,0.004402516760310171,0.13034815052521376,0.7058667325014704,True,5235,mrVI
|
69 |
+
X8,-0.1863760327013623,0.8299614436523739,0.19684104045830442,-0.9468352344989822,0.3437227443854204,-0.5721773826790306,0.199425317276306,False,5235,mrVI
|
70 |
+
X30,0.1709648899115568,1.1864490919578725,0.07191477306517323,2.3773264188238317,0.017438648498505363,0.03001452474744612,0.31191525507566753,True,5235,mrVI
|
71 |
+
X29,0.16259016192741851,1.17655439407851,0.10624097537119166,1.5303903353611954,0.12592013978912955,-0.04563832348252406,0.3708186473373611,False,5235,mrVI
|
72 |
+
X19,-0.15210485000619708,0.8588982205360536,0.09368157563152478,-1.623636760812681,0.10445335500072424,-0.3357173642589508,0.031507664246556655,False,5235,mrVI
|
73 |
+
X10,-0.13871883079003083,0.8704727441871581,0.0919526620418171,-1.5085896124132436,0.1314036903686242,-0.3189427366745756,0.04150507509451398,False,5235,mrVI
|
74 |
+
X28,0.13480284821500288,1.1443111591232238,0.12292733461146824,1.096605963523647,0.27281367945388346,-0.10613030033897891,0.37573599676898467,False,5235,mrVI
|
75 |
+
X17,0.12618988789185345,1.134497575183661,0.09716987762776298,1.298652329019698,0.19406327083982144,-0.06425957264072635,0.31663934842443325,False,5235,mrVI
|
76 |
+
X2,-0.11505377714002465,0.891318210073781,0.06926209708841892,-1.6611362054652892,0.09668609444043855,-0.2508049929270423,0.02069743864699297,False,5235,mrVI
|
77 |
+
X20,-0.11482620512518948,0.8915210722367068,0.1140362744936341,-1.0069270119097014,0.31396985018991164,-0.33833319606383594,0.10868078581345694,False,5235,mrVI
|
78 |
+
X13,0.10802926626499036,1.1140803498800995,0.07128421503106275,1.5154724817817748,0.1296527940008583,-0.03168522786210139,0.24774376039208212,False,5235,mrVI
|
79 |
+
X25,-0.10216492311367717,0.9028806335038344,0.0806412136229041,-1.2669070630735124,0.20518852291510525,-0.26021879748417,0.055888951256815644,False,5235,mrVI
|
80 |
+
X1,0.09131191723155417,1.0956106918205857,0.09104514977334888,1.0029300567780863,0.315894609311974,-0.08713329729126469,0.26975713175437305,False,5235,mrVI
|
81 |
+
X18,0.09078349460331588,1.0950318992762946,0.10325622112285794,0.8792060528275427,0.37928956316318807,-0.11159497997718966,0.2931619691838214,False,5235,mrVI
|
82 |
+
X22,0.08367990502030344,1.0872808049738614,0.10920741843360525,0.7662474419828745,0.443529084548835,-0.13036270195415844,0.29772251199476535,False,5235,mrVI
|
83 |
+
X15,-0.07535753244448995,0.9274118472214293,0.08802901158989988,-0.8560533747164802,0.3919682568781305,-0.24789122475535272,0.09717615986637282,False,5235,mrVI
|
84 |
+
X9,0.07097887478081355,1.073558546469201,0.08807231997574018,0.805915806468649,0.42029139659865844,-0.10163970040652476,0.24359744996815186,False,5235,mrVI
|
85 |
+
X5,-0.06548359901739195,0.9366144080302741,0.07970493443600851,-0.8215752196617861,0.41131869749833183,-0.22170239990209495,0.09073520186731104,False,5235,mrVI
|
86 |
+
X23,-0.048050850267602814,0.9530853212016324,0.1237694672202686,-0.3882286265488098,0.697846850400587,-0.2906345484050401,0.19453284786983446,False,5235,mrVI
|
87 |
+
X6,0.04251741130823262,1.043434223770409,0.08746365878108606,0.4861151694402587,0.6268855122448582,-0.1289082098587965,0.21394303247526172,False,5235,mrVI
|
88 |
+
X11,0.0314710790571523,1.0319715295744332,0.08318207872910689,0.3783396560651232,0.705178289658599,-0.13156279941107252,0.1945049575253771,False,5235,mrVI
|
89 |
+
X24,0.029355850216343293,1.029790980625213,0.1015982156285736,0.2889406082057923,0.7726268275550991,-0.1697729933091954,0.228484693741882,False,5235,mrVI
|
90 |
+
X3,0.027229346145596977,1.027603452630825,0.11429172878126347,0.23824424073337536,0.8116916656494626,-0.19677832599649936,0.2512370182876933,False,5235,mrVI
|
91 |
+
X7,0.023864789642884913,1.0241518325934842,0.11707310196308005,0.20384519793804445,0.8384744714667469,-0.2055942737631375,0.2533238530489073,False,5235,mrVI
|
92 |
+
X27,-0.018775963991324703,0.981399206376499,0.13090813844128435,-0.14342854626831472,0.8859517393785188,-0.27535120061942536,0.23779927263677597,False,5235,mrVI
|
93 |
+
X26,0.018171199503234717,1.018337300307222,0.12640134398525887,0.14375796119188314,0.8856916000793198,-0.22957088230533124,0.2659132813118007,False,5235,mrVI
|
94 |
+
X14,0.017870750292222976,1.0180313876267137,0.11840738727763563,0.15092597432557606,0.8800341106324431,-0.21420346427542905,0.24994496485987502,False,5235,mrVI
|
95 |
+
X21,-0.009032008447575762,0.9910086576165494,0.1170967040774926,-0.07713290069717532,0.9385178199843308,-0.23853733114780576,0.22047331425265423,False,5235,mrVI
|
96 |
+
X16,0.007342118596125888,1.0073691380350283,0.0905935916945425,0.08104456903399482,0.9354065080925328,-0.17021805835530437,0.18490229554755613,False,5235,mrVI
|
97 |
+
X12,0.004490624865882402,1.004500722831459,0.09642914350014153,0.04656916677763306,0.9628566067045071,-0.18450702345443967,0.19348827318620446,False,5235,mrVI
|
98 |
+
const,-1.0706968049740233,0.3427695906299917,0.040499805699904266,-26.437084980300394,5.136584601243389e-154,-1.1500749655267057,-0.991318644421341,True,332,mrVI
|
99 |
+
X8,-0.5475609310399155,0.5783587483044031,0.22133021218941273,-2.4739547557624757,0.013362661832896743,-0.9813601756217726,-0.11376168645805851,True,332,mrVI
|
100 |
+
approval_rate,0.4980848332605597,1.6455667162729402,0.07462990588060983,6.674064872296334,2.4881354442836526e-11,0.35181290556495043,0.6443567609561689,True,332,mrVI
|
101 |
+
X27,0.3801347757382498,1.4624816832007275,0.14363776442422396,2.646482123012919,0.008133380405150744,0.09860993064692214,0.6616596208295774,True,332,mrVI
|
102 |
+
X10,0.3150100840363702,1.3702731287713945,0.11747474950190953,2.681513136840098,0.007329003678118918,0.08476380591976287,0.5452563621529776,True,332,mrVI
|
103 |
+
X4,0.2676386839789072,1.3068748598744473,0.16368012377999536,1.6351324632344728,0.10202128215729081,-0.05316846361494171,0.5884458315727561,False,332,mrVI
|
104 |
+
X23,0.24799042769308086,1.281447665724955,0.1329784909522191,1.8648912761552319,0.06219664550589856,-0.012642625291754056,0.5086234806779157,False,332,mrVI
|
105 |
+
X21,-0.245727428658858,0.7821353835641423,0.13048309196294952,-1.8832127976292279,0.059671535397896644,-0.5014695894976668,0.010014732179950858,False,332,mrVI
|
106 |
+
X3,0.21533099770402042,1.2402723563340667,0.12579973809341535,1.7116967091308384,0.08695257540314814,-0.031231958223645162,0.461893953631686,False,332,mrVI
|
107 |
+
X19,0.16923623472847174,1.1843999022670737,0.10147154448835907,1.667819639306729,0.09535153601580523,-0.029644337924365854,0.36811680738130936,False,332,mrVI
|
108 |
+
X14,-0.1630174141797231,0.8495763936097641,0.13313257836784756,-1.2244742509928954,0.22077337402215158,-0.4239524729496606,0.0979176445902144,False,332,mrVI
|
109 |
+
X20,-0.14385551056867454,0.8660128687266031,0.12117213133312217,-1.1871996389433146,0.2351488832771319,-0.3813485239115514,0.09363750277420232,False,332,mrVI
|
110 |
+
X16,0.13567029248829351,1.1453042159335198,0.09327939933185268,1.454450751828173,0.14582137790860022,-0.047153970701667325,0.31849455567825435,False,332,mrVI
|
111 |
+
X28,0.1318977796518975,1.140991680739134,0.1449804516771504,0.9097625102287167,0.36294776974287446,-0.15225868409766694,0.4160542434014619,False,332,mrVI
|
112 |
+
X29,-0.12662911658614373,0.8810603826902802,0.12260595467477577,-1.0328137562489506,0.3016910648582799,-0.36693237203885454,0.11367413886656705,False,332,mrVI
|
113 |
+
X12,-0.1195318466228402,0.8873357487221523,0.09907918383851194,-1.2064274451196915,0.22765271907552243,-0.31372347856394656,0.0746597853182662,False,332,mrVI
|
114 |
+
X7,0.11509001517057062,1.1219744277460357,0.12130641745126174,0.9487545472753844,0.34274546406921724,-0.12266619412748349,0.35284622446862474,False,332,mrVI
|
115 |
+
X24,-0.10584152132300825,0.8995671989995474,0.11052050723569905,-0.9576640930292487,0.33823216855377414,-0.32245773505807684,0.11077469241206034,False,332,mrVI
|
116 |
+
X1,-0.09001350670492474,0.9139188411557516,0.09991965154277115,-0.9008588932718002,0.3676633497038637,-0.28585242507654823,0.10582541166669875,False,332,mrVI
|
117 |
+
X17,0.08879012587294456,1.0928512710496419,0.09965725990506234,0.8909549184628369,0.37295335592134915,-0.1065345143389252,0.28411476608481434,False,332,mrVI
|
118 |
+
X26,-0.08736144621271436,0.9163458260403301,0.13125045445974248,-0.6656087140598063,0.5056612350885119,-0.3446076099083241,0.1698847174828954,False,332,mrVI
|
119 |
+
X15,0.08549792872826224,1.0892593051897153,0.08888775644194549,0.9618639523667445,0.33611794816629137,-0.08871887256451909,0.25971473002104356,False,332,mrVI
|
120 |
+
X22,0.07646641170296074,1.0794659323058682,0.11944827547385034,0.6401633795014545,0.5220663879178855,-0.157647906241205,0.31058072964712646,False,332,mrVI
|
121 |
+
X9,-0.07495787127247303,0.9277825718044083,0.09261459233808186,-0.8093527097635494,0.4183122954233859,-0.25647913669797273,0.10656339415302665,False,332,mrVI
|
122 |
+
X5,0.06957745450381488,1.0720550934844455,0.07938872531471886,0.8764148086266735,0.38080457074475393,-0.08602158789157734,0.2251764968992071,False,332,mrVI
|
123 |
+
X11,0.06840485438064427,1.0707987382948614,0.08849208964005499,0.7730053009131513,0.4395192434697289,-0.10503645423055356,0.24184616299184208,False,332,mrVI
|
124 |
+
X25,0.05753722658194561,1.0592247012359342,0.0854407929257025,0.6734163461237861,0.500682452221278,-0.10992365036297594,0.22499810352686714,False,332,mrVI
|
125 |
+
X18,0.05262719265130044,1.0540366192649842,0.11133665699870166,0.4726852239861499,0.6364377699370747,-0.16558864522524414,0.27084303052784503,False,332,mrVI
|
126 |
+
X2,-0.04344594778153141,0.9574843068432125,0.06983098558720098,-0.6221585935841987,0.5338375898265355,-0.18031216453738091,0.0934202689743181,False,332,mrVI
|
127 |
+
X13,-0.014089948346758904,0.986008850408005,0.07848166009562602,-0.17953173173950449,0.857520203747812,-0.16791117558110025,0.1397312788875824,False,332,mrVI
|
128 |
+
X30,-0.008420447058718417,0.9916149056076077,0.08084254844442776,-0.1041586048528238,0.91704348377288,-0.1668689304282314,0.15002803631079456,False,332,mrVI
|
129 |
+
X6,-0.0060090092970330545,0.9940090086911817,0.09522751558619029,-0.06310160734577086,0.9496855943750342,-0.19265151018319265,0.18063349158912656,False,332,mrVI
|
130 |
+
const,-0.8047200387835,0.4472131113617856,0.038120879653155484,-21.109692276392384,6.47931600921015e-99,-0.8794355899626705,-0.7300044876043295,True,2132,mrVI
|
131 |
+
approval_rate,0.4274103613896416,1.5332817322644245,0.07317919871825393,5.840599089301421,5.201343709876619e-09,0.2839817674843642,0.570838955294919,True,2132,mrVI
|
132 |
+
X8,-0.2891539204808542,0.7488969259560097,0.19317569494376619,-1.4968442099562653,0.13443379971105343,-0.6677713252591322,0.08946348429742373,False,2132,mrVI
|
133 |
+
X17,0.2377788843860551,1.2684286924254737,0.09337433096306541,2.5465123223223896,0.010880537005077844,0.05476855861792368,0.4207892101541865,True,2132,mrVI
|
134 |
+
X11,0.20054457999331413,1.2220680908130255,0.08372351134808022,2.3953197466784535,0.016605876960469147,0.03644951309184638,0.3646396468947819,True,2132,mrVI
|
135 |
+
X7,0.16936525642893277,1.1845527254150292,0.11892358020070447,1.4241520154632,0.15440247184816067,-0.06372067767700865,0.4024511905348742,False,2132,mrVI
|
136 |
+
X21,-0.16605577650006353,0.8469989902326281,0.11468634337217107,-1.4479123809989516,0.14764155659152614,-0.39083687902811276,0.05872532602798569,False,2132,mrVI
|
137 |
+
X30,0.16232742262762695,1.1762453076072026,0.07481236925735187,2.1697939022519983,0.03002246252208294,0.015697873285105746,0.30895697197014815,True,2132,mrVI
|
138 |
+
X29,0.16056513546513598,1.1741742510358695,0.11204396274520095,1.4330547718155682,0.15184218529249394,-0.05903699620060546,0.38016726713087745,False,2132,mrVI
|
139 |
+
X28,0.15931530169790808,1.1727076451060359,0.13253368895093237,1.202074000648175,0.22933485852558233,-0.10044595538415346,0.41907655877996963,False,2132,mrVI
|
140 |
+
X4,0.1590030879167602,1.172341566768301,0.14920500911110443,1.0656685647755948,0.2865734926383616,-0.13343335625397512,0.45143953208749554,False,2132,mrVI
|
141 |
+
X5,-0.13860678216742217,0.8705702849237132,0.07649698235441342,-1.8119248354824207,0.06999781134892737,-0.2885381125080685,0.011324548173224175,False,2132,mrVI
|
142 |
+
X2,0.13459257988493553,1.144070572021528,0.06794420021740336,1.9809281653809316,0.04759932997919062,0.0014243945004464575,0.2677607652694246,True,2132,mrVI
|
143 |
+
X12,0.10928910504837015,1.115484796014774,0.09321621189124923,1.1724259421298129,0.24102608915860135,-0.07341131303373268,0.291989523130473,False,2132,mrVI
|
144 |
+
X3,-0.09225944536950566,0.9118685387826493,0.1077009749585115,-0.8566259071010804,0.39165166320791867,-0.3033494773880384,0.11883058664902711,False,2132,mrVI
|
145 |
+
X22,-0.09121600297301621,0.912820517657225,0.11098187868608932,-0.8218999718955866,0.41113382898348705,-0.30873648813434473,0.1263044821883123,False,2132,mrVI
|
146 |
+
X26,0.07990039804391261,1.083179175537237,0.12014881732617286,0.6650119395433062,0.5060428565090002,-0.15558695670046824,0.31538775278829345,False,2132,mrVI
|
147 |
+
X10,-0.07954397618157454,0.9235374054269447,0.09536065966273907,-0.8341382752897976,0.4042030687654886,-0.26644743466252463,0.10735948229937554,False,2132,mrVI
|
148 |
+
X19,0.06877410503397793,1.0711942044371379,0.09301110303050834,0.7394182285035316,0.4596530767823831,-0.11352430706816269,0.25107251713611856,False,2132,mrVI
|
149 |
+
X25,-0.05256449467526664,0.9487931269778568,0.07831352046432404,-0.6712058705011551,0.5020893894011289,-0.20605617428788223,0.10092718493734895,False,2132,mrVI
|
150 |
+
X16,0.05098461307109686,1.0523067013902339,0.0898556890692412,0.5674055098704883,0.5704387073058235,-0.12512930131064529,0.227098527452839,False,2132,mrVI
|
151 |
+
X1,-0.04583811588634516,0.9551965808270798,0.09242411696175742,-0.4959540582390603,0.6199268248202269,-0.22698605643430725,0.1353098246616169,False,2132,mrVI
|
152 |
+
X14,-0.04319995448084609,0.9577198705405651,0.12603811752321178,-0.3427530919199121,0.7317842177564061,-0.29023012550556787,0.20383021654387568,False,2132,mrVI
|
153 |
+
X23,0.03781165038780886,1.0385356066772522,0.11996090549495568,0.3151997747249317,0.7526099765961906,-0.19730740393511736,0.27293070471073505,False,2132,mrVI
|
154 |
+
X18,0.03249662689746786,1.0330304086206088,0.10057360016993415,0.32311289287208517,0.7466097464353145,-0.16462400723113454,0.22961726102607025,False,2132,mrVI
|
155 |
+
X27,0.03228067878445589,1.0328073517384062,0.12491504675040072,0.25842105994610565,0.7960819649613773,-0.21254831397346663,0.2771096715423784,False,2132,mrVI
|
156 |
+
X24,0.028529780392912395,1.0289406526351783,0.10181908237906287,0.28020072196976503,0.779323512795673,-0.17103195400896767,0.22809151479479248,False,2132,mrVI
|
157 |
+
X6,0.027971993677423576,1.0283668832434603,0.0879554375391849,0.3180246095070792,0.7504662695675288,-0.14441749614384108,0.20036148349868826,False,2132,mrVI
|
158 |
+
X15,-0.01755853091226805,0.9825947218164629,0.08510811190192999,-0.20630854709244084,0.8365499025328385,-0.18436736503225556,0.14925030320771945,False,2132,mrVI
|
159 |
+
X13,0.01735125767623333,1.0175026651835892,0.07387353228919001,0.2348778667887302,0.8143035288060954,-0.12743820502133588,0.16214072037380253,False,2132,mrVI
|
160 |
+
X20,-0.016858487269481148,0.9832828218268245,0.11155041361373676,-0.15112886383242533,0.8798740639505288,-0.23549328041295173,0.20177630587398945,False,2132,mrVI
|
161 |
+
X9,-0.005537324445440133,0.9944779782771581,0.08633146387044098,-0.06414028208475749,0.9488585273974288,-0.17474388436412536,0.16366923547324508,False,2132,mrVI
|
data/drug_metadata.csv
ADDED
@@ -0,0 +1,380 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
,drug,targets,moa-broad,moa-fine,human-approved,clinical-trials,gpt-notes-approval,canonical_smiles,pubchem_cid
|
2 |
+
0,Talc,,unclear,unclear,yes,yes,Talc used in pharma and cosmetics; safety under review for some uses.,[OH-].[OH-].[O-][Si]12O[Si]3(O[Si](O1)(O[Si](O2)(O3)[O-])[O-])[O-].[Mg+2].[Mg+2].[Mg+2],165411828.0
|
3 |
+
1,Bortezomib,PSMB5,inhibitor/antagonist,Proteasome inhibitor,yes,yes,Approved for multiple myeloma and mantle cell lymphoma.,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,387447.0
|
4 |
+
2,Ixazomib,PSMB5,inhibitor/antagonist,Proteasome inhibitor,yes,yes,Approved for multiple myeloma treatment.,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,25183872.0
|
5 |
+
3,Ixazomib citrate,"PSMB1, PSMB2, PSMB5",inhibitor/antagonist,Proteasome inhibitor,yes,yes,Approved for multiple myeloma treatment as part of a combination therapy.,B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,56844015.0
|
6 |
+
4,Lactate (calcium),,unclear,unclear,yes,yes,"Used in medical settings, but not specifically approved as a standalone drug.",C.CC(C(=O)[O-])O.[Ca+2],168311648.0
|
7 |
+
5,Bisoprolol (hemifumarate),ADRB1,inhibitor/antagonist,Adrenoceptor agonist,yes,yes,"Approved for hypertension, heart failure, and angina.",C.CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O,168312271.0
|
8 |
+
6,Fumaric acid,,inhibitor/antagonist,unclear,yes,yes,Used in psoriasis treatment as part of fumaric acid esters.,C(=CC(=O)O)C(=O)O,444972.0
|
9 |
+
7,Hydroxyurea,"RRM2, RRM1",inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved for sickle cell anemia and certain cancers.,C(=O)(N)NO,3657.0
|
10 |
+
8,L-Eflornithine (monohydrochloride),ODC1,inhibitor/antagonist,unclear,yes,yes,Used to treat sleeping sickness. Approved for human use.,C(CC(C(F)F)(C(=O)O)N)CN.Cl,16048568.0
|
11 |
+
9,Cysteamine (hydrochloride),,unclear,unclear,yes,yes,FDA-approved for cystinosis treatment.,C(CS)N.Cl,9082.0
|
12 |
+
10,Darinaparsin,,unclear,unclear,no,yes,Used in clinical trials for certain cancers only.,C[As](C)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,11683005.0
|
13 |
+
11,Entecavir (monohydrate),,unclear,unclear,yes,yes,Approved for treating hepatitis B infection.,C=C1C(CC(C1CO)O)N2C=NC3=C2N=C(NC3=O)N.O,135526609.0
|
14 |
+
12,Allantoin,,unclear,unclear,yes,yes,Allantoin is approved as a skin protectant by the FDA.,C1(C(=O)NC(=O)N1)NC(=O)N,204.0
|
15 |
+
13,5-Fluorouracil,TYMS,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Widely used chemotherapy drug. Approved for cancer treatment.,C1=C(C(=O)NC(=O)N1)F,3385.0
|
16 |
+
14,L-Thyroxine (sodium salt pentahydrate),,unclear,unclear,yes,yes,"Approved for hypothyroidism, a form of standard thyroid hormone replacement therapy.",C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)[O-])N.O.O.O.O.O.[Na+],23665037.0
|
17 |
+
15,Gallic acid,,inhibitor/antagonist,Cyclooxygenase inhibitor,no,yes,"Used in supplements, studied for antioxidant properties.",C1=C(C=C(C(=C1O)O)O)C(=O)O,370.0
|
18 |
+
16,Gallic acid (hydrate),,inhibitor/antagonist,Cyclooxygenase inhibitor,no,yes,Evaluated in trials but not approved as a standalone drug.,C1=C(C=C(C(=C1O)O)O)C(=O)O.O,24721416.0
|
19 |
+
17,ERK5-IN-2,MAPK7,inhibitor/antagonist,Other MAPK inhibitor,no,no,Not found in clinicaltrials.gov database as of the latest available data.,C1=CC(=C(C(=C1)Br)C(=O)C2=CNC(=C2)C(=O)NC3=CN=CC=C3)F,118959080.0
|
20 |
+
18,Vilanterol,ADRB2,activator/agonist,Adrenoceptor agonist,yes,yes,Combined with fluticasone furoate for asthma and COPD treatment.,C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,10184665.0
|
21 |
+
19,Niclosamide (olamine),STAT3,inhibitor/antagonist,unclear,yes,yes,"Approved for parasitic infections, investigated for other uses.",C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O.C(CO)N,14992.0
|
22 |
+
20,Norepinephrine (hydrochloride),"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1",activator/agonist,Adrenoceptor agonist,yes,yes,Approved for human use as a medication to treat low blood pressure.,C1=CC(=C(C=C1C(CN)O)O)O.Cl,11672905.0
|
23 |
+
21,Triclosan,,inhibitor/antagonist,unclear,no,yes,Banned in soaps; used in some consumer products and healthcare settings.,C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,5564.0
|
24 |
+
22,Mitoxantrone (dihydrochloride),"TOP2A, TOP2B, PRKCA",inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved for cancer and multiple sclerosis treatment.,C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl,51082.0
|
25 |
+
23,Pentamidine (isethionate),PRLR,inhibitor/antagonist,unclear,yes,yes,Used to treat Pneumocystis pneumonia and African trypanosomiasis.,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,8813.0
|
26 |
+
24,Folic acid,,unclear,unclear,yes,yes,Widely used as a dietary supplement and in fortified foods.,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)NC(=N3)N,135398658.0
|
27 |
+
25,Balsalazide (sodium hydrate),"IL6, STAT3",unclear,JAK/STAT inhibitor,yes,yes,Used for ulcerative colitis treatment in humans.,C1=CC(=CC=C1C(=O)NCCC(=O)[O-])N=NC2=CC(=C(C=C2)[O-])C(=O)O.O.O.[Na+].[Na+],92044433.0
|
28 |
+
26,Resveratrol,SIRT1,unclear,unclear,no,yes,"Studies showed promising results, but no approval for therapeutic use.",C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,445154.0
|
29 |
+
27,PF-06260933,MAP4K4,inhibitor/antagonist,Other MAPK inhibitor,no,yes,Investigated for treating pain; not approved for human use.,C1=CC(=CC=C1C2=C(N=CC(=C2)C3=CN=C(C=C3)N)N)Cl,118701008.0
|
30 |
+
28,Daidzin,ALDH2,inhibitor/antagonist,unclear,no,yes,investigated for alcoholism; not approved for treatment,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)OC4C(C(C(C(O4)CO)O)O)O)O,107971.0
|
31 |
+
29,Pemetrexed,"TYMS, DHFR, GART",inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Chemotherapy drug for mesothelioma and non-small cell lung cancer.,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,135410875.0
|
32 |
+
30,Econazole,,unclear,unclear,yes,yes,Antifungal approved for dermatological use.,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl,3198.0
|
33 |
+
31,XRK3F2,,inhibitor/antagonist,unclear,no,no,No results found on clinicaltrials.gov,C1=CC(=CC=C1COC2=C(C=C(C=C2)CNCCO)OCC3=CC=C(C=C3)F)F.Cl,135397144.0
|
34 |
+
32,Arbutin,"MYC, KLF4",inhibitor/antagonist,unclear,no,yes,"Used in cosmetics, trials for skin-lightening, not approved as a drug.",C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,440936.0
|
35 |
+
33,Tucidinostat,"HDAC1, HDAC2, HDAC3, HDAC10, HDAC8, HDAC11",inhibitor/antagonist,HDAC inhibitor,yes,yes,Approved for use in China for certain cancers.,C1=CC(=CN=C1)C=CC(=O)NCC2=CC=C(C=C2)C(=O)NC3=C(C=C(C=C3)F)N,12136798.0
|
36 |
+
34,Pexidartinib (hydrochloride),"CSF1R, KIT, FLT3",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,Approved for tenosynovial giant cell tumor in 2019.,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F.Cl,73053710.0
|
37 |
+
35,Sodium Salicylate,PTGS2,inhibitor/antagonist,Cyclooxygenase inhibitor,no,yes,"Used in studies, NSAID-related research, not approved for standard human therapy.",C1=CC=C(C(=C1)C(=O)[O-])O.[Na+],16760658.0
|
38 |
+
36,Salicylic acid,,inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Used topically for acne and in aspirin synthesis.,C1=CC=C(C(=C1)C(=O)O)O,338.0
|
39 |
+
37,Ataluren,CFTR,inhibitor/antagonist,unclear,yes,yes,For Duchenne muscular dystrophy with specific genetic mutation.,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,11219835.0
|
40 |
+
38,4EGI-1,EIF4E,inhibitor/antagonist,Protein synthesis inhibitor,no,no,No clinical trials found for 4EGI-1 on clinicaltrials.gov.,C1=CC=C(C(=C1)CC(=NNC2=NC(=CS2)C3=CC(=C(C=C3)Cl)Cl)C(=O)O)[N+](=O)[O-],5717952.0
|
41 |
+
39,Clotrimazole,"CYP2A6, CYP51A1",inhibitor/antagonist,unclear,yes,yes,Antifungal used in topical and oral preparations.,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,2812.0
|
42 |
+
40,Phenytoin (sodium),,inhibitor/antagonist,unclear,yes,yes,Commonly used as an anti-seizure medication.,C1=CC=C(C=C1)C2(C(=O)NC(=N2)[O-])C3=CC=CC=C3.[Na+],23679632.0
|
43 |
+
41,SBI-0640756,,inhibitor/antagonist,Protein synthesis inhibitor,no,no,No record found on clinicaltrials.gov.,C1=CC=C(C=C1)C2=C(C(=O)NC3=C2C=C(C=C3)Cl)C(=O)C=CC4=CC(=CN=C4)F,121241171.0
|
44 |
+
42,Oxaprozin,"PTGS1, PTGS2, NFKB1",inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Approved NSAID for arthritis treatment.,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,4614.0
|
45 |
+
43,Baicalin,,activator/agonist,unclear,no,yes,"Used in traditional medicine, researched for various pharmacological effects.",C1=CC=C(C=C1)C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O,64982.0
|
46 |
+
44,Belinostat,HDAC6,inhibitor/antagonist,HDAC inhibitor,yes,yes,Approved for relapsed/refractory peripheral T-cell lymphoma.,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,6918638.0
|
47 |
+
45,Carbamazepine,,inhibitor/antagonist,HDAC inhibitor,yes,yes,Used for epilepsy and neuropathic pain.,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,2554.0
|
48 |
+
46,HI-TOPK-032,PBK,inhibitor/antagonist,unclear,no,no,No results found on clinicaltrials.gov.,C1=CC=C2C(=C1)N=C3C(=C4C=C(C=CN4C3=N2)NC(=O)C5=CC=CS5)C#N,1936439.0
|
49 |
+
47,8-Hydroxyquinoline,,unclear,unclear,no,yes,"Used in some clinical trial formulations, not approved as standalone drug.",C1=CC2=C(C(=C1)O)N=CC=C2,1923.0
|
50 |
+
48,Riluzole hydrochloride,,inhibitor/antagonist,unclear,yes,yes,Used in ALS treatment.,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N.Cl,6419992.0
|
51 |
+
49,Minodronic acid,"P2RX2, P2RX3",inhibitor/antagonist,unclear,no,yes,Investigated for osteoporosis; not approved in major markets.,C1=CC2=NC=C(N2C=C1)CC(O)(P(=O)(O)O)P(=O)(O)O,130956.0
|
52 |
+
50,GSK1059615,"PIK3CA, PIK3CB, PIK3CD, PIK3CG, MTOR",inhibitor/antagonist,PI3K/AKT inhibitor,no,yes,"Investigated in trials, not approved for human use.",C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4,23582824.0
|
53 |
+
51,Gemcitabine,,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved for cancer treatment like pancreatic and non-small cell lung cancer.,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,60750.0
|
54 |
+
52,Cytarabine,,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Used in chemotherapy for leukemia and other cancers.,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,6253.0
|
55 |
+
53,Cytarabine (hydrochloride),,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Used in chemotherapy for leukemia and lymphoma.,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl,6252.0
|
56 |
+
54,Uridine,,unclear,unclear,no,yes,"Studied in trials; not approved as standalone drug, essential body metabolite.",C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,6029.0
|
57 |
+
55,Selinexor,XPO1,inhibitor/antagonist,unclear,yes,yes,Approved for certain cancer treatments.,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,71481097.0
|
58 |
+
56,Furosemide,"SLC12A1, SLC12A2",inhibitor/antagonist,unclear,yes,yes,"Widely used diuretic, approved for various conditions like hypertension and edema.",C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,3440.0
|
59 |
+
57,Adenosine,"ADORA1, ADORA2A, ADORA2B, ADORA3",unclear,unclear,yes,yes,Used for certain arrhythmias; approved as a drug.,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,60961.0
|
60 |
+
58,5-Azacytidine,DNMT1,inhibitor/antagonist,DNA methyltransferase inhibitor,yes,yes,"Approved for use in specific cancers, such as myelodysplastic syndromes.",C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,9444.0
|
61 |
+
59,Clofarabine,,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved for leukemia treatment in pediatric patients.,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,119182.0
|
62 |
+
60,Adenine,,unclear,unclear,no,no,Commonly found in supplements; not a drug approved by itself.,C1=NC2=NC=NC(=C2N1)N,190.0
|
63 |
+
61,Allopurinol,XDH,inhibitor/antagonist,unclear,yes,yes,"Approved for gout treatment, reduces uric acid levels.",C1=NNC2=C1C(=O)NC=N2,135401907.0
|
64 |
+
62,Trifluridine,,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Used to treat viral infections and in cancer therapy (with tipiracil).,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,6256.0
|
65 |
+
63,Brivudine,,unclear,unclear,yes,yes,"Approved in Europe, not widely used in the US.",C1C(C(OC1N2C=C(C(=O)NC2=O)C=CBr)CO)O,446727.0
|
66 |
+
64,Idoxuridine,,unclear,DNA synthesis/repair inhibitor,yes,yes,Used as topical antiviral in eye infections. Approved for human use.,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,5905.0
|
67 |
+
65,Decitabine,"DNMT1, DNMT3A, DNMT3B",inhibitor/antagonist,DNA methyltransferase inhibitor,yes,yes,Approved for treatment of myelodysplastic syndromes and acute myeloid leukemia.,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,451668.0
|
68 |
+
66,Lenalidomide (hemihydrate),"CRBN, IKZF1, IKZF3",inhibitor/antagonist,unclear,yes,yes,Approved for multiple myeloma and other conditions.,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N.C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N.O,46220375.0
|
69 |
+
67,DT-061,,activator/agonist,unclear,no,yes,"Investigated for oncology, no approval yet for human use.",C1CC(C(C(C1)N2C3=CC=CC=C3OC4=CC=CC=C42)O)NS(=O)(=O)C5=CC=C(C=C5)OC(F)(F)F,91885558.0
|
70 |
+
68,BAY1125976,"AKT1, AKT2, AKT3",inhibitor/antagonist,PI3K/AKT inhibitor,no,yes,Cancer treatment trials but not approved for human use.,C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N,70817911.0
|
71 |
+
69,Larotrectinib,"NTRK1, NTRK2, NTRK3",inhibitor/antagonist,Other TK inhibitor,yes,yes,Approved specifically as a cancer treatment for tumors with NTRK gene fusions.,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,46188928.0
|
72 |
+
70,Larotrectinib sulfate,"NTRK1, NTRK2, NTRK3",inhibitor/antagonist,Other TK inhibitor,yes,yes,Larotrectinib sulfate is approved to treat TRK fusion-positive cancers.,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F.OS(=O)(=O)O,67330085.0
|
73 |
+
71,olaparib,"PARP1, PARP2",unclear,DNA synthesis/repair inhibitor,yes,yes,Approved for BRCA-mutated cancers.,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,23725625.0
|
74 |
+
72,Filgotinib,"JAK1, JAK2, TYK2, JAK3",inhibitor/antagonist,JAK/STAT inhibitor,yes,yes,Approved in Japan and EU for rheumatoid arthritis.,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,49831257.0
|
75 |
+
73,ULK-101,"ULK1, ULK2",inhibitor/antagonist,unclear,no,no,No clinical trial data found on clinicaltrials.gov.,C1CC1C(C(F)(F)F)NC(=O)C2=CC(=CS2)C3=C4N=CC(=CN4N=C3)C5=CC=C(C=C5)F,137628686.0
|
76 |
+
74,Oxaliplatin,,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved for use in chemotherapy treatments.,C1CCC(C(C1)[NH-])[NH-].C(=O)(C(=O)O)O.[Pt+2],9887053.0
|
77 |
+
75,Cilostazol,PDE3A,inhibitor/antagonist,unclear,yes,yes,Used to treat intermittent claudication associated with peripheral artery disease.,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,2754.0
|
78 |
+
76,LY2090314,"GSK3B, GSK3A",inhibitor/antagonist,GSK3 inhibitor,no,yes,Investigated for Alzheimer's; not approved for any condition.,C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7,10029385.0
|
79 |
+
77,Cobimetinib,MAP2K1,inhibitor/antagonist,MEK inhibitor,yes,yes,Approved for melanoma in combination with vemurafenib.,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,16222096.0
|
80 |
+
78,Asciminib,ABL1,inhibitor/antagonist,Other TK inhibitor,yes,yes,Approved for chronic myeloid leukemia (CML) treatment.,C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,72165228.0
|
81 |
+
79,Capivasertib,"AKT1, AKT2, AKT3, RPS6KB1, PRKACA, ROCK2, ROCK1",inhibitor/antagonist,PI3K/AKT inhibitor,no,yes,In clinical trials for cancer. Not yet approved for human use.,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,25227436.0
|
82 |
+
80,Penfluridol,DRD2,inhibitor/antagonist,unclear,yes,yes,Long-acting antipsychotic drug approved for human use.,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,33630.0
|
83 |
+
81,Lonafarnib,"HRAS, KRAS, NRAS",inhibitor/antagonist,RAS inhibitor,yes,yes,Approved for progeria treatment in children.,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,148195.0
|
84 |
+
82,Pimozide,"DRD2, DRD3",inhibitor/antagonist,unclear,yes,yes,Approved antipsychotic used mainly for Tourette's syndrome and chronic schizophrenia.,C1CN(CCC1N2C3=CC=CC=C3NC2=O)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,16362.0
|
85 |
+
83,Clonidine (hydrochloride),"ADRA2A, ADRA2B, ADRA2C",activator/agonist,Adrenoceptor agonist,yes,yes,Used for hypertension and ADHD among other conditions.,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl,20179.0
|
86 |
+
84,Brimonidine,"ADRA2A, ADRA2B, ADRA2C",activator/agonist,Adrenoceptor agonist,yes,yes,Used in the form of brimonidine tartrate for glaucoma treatment.,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br,2435.0
|
87 |
+
85,AT7519,"CDK2, CDK4, CDK5, CDK6, CDK9, CDK1, CDK7, GSK3B",inhibitor/antagonist,CDK inhibitor,no,yes,Tested in trials for cancer treatments.,C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl,11338033.0
|
88 |
+
86,Hydroxyfasudil,"ROCK1, ROCK2, PRKACA",inhibitor/antagonist,unclear,no,yes,"Studied for therapeutic potential; derivative of fasudil, which is approved.",C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CNC3=O,3064778.0
|
89 |
+
87,BI-78D3,,inhibitor/antagonist,Other MAPK inhibitor,no,yes,"Investigated for Alzheimer's and inflammatory diseases, not approved for human use.",C1COC2=C(O1)C=CC(=C2)N3C(=O)NN=C3SC4=NC=C(S4)[N+](=O)[O-],2747117.0
|
90 |
+
88,ETC-206,,inhibitor/antagonist,Protein synthesis inhibitor,no,yes,"Investigational drug for cancer, not yet approved for human use.",C1COCCN1C(=O)C2=CC=C(C=C2)C3=CN4C(=NC=C4C5=CC=C(C=C5)C#N)C=C3,71766360.0
|
91 |
+
89,LJI308,"RPS6KA1, RPS6KA3, RPS6KA2",inhibitor/antagonist,Other MAPK inhibitor,no,yes,"Investigational compound, not approved for human use as a drug.",C1COCCN1C2=CC=C(C=C2)C3=C(C=NC=C3)C4=CC(=C(C(=C4)F)O)F,118704762.0
|
92 |
+
90,Bimiralisib,"PIK3CA, PIK3CB, MTOR",inhibitor/antagonist,PI3K/AKT inhibitor,no,yes,Investigational PI3K/mTOR inhibitor; not approved for human use as of 2023.,C1COCCN1C2=NC(=NC(=N2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,58507717.0
|
93 |
+
91,Bentamapimod,"MAPK8, MAPK9, MAPK10",inhibitor/antagonist,Other MAPK inhibitor,no,yes,Investigated for ovarian cancer; not approved for human use.,C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4,10195250.0
|
94 |
+
92,Lipoic acid,,unclear,unclear,yes,yes,"Approved as dietary supplement, not as a drug for specific indications.",C1CSSC1CCCCC(=O)O,6112.0
|
95 |
+
93,Peretinoin,"RXRA, RXRB, RXRG",unclear,Retinoic receptor agonist,no,yes,"Studied for liver cancer, not approved for human use.",CC(=CCCC(=CCCC(=CC=CC(=CC(=O)O)C)C)C)C,6437836.0
|
96 |
+
94,IQ 1,,unclear,unclear,no,yes,Investigational drug; not approved for human use yet.,CC(=O)C1=CC=C(C=C1)NN=C(C2=NC(CC3=CC=CC=C32)(C)C)C(=O)N,5823908.0
|
97 |
+
95,Acetohexamide,,activator/agonist,unclear,yes,yes,"First-generation sulfonylurea, used for type 2 diabetes treatment.",CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,1989.0
|
98 |
+
96,Pentoxifylline,,inhibitor/antagonist,unclear,yes,yes,Used to improve blood flow in peripheral artery disease.,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C,4740.0
|
99 |
+
97,DTP3,,inhibitor/antagonist,unclear,no,yes,Currently being investigated in clinical trials in the UK.,CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CC2=CC=CC=C2)C(=O)N,86295191.0
|
100 |
+
98,Acetazolamide,,inhibitor/antagonist,unclear,yes,yes,"Used to treat glaucoma, epilepsy, and altitude sickness since 1950s.",CC(=O)NC1=NN=C(S1)S(=O)(=O)N,1986.0
|
101 |
+
99,Pasireotide (acetate),"SSTR1, SSTR2, SSTR3, SSTR5",activator/agonist,unclear,yes,yes,Approved for Cushing's disease and acromegaly.,CC(=O)O.C1C(CN2C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN,72205932.0
|
102 |
+
100,Chlorhexidine (diacetate),,unclear,unclear,yes,yes,Used as antiseptic and disinfectant. Approved for human use.,CC(=O)O.CC(=O)O.C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl,9562059.0
|
103 |
+
101,Aspirin,"PTGS1, PTGS2",inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Used widely for pain relief and anti-inflammatory purposes.,CC(=O)OC1=CC=CC=C1C(=O)O,2244.0
|
104 |
+
102,Abiraterone acetate,CYP17A1,inhibitor/antagonist,unclear,yes,yes,Approved for prostate cancer treatment.,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,9821849.0
|
105 |
+
103,Sivelestat (sodium tetrahydrate),ELANE,inhibitor/antagonist,unclear,no,yes,"Approved in Japan, not approved in US/EU.",CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)[O-].O.O.O.O.[Na+],23663985.0
|
106 |
+
104,Atazanavir (sulfate),CYP3A4,inhibitor/antagonist,unclear,yes,yes,"Antiretroviral, approved for HIV treatment.",CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,158550.0
|
107 |
+
105,Terfenadine,HRH1,inhibitor/antagonist,unclear,no,yes,Withdrawn due to cardiac toxicity; replaced by fexofenadine.,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,5405.0
|
108 |
+
106,Bosentan (hydrate),"EDNRA, EDNRB",inhibitor/antagonist,unclear,yes,yes,Approved for treating pulmonary arterial hypertension.,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.O,185462.0
|
109 |
+
107,Dabrafenib,"BRAF, RAF1",inhibitor/antagonist,RAF inhibitor,yes,yes,Approved for melanoma treatment.,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,44462760.0
|
110 |
+
108,Ralimetinib dimesylate,"MAPKAPK2, MAPK14, MAPK11",inhibitor/antagonist,Other MAPK inhibitor,no,yes,Investigated as cancer treatment; not approved for human use.,CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N.CS(=O)(=O)O.CS(=O)(=O)O,11570805.0
|
111 |
+
109,Saquinavir,,inhibitor/antagonist,unclear,yes,yes,Approved as part of antiretroviral therapy for HIV/AIDS.,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O,441243.0
|
112 |
+
110,Pentagastrin,CCKBR,inhibitor/antagonist,unclear,yes,yes,Used mainly in diagnostic tests for gastric functions.,CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N,9853654.0
|
113 |
+
111,Anastrozole,CYP19A1,inhibitor/antagonist,unclear,yes,yes,Used to treat breast cancer in postmenopausal women.,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,2187.0
|
114 |
+
112,Harringtonine,,unclear,Protein synthesis inhibitor,no,yes,"Investigated in trials mainly for cancer treatment, often used as basis for derivatives.",CC(C)(CCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O,276389.0
|
115 |
+
113,Homoharringtonine,,inhibitor/antagonist,Protein synthesis inhibitor,yes,yes,"Used in leukemia treatment, also known as Omacetaxine.",CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O,285033.0
|
116 |
+
114,Flutamide,AR,inhibitor/antagonist,Androgen receptor antagonist,yes,yes,Used to treat prostate cancer as an antiandrogen.,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,3397.0
|
117 |
+
115,Thymopentin,,unclear,unclear,no,yes,In clinical trials for immune deficiency and autoimmune diseases.,CC(C)C(C(=O)NC(CC1=CC=C(C=C1)O)C(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(CCCN=C(N)N)N,451417.0
|
118 |
+
116,Aliskiren,REN,inhibitor/antagonist,unclear,yes,yes,Renin inhibitor for hypertension. Approved in the US and EU.,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,5493444.0
|
119 |
+
117,Verapamil,"CYP3A4, ABCB1",inhibitor/antagonist,unclear,yes,yes,Used as a racemic mixture for hypertension and angina.,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,2520.0
|
120 |
+
118,(R)-Verapamil (hydrochloride),ABCB1,inhibitor/antagonist,unclear,no,yes,"Racemic verapamil is approved, but not specifically (R)-enantiomer alone.",CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl,170014.0
|
121 |
+
119,Ritonavir,,inhibitor/antagonist,unclear,yes,yes,Used in combination HIV therapies.,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,392622.0
|
122 |
+
120,Goserelin (acetate),GNRHR,activator/agonist,unclear,yes,yes,It's approved for prostate and breast cancer treatment.,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O,16052011.0
|
123 |
+
121,Bestatin,ANPEP,inhibitor/antagonist,unclear,no,yes,Studied in trials; not approved for human therapeutic use.,CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O,72172.0
|
124 |
+
122,Bestatin (hydrochloride),,inhibitor/antagonist,unclear,no,yes,Investigated in clinical trials but not approved for human use.,CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O.Cl,11957481.0
|
125 |
+
123,Imiquimod (maleate),TLR7,activator/agonist,unclear,yes,yes,"Approved for skin conditions; imiquimod itself, not specifically maleate salt.",CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N.C(=CC(=O)O)C(=O)O,11595577.0
|
126 |
+
124,Imiquimod (hydrochloride),TLR7,activator/agonist,unclear,yes,yes,Approved for topical treatment of skin conditions like actinic keratosis.,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N.Cl,13982876.0
|
127 |
+
125,Encorafenib,BRAF,inhibitor/antagonist,RAF inhibitor,yes,yes,Approved for use in BRAF-mutant melanoma.,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,50922675.0
|
128 |
+
126,AZD1390,ATM,inhibitor/antagonist,unclear,no,yes,"Investigational ATM kinase inhibitor in clinical trials, not approved for human use.",CC(C)N1C2=C(C=NC3=CC(=C(C=C32)C4=CN=C(C=C4)OCCCN5CCCCC5)F)N(C1=O)C,126689157.0
|
129 |
+
127,Sapanisertib,MTOR,inhibitor/antagonist,MTOR inhibitor,no,yes,"Investigational mTOR inhibitor, not approved yet but studied for cancer treatment.",CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,45375953.0
|
130 |
+
128,Torkinib,"MTOR, PDGFRA, PRKDC, PIK3CD, PIK3CG, PIK3CA, PIK3CB, HCK, SRC, KDR, ABL1, EPHB4, EGFR",inhibitor/antagonist,MTOR inhibitor,no,yes,In clinical trials for cancer treatment but not yet approved.,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(N3)C=CC(=C4)O)N,135565635.0
|
131 |
+
129,Belumosudil,"ROCK2, ROCK1",inhibitor/antagonist,unclear,yes,yes,Approved for chronic graft-versus-host disease in the US.,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,11950170.0
|
132 |
+
130,Belumosudil (mesylate),"ROCK2, ROCK1",inhibitor/antagonist,unclear,yes,yes,Approved for chronic graft-versus-host disease.,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5.CS(=O)(=O)O,146681181.0
|
133 |
+
131,Esmolol (hydrochloride),ADRB1,inhibitor/antagonist,unclear,yes,yes,Used as a beta-1 blocker for acute heart issues.,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl,104769.0
|
134 |
+
132,Erdafitinib,"FGFR1, FGFR2, FGFR3, FGFR4",inhibitor/antagonist,Other TK inhibitor,yes,yes,Approved for bladder cancer treatment.,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,67462786.0
|
135 |
+
133,Malotilate,ALOX5,inhibitor/antagonist,unclear,no,yes,"Investigated, but not approved for human use.",CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C,4006.0
|
136 |
+
134,Fenofibrate,"CYP2C19, CYP2B6, CYP2C9, CYP2C8, CYP3A4, PPARA",unclear,unclear,yes,yes,Fenofibrate is approved for human use in treating hypercholesterolemia.,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,3339.0
|
137 |
+
135,MK-8353,"MAPK3, MAPK1",inhibitor/antagonist,Other MAPK inhibitor,no,yes,Investigated for cancer treatment in clinical trials.,CC(C)OC1=NC=C(C=C1)C2=NNC3=C2C=C(C=C3)NC(=O)C4(CCN(C4)CC(=O)N5CCC(=CC5)C6=CC=C(C=C6)C7=NN(C=N7)C)SC,58282870.0
|
138 |
+
136,crizotinib,"ALK, MET, ROS1",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,Approved for NSCLC treatment.,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,11626560.0
|
139 |
+
137,(S)-Crizotinib,NUDT1,inhibitor/antagonist,unclear,no,yes,"Racemic mixture Crizotinib is approved, not specific enantiomer.",CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,56671814.0
|
140 |
+
138,Crizotinib (hydrochloride),"ALK, MET, ROS1",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,Approved for ALK-positive NSCLC treatment.,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N.Cl,71576688.0
|
141 |
+
139,Aprepitant,TACR1,inhibitor/antagonist,unclear,yes,yes,Aprepitant is approved for preventing chemotherapy-induced nausea and vomiting.,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,135413536.0
|
142 |
+
140,Cinacalcet,CASR,activator/agonist,unclear,yes,yes,Used to treat secondary hyperparathyroidism and parathyroid carcinoma.,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,156419.0
|
143 |
+
141,Naproxen,"PTGS1, PTGS2",inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Used as non-prescription NSAID in many countries.,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)O,156391.0
|
144 |
+
142,Zileuton,ALOX5,inhibitor/antagonist,unclear,yes,yes,Approved for asthma treatment; 5-lipoxygenase inhibitor.,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,60490.0
|
145 |
+
143,Voriconazole,,inhibitor/antagonist,unclear,yes,yes,Approved for treating invasive fungal infections.,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,71616.0
|
146 |
+
144,Carbidopa (monohydrate),AHR,inhibitor/antagonist,unclear,yes,yes,Used in combination with levodopa for Parkinson's treatment.,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,2563.0
|
147 |
+
145,Silodosin,"ADRA1A, ADRA1B, ADRA1D",inhibitor/antagonist,unclear,yes,yes,Approved for benign prostatic hyperplasia treatment.,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,5312125.0
|
148 |
+
146,Darolutamide,AR,inhibitor/antagonist,Androgen receptor antagonist,yes,yes,Approved for treating non-metastatic castration-resistant prostate cancer.,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,67171867.0
|
149 |
+
147,Benproperine (phosphate),ARPC2,inhibitor/antagonist,unclear,yes,yes,Studied as a cough suppressant; not widely approved.,CC(COC1=CC=CC=C1CC2=CC=CC=C2)N3CCCCC3.OP(=O)(O)O,167811.0
|
150 |
+
148,Bicalutamide,AR,inhibitor/antagonist,Androgen receptor antagonist,yes,yes,Approved as antiandrogen for prostate cancer treatment.,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,2375.0
|
151 |
+
149,Captopril,ACE,inhibitor/antagonist,unclear,yes,yes,First ACE inhibitor approved for hypertension and heart failure.,CC(CS)C(=O)N1CCCC1C(=O)O,44093.0
|
152 |
+
150,Tirabrutinib,BTK,inhibitor/antagonist,Other TK inhibitor,no,yes,"In clinical trials, not approved for human use yet.",CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N,54755438.0
|
153 |
+
151,Tirabrutinib (hydrochloride),BTK,inhibitor/antagonist,Other TK inhibitor,no,yes,Not approved in US/EU; used investigationally in some regions.,CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N.Cl,71571562.0
|
154 |
+
152,Mifepristone,"NR3C1, PGR",inhibitor/antagonist,unclear,yes,yes,Approved for medical abortion and Cushing's syndrome treatment.,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,55245.0
|
155 |
+
153,Fostamatinib (disodium hexahydrate),"SYK, FLT3, LYN, LCK",inhibitor/antagonist,Other TK inhibitor,yes,yes,Approved for treatment of chronic immune thrombocytopenia in adults.,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.O.O.O.O.O.O.[Na+].[Na+],146673142.0
|
156 |
+
154,Temuterkib,,inhibitor/antagonist,Other MAPK inhibitor,no,yes,Temuterkib is in clinical trials for cancer treatment.,CC1(C2=C(C=C(S2)C3=NC(=NC=C3)NC4=CC=NN4C)C(=O)N1CCN5CCOCC5)C,121408882.0
|
157 |
+
155,Tetracycline (hydrochloride),,unclear,unclear,yes,yes,Approved antibiotic often used as tetracycline hydrochloride.,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,54704426.0
|
158 |
+
156,Glycyrrhizic acid,,inhibitor/antagonist,unclear,no,yes,"Tested for therapeutic effects, not approved for human use.",CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C,14982.0
|
159 |
+
157,Diammonium Glycyrrhizinate,,unclear,unclear,no,yes,Used in trials for hepatitis. Not approved for general human use.,CC1(C2CCC3(C(C2(CCC1OC4C(C(C(C(O4)C(=O)O)O)O)OC5C(C(C(C(O5)C(=O)O)O)O)O)C)C(=O)C=C6C3(CCC7(C6CC(CC7)(C)C(=O)O)C)C)C)C.N.N,656656.0
|
160 |
+
158,venetoclax,BCL2,inhibitor/antagonist,unclear,yes,yes,Approved for chronic lymphocytic leukemia and other cancers.,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,49846579.0
|
161 |
+
159,Delamanid,,inhibitor/antagonist,unclear,yes,yes,Approved for MDR-TB treatment.,CC1(CN2C=C(N=C2O1)[N+](=O)[O-])COC3=CC=C(C=C3)N4CCC(CC4)OC5=CC=C(C=C5)OC(F)(F)F,6480466.0
|
162 |
+
160,Dexmedetomidine,"ADRA2A, ADRA2B, ADRA2C",activator/agonist,Adrenoceptor agonist,yes,yes,Approved as sedative and analgesic.,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,5311068.0
|
163 |
+
161,Ranolazine,,inhibitor/antagonist,unclear,yes,yes,Approved for treating chronic angina.,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,56959.0
|
164 |
+
162,Lopinavir,,inhibitor/antagonist,unclear,yes,yes,Combined with ritonavir for HIV treatment. Approved for human use.,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,92727.0
|
165 |
+
163,Valdecoxib,PTGS2,inhibitor/antagonist,Cyclooxygenase inhibitor,no,yes,Withdrawn due to safety concerns related to cardiovascular risks.,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,119607.0
|
166 |
+
164,Cloxacillin (sodium),,inhibitor/antagonist,unclear,yes,yes,Approved as a penicillinase-resistant antibiotic for human use.,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+],23675320.0
|
167 |
+
165,Elagolix sodium,GNRHR,inhibitor/antagonist,unclear,yes,yes,Approved for endometriosis pain in women.,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)[O-])C4=C(C(=CC=C4)OC)F.[Na+],24785956.0
|
168 |
+
166,palbociclib,"CDK4, CDK6",inhibitor/antagonist,CDK inhibitor,yes,yes,Approved for human use as a cancer treatment.,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,5330286.0
|
169 |
+
167,Retinoic acid,"RARB, RARG, RARA, PPARD",activator/agonist,Retinoic receptor agonist,yes,yes,Approved for acne and leukemia treatment.,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,444795.0
|
170 |
+
168,PH-797804,MAPK14,inhibitor/antagonist,Other MAPK inhibitor,no,yes,"Investigated as an anti-inflammatory agent, not approved for human use.",CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C,22049997.0
|
171 |
+
169,Ponatinib,"ABL1, PDGFRA, KDR, FGFR1, SRC, KIT",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,Approved for treatment of certain types of leukemia.,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,24826799.0
|
172 |
+
170,Radotinib,ABL1,inhibitor/antagonist,Other TK inhibitor,no,yes,"Tested for chronic myeloid leukemia, not approved in major markets.",CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)N3C=C(N=C3)C)NC4=NC=CC(=N4)C5=NC=CN=C5,16063245.0
|
173 |
+
171,NVP-BHG712,EPHB4,inhibitor/antagonist,unclear,no,yes,Investigated as angiogenesis inhibitor; not approved for human use.,CC1=C(C=C(C=C1)C(=O)NC2=CC=CC(=C2)C(F)(F)F)NC3=C4C=NN(C4=NC(=N3)C5=CN=CC=C5)C,16747388.0
|
174 |
+
172,Canagliflozin,SLC5A2,inhibitor/antagonist,Glucose transporter inhibitor,yes,yes,Approved for type 2 diabetes treatment.,CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,24812758.0
|
175 |
+
173,MK-3903,PRKAA1,activator/agonist,unclear,no,yes,"Investigated for NASH, not yet approved for human use.",CC1=C(C=C(C=C1)OC2=NC3=C(N2)C=C(C(=C3)C4=CC=C(C=C4)C5=CC=CC=C5)Cl)C(=O)O,45256689.0
|
176 |
+
174,EX229,PRKAA1,activator/agonist,unclear,no,no,No clinical trial information found on clinicaltrials.gov.,CC1=C(C=C(C=C1)OC2=NC3=C(N2)C=C(C(=C3)C4=CC5=C(C=C4)N(C=C5)C)Cl)C(=O)O,45256693.0
|
177 |
+
175,Flumatinib (mesylate),ABL1,inhibitor/antagonist,Other TK inhibitor,no,yes,Used in trials for chronic myeloid leukemia.,CC1=C(C=C(C=N1)NC(=O)C2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,46910592.0
|
178 |
+
176,Tucatinib,ERBB2,inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for human use in advanced HER2-positive breast cancer.,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,51039094.0
|
179 |
+
177,Trimetrexate,DHFR,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Used with leucovorin for treating certain types of pneumonia.,CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC(=C(C(=C3)OC)OC)OC,5583.0
|
180 |
+
178,APTO-253,"MYC, KLF4",unclear,unclear,no,yes,"Investigated for cancer, but development discontinued.",CC1=C(C2=C(N1)C=CC(=C2)F)C3=NC4=C5C=CC=NC5=C6C(=C4N3)C=CC=N6,11960271.0
|
181 |
+
179,Vitamin K4,,unclear,unclear,no,yes,Investigated in a clinical trial in Egypt.,CC1=C(C2=CC=CC=C2C(=C1)OC(=O)C)OC(=O)C,11310.0
|
182 |
+
180,Panobinostat,"HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, HDAC10, HDAC11",inhibitor/antagonist,HDAC inhibitor,yes,yes,Approved for multiple myeloma treatment.,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,6918837.0
|
183 |
+
181,Rimonabant,CNR1,inhibitor/antagonist,unclear,no,yes,Withdrawn due to psychiatric side effects.,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,104850.0
|
184 |
+
182,Rimonabant (Hydrochloride),CNR1,inhibitor/antagonist,unclear,no,yes,"Withdrawn due to psychiatric side effects, once used as anti-obesity drug.",CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl.Cl,104849.0
|
185 |
+
183,Ligustrazine,,unclear,unclear,no,yes,"Mainly used in traditional Chinese medicine, limited human trials exist.",CC1=C(N=C(C(=N1)C)C)C,14296.0
|
186 |
+
184,Sulfisoxazole,"EDNRA, EDNRB",inhibitor/antagonist,unclear,yes,yes,Discontinued in U.S.; previously used for bacterial infections.,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,5344.0
|
187 |
+
185,Alpelisib,PIK3CA,inhibitor/antagonist,PI3K/AKT inhibitor,yes,yes,Approved for HR+/HER2- advanced breast cancer in combination with fulvestrant.,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,56649450.0
|
188 |
+
186,Trametinib,"MAP2K1, MAP2K2",inhibitor/antagonist,MEK inhibitor,yes,yes,Approved for melanoma treatment.,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,11707110.0
|
189 |
+
187,Nevirapine,,inhibitor/antagonist,unclear,yes,yes,Antiretroviral for HIV treatment approved for human use.,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,4463.0
|
190 |
+
188,Tomivosertib,,inhibitor/antagonist,Protein synthesis inhibitor,no,yes,In clinical trials for cancer; not FDA approved for human use yet.,CC1=C2C(=O)NC3(N2C(=O)C(=C1)NC4=NC=NC(=C4)N)CCCCC3,118598754.0
|
191 |
+
189,Paclitaxel,,unclear,Microtubule inhibitor,yes,yes,Chemotherapy drug approved for cancer treatment.,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,36314.0
|
192 |
+
190,Docetaxel,,inhibitor/antagonist,Microtubule inhibitor,yes,yes,"Approved anticancer drug, often used in chemotherapy treatments.",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O,148124.0
|
193 |
+
191,Docetaxel (Trihydrate),"TUBB1, TUBB3, TUBB4B, TUBB4A, TUBB2A, TUBB2B",unclear,Microtubule inhibitor,yes,yes,"Approved cancer treatment, commonly used in chemotherapy.",CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)O)C)O.O.O.O,148123.0
|
194 |
+
192,Roxadustat,,inhibitor/antagonist,unclear,yes,yes,"Approved for anemia treatment in some countries, e.g., China, Japan.",CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,11256664.0
|
195 |
+
193,Thymol,TRPA1,activator/agonist,unclear,no,yes,Used in clinical trials as antiseptic and antifungal.,CC1=CC(=C(C=C1)C(C)C)O,6989.0
|
196 |
+
194,Gemfibrozil,"PPARA, CYP2C9, CYP2C19, CYP2C8, CYP1A2",unclear,unclear,yes,yes,Approved for dyslipidemia treatment.,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,3463.0
|
197 |
+
195,Vortioxetine,"SLC6A4, HTR3A, HTR7",unclear,unclear,yes,yes,Approved for major depressive disorder.,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,9966051.0
|
198 |
+
196,OTS514,MAP3K8,inhibitor/antagonist,Other MAPK inhibitor,no,yes,Investigational drug in preclinical and early phase clinical trials.,CC1=CC(=C(C2=C1NC(=O)C3=C2C=CS3)C4=CC=C(C=C4)C(C)CN)O,67448836.0
|
199 |
+
197,Pralsetinib,RET,inhibitor/antagonist,Other TK inhibitor,yes,yes,Approved for RET fusion-positive cancers.,CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)NC(C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC,129073603.0
|
200 |
+
198,Menadione,,unclear,unclear,no,yes,"Used in trials; a vitamin K analog, not fully approved for human use.",CC1=CC(=O)C2=CC=CC=C2C1=O,4055.0
|
201 |
+
199,Ciclopirox,,unclear,unclear,yes,yes,"Approved for antifungal use, primarily in nail and skin treatments.",CC1=CC(=O)N(C(=C1)C2CCCCC2)O,2749.0
|
202 |
+
200,Methylthiouracil,,unclear,unclear,no,yes,"Used in research, not approved for human therapeutic use.",CC1=CC(=O)NC(=S)N1,667493.0
|
203 |
+
201,Tolcapone,COMT,inhibitor/antagonist,unclear,yes,yes,"Used in Parkinson's treatment, subject to liver monitoring.",CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],4659569.0
|
204 |
+
202,Tolmetin,"PTGS1, PTGS2",inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Approved NSAID for pain and inflammation.,CC1=CC=C(C=C1)C(=O)C2=CC=C(N2C)CC(=O)O,5509.0
|
205 |
+
203,Celecoxib,PTGS2,inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Used for arthritis pain and inflammation; approved NSAID.,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,2662.0
|
206 |
+
204,S-Adenosyl-L-methionine (disulfate tosylate),,unclear,unclear,yes,yes,Used as dietary supplement; approved in some countries for depression treatment.,CC1=CC=C(C=C1)S(=O)(=O)O.C[S+](CCC(C(=O)O)N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.OS(=O)(=O)O.OS(=O)(=O)[O-],9875462.0
|
207 |
+
205,Lapatinib ditosylate,"EGFR, ERBB2",inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for use in breast cancer treatment.,CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl.O,11557040.0
|
208 |
+
206,LY-2584702 (tosylate salt),RPS6KB1,inhibitor/antagonist,MTOR inhibitor,no,yes,Investigated in clinical trials for cancer treatment. Not approved for human use.,CC1=CC=C(C=C1)S(=O)(=O)O.CN1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=NN4)C5=CC(=C(C=C5)F)C(F)(F)F,46205871.0
|
209 |
+
207,Edoxaban (tosylate monohydrate),F10,inhibitor/antagonist,unclear,yes,yes,Approved as an anticoagulant for preventing stroke and blood clots.,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O,25022378.0
|
210 |
+
208,Lumateperone (tosylate),"HTR2A, DRD2",unclear,unclear,yes,yes,Approved for schizophrenia; marketed as Caplyta.,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCN2C3CCN(CC3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F,44241743.0
|
211 |
+
209,Mozavaptan,AVPR2,inhibitor/antagonist,unclear,no,yes,In trials for conditions like hyponatremia but not approved for use.,CC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)N3CCCC(C4=CC=CC=C43)N(C)C,119369.0
|
212 |
+
210,Bexarotene,"RXRA, RXRB, RXRG",activator/agonist,Retinoic receptor agonist,yes,yes,Approved for treating cutaneous T-cell lymphoma.,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,82146.0
|
213 |
+
211,Sulfatinib,"FLT1, KDR, FLT4, FGFR1, CSF1R",inhibitor/antagonist,Multi-TK inhibitor,no,yes,"Investigated in trials for neuroendocrine tumors, not yet approved for use.",CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,52920501.0
|
214 |
+
212,Olanzapine,"HTR2A, HTR2C, DRD2, DRD4, ADRA1A, ADRA1B, ADRA1D, HTR6, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",inhibitor/antagonist,unclear,yes,yes,Olanzapine is used in treatment of schizophrenia and bipolar disorder.,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,135398745.0
|
215 |
+
213,AZD-7648,PRKDC,inhibitor/antagonist,DNA synthesis/repair inhibitor,no,yes,"Inhibitor studied for DNA repair, not yet approved for human use.",CC1=CC2=NC=NN2C=C1NC3=NC=C4C(=N3)N(C(=O)N4C)C5CCOCC5,135151360.0
|
216 |
+
214,Megestrol,,unclear,unclear,yes,yes,Used for appetite loss and weight gain in cancer/AIDS patients.,CC1=CC2C(CCC3(C2CCC3(C(=O)C)O)C)C4(C1=CC(=O)CC4)C,19090.0
|
217 |
+
215,Omeprazole (sodium),,inhibitor/antagonist,unclear,yes,yes,Approved in salt form as acid reflux treatment.,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=C(C=C3)OC.[Na+],12108541.0
|
218 |
+
216,Omeprazole,,inhibitor/antagonist,unclear,yes,yes,Used as part of racemic mixture for acid-related conditions.,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,4594.0
|
219 |
+
217,Fedratinib (hydrochloride hydrate),"JAK2, FLT3, RET",inhibitor/antagonist,JAK/STAT inhibitor,yes,yes,Approved for treatment of myelofibrosis.,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4.O.Cl.Cl,67517580.0
|
220 |
+
218,Meloxicam,"PTGS1, PTGS2",inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Meloxicam is an approved NSAID for pain and inflammation.,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,54677470.0
|
221 |
+
219,Pyridoxine,,unclear,unclear,yes,yes,Vitamin B6; essential nutrient approved for various health conditions.,CC1=NC=C(C(=C1O)CO)CO,1054.0
|
222 |
+
220,Pyridoxine (hydrochloride),,unclear,unclear,yes,yes,"Vitamin B6, approved for various medical conditions.",CC1=NC=C(C(=C1O)CO)CO.Cl,6019.0
|
223 |
+
221,Ornidazole,,unclear,unclear,yes,yes,"Used for bacterial and protozoal infections, common in some countries.",CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-],28061.0
|
224 |
+
222,Raltitrexed,TYMS,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved for cancer treatment as thymidylate synthase inhibitor.,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1,135400182.0
|
225 |
+
223,BI-3406,"KRAS, SOS1",inhibitor/antagonist,RAS inhibitor,no,yes,"Investigational compound, clinical trials for KRAS-driven cancers.",CC1=NC2=CC(=C(C=C2C(=N1)NC(C)C3=CC(=CC(=C3)N)C(F)(F)F)OC4CCOC4)OC,138911318.0
|
226 |
+
224,Triamcinolone,NR3C1,unclear,Glucocorticoid receptor agonist,yes,yes,Approved corticosteroid for various inflammatory and allergic conditions.,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,31307.0
|
227 |
+
225,Drospirenone,,unclear,unclear,yes,yes,"Found in birth control, often combined with ethinyl estradiol.",CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,68873.0
|
228 |
+
226,Eplerenone,NR3C2,inhibitor/antagonist,unclear,yes,yes,Used to treat heart failure and hypertension.,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,443872.0
|
229 |
+
227,Quinestrol,,unclear,unclear,yes,yes,Estrogen approved for use in menopausal therapy and contraceptives.,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC5CCCC5,9046.0
|
230 |
+
228,Estrone sulfate (potassium),,unclear,unclear,no,yes,Estrone sulfate used in hormone therapy; potassium salt not specifically approved.,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[K+],23674502.0
|
231 |
+
229,Finasteride,SRD5A2,inhibitor/antagonist,unclear,yes,yes,Used for benign prostatic hyperplasia and male pattern baldness.,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,57363.0
|
232 |
+
230,Fulvestrant,ESR1,inhibitor/antagonist,unclear,yes,yes,Estrogen receptor antagonist used for hormone receptor-positive breast cancer.,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,104741.0
|
233 |
+
231,Monocrotaline,"SLC22A1, SLC22A2",inhibitor/antagonist,unclear,no,no,"Toxic pyrrolizidine alkaloid, not approved for human use.",CC1C(=O)OC2CCN3C2C(=CC3)COC(=O)C(C1(C)O)(C)O,9415.0
|
234 |
+
232,Ouabain (Octahydrate),,unclear,unclear,no,yes,Investigated for heart failure but not approved for human use.,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O.O.O.O.O.O.O.O.O,6364534.0
|
235 |
+
233,Rutin (trihydrate),,unclear,unclear,no,no,Commonly used in supplements; lacks regulatory approval as a drug.,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O.O.O.O,16218542.0
|
236 |
+
234,Hesperidin,,unclear,unclear,no,yes,"Studied for various health benefits, but not approved as a drug.",CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,10621.0
|
237 |
+
235,Digitoxin,,unclear,unclear,no,yes,"Clinical trials for certain conditions, but not FDA approved for human use.",CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,441207.0
|
238 |
+
236,Doxorubicin (hydrochloride),"TOP2A, TOP2B, TOP1",inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Commonly used chemotherapy drug for several cancers.,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,443939.0
|
239 |
+
237,Epirubicin (hydrochloride),TOP2A,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Used in chemotherapies as single agent or in combination treatments.,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)O.Cl,65348.0
|
240 |
+
238,Idarubicin (hydrochloride),TOP2A,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Used in acute myeloid leukemia treatment.,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl,636362.0
|
241 |
+
239,Plicamycin,"SP1, GSTM2",inhibitor/antagonist,unclear,yes,yes,Plicamycin is used to treat testicular cancer and hypercalcemia.,CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O,163659.0
|
242 |
+
240,Rifaximin,,unclear,unclear,yes,yes,Approved for treatment of IBS and hepatic encephalopathy.,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,6436173.0
|
243 |
+
241,Doxycycline (monohydrate),"MMP7, MMP8, MMP9, MMP13, MMP14",inhibitor/antagonist,unclear,yes,yes,Approved antibiotic for bacterial infections.,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.O,54684461.0
|
244 |
+
242,Fusidic acid,,inhibitor/antagonist,unclear,yes,yes,Used topically and orally for bacterial infections.,CC1C2CCC3(C(C2(CCC1O)C)C(CC4C3(CC(C4=C(CCC=C(C)C)C(=O)O)OC(=O)C)C)O)C,3000226.0
|
245 |
+
243,Ipatasertib,"AKT1, AKT2, AKT3",inhibitor/antagonist,PI3K/AKT inhibitor,no,yes,"Investigational cancer drug, not approved for human use.",CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,24788740.0
|
246 |
+
244,Medroxyprogesterone acetate,PGR,unclear,unclear,yes,yes,Approved as a contraceptive and for hormone therapy.,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,6279.0
|
247 |
+
245,Methylprednisolone succinate,NR3C1,unclear,Glucocorticoid receptor agonist,yes,yes,Corticosteroid; approved for reducing inflammation in various conditions.,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC(=O)O)O,16923.0
|
248 |
+
246,Dexamethasone,NR3C1,activator/agonist,Glucocorticoid receptor agonist,yes,yes,Commonly used glucocorticoid for inflammation and immune response regulation.,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,5743.0
|
249 |
+
247,Dihydroartemisinin,,unclear,unclear,yes,yes,"Active metabolite of artemisinin, approved for malaria treatment.",CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)O)C,3000518.0
|
250 |
+
248,Artesunate,,inhibitor/antagonist,JAK/STAT inhibitor,yes,yes,"Used for severe malaria, often partnered with other antimalarial drugs.",CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,6917864.0
|
251 |
+
249,Artemether,,unclear,unclear,yes,yes,Artemether is used in combination with lumefantrine to treat malaria.,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,68911.0
|
252 |
+
250,Rapamycin,"MTOR, FKBP1A",inhibitor/antagonist,MTOR inhibitor,yes,yes,Approved mainly for organ transplantation and cancer treatment.,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)O)C)C)O)OC)C)C)C)OC,5284616.0
|
253 |
+
251,Temsirolimus,MTOR,inhibitor/antagonist,MTOR inhibitor,yes,yes,Approved for treating renal cell carcinoma.,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,6918289.0
|
254 |
+
252,Everolimus,"MTOR, FKBP1A",inhibitor/antagonist,MTOR inhibitor,yes,yes,"Approved for certain types of cancer, organ transplantation, and tuberous sclerosis.",CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,6442177.0
|
255 |
+
253,Tofacitinib,"JAK1, JAK2, JAK3",inhibitor/antagonist,JAK/STAT inhibitor,yes,yes,Approved for rheumatoid arthritis and other conditions.,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,9926791.0
|
256 |
+
254,Tofacitinib (citrate),"JAK1, JAK2, JAK3",inhibitor/antagonist,JAK/STAT inhibitor,yes,yes,Approved for rheumatoid arthritis and other conditions.,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,10174505.0
|
257 |
+
255,Sonidegib,SMO,inhibitor/antagonist,Sonic inhibitor,yes,yes,Approved for basal cell carcinoma treatment.,CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,24775005.0
|
258 |
+
256,AZD-8055,MTOR,inhibitor/antagonist,MTOR inhibitor,no,yes,Investigational drug; explored in trials mainly for cancer treatment.,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C,25262965.0
|
259 |
+
257,Elimusertib hydrochloride,ATR,inhibitor/antagonist,unclear,no,yes,Tested in trials for cancer but not approved for human use.,CC1COCCN1C2=NC3=C(C=CN=C3C4=CC=NN4)C(=C2)C5=CC=NN5C,118869362.0
|
260 |
+
258,Clobetasol propionate,"CYP3A5,CYP3A4",inhibitor/antagonist,unclear,yes,yes,It's a potent corticosteroid for skin conditions.,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,32798.0
|
261 |
+
259,Betamethasone dipropionate,NR3C1,activator/agonist,Glucocorticoid receptor agonist,yes,yes,A corticosteroid approved and used in topical formulations for inflammation.,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,21800.0
|
262 |
+
260,Posaconazole,,unclear,unclear,yes,yes,Broad-spectrum antifungal approved for human use.,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,468595.0
|
263 |
+
261,Pravastatin (sodium),HMGCR,inhibitor/antagonist,unclear,yes,yes,Approved as a cholesterol-lowering agent.,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+],16759173.0
|
264 |
+
262,Ivermectin,,unclear,unclear,yes,yes,Approved for infections in humans and animals.,CCC(C)C1C(CCC2(O1)CC3CC(O2)CC=C(C(C(C=CC=C4COC5C4(C(C=C(C5O)C)C(=O)O3)O)C)OC6CC(C(C(O6)C)OC7CC(C(C(O7)C)O)OC)OC)C)C,6321424.0
|
265 |
+
263,Topotecan (hydrochloride),TOP1,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,"Approved for treating ovarian, small cell lung, and cervical cancer.",CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O.Cl,60699.0
|
266 |
+
264,Vinblastine (sulfate),,inhibitor/antagonist,Microtubule inhibitor,yes,yes,"Used in cancer treatment, notably Hodgkin's lymphoma.",CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,5388983.0
|
267 |
+
265,vincristine,,inhibitor/antagonist,Microtubule inhibitor,yes,yes,Used in chemotherapy for various cancers.,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C=O)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,249332.0
|
268 |
+
266,Indacaterol (maleate),ADRB2,activator/agonist,Adrenoceptor agonist,yes,yes,Approved for COPD as a long-acting bronchodilator.,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O,9827599.0
|
269 |
+
267,Pimitespib,"HSP90AA1, HSP90AB1",inhibitor/antagonist,unclear,no,yes,Investigated in trials for cancer; not approved for human use yet.,CCC1=C(C=CC(=C1)C(=O)N)N2C3=NC=CC(=C3C(=N2)C(C)C)N4C=C(N=C4)C5=CN(N=C5)C,67501411.0
|
270 |
+
268,Irinotecan,TOP1,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,"Used in cancer treatment, especially for colorectal cancer.",CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7,60838.0
|
271 |
+
269,Irinotecan (hydrochloride),TOP1,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved for cancer treatment as a topoisomerase inhibitor.,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)C4(CC)O)C2=NC5=C1C=C(C=C5)OC(=O)N6CCC(CC6)N7CCCCC7.Cl,74990.0
|
272 |
+
270,Dinaciclib,"CDK1, CDK2, CDK5, CDK9",inhibitor/antagonist,CDK inhibitor,no,yes,Investigated in trials; not yet approved for human use.,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,46926350.0
|
273 |
+
271,Pioglitazone,PPARG,activator/agonist,unclear,yes,yes,Approved for type 2 diabetes treatment.,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,4829.0
|
274 |
+
272,Volasertib,"PLK1, PLK2, PLK3",inhibitor/antagonist,unclear,no,yes,"Investigated for cancer treatment, not approved for human use.",CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,10461508.0
|
275 |
+
273,Cyclosporin A,"PPP3CA, PPP3CB, PPP3CC",inhibitor/antagonist,unclear,yes,yes,Immunosuppressant approved for organ transplant patients.,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,5284373.0
|
276 |
+
274,Erythromycin,,inhibitor/antagonist,unclear,yes,yes,Antibiotic used to treat infections; approved for human use.,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,12560.0
|
277 |
+
275,Azithromycin (hydrate),,unclear,unclear,yes,yes,Approved as an antibiotic for bacterial infections.,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O,3033819.0
|
278 |
+
276,Perindopril (erbumine),"STAT3, ACE",inhibitor/antagonist,unclear,yes,yes,Approved ACE inhibitor for hypertension and heart failure.,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.CC(C)(C)N,441313.0
|
279 |
+
277,Sildenafil,PDE5A,inhibitor/antagonist,unclear,yes,yes,Approved for erectile dysfunction and pulmonary arterial hypertension.,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,135398744.0
|
280 |
+
278,Budesonide,NR3C1,activator/agonist,Glucocorticoid receptor agonist,yes,yes,"Used for asthma, Crohn's disease, ulcerative colitis.",CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,5281004.0
|
281 |
+
279,Hexylresorcinol,,inhibitor/antagonist,unclear,yes,yes,Used in throat lozenges and skin creams for antiseptic purposes.,CCCCCCC1=C(C=C(C=C1)O)O,3610.0
|
282 |
+
280,Oleic acid,,activator/agonist,unclear,yes,yes,"Used in food, cosmetics, and as an excipient in pharmaceuticals.",CCCCCCCCC=CCCCCCCCC(=O)O,445639.0
|
283 |
+
281,Fingolimod (hydrochloride),PAK1,unclear,unclear,yes,yes,Approved for multiple sclerosis treatment.,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,107969.0
|
284 |
+
282,Daptomycin,,unclear,unclear,yes,yes,Approved as an antibiotic for skin infections.,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,21585658.0
|
285 |
+
283,Orlistat,,inhibitor/antagonist,unclear,yes,yes,Used to treat obesity by preventing fat absorption.,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,3034010.0
|
286 |
+
284,Levobupivacaine (hydrochloride),SCN5A,inhibitor/antagonist,unclear,yes,yes,Approved as an enantiomer of bupivacaine for anesthetic use.,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,117965.0
|
287 |
+
285,Proglumide,"CCKBR, CCKAR",inhibitor/antagonist,unclear,no,yes,"Proglumide investigated for gastrointestinal use, not widely approved for humans.",CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,4922.0
|
288 |
+
286,Ropivacaine (hydrochloride monohydrate),,inhibitor/antagonist,unclear,yes,yes,A local anesthetic used in surgeries and pain management.,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.O.Cl,6918111.0
|
289 |
+
287,Macitentan,"EDNRA, EDNRB",inhibitor/antagonist,unclear,yes,yes,Approved for pulmonary arterial hypertension treatment.,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,16004692.0
|
290 |
+
288,Vemurafenib,BRAF,inhibitor/antagonist,RAF inhibitor,yes,yes,Approved for treating BRAF V600E mutation-positive melanoma.,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,42611257.0
|
291 |
+
289,Lidocaine (hydrochloride),"MAP2K1, MAPK1, NFKB1",unclear,unclear,yes,yes,Lidocaine hydrochloride is approved as a local anesthetic.,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C.Cl,6314.0
|
292 |
+
290,Sunitinib,"KDR, PDGFRB",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,Approved anticancer drug used for renal cell carcinoma and gastrointestinal stromal tumors.,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,5329102.0
|
293 |
+
291,Procainamide (hydrochloride),DNMT1,inhibitor/antagonist,DNA methyltransferase inhibitor,yes,yes,Used for arrhythmias; often as its hydrochloride salt form.,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl,66068.0
|
294 |
+
292,Lucanthone,,inhibitor/antagonist,unclear,no,yes,"Investigated for cancer treatment, not approved for human use.",CCN(CC)CCNC1=C2C(=C(C=C1)C)SC3=CC=CC=C3C2=O,10180.0
|
295 |
+
293,RMC-6236,KRAS,inhibitor/antagonist,RAS inhibitor,no,yes,"Investigated as a potential cancer treatment, but not approved for human use.",CCN1C2=C3C=C(C=C2)C4=CSC(=N4)CC(C(=O)N5CCCC(N5)C(=O)OCC(CC3=C1C6=C(N=CC(=C6)N7CCN(CC7)C)C(C)OC)(C)C)NC(=O)C8CC8C,164726578.0
|
296 |
+
294,Pemigatinib,"FGFR1, FGFR2, FGFR3, FGFR4",inhibitor/antagonist,Other TK inhibitor,yes,yes,Approved for treating cholangiocarcinoma.,CCN1C2=C3C=C(NC3=NC=C2CN(C1=O)C4=C(C(=CC(=C4F)OC)OC)F)CN5CCOCC5,86705695.0
|
297 |
+
295,Infigratinib,"FGFR1, FGFR2, FGFR3, FGFR4",inhibitor/antagonist,Other TK inhibitor,yes,yes,Used for bile duct cancer treatment.,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,53235510.0
|
298 |
+
296,NG25,"MAP4K2, MAP3K7, LYN, ABL1, ABL2, FER, SRC, EPHA2, EPHB2, EPHB4, ZAK, ZKSCAN1, RAF1",inhibitor/antagonist,Other MAPK inhibitor,no,yes,"NG25 is in preclinical stages, not approved for humans.",CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)C3=CC(=C(C=C3)C)OC4=C5C=CNC5=NC=C4)C(F)(F)F,53340664.0
|
299 |
+
297,Abemaciclib,"CDK4, CDK6",inhibitor/antagonist,CDK inhibitor,yes,yes,"FDA approved for HR-positive, HER2-negative breast cancer.",CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,46220502.0
|
300 |
+
298,Bimatoprost,,unclear,unclear,yes,yes,Approved for treating glaucoma and cosmetic lash applications.,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,5311027.0
|
301 |
+
299,Dorzolamide (hydrochloride),CA2,inhibitor/antagonist,unclear,yes,yes,Approved for glaucoma treatment.,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl,6918132.0
|
302 |
+
300,Tazarotene,"RARA, RARB, RARG",activator/agonist,Retinoic receptor agonist,yes,yes,Topical retinoid approved for psoriasis and acne treatment.,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,5381.0
|
303 |
+
301,Neratinib,"EGFR, ERBB2",inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for breast cancer treatment.,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,9915743.0
|
304 |
+
302,Neratinib (maleate),"EGFR, ERBB2",inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for HER2-positive breast cancer treatment.,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C.C(=CC(=O)O)C(=O)O,67307512.0
|
305 |
+
303,Dapagliflozin,SLC5A2,inhibitor/antagonist,Glucose transporter inhibitor,yes,yes,Approved for diabetes treatment.,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,9887712.0
|
306 |
+
304,"Dapagliflozin ((2S)-1,2-propanediol, hydrate)",SLC5A2,inhibitor/antagonist,Glucose transporter inhibitor,yes,yes,Approved SGLT2 inhibitor for type 2 diabetes and heart failure.,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl.CC(CO)O.O,24906252.0
|
307 |
+
305,Auranofin,"TXNRD1, TXNRD2",inhibitor/antagonist,unclear,yes,yes,Approved for rheumatoid arthritis treatment since 1985.,CCP(CC)CC.CC(=O)OCC1C(C(C(C(O1)[S-])OC(=O)C)OC(=O)C)OC(=O)C.[Au+],24199313.0
|
308 |
+
306,TAK-901,AURKB,inhibitor/antagonist,unclear,no,yes,Investigational cancer drug; not approved for human use yet.,CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=C(N3)N=CC(=C4)C)C)C(=O)NC5CCN(CC5)C,16124208.0
|
309 |
+
307,Loperamide (hydrochloride),,unclear,unclear,yes,yes,"Approved for diarrhea treatment, limited CNS penetration due to P-gp substrate.",CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,71420.0
|
310 |
+
308,Ribociclib,"CDK4, CDK6",inhibitor/antagonist,CDK inhibitor,yes,yes,Approved for human use in combination with letrozole for breast cancer.,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,44631912.0
|
311 |
+
309,Altretamine,,unclear,DNA synthesis/repair inhibitor,yes,yes,Used as a chemotherapy drug for ovarian cancer.,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,2123.0
|
312 |
+
310,Demeclocycline,,inhibitor/antagonist,unclear,yes,yes,"Used off-label for SIADH, primarily an antibiotic.",CN(C)C1C2CC3C(C4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)Cl)O,54680690.0
|
313 |
+
311,Afatinib,"EGFR, ERBB2",inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,"Approved for treatment of certain cancers, such as non-small cell lung cancer.",CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,10184653.0
|
314 |
+
312,Relugolix,GNRHR,inhibitor/antagonist,unclear,yes,yes,Approved for prostate cancer and uterine fibroids treatment.,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,10348973.0
|
315 |
+
313,Citalopram (hydrobromide),SLC6A4,inhibitor/antagonist,unclear,yes,yes,Approved antidepressant; selective serotonin reuptake inhibitor (SSRI).,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.Br,77995.0
|
316 |
+
314,Almonertinib (hydrochloride),EGFR,inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved in China for non-small cell lung cancer.,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC.Cl,137319707.0
|
317 |
+
315,Almonertinib (mesylate),EGFR,inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved in China for NSCLC treatment.,CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=CC(=N2)C3=CN(C4=CC=CC=C43)C5CC5)OC.CS(=O)(=O)O,162368359.0
|
318 |
+
316,Diphenhydramine,HRH1,inhibitor/antagonist,unclear,yes,yes,"Approved antihistamine, used for allergies and as a sleep aid.",CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2,3100.0
|
319 |
+
317,ML264,KLF5,inhibitor/antagonist,unclear,no,no,No clinical trials found on clinicaltrials.gov.,CN(C1CCS(=O)(=O)CC1)C(=O)CNC(=O)C=CC2=CC(=CC=C2)Cl,51003603.0
|
320 |
+
318,Methotrexate,DHFR,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Widely used for cancer and autoimmune diseases treatments.,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,126941.0
|
321 |
+
319,Ivabradine (hydrochloride),HCN4,inhibitor/antagonist,unclear,yes,yes,"Approved for human use, primarily for heart failure and angina management.",CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl,3045381.0
|
322 |
+
320,Rosiglitazone,"PPARG, TRPC5, TRPM3",unclear,unclear,yes,yes,Approved for diabetes; risk of heart failure in some patients.,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,77999.0
|
323 |
+
321,Piroxicam,"PTGS1, PTGS2",inhibitor/antagonist,Cyclooxygenase inhibitor,yes,yes,Approved NSAID for arthritis and pain relief.,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,54676228.0
|
324 |
+
322,c-Kit-IN-1,"KIT, MET, KDR, PDGFRA, PDGFRB",inhibitor/antagonist,Multi-TK inhibitor,no,no,Experimental compound with no clinical trials reported.,CN1C=C(C=N1)C2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=CC=C5)F,46208890.0
|
325 |
+
323,CP21R7,"GSK3B, PRKCA",inhibitor/antagonist,GSK3 inhibitor,no,yes,Investigational drug in research for neurodegenerative diseases.,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CC(=CC=C4)N,5327711.0
|
326 |
+
324,9-ING-41,GSK3B,inhibitor/antagonist,GSK3 inhibitor,no,yes,"Investigational drug, not approved for human use yet.",CN1C=C(C2=CC3=C(C=C21)OCO3)C4=C(C(=O)NC4=O)C5=COC6=C5C=C(C=C6)F,44582816.0
|
327 |
+
325,Binimetinib,"MAP2K1, MAP2K2",inhibitor/antagonist,MEK inhibitor,no,yes,"Investigated for cancer, not approved for human use.",CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,10288191.0
|
328 |
+
326,TAK-733,MAP2K1,inhibitor/antagonist,MEK inhibitor,no,yes,Investigated as anti-cancer MEK inhibitor; not approved for human use.,CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)CC(CO)O,24963252.0
|
329 |
+
327,Bendamustine,,unclear,DNA synthesis/repair inhibitor,yes,yes,Approved for use in leukemia and lymphoma treatment.,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O,65628.0
|
330 |
+
328,Benztropine (mesylate),,inhibitor/antagonist,unclear,yes,yes,Used for Parkinson's disease and drug-induced extrapyramidal symptoms.,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O,238053.0
|
331 |
+
329,Tadalafil,PDE5A,inhibitor/antagonist,unclear,yes,yes,Used for erectile dysfunction and pulmonary arterial hypertension.,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,110635.0
|
332 |
+
330,Vandetanib,"EGFR, KDR",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,Approved for use in medullary thyroid cancer.,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,3081361.0
|
333 |
+
331,Glasdegib,SMO,inhibitor/antagonist,Sonic inhibitor,yes,yes,Glasdegib is approved for acute myeloid leukemia.,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,25166913.0
|
334 |
+
332,Isocorydine,,unclear,unclear,no,no,No clinical trials found on clinicaltrials.gov,CN1CCC2=CC(=C(C3=C2C1CC4=C3C(=C(C=C4)OC)O)OC)OC,10143.0
|
335 |
+
333,Berbamine,CACNA1C,inhibitor/antagonist,unclear,no,no,"Studied for cancer treatment, but not approved for human use yet.",CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)O)OC,275182.0
|
336 |
+
334,Berbamine (dihydrochloride),,inhibitor/antagonist,unclear,no,no,No clinical trial data found on clinicaltrials.gov.,CN1CCC2=CC(=C3C=C2C1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)CC6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)O)OC.Cl.Cl,16217067.0
|
337 |
+
335,Cepharanthine,"CYP3A4, CYP2E1, CYP2C9",inhibitor/antagonist,unclear,no,yes,Studied for cancer and viral diseases; not approved for human use yet.,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,10206.0
|
338 |
+
336,Sinomenine,OPRM1,unclear,unclear,no,yes,Used in trials for pain and arthritis.,CN1CCC23CC(=O)C(=CC2C1CC4=C3C(=C(C=C4)OC)O)OC,5459308.0
|
339 |
+
337,Adagrasib,KRAS,inhibitor/antagonist,RAS inhibitor,yes,yes,Approved for treating KRAS G12C-mutated non-small cell lung cancer.,CN1CCCC1COC2=NC3=C(CCN(C3)C4=CC=CC5=C4C(=CC=C5)Cl)C(=N2)N6CCN(C(C6)CC#N)C(=O)C(=C)F,138611145.0
|
340 |
+
338,LB-100,"PPP2CA, PPP2CB",inhibitor/antagonist,unclear,no,yes,LB-100 is in clinical trials for cancer treatment.,CN1CCN(CC1)C(=O)C2C3CCC(C2C(=O)O)O3,3578572.0
|
341 |
+
339,Entrectinib,"NTRK1, NTRK2, NTRK3, ROS1, ALK",inhibitor/antagonist,Other TK inhibitor,yes,yes,Approved for use in cancers with NTRK gene fusions.,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,25141092.0
|
342 |
+
340,AZD2858,"GSK3B, GSK3A",inhibitor/antagonist,GSK3 inhibitor,no,no,Investigated in rodent models.,CN1CCN(CC1)S(=O)(=O)C2=CC=C(C=C2)C3=CN=C(C(=N3)C(=O)NC4=CN=CC=C4)N,10138980.0
|
343 |
+
341,Capmatinib,MET,inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for NSCLC treatment by FDA in May 2020.,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,25145656.0
|
344 |
+
342,Apalutamide,AR,inhibitor/antagonist,Androgen receptor antagonist,yes,yes,Used for non-metastatic castration-resistant prostate cancer.,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,24872560.0
|
345 |
+
343,Regorafenib,"BRAF, FLT1, FLT4, KDR, KIT, PDGFRB, RAF1, RET, TEK",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,"Used for metastatic colorectal cancer, GIST, HCC.",CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,11167602.0
|
346 |
+
344,Phenylephrine (hydrochloride),"ADRA1A, ADRA1B, ADRA1D",activator/agonist,Adrenoceptor agonist,yes,yes,Widely used as a decongestant and in eye drops.,CNCC(C1=CC(=CC=C1)O)O.Cl,5284443.0
|
347 |
+
345,Rucaparib (phosphate),"PARP1, PARP2, PARP3",inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Approved as a cancer therapy PARP inhibitor.,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2.OP(=O)(O)O,9931953.0
|
348 |
+
346,Clopidogrel,P2RY12,inhibitor/antagonist,unclear,yes,yes,"Antiplatelet drug approved for preventing stroke, heart attack in high-risk patients.",COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,60606.0
|
349 |
+
347,Dimethyl fumarate,NFE2L2,activator/agonist,unclear,yes,yes,Approved for multiple sclerosis treatment.,COC(=O)C=CC(=O)OC,637568.0
|
350 |
+
348,Methyl aminolevulinate (hydrochloride),,unclear,unclear,yes,yes,Used in photodynamic therapy for actinic keratosis.,COC(=O)CCC(=O)CN.Cl,157921.0
|
351 |
+
349,Mebendazole,"TUBA1A, TUBA1B, TUBA1C, TUBB, TUBB1, TUBB2A, TUBB3, TUBB4A, TUBB4B, TUBB6",inhibitor/antagonist,Microtubule inhibitor,yes,yes,Approved for treating parasitic worm infestations.,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,4030.0
|
352 |
+
350,Tranilast,"PLA2G2A, EGR1",inhibitor/antagonist,unclear,yes,yes,Approved for asthma and allergic disorders in some countries.,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,5282230.0
|
353 |
+
351,Gefitinib,EGFR,inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for non-small cell lung cancer.,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,123631.0
|
354 |
+
352,Simotinib,EGFR,inhibitor/antagonist,EGFR/ERBB inhibitor,no,yes,"Investigated in trials, but not approved for human use.",COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCN4CC5(CC5)C6(C4)OCCO6,16735117.0
|
355 |
+
353,Bergenin,,unclear,unclear,no,yes,Investigated for anti-inflammatory and antiulcer effects in clinical trials.,COC1=C(C=C2C(=C1O)C3C(C(C(C(O3)CO)O)O)OC2=O)O,66065.0
|
356 |
+
354,Ferulic acid,"FGFR1, FGFR2",inhibitor/antagonist,Other TK inhibitor,no,yes,Used in skincare; not an FDA-approved drug.,COC1=C(C=CC(=C1)C=CC(=O)O)O,445858.0
|
357 |
+
355,Amsacrine,TOP2A,inhibitor/antagonist,DNA synthesis/repair inhibitor,yes,yes,Used in the treatment of acute leukemias.,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,2179.0
|
358 |
+
356,Palmatine (chloride),"IDO1, WNV NS2B-NS3",inhibitor/antagonist,unclear,no,yes,Used in some traditional medicine; lacks formal approval for human use.,COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC(=C(C=C4CC3)OC)OC)OC.[Cl-],73442.0
|
359 |
+
357,Berberine (chloride hydrate),,unclear,unclear,no,yes,"Used in trials for metabolic/heart diseases, not FDA-approved.",COC1=C(C2=C[N+]3=C(C=C2C=C1)C4=CC5=C(C=C4CC3)OCO5)OC.O.[Cl-],155074.0
|
360 |
+
358,Futibatinib,"FGFR1, FGFR2, FGFR3, FGFR4",inhibitor/antagonist,Other TK inhibitor,yes,yes,Used for cholangiocarcinoma; FDA approved.,COC1=CC(=CC(=C1)C#CC2=NN(C3=NC=NC(=C23)N)C4CCN(C4)C(=O)C=C)OC,71621331.0
|
361 |
+
359,Tubulin inhibitor 6,,inhibitor/antagonist,Microtubule inhibitor,no,no,No available data on human use or clinical trials.,COC1=CC=C(C=C1)C(=O)N2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,2359994.0
|
362 |
+
360,Anethole trithione,,unclear,unclear,no,yes,Investigated for dry mouth in clinical trials.,COC1=CC=C(C=C1)C2=CC(=S)SS2,2194.0
|
363 |
+
361,Cabozantinib (S-malate),"MET, KDR, AXL",inhibitor/antagonist,Multi-TK inhibitor,yes,yes,Approved for medullary thyroid cancer and renal cell carcinoma.,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O,25102846.0
|
364 |
+
362,Fluvoxamine,SLC6A4,unclear,unclear,yes,yes,SSRI approved for treating OCD and depression.,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F,5324346.0
|
365 |
+
363,Fluvoxamine (maleate),,inhibitor/antagonist,unclear,yes,yes,Approved for treating OCD and depression-related disorders in humans.,COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O,9560989.0
|
366 |
+
364,Erlotinib,EGFR,inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for human use for non-small cell lung cancer.,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,176870.0
|
367 |
+
365,Belzutifan,EPAS1,inhibitor/antagonist,unclear,yes,yes,Approved for treating certain cancer types.,CS(=O)(=O)C1=C2C(C(C(C2=C(C=C1)OC3=CC(=CC(=C3)C#N)F)F)F)O,117947097.0
|
368 |
+
366,Vismodegib,"SMO, ABCB1, ABCG2",inhibitor/antagonist,Sonic inhibitor,yes,yes,Approved for treating basal cell carcinoma.,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,24776445.0
|
369 |
+
367,Nimesulide,PTGS2,inhibitor/antagonist,Cyclooxygenase inhibitor,no,yes,Withdrawn in some countries due to safety concerns; not FDA-approved.,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,4495.0
|
370 |
+
368,Nafamostat (mesylate),,inhibitor/antagonist,unclear,yes,yes,"Approved in some countries, often used as anticoagulant.",CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,5311180.0
|
371 |
+
369,Busulfan,,unclear,DNA synthesis/repair inhibitor,yes,yes,Approved for use in bone marrow transplantation.,CS(=O)(=O)OCCCCOS(=O)(=O)C,2478.0
|
372 |
+
370,18β-Glycyrrhetinic acid,,unclear,unclear,no,yes,"Used in cosmetics, derived from licorice root, no approval for human drugs.",C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)O,10114.0
|
373 |
+
371,Trametinib (DMSO_TF solvate),"MAP2K1, MAP2K2",inhibitor/antagonist,MEK inhibitor,yes,yes,"Approved for use in cancer treatment (e.g., melanoma).", CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5 ,11707110.0
|
374 |
+
372,Sacubitril/Valsartan,AGTR1,inhibitor/antagonist,unclear,yes,yes,"Combination drug known as Entresto, used for heart failure treatment.",,
|
375 |
+
373,Pitavastatin (Calcium),HMGCR,inhibitor/antagonist,unclear,yes,yes,"Approved for lowering cholesterol, part of statins class of drugs.", C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.C1C(C1)C2=NC3=CC=CC=C3C(=C2/C=C/[C@@H](O)C[C@@H](O)CC(=O)[O-])C4=CC=C(C=C4)F.[Ca+2],5282451.0
|
376 |
+
374,Verteporfin,YAP1,inhibitor/antagonist,unclear,yes,yes,Used in photodynamic therapy for macular degeneration.,,
|
377 |
+
375,Quinidine (15% dihydroquinidine),KCNH2,inhibitor/antagonist,unclear,yes,yes,Approved for arrhythmias as part of quinine alkaloids.,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@H]3C[C@@H]4CCN3C[C@@H]4C=C)O ,441074.0
|
378 |
+
376,Canagliflozin (hemihydrate),SLC5A2,inhibitor/antagonist,Glucose transporter inhibitor,yes,yes,Approved for type 2 diabetes.,CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F.CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F.O,24997615.0
|
379 |
+
377,Osimertinib (mesylate),EGFR,inhibitor/antagonist,EGFR/ERBB inhibitor,yes,yes,Approved for non-small cell lung cancer treatment.,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O ,78357807.0
|
380 |
+
378,γ-Oryzanol,,inhibitor/antagonist,DNA methyltransferase inhibitor,no,yes,Used in supplements; limited human data.,C[C@H](CCC=C(C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)OC(=O)/C=C/C6=CC(=C(C=C6)O)OC)C)C,5282164.0
|
data/drug_trials_matched.csv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
data/drugs_organs_approved.csv
ADDED
@@ -0,0 +1,377 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
pubchem_id,Bladder/Urinary Tract,Bowel,Breast,CNS/Brain,Cervix,Esophagus/Stomach,Kidney,Liver,Lung,Ovary/Fallopian Tube,Pancreas,Peripheral Nervous System,Skin,Uterus
|
2 |
+
104741,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
3 |
+
74990,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
4 |
+
60838,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
5 |
+
9887053,0,1,0,0,0,1,0,1,0,0,1,0,0,0
|
6 |
+
135410875,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
7 |
+
65348,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
8 |
+
176870,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
9 |
+
36314,1,0,1,0,0,1,0,0,1,0,0,0,0,0
|
10 |
+
2187,0,0,1,1,0,0,0,0,0,0,0,0,0,1
|
11 |
+
60699,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
12 |
+
60750,0,0,0,0,0,0,0,0,1,0,1,0,0,0
|
13 |
+
5281004,0,1,0,0,0,1,1,0,1,0,0,0,0,0
|
14 |
+
148124,0,0,1,0,0,1,0,0,0,0,0,0,0,0
|
15 |
+
23725625,0,0,0,0,0,0,1,0,0,1,0,0,0,0
|
16 |
+
5329102,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
17 |
+
3385,0,1,1,0,0,1,0,1,1,1,0,0,1,0
|
18 |
+
5330286,0,0,1,0,0,0,1,0,0,0,0,0,0,0
|
19 |
+
123631,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
20 |
+
78357807,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
21 |
+
6918289,0,0,1,0,0,0,1,1,1,0,0,0,0,0
|
22 |
+
11167602,0,1,0,0,0,0,1,0,0,0,0,0,0,0
|
23 |
+
443939,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
24 |
+
135398658,0,1,0,0,0,0,0,1,1,0,0,0,1,0
|
25 |
+
2563,0,0,0,1,0,0,0,0,0,0,0,1,0,0
|
26 |
+
10184665,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
27 |
+
46220502,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
28 |
+
25102846,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
29 |
+
444795,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
30 |
+
11707110,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
31 |
+
6256,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
32 |
+
16052011,0,0,1,0,0,0,0,0,0,0,0,0,0,1
|
33 |
+
44631912,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
34 |
+
10184653,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
35 |
+
445639,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
36 |
+
11626560,0,0,0,0,0,0,0,0,1,0,0,0,0,1
|
37 |
+
168311648,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
38 |
+
135398744,0,0,0,0,0,0,0,1,1,0,0,1,0,0
|
39 |
+
1054,0,1,0,0,0,1,1,0,1,0,0,0,0,1
|
40 |
+
119607,1,1,0,1,0,0,1,0,0,0,1,0,1,1
|
41 |
+
42611257,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
42 |
+
60961,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
43 |
+
10288191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
44 |
+
6436173,0,1,0,0,0,0,1,1,0,0,0,0,0,0
|
45 |
+
4594,0,1,0,1,0,1,0,0,0,0,1,0,0,0
|
46 |
+
12108541,0,1,0,1,0,1,0,0,0,0,1,0,0,0
|
47 |
+
16923,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
48 |
+
3100,0,1,0,0,0,0,1,1,1,0,0,0,1,0
|
49 |
+
21800,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
50 |
+
54684461,1,1,0,1,0,0,1,0,1,0,0,0,1,0
|
51 |
+
5284373,0,1,0,0,0,1,1,1,1,0,0,0,1,0
|
52 |
+
44462760,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
53 |
+
24906252,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
54 |
+
2662,1,1,0,0,0,0,0,1,0,0,1,0,0,1
|
55 |
+
5388983,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
56 |
+
107969,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
57 |
+
4740,0,1,0,1,0,0,1,1,1,0,0,0,0,0
|
58 |
+
4829,0,0,0,0,0,0,1,1,1,1,0,0,0,0
|
59 |
+
56649450,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
60 |
+
5564,0,0,1,0,0,0,0,0,0,0,0,0,1,0
|
61 |
+
3657,1,1,0,0,0,0,1,1,1,1,0,0,1,0
|
62 |
+
12560,0,0,0,0,0,1,0,0,1,0,1,0,1,0
|
63 |
+
50922675,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
64 |
+
6419992,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
65 |
+
637568,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
66 |
+
110635,1,0,0,1,0,0,1,0,1,0,0,0,0,0
|
67 |
+
468595,1,1,0,1,0,0,1,1,0,0,0,0,1,0
|
68 |
+
16222096,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
69 |
+
135400182,0,1,0,0,0,0,0,1,0,0,0,0,1,0
|
70 |
+
9887712,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
71 |
+
16760658,1,0,0,0,0,0,1,1,1,0,0,0,1,0
|
72 |
+
249332,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
73 |
+
24776445,0,0,0,0,0,1,1,0,0,0,0,0,1,0
|
74 |
+
3081361,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
75 |
+
126941,0,1,0,1,0,0,0,0,0,0,0,0,1,0
|
76 |
+
67307512,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
77 |
+
9915743,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
78 |
+
451668,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
79 |
+
6442177,0,1,0,1,1,0,1,1,0,0,0,0,1,0
|
80 |
+
10174505,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
81 |
+
9926791,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
82 |
+
2244,1,1,0,1,0,1,0,0,1,0,0,0,0,0
|
83 |
+
31307,1,1,0,1,1,0,1,1,0,0,0,0,1,0
|
84 |
+
387447,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
85 |
+
52920501,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
86 |
+
392622,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
87 |
+
12136798,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
88 |
+
2754,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
89 |
+
23679632,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
90 |
+
6112,0,0,1,0,0,0,1,1,0,0,0,1,0,0
|
91 |
+
2812,0,0,1,0,0,0,1,0,1,0,0,0,0,0
|
92 |
+
19090,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
93 |
+
4055,0,1,0,1,0,0,1,0,1,0,0,0,0,0
|
94 |
+
77995,1,1,0,1,0,1,0,1,1,1,0,0,0,0
|
95 |
+
6279,0,0,1,0,0,0,0,0,0,1,0,0,0,1
|
96 |
+
5282164,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
97 |
+
11672905,0,1,0,1,0,0,0,0,1,0,0,1,0,0
|
98 |
+
25145656,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
99 |
+
3578572,1,1,0,1,0,0,0,1,0,0,0,0,0,0
|
100 |
+
156391,1,1,0,0,0,0,1,0,0,0,0,0,0,0
|
101 |
+
72165228,1,0,0,0,0,0,0,0,1,0,0,0,0,0
|
102 |
+
190,0,0,1,1,0,0,0,0,0,0,0,0,0,0
|
103 |
+
16004692,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
104 |
+
9931953,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
105 |
+
3339,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
106 |
+
5743,1,0,1,0,1,0,0,0,1,0,0,0,0,0
|
107 |
+
9444,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
108 |
+
24788740,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
109 |
+
441243,0,0,0,0,0,0,0,1,0,0,0,0,1,0
|
110 |
+
157921,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
111 |
+
156419,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
112 |
+
5284443,0,0,0,1,0,1,0,0,1,0,0,1,0,0
|
113 |
+
71481097,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
114 |
+
11557040,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
115 |
+
2554,0,0,0,1,0,0,0,0,0,0,0,1,0,0
|
116 |
+
135401907,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
117 |
+
445154,0,0,0,0,0,0,0,0,0,0,1,0,1,1
|
118 |
+
2123,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
119 |
+
24775005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
120 |
+
5311068,1,0,1,1,0,1,1,1,1,0,1,0,0,0
|
121 |
+
6321424,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
122 |
+
14296,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
123 |
+
11256664,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
124 |
+
2478,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
125 |
+
51082,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
126 |
+
60606,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
127 |
+
6314,1,1,0,1,0,0,0,0,1,0,0,1,0,0
|
128 |
+
25022378,0,0,0,1,0,0,1,0,1,0,0,0,0,0
|
129 |
+
8813,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
130 |
+
370,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
131 |
+
148195,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
132 |
+
45375953,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
133 |
+
5381,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
134 |
+
165411828,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
135 |
+
25227436,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
136 |
+
68873,0,0,1,0,0,0,0,0,0,1,0,0,0,0
|
137 |
+
51039094,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
138 |
+
117947097,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
139 |
+
6253,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
140 |
+
2375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
141 |
+
5493444,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
142 |
+
6029,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
143 |
+
24785956,0,0,0,1,0,0,0,0,0,0,0,0,0,1
|
144 |
+
20179,0,0,0,0,0,0,1,0,0,0,0,0,0,1
|
145 |
+
53235510,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
146 |
+
56959,0,0,0,0,0,0,1,0,1,0,0,0,1,0
|
147 |
+
65628,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
148 |
+
441074,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
149 |
+
4495,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
150 |
+
24812758,0,0,0,1,0,0,1,0,0,1,0,0,0,0
|
151 |
+
10461508,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
152 |
+
24997615,0,0,0,1,0,0,1,0,0,1,0,0,0,0
|
153 |
+
67462786,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
154 |
+
86705695,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
155 |
+
25141092,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
156 |
+
10348973,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
157 |
+
636362,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
158 |
+
2520,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
159 |
+
5823908,0,0,0,1,0,0,1,0,1,0,0,0,0,0
|
160 |
+
138611145,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
161 |
+
3034010,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
162 |
+
6918638,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
163 |
+
4463,0,0,0,1,0,0,0,1,0,0,0,0,0,0
|
164 |
+
338,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
165 |
+
56671814,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
166 |
+
71621331,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
167 |
+
9821849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
168 |
+
60490,0,0,0,0,0,0,0,0,1,0,0,1,0,0
|
169 |
+
49831257,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
170 |
+
135398745,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
171 |
+
2435,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
172 |
+
135413536,0,0,1,0,0,0,0,0,0,1,0,0,0,0
|
173 |
+
441313,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
174 |
+
656656,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
175 |
+
92727,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
176 |
+
5583,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
177 |
+
3440,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
178 |
+
6480466,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
179 |
+
56844015,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
180 |
+
25183872,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
181 |
+
21585658,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
182 |
+
71616,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
183 |
+
444972,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
184 |
+
55245,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
185 |
+
4030,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
186 |
+
9082,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
187 |
+
11950170,1,0,0,0,0,0,0,0,1,0,0,0,0,0
|
188 |
+
6918111,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
189 |
+
5284616,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
190 |
+
164726578,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
191 |
+
667493,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
192 |
+
2179,0,1,0,1,0,0,0,0,0,0,0,0,0,0
|
193 |
+
71576688,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
194 |
+
6252,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
195 |
+
3397,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
196 |
+
135526609,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
197 |
+
5282451,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
198 |
+
5905,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
199 |
+
14992,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
200 |
+
46926350,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
201 |
+
49846579,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
202 |
+
24826799,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
203 |
+
5509,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
204 |
+
118869362,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
205 |
+
5311180,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
206 |
+
22049997,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
207 |
+
9853654,0,0,0,0,0,1,0,0,0,0,0,0,0,0
|
208 |
+
44582816,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
209 |
+
162368359,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
210 |
+
58507717,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
211 |
+
24872560,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
212 |
+
148123,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
213 |
+
146681181,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
214 |
+
67171867,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
215 |
+
11570805,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
216 |
+
25166913,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
217 |
+
67330085,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
218 |
+
16362,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
219 |
+
121408882,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
220 |
+
1923,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
221 |
+
126689157,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
222 |
+
118598754,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
223 |
+
72172,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
224 |
+
4659569,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
225 |
+
4922,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
226 |
+
9415,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
227 |
+
445858,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
228 |
+
5324346,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
229 |
+
9560989,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
230 |
+
3463,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
231 |
+
3000226,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
232 |
+
46188928,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
233 |
+
10114,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
234 |
+
53340664,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
235 |
+
6918837,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
236 |
+
119182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
237 |
+
6989,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
238 |
+
67501411,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
239 |
+
129073603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
240 |
+
104850,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
241 |
+
28061,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
242 |
+
3000518,0,0,0,0,0,0,0,0,0,1,0,0,0,0
|
243 |
+
446727,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
244 |
+
285033,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
245 |
+
204,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
246 |
+
23675320,0,0,0,0,0,0,1,0,0,0,0,0,0,0
|
247 |
+
54680690,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
248 |
+
10180,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
249 |
+
9966051,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
250 |
+
11219835,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
251 |
+
11338033,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
252 |
+
25262965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
253 |
+
451417,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
254 |
+
54755438,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
255 |
+
163659,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
256 |
+
44241743,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
257 |
+
5282230,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
258 |
+
91885558,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
259 |
+
10029385,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
260 |
+
71766360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
261 |
+
3610,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
262 |
+
71571562,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
263 |
+
10195250,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
264 |
+
10621,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
265 |
+
155074,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
266 |
+
16063245,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
267 |
+
16759173,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
268 |
+
185462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
269 |
+
24963252,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
270 |
+
16735117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
271 |
+
440936,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
272 |
+
5344,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
273 |
+
5459308,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
274 |
+
54704426,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
275 |
+
57363,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
276 |
+
58282870,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
277 |
+
6917864,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
278 |
+
45256689,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
279 |
+
6918132,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
280 |
+
9046,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
281 |
+
6019,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
282 |
+
138911318,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
283 |
+
443872,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
284 |
+
441207,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
285 |
+
23674502,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
286 |
+
6364534,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
287 |
+
16218542,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
288 |
+
68911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
289 |
+
67517580,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
290 |
+
54677470,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
291 |
+
11310,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
292 |
+
135151360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
293 |
+
82146,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
294 |
+
119369,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
295 |
+
46205871,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
296 |
+
9875462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
297 |
+
2749,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
298 |
+
67448836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
299 |
+
104849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
300 |
+
9827599,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
301 |
+
11960271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
302 |
+
32798,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
303 |
+
51003603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
304 |
+
3033819,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
305 |
+
117965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
306 |
+
2359994,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
307 |
+
73442,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
308 |
+
66065,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
309 |
+
10138980,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
310 |
+
10206,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
311 |
+
16217067,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
312 |
+
275182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
313 |
+
10143,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
314 |
+
238053,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
315 |
+
5327711,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
316 |
+
46208890,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
317 |
+
54676228,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
318 |
+
77999,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
319 |
+
3045381,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
320 |
+
45256693,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
321 |
+
137319707,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
322 |
+
71420,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
323 |
+
16124208,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
324 |
+
24199313,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
325 |
+
5311027,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
326 |
+
66068,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
327 |
+
46910592,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
328 |
+
13982876,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
329 |
+
16747388,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
330 |
+
33630,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
331 |
+
70817911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
332 |
+
46220375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
333 |
+
23582824,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
334 |
+
130956,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
335 |
+
1936439,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
336 |
+
64982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
337 |
+
4614,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
338 |
+
121241171,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
339 |
+
5717952,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
340 |
+
73053710,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
341 |
+
135397144,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
342 |
+
3198,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
343 |
+
107971,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
344 |
+
118701008,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
345 |
+
92044433,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
346 |
+
118959080,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
347 |
+
24721416,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
348 |
+
23665037,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
349 |
+
11683005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
350 |
+
16048568,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
351 |
+
168312271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
352 |
+
137628686,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
353 |
+
3064778,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
354 |
+
14982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
355 |
+
2747117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
356 |
+
146673142,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
357 |
+
44093,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
358 |
+
167811,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
359 |
+
5312125,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
360 |
+
4006,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
361 |
+
104769,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
362 |
+
135565635,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
363 |
+
11595577,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
364 |
+
11957481,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
365 |
+
170014,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
366 |
+
276389,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
367 |
+
5405,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
368 |
+
158550,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
369 |
+
23663985,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
370 |
+
9562059,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
371 |
+
72205932,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
372 |
+
1986,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
373 |
+
86295191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
374 |
+
1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
375 |
+
6437836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
376 |
+
118704762,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
377 |
+
2194,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
data/drugs_organs_tested.csv
ADDED
@@ -0,0 +1,377 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
pubchem_id,Bladder/Urinary Tract,Bowel,Breast,CNS/Brain,Cervix,Esophagus/Stomach,Kidney,Liver,Lung,Ovary/Fallopian Tube,Pancreas,Peripheral Nervous System,Skin,Uterus
|
2 |
+
104741,0,1,1,0,0,1,0,0,1,1,0,0,1,1
|
3 |
+
74990,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
4 |
+
60838,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
5 |
+
9887053,1,1,1,0,0,1,0,1,1,1,1,1,1,1
|
6 |
+
135410875,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
7 |
+
65348,1,1,1,0,0,1,0,1,1,1,1,0,1,0
|
8 |
+
176870,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
9 |
+
36314,1,1,1,1,1,1,0,1,1,1,1,1,1,1
|
10 |
+
2187,0,0,1,1,0,0,0,0,1,1,0,0,0,1
|
11 |
+
60699,1,1,1,1,1,0,1,1,1,1,0,0,1,1
|
12 |
+
60750,1,1,1,1,1,0,1,1,1,1,1,0,1,1
|
13 |
+
5281004,0,1,1,0,0,1,1,1,1,0,0,0,1,0
|
14 |
+
148124,1,1,1,1,1,1,0,0,1,1,1,0,1,1
|
15 |
+
23725625,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
16 |
+
5329102,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
17 |
+
3385,1,1,1,1,1,1,1,1,1,1,1,1,1,1
|
18 |
+
5330286,1,1,1,1,0,0,1,1,1,1,1,0,1,1
|
19 |
+
123631,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
20 |
+
78357807,0,1,0,1,0,0,1,0,1,0,0,0,1,0
|
21 |
+
6918289,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
22 |
+
11167602,1,1,0,1,0,1,1,1,1,1,1,0,1,0
|
23 |
+
443939,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
24 |
+
135398658,1,1,1,1,0,1,1,1,1,1,1,1,1,1
|
25 |
+
2563,0,0,0,1,0,0,0,0,1,0,0,1,0,0
|
26 |
+
10184665,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
27 |
+
46220502,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
28 |
+
25102846,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
29 |
+
444795,1,1,1,1,1,0,1,1,1,0,1,0,1,0
|
30 |
+
11707110,0,1,1,1,1,1,1,1,1,0,1,0,1,0
|
31 |
+
6256,0,1,1,1,0,1,1,1,1,1,1,0,1,0
|
32 |
+
16052011,0,1,1,0,0,0,0,0,0,1,1,0,1,1
|
33 |
+
44631912,0,1,1,1,0,1,1,1,1,1,1,0,1,1
|
34 |
+
10184653,1,1,1,1,0,1,1,1,1,0,1,0,1,1
|
35 |
+
445639,0,1,0,1,0,1,1,1,1,0,1,0,1,0
|
36 |
+
11626560,1,1,1,1,0,1,1,1,1,0,0,0,1,1
|
37 |
+
168311648,1,1,1,1,0,1,1,1,1,1,0,1,1,1
|
38 |
+
135398744,1,1,0,1,0,0,1,1,1,0,1,1,0,1
|
39 |
+
1054,1,1,1,1,0,1,1,1,1,1,1,1,1,1
|
40 |
+
119607,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
41 |
+
42611257,1,1,0,1,0,0,0,0,1,1,1,0,1,0
|
42 |
+
60961,0,1,1,1,0,1,0,0,1,1,1,0,0,1
|
43 |
+
10288191,0,1,1,1,0,0,0,1,1,1,1,0,1,0
|
44 |
+
6436173,0,1,1,1,0,0,1,1,1,0,0,0,1,0
|
45 |
+
4594,0,1,1,1,0,1,0,1,1,1,1,1,1,1
|
46 |
+
12108541,0,1,1,1,0,1,0,1,1,1,1,1,1,1
|
47 |
+
16923,1,1,1,1,0,0,1,1,1,0,0,0,1,0
|
48 |
+
3100,0,1,1,1,0,1,1,1,1,1,1,1,1,1
|
49 |
+
21800,0,1,0,1,0,0,0,0,1,0,0,0,1,0
|
50 |
+
54684461,1,1,1,1,0,1,1,0,1,1,1,0,1,1
|
51 |
+
5284373,0,1,1,1,0,1,1,1,1,0,0,0,1,0
|
52 |
+
44462760,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
53 |
+
24906252,0,1,1,1,0,0,1,1,1,1,1,1,0,0
|
54 |
+
2662,1,1,1,1,1,1,1,1,1,1,1,0,1,1
|
55 |
+
5388983,1,1,1,1,1,0,1,0,1,1,0,0,1,0
|
56 |
+
107969,0,0,1,1,0,0,1,0,1,0,0,1,0,0
|
57 |
+
4740,0,1,1,1,0,0,1,1,1,1,1,0,0,1
|
58 |
+
4829,0,1,1,1,0,0,1,1,1,1,1,0,1,1
|
59 |
+
56649450,0,1,1,1,0,1,0,1,1,1,1,0,1,1
|
60 |
+
5564,0,1,1,1,0,0,1,0,1,0,0,0,1,0
|
61 |
+
3657,1,1,1,1,1,1,1,1,1,1,1,0,1,0
|
62 |
+
12560,0,1,1,1,0,1,1,1,1,0,1,0,1,1
|
63 |
+
50922675,0,1,0,1,0,0,0,1,1,0,1,0,1,0
|
64 |
+
6419992,0,1,1,1,0,0,0,0,1,0,0,1,1,0
|
65 |
+
637568,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
66 |
+
110635,1,1,1,1,0,1,1,1,1,0,1,0,1,0
|
67 |
+
468595,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
68 |
+
16222096,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
69 |
+
135400182,0,1,0,0,0,1,0,1,1,0,1,0,1,0
|
70 |
+
9887712,0,0,1,1,0,0,1,1,1,1,1,1,0,0
|
71 |
+
16760658,1,1,1,1,0,1,1,1,1,0,0,0,1,1
|
72 |
+
249332,1,1,0,1,0,0,1,1,1,1,0,0,0,0
|
73 |
+
24776445,0,1,1,1,0,1,1,1,1,1,1,0,1,0
|
74 |
+
3081361,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
75 |
+
126941,1,1,1,1,0,1,0,1,1,0,0,0,1,0
|
76 |
+
67307512,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
77 |
+
9915743,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
78 |
+
451668,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
79 |
+
6442177,1,1,1,1,1,1,1,1,1,1,1,1,1,1
|
80 |
+
10174505,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
81 |
+
9926791,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
82 |
+
2244,1,1,1,1,0,1,1,0,1,1,1,0,1,0
|
83 |
+
31307,1,1,1,1,1,0,1,1,1,0,1,1,1,1
|
84 |
+
387447,1,1,1,1,1,1,1,1,1,1,1,1,1,0
|
85 |
+
52920501,0,1,1,0,0,1,1,1,1,1,1,0,1,0
|
86 |
+
392622,0,0,1,1,0,0,1,1,1,0,0,0,0,0
|
87 |
+
12136798,1,1,1,1,1,1,0,1,1,0,1,0,1,0
|
88 |
+
2754,0,0,1,1,0,0,1,1,1,0,0,0,1,0
|
89 |
+
23679632,0,0,1,1,0,0,0,1,1,0,1,1,1,0
|
90 |
+
6112,0,1,1,1,0,0,1,1,1,1,1,1,0,0
|
91 |
+
2812,0,1,1,1,0,0,1,1,1,0,0,0,1,0
|
92 |
+
19090,0,1,1,1,0,0,0,1,1,0,0,0,1,1
|
93 |
+
4055,0,1,0,1,0,0,1,1,1,1,1,0,1,0
|
94 |
+
77995,1,1,1,1,0,1,1,1,1,1,1,0,0,0
|
95 |
+
6279,0,0,1,1,0,0,1,0,1,1,0,0,0,1
|
96 |
+
5282164,1,1,1,1,0,0,1,1,1,1,1,0,1,0
|
97 |
+
11672905,0,1,1,1,0,0,0,0,1,0,0,1,0,0
|
98 |
+
25145656,0,1,1,0,0,1,1,1,1,0,0,0,1,0
|
99 |
+
3578572,1,1,1,1,0,0,1,1,1,0,0,0,1,0
|
100 |
+
156391,1,1,1,1,0,1,1,1,1,1,0,0,0,1
|
101 |
+
72165228,1,1,1,1,0,0,1,1,1,0,0,0,1,1
|
102 |
+
190,1,1,1,1,0,1,1,1,1,1,0,0,1,1
|
103 |
+
16004692,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
104 |
+
9931953,1,1,1,0,1,1,0,1,1,1,1,0,0,1
|
105 |
+
3339,0,1,1,1,1,1,1,1,1,0,0,0,0,0
|
106 |
+
5743,1,1,1,1,1,1,0,1,1,0,0,0,1,0
|
107 |
+
9444,1,1,1,1,0,1,1,1,1,1,1,0,1,0
|
108 |
+
24788740,0,0,1,1,0,1,0,1,1,1,0,0,1,1
|
109 |
+
441243,1,1,1,1,0,1,1,1,1,1,0,0,1,0
|
110 |
+
157921,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
111 |
+
156419,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
112 |
+
5284443,0,1,1,1,0,1,1,1,1,0,1,1,1,0
|
113 |
+
71481097,1,1,1,1,0,1,1,1,1,1,1,0,1,1
|
114 |
+
11557040,1,0,1,0,0,1,1,0,1,0,1,0,0,0
|
115 |
+
2554,0,0,0,1,0,0,0,1,1,0,0,1,0,0
|
116 |
+
135401907,0,1,0,1,0,0,1,1,1,1,0,0,0,0
|
117 |
+
445154,0,1,0,1,0,0,1,1,1,1,1,1,1,1
|
118 |
+
2123,1,1,1,1,0,0,1,1,1,1,0,0,1,0
|
119 |
+
24775005,0,1,1,1,0,1,0,1,1,1,1,0,1,0
|
120 |
+
5311068,1,1,1,1,0,1,1,1,1,0,1,0,0,0
|
121 |
+
6321424,0,0,1,1,0,0,0,0,1,1,1,0,1,0
|
122 |
+
14296,0,1,1,1,0,0,1,1,1,0,1,0,1,0
|
123 |
+
11256664,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
124 |
+
2478,1,0,1,1,0,0,0,0,1,1,0,0,1,0
|
125 |
+
51082,1,0,1,1,0,0,0,1,1,1,1,0,0,0
|
126 |
+
60606,0,1,1,1,0,0,1,1,1,1,1,0,0,0
|
127 |
+
6314,1,1,1,1,1,1,1,0,1,0,0,1,1,0
|
128 |
+
25022378,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
129 |
+
8813,0,1,0,0,0,0,1,1,1,0,1,0,1,0
|
130 |
+
370,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
131 |
+
148195,1,1,1,1,0,0,0,1,1,1,0,0,0,0
|
132 |
+
45375953,1,0,1,1,0,0,1,1,1,1,0,0,1,1
|
133 |
+
5381,0,1,1,0,0,0,0,0,0,0,0,0,1,0
|
134 |
+
165411828,0,1,0,1,0,0,0,1,1,0,0,0,0,1
|
135 |
+
25227436,0,0,1,1,0,1,0,0,1,0,0,0,1,1
|
136 |
+
68873,0,0,1,0,0,0,1,0,0,1,0,0,1,1
|
137 |
+
51039094,0,1,1,0,0,1,0,0,1,0,0,0,0,0
|
138 |
+
117947097,0,1,1,1,0,0,1,1,0,1,0,0,0,0
|
139 |
+
6253,0,1,1,1,0,0,0,1,0,0,0,0,0,0
|
140 |
+
2375,1,0,1,1,0,0,1,0,0,1,0,0,0,0
|
141 |
+
5493444,0,1,0,0,0,0,1,0,1,0,0,0,0,0
|
142 |
+
6029,0,1,1,1,0,1,0,1,1,1,1,0,0,0
|
143 |
+
24785956,0,0,0,1,0,0,0,0,0,1,0,0,0,1
|
144 |
+
20179,0,1,1,1,1,0,1,0,0,0,1,1,0,1
|
145 |
+
53235510,1,1,1,1,0,1,0,1,1,0,0,0,1,0
|
146 |
+
56959,0,1,0,1,0,0,1,1,1,0,0,0,1,0
|
147 |
+
65628,1,0,1,1,0,1,1,1,1,1,1,0,0,0
|
148 |
+
441074,0,0,0,1,0,0,0,1,0,0,0,1,0,0
|
149 |
+
4495,0,1,1,1,1,1,0,0,1,0,1,0,1,0
|
150 |
+
24812758,0,0,1,1,0,0,1,1,1,1,0,0,0,0
|
151 |
+
10461508,0,1,1,1,0,1,1,1,1,1,0,0,0,0
|
152 |
+
24997615,0,0,1,1,0,0,1,1,1,1,0,0,0,0
|
153 |
+
67462786,1,0,1,1,0,0,0,1,1,0,0,0,0,0
|
154 |
+
86705695,1,1,1,1,0,1,0,1,1,0,1,0,0,0
|
155 |
+
25141092,0,1,1,1,0,0,1,1,1,1,0,0,1,0
|
156 |
+
10348973,0,0,0,0,0,0,0,0,0,0,0,0,0,1
|
157 |
+
636362,1,0,0,1,0,0,0,1,1,0,0,0,0,0
|
158 |
+
2520,0,1,1,1,0,0,0,1,1,0,1,0,1,0
|
159 |
+
5823908,0,0,0,1,0,1,1,0,1,0,0,0,1,0
|
160 |
+
138611145,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
161 |
+
3034010,0,0,1,1,0,0,0,1,1,1,0,0,0,0
|
162 |
+
6918638,1,0,1,1,0,0,0,1,1,1,1,0,1,0
|
163 |
+
4463,0,1,1,1,0,0,0,1,1,0,1,0,1,1
|
164 |
+
338,0,1,0,1,0,0,0,0,0,0,0,0,1,0
|
165 |
+
56671814,1,0,0,1,0,1,1,1,1,0,0,0,0,0
|
166 |
+
71621331,1,1,1,0,0,1,0,1,1,0,0,0,0,0
|
167 |
+
9821849,1,1,1,0,0,0,1,1,1,0,0,0,0,0
|
168 |
+
60490,0,0,0,0,0,0,0,0,1,0,0,1,1,0
|
169 |
+
49831257,0,1,0,0,0,0,1,0,0,0,0,0,0,0
|
170 |
+
135398745,0,1,1,1,0,1,0,0,1,0,0,0,1,0
|
171 |
+
2435,0,0,0,1,0,0,0,0,0,1,0,0,1,0
|
172 |
+
135413536,0,1,1,1,0,0,0,0,1,1,1,0,1,0
|
173 |
+
441313,0,1,1,1,0,0,1,1,1,0,0,0,0,0
|
174 |
+
656656,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
175 |
+
92727,0,0,1,1,0,0,0,1,1,0,0,0,0,0
|
176 |
+
5583,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
177 |
+
3440,0,1,1,1,0,0,0,1,0,0,0,0,0,0
|
178 |
+
6480466,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
179 |
+
56844015,1,0,1,1,0,0,1,0,1,0,0,0,0,0
|
180 |
+
25183872,1,0,1,1,0,0,1,0,1,0,0,0,0,0
|
181 |
+
21585658,0,0,0,0,0,0,1,1,1,0,0,0,1,0
|
182 |
+
71616,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
183 |
+
444972,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
184 |
+
55245,0,0,1,1,0,0,0,0,1,0,0,0,0,1
|
185 |
+
4030,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
186 |
+
9082,0,0,0,1,0,0,1,1,1,0,0,0,0,0
|
187 |
+
11950170,1,0,0,0,0,0,0,0,1,0,0,0,1,0
|
188 |
+
6918111,0,1,1,1,0,0,1,1,0,0,0,0,0,0
|
189 |
+
5284616,0,0,1,1,0,0,1,0,1,0,0,0,1,0
|
190 |
+
164726578,0,1,0,0,0,0,0,0,1,0,1,0,0,0
|
191 |
+
667493,0,0,0,1,0,0,1,0,1,0,0,1,1,0
|
192 |
+
2179,0,1,0,1,0,1,0,1,0,0,1,0,1,0
|
193 |
+
71576688,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
194 |
+
6252,0,1,0,1,0,0,0,1,1,0,0,0,0,0
|
195 |
+
3397,0,0,0,0,0,0,1,0,0,1,0,0,1,0
|
196 |
+
135526609,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
197 |
+
5282451,0,0,1,1,0,0,1,1,0,0,0,0,0,0
|
198 |
+
5905,0,1,1,0,0,0,0,1,0,0,0,0,0,0
|
199 |
+
14992,0,1,0,0,0,0,1,0,1,0,0,0,0,0
|
200 |
+
46926350,0,0,1,0,0,0,0,0,1,0,1,0,1,0
|
201 |
+
49846579,0,0,1,0,0,0,0,0,1,0,0,0,0,0
|
202 |
+
24826799,0,0,0,1,0,0,0,0,1,0,1,0,0,0
|
203 |
+
5509,0,0,1,1,0,0,0,1,0,0,0,0,0,0
|
204 |
+
118869362,0,1,0,0,0,0,0,0,1,1,1,0,1,0
|
205 |
+
5311180,0,0,0,0,0,0,1,1,1,0,0,0,0,0
|
206 |
+
22049997,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
207 |
+
9853654,0,0,0,0,0,1,0,0,0,0,0,0,0,0
|
208 |
+
44582816,0,0,0,1,0,0,0,0,0,0,1,0,0,0
|
209 |
+
162368359,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
210 |
+
58507717,0,0,1,1,0,0,0,0,0,0,0,0,1,0
|
211 |
+
24872560,1,0,0,0,0,0,0,1,1,1,0,0,1,0
|
212 |
+
148123,0,0,1,0,0,1,0,0,0,0,0,0,1,0
|
213 |
+
146681181,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
214 |
+
67171867,0,0,1,0,0,0,0,1,0,0,0,0,0,0
|
215 |
+
11570805,0,1,1,1,0,0,0,0,0,1,0,0,0,0
|
216 |
+
25166913,0,0,0,1,0,0,1,1,0,0,0,0,0,0
|
217 |
+
67330085,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
218 |
+
16362,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
219 |
+
121408882,0,1,0,1,0,0,0,0,0,0,1,0,0,0
|
220 |
+
1923,0,0,0,1,0,0,0,0,1,0,0,0,1,0
|
221 |
+
126689157,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
222 |
+
118598754,0,1,1,0,0,0,0,0,1,0,0,0,0,0
|
223 |
+
72172,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
224 |
+
4659569,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
225 |
+
4922,0,0,0,0,0,0,0,1,0,0,1,0,0,0
|
226 |
+
9415,0,1,0,0,0,0,0,0,0,0,0,0,1,0
|
227 |
+
445858,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
228 |
+
5324346,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
229 |
+
9560989,0,0,0,1,0,0,0,1,1,0,0,0,1,0
|
230 |
+
3463,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
231 |
+
3000226,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
232 |
+
46188928,0,1,0,1,0,0,0,0,1,0,0,0,0,0
|
233 |
+
10114,0,0,0,0,0,0,1,0,1,0,0,0,0,0
|
234 |
+
53340664,0,0,1,0,0,1,1,0,0,0,0,0,0,0
|
235 |
+
6918837,0,1,0,1,0,0,1,0,0,0,0,0,0,0
|
236 |
+
119182,1,1,0,0,0,1,0,0,0,0,0,0,0,0
|
237 |
+
6989,0,0,0,0,0,0,0,0,1,0,0,0,1,0
|
238 |
+
67501411,0,1,0,0,0,0,0,0,0,0,0,0,0,1
|
239 |
+
129073603,0,1,0,0,0,0,0,0,1,0,0,0,0,0
|
240 |
+
104850,0,0,0,0,0,0,1,1,0,0,0,0,0,0
|
241 |
+
28061,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
242 |
+
3000518,0,0,0,0,0,0,0,0,0,1,0,0,0,0
|
243 |
+
446727,1,1,0,0,0,0,0,0,1,0,0,0,0,0
|
244 |
+
285033,0,0,0,0,0,0,0,1,0,1,0,0,1,0
|
245 |
+
204,0,0,0,1,0,0,1,0,0,0,0,0,1,0
|
246 |
+
23675320,0,0,0,0,0,0,1,1,0,0,0,0,1,0
|
247 |
+
54680690,0,0,0,1,0,0,1,0,0,0,0,0,0,0
|
248 |
+
10180,0,0,0,1,0,0,0,0,1,0,0,0,0,0
|
249 |
+
9966051,0,0,1,0,0,0,0,0,0,0,0,0,1,0
|
250 |
+
11219835,0,1,0,1,0,0,0,0,0,0,0,0,0,0
|
251 |
+
11338033,0,0,0,1,0,0,0,0,0,0,0,0,1,0
|
252 |
+
25262965,0,0,0,1,0,0,0,1,0,0,0,0,0,0
|
253 |
+
451417,0,1,0,0,0,0,0,1,0,0,0,0,0,0
|
254 |
+
54755438,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
255 |
+
163659,0,1,0,0,0,0,0,0,1,0,0,0,0,0
|
256 |
+
44241743,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
257 |
+
5282230,0,0,0,0,0,1,0,0,0,0,0,0,1,0
|
258 |
+
91885558,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
259 |
+
10029385,0,0,0,0,0,0,0,0,0,0,1,0,0,0
|
260 |
+
71766360,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
261 |
+
3610,0,0,0,0,0,0,0,1,0,0,0,0,0,0
|
262 |
+
71571562,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
263 |
+
10195250,0,0,0,0,0,0,0,0,0,0,0,0,0,1
|
264 |
+
10621,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
265 |
+
155074,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
266 |
+
16063245,0,0,0,1,0,0,0,0,0,0,0,0,0,0
|
267 |
+
16759173,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
268 |
+
185462,0,0,0,0,0,0,0,0,0,0,1,0,0,0
|
269 |
+
24963252,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
270 |
+
16735117,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
271 |
+
440936,1,0,0,0,0,0,0,0,0,0,0,0,0,0
|
272 |
+
5344,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
273 |
+
5459308,0,0,1,0,0,0,0,0,0,0,0,0,0,0
|
274 |
+
54704426,0,0,0,0,0,0,0,0,0,0,0,0,1,0
|
275 |
+
57363,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
276 |
+
58282870,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
277 |
+
6917864,0,1,0,0,0,0,0,0,0,0,0,0,0,0
|
278 |
+
45256689,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
279 |
+
6918132,0,0,0,0,0,0,0,0,1,0,0,0,0,0
|
280 |
+
9046,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
281 |
+
6019,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
282 |
+
138911318,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
283 |
+
443872,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
284 |
+
441207,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
285 |
+
23674502,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
286 |
+
6364534,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
287 |
+
16218542,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
288 |
+
68911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
289 |
+
67517580,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
290 |
+
54677470,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
291 |
+
11310,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
292 |
+
135151360,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
293 |
+
82146,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
294 |
+
119369,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
295 |
+
46205871,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
296 |
+
9875462,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
297 |
+
2749,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
298 |
+
67448836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
299 |
+
104849,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
300 |
+
9827599,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
301 |
+
11960271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
302 |
+
32798,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
303 |
+
51003603,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
304 |
+
3033819,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
305 |
+
117965,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
306 |
+
2359994,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
307 |
+
73442,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
308 |
+
66065,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
309 |
+
10138980,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
310 |
+
10206,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
311 |
+
16217067,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
312 |
+
275182,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
313 |
+
10143,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
314 |
+
238053,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
315 |
+
5327711,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
316 |
+
46208890,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
317 |
+
54676228,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
318 |
+
77999,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
319 |
+
3045381,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
320 |
+
45256693,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
321 |
+
137319707,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
322 |
+
71420,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
323 |
+
16124208,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
324 |
+
24199313,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
325 |
+
5311027,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
326 |
+
66068,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
327 |
+
46910592,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
328 |
+
13982876,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
329 |
+
16747388,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
330 |
+
33630,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
331 |
+
70817911,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
332 |
+
46220375,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
333 |
+
23582824,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
334 |
+
130956,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
335 |
+
1936439,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
336 |
+
64982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
337 |
+
4614,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
338 |
+
121241171,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
339 |
+
5717952,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
340 |
+
73053710,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
341 |
+
135397144,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
342 |
+
3198,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
343 |
+
107971,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
344 |
+
118701008,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
345 |
+
92044433,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
346 |
+
118959080,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
347 |
+
24721416,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
348 |
+
23665037,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
349 |
+
11683005,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
350 |
+
16048568,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
351 |
+
168312271,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
352 |
+
137628686,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
353 |
+
3064778,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
354 |
+
14982,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
355 |
+
2747117,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
356 |
+
146673142,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
357 |
+
44093,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
358 |
+
167811,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
359 |
+
5312125,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
360 |
+
4006,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
361 |
+
104769,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
362 |
+
135565635,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
363 |
+
11595577,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
364 |
+
11957481,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
365 |
+
170014,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
366 |
+
276389,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
367 |
+
5405,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
368 |
+
158550,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
369 |
+
23663985,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
370 |
+
9562059,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
371 |
+
72205932,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
372 |
+
1986,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
373 |
+
86295191,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
374 |
+
1989,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
375 |
+
6437836,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
376 |
+
118704762,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
377 |
+
2194,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|
data/indication_to_organ_mapping_all.tsv
ADDED
@@ -0,0 +1,1013 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
indication_mesh_term organ
|
2 |
+
Neoplasms
|
3 |
+
Breast Neoplasms Breast
|
4 |
+
Pancreatic Neoplasms Pancreas
|
5 |
+
Colorectal Neoplasms Bowel
|
6 |
+
Inflammation
|
7 |
+
Carcinoma, Non-Small-Cell Lung Lung
|
8 |
+
Prostatic Neoplasms
|
9 |
+
Ovarian Neoplasms Ovary/Fallopian Tube
|
10 |
+
Brain Neoplasms CNS/Brain
|
11 |
+
Glioblastoma CNS/Brain
|
12 |
+
Medulloblastoma CNS/Brain
|
13 |
+
Melanoma Skin
|
14 |
+
COVID-19 Lung
|
15 |
+
Leukemia, Myeloid, Acute
|
16 |
+
Arthritis, Rheumatoid Skin
|
17 |
+
Hematologic Neoplasms
|
18 |
+
Nervous System Diseases
|
19 |
+
Alzheimer Disease CNS/Brain
|
20 |
+
Multiple Myeloma
|
21 |
+
Liver Neoplasms Liver
|
22 |
+
Psoriasis Skin
|
23 |
+
Head and Neck Neoplasms
|
24 |
+
Kidney Neoplasms Kidney
|
25 |
+
Multiple Sclerosis CNS/Brain
|
26 |
+
Autoimmune Diseases
|
27 |
+
Lung Neoplasms Lung
|
28 |
+
Asthma Lung
|
29 |
+
Lymphoma
|
30 |
+
Diabetes Mellitus, Type 2
|
31 |
+
Parkinson Disease CNS/Brain
|
32 |
+
Inflammatory Bowel Diseases Bowel
|
33 |
+
Non-alcoholic Fatty Liver Disease Liver
|
34 |
+
Stomach Neoplasms Esophagus/Stomach
|
35 |
+
Urinary Bladder Neoplasms Bladder/Urinary Tract
|
36 |
+
Myelodysplastic Syndromes
|
37 |
+
Neuralgia Peripheral Nervous System
|
38 |
+
Lymphoma, Non-Hodgkin
|
39 |
+
Pulmonary Disease, Chronic Obstructive Lung
|
40 |
+
Nociceptive Pain
|
41 |
+
Brain Ischemia CNS/Brain
|
42 |
+
Stroke CNS/Brain
|
43 |
+
Idiopathic Pulmonary Fibrosis Lung
|
44 |
+
Diabetes Mellitus
|
45 |
+
Cardiovascular Diseases
|
46 |
+
Colitis, Ulcerative Bowel
|
47 |
+
Obesity
|
48 |
+
Immune System Diseases
|
49 |
+
Leukemia, Lymphocytic, Chronic, B-Cell
|
50 |
+
Sarcoma
|
51 |
+
Crohn Disease Bowel
|
52 |
+
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
53 |
+
Heart Failure
|
54 |
+
Graft vs Host Disease
|
55 |
+
Dermatitis, Atopic Skin
|
56 |
+
Esophageal Neoplasms Esophagus/Stomach
|
57 |
+
Small Cell Lung Carcinoma Lung
|
58 |
+
Atherosclerosis
|
59 |
+
Leukemia
|
60 |
+
Lupus Erythematosus, Systemic Skin
|
61 |
+
Respiratory Distress Syndrome Lung
|
62 |
+
Myocardial Infarction
|
63 |
+
Amyotrophic Lateral Sclerosis CNS/Brain
|
64 |
+
Eye Diseases
|
65 |
+
Endometrial Neoplasms Uterus
|
66 |
+
Arthritis
|
67 |
+
Bile Duct Neoplasms
|
68 |
+
Peritoneal Neoplasms
|
69 |
+
Lymphoma, Large B-Cell, Diffuse
|
70 |
+
Depression
|
71 |
+
Schizophrenia
|
72 |
+
Hypertension, Pulmonary Lung
|
73 |
+
Lymphoma, B-Cell
|
74 |
+
Mesothelioma
|
75 |
+
Diabetic Retinopathy
|
76 |
+
Fallopian Tube Neoplasms Ovary/Fallopian Tube
|
77 |
+
Liver Cirrhosis Liver
|
78 |
+
Osteoarthritis
|
79 |
+
HIV Infections
|
80 |
+
Diabetic Nephropathies Kidney
|
81 |
+
Brain Injuries, Traumatic CNS/Brain
|
82 |
+
Anxiety Disorders
|
83 |
+
Diabetes Mellitus, Type 1
|
84 |
+
Wound Healing
|
85 |
+
Uterine Cervical Neoplasms Cervix
|
86 |
+
Scleroderma, Systemic Skin
|
87 |
+
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
|
88 |
+
Scleroderma, Diffuse Skin
|
89 |
+
Scleroderma, Limited Skin
|
90 |
+
Wet Macular Degeneration
|
91 |
+
Glaucoma
|
92 |
+
Musculoskeletal Pain
|
93 |
+
Diabetic Neuropathies Peripheral Nervous System
|
94 |
+
Thyroid Neoplasms
|
95 |
+
Depressive Disorder, Major
|
96 |
+
Epilepsy CNS/Brain
|
97 |
+
Kidney Failure, Chronic Kidney
|
98 |
+
Huntington Disease CNS/Brain
|
99 |
+
Lymphoma, Mantle-Cell
|
100 |
+
Hyperlipidemias
|
101 |
+
Macular Edema
|
102 |
+
Osteoporosis
|
103 |
+
Infections
|
104 |
+
Sepsis
|
105 |
+
Dry Eye Syndromes
|
106 |
+
Neoplasms, Squamous Cell
|
107 |
+
Neuroblastoma
|
108 |
+
Hypertension
|
109 |
+
Migraine Disorders CNS/Brain
|
110 |
+
Hodgkin Disease
|
111 |
+
Irritable Bowel Syndrome Bowel
|
112 |
+
Cytokine Release Syndrome
|
113 |
+
Eczema Skin
|
114 |
+
Spinal Cord Injuries CNS/Brain
|
115 |
+
Carcinoma, Neuroendocrine
|
116 |
+
Lymphoma, T-Cell
|
117 |
+
Osteosarcoma
|
118 |
+
Skin Diseases Skin
|
119 |
+
Thrombosis
|
120 |
+
Lymphoma, Follicular
|
121 |
+
Diabetes Complications
|
122 |
+
Peripheral Vascular Diseases
|
123 |
+
Cystic Fibrosis
|
124 |
+
Pneumonia Lung
|
125 |
+
Hepatitis C Liver
|
126 |
+
Primary Myelofibrosis
|
127 |
+
Uveitis
|
128 |
+
Geographic Atrophy
|
129 |
+
Ischemia
|
130 |
+
Pain, Postoperative
|
131 |
+
Gastrointestinal Stromal Tumors Bowel
|
132 |
+
Cachexia
|
133 |
+
Acne Vulgaris Skin
|
134 |
+
Bone Neoplasms
|
135 |
+
Hypercholesterolemia
|
136 |
+
Psychotic Disorders
|
137 |
+
Leukemia, Myelomonocytic, Chronic
|
138 |
+
Dementia CNS/Brain
|
139 |
+
Hepatitis B Liver
|
140 |
+
Sarcoma, Ewing
|
141 |
+
Multiple Sclerosis, Relapsing-Remitting CNS/Brain
|
142 |
+
Blood Coagulation Disorders
|
143 |
+
Coronary Restenosis
|
144 |
+
Cancer Pain
|
145 |
+
Anemia, Sickle Cell
|
146 |
+
Hypersensitivity
|
147 |
+
Sjogren's Syndrome Skin
|
148 |
+
Lymphoma, T-Cell, Peripheral
|
149 |
+
Rhinitis, Allergic Lung
|
150 |
+
Alcoholism
|
151 |
+
Anemia
|
152 |
+
Surgical Procedures, Operative
|
153 |
+
Muscular Dystrophy, Duchenne CNS/Brain
|
154 |
+
Pruritus Skin
|
155 |
+
Arthritis, Psoriatic Skin
|
156 |
+
Lymphoma, T-Cell, Cutaneous Skin
|
157 |
+
Multiple Sclerosis, Chronic Progressive CNS/Brain
|
158 |
+
Bipolar Disorder
|
159 |
+
Waldenstrom Macroglobulinemia
|
160 |
+
Urethral Neoplasms Bladder/Urinary Tract
|
161 |
+
Influenza, Human Lung
|
162 |
+
Diabetic Foot Skin
|
163 |
+
Urinary Bladder, Overactive Bladder/Urinary Tract
|
164 |
+
Fibromyalgia CNS/Brain
|
165 |
+
Liver Cirrhosis, Biliary Liver
|
166 |
+
Polycythemia Vera
|
167 |
+
Urinary Incontinence Bladder/Urinary Tract
|
168 |
+
Neuroendocrine Tumors
|
169 |
+
Angina Pectoris
|
170 |
+
Atrial Fibrillation
|
171 |
+
Attention Deficit Disorder with Hyperactivity
|
172 |
+
Sleep Wake Disorders CNS/Brain
|
173 |
+
Neuralgia, Postherpetic Peripheral Nervous System
|
174 |
+
Conjunctivitis, Allergic
|
175 |
+
Retinitis Pigmentosa
|
176 |
+
Tobacco Use Disorder
|
177 |
+
Endometriosis Uterus
|
178 |
+
Spondylitis, Ankylosing
|
179 |
+
Hypertriglyceridemia
|
180 |
+
Adrenal Gland Neoplasms Kidney
|
181 |
+
Nausea
|
182 |
+
Vomiting
|
183 |
+
Epilepsies, Partial CNS/Brain
|
184 |
+
Lymphoma, B-Cell, Marginal Zone
|
185 |
+
Rhabdomyosarcoma
|
186 |
+
Acute Coronary Syndrome
|
187 |
+
Alopecia Skin
|
188 |
+
Nasopharyngeal Neoplasms
|
189 |
+
Psychomotor Agitation CNS/Brain
|
190 |
+
Thrombocytopenia
|
191 |
+
Rhinitis, Allergic, Seasonal Lung
|
192 |
+
Sleep Initiation and Maintenance Disorders CNS/Brain
|
193 |
+
Vasculitis
|
194 |
+
Hidradenitis Suppurativa Skin
|
195 |
+
Gout
|
196 |
+
Menopause
|
197 |
+
Myasthenia Gravis
|
198 |
+
Thalassemia
|
199 |
+
Carcinoma, Merkel Cell
|
200 |
+
Cocaine-Related Disorders
|
201 |
+
Erectile Dysfunction
|
202 |
+
Neoplasms, Basal Cell Skin
|
203 |
+
Dyskinesia, Drug-Induced Skin
|
204 |
+
Glomerulonephritis, IGA Kidney
|
205 |
+
Opioid-Related Disorders
|
206 |
+
Prostatic Hyperplasia
|
207 |
+
Retinal Diseases
|
208 |
+
Rosacea Skin
|
209 |
+
Lewy Body Disease CNS/Brain
|
210 |
+
Cough Lung
|
211 |
+
Tuberculosis
|
212 |
+
Alopecia Areata Skin
|
213 |
+
Apnea Lung
|
214 |
+
Sarcoma, Kaposi
|
215 |
+
Thrombocytosis
|
216 |
+
Keratosis, Actinic Skin
|
217 |
+
Arthritis, Juvenile Skin
|
218 |
+
Contraception
|
219 |
+
Encephalomyocarditis virus
|
220 |
+
Mastocytosis
|
221 |
+
Postoperative Complications
|
222 |
+
Retinal Vein Occlusion
|
223 |
+
Venous Thrombosis
|
224 |
+
Papillomavirus Infections
|
225 |
+
Corneal Injuries CNS/Brain
|
226 |
+
Anus Neoplasms Bowel
|
227 |
+
Colitis Bowel
|
228 |
+
Lennox Gastaut Syndrome CNS/Brain
|
229 |
+
Prader-Willi Syndrome CNS/Brain
|
230 |
+
Sexual Dysfunction, Physiological
|
231 |
+
Purpura, Thrombocytopenic, Idiopathic
|
232 |
+
Sexual Dysfunctions, Psychological
|
233 |
+
Constipation
|
234 |
+
Gastroesophageal Reflux Esophagus/Stomach
|
235 |
+
Urticaria Skin
|
236 |
+
Gastroparesis
|
237 |
+
Behcet Syndrome Skin
|
238 |
+
Dyspepsia
|
239 |
+
Epidermolysis Bullosa Skin
|
240 |
+
Epilepsies, Myoclonic CNS/Brain
|
241 |
+
Hypotension
|
242 |
+
Muscular Atrophy, Spinal CNS/Brain
|
243 |
+
Radiation Injuries
|
244 |
+
Anemia, Hemolytic, Autoimmune
|
245 |
+
Neuromyelitis Optica CNS/Brain
|
246 |
+
Neutropenia
|
247 |
+
Binge-Eating Disorder
|
248 |
+
Eosinophilic Esophagitis Esophagus/Stomach
|
249 |
+
Burns
|
250 |
+
Lipodystrophy Skin
|
251 |
+
Pemphigus Skin
|
252 |
+
Respiratory Tract Infections Lung
|
253 |
+
Vitiligo Skin
|
254 |
+
Ileus Bowel
|
255 |
+
Anesthesia
|
256 |
+
Angina, Unstable
|
257 |
+
Bacterial Infections
|
258 |
+
Bronchiolitis Obliterans Lung
|
259 |
+
Infertility, Female
|
260 |
+
Menstruation Disturbances
|
261 |
+
Muscle Spasticity CNS/Brain
|
262 |
+
Obsessive-Compulsive Disorder
|
263 |
+
Spinocerebellar Ataxias CNS/Brain
|
264 |
+
Pituitary ACTH Hypersecretion CNS/Brain
|
265 |
+
Anorexia
|
266 |
+
Emphysema Lung
|
267 |
+
Epilepsy, Absence CNS/Brain
|
268 |
+
Fever
|
269 |
+
Friedreich Ataxia CNS/Brain
|
270 |
+
Hyperlipoproteinemia Type II
|
271 |
+
Leishmaniasis Skin
|
272 |
+
Leukemia, Hairy Cell
|
273 |
+
Sinusitis Lung
|
274 |
+
Panic Disorder
|
275 |
+
Lymphoma, Large-Cell, Anaplastic
|
276 |
+
Sleep Disorders, Circadian Rhythm CNS/Brain
|
277 |
+
Severe Acute Respiratory Syndrome Lung
|
278 |
+
Cataract
|
279 |
+
Epilepsy, Generalized CNS/Brain
|
280 |
+
Hemoglobinuria, Paroxysmal
|
281 |
+
Hemophilia A
|
282 |
+
Leiomyoma Uterus
|
283 |
+
Myeloproliferative Disorders
|
284 |
+
Pulmonary Embolism Lung
|
285 |
+
Status Epilepticus CNS/Brain
|
286 |
+
Tuberous Sclerosis
|
287 |
+
Hematopoietic Stem Cell Mobilization
|
288 |
+
Hemophilia B
|
289 |
+
Common Cold Lung
|
290 |
+
Hemolytic-Uremic Syndrome
|
291 |
+
Hemorrhage
|
292 |
+
Myopia
|
293 |
+
Narcolepsy CNS/Brain
|
294 |
+
Nasal Polyps Lung
|
295 |
+
Neuronal Ceroid-Lipofuscinoses CNS/Brain
|
296 |
+
Polycystic Ovary Syndrome Ovary/Fallopian Tube
|
297 |
+
Prurigo Skin
|
298 |
+
Spasms, Infantile CNS/Brain
|
299 |
+
Angioedemas, Hereditary Skin
|
300 |
+
Immunoglobulin Light-chain Amyloidosis
|
301 |
+
Ascites
|
302 |
+
Coronary Thrombosis
|
303 |
+
Hepatitis D Liver
|
304 |
+
Hepatitis, Viral, Human Liver
|
305 |
+
Restless Legs Syndrome CNS/Brain
|
306 |
+
Dermatitis, Seborrheic Skin
|
307 |
+
Ulcer
|
308 |
+
Hyperphosphatemia
|
309 |
+
Drug-Related Side Effects and Adverse Reactions
|
310 |
+
Opioid-Induced Constipation
|
311 |
+
Adrenoleukodystrophy CNS/Brain
|
312 |
+
Dwarfism, Pituitary CNS/Brain
|
313 |
+
Dysmenorrhea
|
314 |
+
Obstetric Labor, Premature
|
315 |
+
Nephritis, Hereditary Kidney
|
316 |
+
Prostatitis
|
317 |
+
Shock, Traumatic
|
318 |
+
Acromegaly CNS/Brain
|
319 |
+
Amyloidosis
|
320 |
+
Anemia, Aplastic
|
321 |
+
Anthrax
|
322 |
+
Cluster Headache CNS/Brain
|
323 |
+
Epilepsy, Tonic-Clonic CNS/Brain
|
324 |
+
Glycogen Storage Disease Type II CNS/Brain
|
325 |
+
Hypoglycemia
|
326 |
+
Hypogonadism
|
327 |
+
Ichthyosis Skin
|
328 |
+
Leprosy
|
329 |
+
Lymphoproliferative Disorders
|
330 |
+
Neurofibromatosis 1
|
331 |
+
Rhinitis, Allergic, Perennial Lung
|
332 |
+
Stomach Ulcer Esophagus/Stomach
|
333 |
+
Bronchitis, Chronic Lung
|
334 |
+
Dyslipidemias
|
335 |
+
Leber Congenital Amaurosis
|
336 |
+
Premature Ejaculation
|
337 |
+
Candidiasis
|
338 |
+
Hypercalcemia
|
339 |
+
Hyperparathyroidism, Secondary
|
340 |
+
Infertility, Male
|
341 |
+
Menorrhagia
|
342 |
+
Wilms Tumor
|
343 |
+
Polymyalgia Rheumatica Skin
|
344 |
+
Venous Insufficiency
|
345 |
+
Ventricular Fibrillation
|
346 |
+
Arthritis, Gouty
|
347 |
+
Eye Infections
|
348 |
+
Severe Combined Immunodeficiency
|
349 |
+
alpha 1-Antitrypsin Deficiency
|
350 |
+
Amyloid Neuropathies, Familial CNS/Brain
|
351 |
+
Tardive Dyskinesia Skin
|
352 |
+
Amino Acid Metabolism, Inborn Errors
|
353 |
+
Urinary Bladder, Neurogenic Bladder/Urinary Tract
|
354 |
+
Edema, Cardiac
|
355 |
+
Gaucher Disease CNS/Brain
|
356 |
+
Hepatorenal Syndrome Liver
|
357 |
+
Herpes Zoster
|
358 |
+
Keratitis
|
359 |
+
Hyperlipoproteinemia Type I
|
360 |
+
Myositis Ossificans
|
361 |
+
Myotonia CNS/Brain
|
362 |
+
Premenstrual Syndrome
|
363 |
+
Purpura, Thrombotic Thrombocytopenic
|
364 |
+
Regeneration
|
365 |
+
Skin Diseases, Infectious Skin
|
366 |
+
Spinal Fusion
|
367 |
+
Urinary Tract Infections Bladder/Urinary Tract
|
368 |
+
von Willebrand Diseases
|
369 |
+
Granulomatosis with Polyangiitis Lung
|
370 |
+
Thrombotic Microangiopathies
|
371 |
+
Reproductive Tract Infections
|
372 |
+
Hypoadrenocorticism, Familial
|
373 |
+
Bulimia
|
374 |
+
Cholestasis, Intrahepatic Liver
|
375 |
+
Dystonia CNS/Brain
|
376 |
+
Hyperoxaluria
|
377 |
+
Peptic Ulcer Esophagus/Stomach
|
378 |
+
Proctitis
|
379 |
+
Sialorrhea
|
380 |
+
Synovitis, Pigmented Villonodular
|
381 |
+
Tennis Elbow
|
382 |
+
Tachycardia, Ventricular
|
383 |
+
Hormone Replacement Therapy
|
384 |
+
Postoperative Nausea and Vomiting
|
385 |
+
Graves Ophthalmopathy
|
386 |
+
Bulimia Nervosa
|
387 |
+
Tendinopathy
|
388 |
+
Cryopyrin-Associated Periodic Syndromes Skin
|
389 |
+
Addison Disease
|
390 |
+
Afibrinogenemia
|
391 |
+
Fabry Disease CNS/Brain
|
392 |
+
Bursitis
|
393 |
+
Disseminated Intravascular Coagulation
|
394 |
+
Duodenal Ulcer Esophagus/Stomach
|
395 |
+
Dyspareunia
|
396 |
+
Esophageal and Gastric Varices Esophagus/Stomach
|
397 |
+
Esophagitis, Peptic Esophagus/Stomach
|
398 |
+
Postpartum Hemorrhage
|
399 |
+
Hypoparathyroidism
|
400 |
+
Hypophosphatasia
|
401 |
+
Labor, Induced
|
402 |
+
Lipoma
|
403 |
+
Metabolism, Inborn Errors
|
404 |
+
Mucocutaneous Lymph Node Syndrome Skin
|
405 |
+
Porphyrias
|
406 |
+
Stomatitis, Aphthous
|
407 |
+
Tachycardia, Supraventricular
|
408 |
+
Thrombophlebitis
|
409 |
+
Turner Syndrome
|
410 |
+
Still's Disease, Adult-Onset Skin
|
411 |
+
Hypophosphatemia
|
412 |
+
Tympanic Membrane Perforation
|
413 |
+
Antithrombin III Deficiency
|
414 |
+
Hyperammonemia
|
415 |
+
Optic Atrophy, Hereditary, Leber CNS/Brain
|
416 |
+
Erdheim-Chester Disease
|
417 |
+
Lymphatic Abnormalities
|
418 |
+
Lymphohistiocytosis, Hemophagocytic
|
419 |
+
Microscopic Polyangiitis CNS/Brain
|
420 |
+
Alstrom Syndrome CNS/Brain
|
421 |
+
Smith-Magenis Syndrome CNS/Brain
|
422 |
+
Atrophic Vaginitis Vulva/Vagina
|
423 |
+
Abortion, Spontaneous
|
424 |
+
Primary Immunodeficiency Diseases
|
425 |
+
Blepharoptosis
|
426 |
+
Cataplexy CNS/Brain
|
427 |
+
Cerebral Palsy CNS/Brain
|
428 |
+
Malignant Carcinoid Syndrome
|
429 |
+
Mucopolysaccharidosis IV Skin
|
430 |
+
Exocrine Pancreatic Insufficiency Pancreas
|
431 |
+
Phenylketonurias CNS/Brain
|
432 |
+
Polyuria
|
433 |
+
Puberty, Delayed
|
434 |
+
Puberty, Precocious
|
435 |
+
Zollinger-Ellison Syndrome
|
436 |
+
Helicobacter Infections
|
437 |
+
HIV Wasting Syndrome
|
438 |
+
Tyrosinemias CNS/Brain
|
439 |
+
Bardet-Biedl Syndrome CNS/Brain
|
440 |
+
Protoporphyria, Erythropoietic
|
441 |
+
Urea Cycle Disorders, Inborn CNS/Brain
|
442 |
+
Anemia, Hemolytic, Congenital Nonspherocytic
|
443 |
+
Anesthesia Recovery Period
|
444 |
+
Cryptorchidism
|
445 |
+
Drug Synergism
|
446 |
+
Factor XI Deficiency
|
447 |
+
Heart Defects, Congenital
|
448 |
+
Hepatitis A Liver
|
449 |
+
von Hippel-Lindau Disease CNS/Brain
|
450 |
+
Hyperbilirubinemia
|
451 |
+
Hypoprothrombinemias
|
452 |
+
Hypothyroidism
|
453 |
+
Jaundice
|
454 |
+
Leukopenia
|
455 |
+
Malignant Hyperthermia
|
456 |
+
alpha-Mannosidosis
|
457 |
+
Neoplasms, Connective Tissue
|
458 |
+
Osteomalacia
|
459 |
+
Paraphilic Disorders
|
460 |
+
Familial Mediterranean Fever
|
461 |
+
Rectal Fistula Bowel
|
462 |
+
Thrombasthenia
|
463 |
+
Trichomonas Infections
|
464 |
+
Vitamin D Deficiency
|
465 |
+
Wolman Disease
|
466 |
+
Mucopolysaccharidosis II CNS/Brain
|
467 |
+
Mucopolysaccharidosis VII Skin
|
468 |
+
Lymphangioleiomyomatosis Uterus
|
469 |
+
Hemangioblastoma
|
470 |
+
Heat Stroke CNS/Brain
|
471 |
+
Coagulation Protein Disorders
|
472 |
+
Hyperparathyroidism, Primary
|
473 |
+
Mevalonate Kinase Deficiency CNS/Brain
|
474 |
+
Perivascular Epithelioid Cell Neoplasms
|
475 |
+
Macular Degeneration
|
476 |
+
Cognition Disorders
|
477 |
+
Gastrointestinal Neoplasms Bowel
|
478 |
+
Acute Lung Injury Lung
|
479 |
+
Gastrointestinal Diseases Bowel
|
480 |
+
Acute Kidney Injury Kidney
|
481 |
+
Reperfusion Injury
|
482 |
+
Autistic Disorder
|
483 |
+
Liver Diseases Liver
|
484 |
+
Stress Disorders, Post-Traumatic
|
485 |
+
Lupus Nephritis Kidney
|
486 |
+
Carcinoid Tumor
|
487 |
+
Leiomyosarcoma
|
488 |
+
Urethritis
|
489 |
+
Renal Insufficiency Kidney
|
490 |
+
Lupus Erythematosus, Cutaneous Skin
|
491 |
+
Metabolic Syndrome
|
492 |
+
Glomerulosclerosis, Focal Segmental Kidney
|
493 |
+
Polycystic Kidney Diseases Kidney
|
494 |
+
Mucositis
|
495 |
+
Liposarcoma
|
496 |
+
Cholangitis, Sclerosing Liver
|
497 |
+
Hearing Loss CNS/Brain
|
498 |
+
Fragile X Syndrome CNS/Brain
|
499 |
+
Rett Syndrome CNS/Brain
|
500 |
+
Sarcoma, Synovial
|
501 |
+
Pemphigoid, Bullous Skin
|
502 |
+
Sarcoidosis
|
503 |
+
Frontotemporal Dementia CNS/Brain
|
504 |
+
Hepatitis Liver
|
505 |
+
Aminophenols
|
506 |
+
Bone Diseases
|
507 |
+
Eye Neoplasms
|
508 |
+
Tourette Syndrome CNS/Brain
|
509 |
+
Supranuclear Palsy, Progressive CNS/Brain
|
510 |
+
Dermatomyositis Skin
|
511 |
+
Delayed Graft Function
|
512 |
+
Phobia, Social
|
513 |
+
Cerebral Hemorrhage CNS/Brain
|
514 |
+
Intervertebral Disc
|
515 |
+
Glomerulonephritis Kidney
|
516 |
+
Polymyositis CNS/Brain
|
517 |
+
Hypereosinophilic Syndrome
|
518 |
+
Graft Rejection
|
519 |
+
Intermittent Claudication
|
520 |
+
Spasm CNS/Brain
|
521 |
+
Muscular Dystrophies, Limb-Girdle CNS/Brain
|
522 |
+
Bronchiectasis Lung
|
523 |
+
Headache
|
524 |
+
Short Bowel Syndrome Bowel
|
525 |
+
Cardiomyopathy, Dilated
|
526 |
+
Myotonic Dystrophy CNS/Brain
|
527 |
+
Myositis, Inclusion Body CNS/Brain
|
528 |
+
Borderline Personality Disorder
|
529 |
+
Gastritis Esophagus/Stomach
|
530 |
+
Photosensitivity Disorders Skin
|
531 |
+
Glomerulonephritis, Membranous Kidney
|
532 |
+
Pyoderma Gangrenosum Skin
|
533 |
+
Multiple System Atrophy CNS/Brain
|
534 |
+
Muscular Dystrophy, Facioscapulohumeral CNS/Brain
|
535 |
+
Pressure Ulcer Skin
|
536 |
+
Food Hypersensitivity
|
537 |
+
Immunologic Deficiency Syndromes
|
538 |
+
Tay-Sachs Disease CNS/Brain
|
539 |
+
Trigeminal Neuralgia Peripheral Nervous System
|
540 |
+
Complex Regional Pain Syndromes CNS/Brain
|
541 |
+
Dyssomnias CNS/Brain
|
542 |
+
Neurodevelopmental Disorders
|
543 |
+
Epileptic Syndromes CNS/Brain
|
544 |
+
Coronary Artery Bypass
|
545 |
+
Enuresis
|
546 |
+
Gastroenteritis
|
547 |
+
Gastrointestinal Motility Bowel
|
548 |
+
Otitis Media
|
549 |
+
Pre-Eclampsia
|
550 |
+
Retinopathy of Prematurity
|
551 |
+
Sandhoff Disease CNS/Brain
|
552 |
+
Dementia, Vascular CNS/Brain
|
553 |
+
Optic Neuropathy, Ischemic Peripheral Nervous System
|
554 |
+
Netherton Syndrome Skin
|
555 |
+
Healthcare-Associated Pneumonia Lung
|
556 |
+
Anorexia Nervosa
|
557 |
+
Brain Diseases CNS/Brain
|
558 |
+
Ehlers-Danlos Syndrome Skin
|
559 |
+
Mucopolysaccharidosis III Skin
|
560 |
+
Pterygium
|
561 |
+
Urination Disorders
|
562 |
+
Varicose Ulcer Skin
|
563 |
+
Neurofibromatosis 2
|
564 |
+
Aortic Valve Stenosis
|
565 |
+
Delirium CNS/Brain
|
566 |
+
Castleman Disease
|
567 |
+
Retinal Detachment
|
568 |
+
Takayasu Arteritis Skin
|
569 |
+
Thromboangiitis Obliterans
|
570 |
+
Tinnitus CNS/Brain
|
571 |
+
Churg-Strauss Syndrome
|
572 |
+
Mitochondrial Myopathies CNS/Brain
|
573 |
+
Lung Diseases, Interstitial Lung
|
574 |
+
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Peripheral Nervous System
|
575 |
+
Myopathies, Structural, Congenital CNS/Brain
|
576 |
+
Gallstones
|
577 |
+
Congenital Hyperinsulinism
|
578 |
+
Usher Syndromes CNS/Brain
|
579 |
+
Immunoglobulin G4-Related Disease
|
580 |
+
Basal Cell Nevus Syndrome Skin
|
581 |
+
Diverticulitis Bowel
|
582 |
+
Glycogen Storage Disease Type I
|
583 |
+
Joint Diseases
|
584 |
+
Leigh Disease CNS/Brain
|
585 |
+
Malabsorption Syndromes
|
586 |
+
Meniere Disease
|
587 |
+
Skin Aging Skin
|
588 |
+
Fibromatosis, Aggressive
|
589 |
+
Ornithine Carbamoyltransferase Deficiency Disease CNS/Brain
|
590 |
+
Idiopathic Hypersomnia CNS/Brain
|
591 |
+
Brain Diseases, Metabolic, Inborn CNS/Brain
|
592 |
+
Pachyonychia Congenita Skin
|
593 |
+
Macrophage Activation Syndrome
|
594 |
+
Diabetic Cardiomyopathies
|
595 |
+
Aspergillosis
|
596 |
+
Biliary Atresia Liver
|
597 |
+
Blepharitis
|
598 |
+
Fuchs' Endothelial Dystrophy
|
599 |
+
Gonorrhea
|
600 |
+
Hepatolenticular Degeneration Liver
|
601 |
+
Hyponatremia
|
602 |
+
Osteogenesis Imperfecta Skin
|
603 |
+
Pancreatic Diseases Pancreas
|
604 |
+
Presbyopia
|
605 |
+
Scleritis
|
606 |
+
Vestibular Diseases
|
607 |
+
Behavior, Addictive
|
608 |
+
Citrullinemia CNS/Brain
|
609 |
+
Hyperargininemia CNS/Brain
|
610 |
+
Demyelinating Autoimmune Diseases, CNS CNS/Brain
|
611 |
+
Muscular Dystrophy, Oculopharyngeal CNS/Brain
|
612 |
+
Argininosuccinic Aciduria CNS/Brain
|
613 |
+
Retinal Telangiectasis
|
614 |
+
Mastodynia
|
615 |
+
Morton Neuroma CNS/Brain
|
616 |
+
Amenorrhea
|
617 |
+
Carbohydrate Metabolism, Inborn Errors
|
618 |
+
Factor VII Deficiency
|
619 |
+
Galactosemias CNS/Brain
|
620 |
+
Hemolysis
|
621 |
+
Hyperplasia
|
622 |
+
Kernicterus CNS/Brain
|
623 |
+
Penile Induration Skin
|
624 |
+
Pericarditis
|
625 |
+
Pulmonary Alveolar Proteinosis Lung
|
626 |
+
HTLV-I Infections
|
627 |
+
Alagille Syndrome
|
628 |
+
Conduct Disorder
|
629 |
+
Unverricht-Lundborg Syndrome CNS/Brain
|
630 |
+
Alexander Disease CNS/Brain
|
631 |
+
Subcutaneous Fat Skin
|
632 |
+
Fibrosis
|
633 |
+
Metabolic Diseases
|
634 |
+
Respiration Disorders Lung
|
635 |
+
Skin Neoplasms Skin
|
636 |
+
Female Urogenital Diseases and Pregnancy Complications
|
637 |
+
Male Urogenital Diseases
|
638 |
+
Dyskinesias Skin
|
639 |
+
Nephrosclerosis Kidney
|
640 |
+
Testicular Neoplasms
|
641 |
+
Central Nervous System Neoplasms CNS/Brain
|
642 |
+
Cardiomyopathies
|
643 |
+
Pancreatitis Pancreas
|
644 |
+
Peripheral Nervous System Diseases Peripheral Nervous System
|
645 |
+
Urogenital Neoplasms
|
646 |
+
Sarcopenia CNS/Brain
|
647 |
+
Encephalitis CNS/Brain
|
648 |
+
Arrhythmias, Cardiac
|
649 |
+
Endocrine System Diseases
|
650 |
+
Kidney Diseases Kidney
|
651 |
+
Thymoma
|
652 |
+
Vaginal Neoplasms Vulva/Vagina
|
653 |
+
Hemorrhagic Fever, Ebola
|
654 |
+
Rhinitis Lung
|
655 |
+
Celiac Disease
|
656 |
+
Diarrhea
|
657 |
+
Neuroectodermal Tumors, Primitive
|
658 |
+
Fractures, Bone
|
659 |
+
Charcot-Marie-Tooth Disease CNS/Brain
|
660 |
+
Dermatitis, Contact Skin
|
661 |
+
Staphylococcal Infections
|
662 |
+
Gliosarcoma
|
663 |
+
Hepatitis, Alcoholic Liver
|
664 |
+
Bone Marrow Diseases
|
665 |
+
Telangiectasia, Hereditary Hemorrhagic
|
666 |
+
Herpes Simplex Skin
|
667 |
+
Myositis CNS/Brain
|
668 |
+
Nephritis Kidney
|
669 |
+
Subarachnoid Hemorrhage CNS/Brain
|
670 |
+
Thymus Neoplasms
|
671 |
+
Respiratory Syncytial Virus Infections Lung
|
672 |
+
Regenerative Medicine
|
673 |
+
Cardiomyopathy, Hypertrophic
|
674 |
+
Carcinoma, Adenoid Cystic
|
675 |
+
Endomyocardial Fibrosis
|
676 |
+
Mouth Neoplasms
|
677 |
+
Periodontitis
|
678 |
+
Trauma, Nervous System CNS/Brain
|
679 |
+
Down Syndrome CNS/Brain
|
680 |
+
Dwarfism
|
681 |
+
Hyperthyroidism
|
682 |
+
Rabies
|
683 |
+
Angelman Syndrome CNS/Brain
|
684 |
+
Neurofibromatoses
|
685 |
+
Amphetamine-Related Disorders
|
686 |
+
Mitochondrial Diseases
|
687 |
+
Hemochromatosis
|
688 |
+
Hypertension, Portal
|
689 |
+
Keloid Skin
|
690 |
+
Muscular Atrophy CNS/Brain
|
691 |
+
Nephrotic Syndrome Kidney
|
692 |
+
Glucose Intolerance
|
693 |
+
Aneurysm
|
694 |
+
Bronchopulmonary Dysplasia Lung
|
695 |
+
Raynaud Disease
|
696 |
+
Respiratory Distress Syndrome, Newborn Lung
|
697 |
+
Respiratory Insufficiency Lung
|
698 |
+
Vascular Diseases
|
699 |
+
Keratitis, Herpetic
|
700 |
+
Stem Cell Transplantation
|
701 |
+
Leukemia, Prolymphocytic, B-Cell
|
702 |
+
Bone Diseases, Metabolic
|
703 |
+
Uterine Cervical Dysplasia Uterus
|
704 |
+
Corneal Ulcer
|
705 |
+
Edema
|
706 |
+
Histiocytosis, Langerhans-Cell Lung
|
707 |
+
Mucopolysaccharidosis I Skin
|
708 |
+
Lymphedema
|
709 |
+
Meningioma CNS/Brain
|
710 |
+
Optic Neuritis CNS/Brain
|
711 |
+
Pulmonary Edema Lung
|
712 |
+
Xerostomia
|
713 |
+
Weight Gain
|
714 |
+
Fatigue Syndrome, Chronic CNS/Brain
|
715 |
+
Antiphospholipid Syndrome
|
716 |
+
Essential Tremor CNS/Brain
|
717 |
+
Bone Regeneration
|
718 |
+
Carcinoma, Squamous Cell Skin
|
719 |
+
Chromosome Deletion
|
720 |
+
Erythromelalgia
|
721 |
+
Esophagitis Esophagus/Stomach
|
722 |
+
Fecal Incontinence
|
723 |
+
Fibrosarcoma
|
724 |
+
Nevus
|
725 |
+
Proteinuria
|
726 |
+
Red-Cell Aplasia, Pure
|
727 |
+
Pouchitis
|
728 |
+
Capillary Leak Syndrome
|
729 |
+
Urinary Bladder, Underactive Bladder/Urinary Tract
|
730 |
+
Postoperative Cognitive Complications
|
731 |
+
Chondrosarcoma
|
732 |
+
Color Vision Defects CNS/Brain
|
733 |
+
Fanconi Anemia
|
734 |
+
Granulomatous Disease, Chronic
|
735 |
+
Leukodystrophy, Globoid Cell CNS/Brain
|
736 |
+
Lymphopenia
|
737 |
+
Spinal Stenosis
|
738 |
+
Tendon Injuries
|
739 |
+
Wiskott-Aldrich Syndrome
|
740 |
+
Glomerulonephritis, Membranoproliferative Kidney
|
741 |
+
Leukemia, Prolymphocytic, T-Cell
|
742 |
+
Urinary Retention Bladder/Urinary Tract
|
743 |
+
Pleural Effusion, Malignant
|
744 |
+
Gangliosidosis, GM1 CNS/Brain
|
745 |
+
MELAS Syndrome CNS/Brain
|
746 |
+
Lichen Planus, Oral Bowel
|
747 |
+
Propionic Acidemia
|
748 |
+
Vascular Calcification
|
749 |
+
Barrett Esophagus Esophagus/Stomach
|
750 |
+
Blindness CNS/Brain
|
751 |
+
Coccidioidomycosis
|
752 |
+
Dysautonomia, Familial CNS/Brain
|
753 |
+
Fatigue
|
754 |
+
Hyperaldosteronism
|
755 |
+
Intervertebral Disc Displacement
|
756 |
+
Leukemia, Mast-Cell
|
757 |
+
Mucopolysaccharidosis VI Skin
|
758 |
+
Mycobacterium Infections, Nontuberculous
|
759 |
+
Neonatal Abstinence Syndrome
|
760 |
+
Pituitary Neoplasms
|
761 |
+
Rickets
|
762 |
+
Teratoma
|
763 |
+
Trisomy
|
764 |
+
Trophoblastic Neoplasms
|
765 |
+
Vertigo CNS/Brain
|
766 |
+
Corneal Edema
|
767 |
+
Choroid Diseases
|
768 |
+
Systemic Inflammatory Response Syndrome
|
769 |
+
Schnitzler Syndrome
|
770 |
+
Invasive Fungal Infections
|
771 |
+
Congenital Bone Marrow Failure Syndromes
|
772 |
+
Alveolitis, Extrinsic Allergic Lung
|
773 |
+
Amblyopia CNS/Brain
|
774 |
+
Arteriovenous Malformations
|
775 |
+
Blepharospasm
|
776 |
+
Marijuana Abuse
|
777 |
+
Cerebellar Diseases CNS/Brain
|
778 |
+
Cholangitis Liver
|
779 |
+
Corneal Diseases
|
780 |
+
Crigler-Najjar Syndrome
|
781 |
+
Cystinosis
|
782 |
+
Ectodermal Dysplasia Skin
|
783 |
+
Esophageal Achalasia Esophagus/Stomach
|
784 |
+
Fibrocystic Breast Disease Breast
|
785 |
+
Fissure in Ano
|
786 |
+
Homocystinuria CNS/Brain
|
787 |
+
Hyperprolactinemia CNS/Brain
|
788 |
+
Hypertrophy
|
789 |
+
Hypocalcemia
|
790 |
+
Disruptive, Impulse Control, and Conduct Disorders
|
791 |
+
Keratoconus
|
792 |
+
Darier Disease Skin
|
793 |
+
Lactation Disorders Skin
|
794 |
+
Leukodystrophy, Metachromatic CNS/Brain
|
795 |
+
Leukoplakia
|
796 |
+
Necrobiosis Lipoidica Skin
|
797 |
+
Penile Neoplasms
|
798 |
+
Pityriasis Rubra Pilaris Skin
|
799 |
+
Polyneuropathies CNS/Brain
|
800 |
+
Pseudohypoaldosteronism
|
801 |
+
Ross River virus
|
802 |
+
Skin Diseases, Vesiculobullous Skin
|
803 |
+
Trichotillomania
|
804 |
+
Wounds and Injuries
|
805 |
+
Choroideremia
|
806 |
+
Osteochondroma
|
807 |
+
Keratosis, Seborrheic Skin
|
808 |
+
Alcohol-Related Disorders
|
809 |
+
Retinoschisis
|
810 |
+
Steatorrhea
|
811 |
+
Hypoalphalipoproteinemias
|
812 |
+
Leukemia, Large Granular Lymphocytic
|
813 |
+
Virus Diseases
|
814 |
+
Substance-Related Disorders
|
815 |
+
Malaria
|
816 |
+
Musculoskeletal Diseases
|
817 |
+
Poisoning
|
818 |
+
Brain Injuries CNS/Brain
|
819 |
+
Dengue
|
820 |
+
Mycoses
|
821 |
+
Chordoma
|
822 |
+
Cytomegalovirus Infections
|
823 |
+
Organophosphate Poisoning
|
824 |
+
Niemann-Pick Diseases CNS/Brain
|
825 |
+
Fatty Liver, Alcoholic Liver
|
826 |
+
Amnesia CNS/Brain
|
827 |
+
Cerebral Infarction CNS/Brain
|
828 |
+
Dermatitis Skin
|
829 |
+
Enterocolitis, Necrotizing Bowel
|
830 |
+
Frailty
|
831 |
+
Deglutition Disorders
|
832 |
+
Picornaviridae Infections
|
833 |
+
Stomatitis
|
834 |
+
West Nile Fever CNS/Brain
|
835 |
+
Motor Neuron Disease CNS/Brain
|
836 |
+
Transfusion Reaction
|
837 |
+
Premenstrual Dysphoric Disorder
|
838 |
+
Chronic Traumatic Encephalopathy CNS/Brain
|
839 |
+
Anaphylaxis
|
840 |
+
Hirsutism Skin
|
841 |
+
Hypothalamic Diseases CNS/Brain
|
842 |
+
Lysosomal Storage Diseases
|
843 |
+
IgG Deficiency
|
844 |
+
Caliciviridae Infections
|
845 |
+
Anemia, Iron-Deficiency
|
846 |
+
Hepatic Insufficiency Liver
|
847 |
+
Hashimoto Disease
|
848 |
+
Leukemia, Myelomonocytic, Juvenile
|
849 |
+
Autoimmune Lymphoproliferative Syndrome
|
850 |
+
Bone Diseases, Infectious
|
851 |
+
Brain Edema CNS/Brain
|
852 |
+
Cryptococcosis
|
853 |
+
Herpesviridae Infections
|
854 |
+
Lecithin Cholesterol Acyltransferase Deficiency
|
855 |
+
Lyme Disease
|
856 |
+
Maple Syrup Urine Disease CNS/Brain
|
857 |
+
Osteopetrosis
|
858 |
+
Tularemia
|
859 |
+
POEMS Syndrome CNS/Brain
|
860 |
+
Pinguecula
|
861 |
+
Intraabdominal Infections
|
862 |
+
Pelvic Inflammatory Disease
|
863 |
+
Albinism Skin
|
864 |
+
Ataxia Telangiectasia CNS/Brain
|
865 |
+
Bone Cysts
|
866 |
+
Cholera
|
867 |
+
Gynecomastia Skin
|
868 |
+
Lipid Metabolism, Inborn Errors
|
869 |
+
Torticollis
|
870 |
+
Toxoplasmosis
|
871 |
+
Xeroderma Pigmentosum
|
872 |
+
Mycobacterium avium-intracellulare Infection
|
873 |
+
Lichen Sclerosus et Atrophicus Skin
|
874 |
+
Neurodegenerative Diseases CNS/Brain
|
875 |
+
Glycogen Storage Disease Type IIb CNS/Brain
|
876 |
+
Neurogenic Bowel Bowel
|
877 |
+
Osteogenesis
|
878 |
+
Muscular Dystrophies CNS/Brain
|
879 |
+
Zika Virus Infection
|
880 |
+
Coronavirus Infections
|
881 |
+
AIDS Dementia Complex CNS/Brain
|
882 |
+
Feeding and Eating Disorders
|
883 |
+
Retinal Artery Occlusion
|
884 |
+
Eye Injuries CNS/Brain
|
885 |
+
Guillain-Barre Syndrome CNS/Brain
|
886 |
+
Adenovirus Infections, Human
|
887 |
+
Leukoencephalopathy, Progressive Multifocal CNS/Brain
|
888 |
+
Neurilemmoma
|
889 |
+
Pneumococcal Infections
|
890 |
+
Pseudomonas Infections
|
891 |
+
Smallpox
|
892 |
+
Lafora Disease CNS/Brain
|
893 |
+
Abnormalities, Multiple
|
894 |
+
Ciliary Motility Disorders Lung
|
895 |
+
Conjunctivitis
|
896 |
+
Diabetes Insipidus
|
897 |
+
Ear Diseases
|
898 |
+
Hemiplegia CNS/Brain
|
899 |
+
Job Syndrome
|
900 |
+
Meningitis CNS/Brain
|
901 |
+
Noonan Syndrome Skin
|
902 |
+
Osteitis Deformans
|
903 |
+
Paget's Disease, Mammary Breast
|
904 |
+
Paget Disease, Extramammary Breast
|
905 |
+
Tetralogy of Fallot
|
906 |
+
Cerebral Amyloid Angiopathy CNS/Brain
|
907 |
+
Burkholderia Infections
|
908 |
+
Epstein-Barr Virus Infections
|
909 |
+
Intracranial Thrombosis CNS/Brain
|
910 |
+
Ataxia CNS/Brain
|
911 |
+
Corneal Dystrophies, Hereditary
|
912 |
+
Ductus Arteriosus, Patent
|
913 |
+
Hamartoma Syndrome, Multiple
|
914 |
+
Hyperventilation Lung
|
915 |
+
Hypothermia
|
916 |
+
Keratoconjunctivitis
|
917 |
+
Long QT Syndrome
|
918 |
+
Myocarditis
|
919 |
+
Nervous System Malformations CNS/Brain
|
920 |
+
Neurotic Disorders
|
921 |
+
Osteosclerosis
|
922 |
+
Phobic Disorders
|
923 |
+
Chronic Kidney Disease-Mineral and Bone Disorder Kidney
|
924 |
+
Schistosomiasis
|
925 |
+
Streptococcal Infections
|
926 |
+
Chagas Disease
|
927 |
+
Wolfram Syndrome CNS/Brain
|
928 |
+
Hepatitis E Liver
|
929 |
+
Gram-Positive Bacterial Infections
|
930 |
+
Amyloidosis, Familial
|
931 |
+
Abdominal Injuries
|
932 |
+
Immunosenescence
|
933 |
+
Cone-Rod Dystrophies
|
934 |
+
Ciliopathies
|
935 |
+
Birdshot Chorioretinopathy
|
936 |
+
Acidosis
|
937 |
+
Agammaglobulinemia
|
938 |
+
Alcoholic Intoxication
|
939 |
+
Anemia, Hemolytic, Congenital
|
940 |
+
Angioedema Skin
|
941 |
+
Bone Diseases, Developmental
|
942 |
+
Botulism CNS/Brain
|
943 |
+
Bradycardia
|
944 |
+
Chlamydia Infections
|
945 |
+
Cryptosporidiosis
|
946 |
+
Encephalitis, Japanese CNS/Brain
|
947 |
+
Encephalomyelitis, Acute Disseminated CNS/Brain
|
948 |
+
Encephalomyelitis, Venezuelan Equine CNS/Brain
|
949 |
+
Endocarditis
|
950 |
+
Fetal Diseases
|
951 |
+
Glycogen Storage Disease
|
952 |
+
Glycogen Storage Disease Type IV
|
953 |
+
Goiter
|
954 |
+
Haemophilus Infections
|
955 |
+
Hemorrhagic Fevers, Viral
|
956 |
+
Hepatic Encephalopathy CNS/Brain
|
957 |
+
Hyperinsulinism
|
958 |
+
Hyperparathyroidism
|
959 |
+
Impetigo Skin
|
960 |
+
Creutzfeldt-Jakob Syndrome CNS/Brain
|
961 |
+
Labyrinth Diseases
|
962 |
+
Marburg Virus Disease
|
963 |
+
Marfan Syndrome Skin
|
964 |
+
Meconium Aspiration Syndrome Lung
|
965 |
+
Melanosis Skin
|
966 |
+
Mucopolysaccharidoses Skin
|
967 |
+
Myelitis, Transverse
|
968 |
+
Ossification, Heterotopic
|
969 |
+
Paralysis CNS/Brain
|
970 |
+
Placental Insufficiency
|
971 |
+
Plague
|
972 |
+
Plant Poisoning
|
973 |
+
Pregnancy, Ectopic
|
974 |
+
Progeria
|
975 |
+
Retinitis
|
976 |
+
Rotavirus Infections
|
977 |
+
Sphingolipidoses CNS/Brain
|
978 |
+
Tachycardia
|
979 |
+
Urinary Calculi Bladder/Urinary Tract
|
980 |
+
Vaginitis Vulva/Vagina
|
981 |
+
Werner Syndrome
|
982 |
+
Yellow Fever
|
983 |
+
Zellweger Syndrome
|
984 |
+
Tumor Lysis Syndrome
|
985 |
+
Pyruvate Dehydrogenase Complex Deficiency Disease CNS/Brain
|
986 |
+
Spastic Paraplegia, Hereditary CNS/Brain
|
987 |
+
Aniridia
|
988 |
+
Postpoliomyelitis Syndrome CNS/Brain
|
989 |
+
Guided Tissue Regeneration, Periodontal
|
990 |
+
Myelinolysis, Central Pontine CNS/Brain
|
991 |
+
Hantavirus Infections
|
992 |
+
Congenital Disorders of Glycosylation
|
993 |
+
Iron Overload
|
994 |
+
Anti-Glomerular Basement Membrane Disease Lung
|
995 |
+
Hyperglycinemia, Nonketotic CNS/Brain
|
996 |
+
Carbamoyl-Phosphate Synthase I Deficiency Disease CNS/Brain
|
997 |
+
Myasthenic Syndromes, Congenital CNS/Brain
|
998 |
+
Vasospasm, Intracranial CNS/Brain
|
999 |
+
Hemangioma, Cavernous, Central Nervous System CNS/Brain
|
1000 |
+
Hermanski-Pudlak Syndrome Skin
|
1001 |
+
Polyomavirus Infections
|
1002 |
+
Optic Atrophy, Autosomal Dominant CNS/Brain
|
1003 |
+
Henipavirus Infections
|
1004 |
+
CADASIL CNS/Brain
|
1005 |
+
Fractures, Cartilage
|
1006 |
+
Dysuria
|
1007 |
+
Hyper-IgM Immunodeficiency Syndrome
|
1008 |
+
Vulvodynia
|
1009 |
+
Vitelliform Macular Dystrophy
|
1010 |
+
Sarcoglycanopathies Lung
|
1011 |
+
Fusariosis Skin
|
1012 |
+
Hand-Foot Syndrome Skin
|
1013 |
+
Chikungunya Fever
|
data/indication_to_organ_mapping_confident.tsv
ADDED
@@ -0,0 +1,422 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
indication_mesh_term organ
|
2 |
+
Breast Neoplasms Breast
|
3 |
+
Pancreatic Neoplasms Pancreas
|
4 |
+
Colorectal Neoplasms Bowel
|
5 |
+
Carcinoma, Non-Small-Cell Lung Lung
|
6 |
+
Ovarian Neoplasms Ovary/Fallopian Tube
|
7 |
+
Brain Neoplasms CNS/Brain
|
8 |
+
Glioblastoma CNS/Brain
|
9 |
+
Medulloblastoma CNS/Brain
|
10 |
+
Melanoma Skin
|
11 |
+
COVID-19 Lung
|
12 |
+
Arthritis, Rheumatoid Skin
|
13 |
+
Alzheimer Disease CNS/Brain
|
14 |
+
Liver Neoplasms Liver
|
15 |
+
Psoriasis Skin
|
16 |
+
Kidney Neoplasms Kidney
|
17 |
+
Multiple Sclerosis CNS/Brain
|
18 |
+
Lung Neoplasms Lung
|
19 |
+
Asthma Lung
|
20 |
+
Parkinson Disease CNS/Brain
|
21 |
+
Inflammatory Bowel Diseases Bowel
|
22 |
+
Non-alcoholic Fatty Liver Disease Liver
|
23 |
+
Stomach Neoplasms Esophagus/Stomach
|
24 |
+
Urinary Bladder Neoplasms Bladder/Urinary Tract
|
25 |
+
Neuralgia Peripheral Nervous System
|
26 |
+
Pulmonary Disease, Chronic Obstructive Lung
|
27 |
+
Brain Ischemia CNS/Brain
|
28 |
+
Stroke CNS/Brain
|
29 |
+
Idiopathic Pulmonary Fibrosis Lung
|
30 |
+
Colitis, Ulcerative Bowel
|
31 |
+
Crohn Disease Bowel
|
32 |
+
Dermatitis, Atopic Skin
|
33 |
+
Esophageal Neoplasms Esophagus/Stomach
|
34 |
+
Small Cell Lung Carcinoma Lung
|
35 |
+
Lupus Erythematosus, Systemic Skin
|
36 |
+
Respiratory Distress Syndrome Lung
|
37 |
+
Amyotrophic Lateral Sclerosis CNS/Brain
|
38 |
+
Endometrial Neoplasms Uterus
|
39 |
+
Hypertension, Pulmonary Lung
|
40 |
+
Fallopian Tube Neoplasms Ovary/Fallopian Tube
|
41 |
+
Liver Cirrhosis Liver
|
42 |
+
Diabetic Nephropathies Kidney
|
43 |
+
Brain Injuries, Traumatic CNS/Brain
|
44 |
+
Uterine Cervical Neoplasms Cervix
|
45 |
+
Scleroderma, Systemic Skin
|
46 |
+
Scleroderma, Diffuse Skin
|
47 |
+
Scleroderma, Limited Skin
|
48 |
+
Diabetic Neuropathies Peripheral Nervous System
|
49 |
+
Epilepsy CNS/Brain
|
50 |
+
Kidney Failure, Chronic Kidney
|
51 |
+
Huntington Disease CNS/Brain
|
52 |
+
Migraine Disorders CNS/Brain
|
53 |
+
Irritable Bowel Syndrome Bowel
|
54 |
+
Eczema Skin
|
55 |
+
Spinal Cord Injuries CNS/Brain
|
56 |
+
Skin Diseases Skin
|
57 |
+
Pneumonia Lung
|
58 |
+
Hepatitis C Liver
|
59 |
+
Gastrointestinal Stromal Tumors Bowel
|
60 |
+
Acne Vulgaris Skin
|
61 |
+
Dementia CNS/Brain
|
62 |
+
Hepatitis B Liver
|
63 |
+
Multiple Sclerosis, Relapsing-Remitting CNS/Brain
|
64 |
+
Sjogren's Syndrome Skin
|
65 |
+
Rhinitis, Allergic Lung
|
66 |
+
Muscular Dystrophy, Duchenne CNS/Brain
|
67 |
+
Pruritus Skin
|
68 |
+
Arthritis, Psoriatic Skin
|
69 |
+
Lymphoma, T-Cell, Cutaneous Skin
|
70 |
+
Multiple Sclerosis, Chronic Progressive CNS/Brain
|
71 |
+
Urethral Neoplasms Bladder/Urinary Tract
|
72 |
+
Influenza, Human Lung
|
73 |
+
Diabetic Foot Skin
|
74 |
+
Urinary Bladder, Overactive Bladder/Urinary Tract
|
75 |
+
Fibromyalgia CNS/Brain
|
76 |
+
Liver Cirrhosis, Biliary Liver
|
77 |
+
Urinary Incontinence Bladder/Urinary Tract
|
78 |
+
Sleep Wake Disorders CNS/Brain
|
79 |
+
Neuralgia, Postherpetic Peripheral Nervous System
|
80 |
+
Endometriosis Uterus
|
81 |
+
Adrenal Gland Neoplasms Kidney
|
82 |
+
Epilepsies, Partial CNS/Brain
|
83 |
+
Alopecia Skin
|
84 |
+
Psychomotor Agitation CNS/Brain
|
85 |
+
Rhinitis, Allergic, Seasonal Lung
|
86 |
+
Sleep Initiation and Maintenance Disorders CNS/Brain
|
87 |
+
Hidradenitis Suppurativa Skin
|
88 |
+
Neoplasms, Basal Cell Skin
|
89 |
+
Dyskinesia, Drug-Induced Skin
|
90 |
+
Glomerulonephritis, IGA Kidney
|
91 |
+
Rosacea Skin
|
92 |
+
Lewy Body Disease CNS/Brain
|
93 |
+
Cough Lung
|
94 |
+
Alopecia Areata Skin
|
95 |
+
Apnea Lung
|
96 |
+
Keratosis, Actinic Skin
|
97 |
+
Arthritis, Juvenile Skin
|
98 |
+
Corneal Injuries CNS/Brain
|
99 |
+
Anus Neoplasms Bowel
|
100 |
+
Colitis Bowel
|
101 |
+
Lennox Gastaut Syndrome CNS/Brain
|
102 |
+
Prader-Willi Syndrome CNS/Brain
|
103 |
+
Gastroesophageal Reflux Esophagus/Stomach
|
104 |
+
Urticaria Skin
|
105 |
+
Behcet Syndrome Skin
|
106 |
+
Epidermolysis Bullosa Skin
|
107 |
+
Epilepsies, Myoclonic CNS/Brain
|
108 |
+
Muscular Atrophy, Spinal CNS/Brain
|
109 |
+
Neuromyelitis Optica CNS/Brain
|
110 |
+
Eosinophilic Esophagitis Esophagus/Stomach
|
111 |
+
Lipodystrophy Skin
|
112 |
+
Pemphigus Skin
|
113 |
+
Respiratory Tract Infections Lung
|
114 |
+
Vitiligo Skin
|
115 |
+
Ileus Bowel
|
116 |
+
Bronchiolitis Obliterans Lung
|
117 |
+
Muscle Spasticity CNS/Brain
|
118 |
+
Spinocerebellar Ataxias CNS/Brain
|
119 |
+
Pituitary ACTH Hypersecretion CNS/Brain
|
120 |
+
Emphysema Lung
|
121 |
+
Epilepsy, Absence CNS/Brain
|
122 |
+
Friedreich Ataxia CNS/Brain
|
123 |
+
Leishmaniasis Skin
|
124 |
+
Sinusitis Lung
|
125 |
+
Sleep Disorders, Circadian Rhythm CNS/Brain
|
126 |
+
Severe Acute Respiratory Syndrome Lung
|
127 |
+
Epilepsy, Generalized CNS/Brain
|
128 |
+
Leiomyoma Uterus
|
129 |
+
Pulmonary Embolism Lung
|
130 |
+
Status Epilepticus CNS/Brain
|
131 |
+
Common Cold Lung
|
132 |
+
Narcolepsy CNS/Brain
|
133 |
+
Nasal Polyps Lung
|
134 |
+
Neuronal Ceroid-Lipofuscinoses CNS/Brain
|
135 |
+
Polycystic Ovary Syndrome Ovary/Fallopian Tube
|
136 |
+
Prurigo Skin
|
137 |
+
Spasms, Infantile CNS/Brain
|
138 |
+
Angioedemas, Hereditary Skin
|
139 |
+
Hepatitis D Liver
|
140 |
+
Hepatitis, Viral, Human Liver
|
141 |
+
Restless Legs Syndrome CNS/Brain
|
142 |
+
Dermatitis, Seborrheic Skin
|
143 |
+
Adrenoleukodystrophy CNS/Brain
|
144 |
+
Dwarfism, Pituitary CNS/Brain
|
145 |
+
Nephritis, Hereditary Kidney
|
146 |
+
Acromegaly CNS/Brain
|
147 |
+
Cluster Headache CNS/Brain
|
148 |
+
Epilepsy, Tonic-Clonic CNS/Brain
|
149 |
+
Glycogen Storage Disease Type II CNS/Brain
|
150 |
+
Ichthyosis Skin
|
151 |
+
Rhinitis, Allergic, Perennial Lung
|
152 |
+
Stomach Ulcer Esophagus/Stomach
|
153 |
+
Bronchitis, Chronic Lung
|
154 |
+
Polymyalgia Rheumatica Skin
|
155 |
+
Amyloid Neuropathies, Familial CNS/Brain
|
156 |
+
Tardive Dyskinesia Skin
|
157 |
+
Urinary Bladder, Neurogenic Bladder/Urinary Tract
|
158 |
+
Gaucher Disease CNS/Brain
|
159 |
+
Hepatorenal Syndrome Liver
|
160 |
+
Myotonia CNS/Brain
|
161 |
+
Skin Diseases, Infectious Skin
|
162 |
+
Urinary Tract Infections Bladder/Urinary Tract
|
163 |
+
Granulomatosis with Polyangiitis Lung
|
164 |
+
Cholestasis, Intrahepatic Liver
|
165 |
+
Dystonia CNS/Brain
|
166 |
+
Peptic Ulcer Esophagus/Stomach
|
167 |
+
Cryopyrin-Associated Periodic Syndromes Skin
|
168 |
+
Fabry Disease CNS/Brain
|
169 |
+
Duodenal Ulcer Esophagus/Stomach
|
170 |
+
Esophageal and Gastric Varices Esophagus/Stomach
|
171 |
+
Esophagitis, Peptic Esophagus/Stomach
|
172 |
+
Mucocutaneous Lymph Node Syndrome Skin
|
173 |
+
Still's Disease, Adult-Onset Skin
|
174 |
+
Optic Atrophy, Hereditary, Leber CNS/Brain
|
175 |
+
Microscopic Polyangiitis CNS/Brain
|
176 |
+
Alstrom Syndrome CNS/Brain
|
177 |
+
Smith-Magenis Syndrome CNS/Brain
|
178 |
+
Atrophic Vaginitis Vulva/Vagina
|
179 |
+
Cataplexy CNS/Brain
|
180 |
+
Cerebral Palsy CNS/Brain
|
181 |
+
Mucopolysaccharidosis IV Skin
|
182 |
+
Exocrine Pancreatic Insufficiency Pancreas
|
183 |
+
Phenylketonurias CNS/Brain
|
184 |
+
Tyrosinemias CNS/Brain
|
185 |
+
Bardet-Biedl Syndrome CNS/Brain
|
186 |
+
Urea Cycle Disorders, Inborn CNS/Brain
|
187 |
+
Hepatitis A Liver
|
188 |
+
von Hippel-Lindau Disease CNS/Brain
|
189 |
+
Rectal Fistula Bowel
|
190 |
+
Mucopolysaccharidosis II CNS/Brain
|
191 |
+
Mucopolysaccharidosis VII Skin
|
192 |
+
Lymphangioleiomyomatosis Uterus
|
193 |
+
Heat Stroke CNS/Brain
|
194 |
+
Mevalonate Kinase Deficiency CNS/Brain
|
195 |
+
Gastrointestinal Neoplasms Bowel
|
196 |
+
Acute Lung Injury Lung
|
197 |
+
Gastrointestinal Diseases Bowel
|
198 |
+
Acute Kidney Injury Kidney
|
199 |
+
Liver Diseases Liver
|
200 |
+
Lupus Nephritis Kidney
|
201 |
+
Renal Insufficiency Kidney
|
202 |
+
Lupus Erythematosus, Cutaneous Skin
|
203 |
+
Glomerulosclerosis, Focal Segmental Kidney
|
204 |
+
Polycystic Kidney Diseases Kidney
|
205 |
+
Cholangitis, Sclerosing Liver
|
206 |
+
Hearing Loss CNS/Brain
|
207 |
+
Fragile X Syndrome CNS/Brain
|
208 |
+
Rett Syndrome CNS/Brain
|
209 |
+
Pemphigoid, Bullous Skin
|
210 |
+
Frontotemporal Dementia CNS/Brain
|
211 |
+
Hepatitis Liver
|
212 |
+
Tourette Syndrome CNS/Brain
|
213 |
+
Supranuclear Palsy, Progressive CNS/Brain
|
214 |
+
Dermatomyositis Skin
|
215 |
+
Cerebral Hemorrhage CNS/Brain
|
216 |
+
Glomerulonephritis Kidney
|
217 |
+
Polymyositis CNS/Brain
|
218 |
+
Spasm CNS/Brain
|
219 |
+
Muscular Dystrophies, Limb-Girdle CNS/Brain
|
220 |
+
Bronchiectasis Lung
|
221 |
+
Short Bowel Syndrome Bowel
|
222 |
+
Myotonic Dystrophy CNS/Brain
|
223 |
+
Myositis, Inclusion Body CNS/Brain
|
224 |
+
Gastritis Esophagus/Stomach
|
225 |
+
Photosensitivity Disorders Skin
|
226 |
+
Glomerulonephritis, Membranous Kidney
|
227 |
+
Pyoderma Gangrenosum Skin
|
228 |
+
Multiple System Atrophy CNS/Brain
|
229 |
+
Muscular Dystrophy, Facioscapulohumeral CNS/Brain
|
230 |
+
Pressure Ulcer Skin
|
231 |
+
Tay-Sachs Disease CNS/Brain
|
232 |
+
Trigeminal Neuralgia Peripheral Nervous System
|
233 |
+
Complex Regional Pain Syndromes CNS/Brain
|
234 |
+
Dyssomnias CNS/Brain
|
235 |
+
Epileptic Syndromes CNS/Brain
|
236 |
+
Gastrointestinal Motility Bowel
|
237 |
+
Sandhoff Disease CNS/Brain
|
238 |
+
Dementia, Vascular CNS/Brain
|
239 |
+
Optic Neuropathy, Ischemic Peripheral Nervous System
|
240 |
+
Netherton Syndrome Skin
|
241 |
+
Healthcare-Associated Pneumonia Lung
|
242 |
+
Brain Diseases CNS/Brain
|
243 |
+
Ehlers-Danlos Syndrome Skin
|
244 |
+
Mucopolysaccharidosis III Skin
|
245 |
+
Varicose Ulcer Skin
|
246 |
+
Delirium CNS/Brain
|
247 |
+
Takayasu Arteritis Skin
|
248 |
+
Tinnitus CNS/Brain
|
249 |
+
Mitochondrial Myopathies CNS/Brain
|
250 |
+
Lung Diseases, Interstitial Lung
|
251 |
+
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Peripheral Nervous System
|
252 |
+
Myopathies, Structural, Congenital CNS/Brain
|
253 |
+
Usher Syndromes CNS/Brain
|
254 |
+
Basal Cell Nevus Syndrome Skin
|
255 |
+
Diverticulitis Bowel
|
256 |
+
Leigh Disease CNS/Brain
|
257 |
+
Skin Aging Skin
|
258 |
+
Ornithine Carbamoyltransferase Deficiency Disease CNS/Brain
|
259 |
+
Idiopathic Hypersomnia CNS/Brain
|
260 |
+
Brain Diseases, Metabolic, Inborn CNS/Brain
|
261 |
+
Pachyonychia Congenita Skin
|
262 |
+
Biliary Atresia Liver
|
263 |
+
Hepatolenticular Degeneration Liver
|
264 |
+
Osteogenesis Imperfecta Skin
|
265 |
+
Pancreatic Diseases Pancreas
|
266 |
+
Citrullinemia CNS/Brain
|
267 |
+
Hyperargininemia CNS/Brain
|
268 |
+
Demyelinating Autoimmune Diseases, CNS CNS/Brain
|
269 |
+
Muscular Dystrophy, Oculopharyngeal CNS/Brain
|
270 |
+
Argininosuccinic Aciduria CNS/Brain
|
271 |
+
Morton Neuroma CNS/Brain
|
272 |
+
Galactosemias CNS/Brain
|
273 |
+
Kernicterus CNS/Brain
|
274 |
+
Penile Induration Skin
|
275 |
+
Pulmonary Alveolar Proteinosis Lung
|
276 |
+
Unverricht-Lundborg Syndrome CNS/Brain
|
277 |
+
Alexander Disease CNS/Brain
|
278 |
+
Subcutaneous Fat Skin
|
279 |
+
Respiration Disorders Lung
|
280 |
+
Skin Neoplasms Skin
|
281 |
+
Dyskinesias Skin
|
282 |
+
Nephrosclerosis Kidney
|
283 |
+
Central Nervous System Neoplasms CNS/Brain
|
284 |
+
Pancreatitis Pancreas
|
285 |
+
Peripheral Nervous System Diseases Peripheral Nervous System
|
286 |
+
Sarcopenia CNS/Brain
|
287 |
+
Encephalitis CNS/Brain
|
288 |
+
Kidney Diseases Kidney
|
289 |
+
Vaginal Neoplasms Vulva/Vagina
|
290 |
+
Rhinitis Lung
|
291 |
+
Charcot-Marie-Tooth Disease CNS/Brain
|
292 |
+
Dermatitis, Contact Skin
|
293 |
+
Hepatitis, Alcoholic Liver
|
294 |
+
Herpes Simplex Skin
|
295 |
+
Myositis CNS/Brain
|
296 |
+
Nephritis Kidney
|
297 |
+
Subarachnoid Hemorrhage CNS/Brain
|
298 |
+
Respiratory Syncytial Virus Infections Lung
|
299 |
+
Trauma, Nervous System CNS/Brain
|
300 |
+
Down Syndrome CNS/Brain
|
301 |
+
Angelman Syndrome CNS/Brain
|
302 |
+
Keloid Skin
|
303 |
+
Muscular Atrophy CNS/Brain
|
304 |
+
Nephrotic Syndrome Kidney
|
305 |
+
Bronchopulmonary Dysplasia Lung
|
306 |
+
Respiratory Distress Syndrome, Newborn Lung
|
307 |
+
Respiratory Insufficiency Lung
|
308 |
+
Uterine Cervical Dysplasia Uterus
|
309 |
+
Histiocytosis, Langerhans-Cell Lung
|
310 |
+
Mucopolysaccharidosis I Skin
|
311 |
+
Meningioma CNS/Brain
|
312 |
+
Optic Neuritis CNS/Brain
|
313 |
+
Pulmonary Edema Lung
|
314 |
+
Fatigue Syndrome, Chronic CNS/Brain
|
315 |
+
Essential Tremor CNS/Brain
|
316 |
+
Carcinoma, Squamous Cell Skin
|
317 |
+
Esophagitis Esophagus/Stomach
|
318 |
+
Urinary Bladder, Underactive Bladder/Urinary Tract
|
319 |
+
Color Vision Defects CNS/Brain
|
320 |
+
Leukodystrophy, Globoid Cell CNS/Brain
|
321 |
+
Glomerulonephritis, Membranoproliferative Kidney
|
322 |
+
Urinary Retention Bladder/Urinary Tract
|
323 |
+
Gangliosidosis, GM1 CNS/Brain
|
324 |
+
MELAS Syndrome CNS/Brain
|
325 |
+
Lichen Planus, Oral Bowel
|
326 |
+
Barrett Esophagus Esophagus/Stomach
|
327 |
+
Blindness CNS/Brain
|
328 |
+
Dysautonomia, Familial CNS/Brain
|
329 |
+
Mucopolysaccharidosis VI Skin
|
330 |
+
Vertigo CNS/Brain
|
331 |
+
Alveolitis, Extrinsic Allergic Lung
|
332 |
+
Amblyopia CNS/Brain
|
333 |
+
Cerebellar Diseases CNS/Brain
|
334 |
+
Cholangitis Liver
|
335 |
+
Ectodermal Dysplasia Skin
|
336 |
+
Esophageal Achalasia Esophagus/Stomach
|
337 |
+
Fibrocystic Breast Disease Breast
|
338 |
+
Homocystinuria CNS/Brain
|
339 |
+
Hyperprolactinemia CNS/Brain
|
340 |
+
Darier Disease Skin
|
341 |
+
Lactation Disorders Skin
|
342 |
+
Leukodystrophy, Metachromatic CNS/Brain
|
343 |
+
Necrobiosis Lipoidica Skin
|
344 |
+
Pityriasis Rubra Pilaris Skin
|
345 |
+
Polyneuropathies CNS/Brain
|
346 |
+
Skin Diseases, Vesiculobullous Skin
|
347 |
+
Keratosis, Seborrheic Skin
|
348 |
+
Brain Injuries CNS/Brain
|
349 |
+
Niemann-Pick Diseases CNS/Brain
|
350 |
+
Fatty Liver, Alcoholic Liver
|
351 |
+
Amnesia CNS/Brain
|
352 |
+
Cerebral Infarction CNS/Brain
|
353 |
+
Dermatitis Skin
|
354 |
+
Enterocolitis, Necrotizing Bowel
|
355 |
+
West Nile Fever CNS/Brain
|
356 |
+
Motor Neuron Disease CNS/Brain
|
357 |
+
Chronic Traumatic Encephalopathy CNS/Brain
|
358 |
+
Hirsutism Skin
|
359 |
+
Hypothalamic Diseases CNS/Brain
|
360 |
+
Hepatic Insufficiency Liver
|
361 |
+
Brain Edema CNS/Brain
|
362 |
+
Maple Syrup Urine Disease CNS/Brain
|
363 |
+
POEMS Syndrome CNS/Brain
|
364 |
+
Albinism Skin
|
365 |
+
Ataxia Telangiectasia CNS/Brain
|
366 |
+
Gynecomastia Skin
|
367 |
+
Lichen Sclerosus et Atrophicus Skin
|
368 |
+
Neurodegenerative Diseases CNS/Brain
|
369 |
+
Glycogen Storage Disease Type IIb CNS/Brain
|
370 |
+
Neurogenic Bowel Bowel
|
371 |
+
Muscular Dystrophies CNS/Brain
|
372 |
+
AIDS Dementia Complex CNS/Brain
|
373 |
+
Eye Injuries CNS/Brain
|
374 |
+
Guillain-Barre Syndrome CNS/Brain
|
375 |
+
Leukoencephalopathy, Progressive Multifocal CNS/Brain
|
376 |
+
Lafora Disease CNS/Brain
|
377 |
+
Ciliary Motility Disorders Lung
|
378 |
+
Hemiplegia CNS/Brain
|
379 |
+
Meningitis CNS/Brain
|
380 |
+
Noonan Syndrome Skin
|
381 |
+
Paget's Disease, Mammary Breast
|
382 |
+
Paget Disease, Extramammary Breast
|
383 |
+
Cerebral Amyloid Angiopathy CNS/Brain
|
384 |
+
Intracranial Thrombosis CNS/Brain
|
385 |
+
Ataxia CNS/Brain
|
386 |
+
Hyperventilation Lung
|
387 |
+
Nervous System Malformations CNS/Brain
|
388 |
+
Chronic Kidney Disease-Mineral and Bone Disorder Kidney
|
389 |
+
Wolfram Syndrome CNS/Brain
|
390 |
+
Hepatitis E Liver
|
391 |
+
Angioedema Skin
|
392 |
+
Botulism CNS/Brain
|
393 |
+
Encephalitis, Japanese CNS/Brain
|
394 |
+
Encephalomyelitis, Acute Disseminated CNS/Brain
|
395 |
+
Encephalomyelitis, Venezuelan Equine CNS/Brain
|
396 |
+
Hepatic Encephalopathy CNS/Brain
|
397 |
+
Impetigo Skin
|
398 |
+
Creutzfeldt-Jakob Syndrome CNS/Brain
|
399 |
+
Marfan Syndrome Skin
|
400 |
+
Meconium Aspiration Syndrome Lung
|
401 |
+
Melanosis Skin
|
402 |
+
Mucopolysaccharidoses Skin
|
403 |
+
Paralysis CNS/Brain
|
404 |
+
Sphingolipidoses CNS/Brain
|
405 |
+
Urinary Calculi Bladder/Urinary Tract
|
406 |
+
Vaginitis Vulva/Vagina
|
407 |
+
Pyruvate Dehydrogenase Complex Deficiency Disease CNS/Brain
|
408 |
+
Spastic Paraplegia, Hereditary CNS/Brain
|
409 |
+
Postpoliomyelitis Syndrome CNS/Brain
|
410 |
+
Myelinolysis, Central Pontine CNS/Brain
|
411 |
+
Anti-Glomerular Basement Membrane Disease Lung
|
412 |
+
Hyperglycinemia, Nonketotic CNS/Brain
|
413 |
+
Carbamoyl-Phosphate Synthase I Deficiency Disease CNS/Brain
|
414 |
+
Myasthenic Syndromes, Congenital CNS/Brain
|
415 |
+
Vasospasm, Intracranial CNS/Brain
|
416 |
+
Hemangioma, Cavernous, Central Nervous System CNS/Brain
|
417 |
+
Hermanski-Pudlak Syndrome Skin
|
418 |
+
Optic Atrophy, Autosomal Dominant CNS/Brain
|
419 |
+
CADASIL CNS/Brain
|
420 |
+
Sarcoglycanopathies Lung
|
421 |
+
Fusariosis Skin
|
422 |
+
Hand-Foot Syndrome Skin
|
data/mapping.csv
ADDED
File without changes
|
data/organ_to_conditions_mapping.json
ADDED
@@ -0,0 +1,1067 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
{
|
2 |
+
"Bowel": [
|
3 |
+
"Colorectal Cancer",
|
4 |
+
"Metastatic Colorectal Cancer",
|
5 |
+
"Ulcerative Colitis",
|
6 |
+
"Colorectal Neoplasms",
|
7 |
+
"Rectal Cancer",
|
8 |
+
"Crohn's Disease",
|
9 |
+
"Gastrointestinal Stromal Tumors",
|
10 |
+
"Colorectal Cancer Metastatic",
|
11 |
+
"Advanced Colorectal Cancer",
|
12 |
+
"Colon Cancer",
|
13 |
+
"Irritable Bowel Syndrome",
|
14 |
+
"Short Bowel Syndrome",
|
15 |
+
"Colitis, Ulcerative",
|
16 |
+
"Crohn Disease",
|
17 |
+
"Colorectal Carcinoma",
|
18 |
+
"Colon Cancer; Rectal Cancer",
|
19 |
+
"Inflammatory Bowel Diseases",
|
20 |
+
"Rectal Neoplasms",
|
21 |
+
"Colorectal Cancer; Metastatic Cancer",
|
22 |
+
"Advanced Gastrointestinal Stromal Tumor",
|
23 |
+
"Colorectal Cancer; Liver Metastases",
|
24 |
+
"Gastrointestinal Stromal Tumor",
|
25 |
+
"Metastatic Colorectal Cancer (mCRC)",
|
26 |
+
"Metastatic Colorectal Adenocarcinoma",
|
27 |
+
"Gastrointestinal Neoplasms",
|
28 |
+
"Upper Gastrointestinal Bleeding",
|
29 |
+
"Irritable Bowel Syndrome With Diarrhea",
|
30 |
+
"Gastrointestinal Cancer",
|
31 |
+
"Colon Cancer; Colorectal Cancer",
|
32 |
+
"Colorectal Cancer (CRC)",
|
33 |
+
"Rectal Adenocarcinoma",
|
34 |
+
"Colon Adenocarcinoma",
|
35 |
+
"Colonoscopy",
|
36 |
+
"Multiple Cancers (Pancreatic, Lung, Esophagogastric, Colorectal, Breast)",
|
37 |
+
"Gastrointestinal Cancers",
|
38 |
+
"BRAF V600E-mutant Metastatic Colorectal Cancer",
|
39 |
+
"Metastatic Colorectal Cancer; MSI",
|
40 |
+
"Pediatric Crohn's Disease",
|
41 |
+
"High-risk Locally Advanced Colorectal Cancer",
|
42 |
+
"Lymphoma and Small Intestine Cancer",
|
43 |
+
"Advanced or Metastatic Solid Tumors; Advanced or Metastatic Colorectal Cancer (mCRC)",
|
44 |
+
"Stage IV Colorectal Cancer",
|
45 |
+
"Inflammatory Bowel Disease",
|
46 |
+
"Collagenous Colitis",
|
47 |
+
"Colorectal Cancer; Liver Metastasis",
|
48 |
+
"Colorectal Cancer with Liver Metastases",
|
49 |
+
"Colorectal Cancer Stage IV",
|
50 |
+
"Colorectal Cancer Metastatic; mCRC",
|
51 |
+
"Solid Tumors and Gastrointestinal Cancer",
|
52 |
+
"Solid Tumor; Colorectal Cancer",
|
53 |
+
"Colorectal; Cancer",
|
54 |
+
"Intestinal Neoplasms",
|
55 |
+
"Ulcerative Colitis Acute",
|
56 |
+
"Colorectal and Gastroesophageal Cancers",
|
57 |
+
"Colorectal Cancer; Metastatic Colorectal Cancer With RAS Mutation",
|
58 |
+
"Inflammatory Bowel Disease (IBD)",
|
59 |
+
"Gastrointestinal Stromal Tumor (GIST)",
|
60 |
+
"Gastrointestinal Neoplasm",
|
61 |
+
"Locally Advanced Rectal Cancer",
|
62 |
+
"Necrotizing Enterocolitis",
|
63 |
+
"HER2-expressing Gastrointestinal Cancers",
|
64 |
+
"Locally Recurrent Rectal Cancer",
|
65 |
+
"Biliary and Colorectal Neoplasms",
|
66 |
+
"Refractory Metastatic Colorectal Cancer",
|
67 |
+
"Recurrent Colon Carcinoma; Recurrent Rectal Carcinoma; Stage IVA Colon Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Rectal Cancer",
|
68 |
+
"Microbial Colonization",
|
69 |
+
"Small Intestinal Adenocarcinoma",
|
70 |
+
"Colon Cancer Liver Metastasis",
|
71 |
+
"Stage IIA Colon Cancer",
|
72 |
+
"Metastatic Colorectal Cancer with Chemotherapy Effects",
|
73 |
+
"Metastatic Colon Cancer",
|
74 |
+
"Ulcerative Colitis; Crohn's Disease",
|
75 |
+
"Ulcerative Colitis; Inflammatory Bowel Diseases",
|
76 |
+
"Colorectal Cancer; Cholangiocarcinoma",
|
77 |
+
"Metastatic Colorectal Cancer with Chemotherapy Complications",
|
78 |
+
"Colonic Neoplasms",
|
79 |
+
"Mucinous Adenocarcinoma of the Colon and Rectum",
|
80 |
+
"Upper Gastrointestinal Hemorrhage",
|
81 |
+
"Microsatellite Stable Metastatic Colorectal Cancer",
|
82 |
+
"Microscopic Colitis",
|
83 |
+
"Colorectal Adenocarcinoma",
|
84 |
+
"Colorectal Adenoma",
|
85 |
+
"Colorectal Cancer; Cancer of Pancreas; Pancreatic Neoplasm; Malignant Neoplasm of Large Intestine; Malignant Tumor of Colon; Colon Carcinoma; Cancer of Colon; Pancreatic Cancer",
|
86 |
+
"Non-small Cell Lung Carcinoma; Urothelial Carcinoma; Gastrointestinal Carcinoma, Non-colon; Upper Aerodigestive Tract Carcinoma",
|
87 |
+
"Lymphoma; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific",
|
88 |
+
"Anorectal Disorders",
|
89 |
+
"Metastatic Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8; Unresectable Carcinoma",
|
90 |
+
"Metastatic Colorectal Cancer; Metastatic Cancer to Liver",
|
91 |
+
"Metastatic Colorectal Cancer; Recurrent Colorectal Cancer",
|
92 |
+
"Colorectal Cancer with Liver Metastasis",
|
93 |
+
"Colorectal Cancer; Peritoneal Metastasis",
|
94 |
+
"Metastatic Microsatellite Stable Colorectal Carcinoma; Refractory Microsatellite Stable Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8",
|
95 |
+
"Colorectal Neoplasms Malignant",
|
96 |
+
"Colorectal Neoplasm",
|
97 |
+
"Colorectal Carcinoma; Colorectal Neoplasms; Colorectal Tumor; Colorectal Adenocarcinoma; Colorectal Cancer (CRC); Colorectal Cancer; Colon Cancer; Colon Adenocarcinoma; Colon Carcinoma; Colon Neoplasm",
|
98 |
+
"Colorectal Cancer; Colorectal Liver Metastases",
|
99 |
+
"BRAF V600E-mutated /MSS Metastatic Colorectal Cancer; Vemurafenib (BRAFi) Plus Cetuximab (EGFRi) Combined With PD-1 Monoclonal Antibody",
|
100 |
+
"MSS; RAS-mutant Colorectal Cancer",
|
101 |
+
"Venous Thromboembolism; Gastro Intestinal Bleeding; Blood Clot",
|
102 |
+
"Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis",
|
103 |
+
"Neoplasms, Colorectal",
|
104 |
+
"Colorectal Cancer Metastatic; Liver Metastasis Colon Cancer",
|
105 |
+
"Metastatic Colorectal Neoplasms",
|
106 |
+
"Metastatic Cancer; Colorectal Cancer; Colorectal Adenocarcinoma",
|
107 |
+
"Adenocarcinoma of Colon; Adenocarcinoma of Rectum; Metastatic Disease",
|
108 |
+
"Advanced Colorectal Carcinoma",
|
109 |
+
"Advanced Colorectal Cancer; Metastatic Colorectal Cancer",
|
110 |
+
"Small Intestinal Bacterial Overgrowth",
|
111 |
+
"Advanced Colorectal Cancer in the Third-line Treatment and Beyond; pMMR/MSS Advanced Colorectal Cancer",
|
112 |
+
"Metastatic Colon Cancer to Liver",
|
113 |
+
"Resected Liver Metastases From Colorectal Cancer",
|
114 |
+
"Advanced Malignant Neoplasm; Colorectal Carcinoma Metastatic in the Liver; Metastatic Malignant Neoplasm in the Liver; Refractory Malignant Neoplasm",
|
115 |
+
"Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer",
|
116 |
+
"Rheumatoid Arthritis and Inflammatory Bowel Disease",
|
117 |
+
"Adenocarcinoma of the Colon; Adenocarcinoma of the Rectum; Recurrent Colon Cancer; Recurrent Rectal Cancer; Stage IV Colon Cancer; Stage IV Rectal Cancer",
|
118 |
+
"Advanced Solid Tumor; Non-Small Cell Lung Cancer; Colorectal Cancer",
|
119 |
+
"Advanced Gastrointestinal Cancer",
|
120 |
+
"Stage II-III Colon Cancer",
|
121 |
+
"Gastro Intestinal Stromal Tumor",
|
122 |
+
"Crohn Disease; Ulcerative Colitis",
|
123 |
+
"Critical Illness with Gastrointestinal Complications",
|
124 |
+
"Gastrointestinal Adenocarcinoma",
|
125 |
+
"Crohn's Disease; Ulcerative Colitis",
|
126 |
+
"Recurrent or Metastatic Colorectal Cancer",
|
127 |
+
"Recurrent Rectal Cancer",
|
128 |
+
"Irritable Bowel Syndrome with SIBO",
|
129 |
+
"Locally Advanced Unresectable or Stage IV Colorectal Cancer"
|
130 |
+
],
|
131 |
+
"Lung": [
|
132 |
+
"Asthma",
|
133 |
+
"Lung Cancer",
|
134 |
+
"Carcinoma, Non-Small-Cell Lung",
|
135 |
+
"Non-small Cell Lung Cancer",
|
136 |
+
"Advanced Non-Small Cell Lung Cancer",
|
137 |
+
"Non Small Cell Lung Cancer",
|
138 |
+
"Pulmonary Disease, Chronic Obstructive",
|
139 |
+
"Pulmonary Arterial Hypertension",
|
140 |
+
"Chronic Obstructive Pulmonary Disease",
|
141 |
+
"Small Cell Lung Cancer",
|
142 |
+
"Pneumonia, Pneumocystis Carinii; HIV Infections",
|
143 |
+
"COPD",
|
144 |
+
"Pulmonary Hypertension",
|
145 |
+
"Non-Small-Cell Lung Carcinoma",
|
146 |
+
"Chronic Obstructive Pulmonary Disease (COPD)",
|
147 |
+
"Idiopathic Pulmonary Fibrosis",
|
148 |
+
"Non-Squamous Non-Small Cell Lung Cancer",
|
149 |
+
"Non-Small-Cell Lung Cancer",
|
150 |
+
"Non-small-cell Lung Cancer",
|
151 |
+
"Pulmonary Embolism",
|
152 |
+
"Mesothelioma",
|
153 |
+
"Lung Neoplasms",
|
154 |
+
"Non-small Cell Lung Cancer (NSCLC)",
|
155 |
+
"Acute Respiratory Distress Syndrome",
|
156 |
+
"Lung Cancer, Non-Small Cell",
|
157 |
+
"Malignant Pleural Mesothelioma",
|
158 |
+
"Non-small Cell Lung Cancer Metastatic",
|
159 |
+
"Pneumonia",
|
160 |
+
"Lung Adenocarcinoma",
|
161 |
+
"Bronchial Asthma",
|
162 |
+
"Malignant Mesothelioma",
|
163 |
+
"Malignant Pleural Effusion",
|
164 |
+
"Small Cell Lung Carcinoma",
|
165 |
+
"Non Small Cell Lung Carcinoma",
|
166 |
+
"Metastatic Non Small Cell Lung Cancer",
|
167 |
+
"Carcinoma, Non-Small Cell Lung",
|
168 |
+
"Stage IV Non-small Cell Lung Cancer",
|
169 |
+
"Pleural Mesothelioma",
|
170 |
+
"Respiratory Syncytial Virus Infections",
|
171 |
+
"Relapsed Small Cell Lung Cancer",
|
172 |
+
"Small Cell Lung Cancer Extensive Stage",
|
173 |
+
"Bronchiectasis",
|
174 |
+
"Pediatric Asthma",
|
175 |
+
"Non-squamous, Non-Small Cell Lung Cancer",
|
176 |
+
"Non Small Cell Lung Cancer (NSCLC)",
|
177 |
+
"COVID-19 Pneumonia",
|
178 |
+
"Non-Small Cell Lung Cancer with Gene Mutations",
|
179 |
+
"Non-Small Cell Lung Cancer (NSCLC)",
|
180 |
+
"Advanced Solid Tumor; Pancreatic Adenocarcinoma; Malignant Melanoma (Cutaneous); Non-small Cell Lung Cancer (NSCLC)",
|
181 |
+
"COPD with Pulmonary Hypertension",
|
182 |
+
"Carcinoma, Non-Small-Cell Lung; Immune-Related Adverse Events",
|
183 |
+
"Bronchopulmonary Dysplasia",
|
184 |
+
"Lung Cancer Stage III with Mutation",
|
185 |
+
"Multiple Cancers (Pancreatic, Lung, Esophagogastric, Colorectal, Breast)",
|
186 |
+
"Non-small-cell Lung Carcinoma",
|
187 |
+
"Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer",
|
188 |
+
"Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific",
|
189 |
+
"Recurrent Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8",
|
190 |
+
"Metastatic Non-Small Cell Lung Cancer",
|
191 |
+
"Recurrent Non-small Cell Lung Cancer",
|
192 |
+
"Lung Cancer, Nonsmall Cell",
|
193 |
+
"Lung Cancer with Hypermethylation",
|
194 |
+
"Lung Cancer; Non-Small Cell Lung Cancer",
|
195 |
+
"Lung Non-Small Cell Carcinoma; Lung Non-Small Cell Squamous Carcinoma; Lung Non-Squamous Non-Small Cell Carcinoma; Stage II Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8",
|
196 |
+
"Locally Advanced or Metastatic Non-Small Cell Lung Cancer",
|
197 |
+
"First Line Non-Small Cell Lung Cancer",
|
198 |
+
"Extensive Stage Small Cell Lung Cancer",
|
199 |
+
"Persistent Pulmonary Hypertension of the Newborn",
|
200 |
+
"Pulmonary Tuberculosis",
|
201 |
+
"Non-small Cell Lung Carcinoma",
|
202 |
+
"Non-squamous Non-small Cell Lung Cancer",
|
203 |
+
"Carcinoma, Non-small Cell Lung",
|
204 |
+
"Copd",
|
205 |
+
"Community-acquired Pneumonia",
|
206 |
+
"Small-cell Lung Cancer; Small Cell Lung Carcinoma",
|
207 |
+
"Community-acquired Respiratory Infections",
|
208 |
+
"Non-Small Cell Lung Cancer; Carcinoma, Squamous Cell; Adenocarcinoma",
|
209 |
+
"Stage IV Lung Cancer",
|
210 |
+
"Extensive-stage Small-cell Lung Cancer",
|
211 |
+
"Cough Variant Asthma",
|
212 |
+
"COPD (Chronic Obstructive Pulmonary Disease)",
|
213 |
+
"Hepatopulmonary Syndrome",
|
214 |
+
"Metastatic Lung Cancer",
|
215 |
+
"Lung Carcinoma",
|
216 |
+
"Solid Tumor; Non-Small Cell Lung Cancer; Head and Neck Cancer; Melanoma; Gastric Cancer; Renal Cell Carcinoma; Urothelial Carcinoma",
|
217 |
+
"Carcinoma, Non-Small-Cell Lung; Synchronous Neoplasms",
|
218 |
+
"Non Small-cell Lung Cancer",
|
219 |
+
"Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC V8; Clinical Stage IV Cutaneous Melanoma AJCC V8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Renal Cell Carcinoma; Ovarian Carcinoma; Pathologic Stage III Cutaneous Melanoma AJCC V8; Pathologic Stage IIIA Cutaneous Melanoma AJCC V8; Pathologic Stage IIIB Cutaneous Melanoma AJCC V8; Pathologic Stage IIIC Cutaneous Melanoma AJCC V8; Pathologic Stage IIID Cutaneous Melanoma AJCC V8; Pathologic Stage IV Cutaneous Melanoma AJCC V8; Primary Peritoneal Carcinoma; Stage III Lung Cancer AJCC V8; Stage III Renal Cell Cancer AJCC V8; Stage IIIA Lung Cancer AJCC V8; Stage IIIB Lung Cancer AJCC V8; Stage IIIC Lung Cancer AJCC V8; Stage IV Lung Cancer AJCC V8; Stage IV Renal Cell Cancer AJCC V8; Stage IVA Lung Cancer AJCC V8; Stage IVB Lung Cancer AJCC V8; Triple-Negative Breast Carcinoma; Unresectable Lung Non-Small Cell Carcinoma; Unresectable Melanoma; Unresectable Renal Cell Carcinoma",
|
220 |
+
"Metastatic Non-small Cell Lung Cancer",
|
221 |
+
"EGFR Positive Non-small Cell Lung Cancer",
|
222 |
+
"EGFR-mutant Non-small Cell Lung Cancer",
|
223 |
+
"Respiratory Syncytial Virus Infection",
|
224 |
+
"Respiratory Tract Infections",
|
225 |
+
"Advanced Malignant Mesothelioma; Epithelial Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatous Mesothelioma",
|
226 |
+
"Metastatic Non-Small Cell Lung Cancer (NSCLC)",
|
227 |
+
"Pulmonary Aspiration of Gastric Contents",
|
228 |
+
"Advanced Non-small Cell Lung Cancer",
|
229 |
+
"Chronic Thromboembolic Pulmonary Hypertension; Idiopathic Pulmonary Arterial Hypertension",
|
230 |
+
"Bronchiolitis Obliterans",
|
231 |
+
"Bronchiolitis",
|
232 |
+
"Heart Failure with Pulmonary Hypertension",
|
233 |
+
"Lung Neoplasm Malignant",
|
234 |
+
"Non-small Cell Lung Cancer Stage IV",
|
235 |
+
"Pulmonary Sarcoidosis",
|
236 |
+
"Acute Hypoxemic Respiratory Failure",
|
237 |
+
"Carcinoma, Small Cell; Lung Cancer; Small Cell Lung Cancer",
|
238 |
+
"Respiratory Diseases",
|
239 |
+
"Covid19; SARS (Severe Acute Respiratory Syndrome)",
|
240 |
+
"Carcinoma; Non-Small-Cell Lung",
|
241 |
+
"Non-Small Cell Lung Cancer",
|
242 |
+
"Acute Exacerbation of Chronic Obstructive Pulmonary Disease",
|
243 |
+
"Non Small Cell Lung Cancer; Hepatitis B",
|
244 |
+
"Non Small Cell Lung Cancer; Small-cell Lung Cancer",
|
245 |
+
"Non Small Cell Lung Cancer; Lung Cancer",
|
246 |
+
"Nonsquamous Nonsmall Cell Neoplasm of Lung",
|
247 |
+
"Lungcancer",
|
248 |
+
"Lung Transplant",
|
249 |
+
"ASTHMA",
|
250 |
+
"Non-small Cell Lung Cancer (NSCLC); EGFR-TKI Resistant Mutation; EGFR-TKI Sensitizing Mutation; Germline Mutations; Somatic Mutation",
|
251 |
+
"Non-squamous Nonsmall Cell Neoplasm of Lung",
|
252 |
+
"Non-small-cell Lung Cancer With Somatic EGFR Mutations",
|
253 |
+
"Non-small Cell Lung Carcinoma; Urothelial Carcinoma; Gastrointestinal Carcinoma, Non-colon; Upper Aerodigestive Tract Carcinoma",
|
254 |
+
"Head and Neck Cancer; Lung Cancer",
|
255 |
+
"Non-small Cell Lung Cancer(NSCLC)",
|
256 |
+
"Asthma with Obesity",
|
257 |
+
"Chronic Thromboembolic Pulmonary Hypertension",
|
258 |
+
"Non-Small Cell Lung Cancer with Genetic Mutations",
|
259 |
+
"Breast and Lung Cancer",
|
260 |
+
"HER2-mutant Non-Small Cell Lung Cancer",
|
261 |
+
"Lung Neoplasm",
|
262 |
+
"Metastatic Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage IV Lung Cancer AJCC v8",
|
263 |
+
"Non-Small Cell Lung Carcinoma with EGFR Mutation",
|
264 |
+
"Ventilator Associated Pneumonia",
|
265 |
+
"Arterial Pulmonary Hypertension (PAH)",
|
266 |
+
"Metastatic Castration-Resistant Prostate Cancer; Metastatic Breast Cancer; Non-small Cell Lung Cancer; Advanced Solid Tumors",
|
267 |
+
"Breast Cancer; Non-small Cell Lung Cancer; Melanoma; Brain Metastases",
|
268 |
+
"Acute Respiratory Tract Infections",
|
269 |
+
"Severe Asthma",
|
270 |
+
"Severe Acute Respiratory Syndrome",
|
271 |
+
"Recurrent Non-Small Cell Lung Carcinoma; Stage IIIA Non-Small Cell Lung Cancer; Stage IIIB Non-Small Cell Lung Cancer; Stage IV Non-Small Cell Lung Cancer",
|
272 |
+
"Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)",
|
273 |
+
"Lung Adenocarcinoma and Squamous Cell Carcinoma",
|
274 |
+
"Pleural Effusion",
|
275 |
+
"Small-Cell Lung Cancer",
|
276 |
+
"Advanced Lung Adenocarcinoma",
|
277 |
+
"Small-cell Lung Cancer",
|
278 |
+
"Pleural Neoplasm",
|
279 |
+
"Bacterial Pneumonia",
|
280 |
+
"Acute Pulmonary Embolism",
|
281 |
+
"Recurrent Non-Small Cell Lung Carcinoma; Stage IV Non-Small Cell Lung Cancer AJCC v7",
|
282 |
+
"Skin Rash with Lung Cancer",
|
283 |
+
"Allergic Bronchopulmonary Aspergillosis",
|
284 |
+
"Advanced Non Small Cell Lung Cancer; MET Exon 14 Mutation",
|
285 |
+
"Advanced Non Small Cell Lung Cancer (NSCLC)",
|
286 |
+
"Pulmonary Arterial Hypertension (PAH)",
|
287 |
+
"Pulmonary Arterial Hypertension; Pulmonary Hypertension",
|
288 |
+
"Leptomeningeal Metastasis; Non-small Cell Lung Cancer; EGFR Activating Mutation",
|
289 |
+
"Advanced Non-squamous Cell Non-small Cell Lung Cancer",
|
290 |
+
"Bronchoscopy with Sedation",
|
291 |
+
"Respiratory Failure",
|
292 |
+
"Advanced Lung Non-Small Cell Carcinoma; Recurrent Lung Non-Small Cell Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8; Stage IV Lung Cancer AJCC v8; Stage IVA Lung Cancer AJCC v8; Stage IVB Lung Cancer AJCC v8",
|
293 |
+
"EGFR Mutation Positive Non Small Cell Lung Cancer",
|
294 |
+
"EGFR Gene Mutation; Nonsmall Cell Lung Cancer",
|
295 |
+
"SMALL CELL LUNG CARCINOMA",
|
296 |
+
"Advanced Solid Tumor; Non-Small Cell Lung Cancer; Colorectal Cancer",
|
297 |
+
"Stage IV Non-Small Cell Lung Cancer",
|
298 |
+
"Lung Cancer (NSCLC)",
|
299 |
+
"Stage III Non-Small Cell Lung Cancer",
|
300 |
+
"Lower Respiratory Tract Infection",
|
301 |
+
"Lung Cancer; Non-small Cell Lung Cancer",
|
302 |
+
"Lung Diseases",
|
303 |
+
"Lung Cancer; Solid Tumor; Gastric Cancer; Urothelial Cancer; Endometrial Cancer; Multiple Myeloma; Myeloproliferative Neoplasms; Breast Cancer; Cholangiocarcinoma; UC; MPN",
|
304 |
+
"Lung Cancer; Lung Diseases",
|
305 |
+
"Lung Cancer, Non-Small Cell; Non-Small-Cell Lung Cancer",
|
306 |
+
"Stage IB Lung Non-Small Cell Carcinoma AJCC v7; Stage II Lung Non-Small Cell Cancer AJCC v7; Stage IIA Lung Cancer AJCC v8; Stage IIB Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIA Lung Non-Small Cell Cancer AJCC v7; Stage IIIB Lung Cancer AJCC v8",
|
307 |
+
"Squamous Cell Lung Carcinoma",
|
308 |
+
"Recurrent Small Cell Lung Carcinoma",
|
309 |
+
"Persistent Pulmonary Hypertension of Newborn",
|
310 |
+
"Extensive Stage Small Cell Lung Cancer (ES-SCLC)",
|
311 |
+
"Extensive Stage Small Cell Lung Cancer; Recurrent Small Cell Lung Cancer",
|
312 |
+
"Peritoneal Malignant Mesothelioma",
|
313 |
+
"Extensive-stage Small Cell Lung Cancer",
|
314 |
+
"Deep Venous Thrombosis; Pulmonary Embolism",
|
315 |
+
"EGFR-Positive Non-Small Cell Lung Cancer",
|
316 |
+
"Advanced Cancer; Metastatic Cancer; Non-Hodgkin's Lymphoma; Metastatic Breast Cancer; Malignant Mesothelioma; Non-small Cell Lung Cancer",
|
317 |
+
"Solid Tumors and Non-small Cell Lung Carcinoma"
|
318 |
+
],
|
319 |
+
"Esophagus/Stomach": [
|
320 |
+
"Gastric Cancer",
|
321 |
+
"Esophageal Cancer",
|
322 |
+
"Esophageal Squamous Cell Carcinoma",
|
323 |
+
"Eosinophilic Esophagitis",
|
324 |
+
"Gastroesophageal Reflux Disease",
|
325 |
+
"Esophageal and Gastric Cancer",
|
326 |
+
"Stomach Neoplasms",
|
327 |
+
"Advanced Gastric Cancer",
|
328 |
+
"Gastric Ulcer",
|
329 |
+
"Gastroesophageal Reflux",
|
330 |
+
"GERD",
|
331 |
+
"Stomach Neoplasm",
|
332 |
+
"Gastric Adenocarcinoma",
|
333 |
+
"Esophageal Neoplasms",
|
334 |
+
"Gastroesophageal Reflux Disease (GERD)",
|
335 |
+
"Stomach Cancer",
|
336 |
+
"Multiple Cancers (Pancreatic, Lung, Esophagogastric, Colorectal, Breast)",
|
337 |
+
"Esophageal Carcinoma",
|
338 |
+
"Metastatic Gastro-esophageal Adenocarcinoma",
|
339 |
+
"Advanced Gastroesophageal Adenocarcinoma",
|
340 |
+
"Reflux Esophagitis",
|
341 |
+
"Advanced Esophageal Carcinoma",
|
342 |
+
"Metastatic Gastric Cancer",
|
343 |
+
"Colorectal and Gastroesophageal Cancers",
|
344 |
+
"Esophageal Squamous Cell Carcinoma; Oligometastatic Disease; Radiotherapy",
|
345 |
+
"Esophagogastric Adenocarcinoma",
|
346 |
+
"Erosive Esophagitis",
|
347 |
+
"Stage IV Gastric Cancer With Metastasis",
|
348 |
+
"Gastric Acid Studies",
|
349 |
+
"Gastric and Gastroesophageal Junction Adenocarcinoma",
|
350 |
+
"Gastro-oesophageal Reflux Disease",
|
351 |
+
"Stomach Ulcer",
|
352 |
+
"Solid Tumor; Non-Small Cell Lung Cancer; Head and Neck Cancer; Melanoma; Gastric Cancer; Renal Cell Carcinoma; Urothelial Carcinoma",
|
353 |
+
"Pulmonary Aspiration of Gastric Contents",
|
354 |
+
"Advanced Gastric Adenocarcinoma",
|
355 |
+
"Advanced Gastric and Gastro-esophageal Junction Cancer",
|
356 |
+
"Helicobacter-associated Gastritis",
|
357 |
+
"Esophageal and Gastroesophageal Junction Cancer",
|
358 |
+
"Gastric and Gastroesophageal Junction Cancer",
|
359 |
+
"Metastatic Gastric Cancer; Locally Advanced Gastric Adenocarcinoma; Gastric Cancer Adenocarcinoma Metastatic",
|
360 |
+
"HER2-positive Gastroesophageal Cancer",
|
361 |
+
"Gastroesophageal Cancer with HER2 Mutation",
|
362 |
+
"Eosinophilic Esophagitis (EoE)",
|
363 |
+
"Advanced Esophageal Squamous Cell Carcinoma",
|
364 |
+
"HER-2 Positive Gastric or Gastroesophageal Junction Adenocarcinoma",
|
365 |
+
"Esophageal Cancer; Cancer of the Esophagus; Esophagus Cancer; Esophageal Neoplasm; Cancer of Esophagus",
|
366 |
+
"Esophageal Cancer; Gastric Cancer; Stomach Cancer",
|
367 |
+
"Esophagus Squamous Cell Carcinoma",
|
368 |
+
"Esophagitis",
|
369 |
+
"Esophageal Neoplasm",
|
370 |
+
"Gastro Esophageal Reflux",
|
371 |
+
"Gastroesophageal Junction Adenocarcinoma",
|
372 |
+
"Lung Cancer; Solid Tumor; Gastric Cancer; Urothelial Cancer; Endometrial Cancer; Multiple Myeloma; Myeloproliferative Neoplasms; Breast Cancer; Cholangiocarcinoma; UC; MPN",
|
373 |
+
"Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma",
|
374 |
+
"Gastric Cancer; GastroEsophageal Cancer",
|
375 |
+
"Gastric Cancer; Adenocarcinoma of the Esophagogastric Junction",
|
376 |
+
"Chemotherapy-Induced Gastric Toxicity",
|
377 |
+
"Gastric and Pancreatic Cancer",
|
378 |
+
"Gastric Cancer with Peritoneal Metastases",
|
379 |
+
"Gastric Cancer; HER2 Overexpressing Gastric Carcinoma",
|
380 |
+
"Gastric and Gastro-esophageal Junction Cancer",
|
381 |
+
"Locally Advanced Gastric Adenocarcinoma"
|
382 |
+
],
|
383 |
+
"Pancreas": [
|
384 |
+
"Pancreatic Cancer",
|
385 |
+
"Metastatic Pancreatic Cancer",
|
386 |
+
"Pancreatic Adenocarcinoma",
|
387 |
+
"Pancreatic Ductal Adenocarcinoma",
|
388 |
+
"Pancreatic Neoplasms",
|
389 |
+
"Metastatic Pancreatic Adenocarcinoma",
|
390 |
+
"Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Prostate Carcinoma; Advanced Sarcoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Recurrent Adult Soft Tissue Sarcoma; Recurrent Breast Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Prostate Carcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8",
|
391 |
+
"Advanced Pancreatic Cancer",
|
392 |
+
"Pancreas Cancer",
|
393 |
+
"Pancreatic Ductal Carcinoma",
|
394 |
+
"Metastatic Pancreatic Adenocarcinoma; Recurrent Pancreatic Carcinoma; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer",
|
395 |
+
"Metastatic Pancreatic Ductal Adenocarcinoma",
|
396 |
+
"Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8",
|
397 |
+
"Pancreatic Cancer Resectable",
|
398 |
+
"Unresectable Pancreatic Cancer",
|
399 |
+
"Advanced Solid Tumor; Pancreatic Adenocarcinoma; Malignant Melanoma (Cutaneous); Non-small Cell Lung Cancer (NSCLC)",
|
400 |
+
"Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage II Pancreatic Cancer; Stage III Pancreatic Cancer; Stage IV Pancreatic Cancer",
|
401 |
+
"Pancreatic Ductal Carcinoma; Advanced Cancer; Epithelial Tumor",
|
402 |
+
"Multiple Cancers (Pancreatic, Lung, Esophagogastric, Colorectal, Breast)",
|
403 |
+
"Locally Advanced Pancreatic Cancer",
|
404 |
+
"Acute Pancreatitis",
|
405 |
+
"Metastatic Pancreatic Cancer; Pancreatic Cancer",
|
406 |
+
"Pancreatic Cancer; Metastasis; Surgery; Oligometastatic Disease",
|
407 |
+
"Acinar Cell Adenocarcinoma of the Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Recurrent Pancreatic Cancer; Stage II Pancreatic Cancer; Stage III Pancreatic Cancer",
|
408 |
+
"Stage IV Pancreatic Cancer",
|
409 |
+
"Non-Resectable Pancreas Carcinoma",
|
410 |
+
"Locally Advanced Pancreatic Adenocarcinoma; Chemotherapy Effect; Borderline Resectable Pancreatic Adenocarcinoma; Pancreatectomy",
|
411 |
+
"Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Ductal Adenocarcinoma; Borderline Resectable Pancreatic Ductal Adenocarcinoma; Locally Advanced Pancreatic Ductal Adenocarcinoma",
|
412 |
+
"Pancreatic Cancer; Unresectable Pancreatic Cancer; Metastatic Pancreatic Cancer; KRAS P.G12C",
|
413 |
+
"Ductal Adenocarcinoma of Pancreas; Adenocarcinoma of Ampulla",
|
414 |
+
"Resectable Pancreatic Cancer",
|
415 |
+
"Pancreatic Carcinoma",
|
416 |
+
"Carcinoma, Pancreatic Ductal; Prognosis",
|
417 |
+
"Colorectal Cancer; Cancer of Pancreas; Pancreatic Neoplasm; Malignant Neoplasm of Large Intestine; Malignant Tumor of Colon; Colon Carcinoma; Cancer of Colon; Pancreatic Cancer",
|
418 |
+
"Cancer of Pancreas; Unresectable Pancreatic Cancer; Chemotherapy Effect; SBRT",
|
419 |
+
"Pancreatic Adenocarcinoma Treatment",
|
420 |
+
"Post-ERCP Acute Pancreatitis",
|
421 |
+
"Advanced Pancreatic Carcinoma",
|
422 |
+
"Pancreas Adenocarcinoma; Borderline Resectable Pancreatic Adenocarcinoma; Locally Advanced Pancreatic Adenocarcinoma",
|
423 |
+
"Gastric and Pancreatic Cancer",
|
424 |
+
"Pancreatic Ductal Adenocarcinoma (PDAC)",
|
425 |
+
"Pancreatic Neoplasms; Digestive System Neoplasms; Neoplasms by Site; Neoplasms; Endocrine Gland Neoplasms; Pancreatic Diseases; Digestive System Diseases; Endocrine System Diseases; Gemcitabine; Antimetabolites, Antineoplastic",
|
426 |
+
"Pancreatitis",
|
427 |
+
"Pancreatic Cancer; Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Adenocarcinoma",
|
428 |
+
"Pancreatic Cancer, Adult",
|
429 |
+
"Pancreatic Cancer; Metastatic Pancreatic Cancer"
|
430 |
+
],
|
431 |
+
"Skin": [
|
432 |
+
"Melanoma",
|
433 |
+
"Psoriasis",
|
434 |
+
"Atopic Dermatitis",
|
435 |
+
"Acne Vulgaris",
|
436 |
+
"Psoriasis Vulgaris",
|
437 |
+
"Malignant Melanoma",
|
438 |
+
"Metastatic Melanoma",
|
439 |
+
"Rosacea",
|
440 |
+
"Plaque Psoriasis",
|
441 |
+
"Head and Neck Squamous Cell Carcinoma",
|
442 |
+
"Esophageal Squamous Cell Carcinoma",
|
443 |
+
"Acne",
|
444 |
+
"Melanoma (Skin)",
|
445 |
+
"Basal Cell Carcinoma",
|
446 |
+
"Actinic Keratosis",
|
447 |
+
"Squamous Cell Carcinoma of the Head and Neck",
|
448 |
+
"Dermatitis, Atopic",
|
449 |
+
"Squamous Cell Carcinoma of Head and Neck",
|
450 |
+
"Chronic Plaque Psoriasis",
|
451 |
+
"Uveal Melanoma",
|
452 |
+
"Scalp Psoriasis",
|
453 |
+
"Head and Neck Squamous Cell Carcinoma (HNSCC)",
|
454 |
+
"Malignant Melanoma, Neoplasms",
|
455 |
+
"Melanoma Stage III; Melanoma Stage IV",
|
456 |
+
"Papulopustular Rosacea",
|
457 |
+
"Squamous Cell Carcinoma",
|
458 |
+
"Advanced Solid Tumor; Pancreatic Adenocarcinoma; Malignant Melanoma (Cutaneous); Non-small Cell Lung Cancer (NSCLC)",
|
459 |
+
"Skin and Connective Tissue Diseases",
|
460 |
+
"Malignant Melanoma Stage III",
|
461 |
+
"Melanoma with Brain Metastases",
|
462 |
+
"Locally Advanced Head and Neck Squamous Cell Carcinoma",
|
463 |
+
"Advanced Solid Tumors; Metastatic Melanoma",
|
464 |
+
"Skin Cancer",
|
465 |
+
"Atrophic Acne Scar",
|
466 |
+
"Moderate to Severe Plaque Psoriasis",
|
467 |
+
"Moderate-to-Severe Atopic Dermatitis",
|
468 |
+
"Esophageal Squamous Cell Carcinoma; Oligometastatic Disease; Radiotherapy",
|
469 |
+
"Dermatitis Atopic",
|
470 |
+
"Atopic Dermatitis (AD)",
|
471 |
+
"Non-Small Cell Lung Cancer; Carcinoma, Squamous Cell; Adenocarcinoma",
|
472 |
+
"Oral Squamous Cell Carcinoma",
|
473 |
+
"Solid Tumor; Non-Small Cell Lung Cancer; Head and Neck Cancer; Melanoma; Gastric Cancer; Renal Cell Carcinoma; Urothelial Carcinoma",
|
474 |
+
"Nail Psoriasis",
|
475 |
+
"Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC V8; Clinical Stage IV Cutaneous Melanoma AJCC V8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Renal Cell Carcinoma; Ovarian Carcinoma; Pathologic Stage III Cutaneous Melanoma AJCC V8; Pathologic Stage IIIA Cutaneous Melanoma AJCC V8; Pathologic Stage IIIB Cutaneous Melanoma AJCC V8; Pathologic Stage IIIC Cutaneous Melanoma AJCC V8; Pathologic Stage IIID Cutaneous Melanoma AJCC V8; Pathologic Stage IV Cutaneous Melanoma AJCC V8; Primary Peritoneal Carcinoma; Stage III Lung Cancer AJCC V8; Stage III Renal Cell Cancer AJCC V8; Stage IIIA Lung Cancer AJCC V8; Stage IIIB Lung Cancer AJCC V8; Stage IIIC Lung Cancer AJCC V8; Stage IV Lung Cancer AJCC V8; Stage IV Renal Cell Cancer AJCC V8; Stage IVA Lung Cancer AJCC V8; Stage IVB Lung Cancer AJCC V8; Triple-Negative Breast Carcinoma; Unresectable Lung Non-Small Cell Carcinoma; Unresectable Melanoma; Unresectable Renal Cell Carcinoma",
|
476 |
+
"Metastatic Malignant Neoplasm in the Brain; Metastatic Melanoma; Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7; Unresectable Melanoma",
|
477 |
+
"Advanced Melanoma",
|
478 |
+
"Psoriasis of Scalp",
|
479 |
+
"Malignant Melanoma of Soft Parts",
|
480 |
+
"Recurrent Melanoma; Stage IIIA Melanoma; Stage IIIB Melanoma; Stage IIIC Melanoma; Stage IV Melanoma",
|
481 |
+
"Melanoma; Skin Cancer",
|
482 |
+
"Metastatic Uveal Melanoma",
|
483 |
+
"Melanoma and Solid Tumors",
|
484 |
+
"Head and Neck Neoplasms; Carcinoma, Squamous Cell",
|
485 |
+
"Head and Neck Squamous Cell Cancer",
|
486 |
+
"Hand Eczema",
|
487 |
+
"Hypertrophic Scar",
|
488 |
+
"Metastatic Melanoma; Melanoma; BRAF-mutated Metastatic Melanoma; V600EBRAF-mutated Metastatic Melanoma",
|
489 |
+
"Metastatic NRAS Melanoma",
|
490 |
+
"Atopic Dermatitis; Eczema",
|
491 |
+
"Acne Rosacea",
|
492 |
+
"Neurodermatitis",
|
493 |
+
"BRAF v600 Mutated Metastatic Melanoma",
|
494 |
+
"Breast Cancer; Non-small Cell Lung Cancer; Melanoma; Brain Metastases",
|
495 |
+
"Acute Bacterial Skin and Skin Structure Infection",
|
496 |
+
"Chronic Hand Eczema",
|
497 |
+
"Eczema",
|
498 |
+
"Lung Adenocarcinoma and Squamous Cell Carcinoma",
|
499 |
+
"Advanced Esophageal Squamous Cell Carcinoma",
|
500 |
+
"Recurrent Melanoma; Stage IV Melanoma",
|
501 |
+
"Photodamaged Skin",
|
502 |
+
"Skin Rash with Lung Cancer",
|
503 |
+
"Esophagus Squamous Cell Carcinoma",
|
504 |
+
"Psoriasis Vulgaris; Psoriasis",
|
505 |
+
"Chronic Actinic Dermatitis",
|
506 |
+
"Advanced Non-squamous Cell Non-small Cell Lung Cancer",
|
507 |
+
"Metastatic Head and Neck Squamous Cell Carcinoma",
|
508 |
+
"Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma",
|
509 |
+
"Squamous Cell Lung Carcinoma"
|
510 |
+
],
|
511 |
+
"Uterus": [
|
512 |
+
"Endometrial Cancer",
|
513 |
+
"Endometriosis",
|
514 |
+
"Advanced Malignant Solid Neoplasm; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Malignant Solid Neoplasm; Malignant Female Reproductive System Neoplasm; Metastatic HER2-Negative Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Recurrent Endometrial Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Malignant Female Reproductive System Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Unresectable HER2-Negative Breast Carcinoma; Unresectable Malignant Solid Neoplasm",
|
515 |
+
"Endometrial Hyperplasia",
|
516 |
+
"Uterine Fibroids",
|
517 |
+
"Endometrial Carcinoma",
|
518 |
+
"Endometrial Neoplasms",
|
519 |
+
"Endometriosis-related Pain",
|
520 |
+
"Heavy Menstrual Bleeding; Uterine Fibroids",
|
521 |
+
"Dysfunctional Uterine Bleeding",
|
522 |
+
"Atypical Endometrial Hyperplasia",
|
523 |
+
"Uterine Disorders",
|
524 |
+
"Uterine Cervical Neoplasms",
|
525 |
+
"Infertility and Endometriosis",
|
526 |
+
"Advanced Endometrial Cancer",
|
527 |
+
"Chronic Endometritis",
|
528 |
+
"Stage I Endometrial Cancer",
|
529 |
+
"Endometrial Neoplasms with Fertility Preservation",
|
530 |
+
"Endometrium Cancer",
|
531 |
+
"Endometriosis with Pain",
|
532 |
+
"Breast Cancer; Advanced Breast Cancer; Metastatic Breast Cancer; Endometrial Cancer",
|
533 |
+
"Ovarian Cancer; Endometrial Cancer",
|
534 |
+
"PIK3CA Mutation; Solid Tumor, Adult; HER2-negative Breast Cancer; Breast Cancer; Metastatic Breast Cancer; Advanced Breast Cancer; Unresectable Solid Tumor; Endometrial Cancer",
|
535 |
+
"Intrauterine Growth Restriction",
|
536 |
+
"Lung Cancer; Solid Tumor; Gastric Cancer; Urothelial Cancer; Endometrial Cancer; Multiple Myeloma; Myeloproliferative Neoplasms; Breast Cancer; Cholangiocarcinoma; UC; MPN",
|
537 |
+
"Renal Cell Carcinoma; Ovarian Carcinoma; Thyroid Carcinoma; Breast Carcinoma; Endometrium Carcinoma"
|
538 |
+
],
|
539 |
+
"Breast": [
|
540 |
+
"Breast Cancer",
|
541 |
+
"Metastatic Breast Cancer",
|
542 |
+
"Breast Neoplasms",
|
543 |
+
"Advanced Breast Cancer",
|
544 |
+
"Triple Negative Breast Cancer",
|
545 |
+
"Breast Cancer Female",
|
546 |
+
"Breast Neoplasm",
|
547 |
+
"Neoplasms, Breast",
|
548 |
+
"Early Breast Cancer",
|
549 |
+
"HER2-positive Breast Cancer",
|
550 |
+
"Breast Cancer Metastatic",
|
551 |
+
"Female Breast Neoplasm",
|
552 |
+
"Triple-negative Breast Cancer",
|
553 |
+
"Breast Cancer; Metastatic Breast Cancer",
|
554 |
+
"Breast Cancer Stage IV",
|
555 |
+
"Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Prostate Carcinoma; Advanced Sarcoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Recurrent Adult Soft Tissue Sarcoma; Recurrent Breast Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Prostate Carcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8",
|
556 |
+
"Triple Negative Breast Neoplasms",
|
557 |
+
"Breast Carcinoma",
|
558 |
+
"Breast Cancer; HER2-positive Breast Cancer",
|
559 |
+
"Advanced Malignant Solid Neoplasm; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Malignant Solid Neoplasm; Malignant Female Reproductive System Neoplasm; Metastatic HER2-Negative Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Recurrent Endometrial Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Malignant Female Reproductive System Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Unresectable HER2-Negative Breast Carcinoma; Unresectable Malignant Solid Neoplasm",
|
560 |
+
"Breast Neoplasms with Metastasis",
|
561 |
+
"Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer",
|
562 |
+
"Triple-Negative Breast Cancer",
|
563 |
+
"Early-stage Breast Cancer",
|
564 |
+
"ER-Positive HER2-Negative Breast Cancer",
|
565 |
+
"Advanced or Metastatic Breast Cancer",
|
566 |
+
"Tubular Breast Cancer Stage II; Mucinous Breast Cancer Stage II; Breast Cancer Female NOS; Invasive Ductal Breast Cancer; Tubular Breast Cancer Stage III; HER-2 Positive Breast Cancer; Inflammatory Breast Cancer Stage IV; Inflammatory Breast Cancer",
|
567 |
+
"Breast and Ovarian Cancer",
|
568 |
+
"Multiple Cancers (Pancreatic, Lung, Esophagogastric, Colorectal, Breast)",
|
569 |
+
"Lactation and Breastfeeding with Drug Exposure",
|
570 |
+
"Metastatic ER-positive/HER2-negative Breast Cancer",
|
571 |
+
"Malignant Neoplasm of Breast",
|
572 |
+
"HR+/HER2- Locally Advanced, Metastatic Breast Cancer",
|
573 |
+
"Metastatic Breast Cancer; Advanced Breast Cancer; Quality of Life; Toxicity; Older Patients",
|
574 |
+
"Metastatic Breast Cancer; ER+ Breast Cancer; Advanced Breast Cancer",
|
575 |
+
"Advanced Breast Cancer; Metastatic Breast Cancer",
|
576 |
+
"Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer",
|
577 |
+
"Locally Advanced or Metastatic Breast Cancer",
|
578 |
+
"Locally Advanced (Inoperable) or Metastatic Breast Cancer",
|
579 |
+
"Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8",
|
580 |
+
"HER2 Positive Breast Cancer",
|
581 |
+
"HER2+ Breast Cancer",
|
582 |
+
"Advanced Metastatic Breast Cancer",
|
583 |
+
"HER2-positive Breast Cancer with Brain Metastases",
|
584 |
+
"HER2-positive Metastatic Breast Cancer",
|
585 |
+
"Hormone Receptor Positive Advanced Breast Cancer",
|
586 |
+
"Breast Neoplasms; Breast Cancer",
|
587 |
+
"Invasive Breast Cancer",
|
588 |
+
"Breast Neoplasms; Breast Cancer; Breast Tumors; Angiosarcoma; TNBC - Triple-Negative Breast Cancer; HER2-positive Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Hormone Receptor Negative Tumor; Early-stage Breast Cancer; Locally Advanced Breast Cancer",
|
589 |
+
"Early Stage Breast Cancer",
|
590 |
+
"Breast Cancer; Breast Neoplasms",
|
591 |
+
"Breast Cancer; Metastatic Cancer",
|
592 |
+
"Triple Negative Breast Cancer (TNBC)",
|
593 |
+
"Breast Cancer; Malignant Neoplasm of Breast",
|
594 |
+
"Triple-negative Breast Cancer; TNBC - Triple-Negative Breast Cancer",
|
595 |
+
"HR Positive HER2 Negative Advanced Breast Cancer",
|
596 |
+
"HR+/HER2- Advanced Breast Cancer; Targeted Therapy",
|
597 |
+
"Breastfeeding",
|
598 |
+
"HR+/HER2- Advanced/Metastatic Breast Cancer",
|
599 |
+
"Breast Cancer; Breast Cancer Stage IV; Metastatic Breast Cancer",
|
600 |
+
"Breast Cancer; Gynecologic Cancer; HNSCC; Solid Tumors, Adult",
|
601 |
+
"TNBC - Triple-Negative Breast Cancer",
|
602 |
+
"PIK3CA-Mutated Breast Cancer",
|
603 |
+
"HER-2 Positive Breast Cancer",
|
604 |
+
"Neoplasms; Breast Neoplasms",
|
605 |
+
"HER2-negative Breast Cancer",
|
606 |
+
"Carcinoma Breast Stage IV",
|
607 |
+
"Breast Cancer with Heart Failure",
|
608 |
+
"Breast Inflammatory Carcinoma; Locally Advanced Breast Carcinoma; Metastatic Breast Carcinoma; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Stage IV Breast Cancer AJCC v6 and v7",
|
609 |
+
"Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Invasive Breast Carcinoma; Locally Advanced HER2-Positive Breast Carcinoma; Metastatic HER2-Positive Breast Carcinoma; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8; Prognostic Stage IV Breast Cancer AJCC v8",
|
610 |
+
"Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC V8; Clinical Stage IV Cutaneous Melanoma AJCC V8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Renal Cell Carcinoma; Ovarian Carcinoma; Pathologic Stage III Cutaneous Melanoma AJCC V8; Pathologic Stage IIIA Cutaneous Melanoma AJCC V8; Pathologic Stage IIIB Cutaneous Melanoma AJCC V8; Pathologic Stage IIIC Cutaneous Melanoma AJCC V8; Pathologic Stage IIID Cutaneous Melanoma AJCC V8; Pathologic Stage IV Cutaneous Melanoma AJCC V8; Primary Peritoneal Carcinoma; Stage III Lung Cancer AJCC V8; Stage III Renal Cell Cancer AJCC V8; Stage IIIA Lung Cancer AJCC V8; Stage IIIB Lung Cancer AJCC V8; Stage IIIC Lung Cancer AJCC V8; Stage IV Lung Cancer AJCC V8; Stage IV Renal Cell Cancer AJCC V8; Stage IVA Lung Cancer AJCC V8; Stage IVB Lung Cancer AJCC V8; Triple-Negative Breast Carcinoma; Unresectable Lung Non-Small Cell Carcinoma; Unresectable Melanoma; Unresectable Renal Cell Carcinoma",
|
611 |
+
"Breast Cancer Stage II-III",
|
612 |
+
"Metastatic Breast Cancer; ER-positive Breast Cancer; Luminal B; Her2 Enriched; Basal Like",
|
613 |
+
"Metastatic HER2-negative Breast Cancer",
|
614 |
+
"Recurrent Breast Cancer",
|
615 |
+
"Breast Cancer; Osteoporosis",
|
616 |
+
"Hormone-Receptor Positive Breast Carcinoma",
|
617 |
+
"Breast Cancer, Familial Male; Radiotherapy; Complications; Chemotherapeutic Toxicity; Immune Checkpoint Inhibitor; CDK4/6 Inhibitor; Trastuzumab; Pertuzumab; PARP Inhibitor",
|
618 |
+
"ER+ HER2- Advanced Breast Cancer",
|
619 |
+
"Advanced Hormone Receptor Positive Breast Cancer",
|
620 |
+
"Advanced Breast Cancer; Female Breast Cancer",
|
621 |
+
"Breast Cancer Invasive",
|
622 |
+
"Metastatic Triple Negative Breast Cancer",
|
623 |
+
"Hormone Receptor Positive HER-2 Negative Breast Cancer",
|
624 |
+
"Hormone Receptor Positive Breast Cancer; Metastatic Breast Cancer; Hormone Receptor Negative Breast Cancer",
|
625 |
+
"Breast Neoplasm Malignant Female",
|
626 |
+
"HR+/HER2- Breast Cancer",
|
627 |
+
"Breast Cancer; HER2-positive Breast Cancer; ER Positive Breast Cancer; PR-Positive Breast Cancer",
|
628 |
+
"BREAST CANCER",
|
629 |
+
"Breast Cancer; Hormone Receptor Positive Tumor",
|
630 |
+
"Breast Cancer; Neoplasm Metastasis",
|
631 |
+
"Breast, Prostate, and Ovarian Cancers",
|
632 |
+
"Breast Cancer; Triple Negative Breast Cancer (TNBC); Early Stage Breast Cancer; Immunotherapy; Probiotic",
|
633 |
+
"Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer",
|
634 |
+
"HR-positive, HER2-negative Advanced Breast Cancer",
|
635 |
+
"Breast Cancer with Hand-Foot Syndrome",
|
636 |
+
"Metastatic ER+ Her2- Breast Cancer; Postmenopausal",
|
637 |
+
"Breast and Lung Cancer",
|
638 |
+
"HER2-positive Breast Cancer; Postmenopausal; Metastatic Breast Cancer",
|
639 |
+
"Breast Cancer; Metastatic Breast Cancer; Hormone Receptor-positive Breast Cancer; HER2-negative Breast Cancer",
|
640 |
+
"Breast Cancer with Neutropenia",
|
641 |
+
"Breast Cancer; Metastasis",
|
642 |
+
"Metastatic Breast Cancer; Breast Cancer",
|
643 |
+
"Metastatic Breast Cancer; ER Positive Breast Cancer; HER2-negative Breast Cancer",
|
644 |
+
"Metastatic Breast Cancer; Estrogen Receptor Positive Tumor; Breast Cancer Nos Premenopausal",
|
645 |
+
"Breast Cancer; Neoadjuvant Chemotherapy",
|
646 |
+
"Breast Cancer; Hormone Receptor-positive Breast Cancer; Hormone Therapy",
|
647 |
+
"Metastatic Breast Cancer; Locally Advanced Breast Cancer",
|
648 |
+
"Metastatic Castration-Resistant Prostate Cancer; Metastatic Breast Cancer; Non-small Cell Lung Cancer; Advanced Solid Tumors",
|
649 |
+
"HER2 Negative Breast Cancer",
|
650 |
+
"Geriatric Breast Cancer CDK4/6 Inhibitor Study",
|
651 |
+
"Breast Cancer; Non-small Cell Lung Cancer; Melanoma; Brain Metastases",
|
652 |
+
"HER2+ Metastatic Breast Cancer",
|
653 |
+
"HER-2 Positive Breast Cancer; Estrogen Receptor Positive Breast Cancer",
|
654 |
+
"Metastatic Breast Cancer; Locally Advanced Breast Cancer; Advanced Breast Cancer; BRCA2 Mutation; BRCA1 Mutation",
|
655 |
+
"Metastatic Breast Cancer; Recurrent Breast Cancer",
|
656 |
+
"Metastatic Breast Cancer; Tumor; Muscle Neoplasms; Chronic Pain",
|
657 |
+
"Breast Cancer; Neoplasms; Breast Diseases",
|
658 |
+
"Breast Cancer with Brain Metastases",
|
659 |
+
"Primary Breast Cancer",
|
660 |
+
"Hormone-receptor-positive HER2-negative Breast Cancer",
|
661 |
+
"Metastatic ER-Positive Breast Cancer",
|
662 |
+
"Stage IV Hormone Receptor Positive HER2 Negative Breast Cancer",
|
663 |
+
"Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer",
|
664 |
+
"Breast Cancer; Breast Neoplasm",
|
665 |
+
"Estrogen Receptor-positive Breast Cancer",
|
666 |
+
"Breast Cancer; Breast Carcinoma; Cancer of Breast; Malignant Tumor of Breast",
|
667 |
+
"Breast Cancer; Breast Carcinoma; Breast Neoplasms; Breast Tumors; Cancer of Breast",
|
668 |
+
"Breast Cancer Metastatic; Hormone Receptor Positive Malignant Neoplasm of Breast",
|
669 |
+
"Breast Cancer; Advanced Breast Cancer; Metastatic Breast Cancer; Endometrial Cancer",
|
670 |
+
"Advanced Breast and Ovarian Cancer",
|
671 |
+
"Breast Cancer Triple Negative",
|
672 |
+
"Breast Cancer (ER+/HER2-)",
|
673 |
+
"Hormone Receptor-positive Breast Cancer",
|
674 |
+
"Breast Cancer Adjuvant Therapy",
|
675 |
+
"Hormone Receptor-positive Metastatic Breast Cancer; HER2-negative Metastatic Breast Cancer",
|
676 |
+
"Advanced or Metastatic ER+ Breast Cancer",
|
677 |
+
"Breast Cancer, Metastatic Breast Cancer",
|
678 |
+
"Early Stage HER2+ Breast Cancer",
|
679 |
+
"Stage IV (Metastatic) Breast Cancer; Metastatic Breast Cancer; ER Positive Breast Cancer; PR-Positive Breast Cancer; HER2-negative Breast Cancer; Invasive Breast Cancer",
|
680 |
+
"Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer",
|
681 |
+
"Advanced Breast Cancer; Treatment; HR Low/HER2 Negative",
|
682 |
+
"Advanced HR+/HER2- Breast Cancer",
|
683 |
+
"Breast Cancer; Chemotherapy-induced Alopecia",
|
684 |
+
"Advanced Breast Cancer; Breast Cancer",
|
685 |
+
"PIK3CA Mutation; Solid Tumor, Adult; HER2-negative Breast Cancer; Breast Cancer; Metastatic Breast Cancer; Advanced Breast Cancer; Unresectable Solid Tumor; Endometrial Cancer",
|
686 |
+
"Lung Cancer; Solid Tumor; Gastric Cancer; Urothelial Cancer; Endometrial Cancer; Multiple Myeloma; Myeloproliferative Neoplasms; Breast Cancer; Cholangiocarcinoma; UC; MPN",
|
687 |
+
"Triple-Negative Breast Carcinoma",
|
688 |
+
"Breast Cancer; Cancer of Breast; Breast Neoplasms; Cancer of the Breast",
|
689 |
+
"Breast Cancer; Cancer",
|
690 |
+
"Renal Cell Carcinoma; Ovarian Carcinoma; Thyroid Carcinoma; Breast Carcinoma; Endometrium Carcinoma",
|
691 |
+
"Hormone Receptor-Positive Breast Cancer",
|
692 |
+
"Advanced/Metastatic Breast Cancer, HER2-Negative",
|
693 |
+
"Breast Cancer; Chemotherapy Effect",
|
694 |
+
"Early Stage Triple-Negative Breast Carcinoma",
|
695 |
+
"Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8; Metastatic Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain; Prognostic Stage IV Breast Cancer AJCC v8",
|
696 |
+
"Breast Adenocarcinoma; Estrogen Receptor Negative; HER2/Neu Negative; Progesterone Receptor Negative; Stage IB Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIC Breast Cancer; Triple-Negative Breast Carcinoma",
|
697 |
+
"Advanced Cancer; Metastatic Cancer; Non-Hodgkin's Lymphoma; Metastatic Breast Cancer; Malignant Mesothelioma; Non-small Cell Lung Cancer",
|
698 |
+
"Breast Cancer (Various Types and Stages)"
|
699 |
+
],
|
700 |
+
"Ovary/Fallopian Tube": [
|
701 |
+
"Ovarian Cancer",
|
702 |
+
"Polycystic Ovary Syndrome",
|
703 |
+
"Ovarian Neoplasms",
|
704 |
+
"Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer",
|
705 |
+
"Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer",
|
706 |
+
"Advanced Breast Carcinoma; Advanced Malignant Solid Neoplasm; Advanced Ovarian Carcinoma; Advanced Pancreatic Carcinoma; Advanced Prostate Carcinoma; Advanced Sarcoma; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Recurrent Adult Soft Tissue Sarcoma; Recurrent Breast Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Prostate Carcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Ovarian Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Ovarian Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8",
|
707 |
+
"Advanced Malignant Solid Neoplasm; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8; Locally Advanced Malignant Solid Neoplasm; Malignant Female Reproductive System Neoplasm; Metastatic HER2-Negative Breast Carcinoma; Metastatic Malignant Solid Neoplasm; Recurrent Endometrial Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Malignant Female Reproductive System Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Unresectable HER2-Negative Breast Carcinoma; Unresectable Malignant Solid Neoplasm",
|
708 |
+
"Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma",
|
709 |
+
"Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma",
|
710 |
+
"Breast and Ovarian Cancer",
|
711 |
+
"Relapsed Ovarian Cancer, BRCA Mutation, Platinum Sensitivity",
|
712 |
+
"Recurrent Ovarian Cancer",
|
713 |
+
"Ovarian Cancer; Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer; Platinum-resistant Ovarian Cancer",
|
714 |
+
"Ovary Cancer",
|
715 |
+
"Platinum-resistant Ovarian Cancer",
|
716 |
+
"Premature Ovarian Failure",
|
717 |
+
"Polycystic Ovary Syndrome (PCOS)",
|
718 |
+
"Polycystic Ovarian Syndrome",
|
719 |
+
"Ovarian and Related Carcinomas",
|
720 |
+
"Ovarian and Peritoneal Cancer",
|
721 |
+
"Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Neoplasms",
|
722 |
+
"Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC V8; Clinical Stage IV Cutaneous Melanoma AJCC V8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Renal Cell Carcinoma; Ovarian Carcinoma; Pathologic Stage III Cutaneous Melanoma AJCC V8; Pathologic Stage IIIA Cutaneous Melanoma AJCC V8; Pathologic Stage IIIB Cutaneous Melanoma AJCC V8; Pathologic Stage IIIC Cutaneous Melanoma AJCC V8; Pathologic Stage IIID Cutaneous Melanoma AJCC V8; Pathologic Stage IV Cutaneous Melanoma AJCC V8; Primary Peritoneal Carcinoma; Stage III Lung Cancer AJCC V8; Stage III Renal Cell Cancer AJCC V8; Stage IIIA Lung Cancer AJCC V8; Stage IIIB Lung Cancer AJCC V8; Stage IIIC Lung Cancer AJCC V8; Stage IV Lung Cancer AJCC V8; Stage IV Renal Cell Cancer AJCC V8; Stage IVA Lung Cancer AJCC V8; Stage IVB Lung Cancer AJCC V8; Triple-Negative Breast Carcinoma; Unresectable Lung Non-Small Cell Carcinoma; Unresectable Melanoma; Unresectable Renal Cell Carcinoma",
|
723 |
+
"Breast, Prostate, and Ovarian Cancers",
|
724 |
+
"Epithelial Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Ovarian Cancer",
|
725 |
+
"Epithelial Ovarian and Related Cancers",
|
726 |
+
"Platinum-resistant Ovarian Cancer; Platinum-refractory Ovarian Carcinoma; Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma",
|
727 |
+
"Advanced Breast and Ovarian Cancer",
|
728 |
+
"Advanced Ovarian Cancer",
|
729 |
+
"Primary Ovarian Insufficiency",
|
730 |
+
"Ovarian and Peritoneal Carcinoma",
|
731 |
+
"Ovarian Epithelial Cancer",
|
732 |
+
"Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer",
|
733 |
+
"Ovarian Cancer and Related Malignancies",
|
734 |
+
"Ovarian Cancer; Endometrial Cancer",
|
735 |
+
"Ovarian and Related Cancers",
|
736 |
+
"Renal Cell Carcinoma; Ovarian Carcinoma; Thyroid Carcinoma; Breast Carcinoma; Endometrium Carcinoma"
|
737 |
+
],
|
738 |
+
"Cervix": [
|
739 |
+
"Cervical Cancer",
|
740 |
+
"Advanced Cancer; Metastatic Cervical Cancer",
|
741 |
+
"Cervical Radiculopathy",
|
742 |
+
"Uterine Cervical Neoplasms",
|
743 |
+
"Cervical Pain",
|
744 |
+
"Cervical Intraepithelial Neoplasia"
|
745 |
+
],
|
746 |
+
"CNS/Brain": [
|
747 |
+
"Multiple Sclerosis",
|
748 |
+
"Parkinson Disease",
|
749 |
+
"Neuroblastoma",
|
750 |
+
"Parkinson's Disease",
|
751 |
+
"Stroke",
|
752 |
+
"Epilepsy",
|
753 |
+
"Amyotrophic Lateral Sclerosis",
|
754 |
+
"Ischemic Stroke",
|
755 |
+
"Alzheimer's Disease",
|
756 |
+
"Alzheimer Disease",
|
757 |
+
"Brain and Central Nervous System Tumors",
|
758 |
+
"Primary Central Nervous System Lymphoma",
|
759 |
+
"Cerebral Palsy",
|
760 |
+
"Relapsing-Remitting Multiple Sclerosis",
|
761 |
+
"Glioblastoma",
|
762 |
+
"Relapsing Remitting Multiple Sclerosis",
|
763 |
+
"Acute Ischemic Stroke",
|
764 |
+
"Hepatic Encephalopathy",
|
765 |
+
"Traumatic Brain Injury",
|
766 |
+
"Relapsing Multiple Sclerosis",
|
767 |
+
"Glioma",
|
768 |
+
"Dementia",
|
769 |
+
"Cerebrovascular Accident",
|
770 |
+
"Amyotrophic Lateral Sclerosis (ALS)",
|
771 |
+
"Glioblastoma Multiforme",
|
772 |
+
"Relapsing-remitting Multiple Sclerosis",
|
773 |
+
"Central Nervous System Lymphoma",
|
774 |
+
"Intracerebral Hemorrhage",
|
775 |
+
"Advanced Parkinson's Disease",
|
776 |
+
"Idiopathic Parkinson's Disease",
|
777 |
+
"Acute Stroke",
|
778 |
+
"Brain Tumors",
|
779 |
+
"Stroke with Atrial Fibrillation",
|
780 |
+
"Brain Tumors; Central Nervous System Tumors",
|
781 |
+
"Amyotrophic Lateral Sclerosis; ALS",
|
782 |
+
"Brain Metastases",
|
783 |
+
"Cerebral Infarction",
|
784 |
+
"Seizures",
|
785 |
+
"Alzheimer Disease; Preclinical Alzheimer's Disease; Prodromal Alzheimer's Disease; Alzheimer's Disease (Incl Subtypes); Mild Cognitive Impairment",
|
786 |
+
"Chronic Stroke",
|
787 |
+
"Atrial Fibrillation and Stroke",
|
788 |
+
"Atrial Fibrillation; Stroke; Bleeding",
|
789 |
+
"Progressive Multiple Sclerosis",
|
790 |
+
"Stroke Rehabilitation",
|
791 |
+
"Meningioma",
|
792 |
+
"Relapsing Forms of Multiple Sclerosis",
|
793 |
+
"Melanoma with Brain Metastases",
|
794 |
+
"Agitation in Patients With Dementia of the Alzheimer's Type",
|
795 |
+
"Neuroblastoma Recurrent",
|
796 |
+
"HER2-positive Breast Cancer with Brain Metastases",
|
797 |
+
"Glioblastoma Multiforme; Gliosarcoma",
|
798 |
+
"Relapsing-Remitting Multiple Sclerosis; Multiple Sclerosis",
|
799 |
+
"Alzheimer Disease and Dementia",
|
800 |
+
"Secondary Progressive Multiple Sclerosis",
|
801 |
+
"Primary CNS Lymphoma",
|
802 |
+
"Ganglioneuroblastoma; Neuroblastoma",
|
803 |
+
"Malignant Glioma",
|
804 |
+
"Toxoplasmosis, Cerebral; HIV Infections",
|
805 |
+
"Focal Epilepsy",
|
806 |
+
"Brain and Central Nervous System Conditions",
|
807 |
+
"Metastatic Malignant Neoplasm in the Brain; Metastatic Melanoma; Stage III Cutaneous Melanoma AJCC v7; Stage IIIA Cutaneous Melanoma AJCC v7; Stage IIIB Cutaneous Melanoma AJCC v7; Stage IIIC Cutaneous Melanoma AJCC v7; Stage IV Cutaneous Melanoma AJCC v6 and v7; Unresectable Melanoma",
|
808 |
+
"Brain Tumor",
|
809 |
+
"Diabetes Mellitus with Stroke",
|
810 |
+
"Adult Patients With Newly Diagnosed or Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL); Or Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)",
|
811 |
+
"Recurrent Glioblastoma",
|
812 |
+
"Glioblastoma, Adult",
|
813 |
+
"Glioblastoma; Recurrent Disease; Recurrent Glioblastoma",
|
814 |
+
"CVA (Cerebrovascular Accident); Stroke; Upper Extremity Paresis",
|
815 |
+
"CNS Embryonal Tumors",
|
816 |
+
"Malignant Gliomas",
|
817 |
+
"Low-Grade Glioma",
|
818 |
+
"CNS Lymphoma",
|
819 |
+
"Recurrent CNS Tumors",
|
820 |
+
"Multiple Sclerosis; Healthy",
|
821 |
+
"Neuroblastoma and Lymphoma",
|
822 |
+
"Non-Epileptic Seizures",
|
823 |
+
"Breast Cancer; Non-small Cell Lung Cancer; Melanoma; Brain Metastases",
|
824 |
+
"Transient Ischemic Attack and Minor Ischemic Stroke",
|
825 |
+
"Cerebrovascular Disease",
|
826 |
+
"Cerebrovascular Disorders",
|
827 |
+
"Brain Death",
|
828 |
+
"Recurrent Neuroblastoma; Stage 2A Neuroblastoma; Stage 2B Neuroblastoma; Stage 3 Neuroblastoma; Stage 4 Neuroblastoma; Stage 4S Neuroblastoma",
|
829 |
+
"Cerebral Small Vessel Disease",
|
830 |
+
"Epilepsy and Cognition Disorders",
|
831 |
+
"Breast Cancer with Brain Metastases",
|
832 |
+
"Gliomas and Neuroglial Tumors",
|
833 |
+
"Gliomas and Neuronal Tumors",
|
834 |
+
"Depression; Relapsing-remitting Multiple Sclerosis",
|
835 |
+
"Diffuse Intrinsic Pontine Glioma",
|
836 |
+
"Primary Progressive Multiple Sclerosis",
|
837 |
+
"Brain Neoplasms",
|
838 |
+
"Refractory or Recurrent Neuroblastoma in Children",
|
839 |
+
"Ganglioneuroblastoma, Nodular; Neuroblastoma",
|
840 |
+
"Pediatric Low-grade Glioma",
|
841 |
+
"Cerebrovascular and Cognitive Disorders",
|
842 |
+
"Stroke, Ischemic",
|
843 |
+
"Stroke, Cardiovascular",
|
844 |
+
"Stroke Patients",
|
845 |
+
"Early Onset Alzheimer Disease",
|
846 |
+
"Focal Onset Seizure",
|
847 |
+
"Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8; Metastatic Breast Carcinoma; Metastatic Malignant Neoplasm in the Brain; Prognostic Stage IV Breast Cancer AJCC v8",
|
848 |
+
"Recurrent or Progressive Glioblastoma",
|
849 |
+
"CNS Tumors and Neoplasms",
|
850 |
+
"Adult Malignant Gliomas",
|
851 |
+
"Parkinson Disease with Depression",
|
852 |
+
"Parkinsonian Signs in Older Persons",
|
853 |
+
"Huntington Disease",
|
854 |
+
"Leptomeningeal Metastasis"
|
855 |
+
],
|
856 |
+
|
857 |
+
"Liver": [
|
858 |
+
"Hepatocellular Carcinoma",
|
859 |
+
"Liver Cancer",
|
860 |
+
"Carcinoma, Hepatocellular",
|
861 |
+
"Hepatic Encephalopathy",
|
862 |
+
"Hepatitis C",
|
863 |
+
"Liver Transplantation",
|
864 |
+
"Biliary Tract Cancer",
|
865 |
+
"Chronic Hepatitis C",
|
866 |
+
"Cholangiocarcinoma",
|
867 |
+
"Hepatic Impairment",
|
868 |
+
"Chronic Hepatitis B",
|
869 |
+
"Primary Biliary Cirrhosis",
|
870 |
+
"Fatty Liver",
|
871 |
+
"Liver Cirrhosis",
|
872 |
+
"Hepatic Insufficiency",
|
873 |
+
"Alcoholic Hepatitis",
|
874 |
+
"Cirrhosis",
|
875 |
+
"Non-alcoholic Fatty Liver Disease",
|
876 |
+
"Advanced Hepatocellular Carcinoma",
|
877 |
+
"Intrahepatic Cholangiocarcinoma",
|
878 |
+
"Hepatocellular Carcinoma (HCC)",
|
879 |
+
"Colorectal Cancer; Liver Metastases",
|
880 |
+
"Hepatitis B",
|
881 |
+
"Hepatocellular Carcinoma Non-resectable",
|
882 |
+
"Liver Diseases",
|
883 |
+
"Liver Transplant",
|
884 |
+
"Chronic Hepatitis C Infection",
|
885 |
+
"Childhood Liver Malignancies",
|
886 |
+
"Non-Alcoholic Fatty Liver Disease",
|
887 |
+
"Primary Hepatocellular Carcinoma",
|
888 |
+
"Hepatoblastoma",
|
889 |
+
"Decompensated Cirrhosis",
|
890 |
+
"Nonalcoholic Steatohepatitis",
|
891 |
+
"Liver Disease",
|
892 |
+
"Advanced Biliary Tract Cancer",
|
893 |
+
"Biliary Tract Carcinoma",
|
894 |
+
"Biliary Tract Neoplasms",
|
895 |
+
"Liver Fibrosis",
|
896 |
+
"HIV and Hepatitis C Coinfection",
|
897 |
+
"Non-Alcoholic Steatohepatitis",
|
898 |
+
"Colorectal Cancer; Liver Metastasis",
|
899 |
+
"Colorectal Cancer with Liver Metastases",
|
900 |
+
"Liver Transplantation; Hepatocellular Carcinoma; Tumor Recurrence and Metastasis; Survival; Adjuvant Chemotherapy",
|
901 |
+
"Hepatic Carcinoma",
|
902 |
+
"Primary Biliary Cholangitis",
|
903 |
+
"Severe Alcoholic Hepatitis",
|
904 |
+
"Non-alcoholic Steatohepatitis",
|
905 |
+
"Hepatitis C Virus",
|
906 |
+
"Hepatopulmonary Syndrome",
|
907 |
+
"Unresectable Hepatocellular Carcinoma",
|
908 |
+
"Fatty Liver Disease",
|
909 |
+
"Decompensated Liver Cirrhosis",
|
910 |
+
"Metastatic Biliary Cancer",
|
911 |
+
"Biliary and Colorectal Neoplasms",
|
912 |
+
"Biliary Atresia",
|
913 |
+
"Metastatic Biliary Tract Cancer",
|
914 |
+
"Primary Sclerosing Cholangitis",
|
915 |
+
"Colon Cancer Liver Metastasis",
|
916 |
+
"Colorectal Cancer; Cholangiocarcinoma",
|
917 |
+
"Hepatitis",
|
918 |
+
"Non Small Cell Lung Cancer; Hepatitis B",
|
919 |
+
"Metabolic Associated Fatty Liver Disease",
|
920 |
+
"Chronic Hepatitis D",
|
921 |
+
"Moderate Hepatic Impairment",
|
922 |
+
"Hepatitis D",
|
923 |
+
"Metastatic Colorectal Cancer; Metastatic Cancer to Liver",
|
924 |
+
"Colorectal Cancer with Liver Metastasis",
|
925 |
+
"Colorectal Cancer; Colorectal Liver Metastases",
|
926 |
+
"HIV; Hepatitis C",
|
927 |
+
"Colorectal Cancer Metastatic; Liver Metastasis Colon Cancer",
|
928 |
+
"Biliary Tract Cancers",
|
929 |
+
"Primary Biliary Cholangitis (PBC)",
|
930 |
+
"Chronic Hepatitis C Virus",
|
931 |
+
"Chronic Hepatitis D Infection",
|
932 |
+
"Biliary Liver Cirrhosis",
|
933 |
+
"Metastatic Colon Cancer to Liver",
|
934 |
+
"Liver Lymphoma; Mantle Cell Lymphoma",
|
935 |
+
"Resected Liver Metastases From Colorectal Cancer",
|
936 |
+
"Advanced Malignant Neoplasm; Colorectal Carcinoma Metastatic in the Liver; Metastatic Malignant Neoplasm in the Liver; Refractory Malignant Neoplasm",
|
937 |
+
"Recurrent Hepatitis C",
|
938 |
+
"Advanced Biliary Tract Carcinoma",
|
939 |
+
"Drug-Induced Liver Injury (DILI)",
|
940 |
+
"Lung Cancer; Solid Tumor; Gastric Cancer; Urothelial Cancer; Endometrial Cancer; Multiple Myeloma; Myeloproliferative Neoplasms; Breast Cancer; Cholangiocarcinoma; UC; MPN",
|
941 |
+
"Chronic Drug-induced Liver Injury",
|
942 |
+
"Parenteral Nutrition Associated Liver Disease",
|
943 |
+
"Human Immunodeficiency Virus; Hepatitis B, Chronic; Hepatitis C, Chronic"
|
944 |
+
],
|
945 |
+
"Kidney": [
|
946 |
+
"Renal Cell Carcinoma",
|
947 |
+
"Carcinoma, Renal Cell",
|
948 |
+
"Kidney Transplantation",
|
949 |
+
"Chronic Kidney Disease",
|
950 |
+
"Metastatic Renal Cell Carcinoma",
|
951 |
+
"Kidney Cancer",
|
952 |
+
"Chronic Kidney Diseases",
|
953 |
+
"Renal Transplantation",
|
954 |
+
"Acute Kidney Injury",
|
955 |
+
"End Stage Renal Disease",
|
956 |
+
"Lupus Nephritis",
|
957 |
+
"Diabetic Nephropathy",
|
958 |
+
"Diabetic Nephropathies",
|
959 |
+
"Kidney Failure, Chronic",
|
960 |
+
"Renal Impairment",
|
961 |
+
"Renal Cell Cancer",
|
962 |
+
"Kidney Diseases",
|
963 |
+
"Advanced Renal Cell Carcinoma",
|
964 |
+
"Renal Failure",
|
965 |
+
"Kidney Transplant",
|
966 |
+
"Metastatic Renal Cell Carcinoma (mRCC)",
|
967 |
+
"Chronic Renal Failure",
|
968 |
+
"Kidney Neoplasms",
|
969 |
+
"Renal Insufficiency",
|
970 |
+
"Clear Cell Renal Cell Carcinoma",
|
971 |
+
"Renal Transplant",
|
972 |
+
"End-stage Renal Disease",
|
973 |
+
"Idiopathic Membranous Nephropathy",
|
974 |
+
"Chronic Renal Insufficiency",
|
975 |
+
"Type 2 Diabetes with Diabetic Nephropathy",
|
976 |
+
"Kidney Disease",
|
977 |
+
"Depression with Acute Kidney Injury",
|
978 |
+
"Chronic Kidney Disease With High Proteinuria",
|
979 |
+
"Chronic Kidney Disease and Hypertension",
|
980 |
+
"Secondary Hyperparathyroidism; Chronic Kidney Disease",
|
981 |
+
"Type 2 Diabetes; Diabetic Kidney Disease",
|
982 |
+
"Locally Advanced Papillary Renal Cell Carcinoma; Metastatic Papillary Renal Cell Carcinoma; Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7; Type 1 Papillary Renal Cell Carcinoma; Type 2 Papillary Renal Cell Carcinoma; Unresectable Renal Cell Carcinoma",
|
983 |
+
"Cardiovascular Events; Type2 Diabetes; Renal Disease",
|
984 |
+
"Solid Tumor; Non-Small Cell Lung Cancer; Head and Neck Cancer; Melanoma; Gastric Cancer; Renal Cell Carcinoma; Urothelial Carcinoma",
|
985 |
+
"Congenital Adrenal Hyperplasia",
|
986 |
+
"Glomerulonephritis",
|
987 |
+
"Membranous Glomerulonephritis",
|
988 |
+
"Nephrolithiasis",
|
989 |
+
"Nephrotic Syndrome",
|
990 |
+
"Advanced Malignant Solid Neoplasm; Clinical Stage III Cutaneous Melanoma AJCC V8; Clinical Stage IV Cutaneous Melanoma AJCC V8; Fallopian Tube Carcinoma; Metastatic Lung Non-Small Cell Carcinoma; Metastatic Malignant Solid Neoplasm; Metastatic Melanoma; Metastatic Renal Cell Carcinoma; Ovarian Carcinoma; Pathologic Stage III Cutaneous Melanoma AJCC V8; Pathologic Stage IIIA Cutaneous Melanoma AJCC V8; Pathologic Stage IIIB Cutaneous Melanoma AJCC V8; Pathologic Stage IIIC Cutaneous Melanoma AJCC V8; Pathologic Stage IIID Cutaneous Melanoma AJCC V8; Pathologic Stage IV Cutaneous Melanoma AJCC V8; Primary Peritoneal Carcinoma; Stage III Lung Cancer AJCC V8; Stage III Renal Cell Cancer AJCC V8; Stage IIIA Lung Cancer AJCC V8; Stage IIIB Lung Cancer AJCC V8; Stage IIIC Lung Cancer AJCC V8; Stage IV Lung Cancer AJCC V8; Stage IV Renal Cell Cancer AJCC V8; Stage IVA Lung Cancer AJCC V8; Stage IVB Lung Cancer AJCC V8; Triple-Negative Breast Carcinoma; Unresectable Lung Non-Small Cell Carcinoma; Unresectable Melanoma; Unresectable Renal Cell Carcinoma",
|
991 |
+
"Diabetic Nephropathy Type 2",
|
992 |
+
"Renal Colic",
|
993 |
+
"Renal Function",
|
994 |
+
"Primary Membranous Nephropathy",
|
995 |
+
"Chronic Kidney Failure and Transplantation",
|
996 |
+
"Heart Failure; Chronic Kidney Disease",
|
997 |
+
"ccRCC; RCC; Kidney Cancer; Clear Cell Renal Cell Carcinoma; Renal Cell Carcinoma",
|
998 |
+
"Clear Cell Metastatic Renal Cell Carcinoma",
|
999 |
+
"Clear-cell Metastatic Renal Cell Carcinoma",
|
1000 |
+
"Immunoglobulin A Nephropathy",
|
1001 |
+
"Metastatic Kidney Medullary Carcinoma; Metastatic Renal Cell Carcinoma; SMARCB1 Negative; Stage III Renal Cell Cancer AJCC V8; Stage IV Renal Cell Cancer AJCC V8",
|
1002 |
+
"Chronic Renal Disease",
|
1003 |
+
"Nephrotoxicity",
|
1004 |
+
"Nephropathic Cystinosis",
|
1005 |
+
"Metastatic Renal Cancer",
|
1006 |
+
"Secondary Hyperparathyroidism in End Stage Renal Disease",
|
1007 |
+
"Renal Pelvis and Ureter Urothelial Carcinoma",
|
1008 |
+
"Primary IgA Nephropathy",
|
1009 |
+
"Kidney Transplant Recipients",
|
1010 |
+
"Kidney Transplant Rejection",
|
1011 |
+
"End-stage Kidney Disease",
|
1012 |
+
"End-Stage Renal Disease",
|
1013 |
+
"Advanced Renal Cell Carcinoma; Metastatic Renal Cell Carcinoma",
|
1014 |
+
"Anemia of Chronic Kidney Disease",
|
1015 |
+
"Renal Cell Carcinoma; Ovarian Carcinoma; Thyroid Carcinoma; Breast Carcinoma; Endometrium Carcinoma",
|
1016 |
+
"Renal Cell Carcinoma; Kidney Cancer",
|
1017 |
+
"Renal Disease",
|
1018 |
+
"Chronic Kidney Failure",
|
1019 |
+
"Renal Cancer"
|
1020 |
+
],
|
1021 |
+
|
1022 |
+
"Peripheral Nervous System": [
|
1023 |
+
"Chemotherapy-induced Peripheral Neuropathy",
|
1024 |
+
"Peripheral Neuropathy",
|
1025 |
+
"Diabetic Peripheral Neuropathy",
|
1026 |
+
"Trigeminal Neuralgia",
|
1027 |
+
"Diabetic Neuropathy, Painful",
|
1028 |
+
"Peripheral Diabetic Neuropathy",
|
1029 |
+
"Diabetic Polyneuropathy",
|
1030 |
+
"Nonarteritic Anterior Ischemic Optic Neuropathy",
|
1031 |
+
"Chemotherapy Induced Peripheral Neuropathy",
|
1032 |
+
"Diabetic Neuropathy",
|
1033 |
+
"Painful Diabetic Neuropathy",
|
1034 |
+
"Optic Neuritis"
|
1035 |
+
],
|
1036 |
+
"Vulva/Vagina": [
|
1037 |
+
"Vaginal Disease"
|
1038 |
+
],
|
1039 |
+
"Bladder/Urinary Tract": [
|
1040 |
+
"Bladder Cancer",
|
1041 |
+
"Urothelial Carcinoma; Bladder Cancer; Urinary Bladder Neoplasms",
|
1042 |
+
"Urinary Tract Cancers",
|
1043 |
+
"Urothelial Carcinoma",
|
1044 |
+
"Overactive Bladder",
|
1045 |
+
"Urinary Bladder Neoplasms",
|
1046 |
+
"Urinary Tract Infection",
|
1047 |
+
"Urothelial Cancer",
|
1048 |
+
"Metastatic Urothelial Cancer",
|
1049 |
+
"Interstitial Cystitis",
|
1050 |
+
"Urinary Tract Infections",
|
1051 |
+
"Muscle Invasive Bladder Cancer; High Risk Urothelial Carcinoma of the Upper Urinary Tracts",
|
1052 |
+
"Gallbladder Neoplasms",
|
1053 |
+
"Non-Muscle Invasive Bladder Cancer",
|
1054 |
+
"Lower Urinary Tract Symptoms",
|
1055 |
+
"Solid Tumor; Non-Small Cell Lung Cancer; Head and Neck Cancer; Melanoma; Gastric Cancer; Renal Cell Carcinoma; Urothelial Carcinoma",
|
1056 |
+
"Non-Muscle Invasive Bladder Urothelial Carcinoma",
|
1057 |
+
"Non-muscle Invasive Bladder Cancer",
|
1058 |
+
"Bladder Urothelial Carcinoma",
|
1059 |
+
"Muscle Invasive Bladder Cancer",
|
1060 |
+
"Non-small Cell Lung Carcinoma; Urothelial Carcinoma; Gastrointestinal Carcinoma, Non-colon; Upper Aerodigestive Tract Carcinoma",
|
1061 |
+
"Upper Urinary Tract Urothelial Carcinoma",
|
1062 |
+
"Urethral Stricture",
|
1063 |
+
"Renal Pelvis and Ureter Urothelial Carcinoma",
|
1064 |
+
"Lung Cancer; Solid Tumor; Gastric Cancer; Urothelial Cancer; Endometrial Cancer; Multiple Myeloma; Myeloproliferative Neoplasms; Breast Cancer; Cholangiocarcinoma; UC; MPN"
|
1065 |
+
]
|
1066 |
+
|
1067 |
+
}
|
data/standardized_conditions.txt
ADDED
The diff for this file is too large to render.
See raw diff
|
|
data/tahoe_drugs_clinical_trials.csv
ADDED
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
1 |
+
version https://git-lfs.github.com/spec/v1
|
2 |
+
oid sha256:d2947165c10d719debd38bf07d9729beeba193d3e22a1f5072fb933c4bd2dabd
|
3 |
+
size 16008886
|
data/tahoe_drugs_drug_info.csv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
data/tahoe_drugs_pubchem_trials_info.csv
ADDED
@@ -0,0 +1,697 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
pubchem_id,source,has_trials,trial_count
|
2 |
+
165411828,EU Clinical Trials Register,True,2
|
3 |
+
387447,ClinicalTrials.gov,True,762
|
4 |
+
387447,EU Clinical Trials Register,True,212
|
5 |
+
387447,NIPH Clinical Trials Search of Japan,True,74
|
6 |
+
25183872,ClinicalTrials.gov,True,93
|
7 |
+
25183872,EU Clinical Trials Register,True,21
|
8 |
+
25183872,NIPH Clinical Trials Search of Japan,True,16
|
9 |
+
56844015,ClinicalTrials.gov,True,48
|
10 |
+
56844015,EU Clinical Trials Register,True,28
|
11 |
+
444972,ClinicalTrials.gov,True,2
|
12 |
+
444972,NIPH Clinical Trials Search of Japan,True,1
|
13 |
+
3657,ClinicalTrials.gov,True,172
|
14 |
+
3657,EU Clinical Trials Register,True,33
|
15 |
+
3657,NIPH Clinical Trials Search of Japan,True,3
|
16 |
+
9082,ClinicalTrials.gov,True,1
|
17 |
+
9082,EU Clinical Trials Register,True,5
|
18 |
+
11683005,ClinicalTrials.gov,True,10
|
19 |
+
11683005,NIPH Clinical Trials Search of Japan,True,1
|
20 |
+
135526609,EU Clinical Trials Register,True,13
|
21 |
+
135526609,NIPH Clinical Trials Search of Japan,True,1
|
22 |
+
204,ClinicalTrials.gov,True,1
|
23 |
+
204,EU Clinical Trials Register,True,2
|
24 |
+
3385,ClinicalTrials.gov,True,1327
|
25 |
+
3385,EU Clinical Trials Register,True,446
|
26 |
+
3385,NIPH Clinical Trials Search of Japan,True,47
|
27 |
+
10184665,ClinicalTrials.gov,True,27
|
28 |
+
10184665,EU Clinical Trials Register,True,23
|
29 |
+
10184665,NIPH Clinical Trials Search of Japan,True,7
|
30 |
+
14992,EU Clinical Trials Register,True,2
|
31 |
+
11672905,ClinicalTrials.gov,True,1
|
32 |
+
5564,ClinicalTrials.gov,True,10
|
33 |
+
5564,EU Clinical Trials Register,True,1
|
34 |
+
51082,ClinicalTrials.gov,True,121
|
35 |
+
51082,EU Clinical Trials Register,True,18
|
36 |
+
8813,ClinicalTrials.gov,True,23
|
37 |
+
8813,EU Clinical Trials Register,True,1
|
38 |
+
135398658,ClinicalTrials.gov,True,234
|
39 |
+
135398658,EU Clinical Trials Register,True,36
|
40 |
+
135398658,NIPH Clinical Trials Search of Japan,True,19
|
41 |
+
445154,ClinicalTrials.gov,True,125
|
42 |
+
445154,EU Clinical Trials Register,True,130
|
43 |
+
445154,NIPH Clinical Trials Search of Japan,True,7
|
44 |
+
107971,ClinicalTrials.gov,True,1
|
45 |
+
135410875,ClinicalTrials.gov,True,749
|
46 |
+
135410875,EU Clinical Trials Register,True,215
|
47 |
+
135410875,NIPH Clinical Trials Search of Japan,True,162
|
48 |
+
440936,ClinicalTrials.gov,True,1
|
49 |
+
440936,EU Clinical Trials Register,True,2
|
50 |
+
12136798,ClinicalTrials.gov,True,17
|
51 |
+
12136798,EU Clinical Trials Register,True,1
|
52 |
+
12136798,NIPH Clinical Trials Search of Japan,True,4
|
53 |
+
73053710,EU Clinical Trials Register,True,2
|
54 |
+
16760658,ClinicalTrials.gov,True,1
|
55 |
+
16760658,EU Clinical Trials Register,True,1
|
56 |
+
338,ClinicalTrials.gov,True,13
|
57 |
+
338,EU Clinical Trials Register,True,7
|
58 |
+
338,NIPH Clinical Trials Search of Japan,True,2
|
59 |
+
11219835,ClinicalTrials.gov,True,31
|
60 |
+
11219835,EU Clinical Trials Register,True,18
|
61 |
+
11219835,NIPH Clinical Trials Search of Japan,True,2
|
62 |
+
2812,ClinicalTrials.gov,True,26
|
63 |
+
2812,EU Clinical Trials Register,True,10
|
64 |
+
4614,ClinicalTrials.gov,True,1
|
65 |
+
6918638,ClinicalTrials.gov,True,49
|
66 |
+
6918638,EU Clinical Trials Register,True,10
|
67 |
+
2554,ClinicalTrials.gov,True,92
|
68 |
+
2554,EU Clinical Trials Register,True,21
|
69 |
+
2554,NIPH Clinical Trials Search of Japan,True,1
|
70 |
+
130956,ClinicalTrials.gov,True,4
|
71 |
+
130956,NIPH Clinical Trials Search of Japan,True,6
|
72 |
+
23582824,ClinicalTrials.gov,True,1
|
73 |
+
60750,ClinicalTrials.gov,True,1516
|
74 |
+
60750,EU Clinical Trials Register,True,426
|
75 |
+
60750,NIPH Clinical Trials Search of Japan,True,273
|
76 |
+
6253,ClinicalTrials.gov,True,996
|
77 |
+
6253,EU Clinical Trials Register,True,187
|
78 |
+
6253,NIPH Clinical Trials Search of Japan,True,37
|
79 |
+
6252,ClinicalTrials.gov,True,2
|
80 |
+
6252,EU Clinical Trials Register,True,3
|
81 |
+
6029,ClinicalTrials.gov,True,9
|
82 |
+
6029,NIPH Clinical Trials Search of Japan,True,1
|
83 |
+
71481097,ClinicalTrials.gov,True,148
|
84 |
+
71481097,EU Clinical Trials Register,True,25
|
85 |
+
3440,ClinicalTrials.gov,True,165
|
86 |
+
3440,EU Clinical Trials Register,True,42
|
87 |
+
3440,NIPH Clinical Trials Search of Japan,True,33
|
88 |
+
60961,ClinicalTrials.gov,True,59
|
89 |
+
60961,EU Clinical Trials Register,True,20
|
90 |
+
60961,NIPH Clinical Trials Search of Japan,True,4
|
91 |
+
9444,ClinicalTrials.gov,True,543
|
92 |
+
9444,EU Clinical Trials Register,True,115
|
93 |
+
9444,NIPH Clinical Trials Search of Japan,True,17
|
94 |
+
119182,ClinicalTrials.gov,True,142
|
95 |
+
119182,EU Clinical Trials Register,True,37
|
96 |
+
135401907,ClinicalTrials.gov,True,152
|
97 |
+
135401907,EU Clinical Trials Register,True,53
|
98 |
+
135401907,NIPH Clinical Trials Search of Japan,True,18
|
99 |
+
6256,ClinicalTrials.gov,True,5
|
100 |
+
6256,EU Clinical Trials Register,True,17
|
101 |
+
6256,NIPH Clinical Trials Search of Japan,True,5
|
102 |
+
446727,ClinicalTrials.gov,True,2
|
103 |
+
446727,EU Clinical Trials Register,True,3
|
104 |
+
5905,ClinicalTrials.gov,True,1
|
105 |
+
451668,ClinicalTrials.gov,True,316
|
106 |
+
451668,EU Clinical Trials Register,True,33
|
107 |
+
451668,NIPH Clinical Trials Search of Japan,True,3
|
108 |
+
70817911,ClinicalTrials.gov,True,1
|
109 |
+
46188928,ClinicalTrials.gov,True,15
|
110 |
+
46188928,EU Clinical Trials Register,True,2
|
111 |
+
46188928,NIPH Clinical Trials Search of Japan,True,1
|
112 |
+
67330085,ClinicalTrials.gov,True,5
|
113 |
+
23725625,ClinicalTrials.gov,True,368
|
114 |
+
23725625,EU Clinical Trials Register,True,131
|
115 |
+
23725625,NIPH Clinical Trials Search of Japan,True,29
|
116 |
+
49831257,ClinicalTrials.gov,True,51
|
117 |
+
49831257,EU Clinical Trials Register,True,28
|
118 |
+
49831257,NIPH Clinical Trials Search of Japan,True,4
|
119 |
+
9887053,ClinicalTrials.gov,True,1177
|
120 |
+
9887053,EU Clinical Trials Register,True,353
|
121 |
+
9887053,NIPH Clinical Trials Search of Japan,True,170
|
122 |
+
2754,ClinicalTrials.gov,True,117
|
123 |
+
2754,EU Clinical Trials Register,True,7
|
124 |
+
2754,NIPH Clinical Trials Search of Japan,True,51
|
125 |
+
10029385,ClinicalTrials.gov,True,3
|
126 |
+
16222096,ClinicalTrials.gov,True,100
|
127 |
+
16222096,EU Clinical Trials Register,True,30
|
128 |
+
16222096,NIPH Clinical Trials Search of Japan,True,1
|
129 |
+
72165228,ClinicalTrials.gov,True,22
|
130 |
+
72165228,EU Clinical Trials Register,True,8
|
131 |
+
72165228,NIPH Clinical Trials Search of Japan,True,3
|
132 |
+
25227436,ClinicalTrials.gov,True,47
|
133 |
+
25227436,EU Clinical Trials Register,True,17
|
134 |
+
25227436,NIPH Clinical Trials Search of Japan,True,5
|
135 |
+
33630,EU Clinical Trials Register,True,1
|
136 |
+
148195,ClinicalTrials.gov,True,31
|
137 |
+
148195,EU Clinical Trials Register,True,4
|
138 |
+
16362,ClinicalTrials.gov,True,8
|
139 |
+
16362,EU Clinical Trials Register,True,6
|
140 |
+
20179,ClinicalTrials.gov,True,11
|
141 |
+
20179,EU Clinical Trials Register,True,43
|
142 |
+
2435,ClinicalTrials.gov,True,25
|
143 |
+
2435,EU Clinical Trials Register,True,6
|
144 |
+
2435,NIPH Clinical Trials Search of Japan,True,6
|
145 |
+
11338033,ClinicalTrials.gov,True,2
|
146 |
+
71766360,ClinicalTrials.gov,True,2
|
147 |
+
58507717,ClinicalTrials.gov,True,10
|
148 |
+
58507717,EU Clinical Trials Register,True,5
|
149 |
+
10195250,ClinicalTrials.gov,True,1
|
150 |
+
10195250,EU Clinical Trials Register,True,1
|
151 |
+
6112,ClinicalTrials.gov,True,18
|
152 |
+
6112,EU Clinical Trials Register,True,1
|
153 |
+
6437836,ClinicalTrials.gov,True,1
|
154 |
+
6437836,NIPH Clinical Trials Search of Japan,True,1
|
155 |
+
4740,ClinicalTrials.gov,True,143
|
156 |
+
4740,EU Clinical Trials Register,True,20
|
157 |
+
1986,ClinicalTrials.gov,True,130
|
158 |
+
1986,EU Clinical Trials Register,True,16
|
159 |
+
1986,NIPH Clinical Trials Search of Japan,True,3
|
160 |
+
9562059,ClinicalTrials.gov,True,2
|
161 |
+
9562059,EU Clinical Trials Register,True,1
|
162 |
+
2244,ClinicalTrials.gov,True,877
|
163 |
+
2244,EU Clinical Trials Register,True,203
|
164 |
+
2244,NIPH Clinical Trials Search of Japan,True,95
|
165 |
+
9821849,ClinicalTrials.gov,True,181
|
166 |
+
9821849,EU Clinical Trials Register,True,65
|
167 |
+
9821849,NIPH Clinical Trials Search of Japan,True,4
|
168 |
+
23663985,ClinicalTrials.gov,True,2
|
169 |
+
23663985,NIPH Clinical Trials Search of Japan,True,4
|
170 |
+
158550,ClinicalTrials.gov,True,6
|
171 |
+
158550,EU Clinical Trials Register,True,63
|
172 |
+
185462,EU Clinical Trials Register,True,19
|
173 |
+
44462760,ClinicalTrials.gov,True,110
|
174 |
+
44462760,EU Clinical Trials Register,True,34
|
175 |
+
44462760,NIPH Clinical Trials Search of Japan,True,7
|
176 |
+
11570805,ClinicalTrials.gov,True,3
|
177 |
+
11570805,EU Clinical Trials Register,True,1
|
178 |
+
441243,ClinicalTrials.gov,True,55
|
179 |
+
441243,EU Clinical Trials Register,True,19
|
180 |
+
441243,NIPH Clinical Trials Search of Japan,True,1
|
181 |
+
9853654,ClinicalTrials.gov,True,1
|
182 |
+
9853654,EU Clinical Trials Register,True,1
|
183 |
+
2187,ClinicalTrials.gov,True,250
|
184 |
+
2187,EU Clinical Trials Register,True,74
|
185 |
+
2187,NIPH Clinical Trials Search of Japan,True,17
|
186 |
+
285033,ClinicalTrials.gov,True,28
|
187 |
+
285033,EU Clinical Trials Register,True,5
|
188 |
+
3397,ClinicalTrials.gov,True,56
|
189 |
+
3397,EU Clinical Trials Register,True,5
|
190 |
+
3397,NIPH Clinical Trials Search of Japan,True,6
|
191 |
+
451417,ClinicalTrials.gov,True,8
|
192 |
+
5493444,ClinicalTrials.gov,True,131
|
193 |
+
5493444,EU Clinical Trials Register,True,78
|
194 |
+
5493444,NIPH Clinical Trials Search of Japan,True,22
|
195 |
+
2520,ClinicalTrials.gov,True,64
|
196 |
+
2520,EU Clinical Trials Register,True,9
|
197 |
+
2520,NIPH Clinical Trials Search of Japan,True,1
|
198 |
+
170014,EU Clinical Trials Register,True,3
|
199 |
+
392622,ClinicalTrials.gov,True,402
|
200 |
+
392622,EU Clinical Trials Register,True,189
|
201 |
+
392622,NIPH Clinical Trials Search of Japan,True,5
|
202 |
+
16052011,ClinicalTrials.gov,True,98
|
203 |
+
16052011,EU Clinical Trials Register,True,30
|
204 |
+
16052011,NIPH Clinical Trials Search of Japan,True,11
|
205 |
+
72172,ClinicalTrials.gov,True,3
|
206 |
+
72172,NIPH Clinical Trials Search of Japan,True,1
|
207 |
+
50922675,ClinicalTrials.gov,True,78
|
208 |
+
50922675,EU Clinical Trials Register,True,34
|
209 |
+
50922675,NIPH Clinical Trials Search of Japan,True,5
|
210 |
+
126689157,ClinicalTrials.gov,True,6
|
211 |
+
126689157,EU Clinical Trials Register,True,1
|
212 |
+
45375953,ClinicalTrials.gov,True,44
|
213 |
+
45375953,EU Clinical Trials Register,True,6
|
214 |
+
11950170,ClinicalTrials.gov,True,23
|
215 |
+
104769,ClinicalTrials.gov,True,9
|
216 |
+
104769,EU Clinical Trials Register,True,10
|
217 |
+
67462786,ClinicalTrials.gov,True,37
|
218 |
+
67462786,EU Clinical Trials Register,True,7
|
219 |
+
67462786,NIPH Clinical Trials Search of Japan,True,4
|
220 |
+
3339,ClinicalTrials.gov,True,126
|
221 |
+
3339,EU Clinical Trials Register,True,40
|
222 |
+
3339,NIPH Clinical Trials Search of Japan,True,8
|
223 |
+
58282870,ClinicalTrials.gov,True,3
|
224 |
+
11626560,ClinicalTrials.gov,True,113
|
225 |
+
11626560,EU Clinical Trials Register,True,26
|
226 |
+
11626560,NIPH Clinical Trials Search of Japan,True,8
|
227 |
+
135413536,ClinicalTrials.gov,True,130
|
228 |
+
135413536,EU Clinical Trials Register,True,36
|
229 |
+
135413536,NIPH Clinical Trials Search of Japan,True,51
|
230 |
+
156419,ClinicalTrials.gov,True,56
|
231 |
+
156419,EU Clinical Trials Register,True,26
|
232 |
+
156419,NIPH Clinical Trials Search of Japan,True,10
|
233 |
+
156391,ClinicalTrials.gov,True,162
|
234 |
+
156391,EU Clinical Trials Register,True,30
|
235 |
+
156391,NIPH Clinical Trials Search of Japan,True,1
|
236 |
+
60490,ClinicalTrials.gov,True,15
|
237 |
+
60490,EU Clinical Trials Register,True,1
|
238 |
+
71616,ClinicalTrials.gov,True,104
|
239 |
+
71616,EU Clinical Trials Register,True,35
|
240 |
+
71616,NIPH Clinical Trials Search of Japan,True,6
|
241 |
+
5312125,ClinicalTrials.gov,True,31
|
242 |
+
5312125,EU Clinical Trials Register,True,5
|
243 |
+
5312125,NIPH Clinical Trials Search of Japan,True,26
|
244 |
+
67171867,ClinicalTrials.gov,True,82
|
245 |
+
67171867,EU Clinical Trials Register,True,20
|
246 |
+
67171867,NIPH Clinical Trials Search of Japan,True,5
|
247 |
+
2375,ClinicalTrials.gov,True,151
|
248 |
+
2375,EU Clinical Trials Register,True,28
|
249 |
+
2375,NIPH Clinical Trials Search of Japan,True,11
|
250 |
+
44093,ClinicalTrials.gov,True,33
|
251 |
+
44093,EU Clinical Trials Register,True,12
|
252 |
+
54755438,ClinicalTrials.gov,True,12
|
253 |
+
54755438,EU Clinical Trials Register,True,3
|
254 |
+
54755438,NIPH Clinical Trials Search of Japan,True,2
|
255 |
+
55245,ClinicalTrials.gov,True,131
|
256 |
+
55245,EU Clinical Trials Register,True,23
|
257 |
+
121408882,ClinicalTrials.gov,True,9
|
258 |
+
54704426,ClinicalTrials.gov,True,4
|
259 |
+
54704426,EU Clinical Trials Register,True,1
|
260 |
+
54704426,NIPH Clinical Trials Search of Japan,True,1
|
261 |
+
14982,ClinicalTrials.gov,True,8
|
262 |
+
14982,EU Clinical Trials Register,True,2
|
263 |
+
14982,NIPH Clinical Trials Search of Japan,True,3
|
264 |
+
656656,ClinicalTrials.gov,True,3
|
265 |
+
49846579,ClinicalTrials.gov,True,536
|
266 |
+
49846579,EU Clinical Trials Register,True,101
|
267 |
+
49846579,NIPH Clinical Trials Search of Japan,True,13
|
268 |
+
6480466,ClinicalTrials.gov,True,28
|
269 |
+
6480466,EU Clinical Trials Register,True,4
|
270 |
+
5311068,ClinicalTrials.gov,True,1057
|
271 |
+
5311068,EU Clinical Trials Register,True,57
|
272 |
+
5311068,NIPH Clinical Trials Search of Japan,True,63
|
273 |
+
56959,ClinicalTrials.gov,True,81
|
274 |
+
56959,EU Clinical Trials Register,True,19
|
275 |
+
92727,ClinicalTrials.gov,True,11
|
276 |
+
92727,EU Clinical Trials Register,True,79
|
277 |
+
119607,ClinicalTrials.gov,True,19
|
278 |
+
119607,EU Clinical Trials Register,True,1
|
279 |
+
23675320,EU Clinical Trials Register,True,3
|
280 |
+
24785956,EU Clinical Trials Register,True,4
|
281 |
+
5330286,ClinicalTrials.gov,True,302
|
282 |
+
5330286,EU Clinical Trials Register,True,71
|
283 |
+
5330286,NIPH Clinical Trials Search of Japan,True,9
|
284 |
+
444795,ClinicalTrials.gov,True,143
|
285 |
+
444795,EU Clinical Trials Register,True,25
|
286 |
+
22049997,ClinicalTrials.gov,True,14
|
287 |
+
22049997,EU Clinical Trials Register,True,5
|
288 |
+
24826799,ClinicalTrials.gov,True,56
|
289 |
+
24826799,EU Clinical Trials Register,True,29
|
290 |
+
24826799,NIPH Clinical Trials Search of Japan,True,7
|
291 |
+
16063245,ClinicalTrials.gov,True,4
|
292 |
+
24812758,ClinicalTrials.gov,True,119
|
293 |
+
24812758,EU Clinical Trials Register,True,24
|
294 |
+
24812758,NIPH Clinical Trials Search of Japan,True,40
|
295 |
+
46910592,ClinicalTrials.gov,True,2
|
296 |
+
51039094,ClinicalTrials.gov,True,53
|
297 |
+
51039094,EU Clinical Trials Register,True,10
|
298 |
+
51039094,NIPH Clinical Trials Search of Japan,True,6
|
299 |
+
11960271,ClinicalTrials.gov,True,1
|
300 |
+
6918837,ClinicalTrials.gov,True,130
|
301 |
+
6918837,EU Clinical Trials Register,True,27
|
302 |
+
6918837,NIPH Clinical Trials Search of Japan,True,2
|
303 |
+
104850,ClinicalTrials.gov,True,45
|
304 |
+
104850,EU Clinical Trials Register,True,32
|
305 |
+
14296,ClinicalTrials.gov,True,1
|
306 |
+
56649450,ClinicalTrials.gov,True,89
|
307 |
+
56649450,EU Clinical Trials Register,True,20
|
308 |
+
56649450,NIPH Clinical Trials Search of Japan,True,3
|
309 |
+
11707110,ClinicalTrials.gov,True,223
|
310 |
+
11707110,EU Clinical Trials Register,True,55
|
311 |
+
11707110,NIPH Clinical Trials Search of Japan,True,7
|
312 |
+
4463,ClinicalTrials.gov,True,123
|
313 |
+
4463,EU Clinical Trials Register,True,32
|
314 |
+
118598754,ClinicalTrials.gov,True,9
|
315 |
+
36314,ClinicalTrials.gov,True,2883
|
316 |
+
36314,EU Clinical Trials Register,True,594
|
317 |
+
36314,NIPH Clinical Trials Search of Japan,True,257
|
318 |
+
148124,ClinicalTrials.gov,True,1729
|
319 |
+
148124,EU Clinical Trials Register,True,471
|
320 |
+
148124,NIPH Clinical Trials Search of Japan,True,240
|
321 |
+
148123,ClinicalTrials.gov,True,2
|
322 |
+
148123,EU Clinical Trials Register,True,29
|
323 |
+
11256664,ClinicalTrials.gov,True,60
|
324 |
+
11256664,EU Clinical Trials Register,True,8
|
325 |
+
11256664,NIPH Clinical Trials Search of Japan,True,3
|
326 |
+
6989,ClinicalTrials.gov,True,2
|
327 |
+
6989,NIPH Clinical Trials Search of Japan,True,1
|
328 |
+
3463,ClinicalTrials.gov,True,34
|
329 |
+
3463,EU Clinical Trials Register,True,2
|
330 |
+
9966051,ClinicalTrials.gov,True,98
|
331 |
+
9966051,EU Clinical Trials Register,True,37
|
332 |
+
9966051,NIPH Clinical Trials Search of Japan,True,2
|
333 |
+
129073603,ClinicalTrials.gov,True,11
|
334 |
+
129073603,EU Clinical Trials Register,True,5
|
335 |
+
129073603,NIPH Clinical Trials Search of Japan,True,4
|
336 |
+
4055,ClinicalTrials.gov,True,2
|
337 |
+
2749,ClinicalTrials.gov,True,6
|
338 |
+
2749,EU Clinical Trials Register,True,12
|
339 |
+
4659569,ClinicalTrials.gov,True,26
|
340 |
+
4659569,EU Clinical Trials Register,True,7
|
341 |
+
4659569,NIPH Clinical Trials Search of Japan,True,1
|
342 |
+
2662,ClinicalTrials.gov,True,451
|
343 |
+
2662,EU Clinical Trials Register,True,62
|
344 |
+
2662,NIPH Clinical Trials Search of Japan,True,32
|
345 |
+
11557040,ClinicalTrials.gov,True,1
|
346 |
+
11557040,EU Clinical Trials Register,True,77
|
347 |
+
25022378,ClinicalTrials.gov,True,12
|
348 |
+
25022378,EU Clinical Trials Register,True,28
|
349 |
+
25022378,NIPH Clinical Trials Search of Japan,True,2
|
350 |
+
44241743,ClinicalTrials.gov,True,9
|
351 |
+
44241743,EU Clinical Trials Register,True,8
|
352 |
+
82146,ClinicalTrials.gov,True,32
|
353 |
+
82146,EU Clinical Trials Register,True,5
|
354 |
+
82146,NIPH Clinical Trials Search of Japan,True,6
|
355 |
+
52920501,ClinicalTrials.gov,True,62
|
356 |
+
52920501,EU Clinical Trials Register,True,3
|
357 |
+
52920501,NIPH Clinical Trials Search of Japan,True,1
|
358 |
+
135398745,ClinicalTrials.gov,True,313
|
359 |
+
135398745,EU Clinical Trials Register,True,78
|
360 |
+
135398745,NIPH Clinical Trials Search of Japan,True,35
|
361 |
+
135151360,ClinicalTrials.gov,True,1
|
362 |
+
135151360,EU Clinical Trials Register,True,1
|
363 |
+
19090,ClinicalTrials.gov,True,6
|
364 |
+
19090,EU Clinical Trials Register,True,3
|
365 |
+
12108541,EU Clinical Trials Register,True,9
|
366 |
+
4594,ClinicalTrials.gov,True,284
|
367 |
+
4594,EU Clinical Trials Register,True,64
|
368 |
+
4594,NIPH Clinical Trials Search of Japan,True,36
|
369 |
+
67517580,EU Clinical Trials Register,True,2
|
370 |
+
54677470,ClinicalTrials.gov,True,77
|
371 |
+
54677470,EU Clinical Trials Register,True,3
|
372 |
+
54677470,NIPH Clinical Trials Search of Japan,True,9
|
373 |
+
1054,ClinicalTrials.gov,True,37
|
374 |
+
1054,EU Clinical Trials Register,True,2
|
375 |
+
1054,NIPH Clinical Trials Search of Japan,True,3
|
376 |
+
6019,ClinicalTrials.gov,True,14
|
377 |
+
6019,EU Clinical Trials Register,True,4
|
378 |
+
6019,NIPH Clinical Trials Search of Japan,True,1
|
379 |
+
28061,ClinicalTrials.gov,True,5
|
380 |
+
28061,EU Clinical Trials Register,True,2
|
381 |
+
135400182,ClinicalTrials.gov,True,33
|
382 |
+
135400182,EU Clinical Trials Register,True,3
|
383 |
+
31307,ClinicalTrials.gov,True,85
|
384 |
+
31307,EU Clinical Trials Register,True,17
|
385 |
+
31307,NIPH Clinical Trials Search of Japan,True,10
|
386 |
+
68873,ClinicalTrials.gov,True,13
|
387 |
+
68873,EU Clinical Trials Register,True,24
|
388 |
+
68873,NIPH Clinical Trials Search of Japan,True,1
|
389 |
+
443872,ClinicalTrials.gov,True,96
|
390 |
+
443872,EU Clinical Trials Register,True,29
|
391 |
+
443872,NIPH Clinical Trials Search of Japan,True,24
|
392 |
+
57363,ClinicalTrials.gov,True,52
|
393 |
+
57363,EU Clinical Trials Register,True,8
|
394 |
+
57363,NIPH Clinical Trials Search of Japan,True,2
|
395 |
+
104741,ClinicalTrials.gov,True,368
|
396 |
+
104741,EU Clinical Trials Register,True,84
|
397 |
+
104741,NIPH Clinical Trials Search of Japan,True,20
|
398 |
+
10621,ClinicalTrials.gov,True,13
|
399 |
+
10621,NIPH Clinical Trials Search of Japan,True,5
|
400 |
+
441207,ClinicalTrials.gov,True,3
|
401 |
+
441207,EU Clinical Trials Register,True,2
|
402 |
+
443939,ClinicalTrials.gov,True,664
|
403 |
+
443939,EU Clinical Trials Register,True,196
|
404 |
+
443939,NIPH Clinical Trials Search of Japan,True,1
|
405 |
+
65348,ClinicalTrials.gov,True,88
|
406 |
+
65348,EU Clinical Trials Register,True,38
|
407 |
+
636362,ClinicalTrials.gov,True,9
|
408 |
+
636362,EU Clinical Trials Register,True,15
|
409 |
+
163659,ClinicalTrials.gov,True,3
|
410 |
+
6436173,ClinicalTrials.gov,True,149
|
411 |
+
6436173,EU Clinical Trials Register,True,33
|
412 |
+
6436173,NIPH Clinical Trials Search of Japan,True,10
|
413 |
+
54684461,ClinicalTrials.gov,True,17
|
414 |
+
54684461,EU Clinical Trials Register,True,9
|
415 |
+
3000226,ClinicalTrials.gov,True,6
|
416 |
+
3000226,EU Clinical Trials Register,True,12
|
417 |
+
24788740,ClinicalTrials.gov,True,54
|
418 |
+
24788740,EU Clinical Trials Register,True,19
|
419 |
+
24788740,NIPH Clinical Trials Search of Japan,True,6
|
420 |
+
6279,ClinicalTrials.gov,True,74
|
421 |
+
6279,EU Clinical Trials Register,True,10
|
422 |
+
6279,NIPH Clinical Trials Search of Japan,True,3
|
423 |
+
16923,ClinicalTrials.gov,True,4
|
424 |
+
16923,EU Clinical Trials Register,True,9
|
425 |
+
5743,ClinicalTrials.gov,True,2246
|
426 |
+
5743,EU Clinical Trials Register,True,487
|
427 |
+
5743,NIPH Clinical Trials Search of Japan,True,197
|
428 |
+
3000518,ClinicalTrials.gov,True,8
|
429 |
+
6917864,ClinicalTrials.gov,True,79
|
430 |
+
6917864,EU Clinical Trials Register,True,3
|
431 |
+
68911,ClinicalTrials.gov,True,9
|
432 |
+
5284616,ClinicalTrials.gov,True,519
|
433 |
+
5284616,EU Clinical Trials Register,True,105
|
434 |
+
5284616,NIPH Clinical Trials Search of Japan,True,30
|
435 |
+
6918289,ClinicalTrials.gov,True,188
|
436 |
+
6918289,EU Clinical Trials Register,True,45
|
437 |
+
6918289,NIPH Clinical Trials Search of Japan,True,1
|
438 |
+
6442177,ClinicalTrials.gov,True,667
|
439 |
+
6442177,EU Clinical Trials Register,True,263
|
440 |
+
6442177,NIPH Clinical Trials Search of Japan,True,23
|
441 |
+
9926791,ClinicalTrials.gov,True,180
|
442 |
+
9926791,EU Clinical Trials Register,True,56
|
443 |
+
9926791,NIPH Clinical Trials Search of Japan,True,12
|
444 |
+
10174505,ClinicalTrials.gov,True,8
|
445 |
+
10174505,EU Clinical Trials Register,True,56
|
446 |
+
24775005,ClinicalTrials.gov,True,39
|
447 |
+
24775005,EU Clinical Trials Register,True,14
|
448 |
+
25262965,ClinicalTrials.gov,True,5
|
449 |
+
25262965,EU Clinical Trials Register,True,1
|
450 |
+
118869362,ClinicalTrials.gov,True,10
|
451 |
+
118869362,EU Clinical Trials Register,True,1
|
452 |
+
32798,ClinicalTrials.gov,True,39
|
453 |
+
32798,EU Clinical Trials Register,True,27
|
454 |
+
32798,NIPH Clinical Trials Search of Japan,True,3
|
455 |
+
21800,ClinicalTrials.gov,True,18
|
456 |
+
21800,EU Clinical Trials Register,True,27
|
457 |
+
21800,NIPH Clinical Trials Search of Japan,True,1
|
458 |
+
468595,ClinicalTrials.gov,True,57
|
459 |
+
468595,EU Clinical Trials Register,True,29
|
460 |
+
16759173,ClinicalTrials.gov,True,17
|
461 |
+
16759173,EU Clinical Trials Register,True,11
|
462 |
+
16759173,NIPH Clinical Trials Search of Japan,True,1
|
463 |
+
6321424,ClinicalTrials.gov,True,151
|
464 |
+
6321424,EU Clinical Trials Register,True,24
|
465 |
+
6321424,NIPH Clinical Trials Search of Japan,True,5
|
466 |
+
60699,ClinicalTrials.gov,True,153
|
467 |
+
60699,EU Clinical Trials Register,True,41
|
468 |
+
5388983,ClinicalTrials.gov,True,59
|
469 |
+
5388983,EU Clinical Trials Register,True,19
|
470 |
+
249332,ClinicalTrials.gov,True,444
|
471 |
+
249332,EU Clinical Trials Register,True,62
|
472 |
+
249332,NIPH Clinical Trials Search of Japan,True,1
|
473 |
+
9827599,ClinicalTrials.gov,True,6
|
474 |
+
9827599,EU Clinical Trials Register,True,42
|
475 |
+
9827599,NIPH Clinical Trials Search of Japan,True,1
|
476 |
+
67501411,ClinicalTrials.gov,True,4
|
477 |
+
67501411,NIPH Clinical Trials Search of Japan,True,4
|
478 |
+
60838,ClinicalTrials.gov,True,623
|
479 |
+
60838,EU Clinical Trials Register,True,250
|
480 |
+
60838,NIPH Clinical Trials Search of Japan,True,151
|
481 |
+
74990,ClinicalTrials.gov,True,318
|
482 |
+
74990,EU Clinical Trials Register,True,106
|
483 |
+
74990,NIPH Clinical Trials Search of Japan,True,4
|
484 |
+
46926350,ClinicalTrials.gov,True,18
|
485 |
+
46926350,EU Clinical Trials Register,True,1
|
486 |
+
4829,ClinicalTrials.gov,True,361
|
487 |
+
4829,EU Clinical Trials Register,True,97
|
488 |
+
4829,NIPH Clinical Trials Search of Japan,True,61
|
489 |
+
10461508,ClinicalTrials.gov,True,23
|
490 |
+
10461508,EU Clinical Trials Register,True,6
|
491 |
+
10461508,NIPH Clinical Trials Search of Japan,True,1
|
492 |
+
5284373,ClinicalTrials.gov,True,606
|
493 |
+
5284373,EU Clinical Trials Register,True,165
|
494 |
+
5284373,NIPH Clinical Trials Search of Japan,True,30
|
495 |
+
12560,ClinicalTrials.gov,True,58
|
496 |
+
12560,EU Clinical Trials Register,True,20
|
497 |
+
12560,NIPH Clinical Trials Search of Japan,True,3
|
498 |
+
3033819,ClinicalTrials.gov,True,2
|
499 |
+
3033819,EU Clinical Trials Register,True,21
|
500 |
+
441313,ClinicalTrials.gov,True,5
|
501 |
+
441313,EU Clinical Trials Register,True,12
|
502 |
+
135398744,ClinicalTrials.gov,True,262
|
503 |
+
135398744,EU Clinical Trials Register,True,52
|
504 |
+
135398744,NIPH Clinical Trials Search of Japan,True,7
|
505 |
+
5281004,ClinicalTrials.gov,True,230
|
506 |
+
5281004,EU Clinical Trials Register,True,154
|
507 |
+
5281004,NIPH Clinical Trials Search of Japan,True,31
|
508 |
+
445639,ClinicalTrials.gov,True,8
|
509 |
+
445639,NIPH Clinical Trials Search of Japan,True,3
|
510 |
+
107969,ClinicalTrials.gov,True,25
|
511 |
+
107969,EU Clinical Trials Register,True,52
|
512 |
+
21585658,ClinicalTrials.gov,True,76
|
513 |
+
21585658,EU Clinical Trials Register,True,34
|
514 |
+
21585658,NIPH Clinical Trials Search of Japan,True,5
|
515 |
+
3034010,ClinicalTrials.gov,True,44
|
516 |
+
3034010,EU Clinical Trials Register,True,11
|
517 |
+
3034010,NIPH Clinical Trials Search of Japan,True,1
|
518 |
+
117965,ClinicalTrials.gov,True,14
|
519 |
+
117965,EU Clinical Trials Register,True,83
|
520 |
+
117965,NIPH Clinical Trials Search of Japan,True,2
|
521 |
+
4922,ClinicalTrials.gov,True,6
|
522 |
+
4922,EU Clinical Trials Register,True,2
|
523 |
+
6918111,ClinicalTrials.gov,True,6
|
524 |
+
6918111,EU Clinical Trials Register,True,82
|
525 |
+
6918111,NIPH Clinical Trials Search of Japan,True,1
|
526 |
+
16004692,ClinicalTrials.gov,True,52
|
527 |
+
16004692,EU Clinical Trials Register,True,29
|
528 |
+
16004692,NIPH Clinical Trials Search of Japan,True,6
|
529 |
+
42611257,ClinicalTrials.gov,True,133
|
530 |
+
42611257,EU Clinical Trials Register,True,44
|
531 |
+
42611257,NIPH Clinical Trials Search of Japan,True,2
|
532 |
+
6314,ClinicalTrials.gov,True,85
|
533 |
+
6314,EU Clinical Trials Register,True,43
|
534 |
+
6314,NIPH Clinical Trials Search of Japan,True,11
|
535 |
+
5329102,ClinicalTrials.gov,True,247
|
536 |
+
5329102,EU Clinical Trials Register,True,122
|
537 |
+
5329102,NIPH Clinical Trials Search of Japan,True,16
|
538 |
+
66068,EU Clinical Trials Register,True,1
|
539 |
+
10180,ClinicalTrials.gov,True,2
|
540 |
+
164726578,ClinicalTrials.gov,True,7
|
541 |
+
86705695,ClinicalTrials.gov,True,43
|
542 |
+
86705695,EU Clinical Trials Register,True,16
|
543 |
+
86705695,NIPH Clinical Trials Search of Japan,True,7
|
544 |
+
53235510,ClinicalTrials.gov,True,27
|
545 |
+
53235510,EU Clinical Trials Register,True,8
|
546 |
+
53235510,NIPH Clinical Trials Search of Japan,True,1
|
547 |
+
46220502,ClinicalTrials.gov,True,198
|
548 |
+
46220502,EU Clinical Trials Register,True,39
|
549 |
+
46220502,NIPH Clinical Trials Search of Japan,True,15
|
550 |
+
5311027,ClinicalTrials.gov,True,40
|
551 |
+
5311027,EU Clinical Trials Register,True,32
|
552 |
+
5311027,NIPH Clinical Trials Search of Japan,True,7
|
553 |
+
6918132,ClinicalTrials.gov,True,13
|
554 |
+
6918132,EU Clinical Trials Register,True,17
|
555 |
+
6918132,NIPH Clinical Trials Search of Japan,True,4
|
556 |
+
5381,ClinicalTrials.gov,True,32
|
557 |
+
5381,EU Clinical Trials Register,True,12
|
558 |
+
9915743,ClinicalTrials.gov,True,78
|
559 |
+
9915743,EU Clinical Trials Register,True,20
|
560 |
+
67307512,ClinicalTrials.gov,True,4
|
561 |
+
67307512,EU Clinical Trials Register,True,3
|
562 |
+
9887712,ClinicalTrials.gov,True,446
|
563 |
+
9887712,EU Clinical Trials Register,True,134
|
564 |
+
9887712,NIPH Clinical Trials Search of Japan,True,84
|
565 |
+
24906252,ClinicalTrials.gov,True,2
|
566 |
+
24906252,EU Clinical Trials Register,True,44
|
567 |
+
24906252,NIPH Clinical Trials Search of Japan,True,1
|
568 |
+
24199313,EU Clinical Trials Register,True,1
|
569 |
+
16124208,ClinicalTrials.gov,True,2
|
570 |
+
71420,ClinicalTrials.gov,True,6
|
571 |
+
71420,EU Clinical Trials Register,True,1
|
572 |
+
71420,NIPH Clinical Trials Search of Japan,True,1
|
573 |
+
44631912,ClinicalTrials.gov,True,146
|
574 |
+
44631912,EU Clinical Trials Register,True,42
|
575 |
+
44631912,NIPH Clinical Trials Search of Japan,True,1
|
576 |
+
2123,ClinicalTrials.gov,True,1
|
577 |
+
54680690,ClinicalTrials.gov,True,2
|
578 |
+
10184653,ClinicalTrials.gov,True,168
|
579 |
+
10184653,EU Clinical Trials Register,True,51
|
580 |
+
10184653,NIPH Clinical Trials Search of Japan,True,44
|
581 |
+
10348973,ClinicalTrials.gov,True,44
|
582 |
+
10348973,EU Clinical Trials Register,True,8
|
583 |
+
10348973,NIPH Clinical Trials Search of Japan,True,8
|
584 |
+
77995,ClinicalTrials.gov,True,11
|
585 |
+
77995,EU Clinical Trials Register,True,16
|
586 |
+
3100,ClinicalTrials.gov,True,137
|
587 |
+
3100,EU Clinical Trials Register,True,3
|
588 |
+
3100,NIPH Clinical Trials Search of Japan,True,7
|
589 |
+
126941,ClinicalTrials.gov,True,1230
|
590 |
+
126941,EU Clinical Trials Register,True,248
|
591 |
+
126941,NIPH Clinical Trials Search of Japan,True,44
|
592 |
+
3045381,EU Clinical Trials Register,True,31
|
593 |
+
3045381,NIPH Clinical Trials Search of Japan,True,1
|
594 |
+
77999,ClinicalTrials.gov,True,142
|
595 |
+
77999,EU Clinical Trials Register,True,27
|
596 |
+
54676228,ClinicalTrials.gov,True,16
|
597 |
+
54676228,EU Clinical Trials Register,True,4
|
598 |
+
44582816,ClinicalTrials.gov,True,10
|
599 |
+
44582816,EU Clinical Trials Register,True,1
|
600 |
+
10288191,ClinicalTrials.gov,True,115
|
601 |
+
10288191,EU Clinical Trials Register,True,39
|
602 |
+
10288191,NIPH Clinical Trials Search of Japan,True,4
|
603 |
+
24963252,ClinicalTrials.gov,True,3
|
604 |
+
65628,ClinicalTrials.gov,True,245
|
605 |
+
65628,EU Clinical Trials Register,True,66
|
606 |
+
65628,NIPH Clinical Trials Search of Japan,True,21
|
607 |
+
110635,ClinicalTrials.gov,True,193
|
608 |
+
110635,EU Clinical Trials Register,True,47
|
609 |
+
110635,NIPH Clinical Trials Search of Japan,True,32
|
610 |
+
3081361,ClinicalTrials.gov,True,97
|
611 |
+
3081361,EU Clinical Trials Register,True,30
|
612 |
+
3081361,NIPH Clinical Trials Search of Japan,True,4
|
613 |
+
25166913,ClinicalTrials.gov,True,26
|
614 |
+
25166913,EU Clinical Trials Register,True,9
|
615 |
+
10206,ClinicalTrials.gov,True,1
|
616 |
+
10206,NIPH Clinical Trials Search of Japan,True,1
|
617 |
+
5459308,ClinicalTrials.gov,True,1
|
618 |
+
138611145,ClinicalTrials.gov,True,30
|
619 |
+
138611145,EU Clinical Trials Register,True,4
|
620 |
+
25141092,ClinicalTrials.gov,True,35
|
621 |
+
25141092,EU Clinical Trials Register,True,11
|
622 |
+
25141092,NIPH Clinical Trials Search of Japan,True,4
|
623 |
+
25145656,ClinicalTrials.gov,True,50
|
624 |
+
25145656,EU Clinical Trials Register,True,20
|
625 |
+
25145656,NIPH Clinical Trials Search of Japan,True,6
|
626 |
+
24872560,ClinicalTrials.gov,True,116
|
627 |
+
24872560,EU Clinical Trials Register,True,18
|
628 |
+
24872560,NIPH Clinical Trials Search of Japan,True,3
|
629 |
+
11167602,ClinicalTrials.gov,True,244
|
630 |
+
11167602,EU Clinical Trials Register,True,69
|
631 |
+
11167602,NIPH Clinical Trials Search of Japan,True,22
|
632 |
+
5284443,ClinicalTrials.gov,True,14
|
633 |
+
5284443,EU Clinical Trials Register,True,20
|
634 |
+
5284443,NIPH Clinical Trials Search of Japan,True,2
|
635 |
+
9931953,ClinicalTrials.gov,True,3
|
636 |
+
9931953,EU Clinical Trials Register,True,2
|
637 |
+
60606,ClinicalTrials.gov,True,501
|
638 |
+
60606,EU Clinical Trials Register,True,155
|
639 |
+
60606,NIPH Clinical Trials Search of Japan,True,54
|
640 |
+
637568,ClinicalTrials.gov,True,87
|
641 |
+
637568,EU Clinical Trials Register,True,56
|
642 |
+
157921,ClinicalTrials.gov,True,5
|
643 |
+
157921,EU Clinical Trials Register,True,25
|
644 |
+
4030,ClinicalTrials.gov,True,22
|
645 |
+
4030,EU Clinical Trials Register,True,2
|
646 |
+
5282230,ClinicalTrials.gov,True,13
|
647 |
+
5282230,EU Clinical Trials Register,True,1
|
648 |
+
5282230,NIPH Clinical Trials Search of Japan,True,15
|
649 |
+
123631,ClinicalTrials.gov,True,273
|
650 |
+
123631,EU Clinical Trials Register,True,40
|
651 |
+
123631,NIPH Clinical Trials Search of Japan,True,39
|
652 |
+
445858,NIPH Clinical Trials Search of Japan,True,4
|
653 |
+
2179,ClinicalTrials.gov,True,9
|
654 |
+
2179,EU Clinical Trials Register,True,8
|
655 |
+
71621331,ClinicalTrials.gov,True,18
|
656 |
+
71621331,EU Clinical Trials Register,True,6
|
657 |
+
71621331,NIPH Clinical Trials Search of Japan,True,6
|
658 |
+
25102846,ClinicalTrials.gov,True,41
|
659 |
+
25102846,EU Clinical Trials Register,True,43
|
660 |
+
25102846,NIPH Clinical Trials Search of Japan,True,3
|
661 |
+
5324346,ClinicalTrials.gov,True,50
|
662 |
+
5324346,EU Clinical Trials Register,True,6
|
663 |
+
5324346,NIPH Clinical Trials Search of Japan,True,7
|
664 |
+
9560989,ClinicalTrials.gov,True,6
|
665 |
+
9560989,EU Clinical Trials Register,True,5
|
666 |
+
176870,ClinicalTrials.gov,True,459
|
667 |
+
176870,EU Clinical Trials Register,True,137
|
668 |
+
176870,NIPH Clinical Trials Search of Japan,True,106
|
669 |
+
117947097,ClinicalTrials.gov,True,25
|
670 |
+
117947097,EU Clinical Trials Register,True,9
|
671 |
+
117947097,NIPH Clinical Trials Search of Japan,True,2
|
672 |
+
24776445,ClinicalTrials.gov,True,82
|
673 |
+
24776445,EU Clinical Trials Register,True,21
|
674 |
+
4495,ClinicalTrials.gov,True,6
|
675 |
+
4495,EU Clinical Trials Register,True,3
|
676 |
+
4495,NIPH Clinical Trials Search of Japan,True,1
|
677 |
+
5311180,ClinicalTrials.gov,True,16
|
678 |
+
5311180,EU Clinical Trials Register,True,2
|
679 |
+
5311180,NIPH Clinical Trials Search of Japan,True,10
|
680 |
+
2478,ClinicalTrials.gov,True,443
|
681 |
+
2478,EU Clinical Trials Register,True,48
|
682 |
+
2478,NIPH Clinical Trials Search of Japan,True,33
|
683 |
+
10114,ClinicalTrials.gov,True,5
|
684 |
+
10114,EU Clinical Trials Register,True,1
|
685 |
+
10114,NIPH Clinical Trials Search of Japan,True,1
|
686 |
+
5282451,ClinicalTrials.gov,True,4
|
687 |
+
5282451,EU Clinical Trials Register,True,12
|
688 |
+
5282451,NIPH Clinical Trials Search of Japan,True,1
|
689 |
+
441074,ClinicalTrials.gov,True,17
|
690 |
+
441074,EU Clinical Trials Register,True,1
|
691 |
+
441074,NIPH Clinical Trials Search of Japan,True,1
|
692 |
+
24997615,ClinicalTrials.gov,True,3
|
693 |
+
24997615,EU Clinical Trials Register,True,13
|
694 |
+
78357807,ClinicalTrials.gov,True,15
|
695 |
+
78357807,EU Clinical Trials Register,True,36
|
696 |
+
78357807,NIPH Clinical Trials Search of Japan,True,1
|
697 |
+
5282164,ClinicalTrials.gov,True,3
|
data/trial_conditions_standardized.csv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
data_for_classifier/assoc_drug_organ.tsv
ADDED
@@ -0,0 +1,523 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
drug_organ is_associated_with_indication
|
2 |
+
Flumatinib (mesylate)_CNS/Brain 1
|
3 |
+
Flumatinib (mesylate)_Uterus 1
|
4 |
+
Captopril_CNS/Brain 1
|
5 |
+
Captopril_CNS/Brain 1
|
6 |
+
Captopril_Liver 1
|
7 |
+
Captopril_Liver 1
|
8 |
+
Indacaterol (maleate)_Lung 1
|
9 |
+
Indacaterol (maleate)_Lung 1
|
10 |
+
Indacaterol (maleate)_Lung 1
|
11 |
+
Carbidopa (monohydrate)_Lung 1
|
12 |
+
Carbidopa (monohydrate)_Bowel 1
|
13 |
+
Carbidopa (monohydrate)_Lung 1
|
14 |
+
Carbidopa (monohydrate)_Kidney 1
|
15 |
+
Carbidopa (monohydrate)_Skin 1
|
16 |
+
Carbidopa (monohydrate)_Skin 1
|
17 |
+
Carbidopa (monohydrate)_Skin 1
|
18 |
+
Carbidopa (monohydrate)_Kidney 1
|
19 |
+
Carbidopa (monohydrate)_Kidney 1
|
20 |
+
Carbidopa (monohydrate)_Kidney 1
|
21 |
+
Daidzin_Skin 1
|
22 |
+
Daidzin_Skin 1
|
23 |
+
Daidzin_Skin 1
|
24 |
+
Daidzin_Skin 1
|
25 |
+
Daidzin_Lung 1
|
26 |
+
Daidzin_Lung 1
|
27 |
+
Daidzin_CNS/Brain 1
|
28 |
+
Daidzin_CNS/Brain 1
|
29 |
+
Daidzin_CNS/Brain 1
|
30 |
+
Daidzin_CNS/Brain 1
|
31 |
+
Daidzin_Esophagus/Stomach 1
|
32 |
+
Daidzin_Esophagus/Stomach 1
|
33 |
+
Daidzin_Esophagus/Stomach 1
|
34 |
+
Daidzin_Esophagus/Stomach 1
|
35 |
+
Daidzin_Esophagus/Stomach 1
|
36 |
+
Daidzin_Liver 1
|
37 |
+
Daidzin_Liver 1
|
38 |
+
Daidzin_Skin 1
|
39 |
+
Daidzin_Skin 1
|
40 |
+
Daidzin_Skin 1
|
41 |
+
Daidzin_Skin 1
|
42 |
+
Daidzin_Bowel 1
|
43 |
+
Daidzin_Bowel 1
|
44 |
+
Daidzin_Bowel 1
|
45 |
+
Daidzin_Bowel 1
|
46 |
+
Daidzin_Bowel 1
|
47 |
+
Daidzin_Bowel 1
|
48 |
+
Daidzin_Skin 1
|
49 |
+
Daidzin_Lung 1
|
50 |
+
Daidzin_CNS/Brain 1
|
51 |
+
Daidzin_CNS/Brain 1
|
52 |
+
Daidzin_CNS/Brain 1
|
53 |
+
Daidzin_CNS/Brain 1
|
54 |
+
Daidzin_CNS/Brain 1
|
55 |
+
Daidzin_CNS/Brain 1
|
56 |
+
Daidzin_CNS/Brain 1
|
57 |
+
Daidzin_CNS/Brain 1
|
58 |
+
Daidzin_CNS/Brain 1
|
59 |
+
Daidzin_Lung 1
|
60 |
+
Daidzin_Lung 1
|
61 |
+
Daidzin_Lung 1
|
62 |
+
Daidzin_Kidney 1
|
63 |
+
Daidzin_Kidney 1
|
64 |
+
Daidzin_Kidney 1
|
65 |
+
Zileuton_Liver 1
|
66 |
+
Bestatin_Liver 1
|
67 |
+
Apalutamide_Esophagus/Stomach 1
|
68 |
+
Apalutamide_CNS/Brain 1
|
69 |
+
Apalutamide_Esophagus/Stomach 1
|
70 |
+
Apalutamide_Kidney 1
|
71 |
+
Benproperine (phosphate)_Bowel 1
|
72 |
+
Benproperine (phosphate)_Bowel 1
|
73 |
+
Benproperine (phosphate)_Bowel 1
|
74 |
+
AZD1390_CNS/Brain 1
|
75 |
+
AZD1390_Bladder/Urinary Tract 1
|
76 |
+
AZD1390_Breast 1
|
77 |
+
AZD1390_Breast 1
|
78 |
+
AZD1390_Breast 1
|
79 |
+
AZD1390_Breast 1
|
80 |
+
AZD1390_Lung 1
|
81 |
+
AZD1390_Lung 1
|
82 |
+
AZD1390_Esophagus/Stomach 1
|
83 |
+
AZD1390_Uterus 1
|
84 |
+
AZD1390_Uterus 1
|
85 |
+
AZD1390_Uterus 1
|
86 |
+
AZD1390_Lung 1
|
87 |
+
AZD1390_Skin 1
|
88 |
+
AZD1390_Skin 1
|
89 |
+
AZD1390_Skin 1
|
90 |
+
AZD1390_Skin 1
|
91 |
+
AZD1390_Pancreas 1
|
92 |
+
AZD1390_Esophagus/Stomach 1
|
93 |
+
AZD1390_Bowel 1
|
94 |
+
AZD1390_Uterus 1
|
95 |
+
Elimusertib hydrochloride_Skin 1
|
96 |
+
Elimusertib hydrochloride_Esophagus/Stomach 1
|
97 |
+
venetoclax_Skin 1
|
98 |
+
venetoclax_Skin 1
|
99 |
+
venetoclax_Skin 1
|
100 |
+
venetoclax_Liver 1
|
101 |
+
venetoclax_Liver 1
|
102 |
+
venetoclax_Liver 1
|
103 |
+
venetoclax_Liver 1
|
104 |
+
venetoclax_Liver 1
|
105 |
+
Vemurafenib_Lung 1
|
106 |
+
Vemurafenib_Lung 1
|
107 |
+
Vemurafenib_Lung 1
|
108 |
+
Vemurafenib_Bladder/Urinary Tract 1
|
109 |
+
Vemurafenib_Lung 1
|
110 |
+
Vemurafenib_Lung 1
|
111 |
+
Vemurafenib_Skin 1
|
112 |
+
Vemurafenib_Skin 1
|
113 |
+
Vemurafenib_CNS/Brain 1
|
114 |
+
Vemurafenib_Skin 1
|
115 |
+
Vemurafenib_Skin 1
|
116 |
+
Vemurafenib_Esophagus/Stomach 1
|
117 |
+
Vemurafenib_Skin 1
|
118 |
+
Vemurafenib_Bowel 1
|
119 |
+
Vemurafenib_Uterus 1
|
120 |
+
Tirabrutinib (hydrochloride)_Lung 1
|
121 |
+
Tirabrutinib (hydrochloride)_CNS/Brain 1
|
122 |
+
Dorzolamide (hydrochloride)_Lung 1
|
123 |
+
Dorzolamide (hydrochloride)_Lung 1
|
124 |
+
Dorzolamide (hydrochloride)_Lung 1
|
125 |
+
Cinacalcet_Lung 1
|
126 |
+
Cinacalcet_Lung 1
|
127 |
+
Cinacalcet_Skin 1
|
128 |
+
Pentagastrin_Esophagus/Stomach 1
|
129 |
+
Pentagastrin_Esophagus/Stomach 1
|
130 |
+
Pentagastrin_Esophagus/Stomach 1
|
131 |
+
Ataluren_Esophagus/Stomach 1
|
132 |
+
Ataluren_Esophagus/Stomach 1
|
133 |
+
Ataluren_Uterus 1
|
134 |
+
Ataluren_Uterus 1
|
135 |
+
Ataluren_Bowel 1
|
136 |
+
Abiraterone acetate_Liver 1
|
137 |
+
Abiraterone acetate_Bowel 1
|
138 |
+
Abiraterone acetate_Bowel 1
|
139 |
+
Abiraterone acetate_Kidney 1
|
140 |
+
Abiraterone acetate_Kidney 1
|
141 |
+
Anastrozole_CNS/Brain 1
|
142 |
+
Anastrozole_Lung 1
|
143 |
+
Anastrozole_Lung 1
|
144 |
+
Anastrozole_Breast 1
|
145 |
+
Anastrozole_Breast 1
|
146 |
+
Anastrozole_Breast 1
|
147 |
+
Anastrozole_Breast 1
|
148 |
+
Anastrozole_Breast 1
|
149 |
+
Anastrozole_Breast 1
|
150 |
+
Anastrozole_Breast 1
|
151 |
+
Anastrozole_Breast 1
|
152 |
+
Anastrozole_Skin 1
|
153 |
+
Anastrozole_Skin 1
|
154 |
+
Anastrozole_Liver 1
|
155 |
+
Anastrozole_Liver 1
|
156 |
+
Anastrozole_Uterus 1
|
157 |
+
Anastrozole_Uterus 1
|
158 |
+
Anastrozole_Uterus 1
|
159 |
+
Anastrozole_Uterus 1
|
160 |
+
Anastrozole_Kidney 1
|
161 |
+
Procainamide (hydrochloride)_Liver 1
|
162 |
+
Procainamide (hydrochloride)_Liver 1
|
163 |
+
Procainamide (hydrochloride)_Liver 1
|
164 |
+
Procainamide (hydrochloride)_Liver 1
|
165 |
+
Procainamide (hydrochloride)_Liver 1
|
166 |
+
Procainamide (hydrochloride)_CNS/Brain 1
|
167 |
+
Penfluridol_Esophagus/Stomach 1
|
168 |
+
Penfluridol_CNS/Brain 1
|
169 |
+
Osimertinib (mesylate)_Lung 1
|
170 |
+
Osimertinib (mesylate)_Lung 1
|
171 |
+
Osimertinib (mesylate)_Lung 1
|
172 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
173 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
174 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
175 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
176 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
177 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
178 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
179 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
180 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
181 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
182 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
183 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
184 |
+
Osimertinib (mesylate)_CNS/Brain 1
|
185 |
+
Osimertinib (mesylate)_Bowel 1
|
186 |
+
4EGI-1_Bowel 1
|
187 |
+
Belzutifan_Skin 1
|
188 |
+
Belzutifan_Kidney 1
|
189 |
+
NVP-BHG712_Bowel 1
|
190 |
+
Tucatinib_Lung 1
|
191 |
+
Tucatinib_Lung 1
|
192 |
+
Tucatinib_Bladder/Urinary Tract 1
|
193 |
+
Tucatinib_Lung 1
|
194 |
+
Tucatinib_Lung 1
|
195 |
+
Tucatinib_Skin 1
|
196 |
+
Tucatinib_Esophagus/Stomach 1
|
197 |
+
Tucatinib_Esophagus/Stomach 1
|
198 |
+
Tucatinib_Bowel 1
|
199 |
+
Tucatinib_Bowel 1
|
200 |
+
Tucatinib_Uterus 1
|
201 |
+
Tucatinib_Kidney 1
|
202 |
+
Tucatinib_Kidney 1
|
203 |
+
Fulvestrant_Breast 1
|
204 |
+
Fulvestrant_Breast 1
|
205 |
+
Fulvestrant_Breast 1
|
206 |
+
Fulvestrant_Breast 1
|
207 |
+
Fulvestrant_Breast 1
|
208 |
+
Fulvestrant_Breast 1
|
209 |
+
Fulvestrant_Breast 1
|
210 |
+
Fulvestrant_Breast 1
|
211 |
+
Fulvestrant_Breast 1
|
212 |
+
Fulvestrant_Breast 1
|
213 |
+
Fulvestrant_Breast 1
|
214 |
+
Fulvestrant_Breast 1
|
215 |
+
Fulvestrant_Breast 1
|
216 |
+
Fulvestrant_Breast 1
|
217 |
+
Fulvestrant_Breast 1
|
218 |
+
Fulvestrant_Breast 1
|
219 |
+
Fulvestrant_Breast 1
|
220 |
+
Fulvestrant_Breast 1
|
221 |
+
Fulvestrant_Breast 1
|
222 |
+
Fulvestrant_Breast 1
|
223 |
+
Fulvestrant_Breast 1
|
224 |
+
Fulvestrant_Breast 1
|
225 |
+
Fulvestrant_Breast 1
|
226 |
+
Fulvestrant_Breast 1
|
227 |
+
Fulvestrant_Breast 1
|
228 |
+
Fulvestrant_Breast 1
|
229 |
+
Fulvestrant_Breast 1
|
230 |
+
Fulvestrant_Breast 1
|
231 |
+
Fulvestrant_Breast 1
|
232 |
+
Fulvestrant_Breast 1
|
233 |
+
Fulvestrant_Breast 1
|
234 |
+
Fulvestrant_Breast 1
|
235 |
+
Fulvestrant_Breast 1
|
236 |
+
Fulvestrant_Breast 1
|
237 |
+
Fulvestrant_Breast 1
|
238 |
+
Fulvestrant_Breast 1
|
239 |
+
Fulvestrant_Breast 1
|
240 |
+
Fulvestrant_Breast 1
|
241 |
+
Fulvestrant_Breast 1
|
242 |
+
Fulvestrant_Breast 1
|
243 |
+
Fulvestrant_Breast 1
|
244 |
+
Fulvestrant_Lung 1
|
245 |
+
Fulvestrant_Esophagus/Stomach 1
|
246 |
+
Fulvestrant_Skin 1
|
247 |
+
Fulvestrant_Uterus 1
|
248 |
+
9-ING-41_Liver 1
|
249 |
+
9-ING-41_Liver 1
|
250 |
+
Pitavastatin (Calcium)_CNS/Brain 1
|
251 |
+
ML264_Skin 1
|
252 |
+
ML264_Lung 1
|
253 |
+
ML264_Lung 1
|
254 |
+
ML264_Lung 1
|
255 |
+
ML264_Lung 1
|
256 |
+
ML264_Lung 1
|
257 |
+
ML264_Lung 1
|
258 |
+
ML264_Lung 1
|
259 |
+
ML264_Lung 1
|
260 |
+
ML264_Lung 1
|
261 |
+
ML264_Bladder/Urinary Tract 1
|
262 |
+
ML264_Breast 1
|
263 |
+
ML264_Breast 1
|
264 |
+
ML264_Breast 1
|
265 |
+
ML264_Breast 1
|
266 |
+
ML264_Breast 1
|
267 |
+
ML264_Lung 1
|
268 |
+
ML264_Skin 1
|
269 |
+
ML264_Skin 1
|
270 |
+
ML264_Skin 1
|
271 |
+
ML264_Lung 1
|
272 |
+
ML264_Lung 1
|
273 |
+
ML264_Kidney 1
|
274 |
+
ML264_Liver 1
|
275 |
+
ML264_Pancreas 1
|
276 |
+
ML264_Pancreas 1
|
277 |
+
ML264_Pancreas 1
|
278 |
+
ML264_Pancreas 1
|
279 |
+
ML264_Pancreas 1
|
280 |
+
ML264_Pancreas 1
|
281 |
+
ML264_Bowel 1
|
282 |
+
ML264_Bowel 1
|
283 |
+
ML264_Uterus 1
|
284 |
+
ML264_Uterus 1
|
285 |
+
ML264_Uterus 1
|
286 |
+
ML264_Uterus 1
|
287 |
+
ML264_Kidney 1
|
288 |
+
ML264_Kidney 1
|
289 |
+
Adagrasib_Bowel 1
|
290 |
+
Adagrasib_Bladder/Urinary Tract 1
|
291 |
+
Adagrasib_Lung 1
|
292 |
+
Adagrasib_Lung 1
|
293 |
+
Adagrasib_Lung 1
|
294 |
+
Adagrasib_Skin 1
|
295 |
+
Adagrasib_Skin 1
|
296 |
+
Adagrasib_Esophagus/Stomach 1
|
297 |
+
Adagrasib_Liver 1
|
298 |
+
Adagrasib_Liver 1
|
299 |
+
Adagrasib_Liver 1
|
300 |
+
Adagrasib_Liver 1
|
301 |
+
Adagrasib_Liver 1
|
302 |
+
Adagrasib_Skin 1
|
303 |
+
Adagrasib_Skin 1
|
304 |
+
Adagrasib_Pancreas 1
|
305 |
+
Adagrasib_Pancreas 1
|
306 |
+
Adagrasib_Esophagus/Stomach 1
|
307 |
+
Adagrasib_Bowel 1
|
308 |
+
Adagrasib_Uterus 1
|
309 |
+
Adagrasib_Kidney 1
|
310 |
+
TAK-733_Lung 1
|
311 |
+
TAK-733_Lung 1
|
312 |
+
TAK-733_Skin 1
|
313 |
+
TAK-733_CNS/Brain 1
|
314 |
+
TAK-733_Skin 1
|
315 |
+
TAK-733_Bowel 1
|
316 |
+
OTS514_Lung 1
|
317 |
+
OTS514_Lung 1
|
318 |
+
OTS514_Bowel 1
|
319 |
+
OTS514_Bowel 1
|
320 |
+
OTS514_Liver 1
|
321 |
+
OTS514_Bowel 1
|
322 |
+
OTS514_Bowel 1
|
323 |
+
OTS514_Bowel 1
|
324 |
+
PF-06260933_Lung 1
|
325 |
+
PF-06260933_Lung 1
|
326 |
+
PF-06260933_Lung 1
|
327 |
+
PF-06260933_Lung 1
|
328 |
+
PF-06260933_Bowel 1
|
329 |
+
PF-06260933_CNS/Brain 1
|
330 |
+
PF-06260933_CNS/Brain 1
|
331 |
+
PH-797804_Skin 1
|
332 |
+
Capmatinib_Lung 1
|
333 |
+
Capmatinib_Lung 1
|
334 |
+
Capmatinib_Lung 1
|
335 |
+
Capmatinib_Lung 1
|
336 |
+
Capmatinib_Liver 1
|
337 |
+
Capmatinib_Liver 1
|
338 |
+
Capmatinib_Liver 1
|
339 |
+
Capmatinib_Liver 1
|
340 |
+
Capmatinib_Liver 1
|
341 |
+
AZD-8055_Bowel 1
|
342 |
+
AZD-8055_Uterus 1
|
343 |
+
Dimethyl fumarate_Skin 1
|
344 |
+
Dimethyl fumarate_Skin 1
|
345 |
+
Dimethyl fumarate_Skin 1
|
346 |
+
Dimethyl fumarate_Skin 1
|
347 |
+
Dimethyl fumarate_Skin 1
|
348 |
+
Dimethyl fumarate_Lung 1
|
349 |
+
Dimethyl fumarate_Bladder/Urinary Tract 1
|
350 |
+
Dimethyl fumarate_Lung 1
|
351 |
+
Dimethyl fumarate_Lung 1
|
352 |
+
Dimethyl fumarate_Skin 1
|
353 |
+
Dimethyl fumarate_Esophagus/Stomach 1
|
354 |
+
Dimethyl fumarate_Uterus 1
|
355 |
+
Dimethyl fumarate_Kidney 1
|
356 |
+
Dimethyl fumarate_Kidney 1
|
357 |
+
Budesonide_Lung 1
|
358 |
+
Budesonide_Lung 1
|
359 |
+
Budesonide_Lung 1
|
360 |
+
Budesonide_Lung 1
|
361 |
+
Budesonide_Lung 1
|
362 |
+
Budesonide_Lung 1
|
363 |
+
Budesonide_Liver 1
|
364 |
+
Eplerenone_CNS/Brain 1
|
365 |
+
Eplerenone_CNS/Brain 1
|
366 |
+
Eplerenone_Liver 1
|
367 |
+
Eplerenone_Liver 1
|
368 |
+
Eplerenone_Liver 1
|
369 |
+
Eplerenone_Kidney 1
|
370 |
+
(S)-Crizotinib_CNS/Brain 1
|
371 |
+
(S)-Crizotinib_CNS/Brain 1
|
372 |
+
(S)-Crizotinib_CNS/Brain 1
|
373 |
+
(S)-Crizotinib_CNS/Brain 1
|
374 |
+
Sinomenine_Liver 1
|
375 |
+
Sinomenine_Skin 1
|
376 |
+
Clopidogrel_Bowel 1
|
377 |
+
Clopidogrel_CNS/Brain 1
|
378 |
+
Fingolimod (hydrochloride)_Bowel 1
|
379 |
+
Cilostazol_Skin 1
|
380 |
+
Cilostazol_Lung 1
|
381 |
+
Cilostazol_Lung 1
|
382 |
+
Cilostazol_Lung 1
|
383 |
+
Cilostazol_Lung 1
|
384 |
+
Cilostazol_Lung 1
|
385 |
+
Cilostazol_Liver 1
|
386 |
+
Cilostazol_Liver 1
|
387 |
+
Cilostazol_CNS/Brain 1
|
388 |
+
Medroxyprogesterone acetate_Lung 1
|
389 |
+
Alpelisib_Bowel 1
|
390 |
+
Alpelisib_Bladder/Urinary Tract 1
|
391 |
+
Alpelisib_Lung 1
|
392 |
+
Alpelisib_Lung 1
|
393 |
+
Alpelisib_Lung 1
|
394 |
+
Alpelisib_Skin 1
|
395 |
+
Alpelisib_Esophagus/Stomach 1
|
396 |
+
Alpelisib_CNS/Brain 1
|
397 |
+
Alpelisib_CNS/Brain 1
|
398 |
+
Alpelisib_Skin 1
|
399 |
+
Alpelisib_Pancreas 1
|
400 |
+
Alpelisib_Pancreas 1
|
401 |
+
Alpelisib_Esophagus/Stomach 1
|
402 |
+
Alpelisib_Vulva/Vagina 1
|
403 |
+
Alpelisib_Bowel 1
|
404 |
+
Alpelisib_Uterus 1
|
405 |
+
Alpelisib_Lung 1
|
406 |
+
Pioglitazone_Lung 1
|
407 |
+
Pioglitazone_Lung 1
|
408 |
+
Pioglitazone_Breast 1
|
409 |
+
Pioglitazone_Liver 1
|
410 |
+
Pioglitazone_Liver 1
|
411 |
+
Pioglitazone_Liver 1
|
412 |
+
Pioglitazone_Liver 1
|
413 |
+
Pioglitazone_Liver 1
|
414 |
+
Pioglitazone_Liver 1
|
415 |
+
Pioglitazone_Liver 1
|
416 |
+
Pioglitazone_Liver 1
|
417 |
+
Pioglitazone_Liver 1
|
418 |
+
Pioglitazone_Skin 1
|
419 |
+
Pioglitazone_Liver 1
|
420 |
+
EX229_Bowel 1
|
421 |
+
EX229_Bowel 1
|
422 |
+
EX229_Bowel 1
|
423 |
+
EX229_Bowel 1
|
424 |
+
EX229_Bowel 1
|
425 |
+
EX229_Bowel 1
|
426 |
+
EX229_Kidney 1
|
427 |
+
EX229_CNS/Brain 1
|
428 |
+
EX229_CNS/Brain 1
|
429 |
+
EX229_Skin 1
|
430 |
+
EX229_Skin 1
|
431 |
+
EX229_Esophagus/Stomach 1
|
432 |
+
EX229_Esophagus/Stomach 1
|
433 |
+
EX229_Esophagus/Stomach 1
|
434 |
+
EX229_Esophagus/Stomach 1
|
435 |
+
EX229_Esophagus/Stomach 1
|
436 |
+
EX229_Esophagus/Stomach 1
|
437 |
+
EX229_Esophagus/Stomach 1
|
438 |
+
EX229_Esophagus/Stomach 1
|
439 |
+
EX229_Esophagus/Stomach 1
|
440 |
+
EX229_Esophagus/Stomach 1
|
441 |
+
EX229_Bowel 1
|
442 |
+
EX229_Bowel 1
|
443 |
+
EX229_Bowel 1
|
444 |
+
EX229_Bowel 1
|
445 |
+
EX229_Bowel 1
|
446 |
+
EX229_Lung 1
|
447 |
+
AZD-7648_Skin 1
|
448 |
+
AZD-7648_Liver 1
|
449 |
+
AZD-7648_Bowel 1
|
450 |
+
Pentamidine (isethionate)_CNS/Brain 1
|
451 |
+
Nimesulide_Skin 1
|
452 |
+
Nimesulide_Bowel 1
|
453 |
+
Nimesulide_Kidney 1
|
454 |
+
Nimesulide_Kidney 1
|
455 |
+
Pralsetinib_Lung 1
|
456 |
+
Pralsetinib_Lung 1
|
457 |
+
Pralsetinib_Skin 1
|
458 |
+
LY-2584702 (tosylate salt)_Bowel 1
|
459 |
+
LY-2584702 (tosylate salt)_CNS/Brain 1
|
460 |
+
LY-2584702 (tosylate salt)_Bowel 1
|
461 |
+
LY-2584702 (tosylate salt)_Bowel 1
|
462 |
+
Resveratrol_Liver 1
|
463 |
+
Resveratrol_Kidney 1
|
464 |
+
Fluvoxamine_Lung 1
|
465 |
+
Glasdegib_CNS/Brain 1
|
466 |
+
Glasdegib_CNS/Brain 1
|
467 |
+
Finasteride_Skin 1
|
468 |
+
Finasteride_Breast 1
|
469 |
+
Finasteride_Breast 1
|
470 |
+
Finasteride_Breast 1
|
471 |
+
Finasteride_Breast 1
|
472 |
+
Finasteride_CNS/Brain 1
|
473 |
+
Niclosamide (olamine)_Lung 1
|
474 |
+
Niclosamide (olamine)_Lung 1
|
475 |
+
Niclosamide (olamine)_Lung 1
|
476 |
+
Niclosamide (olamine)_Bowel 1
|
477 |
+
Niclosamide (olamine)_Bowel 1
|
478 |
+
Niclosamide (olamine)_Bowel 1
|
479 |
+
Niclosamide (olamine)_Bowel 1
|
480 |
+
Niclosamide (olamine)_Bowel 1
|
481 |
+
Niclosamide (olamine)_Bowel 1
|
482 |
+
Niclosamide (olamine)_Bowel 1
|
483 |
+
Niclosamide (olamine)_Bowel 1
|
484 |
+
Niclosamide (olamine)_Bowel 1
|
485 |
+
Niclosamide (olamine)_Bowel 1
|
486 |
+
Niclosamide (olamine)_Bowel 1
|
487 |
+
Niclosamide (olamine)_CNS/Brain 1
|
488 |
+
Niclosamide (olamine)_CNS/Brain 1
|
489 |
+
Niclosamide (olamine)_CNS/Brain 1
|
490 |
+
Niclosamide (olamine)_CNS/Brain 1
|
491 |
+
Niclosamide (olamine)_CNS/Brain 1
|
492 |
+
Niclosamide (olamine)_CNS/Brain 1
|
493 |
+
Niclosamide (olamine)_Skin 1
|
494 |
+
Niclosamide (olamine)_Bowel 1
|
495 |
+
Niclosamide (olamine)_Bowel 1
|
496 |
+
Niclosamide (olamine)_Bowel 1
|
497 |
+
Niclosamide (olamine)_Bowel 1
|
498 |
+
Niclosamide (olamine)_Bowel 1
|
499 |
+
Niclosamide (olamine)_Kidney 1
|
500 |
+
Imiquimod (hydrochloride)_Skin 1
|
501 |
+
Irinotecan (hydrochloride)_Skin 1
|
502 |
+
Irinotecan (hydrochloride)_Skin 1
|
503 |
+
Irinotecan (hydrochloride)_Liver 1
|
504 |
+
Irinotecan (hydrochloride)_Liver 1
|
505 |
+
Irinotecan (hydrochloride)_Liver 1
|
506 |
+
Irinotecan (hydrochloride)_Liver 1
|
507 |
+
Irinotecan (hydrochloride)_Liver 1
|
508 |
+
Irinotecan (hydrochloride)_Skin 1
|
509 |
+
Irinotecan (hydrochloride)_Kidney 1
|
510 |
+
Irinotecan (hydrochloride)_Kidney 1
|
511 |
+
Amsacrine_Liver 1
|
512 |
+
Amsacrine_Esophagus/Stomach 1
|
513 |
+
Thymol_Skin 1
|
514 |
+
Thymol_Skin 1
|
515 |
+
Selinexor_Lung 1
|
516 |
+
Selinexor_Lung 1
|
517 |
+
Selinexor_Kidney 1
|
518 |
+
Verteporfin_Liver 1
|
519 |
+
Verteporfin_CNS/Brain 1
|
520 |
+
Verteporfin_CNS/Brain 1
|
521 |
+
Verteporfin_Ovary/Fallopian Tube 1
|
522 |
+
Verteporfin_Ovary/Fallopian Tube 1
|
523 |
+
Verteporfin_Ovary/Fallopian Tube 1
|
data_for_classifier/depmap_dependency_scores.tsv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
data_for_classifier/ldvae_embeddings.tsv
ADDED
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
1 |
+
version https://git-lfs.github.com/spec/v1
|
2 |
+
oid sha256:8cc8fe11d346abc9e2f5d06783355e999206dd2cb6fad5ce3d409f3f9f6bd748
|
3 |
+
size 54661006
|
data_for_classifier/ldvae_raw_embeddings.tsv
ADDED
@@ -0,0 +1,3 @@
|
|
|
|
|
|
|
|
|
1 |
+
version https://git-lfs.github.com/spec/v1
|
2 |
+
oid sha256:deaa9459db1f49e55d614238696581da4d76a116b2ee436af176847014c27850
|
3 |
+
size 50813772
|
data_for_classifier/max_edist.csv
ADDED
The diff for this file is too large to render.
See raw diff
|
|
data_for_classifier/tahoe_drug_ae_seriousness_ratio.csv
ADDED
@@ -0,0 +1,300 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
drug_name,mean_serious_flag
|
2 |
+
5-Azacytidine,1.01
|
3 |
+
5-Fluorouracil,1.13
|
4 |
+
8-Hydroxyquinoline,1.1428571428571428
|
5 |
+
9-ING-41,1.0
|
6 |
+
Abemaciclib,1.34
|
7 |
+
Abiraterone acetate,1.01
|
8 |
+
Acetazolamide,1.09
|
9 |
+
Acetohexamide,1.25
|
10 |
+
Adagrasib,1.032258064516129
|
11 |
+
Adenine,1.12
|
12 |
+
Adenosine,1.14
|
13 |
+
Afatinib,1.03
|
14 |
+
Aliskiren,1.01
|
15 |
+
Allantoin,1.05
|
16 |
+
Allopurinol,1.62
|
17 |
+
Almonertinib (mesylate),1.0
|
18 |
+
Alpelisib,1.42
|
19 |
+
Altretamine,1.1
|
20 |
+
Amsacrine,1.0
|
21 |
+
Anastrozole,1.12
|
22 |
+
Anethole trithione,1.02
|
23 |
+
Apalutamide,1.08
|
24 |
+
Aprepitant,1.01
|
25 |
+
Arbutin,1.0
|
26 |
+
Artemether,1.06
|
27 |
+
Artesunate,1.01
|
28 |
+
Asciminib,1.07
|
29 |
+
Aspirin,1.34
|
30 |
+
Ataluren,1.631578947368421
|
31 |
+
Atazanavir (sulfate),1.05
|
32 |
+
Auranofin,1.1237113402061856
|
33 |
+
Azithromycin (hydrate),1.0169491525423728
|
34 |
+
Baicalin,1.6666666666666667
|
35 |
+
Belinostat,1.02
|
36 |
+
Belumosudil,1.56
|
37 |
+
Belumosudil (mesylate),1.02
|
38 |
+
Belzutifan,1.07
|
39 |
+
Bendamustine,1.03
|
40 |
+
Benproperine (phosphate),1.0357142857142858
|
41 |
+
Benztropine (mesylate),1.3
|
42 |
+
Berbamine,1.1111111111111112
|
43 |
+
Berbamine (dihydrochloride),1.3333333333333333
|
44 |
+
Berberine (chloride hydrate),1.0
|
45 |
+
Bestatin,1.2
|
46 |
+
Betamethasone dipropionate,1.39
|
47 |
+
Bexarotene,1.32
|
48 |
+
Bicalutamide,1.11
|
49 |
+
Bimatoprost,1.14
|
50 |
+
Bimiralisib,1.0
|
51 |
+
Binimetinib,1.03
|
52 |
+
Bisoprolol (hemifumarate),1.0
|
53 |
+
Bortezomib,1.0
|
54 |
+
Bosentan (hydrate),1.0303030303030303
|
55 |
+
Brimonidine,1.95
|
56 |
+
Brivudine,1.01
|
57 |
+
Budesonide,1.03
|
58 |
+
Busulfan,1.01
|
59 |
+
Cabozantinib (S-malate),1.1408450704225352
|
60 |
+
Canagliflozin,1.26
|
61 |
+
Canagliflozin (hemihydrate),1.1764705882352942
|
62 |
+
Capivasertib,1.13
|
63 |
+
Capmatinib,1.21
|
64 |
+
Captopril,1.01
|
65 |
+
Carbamazepine,1.08
|
66 |
+
Carbidopa (monohydrate),1.0434782608695652
|
67 |
+
Celecoxib,1.13
|
68 |
+
Cepharanthine,1.04
|
69 |
+
Chlorhexidine (diacetate),1.2195121951219512
|
70 |
+
Ciclopirox,1.47
|
71 |
+
Cilostazol,1.19
|
72 |
+
Cinacalcet,1.09
|
73 |
+
Citalopram (hydrobromide),1.28
|
74 |
+
Clobetasol propionate,1.38
|
75 |
+
Clofarabine,1.01
|
76 |
+
Clonidine (hydrochloride),1.28
|
77 |
+
Clopidogrel,1.07
|
78 |
+
Clotrimazole,1.2
|
79 |
+
Cloxacillin (sodium),1.08
|
80 |
+
Cobimetinib,1.01
|
81 |
+
Cyclosporin A,1.0
|
82 |
+
Cysteamine (hydrochloride),1.03125
|
83 |
+
Cytarabine,1.0
|
84 |
+
Cytarabine (hydrochloride),1.0
|
85 |
+
Dabrafenib,1.01
|
86 |
+
Dapagliflozin,1.08
|
87 |
+
Daptomycin,1.08
|
88 |
+
Darolutamide,1.3
|
89 |
+
Decitabine,1.04
|
90 |
+
Delamanid,1.0
|
91 |
+
Demeclocycline,1.16
|
92 |
+
Dexamethasone,1.04
|
93 |
+
Dexmedetomidine,1.03
|
94 |
+
Diammonium Glycyrrhizinate,1.0
|
95 |
+
Digitoxin,1.04
|
96 |
+
Dihydroartemisinin,1.0
|
97 |
+
Dimethyl fumarate,1.54
|
98 |
+
Dinaciclib,1.0
|
99 |
+
Diphenhydramine,1.09
|
100 |
+
Docetaxel,1.02
|
101 |
+
Docetaxel (Trihydrate),1.0
|
102 |
+
Dorzolamide (hydrochloride),1.4
|
103 |
+
Doxorubicin (hydrochloride),1.02
|
104 |
+
Doxycycline (monohydrate),1.2
|
105 |
+
Drospirenone,1.26
|
106 |
+
Econazole,1.19
|
107 |
+
Edoxaban (tosylate monohydrate),1.0
|
108 |
+
Elagolix sodium,1.8
|
109 |
+
Encorafenib,1.09
|
110 |
+
Entecavir (monohydrate),1.024390243902439
|
111 |
+
Entrectinib,1.14
|
112 |
+
Epirubicin (hydrochloride),1.01
|
113 |
+
Eplerenone,1.12
|
114 |
+
Erdafitinib,1.33
|
115 |
+
Erlotinib,1.0
|
116 |
+
Erythromycin,1.39
|
117 |
+
Esmolol (hydrochloride),1.11
|
118 |
+
Everolimus,1.05
|
119 |
+
Fenofibrate,1.28
|
120 |
+
Ferulic acid,1.0
|
121 |
+
Filgotinib,1.01
|
122 |
+
Finasteride,1.22
|
123 |
+
Fingolimod (hydrochloride),1.02
|
124 |
+
Flumatinib (mesylate),1.0
|
125 |
+
Flutamide,1.17
|
126 |
+
Fluvoxamine,1.1
|
127 |
+
Fluvoxamine (maleate),1.17
|
128 |
+
Folic acid,1.46
|
129 |
+
Fulvestrant,1.07
|
130 |
+
Fumaric acid,1.08
|
131 |
+
Furosemide,1.52
|
132 |
+
Fusidic acid,1.02
|
133 |
+
Futibatinib,1.088235294117647
|
134 |
+
Gallic acid,2.0
|
135 |
+
Gefitinib,1.02
|
136 |
+
Gemcitabine,1.0
|
137 |
+
Gemfibrozil,1.34
|
138 |
+
Glasdegib,1.02
|
139 |
+
Glycyrrhizic acid,1.01
|
140 |
+
Goserelin (acetate),1.06
|
141 |
+
Harringtonine,1.0
|
142 |
+
Hesperidin,1.06
|
143 |
+
Hexylresorcinol,1.5555555555555556
|
144 |
+
Homoharringtonine,1.0120481927710843
|
145 |
+
Hydroxyurea,1.47
|
146 |
+
Idarubicin (hydrochloride),1.03
|
147 |
+
Idoxuridine,1.3
|
148 |
+
Indacaterol (maleate),1.0
|
149 |
+
Infigratinib,1.0952380952380953
|
150 |
+
Ipatasertib,1.02
|
151 |
+
Irinotecan,1.24
|
152 |
+
Irinotecan (hydrochloride),1.01
|
153 |
+
Ivabradine (hydrochloride),1.01
|
154 |
+
Ivermectin,1.17
|
155 |
+
Ixazomib,1.02
|
156 |
+
Ixazomib citrate,1.0208333333333333
|
157 |
+
LY2090314,1.0
|
158 |
+
Lactate (calcium),1.1
|
159 |
+
Lapatinib ditosylate,1.03
|
160 |
+
Larotrectinib,1.05
|
161 |
+
Larotrectinib sulfate,1.0
|
162 |
+
Lenalidomide (hemihydrate),1.0625
|
163 |
+
Levobupivacaine (hydrochloride),1.0
|
164 |
+
Lidocaine (hydrochloride),1.09
|
165 |
+
Ligustrazine,1.0
|
166 |
+
Lipoic acid,1.24
|
167 |
+
Lonafarnib,1.0392156862745099
|
168 |
+
Loperamide (hydrochloride),1.05
|
169 |
+
Lopinavir,1.02
|
170 |
+
Lumateperone (tosylate),1.0
|
171 |
+
Macitentan,1.05
|
172 |
+
Mebendazole,1.1
|
173 |
+
Medroxyprogesterone acetate,1.31
|
174 |
+
Megestrol,1.16
|
175 |
+
Meloxicam,1.31
|
176 |
+
Menadione,1.36
|
177 |
+
Methotrexate,1.04
|
178 |
+
Methyl aminolevulinate (hydrochloride),1.0
|
179 |
+
Methylprednisolone succinate,1.0810810810810811
|
180 |
+
Methylthiouracil,2.0
|
181 |
+
Mifepristone,1.68
|
182 |
+
Minodronic acid,1.02
|
183 |
+
Mozavaptan,1.0
|
184 |
+
Nafamostat (mesylate),1.041237113402062
|
185 |
+
Naproxen,1.17
|
186 |
+
Neratinib,1.13
|
187 |
+
Neratinib (maleate),1.3333333333333333
|
188 |
+
Nevirapine,1.01
|
189 |
+
Nimesulide,1.0
|
190 |
+
Norepinephrine (hydrochloride),1.03
|
191 |
+
Olanzapine,1.03
|
192 |
+
Oleic acid,1.5357142857142858
|
193 |
+
Omeprazole,1.44
|
194 |
+
Omeprazole (sodium),1.15
|
195 |
+
Orlistat,1.04
|
196 |
+
Ornidazole,1.04
|
197 |
+
Osimertinib (mesylate),1.01
|
198 |
+
Oxaliplatin,1.03
|
199 |
+
Oxaprozin,1.54
|
200 |
+
PH-797804,1.0
|
201 |
+
Paclitaxel,1.02
|
202 |
+
Palmatine (chloride),1.0
|
203 |
+
Panobinostat,1.29
|
204 |
+
Pemetrexed,1.0
|
205 |
+
Pemigatinib,1.75
|
206 |
+
Penfluridol,1.0
|
207 |
+
Pentagastrin,1.0
|
208 |
+
Pentamidine (isethionate),1.08
|
209 |
+
Pentoxifylline,1.22
|
210 |
+
Peretinoin,1.0
|
211 |
+
Perindopril (erbumine),1.02
|
212 |
+
Phenylephrine (hydrochloride),1.19
|
213 |
+
Phenytoin (sodium),1.14
|
214 |
+
Pimitespib,1.0
|
215 |
+
Pimozide,1.08
|
216 |
+
Pioglitazone,1.19
|
217 |
+
Piroxicam,1.09
|
218 |
+
Pitavastatin (Calcium),1.23
|
219 |
+
Ponatinib,1.07
|
220 |
+
Posaconazole,1.04
|
221 |
+
Pralsetinib,1.01
|
222 |
+
Pravastatin (sodium),1.36
|
223 |
+
Procainamide (hydrochloride),1.14
|
224 |
+
Proglumide,1.25
|
225 |
+
Pyridoxine,1.13
|
226 |
+
Pyridoxine (hydrochloride),1.07
|
227 |
+
Quinestrol,1.2
|
228 |
+
Radotinib,1.0
|
229 |
+
Raltitrexed,1.01
|
230 |
+
Ranolazine,1.01
|
231 |
+
Rapamycin,1.11
|
232 |
+
Regorafenib,1.02
|
233 |
+
Relugolix,1.3
|
234 |
+
Resveratrol,1.47
|
235 |
+
Retinoic acid,1.03
|
236 |
+
Ribociclib,1.04
|
237 |
+
Rifaximin,1.01
|
238 |
+
Rimonabant,1.0192307692307692
|
239 |
+
Ritonavir,1.05
|
240 |
+
Ropivacaine (hydrochloride monohydrate),1.0
|
241 |
+
Rosiglitazone,1.02
|
242 |
+
Roxadustat,1.03
|
243 |
+
Sacubitril/Valsartan,1.27
|
244 |
+
Salicylic acid,1.16
|
245 |
+
Sapanisertib,1.0
|
246 |
+
Saquinavir,1.04
|
247 |
+
Selinexor,1.01
|
248 |
+
Sildenafil,1.33
|
249 |
+
Silodosin,1.11
|
250 |
+
Sinomenine,1.0
|
251 |
+
Sivelestat (sodium tetrahydrate),1.0
|
252 |
+
Sodium Salicylate,1.04
|
253 |
+
Sonidegib,1.07
|
254 |
+
Sulfatinib,1.0
|
255 |
+
Sulfisoxazole,1.1978021978021978
|
256 |
+
Sunitinib,1.16
|
257 |
+
Tadalafil,1.05
|
258 |
+
Talc,1.07
|
259 |
+
Tazarotene,1.76
|
260 |
+
Temsirolimus,1.04
|
261 |
+
Temuterkib,1.0
|
262 |
+
Terfenadine,1.2584269662921348
|
263 |
+
Tetracycline (hydrochloride),1.45
|
264 |
+
Thymol,1.14
|
265 |
+
Thymopentin,1.027027027027027
|
266 |
+
Tirabrutinib,1.0208333333333333
|
267 |
+
Tirabrutinib (hydrochloride),1.0
|
268 |
+
Tofacitinib,1.02
|
269 |
+
Tofacitinib (citrate),1.02
|
270 |
+
Tolcapone,1.09
|
271 |
+
Tolmetin,1.59
|
272 |
+
Tomivosertib,1.0
|
273 |
+
Topotecan (hydrochloride),1.01
|
274 |
+
Trametinib,1.0
|
275 |
+
Tranilast,1.0930232558139534
|
276 |
+
Triamcinolone,1.34
|
277 |
+
Triclosan,1.1
|
278 |
+
Trifluridine,1.34
|
279 |
+
Trimetrexate,1.0
|
280 |
+
Tucatinib,1.07
|
281 |
+
Tucidinostat,1.0
|
282 |
+
Uridine,1.2604166666666667
|
283 |
+
Valdecoxib,1.21
|
284 |
+
Vandetanib,1.02
|
285 |
+
Vemurafenib,1.06
|
286 |
+
Verapamil,1.35
|
287 |
+
Verteporfin,1.05
|
288 |
+
Vilanterol,1.06
|
289 |
+
Vinblastine (sulfate),1.06
|
290 |
+
Vismodegib,1.02
|
291 |
+
Vitamin K4,1.3333333333333333
|
292 |
+
Volasertib,1.0
|
293 |
+
Voriconazole,1.08
|
294 |
+
Vortioxetine,1.64
|
295 |
+
Zileuton,1.62
|
296 |
+
crizotinib,1.12
|
297 |
+
olaparib,1.17
|
298 |
+
palbociclib,1.08
|
299 |
+
venetoclax,1.0
|
300 |
+
vincristine,1.01
|
data_for_classifier/tahoe_drug_ae_severity_score.csv
ADDED
@@ -0,0 +1,300 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
+
drug_name,ae_severity_score
|
2 |
+
5-Azacytidine,371
|
3 |
+
5-Fluorouracil,285
|
4 |
+
8-Hydroxyquinoline,54
|
5 |
+
9-ING-41,8
|
6 |
+
Abemaciclib,275
|
7 |
+
Abiraterone acetate,250
|
8 |
+
Acetazolamide,218
|
9 |
+
Acetohexamide,11
|
10 |
+
Adagrasib,2380
|
11 |
+
Adenine,417
|
12 |
+
Adenosine,257
|
13 |
+
Afatinib,306
|
14 |
+
Aliskiren,310
|
15 |
+
Allantoin,1400
|
16 |
+
Allopurinol,55
|
17 |
+
Almonertinib (mesylate),57
|
18 |
+
Alpelisib,341
|
19 |
+
Altretamine,238
|
20 |
+
Amsacrine,431
|
21 |
+
Anastrozole,186
|
22 |
+
Anethole trithione,478
|
23 |
+
Apalutamide,301
|
24 |
+
Aprepitant,320
|
25 |
+
Arbutin,200
|
26 |
+
Artemether,570
|
27 |
+
Artesunate,289
|
28 |
+
Asciminib,1653
|
29 |
+
Aspirin,167
|
30 |
+
Ataluren,273
|
31 |
+
Atazanavir (sulfate),136
|
32 |
+
Auranofin,326
|
33 |
+
Azithromycin (hydrate),171
|
34 |
+
Baicalin,34
|
35 |
+
Belinostat,1895
|
36 |
+
Belumosudil,2846
|
37 |
+
Belumosudil (mesylate),2785
|
38 |
+
Belzutifan,2537
|
39 |
+
Bendamustine,340
|
40 |
+
Benproperine (phosphate),604
|
41 |
+
Benztropine (mesylate),284
|
42 |
+
Berbamine,47
|
43 |
+
Berbamine (dihydrochloride),30
|
44 |
+
Berberine (chloride hydrate),50
|
45 |
+
Bestatin,151
|
46 |
+
Betamethasone dipropionate,171
|
47 |
+
Bexarotene,175
|
48 |
+
Bicalutamide,237
|
49 |
+
Bimatoprost,202
|
50 |
+
Bimiralisib,38
|
51 |
+
Binimetinib,416
|
52 |
+
Bisoprolol (hemifumarate),270
|
53 |
+
Bortezomib,208
|
54 |
+
Bosentan (hydrate),117
|
55 |
+
Brimonidine,6
|
56 |
+
Brivudine,1301
|
57 |
+
Budesonide,250
|
58 |
+
Busulfan,242
|
59 |
+
Cabozantinib (S-malate),1570
|
60 |
+
Canagliflozin,183
|
61 |
+
Canagliflozin (hemihydrate),144
|
62 |
+
Capivasertib,2569
|
63 |
+
Capmatinib,1138
|
64 |
+
Captopril,293
|
65 |
+
Carbamazepine,199
|
66 |
+
Carbidopa (monohydrate),396
|
67 |
+
Celecoxib,255
|
68 |
+
Cepharanthine,879
|
69 |
+
Chlorhexidine (diacetate),448
|
70 |
+
Ciclopirox,109
|
71 |
+
Cilostazol,249
|
72 |
+
Cinacalcet,308
|
73 |
+
Citalopram (hydrobromide),230
|
74 |
+
Clobetasol propionate,201
|
75 |
+
Clofarabine,435
|
76 |
+
Clonidine (hydrochloride),168
|
77 |
+
Clopidogrel,168
|
78 |
+
Clotrimazole,171
|
79 |
+
Cloxacillin (sodium),1007
|
80 |
+
Cobimetinib,280
|
81 |
+
Cyclosporin A,260
|
82 |
+
Cysteamine (hydrochloride),770
|
83 |
+
Cytarabine,309
|
84 |
+
Cytarabine (hydrochloride),247
|
85 |
+
Dabrafenib,221
|
86 |
+
Dapagliflozin,264
|
87 |
+
Daptomycin,369
|
88 |
+
Darolutamide,2187
|
89 |
+
Decitabine,320
|
90 |
+
Delamanid,441
|
91 |
+
Demeclocycline,380
|
92 |
+
Dexamethasone,304
|
93 |
+
Dexmedetomidine,260
|
94 |
+
Diammonium Glycyrrhizinate,688
|
95 |
+
Digitoxin,315
|
96 |
+
Dihydroartemisinin,30
|
97 |
+
Dimethyl fumarate,107
|
98 |
+
Dinaciclib,128
|
99 |
+
Diphenhydramine,319
|
100 |
+
Docetaxel,265
|
101 |
+
Docetaxel (Trihydrate),19
|
102 |
+
Dorzolamide (hydrochloride),93
|
103 |
+
Doxorubicin (hydrochloride),280
|
104 |
+
Doxycycline (monohydrate),128
|
105 |
+
Drospirenone,148
|
106 |
+
Econazole,287
|
107 |
+
Edoxaban (tosylate monohydrate),30
|
108 |
+
Elagolix sodium,1969
|
109 |
+
Encorafenib,584
|
110 |
+
Entecavir (monohydrate),271
|
111 |
+
Entrectinib,541
|
112 |
+
Epirubicin (hydrochloride),273
|
113 |
+
Eplerenone,245
|
114 |
+
Erdafitinib,268
|
115 |
+
Erlotinib,384
|
116 |
+
Erythromycin,134
|
117 |
+
Esmolol (hydrochloride),1364
|
118 |
+
Everolimus,315
|
119 |
+
Fenofibrate,196
|
120 |
+
Ferulic acid,160
|
121 |
+
Filgotinib,1563
|
122 |
+
Finasteride,180
|
123 |
+
Fingolimod (hydrochloride),684
|
124 |
+
Flumatinib (mesylate),115
|
125 |
+
Flutamide,228
|
126 |
+
Fluvoxamine,221
|
127 |
+
Fluvoxamine (maleate),247
|
128 |
+
Folic acid,134
|
129 |
+
Fulvestrant,253
|
130 |
+
Fumaric acid,996
|
131 |
+
Furosemide,128
|
132 |
+
Fusidic acid,156
|
133 |
+
Futibatinib,538
|
134 |
+
Gallic acid,30
|
135 |
+
Gefitinib,170
|
136 |
+
Gemcitabine,319
|
137 |
+
Gemfibrozil,156
|
138 |
+
Glasdegib,449
|
139 |
+
Glycyrrhizic acid,410
|
140 |
+
Goserelin (acetate),309
|
141 |
+
Harringtonine,0
|
142 |
+
Hesperidin,245
|
143 |
+
Hexylresorcinol,148
|
144 |
+
Homoharringtonine,193
|
145 |
+
Hydroxyurea,151
|
146 |
+
Idarubicin (hydrochloride),309
|
147 |
+
Idoxuridine,48
|
148 |
+
Indacaterol (maleate),503
|
149 |
+
Infigratinib,474
|
150 |
+
Ipatasertib,1090
|
151 |
+
Irinotecan,173
|
152 |
+
Irinotecan (hydrochloride),263
|
153 |
+
Ivabradine (hydrochloride),555
|
154 |
+
Ivermectin,332
|
155 |
+
Ixazomib,351
|
156 |
+
Ixazomib citrate,1591
|
157 |
+
LY2090314,6
|
158 |
+
Lactate (calcium),1416
|
159 |
+
Lapatinib ditosylate,614
|
160 |
+
Larotrectinib,1324
|
161 |
+
Larotrectinib sulfate,66
|
162 |
+
Lenalidomide (hemihydrate),431
|
163 |
+
Levobupivacaine (hydrochloride),1593
|
164 |
+
Lidocaine (hydrochloride),216
|
165 |
+
Ligustrazine,279
|
166 |
+
Lipoic acid,147
|
167 |
+
Lonafarnib,341
|
168 |
+
Loperamide (hydrochloride),297
|
169 |
+
Lopinavir,236
|
170 |
+
Lumateperone (tosylate),30
|
171 |
+
Macitentan,341
|
172 |
+
Mebendazole,188
|
173 |
+
Medroxyprogesterone acetate,142
|
174 |
+
Megestrol,259
|
175 |
+
Meloxicam,142
|
176 |
+
Menadione,355
|
177 |
+
Methotrexate,243
|
178 |
+
Methyl aminolevulinate (hydrochloride),79
|
179 |
+
Methylprednisolone succinate,146
|
180 |
+
Methylthiouracil,0
|
181 |
+
Mifepristone,85
|
182 |
+
Minodronic acid,570
|
183 |
+
Mozavaptan,11
|
184 |
+
Nafamostat (mesylate),1758
|
185 |
+
Naproxen,206
|
186 |
+
Neratinib,917
|
187 |
+
Neratinib (maleate),87
|
188 |
+
Nevirapine,277
|
189 |
+
Nimesulide,223
|
190 |
+
Norepinephrine (hydrochloride),2095
|
191 |
+
Olanzapine,283
|
192 |
+
Oleic acid,176
|
193 |
+
Omeprazole,153
|
194 |
+
Omeprazole (sodium),232
|
195 |
+
Orlistat,179
|
196 |
+
Ornidazole,488
|
197 |
+
Osimertinib (mesylate),1337
|
198 |
+
Oxaliplatin,240
|
199 |
+
Oxaprozin,62
|
200 |
+
PH-797804,9
|
201 |
+
Paclitaxel,268
|
202 |
+
Palmatine (chloride),0
|
203 |
+
Panobinostat,230
|
204 |
+
Pemetrexed,312
|
205 |
+
Pemigatinib,2744
|
206 |
+
Penfluridol,116
|
207 |
+
Pentagastrin,0
|
208 |
+
Pentamidine (isethionate),371
|
209 |
+
Pentoxifylline,202
|
210 |
+
Peretinoin,3
|
211 |
+
Perindopril (erbumine),217
|
212 |
+
Phenylephrine (hydrochloride),305
|
213 |
+
Phenytoin (sodium),248
|
214 |
+
Pimitespib,27
|
215 |
+
Pimozide,303
|
216 |
+
Pioglitazone,290
|
217 |
+
Piroxicam,144
|
218 |
+
Pitavastatin (Calcium),189
|
219 |
+
Ponatinib,309
|
220 |
+
Posaconazole,393
|
221 |
+
Pralsetinib,1882
|
222 |
+
Pravastatin (sodium),162
|
223 |
+
Procainamide (hydrochloride),1430
|
224 |
+
Proglumide,33
|
225 |
+
Pyridoxine,342
|
226 |
+
Pyridoxine (hydrochloride),274
|
227 |
+
Quinestrol,35
|
228 |
+
Radotinib,36
|
229 |
+
Raltitrexed,220
|
230 |
+
Ranolazine,211
|
231 |
+
Rapamycin,253
|
232 |
+
Regorafenib,351
|
233 |
+
Relugolix,2417
|
234 |
+
Resveratrol,113
|
235 |
+
Retinoic acid,138
|
236 |
+
Ribociclib,370
|
237 |
+
Rifaximin,395
|
238 |
+
Rimonabant,127
|
239 |
+
Ritonavir,291
|
240 |
+
Ropivacaine (hydrochloride monohydrate),60
|
241 |
+
Rosiglitazone,333
|
242 |
+
Roxadustat,2174
|
243 |
+
Sacubitril/Valsartan,460
|
244 |
+
Salicylic acid,284
|
245 |
+
Sapanisertib,93
|
246 |
+
Saquinavir,161
|
247 |
+
Selinexor,480
|
248 |
+
Sildenafil,258
|
249 |
+
Silodosin,289
|
250 |
+
Sinomenine,0
|
251 |
+
Sivelestat (sodium tetrahydrate),95
|
252 |
+
Sodium Salicylate,1260
|
253 |
+
Sonidegib,373
|
254 |
+
Sulfatinib,3
|
255 |
+
Sulfisoxazole,252
|
256 |
+
Sunitinib,268
|
257 |
+
Tadalafil,331
|
258 |
+
Talc,274
|
259 |
+
Tazarotene,131
|
260 |
+
Temsirolimus,303
|
261 |
+
Temuterkib,27
|
262 |
+
Terfenadine,670
|
263 |
+
Tetracycline (hydrochloride),388
|
264 |
+
Thymol,1049
|
265 |
+
Thymopentin,630
|
266 |
+
Tirabrutinib,776
|
267 |
+
Tirabrutinib (hydrochloride),196
|
268 |
+
Tofacitinib,347
|
269 |
+
Tofacitinib (citrate),371
|
270 |
+
Tolcapone,770
|
271 |
+
Tolmetin,464
|
272 |
+
Tomivosertib,0
|
273 |
+
Topotecan (hydrochloride),300
|
274 |
+
Trametinib,291
|
275 |
+
Tranilast,980
|
276 |
+
Triamcinolone,129
|
277 |
+
Triclosan,1232
|
278 |
+
Trifluridine,238
|
279 |
+
Trimetrexate,6
|
280 |
+
Tucatinib,641
|
281 |
+
Tucidinostat,2775
|
282 |
+
Uridine,1535
|
283 |
+
Valdecoxib,335
|
284 |
+
Vandetanib,196
|
285 |
+
Vemurafenib,173
|
286 |
+
Verapamil,172
|
287 |
+
Verteporfin,254
|
288 |
+
Vilanterol,481
|
289 |
+
Vinblastine (sulfate),290
|
290 |
+
Vismodegib,350
|
291 |
+
Vitamin K4,34
|
292 |
+
Volasertib,53
|
293 |
+
Voriconazole,320
|
294 |
+
Vortioxetine,44
|
295 |
+
Zileuton,1066
|
296 |
+
crizotinib,333
|
297 |
+
olaparib,239
|
298 |
+
palbociclib,283
|
299 |
+
venetoclax,378
|
300 |
+
vincristine,262
|
data_for_classifier/tahoe_largest_edist_per_drug_cell_line_combo.csv
ADDED
The diff for this file is too large to render.
See raw diff
|
|